data_2k9f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k9f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 m -125.39 61.85 37.24 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 112.043 0.386 . . . . 10.0 112.043 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.28 -38.34 12.14 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.932 1.755 . . . . 10.0 111.857 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -62.61 -43.69 98.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.871 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -42.79 95.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.626 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -61.87 -30.3 70.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.034 0.445 . . . . 10.0 110.703 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 m -84.12 -7.14 59.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.187 -0.46 . . . . 10.0 111.456 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -91.24 -8.15 49.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.14 0.495 . . . . 10.0 109.907 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.25 110.7 2.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.418 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.47 140.61 30.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.736 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.2 p -81.2 174.06 11.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.324 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.53 -10.86 58.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.239 0.542 . . . . 10.0 110.135 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -91.95 -4.55 54.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.194 -0.912 . . . . 10.0 109.421 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 79.68 9.98 1.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.067 -0.97 . . . . 10.0 111.836 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 mtt85 -94.64 144.79 28.5 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 10.0 109.998 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.78 148.93 78.16 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.242 1.962 . . . . 10.0 111.387 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.79 -8.52 15.38 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -24.04 52.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.795 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.2 m -61.53 -21.03 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.039 0.447 . . . . 10.0 111.709 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -131.34 23.66 4.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.257 0.551 . . . . 10.0 110.42 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.7 mt -135.33 56.07 1.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.451 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -155.94 -179.71 8.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.36 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 mttp 69.67 14.8 8.16 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.891 0.7 . . . . 10.0 112.891 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.78 39.18 29.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.013 0.435 . . . . 10.0 111.054 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -107.96 145.29 31.1 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.153 -0.476 . . . . 10.0 111.176 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.17 143.74 94.83 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.687 2.258 . . . . 10.0 111.543 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -116.41 143.49 45.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.664 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.3 tp -124.01 105.7 9.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.97 0.414 . . . . 10.0 110.047 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.44 117.52 37.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.867 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HZ1' ' CD ' ' A' ' 42' ' ' GLU . 17.4 ttpt -112.61 119.98 40.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.818 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -88.7 146.92 24.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.569 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -148.94 166.98 26.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.859 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.28 142.81 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.627 -0.509 . . . . 10.0 109.627 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -67.44 -63.85 0.98 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.5 64.16 4.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.494 0.553 . . . . 10.0 112.494 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.6 t -131.94 135.62 26.94 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.076 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.45 -49.54 3.33 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.517 2.145 . . . . 10.0 112.344 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.17 -44.26 95.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.239 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.9 m -66.33 -31.16 71.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 10.0 111.389 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -62.86 -46.78 86.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.99 -38.68 79.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.93 0.395 . . . . 10.0 110.676 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.456 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 1.2 tm-20 -66.88 -24.74 66.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.859 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.1 mt -55.27 -44.56 75.74 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.822 0.344 . . . . 10.0 111.416 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.48 -33.42 81.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.577 -0.821 . . . . 10.0 111.128 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -68.85 -40.01 79.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.355 -0.423 . . . . 10.0 110.662 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.4 m -55.19 -47.55 75.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.424 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.86 -44.14 86.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.061 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -60.63 -44.49 96.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.03 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -71.35 -37.89 71.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 10.0 111.698 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.91 -22.08 66.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.041 0.448 . . . . 10.0 111.234 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -88.55 -6.69 57.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.629 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.2 135.5 50.69 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.769 0.319 . . . . 10.0 110.369 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.42 -33.93 68.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.925 -0.579 . . . . 10.0 112.214 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -73.53 -37.75 65.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.968 0.413 . . . . 10.0 110.919 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -78.21 -10.32 59.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.925 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m -75.64 5.36 6.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.913 0.387 . . . . 10.0 111.53 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -87.04 -15.22 39.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.047 0.451 . . . . 10.0 110.52 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.44 148.4 51.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 10.0 109.814 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -82.87 88.19 6.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.763 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.48 121.54 26.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.542 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.2 pt -133.73 157.62 42.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.991 0.424 . . . . 10.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.83 117.55 33.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.166 -0.47 . . . . 10.0 109.811 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.96 143.35 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.863 0.364 . . . . 10.0 111.337 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.39 146.76 38.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -104.17 100.9 23.28 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.75 118.51 5.41 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.758 2.305 . . . . 10.0 112.067 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.88 -12.71 67.01 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.965 -0.636 . . . . 10.0 112.539 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -96.92 144.43 26.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.158 -0.312 . . . . 10.0 110.158 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 60.4 30.41 19.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.737 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t60 66.37 19.0 10.97 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.653 -0.703 . . . . 10.0 112.811 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -77.6 -175.58 3.91 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -65.45 127.89 33.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.795 0.331 . . . . 10.0 111.039 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -66.46 163.41 18.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.961 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.96 125.62 24.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.549 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.97 -17.32 35.38 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -107.23 -41.68 5.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.029 0.442 . . . . 10.0 109.867 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -62.62 -50.92 69.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.594 . . . . 10.0 112.496 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.91 -28.07 69.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.047 0.451 . . . . 10.0 110.687 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -75.55 -30.69 59.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.681 -0.691 . . . . 10.0 109.911 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -65.25 -50.04 67.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.526 -0.761 . . . . 10.0 109.499 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -63.89 -30.02 71.15 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.079 -0.51 . . . . 10.0 111.107 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.46 -24.1 67.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.178 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.14 8.15 41.51 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.105 -0.569 . . . . 10.0 111.98 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 mt -95.19 -179.65 4.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.797 0.332 . . . . 10.0 110.879 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -97.93 -178.48 4.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.678 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 66.97 84.06 0.17 Allowed Pre-proline 0 N--CA 1.464 0.269 0 O-C-N 123.647 0.592 . . . . 10.0 112.053 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.1 37.96 0.72 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.633 2.222 . . . . 10.0 111.663 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -150.02 25.08 0.83 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.694 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -93.36 117.9 67.51 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.545 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.56 66.97 5.59 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.745 2.297 . . . . 10.0 111.489 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.08 117.91 31.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.772 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.3 t -103.2 142.45 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.64 106.4 17.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.123 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -93.48 91.35 7.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.243 0.545 . . . . 10.0 110.267 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.03 113.72 4.67 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.22 -24.64 26.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.857 -0.687 . . . . 10.0 113.06 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.81 44.15 3.98 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.513 -0.851 . . . . 10.0 111.413 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -33.72 74.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 10.0 110.627 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.2 mm -92.27 -43.45 13.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.224 -0.444 . . . . 10.0 109.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.51 -44.95 95.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.688 -0.687 . . . . 10.0 112.394 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -68.15 -40.77 82.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.9 m -66.54 -22.12 66.16 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.57 5.06 24.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.464 -0.334 . . . . 10.0 110.669 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.3 t30 52.37 50.08 19.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.665 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 98.3 mt -75.26 109.38 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.258 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.4 p -115.59 -10.32 11.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.586 -0.733 . . . . 10.0 112.025 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.14 142.1 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.562 0.22 . . . . 10.0 111.293 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -107.24 153.99 40.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.653 -0.499 . . . . 10.0 109.653 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.07 159.16 83.63 Favored 'Cis proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.339 -1.525 . . . . 10.0 112.058 -0.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 m -122.18 124.3 43.53 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -108.76 104.2 13.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.02 0.438 . . . . 10.0 110.898 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.47 29.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.164 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.0 tp -95.69 112.62 24.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.584 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.5 127.25 51.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.3 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.79 171.98 29.66 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 116.016 -0.538 . . . . 10.0 112.618 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -65.58 -14.42 61.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.256 0.465 . . . . 10.0 112.256 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.24 0.95 57.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 10.0 111.87 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.89 37.74 15.41 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.82 -0.705 . . . . 10.0 113.191 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -132.99 146.96 52.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.785 -0.244 . . . . 10.0 110.666 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.6 111.48 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.098 -0.334 . . . . 10.0 110.098 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -96.44 -35.87 11.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.357 -0.383 . . . . 10.0 111.512 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.35 150.27 40.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.628 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 tp -144.21 116.94 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 t -119.48 130.76 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.844 0.354 . . . . 10.0 111.637 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -101.96 107.23 18.31 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.158 -0.682 . . . . 10.0 109.158 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.42 -141.93 11.92 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.488 -0.645 . . . . 10.0 111.488 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.7 m -119.5 147.22 44.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.84 0.352 . . . . 10.0 111.066 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.9 pt -104.72 176.57 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.264 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -146.6 171.67 14.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.443 -0.344 . . . . 10.0 110.57 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -61.53 -46.88 88.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.932 0.345 . . . . 10.0 111.932 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.65 88.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 10.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -66.8 -39.19 87.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.351 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.64 -42.88 99.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 10.0 109.75 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.75 -35.92 82.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.603 . . . . 10.0 110.41 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.7 -39.29 88.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 10.0 109.975 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -64.38 -36.32 83.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.585 -0.734 . . . . 10.0 110.523 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.2 mt -67.11 -29.44 46.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.022 -0.536 . . . . 10.0 109.763 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -83.38 -50.34 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.793 -0.64 . . . . 10.0 111.246 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -144.43 120.67 6.24 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.8 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.24 -6.29 18.88 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.004 2.469 . . . . 10.0 112.707 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -94.11 -3.15 51.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.925 0.393 . . . . 10.0 110.897 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.13 73.44 6.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.526 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -74.2 155.43 38.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.25 -0.881 . . . . 10.0 111.513 -179.522 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.438 ' H3 ' ' CG ' ' B' ' 4' ' ' ASP . 58.6 mtt . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 112.203 0.446 . . . . 10.0 112.203 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.3 -10.14 45.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 25.2 tp -142.41 -77.92 0.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.126 -0.23 . . . . 10.0 111.143 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . 0.438 ' CG ' ' H3 ' ' B' ' 1' ' ' MET . 25.2 m-20 57.71 39.09 27.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.827 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.13 166.3 31.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.793 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.3 m120 68.4 -172.32 0.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.776 0.673 . . . . 10.0 111.865 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -99.69 13.9 32.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.36 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.43 -13.94 59.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.446 0.535 . . . . 10.0 112.446 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.08 133.27 23.44 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.673 0.273 . . . . 10.0 111.734 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.4 151.41 85.63 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 123.097 2.532 . . . . 10.0 112.453 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.86 -33.75 72.84 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.746 2.964 . . . . 10.0 113.707 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -55.75 -28.15 54.44 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.38 -11.4 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 10.0 111.075 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.01 -7.61 54.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.275 -0.421 . . . . 10.0 111.932 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -122.19 129.84 52.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.944 0.402 . . . . 10.0 111.364 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.16 92.06 25.41 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.13 102.0 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.5 2.133 . . . . 10.0 113.428 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -95.81 110.56 22.71 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -92.57 120.55 33.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.477 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.26 100.8 8.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.614 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.11 118.29 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.194 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.67 -170.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 10.0 110.347 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.65 -22.32 20.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.009 0.433 . . . . 10.0 111.608 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -86.73 -39.23 16.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.156 0.503 . . . . 10.0 110.272 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.91 -171.4 36.89 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.663 -0.699 . . . . 10.0 111.629 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -107.75 129.59 61.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.338 -0.616 . . . . 10.0 109.338 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -115.89 117.98 31.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.813 0.339 . . . . 10.0 110.186 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.88 118.02 48.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.277 0.56 . . . . 10.0 110.553 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -121.63 90.96 3.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.545 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -94.2 119.18 32.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.204 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 62.4 mtm-85 -77.0 118.38 19.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.232 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.06 136.49 24.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.354 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 146.07 51.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.403 -0.362 . . . . 10.0 110.284 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.21 92.76 0.57 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.991 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.49 -16.71 1.12 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.404 -0.678 . . . . 10.0 111.404 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -105.78 151.95 23.83 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -143.98 139.9 29.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.945 0.402 . . . . 10.0 111.191 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 43.8 mtt -110.41 150.5 28.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.99 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -92.09 116.52 29.0 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.77 -0.456 . . . . 10.0 109.77 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -61.32 -23.02 65.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.208 0.528 . . . . 10.0 111.331 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.8 -6.82 59.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.522 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -123.8 0.05 8.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.494 -0.321 . . . . 10.0 111.631 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 92.9 mt -78.87 117.77 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.024 0.44 . . . . 10.0 109.817 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.56 123.41 52.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.826 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -153.81 120.57 1.05 Allowed Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.643 -0.789 . . . . 10.0 111.995 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -160.46 140.47 11.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.808 0.337 . . . . 10.0 111.015 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 11.6 t -139.72 126.23 20.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.134 -0.484 . . . . 10.0 109.893 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -174.56 158.36 2.45 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.426 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -74.26 -66.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.256 1.97 . . . . 10.0 111.072 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.64 53.79 1.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.129 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.45 51.0 6.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.608 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.18 43.58 1.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.8 -0.637 . . . . 10.0 110.422 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 18.6 tp -107.45 144.64 34.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.092 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.63 -66.72 1.89 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.418 -0.896 . . . . 10.0 111.284 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -171.63 149.7 2.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 122.596 0.358 . . . . 10.0 110.179 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.81 106.47 1.86 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.495 2.13 . . . . 10.0 110.434 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -86.67 99.58 11.85 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.061 0.458 . . . . 10.0 111.376 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -84.59 157.91 21.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.799 -0.637 . . . . 10.0 110.352 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 50.2 m -86.72 -20.4 27.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.645 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? 70.57 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.711 -0.677 . . . . 10.0 112.292 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.87 -127.8 6.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.21 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -116.69 158.88 23.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.624 0.249 . . . . 10.0 110.873 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.24 132.81 34.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -114.47 127.01 55.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.508 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.88 149.56 46.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.548 -0.908 . . . . 10.0 108.548 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -146.56 171.02 15.72 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.935 -0.306 . . . . 10.0 111.382 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.98 -23.55 14.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.284 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -114.76 -40.74 3.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.887 0.375 . . . . 10.0 110.949 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -87.68 -6.13 58.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.185 -0.462 . . . . 10.0 111.616 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.7 -73.55 2.07 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 121.105 -0.569 . . . . 10.0 112.16 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -173.92 122.89 0.33 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.862 0.465 . . . . 10.0 109.968 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -139.88 162.98 33.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.438 -0.346 . . . . 10.0 110.545 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -74.28 127.2 32.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.96 159.75 38.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.354 0.597 . . . . 10.0 112.091 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -114.5 127.33 55.76 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.404 -1.332 . . . . 10.0 107.404 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -113.58 -3.79 13.58 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -173.89 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.599 . . . . 10.0 109.472 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -91.19 126.41 36.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.774 -1.103 . . . . 10.0 109.712 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -153.42 112.87 3.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.889 0.376 . . . . 10.0 111.173 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -145.94 119.41 9.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.381 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -127.87 120.95 55.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.069 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.19 134.57 44.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.66 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -113.81 98.91 48.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.092 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.14 127.96 3.54 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.949 2.433 . . . . 10.0 111.782 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -74.04 148.29 42.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.881 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.66 -5.19 32.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.465 0.65 . . . . 10.0 109.754 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -134.95 129.48 34.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.166 -0.925 . . . . 10.0 108.785 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.9 80.41 4.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.237 0.542 . . . . 10.0 111.307 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 4.1 m -128.4 143.26 41.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.557 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.19 54.04 4.67 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.336 -0.706 . . . . 10.0 111.336 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -105.78 153.84 39.74 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.68 -0.26 . . . . 10.0 110.47 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.7 141.91 42.52 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.44 2.093 . . . . 10.0 110.436 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -132.57 154.14 50.31 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.232 0.456 . . . . 10.0 112.232 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -98.25 150.83 21.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 10.0 109.658 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.97 114.32 22.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.584 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 42.0 t -104.19 114.82 44.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.058 -0.519 . . . . 10.0 109.987 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 93.0 mt -125.1 136.77 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.402 . . . . 10.0 111.154 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 19.1 m -133.69 118.04 17.67 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.132 -0.485 . . . . 10.0 109.839 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -98.62 109.38 22.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.462 -0.335 . . . . 10.0 111.335 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.94 128.87 50.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.444 -0.344 . . . . 10.0 110.945 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.49 -155.64 12.58 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.851 -0.69 . . . . 10.0 111.617 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 73.5 m -155.56 176.99 11.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.3 -0.259 . . . . 10.0 110.3 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -116.98 145.03 43.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.89 -10.68 22.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.442 0.534 . . . . 10.0 112.442 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.45 -0.76 55.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.517 -0.31 . . . . 10.0 111.785 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.7 20.63 23.8 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.669 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 4.6 t -103.27 136.73 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.436 -0.579 . . . . 10.0 109.436 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 17.4 t -122.57 97.97 5.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.683 0.277 . . . . 10.0 110.767 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -84.23 143.94 43.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.859 0.361 . . . . 10.0 111.361 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.31 163.64 33.67 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.586 2.191 . . . . 10.0 111.241 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -75.74 80.56 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.372 2.048 . . . . 10.0 111.86 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 12.8 t -60.84 108.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.69 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -100.41 130.41 46.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.514 0.673 . . . . 10.0 111.833 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.6 124.86 36.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.393 -0.822 . . . . 10.0 109.951 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.39 130.26 49.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.077 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -114.86 149.17 37.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.452 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.02 114.28 28.26 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.98 -0.748 . . . . 10.0 108.98 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 23.3 mm -85.61 99.86 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.212 0.529 . . . . 10.0 111.057 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -108.75 -6.66 15.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.529 -0.76 . . . . 10.0 110.195 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.7 97.57 2.51 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.509 -0.769 . . . . 10.0 111.191 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -153.48 -15.94 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.824 0.345 . . . . 10.0 111.504 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.95 -76.91 1.49 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.697 -0.763 . . . . 10.0 111.891 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.76 145.83 28.61 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.311 -0.255 . . . . 10.0 110.311 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -136.88 146.37 45.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 10.0 111.024 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.21 147.71 38.43 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.098 -0.501 . . . . 10.0 109.695 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.9 136.92 43.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.401 2.067 . . . . 10.0 111.74 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -91.86 70.28 5.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.137 0.494 . . . . 10.0 111.304 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.602 -0.713 . . . . 10.0 109.741 179.733 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 110.067 -0.346 . . . . 10.0 110.067 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 m -132.05 65.89 76.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 111.981 0.363 . . . . 10.0 111.981 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.91 -40.29 45.13 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.38 2.053 . . . . 10.0 111.617 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -60.54 -38.35 84.19 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 115.949 -0.568 . . . . 10.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.9 m -67.45 -47.22 70.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.703 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.55 -35.25 75.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 10.0 111.005 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m -84.27 -4.73 59.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.437 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.6 m -90.15 -18.6 25.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.384 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.59 124.42 23.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.706 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -107.77 151.91 25.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.089 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.8 p -84.74 174.32 9.99 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.474 -0.565 . . . . 10.0 109.474 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.12 -7.87 33.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.129 0.49 . . . . 10.0 110.515 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -95.96 1.71 53.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.351 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.0 t30 75.45 16.5 2.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -103.89 135.42 19.36 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.037 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.61 145.26 95.22 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.782 2.321 . . . . 10.0 111.551 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.37 -9.7 27.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 10.0 112.043 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.73 -19.9 44.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.394 -0.367 . . . . 10.0 111.817 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.21 -16.02 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.027 0.441 . . . . 10.0 111.383 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -127.07 22.55 6.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.572 0.701 . . . . 10.0 109.34 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.1 mt -134.02 34.12 3.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.405 -0.816 . . . . 10.0 110.428 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -127.7 176.08 7.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.478 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt 68.18 17.39 9.38 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.504 -0.771 . . . . 10.0 112.53 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 51.51 43.39 29.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.509 -0.768 . . . . 10.0 112.077 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -103.28 145.5 30.72 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.832 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.19 131.83 47.51 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.715 2.277 . . . . 10.0 111.066 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -99.79 136.22 40.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.905 0.384 . . . . 10.0 111.226 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.1 tp -117.74 99.58 7.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.7 mt -91.87 122.88 43.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 10.0 111.147 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.486 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 3.9 tmmm? -117.24 121.82 42.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.495 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -95.92 134.49 38.85 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.594 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -134.97 -179.11 5.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.064 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.09 150.05 51.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.223 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.99 -40.86 16.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.066 0.46 . . . . 10.0 110.497 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -86.75 65.61 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.98 -0.555 . . . . 10.0 111.466 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.1 t -161.18 129.34 2.87 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.223 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.13 -41.76 2.43 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.571 2.181 . . . . 10.0 112.094 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.57 -43.21 97.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.928 0.394 . . . . 10.0 111.495 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.8 m -69.29 -23.1 63.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.269 -0.423 . . . . 10.0 111.077 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.6 tp -66.64 -40.54 88.78 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.112 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.45 -34.85 68.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.105 0.479 . . . . 10.0 110.308 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -61.67 -32.21 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.634 -0.712 . . . . 10.0 111.115 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.2 mt -56.25 -42.51 77.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.787 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.77 -36.82 92.75 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.909 -0.662 . . . . 10.0 111.475 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -69.9 -39.59 76.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.361 . . . . 10.0 110.073 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.6 m -61.61 -45.07 95.64 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.431 -0.581 . . . . 10.0 109.431 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.1 -35.13 76.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.519 -0.764 . . . . 10.0 110.375 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -72.33 -46.03 57.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.729 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -63.71 -33.12 74.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 10.0 111.421 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.06 -13.39 57.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.7 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -105.57 -3.41 22.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.375 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.39 144.66 53.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.093 0.473 . . . . 10.0 111.822 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.02 84.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.719 -0.673 . . . . 10.0 112.13 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -74.58 -43.75 54.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 10.0 110.943 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -61.04 -20.44 62.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 10.0 112.13 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -67.73 -5.41 15.95 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.863 0.363 . . . . 10.0 111.826 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 m -77.06 -17.01 59.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 10.0 110.561 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.24 169.42 15.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.923 -0.58 . . . . 10.0 109.998 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.84 98.1 8.0 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.233 -0.284 . . . . 10.0 110.233 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.0 tp -86.15 127.6 34.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.291 -0.413 . . . . 10.0 111.39 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.41 144.94 30.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.497 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.57 110.99 23.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.025 -0.534 . . . . 10.0 109.702 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -109.24 137.39 41.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.052 0.454 . . . . 10.0 111.548 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.39 146.89 52.47 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -109.91 96.11 23.43 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 112.222 0.453 . . . . 10.0 112.222 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.31 132.25 30.92 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.365 2.043 . . . . 10.0 111.357 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.98 6.08 88.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.072 -0.585 . . . . 10.0 112.534 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -121.72 148.49 44.54 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.155 -0.313 . . . . 10.0 110.155 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 59.92 21.17 10.17 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.5 t60 69.57 27.73 4.74 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.462 -0.79 . . . . 10.0 112.287 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -88.26 -168.35 2.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -63.57 145.08 56.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.711 0.291 . . . . 10.0 111.033 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -80.9 161.78 24.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.806 0.336 . . . . 10.0 111.367 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.44 150.17 27.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.533 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.03 -47.13 3.76 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.273 -0.731 . . . . 10.0 111.273 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -76.65 -39.72 51.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.676 -0.49 . . . . 10.0 109.676 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -63.05 -36.32 83.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.485 -0.779 . . . . 10.0 111.891 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -66.11 -32.14 73.42 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.775 -0.37 . . . . 10.0 111.021 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.92 -27.49 63.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.04 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -61.32 -57.71 11.2 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.503 -0.772 . . . . 10.0 109.707 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -65.93 -36.32 83.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.102 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.82 -20.78 58.95 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.224 0.453 . . . . 10.0 112.224 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.21 5.23 38.59 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.592 -0.813 . . . . 10.0 112.192 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.2 mt -100.46 -178.29 3.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.895 0.378 . . . . 10.0 111.185 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -103.54 -177.78 3.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.136 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 69.0 78.56 0.23 Allowed Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 123.007 0.523 . . . . 10.0 111.035 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.15 12.25 1.83 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.736 2.29 . . . . 10.0 112.063 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -108.57 11.25 26.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.402 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.9 mt -88.5 111.13 41.83 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.574 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.56 69.83 5.85 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.465 2.11 . . . . 10.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.1 t -78.56 107.78 11.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.844 -0.616 . . . . 10.0 111.305 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.5 t -92.34 137.34 22.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.762 -0.653 . . . . 10.0 109.918 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.47 100.44 11.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.59 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -94.81 85.35 4.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.171 0.51 . . . . 10.0 110.05 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -62.38 114.75 3.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.655 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.71 -11.92 67.86 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.653 -0.784 . . . . 10.0 112.897 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.53 55.95 7.14 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.632 -0.794 . . . . 10.0 112.269 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.84 -44.15 81.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.178 0.514 . . . . 10.0 110.253 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.5 mm -77.74 -41.14 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.295 -0.631 . . . . 10.0 109.295 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.48 86.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.714 -0.676 . . . . 10.0 111.338 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -70.84 -41.74 71.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.985 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.9 m -65.92 -27.89 68.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.097 0.406 . . . . 10.0 112.097 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.72 -2.74 31.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.723 0.297 . . . . 10.0 110.898 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t30 54.21 55.88 7.66 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.686 -0.688 . . . . 10.0 111.471 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 87.5 mt -80.65 126.15 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.659 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 p -127.34 -1.99 6.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.898 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.9 p -154.18 151.72 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.575 0.226 . . . . 10.0 111.007 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -117.3 156.21 49.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -87.33 130.16 11.0 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.734 -1.361 . . . . 10.0 111.585 -0.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.4 m -94.35 130.73 40.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.135 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 19.3 m95 -112.84 115.34 28.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.462 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.09 116.91 32.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.346 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.4 tp -97.12 111.88 23.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.133 0.492 . . . . 10.0 110.939 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.1 129.31 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.62 -0.881 . . . . 10.0 108.62 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.59 175.58 33.45 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.859 -0.686 . . . . 10.0 112.262 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -72.21 -1.95 17.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.019 0.438 . . . . 10.0 111.176 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.46 -14.02 33.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.135 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.47 21.44 31.93 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.869 -0.682 . . . . 10.0 112.607 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -126.63 166.1 17.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.855 0.36 . . . . 10.0 111.289 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.22 125.33 31.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.688 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -113.76 -39.6 3.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.818 0.342 . . . . 10.0 111.848 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.53 151.3 43.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.688 0.28 . . . . 10.0 110.891 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.12 128.51 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 10.0 110.629 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.11 128.93 74.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.578 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -129.39 114.8 16.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.272 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.79 -85.58 0.19 Allowed Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.415 -0.898 . . . . 10.0 112.757 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.9 m -160.75 163.21 32.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.077 -0.342 . . . . 10.0 110.077 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.03 170.73 18.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.557 0.218 . . . . 10.0 111.294 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -147.17 163.34 36.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.007 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -57.66 -45.89 84.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.613 0.598 . . . . 10.0 112.613 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.8 95.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.847 0.356 . . . . 10.0 111.097 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -65.0 -40.9 95.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.176 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.91 -47.56 85.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.848 -0.615 . . . . 10.0 110.644 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.56 -37.81 88.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.713 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.41 97.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.742 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.1 tp -62.73 -36.11 81.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.134 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.8 mt -73.12 -26.78 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.077 0.465 . . . . 10.0 110.048 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -80.88 -40.99 23.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.311 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -154.15 113.9 2.51 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.177 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.06 -7.88 18.38 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.003 2.469 . . . . 10.0 112.449 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -86.36 -6.69 58.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.876 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.55 96.59 4.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.345 -0.389 . . . . 10.0 111.474 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -102.08 128.38 48.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.417 -0.586 . . . . 10.0 109.417 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 36.2 tp . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.108 -0.948 . . . . 10.0 111.633 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.909 0.385 . . . . 10.0 110.773 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.71 -60.41 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 61.7 tp -113.91 -65.31 1.2 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.847 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 52.79 41.12 31.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.446 0.641 . . . . 10.0 111.246 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.1 170.68 18.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.449 -0.796 . . . . 10.0 110.278 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.39 -159.34 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.855 0.722 . . . . 10.0 111.921 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -105.63 16.19 25.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.482 -0.781 . . . . 10.0 109.757 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -81.04 2.87 25.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 10.0 112.374 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.85 132.77 16.25 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.43 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.89 145.64 96.23 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.031 2.487 . . . . 10.0 112.35 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.37 -36.25 68.18 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.532 2.822 . . . . 10.0 113.136 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -62.71 -14.23 41.73 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.07 0.462 . . . . 10.0 111.96 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -121.17 -3.08 9.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.633 0.73 . . . . 10.0 109.93 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.6 -3.78 54.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 10.0 112.25 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -122.29 125.14 45.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.888 0.375 . . . . 10.0 111.165 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.03 90.82 10.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.275 -0.639 . . . . 10.0 109.275 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.73 96.28 0.99 Allowed 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.955 2.436 . . . . 10.0 112.879 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.42 98.17 10.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.05 116.34 27.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.819 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.26 109.95 19.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.703 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.87 114.81 30.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.275 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.96 170.49 7.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.23 -0.656 . . . . 10.0 109.23 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.51 -42.84 77.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.98 0.363 . . . . 10.0 111.98 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.9 -15.03 59.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.567 0.58 . . . . 10.0 112.567 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 165.11 166.4 24.02 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.424 -0.893 . . . . 10.0 112.228 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -90.52 137.43 21.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.18 -0.304 . . . . 10.0 110.18 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -120.53 112.15 18.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.922 -0.399 . . . . 10.0 109.922 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 6.8 p -91.79 121.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.051 0.453 . . . . 10.0 110.956 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -124.53 79.32 1.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.039 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -87.27 112.5 22.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 10.0 111.057 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -76.47 118.9 19.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.414 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 45.9 mt -92.65 140.19 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.719 -0.673 . . . . 10.0 110.33 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.94 149.79 39.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.396 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.08 77.74 1.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.168 0.509 . . . . 10.0 111.486 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 169.57 -21.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.376 -0.69 . . . . 10.0 111.376 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.41 150.17 24.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.221 -0.659 . . . . 10.0 109.221 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -142.15 136.54 30.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.048 0.452 . . . . 10.0 111.597 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 48.4 mtt -108.27 152.92 23.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.653 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -95.1 126.81 40.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.527 -0.546 . . . . 10.0 109.527 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -60.51 -28.96 68.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.051 0.453 . . . . 10.0 111.841 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.16 -0.94 51.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.994 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -113.06 -26.11 8.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.35 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.87 115.41 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.24 0.543 . . . . 10.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.51 122.98 59.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.871 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.28 129.37 3.45 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.685 -0.769 . . . . 10.0 111.909 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -157.76 138.24 12.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.806 0.336 . . . . 10.0 111.26 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 4.7 t -139.25 126.9 21.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.732 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -178.3 164.13 1.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.365 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.11 -76.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.244 1.962 . . . . 10.0 111.148 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.32 49.19 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.983 0.421 . . . . 10.0 110.651 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 t0 63.24 56.2 1.75 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.501 -0.772 . . . . 10.0 112.101 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -117.61 57.24 0.82 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.126 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.5 tp -115.6 147.62 40.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.134 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.5 -74.07 0.98 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.627 -0.797 . . . . 10.0 111.563 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.36 145.49 4.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.58 108.61 1.45 Allowed 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.472 2.115 . . . . 10.0 111.236 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 16.7 m -79.15 98.54 6.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.257 -0.429 . . . . 10.0 111.629 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -80.21 144.64 32.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.787 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -86.23 -9.33 56.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt 71.66 127.77 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.864 0.727 . . . . 10.0 112.542 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.77 -127.61 4.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.528 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -119.77 145.4 46.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.647 0.223 . . . . 10.0 110.412 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -85.87 125.61 33.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -111.4 134.56 52.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.038 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -77.14 128.37 34.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -116.17 174.49 6.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.983 0.421 . . . . 10.0 111.241 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -101.09 -26.83 13.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.015 -0.539 . . . . 10.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -118.95 -39.36 2.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.703 0.287 . . . . 10.0 111.487 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -79.47 -14.0 59.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 10.0 111.405 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.55 -89.71 1.63 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.863 -0.684 . . . . 10.0 112.053 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -159.03 115.45 2.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.029 -0.36 . . . . 10.0 110.029 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -137.23 164.35 28.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.866 0.365 . . . . 10.0 111.209 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -78.11 127.92 33.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.971 -0.751 . . . . 10.0 108.971 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.5 155.72 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.394 0.516 . . . . 10.0 112.394 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -117.0 128.6 55.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.556 -1.276 . . . . 10.0 107.556 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -118.3 5.87 11.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.397 0.517 . . . . 10.0 112.397 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 179.25 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -87.47 112.06 21.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.677 -1.147 . . . . 10.0 110.867 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.7 120.21 11.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.863 0.363 . . . . 10.0 110.871 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -155.36 120.77 4.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.15 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.04 124.46 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.348 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.72 144.93 28.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.235 -0.439 . . . . 10.0 109.897 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -120.66 100.28 46.84 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.41 121.59 3.87 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.8 2.334 . . . . 10.0 111.346 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.97 151.35 35.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.019 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.63 -2.41 48.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.293 0.568 . . . . 10.0 109.817 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -152.63 111.23 3.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.325 -0.852 . . . . 10.0 109.266 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.85 92.29 6.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.982 0.42 . . . . 10.0 110.64 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.48 158.05 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.137 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.91 51.96 2.25 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.124 -0.56 . . . . 10.0 111.846 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -117.02 145.84 36.59 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.87 117.06 4.63 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.247 1.965 . . . . 10.0 110.513 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.06 151.95 20.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.329 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -100.35 148.92 24.16 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.4 -0.592 . . . . 10.0 109.4 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 35.5 tp -122.32 125.65 46.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.78 0.324 . . . . 10.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 39.9 t -111.02 122.28 65.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 87.0 mt -127.42 123.84 37.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.856 0.36 . . . . 10.0 111.318 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 17.5 m -113.62 121.69 44.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -102.63 107.5 18.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.759 0.314 . . . . 10.0 111.47 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.04 125.33 42.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.91 0.386 . . . . 10.0 110.211 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.83 -159.09 13.67 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.675 -0.774 . . . . 10.0 111.359 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 10.3 m -152.7 -177.77 6.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' B' ' 105' ' ' ALA . . . -118.66 149.24 41.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -75.06 21.69 0.12 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.973 0.416 . . . . 10.0 111.502 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' B' ' 103' ' ' ALA . . . -122.78 -1.03 8.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.864 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.95 -26.03 12.1 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.754 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.9 t -62.12 140.19 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.616 0.246 . . . . 10.0 110.77 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 47.5 t -137.2 99.31 3.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.888 0.375 . . . . 10.0 110.465 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -80.58 151.79 71.96 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.779 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.12 161.17 45.57 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.861 2.374 . . . . 10.0 111.651 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.75 52.6 3.76 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.864 2.376 . . . . 10.0 113.077 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 33.5 t -56.57 131.44 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.028 0.442 . . . . 10.0 110.784 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -113.21 168.34 9.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.49 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.0 m -147.79 138.44 23.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.499 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -100.49 131.08 46.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.508 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -112.85 143.22 44.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.286 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -105.98 111.3 23.88 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.38 88.14 2.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.28 0.562 . . . . 10.0 110.846 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -102.92 -11.37 18.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.62 -0.718 . . . . 10.0 110.695 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.09 83.77 1.4 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.037 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -140.2 7.11 2.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.996 0.426 . . . . 10.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.73 -80.0 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.112 -0.565 . . . . 10.0 112.367 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 1.7 m -105.91 145.85 30.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -130.51 152.41 49.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.711 0.291 . . . . 10.0 111.328 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.15 138.72 15.15 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.708 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.81 138.61 23.75 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.467 2.112 . . . . 10.0 112.335 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -92.01 92.72 8.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.519 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 34.0 m . . . . . 0 C--O 1.252 1.202 0 CA-C-O 118.856 -0.593 . . . . 10.0 109.644 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.54 69.35 79.76 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 120.762 0.315 . . . . 10.0 110.798 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.1 -30.13 90.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.866 2.377 . . . . 10.0 112.877 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -61.71 -39.57 91.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.752 0.311 . . . . 10.0 110.91 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -71.08 -37.69 72.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 10.0 110.1 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 tp -65.04 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.904 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.1 m -84.86 -24.82 28.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.605 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 m -67.04 -28.43 68.21 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.069 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.06 112.51 1.37 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.83 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.01 138.9 40.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.08 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.0 p -77.53 168.72 19.53 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.041 -0.527 . . . . 10.0 109.671 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.28 -8.05 42.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.393 0.616 . . . . 10.0 110.029 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -91.1 2.16 56.54 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.247 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 t30 69.21 30.26 4.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.952 -1.022 . . . . 10.0 111.466 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtt85 -119.08 137.22 24.91 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.931 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.31 144.83 95.82 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.372 2.048 . . . . 10.0 110.899 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.96 -9.93 18.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.024 0.379 . . . . 10.0 112.024 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.5 m -56.17 -21.85 25.34 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.435 0.531 . . . . 10.0 112.435 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 m -64.9 -24.61 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.02 0.438 . . . . 10.0 111.138 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -118.97 17.38 13.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.487 0.661 . . . . 10.0 109.699 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 91.5 mt -125.22 43.66 2.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.313 -0.858 . . . . 10.0 109.618 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -141.65 -179.36 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.142 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.5 mttp 72.48 3.61 4.74 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.988 0.805 . . . . 10.0 112.179 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 54.0 47.77 22.64 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.881 -0.599 . . . . 10.0 111.071 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -116.36 150.09 44.77 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.441 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.82 127.41 26.09 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.053 2.502 . . . . 10.0 112.028 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -102.09 137.07 40.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.242 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.2 tp -118.7 106.09 12.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.84 -0.43 . . . . 10.0 109.84 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.7 mt -97.37 123.26 49.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.759 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.511 ' HZ1' ' CD ' ' A' ' 42' ' ' GLU . 19.6 ttpt -116.03 126.03 53.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.361 -0.382 . . . . 10.0 110.644 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.33 144.85 26.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.494 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -145.67 166.93 24.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.613 -0.267 . . . . 10.0 111.155 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.51 144.34 39.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.139 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 m -70.51 -52.46 21.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.585 0.587 . . . . 10.0 112.585 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -90.89 44.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.96 0.409 . . . . 10.0 111.694 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.7 t -119.84 119.67 30.99 Favored Pre-proline 0 C--N 1.317 -0.826 0 C-N-CA 120.88 -0.328 . . . . 10.0 111.368 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.95 -38.23 48.46 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.687 2.258 . . . . 10.0 111.793 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.47 -44.98 81.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.343 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.6 m -72.19 -24.72 61.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.235 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -55.31 31.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 10.0 111.474 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.09 -34.03 77.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.024 0.44 . . . . 10.0 110.496 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.511 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 2.5 tm-20 -65.13 -27.95 69.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.679 -0.692 . . . . 10.0 111.569 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -56.39 -40.64 74.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.914 0.388 . . . . 10.0 110.864 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.76 -32.6 78.28 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.147 -0.781 . . . . 10.0 111.147 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -71.57 -36.63 70.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.936 -0.394 . . . . 10.0 109.936 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -61.35 -47.7 84.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.037 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -64.77 -37.6 88.15 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.522 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -60.12 -46.16 90.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.23 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -66.5 -32.53 73.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.023 -0.535 . . . . 10.0 111.025 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.51 -16.12 63.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.21 0.528 . . . . 10.0 111.111 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -99.2 -3.57 34.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.472 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.5 147.16 29.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.376 -0.375 . . . . 10.0 110.653 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 -31.13 72.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.862 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -66.61 -51.51 55.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 10.0 111.035 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -75.67 -10.25 59.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.674 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -75.74 -7.37 54.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.192 0.52 . . . . 10.0 110.195 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.89 4.62 52.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.836 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.78 173.29 11.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.85 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -106.58 89.36 3.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.899 0.38 . . . . 10.0 110.299 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -88.51 127.01 35.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.879 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.8 pt -142.28 152.28 18.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.985 0.421 . . . . 10.0 111.27 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.09 126.3 52.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.299 -0.63 . . . . 10.0 109.299 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.6 t -122.08 141.99 40.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.835 0.35 . . . . 10.0 111.474 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.36 148.28 52.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.8 m -110.74 97.42 33.16 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.663 0.268 . . . . 10.0 111.624 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -60.17 123.69 13.68 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.882 2.388 . . . . 10.0 112.525 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.7 -21.5 29.46 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.797 -0.638 . . . . 10.0 112.86 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.0 143.68 28.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.648 0.261 . . . . 10.0 110.508 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 60.02 22.81 11.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.911 -0.586 . . . . 10.0 112.385 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 71.12 24.54 3.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.78 -0.645 . . . . 10.0 112.561 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.55 -175.34 5.74 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.54 0.21 . . . . 10.0 110.798 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -58.57 136.16 57.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.494 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -76.25 174.37 10.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.875 0.369 . . . . 10.0 111.866 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.8 144.26 55.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.736 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 -47.02 3.59 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.014 -0.835 . . . . 10.0 111.014 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -47.21 81.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 10.0 109.908 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.78 -32.1 73.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.471 -0.786 . . . . 10.0 110.907 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.12 -44.57 94.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.666 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -71.28 -31.39 67.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.782 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -58.87 -47.06 86.24 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.864 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -73.6 -40.94 63.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.366 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.49 68.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 10.0 111.395 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.44 23.08 36.59 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.955 -0.641 . . . . 10.0 112.623 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 mt -117.53 170.11 9.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.833 0.349 . . . . 10.0 110.766 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -89.58 176.02 7.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.798 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 71.09 73.81 0.26 Allowed Pre-proline 0 N--CA 1.465 0.3 0 O-C-N 123.883 0.739 . . . . 10.0 111.448 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.45 -1.57 11.21 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.482 2.122 . . . . 10.0 112.188 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.88 -0.81 44.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.895 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.69 114.97 39.5 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.764 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.86 77.65 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.62 2.213 . . . . 10.0 111.581 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.1 t -92.32 118.66 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.094 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 t -100.75 144.62 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.74 -0.663 . . . . 10.0 109.963 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.43 117.38 33.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.499 -0.319 . . . . 10.0 111.125 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -108.18 96.03 6.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 10.0 110.044 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -67.62 112.52 4.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.766 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.59 -9.45 62.43 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.995 -0.622 . . . . 10.0 112.242 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.21 50.92 41.8 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.964 -0.636 . . . . 10.0 112.187 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -46.8 88.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.9 0.381 . . . . 10.0 111.262 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.85 -42.47 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.96 90.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.541 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -69.64 -36.72 76.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.812 0.339 . . . . 10.0 111.409 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -64.6 -33.51 76.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.215 0.45 . . . . 10.0 112.215 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -100.82 -2.86 31.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.673 0.273 . . . . 10.0 110.919 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 43.7 t30 60.58 61.44 1.72 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.92 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.8 mt -97.84 105.37 17.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.422 -0.808 . . . . 10.0 110.956 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.77 13.24 14.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.926 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 p -147.0 150.5 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.617 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -124.18 153.64 68.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -89.74 128.17 7.67 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 124.0 -1.25 . . . . 10.0 111.689 -0.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.9 m -96.21 136.27 36.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.361 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -114.14 110.99 20.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.214 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.21 110.23 22.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.51 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.1 tp -91.72 112.7 24.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.688 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 84.4 mt -99.74 137.72 26.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.82 173.25 55.12 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.64 -0.791 . . . . 10.0 112.799 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -65.2 -14.49 60.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 10.0 111.716 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.35 -19.72 29.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.151 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 105.06 -0.08 41.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.82 -0.705 . . . . 10.0 111.945 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -96.57 158.48 15.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.232 -0.285 . . . . 10.0 110.232 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.14 118.87 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.921 0.391 . . . . 10.0 111.171 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -51.53 6.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.695 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -156.87 142.26 17.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.119 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -116.25 119.25 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.051 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.9 t -107.92 120.51 59.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.786 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -126.39 125.1 41.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.626 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 142.33 -97.22 0.2 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.722 -0.751 . . . . 10.0 111.829 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.7 t -160.35 138.2 9.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.022 -0.362 . . . . 10.0 110.022 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.9 pt -121.71 150.64 25.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.001 0.429 . . . . 10.0 110.875 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -114.28 174.92 5.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.649 . . . . 10.0 110.256 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.18 -45.3 91.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.71 0.263 . . . . 10.0 111.71 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.16 -41.97 84.96 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.515 -0.312 . . . . 10.0 110.59 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.18 -44.46 88.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.868 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.07 92.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.672 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.93 -34.34 75.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.765 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.2 85.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.383 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.44 -33.89 75.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.52 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 76.5 mt -67.44 -31.83 54.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.669 -0.493 . . . . 10.0 109.669 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.45 -61.24 2.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.772 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -127.64 117.31 21.12 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.341 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.26 -3.55 12.57 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.087 2.525 . . . . 10.0 112.574 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -95.81 -2.52 47.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.624 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.64 116.99 10.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.041 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -122.53 160.25 26.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.633 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.283 0.989 . . . . 10.0 112.972 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.422 ' H3 ' ' CG ' ' B' ' 4' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.622 0.248 . . . . 10.0 111.354 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.24 -65.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.198 0.444 . . . . 10.0 112.198 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 54.9 tp -85.37 -82.57 0.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . 0.422 ' CG ' ' H3 ' ' B' ' 1' ' ' MET . 76.3 m-20 62.24 45.82 6.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.619 0.724 . . . . 10.0 110.899 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.08 154.05 38.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.374 -0.83 . . . . 10.0 110.13 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.76 -163.63 0.23 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.79 0.681 . . . . 10.0 112.145 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -98.78 29.7 3.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.968 0.413 . . . . 10.0 111.085 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.65 15.27 14.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.146 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.63 137.61 11.53 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.789 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.11 151.05 86.78 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.931 2.421 . . . . 10.0 112.356 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.29 -36.03 85.38 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.302 2.668 . . . . 10.0 113.152 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -69.06 -2.86 11.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.932 0.396 . . . . 10.0 112.023 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -131.82 5.86 4.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.473 0.654 . . . . 10.0 109.623 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.74 -1.84 31.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.702 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -134.19 128.97 35.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.814 0.34 . . . . 10.0 110.96 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.6 91.38 20.55 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.67 105.26 1.27 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.679 2.253 . . . . 10.0 112.727 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.12 99.4 12.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.236 -0.653 . . . . 10.0 109.236 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -89.33 102.99 15.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.882 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.26 101.78 10.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.52 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 81.1 t -89.82 119.59 37.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.616 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.1 -176.37 3.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.175 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.48 -35.9 34.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.403 -0.362 . . . . 10.0 111.29 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.35 -34.95 28.28 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.22 -178.61 40.14 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.762 -0.733 . . . . 10.0 112.077 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.86 135.88 38.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -123.48 114.87 20.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.954 0.407 . . . . 10.0 110.524 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.69 122.56 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.403 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -125.03 80.35 1.87 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.951 0.405 . . . . 10.0 110.315 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -77.35 111.71 13.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 10.0 111.141 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 -72.35 112.73 8.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.372 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 63.4 mt -90.23 135.73 25.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.975 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.41 149.27 50.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.21 92.65 1.02 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.059 0.457 . . . . 10.0 111.576 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.95 -22.06 0.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.369 -0.692 . . . . 10.0 111.369 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -105.37 154.28 20.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -146.6 139.23 25.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.983 0.42 . . . . 10.0 111.184 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 37.8 mtt -110.99 159.04 18.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.849 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -100.91 127.36 47.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -59.31 -30.7 68.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.183 0.438 . . . . 10.0 112.183 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.68 3.84 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.94 0.4 . . . . 10.0 111.181 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -116.83 -20.47 9.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.336 -0.393 . . . . 10.0 111.801 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 60.8 mt -77.22 96.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.092 0.472 . . . . 10.0 110.724 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.21 108.88 20.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.315 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.59 138.66 10.21 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.846 -0.692 . . . . 10.0 111.562 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -160.98 145.52 13.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.608 0.242 . . . . 10.0 111.066 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 15.1 t -141.51 125.63 17.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.191 -0.459 . . . . 10.0 109.879 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -179.0 161.75 1.02 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.154 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -73.92 -63.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.435 2.09 . . . . 10.0 110.909 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.36 58.49 1.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 10.0 109.809 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 5.5 t70 61.96 33.62 17.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.53 -0.759 . . . . 10.0 112.455 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -90.16 55.09 2.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.4 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 19.0 tp -121.5 145.47 47.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.104 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.46 -76.8 0.85 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.587 -0.816 . . . . 10.0 111.309 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -161.17 143.46 9.18 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.9 108.52 1.11 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.526 2.151 . . . . 10.0 111.18 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.6 m -82.46 103.55 12.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.849 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.4 158.91 18.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 51.0 m -91.79 -14.06 30.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.622 -0.263 . . . . 10.0 110.831 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? 71.82 127.9 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.76 -0.655 . . . . 10.0 112.284 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.81 -133.0 5.61 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.135 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -117.41 140.24 49.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.527 0.203 . . . . 10.0 110.564 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.31 121.65 24.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.457 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -98.72 139.91 33.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -78.56 141.54 38.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.39 170.49 15.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.636 0.255 . . . . 10.0 110.495 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -24.83 10.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.961 0.41 . . . . 10.0 110.994 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -102.82 -44.75 5.19 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.202 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -89.61 -9.62 49.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.583 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.08 -77.78 1.89 Allowed Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.827 -0.624 . . . . 10.0 112.296 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -173.81 117.91 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.752 0.31 . . . . 10.0 110.496 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -141.02 162.16 36.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.144 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.6 m -68.83 127.24 32.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.812 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.2 m -127.3 161.8 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 10.0 111.731 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -118.24 128.1 54.36 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.868 -1.16 . . . . 10.0 107.868 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -112.27 -3.8 14.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.768 0.655 . . . . 10.0 112.768 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -175.93 -36.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.987 -0.746 . . . . 10.0 108.987 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -86.26 125.04 33.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.086 -0.961 . . . . 10.0 109.767 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.37 116.77 4.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.323 . . . . 10.0 111.523 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -153.61 125.38 7.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.163 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.3 t -129.99 131.75 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.252 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.56 142.01 39.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.704 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -120.22 112.26 34.7 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.263 0.468 . . . . 10.0 112.263 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -93.08 124.62 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.521 2.814 . . . . 10.0 111.55 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.01 148.04 40.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.988 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.3 -3.21 53.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.324 0.583 . . . . 10.0 109.73 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -153.47 124.7 7.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.867 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.75 89.77 8.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.04 0.448 . . . . 10.0 110.352 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.64 147.15 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.71 47.33 3.83 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.073 -0.584 . . . . 10.0 112.344 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -106.67 145.44 31.07 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.53 116.02 4.54 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.319 2.013 . . . . 10.0 111.288 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.77 165.4 11.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.967 0.413 . . . . 10.0 111.832 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -109.2 151.76 26.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.979 -0.555 . . . . 10.0 109.828 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 56.0 tp -120.54 115.55 23.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.974 0.416 . . . . 10.0 110.664 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.88 126.44 64.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.535 -0.542 . . . . 10.0 109.535 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 66.8 mt -133.13 121.06 22.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.925 0.393 . . . . 10.0 111.895 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 5.0 m -108.8 119.22 38.91 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -100.58 109.48 21.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.777 0.322 . . . . 10.0 111.561 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -124.32 119.35 29.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.968 0.413 . . . . 10.0 110.533 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.36 -160.79 11.08 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.603 -0.808 . . . . 10.0 111.877 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 13.1 m -151.21 -172.42 4.2 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.22 147.73 52.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.259 -0.274 . . . . 10.0 110.259 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.47 6.08 2.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 10.0 111.753 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.19 5.33 29.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.892 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.52 -7.74 56.2 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.626 -0.797 . . . . 10.0 113.087 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.33 142.75 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.739 0.304 . . . . 10.0 110.471 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 47.9 t -142.52 85.56 1.91 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.941 0.401 . . . . 10.0 110.068 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -74.09 152.35 88.44 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.79 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.82 165.18 31.9 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.827 2.351 . . . . 10.0 111.377 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.42 68.11 5.28 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.657 2.238 . . . . 10.0 112.947 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 4.8 t -62.65 120.78 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 10.0 109.943 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -108.03 153.91 22.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.094 0.473 . . . . 10.0 111.37 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.68 138.77 41.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.822 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.19 124.45 50.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.82 0.343 . . . . 10.0 110.571 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -111.57 142.73 43.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.618 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -103.98 121.41 43.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.263 -0.426 . . . . 10.0 109.877 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 23.1 mm -94.66 88.83 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.967 0.413 . . . . 10.0 110.787 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -95.03 -35.02 12.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.549 . . . . 10.0 111.45 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.4 60.78 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.43 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -120.0 -0.89 10.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.81 0.338 . . . . 10.0 111.101 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.26 -76.14 1.5 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.002 -0.618 . . . . 10.0 111.658 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 3.9 m -103.21 140.25 37.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.565 -0.531 . . . . 10.0 109.565 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -129.86 161.36 30.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.142 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.18 146.97 24.67 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.26 121.56 9.43 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.557 2.171 . . . . 10.0 112.42 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -82.64 62.89 6.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.355 0.598 . . . . 10.0 110.01 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.091 -179.285 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 tpt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.098 -0.334 . . . . 10.0 110.098 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.65 82.64 48.26 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.562 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.01 -25.71 58.97 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.55 2.167 . . . . 10.0 111.566 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -46.83 87.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.833 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -60.56 -42.54 96.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.302 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.97 -32.84 74.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.806 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.0 m -81.91 -25.6 34.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.054 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.3 m -65.68 -26.71 67.9 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.756 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -55.69 128.0 32.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.878 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -115.47 149.55 37.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.638 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.4 p -89.34 174.96 7.53 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.046 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.56 -19.36 65.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.411 . . . . 10.0 111.008 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.31 9.13 27.16 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 64.84 30.57 12.11 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.703 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 mtp85 -112.27 137.65 21.59 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.932 -0.577 . . . . 10.0 109.93 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.32 139.48 90.21 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.615 2.21 . . . . 10.0 111.409 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.14 -10.08 20.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 10.0 112.008 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 t -59.85 -18.41 43.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.647 -0.252 . . . . 10.0 111.494 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.18 -15.54 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-O 120.788 0.328 . . . . 10.0 111.018 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -127.06 22.92 6.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.56 . . . . 10.0 109.714 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.4 mt -133.0 27.28 4.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.024 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -118.97 174.6 6.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.6 mttp 69.32 15.7 8.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.127 -0.942 . . . . 10.0 112.902 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.18 51.21 14.89 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.512 0.507 . . . . 10.0 111.242 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -112.65 143.37 28.86 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.218 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.26 134.08 56.81 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.725 2.283 . . . . 10.0 110.956 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -106.78 143.91 34.19 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.967 0.413 . . . . 10.0 111.22 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tp -121.47 97.94 5.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.156 -0.683 . . . . 10.0 109.156 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.0 mt -89.39 112.22 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.025 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.5 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 5.7 tmmm? -106.59 120.88 43.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.88 0.371 . . . . 10.0 110.826 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -90.33 127.9 36.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.208 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -121.37 173.89 7.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.078 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.83 138.48 54.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.102 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -77.49 -47.43 19.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.36 29.1 1.0 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.077 0.769 . . . . 10.0 113.077 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -119.65 125.98 27.18 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 111.665 0.246 . . . . 10.0 111.665 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.01 -43.85 17.92 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.832 2.355 . . . . 10.0 112.457 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.97 -44.52 96.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.167 0.508 . . . . 10.0 111.135 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.9 -28.52 67.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.888 -0.596 . . . . 10.0 111.496 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.7 mt -63.62 -44.77 92.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.845 0.355 . . . . 10.0 110.464 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.6 m -69.63 -31.61 69.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.668 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.5 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -63.93 -28.82 70.09 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.057 -0.52 . . . . 10.0 110.646 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.91 -42.48 84.83 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.442 -0.345 . . . . 10.0 111.321 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.04 -44.46 97.3 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.796 -0.716 . . . . 10.0 111.421 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -65.49 -34.67 78.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.867 0.365 . . . . 10.0 110.192 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.3 m -61.33 -46.88 88.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.161 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.56 -40.93 98.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.955 0.407 . . . . 10.0 110.429 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.22 -47.66 78.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 10.0 111.003 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -65.01 -33.93 77.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.576 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.44 -6.28 34.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.918 0.389 . . . . 10.0 111.283 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -113.11 9.07 18.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.207 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -85.63 146.54 26.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.439 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.32 73.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.856 0.687 . . . . 10.0 112.856 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -74.67 -39.2 62.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.835 0.35 . . . . 10.0 111.155 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -75.5 -20.3 58.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.495 0.554 . . . . 10.0 112.495 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.8 m -65.93 -6.54 12.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.34 . . . . 10.0 111.902 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -77.3 -18.37 57.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 10.0 110.147 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -125.91 -178.67 4.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.701 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -113.39 100.36 8.48 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.182 -0.303 . . . . 10.0 110.182 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.07 129.29 35.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.598 -0.273 . . . . 10.0 111.022 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.3 pt -138.22 155.73 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.988 0.423 . . . . 10.0 111.415 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.97 109.43 18.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 10.0 109.648 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.0 t -111.14 140.99 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.94 0.4 . . . . 10.0 111.482 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -135.44 149.63 49.64 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 m -110.03 97.97 32.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.39 126.63 21.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.942 2.428 . . . . 10.0 112.507 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.61 -36.8 3.3 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.8 -0.637 . . . . 10.0 113.171 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -66.44 134.36 52.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.621 0.248 . . . . 10.0 110.999 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.14 29.7 19.32 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.639 0.607 . . . . 10.0 112.639 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.08 21.14 3.24 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.299 0.852 . . . . 10.0 113.299 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.34 178.3 5.95 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -61.52 124.93 22.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -61.73 156.95 18.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.913 0.387 . . . . 10.0 111.734 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -59.27 151.47 23.17 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.403 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.58 -44.97 3.3 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.22 -39.51 17.71 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -57.44 -46.2 83.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.584 -0.735 . . . . 10.0 112.136 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -63.48 -31.69 72.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.9 0.381 . . . . 10.0 111.541 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -75.6 -22.62 56.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.142 0.496 . . . . 10.0 110.464 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -65.47 -46.69 78.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.493 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -72.43 -32.71 66.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.819 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.49 -31.71 68.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.963 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.39 23.89 34.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.398 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.5 mt -115.71 -161.82 0.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.408 . . . . 10.0 111.361 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -118.59 -168.89 1.62 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 63.24 76.3 0.37 Allowed Pre-proline 0 C--O 1.234 0.24 0 O-C-N 123.456 0.472 . . . . 10.0 111.559 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.4 0.76 9.12 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.666 2.244 . . . . 10.0 112.272 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -104.43 6.47 34.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.089 0.471 . . . . 10.0 110.428 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.2 mt -84.81 115.21 59.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.125 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.06 76.9 3.98 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.658 2.239 . . . . 10.0 111.393 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.25 118.47 30.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.982 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.9 t -103.88 142.8 16.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.861 -0.609 . . . . 10.0 109.95 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.9 m -107.58 107.51 18.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.145 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -97.86 92.32 5.77 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.251 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -63.08 107.91 1.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.918 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.54 -10.53 68.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.823 -0.703 . . . . 10.0 112.872 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.9 55.9 6.91 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.263 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.96 -45.1 87.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.937 0.399 . . . . 10.0 110.642 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.3 mm -78.67 -37.85 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.485 -0.561 . . . . 10.0 109.485 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.23 95.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.586 -0.734 . . . . 10.0 111.599 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -70.08 -37.22 75.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.762 0.315 . . . . 10.0 111.529 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.2 m -62.84 -23.44 67.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.447 -0.342 . . . . 10.0 111.833 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.2 mt -111.87 4.4 18.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.659 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.8 t30 54.3 44.4 29.07 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.429 0.633 . . . . 10.0 111.631 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.8 mt -80.41 101.53 5.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.839 -0.619 . . . . 10.0 111.551 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.9 m -118.95 29.88 7.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.87 -0.605 . . . . 10.0 110.564 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.4 p -160.71 151.14 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.281 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -130.89 155.29 81.67 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.74 141.97 30.55 Favored 'Cis proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.355 -1.519 . . . . 10.0 111.26 -1.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.7 m -118.23 126.76 52.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.654 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -107.72 108.39 19.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.91 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.01 115.68 27.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.154 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.4 tp -90.94 115.78 28.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.595 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.9 135.68 41.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.211 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.69 178.95 38.47 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.03 -0.605 . . . . 10.0 112.63 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -71.45 -4.59 27.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.906 0.384 . . . . 10.0 111.984 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -98.92 -4.43 32.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.993 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 86.06 16.79 62.32 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.815 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -109.09 163.09 13.64 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.162 -0.31 . . . . 10.0 110.162 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.34 122.75 25.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.855 0.36 . . . . 10.0 110.418 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.18 -40.92 6.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.95 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -160.78 161.89 32.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.498 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -138.03 120.76 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.013 0.435 . . . . 10.0 110.484 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.4 t -115.66 107.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 10.0 109.872 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -115.21 133.62 55.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.452 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.65 -75.72 0.42 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.415 -0.897 . . . . 10.0 112.96 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.9 m -159.88 159.26 32.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.018 -0.364 . . . . 10.0 110.018 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.38 170.6 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.311 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -156.0 174.33 15.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.643 -0.253 . . . . 10.0 111.132 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.19 -40.01 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.57 -46.23 87.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 10.0 110.902 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -67.94 -37.74 81.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.953 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.51 80.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.38 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.78 -38.97 92.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.739 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.17 91.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.262 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.1 tp -62.88 -35.65 80.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 10.0 111.646 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.2 mt -70.1 -27.89 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.214 0.53 . . . . 10.0 110.552 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -89.11 -47.33 8.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.077 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -137.15 110.61 9.14 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.622 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.48 3.45 4.2 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.306 2.67 . . . . 10.0 112.812 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -93.1 -7.27 46.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.458 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.04 131.34 44.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.005 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -133.31 136.9 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.465 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.092 0 N-CA-C 113.944 1.09 . . . . 10.0 113.944 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.716 0.293 . . . . 10.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.75 -53.1 59.49 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.314 -0.403 . . . . 10.0 112.086 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 49.6 tp -89.73 -73.09 0.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.131 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 57.59 35.46 25.76 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.214 0.531 . . . . 10.0 110.918 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.67 167.81 27.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.778 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.8 m120 65.68 -170.36 0.19 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.721 0.638 . . . . 10.0 112.398 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -101.17 19.44 17.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.124 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -88.97 20.24 3.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.614 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.3 136.56 13.26 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.279 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -61.42 150.23 86.0 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.166 2.577 . . . . 10.0 112.11 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.18 -40.09 60.83 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.682 2.921 . . . . 10.0 113.365 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -65.24 -19.65 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.009 0.374 . . . . 10.0 112.009 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -106.91 -10.53 15.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.367 0.604 . . . . 10.0 110.041 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.49 -8.22 59.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.539 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -134.08 131.53 38.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.923 0.392 . . . . 10.0 111.571 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.59 91.57 42.12 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.37 108.74 2.58 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.12 2.547 . . . . 10.0 113.32 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -104.43 107.93 19.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.963 -0.755 . . . . 10.0 108.963 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.19 120.45 35.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.57 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.71 108.66 14.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.354 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 85.1 t -98.86 128.13 50.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.218 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.69 -166.94 1.34 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.291 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.31 -38.03 27.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.533 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.09 -41.66 85.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.216 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 178.12 -168.28 39.48 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.664 -0.779 . . . . 10.0 112.274 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 86.1 t -101.92 131.74 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.79 -0.448 . . . . 10.0 109.79 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -121.42 118.96 30.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.956 0.408 . . . . 10.0 110.765 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 p -103.47 116.96 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.12 0.486 . . . . 10.0 110.439 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -123.91 82.25 2.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.484 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -87.62 134.25 33.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.79 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 71.6 mtm-85 -85.52 129.36 34.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.298 -0.41 . . . . 10.0 111.034 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 76.9 mt -101.78 132.58 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.003 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.38 144.33 57.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.441 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.35 91.79 0.26 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.458 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.43 -23.06 0.95 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.427 -0.669 . . . . 10.0 111.427 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -100.74 159.24 15.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.103 -0.702 . . . . 10.0 109.103 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -150.32 136.57 18.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.131 0.491 . . . . 10.0 111.581 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 23.7 mtt -107.48 153.22 23.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.389 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -96.16 127.07 41.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.071 -0.714 . . . . 10.0 109.071 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -59.06 -33.79 71.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.849 0.356 . . . . 10.0 111.402 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.04 1.3 32.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.229 -0.442 . . . . 10.0 111.302 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -116.53 -6.72 11.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 10.0 111.427 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 81.0 mt -87.97 96.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 10.0 110.055 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 39.1 t -91.34 117.95 35.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.304 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.71 140.89 9.55 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.614 -0.803 . . . . 10.0 111.847 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -163.71 147.46 10.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.789 0.328 . . . . 10.0 110.713 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 9.4 t -144.18 120.41 10.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.143 -0.48 . . . . 10.0 109.854 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -174.96 155.19 1.83 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.47 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.13 -66.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.837 2.358 . . . . 10.0 111.52 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.42 36.18 2.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.48 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 13.8 t0 64.58 33.16 11.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.495 -0.775 . . . . 10.0 112.611 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.78 76.6 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.92 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -131.98 155.51 47.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.681 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.04 -80.46 0.64 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.094 -0.803 . . . . 10.0 111.094 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -168.99 147.8 3.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.841 -0.429 . . . . 10.0 109.841 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.02 110.53 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.637 2.225 . . . . 10.0 110.919 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.9 m -95.25 100.62 12.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.016 0.436 . . . . 10.0 111.401 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -80.58 168.16 19.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.98 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 42.4 m -97.67 -7.2 31.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.713 -0.221 . . . . 10.0 111.39 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt 69.41 117.6 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.829 0.677 . . . . 10.0 112.829 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.53 -125.34 5.57 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.914 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.21 158.4 28.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -94.31 123.31 37.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.932 0.396 . . . . 10.0 110.667 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -100.97 130.02 46.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.982 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.41 120.83 23.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.392 -0.966 . . . . 10.0 108.392 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -110.2 176.05 5.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.104 0.478 . . . . 10.0 111.432 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -110.06 -25.1 10.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.214 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.61 -42.68 3.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.054 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -88.32 4.55 45.65 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.072 0.397 . . . . 10.0 112.072 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.98 -89.57 1.18 Allowed Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.715 -0.755 . . . . 10.0 111.859 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -171.09 123.9 0.61 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -136.57 167.3 21.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.337 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 15.2 m -75.34 128.78 36.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.521 -0.918 . . . . 10.0 108.521 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.65 162.69 32.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.433 0.635 . . . . 10.0 112.46 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -122.09 129.09 52.07 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.718 -1.216 . . . . 10.0 107.718 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -110.39 -15.54 13.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.721 0.637 . . . . 10.0 112.721 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -159.88 -35.24 0.06 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.6 OUTLIER -83.98 144.33 29.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.031 -0.986 . . . . 10.0 108.779 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -170.13 101.57 0.29 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.857 0.36 . . . . 10.0 111.042 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -140.57 120.37 13.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.118 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.36 123.54 62.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.155 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.27 141.28 36.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.723 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -119.82 104.35 44.59 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.539 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.4 126.12 3.07 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.781 2.321 . . . . 10.0 111.448 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -70.14 151.27 45.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.918 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.05 -11.74 25.95 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -149.35 122.29 8.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.166 -0.924 . . . . 10.0 109.075 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.84 85.95 6.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.087 0.47 . . . . 10.0 110.651 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 m -114.63 160.55 13.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.858 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.63 2.38 82.54 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.77 -0.728 . . . . 10.0 111.695 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.68 125.45 82.78 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.572 -0.314 . . . . 10.0 110.893 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.13 101.31 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.407 2.071 . . . . 10.0 110.6 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.63 163.91 18.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.673 0.619 . . . . 10.0 112.673 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -114.04 160.65 18.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.298 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 18.6 tp -127.42 135.84 51.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.922 0.391 . . . . 10.0 110.772 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.37 126.1 71.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 79.9 mt -129.99 126.62 38.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.889 0.376 . . . . 10.0 112.004 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 4.0 m -111.52 117.87 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -98.52 100.29 11.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.945 0.35 . . . . 10.0 111.945 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -117.61 122.05 42.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.104 0.478 . . . . 10.0 110.894 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.79 -162.33 12.46 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.937 -0.649 . . . . 10.0 111.685 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.5 m -151.95 -175.13 5.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.43 -0.582 . . . . 10.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.07 144.56 51.11 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -69.37 -4.05 16.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.156 0.503 . . . . 10.0 111.202 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.52 -13.37 43.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.982 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 118.1 -18.15 11.43 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.975 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 6.3 t -66.61 141.99 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.606 0.241 . . . . 10.0 110.473 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 13.8 t -137.49 87.74 2.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.14 0.495 . . . . 10.0 110.005 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -76.1 151.95 84.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.875 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.35 163.72 34.04 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.8 2.333 . . . . 10.0 111.521 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.0 79.15 3.2 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.623 2.215 . . . . 10.0 112.247 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.0 101.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -86.67 149.47 24.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.127 0.489 . . . . 10.0 111.701 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.09 140.89 44.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.205 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.48 137.64 38.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.007 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.81 135.54 53.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.662 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -95.13 119.48 33.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.302 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 16.5 mm -95.74 76.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 10.0 110.665 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -88.75 -24.55 22.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.005 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.54 53.89 0.17 Allowed Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.925 -0.655 . . . . 10.0 112.406 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -104.6 -4.69 22.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.246 0.546 . . . . 10.0 109.955 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.85 -77.11 1.94 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.276 -0.73 . . . . 10.0 111.276 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 2.3 m -101.81 140.03 36.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -128.09 152.72 47.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.926 0.393 . . . . 10.0 110.817 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.3 151.72 70.05 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.147 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.0 116.23 3.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.468 2.112 . . . . 10.0 111.75 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -82.77 81.47 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.241 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.927 -0.559 . . . . 10.0 109.964 -179.801 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.88 71.1 14.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.861 0.362 . . . . 10.0 111.597 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.97 -31.98 55.08 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.387 2.058 . . . . 10.0 112.256 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -61.88 -41.97 98.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.722 0.296 . . . . 10.0 110.874 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.75 -43.06 80.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.614 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.0 tp -61.95 -34.69 76.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.831 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -80.48 -13.74 58.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.236 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.4 m -84.86 -12.31 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 10.0 110.535 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -59.38 120.79 9.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.254 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.73 133.24 51.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.563 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.9 p -74.09 171.17 14.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.638 -0.504 . . . . 10.0 109.638 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.96 -12.24 60.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.432 0.634 . . . . 10.0 110.542 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -96.03 7.92 45.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.291 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 71.01 19.03 5.77 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.399 -0.819 . . . . 10.0 112.401 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -102.79 143.93 27.6 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.918 -0.401 . . . . 10.0 109.918 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.48 142.1 76.77 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.404 2.07 . . . . 10.0 111.318 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.76 -8.52 28.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.429 -0.35 . . . . 10.0 111.783 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.66 -24.27 55.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.637 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 m -63.16 -18.73 22.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.932 0.396 . . . . 10.0 111.579 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -126.03 24.27 6.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.433 0.635 . . . . 10.0 109.927 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -138.6 58.82 1.65 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.269 -0.878 . . . . 10.0 109.441 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -154.37 -178.7 7.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.98 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? 66.85 12.78 9.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.598 -0.728 . . . . 10.0 112.316 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 55.3 38.31 30.17 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.075 0.464 . . . . 10.0 111.689 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -107.51 151.56 41.03 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.704 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.84 152.16 59.39 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.009 2.472 . . . . 10.0 112.153 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.88 141.71 48.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.64 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.7 tp -122.33 94.97 4.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.6 mt -93.38 122.51 44.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.613 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.509 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 3.6 tmmt? -123.08 129.7 51.82 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.978 0.418 . . . . 10.0 111.134 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -92.8 137.88 31.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.307 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -132.57 171.91 13.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.145 -0.48 . . . . 10.0 110.475 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.67 137.54 54.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.756 0.312 . . . . 10.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.28 -39.99 46.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.928 -0.578 . . . . 10.0 112.12 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -91.64 25.02 2.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.404 0.52 . . . . 10.0 112.404 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.3 t -115.6 124.33 30.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.24 -41.96 24.92 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.771 2.314 . . . . 10.0 112.142 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.72 -31.53 72.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.988 0.423 . . . . 10.0 111.07 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.1 m -84.19 -14.95 48.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.568 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 mt -71.55 -45.79 61.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.556 -0.293 . . . . 10.0 111.752 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -22.04 62.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.426 0.631 . . . . 10.0 110.559 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.509 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -70.67 -23.69 62.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.353 -0.84 . . . . 10.0 111.458 -179.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -58.55 -53.93 52.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.118 0.414 . . . . 10.0 112.118 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.56 -35.76 89.9 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.047 -0.597 . . . . 10.0 111.943 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -66.95 -41.68 86.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.791 0.329 . . . . 10.0 110.46 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.9 m -61.72 -43.92 97.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.96 -0.563 . . . . 10.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -39.82 92.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.774 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.56 -40.09 95.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.114 0.483 . . . . 10.0 110.337 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -73.64 -34.12 64.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.891 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.06 -13.78 60.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.001 0.429 . . . . 10.0 111.623 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -113.01 10.62 18.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.131 0.491 . . . . 10.0 110.699 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -81.1 140.31 35.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.911 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.64 -33.36 74.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.159 0.429 . . . . 10.0 112.159 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -77.31 -37.86 51.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.721 0.296 . . . . 10.0 111.519 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -77.58 -10.26 59.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.017 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.5 t -69.18 -12.32 61.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 10.0 111.521 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 m -80.16 -2.96 46.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.918 0.389 . . . . 10.0 111.167 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.27 159.36 41.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.222 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -94.89 92.4 6.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.816 0.341 . . . . 10.0 110.339 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.76 124.48 30.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.791 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 pt -140.94 141.63 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.915 0.388 . . . . 10.0 111.434 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.49 113.33 26.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.563 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.65 142.81 22.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.886 0.374 . . . . 10.0 111.621 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -137.41 140.44 41.32 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 m -98.19 104.99 25.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.774 0.321 . . . . 10.0 111.854 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.9 121.56 8.93 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.745 2.297 . . . . 10.0 112.261 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.05 -4.78 83.22 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.577 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -111.15 148.98 31.56 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.302 -0.259 . . . . 10.0 110.302 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.6 mt 60.61 29.15 18.8 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.412 0.445 . . . . 10.0 111.667 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.0 19.24 9.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.465 -0.788 . . . . 10.0 112.105 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -80.95 179.95 7.61 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.689 0.28 . . . . 10.0 110.893 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.8 mmtt -69.18 142.24 54.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.902 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -73.19 165.69 24.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.476 -0.329 . . . . 10.0 111.303 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -55.16 147.18 16.79 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.763 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.44 -57.24 4.73 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.586 -1.006 . . . . 10.0 110.586 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.86 -44.94 95.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.401 0.619 . . . . 10.0 109.424 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -67.43 -39.01 85.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.258 -0.883 . . . . 10.0 111.33 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -65.14 -42.83 93.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.839 0.352 . . . . 10.0 111.075 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -65.55 -24.67 67.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.402 . . . . 10.0 110.854 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -64.9 -47.15 78.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.658 -0.868 . . . . 10.0 108.658 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -66.27 -41.22 90.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.714 -0.676 . . . . 10.0 110.732 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.23 -31.22 65.3 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.993 -0.549 . . . . 10.0 111.002 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.38 35.33 5.04 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.835 -0.698 . . . . 10.0 112.067 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mt -118.3 -178.22 3.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.81 0.338 . . . . 10.0 110.814 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -100.31 171.44 7.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 66.6 82.11 0.2 Allowed Pre-proline 0 N--CA 1.466 0.326 0 O-C-N 123.556 0.535 . . . . 10.0 111.41 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.73 1.36 6.45 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.45 2.1 . . . . 10.0 112.915 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -104.73 6.24 34.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.534 0.207 . . . . 10.0 111.108 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -69.05 116.84 45.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.755 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.94 69.01 8.07 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.543 2.162 . . . . 10.0 111.696 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.51 124.78 41.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.717 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 t -112.03 142.53 24.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.31 104.3 16.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.814 0.34 . . . . 10.0 110.986 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -85.77 79.92 9.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.137 0.494 . . . . 10.0 110.039 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -65.67 110.26 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.601 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.34 -25.18 27.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.875 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.27 51.51 2.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.651 -0.785 . . . . 10.0 111.654 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -51.6 66.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.009 0.433 . . . . 10.0 110.45 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.5 mm -81.89 -38.18 15.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.021 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.51 83.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.281 -0.872 . . . . 10.0 111.787 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -80.57 -28.28 37.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 10.0 111.184 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -63.02 -47.03 84.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.57 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -101.37 -5.76 24.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.849 0.314 . . . . 10.0 111.849 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 t30 65.79 70.82 0.43 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.57 0.7 . . . . 10.0 111.638 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -86.47 126.44 40.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.433 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.41 23.52 2.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.877 0.37 . . . . 10.0 111.245 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.5 p -172.05 157.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.409 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -123.51 150.49 61.25 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.511 -0.552 . . . . 10.0 109.511 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -90.09 132.38 9.18 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.315 -1.535 . . . . 10.0 111.978 -0.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.7 m -93.61 121.45 35.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.189 -0.46 . . . . 10.0 109.939 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -106.62 108.47 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.829 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.13 110.12 22.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.208 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 38.6 tp -90.81 112.01 23.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.699 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.0 133.11 45.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -71.38 -179.51 30.96 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.056 -0.592 . . . . 10.0 113.121 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -75.56 -4.9 42.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 10.0 111.405 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.98 -12.39 25.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.236 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 99.95 5.08 55.25 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.754 -0.736 . . . . 10.0 113.216 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -106.5 152.91 23.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.686 0.279 . . . . 10.0 111.24 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.92 118.67 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.094 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.53 -48.72 7.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.554 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -147.75 141.79 25.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.592 -0.277 . . . . 10.0 111.132 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -121.89 121.64 64.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.307 -0.406 . . . . 10.0 109.999 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.0 t -113.22 125.89 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.688 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -126.17 110.58 13.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.427 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 157.79 -87.47 0.12 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.173 -1.013 . . . . 10.0 113.2 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.5 t -170.57 131.17 0.89 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt -116.01 158.05 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.726 0.298 . . . . 10.0 110.796 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -108.23 171.48 7.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.473 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.53 -40.4 96.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.021 0.378 . . . . 10.0 112.021 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.4 88.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.556 -0.293 . . . . 10.0 110.767 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -61.89 -41.8 98.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.746 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.3 96.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 10.0 110.364 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.8 mt -71.52 -26.5 62.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.972 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.93 -34.35 29.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.504 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.5 tp -62.86 -33.95 76.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.25 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 13.3 pt -83.03 15.91 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.124 0.487 . . . . 10.0 111.31 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -133.69 -48.33 0.82 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.655 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -138.25 97.36 9.63 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.302 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.94 2.57 4.05 Favored 'Trans proline' 0 CA--C 1.526 0.092 0 C-N-CA 123.014 2.476 . . . . 10.0 112.83 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -95.36 -5.32 43.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.825 0.345 . . . . 10.0 110.132 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.17 134.6 36.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.836 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -126.09 155.08 42.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.16 -0.682 . . . . 10.0 109.16 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.98 0 N-CA-C 113.57 0.952 . . . . 10.0 113.57 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 47.4 mtt . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.599 0.238 . . . . 10.0 111.32 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.65 -83.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.462 -0.335 . . . . 10.0 111.287 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 34.8 tp -93.32 -55.04 3.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.005 -0.278 . . . . 10.0 110.896 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 53.6 35.58 21.33 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.672 0.608 . . . . 10.0 111.518 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.93 166.44 27.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.441 -0.8 . . . . 10.0 110.555 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.91 -160.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.413 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -107.16 28.46 8.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.302 0.572 . . . . 10.0 109.925 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -92.95 7.68 42.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.96 -0.564 . . . . 10.0 111.391 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -133.17 140.81 38.53 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.772 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.88 148.7 93.14 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.125 2.55 . . . . 10.0 112.333 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.28 -37.76 81.18 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.46 2.773 . . . . 10.0 113.456 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -63.98 -20.89 66.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 10.0 111.936 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -111.57 -6.32 14.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.253 0.549 . . . . 10.0 110.468 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.12 -17.36 46.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.042 -0.527 . . . . 10.0 111.793 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -127.54 125.81 41.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.711 0.291 . . . . 10.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.76 89.8 16.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.114 -0.494 . . . . 10.0 109.757 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.26 106.5 2.18 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.996 2.464 . . . . 10.0 112.707 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -101.57 110.23 22.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.665 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -92.73 117.08 29.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.152 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.68 98.03 6.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.284 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 t -82.18 117.12 27.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.204 -0.453 . . . . 10.0 109.94 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.27 -174.32 2.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.476 -0.329 . . . . 10.0 110.808 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.14 -37.88 53.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.422 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.3 -36.68 39.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.788 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.52 -179.75 45.32 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.521 -0.847 . . . . 10.0 112.432 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.44 128.74 42.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -114.94 110.23 19.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.94 124.11 47.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.904 0.383 . . . . 10.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -127.03 87.94 2.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.195 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -91.55 118.04 30.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.94 0.4 . . . . 10.0 110.765 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 mtm-85 -78.2 126.18 30.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.702 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 23.7 mt -101.93 141.25 18.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.263 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.42 151.21 47.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.039 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.92 81.68 2.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.142 0.496 . . . . 10.0 111.381 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.05 -21.22 0.13 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.063 -0.815 . . . . 10.0 111.063 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.23 147.15 28.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -139.78 136.08 33.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.094 0.474 . . . . 10.0 111.009 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 43.2 mtt -106.91 152.18 24.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.973 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -92.11 125.59 36.85 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.903 -0.777 . . . . 10.0 108.903 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -59.85 -29.66 68.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.716 0.293 . . . . 10.0 111.668 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.39 -8.62 59.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.36 . . . . 10.0 111.17 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -107.45 -13.81 15.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.838 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 85.3 mt -80.84 102.24 6.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.022 0.439 . . . . 10.0 109.847 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.77 129.85 44.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.683 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.6 129.04 2.64 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.686 -0.769 . . . . 10.0 111.911 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -156.47 137.81 13.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.818 0.342 . . . . 10.0 111.097 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 13.2 t -138.49 125.11 20.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.494 -0.558 . . . . 10.0 109.494 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -177.9 160.1 1.27 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.316 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.08 -76.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.687 2.258 . . . . 10.0 110.635 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.57 48.62 0.83 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.447 0.641 . . . . 10.0 109.839 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 6.7 t0 63.63 35.82 11.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.998 -1.001 . . . . 10.0 112.427 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.65 67.57 6.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.79 -0.641 . . . . 10.0 111.075 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 19.1 tp -125.28 144.45 50.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 10.0 109.798 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.46 -64.94 1.91 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.561 -0.828 . . . . 10.0 112.254 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -169.29 157.71 7.07 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.0 -0.37 . . . . 10.0 110.0 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.99 97.72 1.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.514 2.143 . . . . 10.0 110.427 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m -78.97 100.37 7.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.971 0.415 . . . . 10.0 111.611 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -87.96 149.48 24.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.095 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m -79.98 -14.13 58.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.701 0.286 . . . . 10.0 110.755 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? 72.72 136.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.672 -0.695 . . . . 10.0 112.332 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.38 -133.24 4.33 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.003 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -116.18 149.38 39.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -86.66 136.27 33.09 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -114.8 130.85 56.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.636 0.255 . . . . 10.0 110.791 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.18 119.75 18.82 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.14 -177.76 3.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.79 -0.641 . . . . 10.0 109.429 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -112.2 -51.6 2.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.683 0.277 . . . . 10.0 111.097 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -84.49 -30.13 25.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.253 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -95.91 -10.11 29.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.997 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.23 -92.66 1.39 Allowed Glycine 0 C--O 1.224 -0.488 0 C-N-CA 120.853 -0.689 . . . . 10.0 112.734 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -165.2 115.57 1.1 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.758 0.313 . . . . 10.0 110.615 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -144.06 170.53 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.258 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 3.4 m -74.14 134.35 42.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.548 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.65 161.02 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.97 0.414 . . . . 10.0 111.131 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -115.98 130.98 57.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.185 -1.043 . . . . 10.0 108.185 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -114.22 -6.84 13.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.793 0.664 . . . . 10.0 112.793 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -173.17 -37.0 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.26 135.49 34.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.918 -1.037 . . . . 10.0 109.537 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.7 110.98 1.54 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.002 0.43 . . . . 10.0 111.382 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -151.39 121.25 7.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.254 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 t -125.89 131.96 71.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.56 135.74 48.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.875 0.369 . . . . 10.0 110.435 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -113.73 108.28 51.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.374 -0.376 . . . . 10.0 111.626 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.41 131.08 4.02 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.836 2.358 . . . . 10.0 111.655 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -76.34 142.77 41.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 10.0 109.942 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.9 11.22 38.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.096 0.474 . . . . 10.0 110.661 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -166.69 128.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.697 -0.683 . . . . 10.0 109.656 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.38 81.41 5.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.995 0.426 . . . . 10.0 111.337 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.5 126.72 73.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.996 -0.547 . . . . 10.0 110.74 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.46 58.26 4.87 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.045 -0.598 . . . . 10.0 111.77 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -113.78 149.17 41.34 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.93 95.23 0.48 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.138 1.892 . . . . 10.0 111.472 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.28 140.16 38.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.262 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -91.86 147.3 23.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 35.9 tp -118.6 127.79 53.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.881 0.372 . . . . 10.0 110.887 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.37 121.15 66.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.031 -0.729 . . . . 10.0 109.031 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.14 137.61 53.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 10.0 111.324 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 7.3 m -129.02 121.0 27.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -104.77 118.5 36.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.919 0.39 . . . . 10.0 111.457 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 11.3 tp60 -132.9 123.71 26.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.32 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.88 -158.33 9.43 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.66 -0.781 . . . . 10.0 111.737 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 20.3 m -152.05 175.57 12.41 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.283 -0.636 . . . . 10.0 109.283 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -115.71 148.81 39.35 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.142 -0.318 . . . . 10.0 110.142 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.39 -10.55 44.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.237 0.458 . . . . 10.0 112.237 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.52 6.98 46.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 10.0 111.507 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.82 -6.8 67.4 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.761 -0.733 . . . . 10.0 112.549 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 5.7 t -68.35 136.26 26.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.843 -0.429 . . . . 10.0 109.843 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 21.6 t -127.31 107.98 10.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.692 0.282 . . . . 10.0 110.744 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -97.72 148.34 34.31 Favored Pre-proline 0 C--N 1.327 -0.402 0 O-C-N 122.226 -0.296 . . . . 10.0 111.625 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.53 159.49 52.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.927 2.418 . . . . 10.0 111.666 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.51 83.59 1.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.583 2.189 . . . . 10.0 111.72 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.17 122.86 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.01 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -104.71 150.32 24.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.03 0.443 . . . . 10.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -141.5 138.78 33.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.004 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -107.78 134.93 50.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.556 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -122.38 150.02 43.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.853 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -116.42 116.21 27.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.751 0.31 . . . . 10.0 110.171 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 19.9 mm -94.15 93.13 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.044 0.45 . . . . 10.0 111.06 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -102.08 -13.45 17.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.319 0.58 . . . . 10.0 110.926 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 122.5 110.87 2.07 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.634 -0.793 . . . . 10.0 112.095 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -176.02 -22.13 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 10.0 110.565 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.92 -74.3 2.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.707 -0.758 . . . . 10.0 111.861 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.62 129.45 35.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 10.0 111.238 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -132.84 150.26 52.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.327 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.65 146.99 34.18 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.239 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.74 118.62 5.63 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.487 2.125 . . . . 10.0 112.407 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -75.51 82.57 2.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.489 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.877 -0.582 . . . . 10.0 109.995 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 m -127.49 64.81 64.32 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 112.229 0.455 . . . . 10.0 112.229 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.58 -36.63 63.38 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.062 1.841 . . . . 10.0 111.973 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -65.89 -37.17 85.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.734 0.302 . . . . 10.0 110.985 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -70.33 -31.45 68.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.651 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.34 -32.04 73.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.221 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 m -86.79 -8.24 57.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.833 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 m -76.5 -23.08 53.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.593 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -73.52 118.14 16.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.284 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -111.19 147.55 34.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.386 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 p -71.3 178.26 3.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.084 -0.507 . . . . 10.0 111.332 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.17 -14.98 62.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.05 0.453 . . . . 10.0 110.465 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -89.0 -2.2 58.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.632 -0.713 . . . . 10.0 109.319 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.6 t30 75.22 19.67 2.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.854 -1.066 . . . . 10.0 110.554 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -101.13 126.54 34.5 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.226 -0.897 . . . . 10.0 109.278 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.49 140.49 35.49 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.132 2.555 . . . . 10.0 112.397 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.41 -2.56 8.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.302 0.482 . . . . 10.0 112.302 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.12 -16.13 29.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 10.0 111.439 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.73 -23.97 34.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.991 0.425 . . . . 10.0 111.052 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -120.42 4.27 10.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.686 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.6 mt -108.81 26.65 10.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.267 0.556 . . . . 10.0 110.348 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -128.97 -174.94 3.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.913 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt 68.92 11.15 8.26 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.72 0.638 . . . . 10.0 111.151 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.37 41.54 32.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.36 -0.837 . . . . 10.0 111.82 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -110.42 138.89 21.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.95 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.23 125.67 19.94 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.962 2.441 . . . . 10.0 111.713 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.8 117.86 34.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.757 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tp -89.23 110.03 20.84 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.4 mt -93.58 118.53 39.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 10.0 111.992 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.557 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 14.8 tttt -119.92 129.64 54.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.482 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -99.07 135.35 40.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.465 -0.334 . . . . 10.0 111.085 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -122.42 -178.6 3.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 10.0 110.812 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.22 146.38 35.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.571 0.225 . . . . 10.0 111.133 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.7 -31.34 14.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.705 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -82.32 11.0 5.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.189 0.44 . . . . 10.0 112.189 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.89 125.82 27.19 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.74 0.305 . . . . 10.0 111.449 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.8 -35.44 9.59 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.533 2.156 . . . . 10.0 112.63 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.7 mt -64.52 -47.04 80.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.38 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 76.7 m -69.46 -20.1 63.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.275 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 tp -69.09 -41.73 77.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.594 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.99 -32.88 69.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.129 0.49 . . . . 10.0 110.223 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.557 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -63.12 -23.41 67.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.622 -0.717 . . . . 10.0 110.978 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.9 mt -59.5 -36.73 76.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 10.0 110.352 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.78 -37.09 88.3 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.564 -1.014 . . . . 10.0 110.564 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.33 -36.01 73.99 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -61.87 -41.62 98.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.806 -0.634 . . . . 10.0 109.852 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -61.55 -39.18 90.18 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 120.962 0.41 . . . . 10.0 109.945 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -63.08 -44.14 96.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.705 -0.68 . . . . 10.0 109.727 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -68.52 -33.5 74.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.983 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.43 -2.73 20.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.123 0.487 . . . . 10.0 110.821 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -125.3 14.82 8.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.74 -0.663 . . . . 10.0 109.603 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -87.05 140.92 29.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.447 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.73 94.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.165 0.431 . . . . 10.0 112.165 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -76.39 -37.81 56.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.77 0.319 . . . . 10.0 111.321 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -71.16 -16.0 62.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.322 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.9 t -72.26 -0.28 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 10.0 111.673 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -75.49 -22.05 57.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 10.0 110.222 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.96 169.05 15.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 10.0 109.72 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -100.08 97.5 8.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.673 0.273 . . . . 10.0 110.315 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.2 tp -83.29 130.81 35.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.442 -0.344 . . . . 10.0 110.944 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.6 pt -135.9 146.71 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.966 0.413 . . . . 10.0 111.156 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.03 105.98 16.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.236 -0.438 . . . . 10.0 109.908 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.4 t -103.31 146.51 10.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.124 0.487 . . . . 10.0 111.71 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.44 146.25 33.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.205 -1.035 . . . . 10.0 108.205 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.1 m -106.46 98.63 20.68 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 112.196 0.443 . . . . 10.0 112.196 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.0 123.51 13.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.944 2.429 . . . . 10.0 112.27 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.98 -13.36 66.37 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.944 -0.646 . . . . 10.0 112.954 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -94.42 139.05 31.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.822 0.311 . . . . 10.0 110.469 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.03 35.55 26.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.08 -0.509 . . . . 10.0 112.183 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.36 20.73 8.56 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.026 0.75 . . . . 10.0 113.026 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.69 -179.07 4.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.718 0.294 . . . . 10.0 110.723 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -67.39 121.3 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.218 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -66.5 155.56 37.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.706 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.09 130.79 47.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.176 -0.466 . . . . 10.0 111.173 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.16 -40.41 2.53 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.586 -1.406 . . . . 10.0 109.586 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -97.4 -34.84 10.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.965 0.412 . . . . 10.0 110.103 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.26 -50.97 69.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.706 . . . . 10.0 112.432 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -35.31 76.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.457 -0.338 . . . . 10.0 111.482 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -70.65 -28.9 65.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.765 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -60.99 -49.74 76.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.623 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -73.93 -32.06 63.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.605 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.88 -18.99 63.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.6 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.74 5.88 43.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.938 -0.648 . . . . 10.0 111.689 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.0 mt -106.49 177.48 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.958 0.408 . . . . 10.0 111.042 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.427 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 49.3 t30 -98.22 -162.65 0.97 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.765 -0.652 . . . . 10.0 109.942 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.427 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 13.5 m-85 65.43 78.28 0.26 Allowed Pre-proline 0 N--CA 1.464 0.258 0 C-N-CA 122.829 0.451 . . . . 10.0 111.356 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.05 -0.69 10.57 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.616 2.211 . . . . 10.0 112.3 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -101.22 10.55 40.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.5 mt -85.76 112.56 45.71 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.019 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.03 63.44 8.71 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.571 2.181 . . . . 10.0 111.051 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.3 t -73.38 117.89 17.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.825 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.28 138.98 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.439 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 107.09 19.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.119 -0.492 . . . . 10.0 110.922 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -103.18 84.33 2.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.894 0.378 . . . . 10.0 110.237 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -63.9 116.87 6.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 10.0 112.109 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.96 -19.66 53.91 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.825 -0.703 . . . . 10.0 112.629 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.77 50.71 5.13 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.106 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.12 99.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.976 0.417 . . . . 10.0 110.523 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.9 mm -82.88 -40.2 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.889 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.63 -45.12 95.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.759 -0.655 . . . . 10.0 111.655 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -72.0 -30.04 64.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -65.86 -38.53 89.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.948 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.13 7.2 44.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.947 0.404 . . . . 10.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.3 t30 50.48 60.98 3.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.421 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.9 mt -87.14 98.46 7.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.752 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.21 8.62 25.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.914 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.0 p -149.17 154.53 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.67 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -131.05 152.63 81.01 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.252 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.39 161.7 76.75 Favored 'Cis proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.935 -1.694 . . . . 10.0 111.372 -1.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 m -127.67 131.34 49.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.698 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -118.82 125.12 48.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.19 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.54 113.08 26.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.843 0.354 . . . . 10.0 110.332 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.1 tp -89.51 101.12 13.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.168 0.509 . . . . 10.0 111.293 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.28 133.13 32.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.666 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.26 -177.43 49.96 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.088 -0.577 . . . . 10.0 113.244 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -67.86 -11.4 58.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.265 0.469 . . . . 10.0 112.265 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.36 -7.94 30.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 10.0 111.382 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.38 -7.0 63.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.684 -0.769 . . . . 10.0 112.626 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -89.0 156.0 19.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.734 0.302 . . . . 10.0 110.844 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.6 t -78.55 107.75 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.149 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -81.99 -41.52 20.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.263 -0.426 . . . . 10.0 111.507 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -148.76 160.01 43.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.372 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.9 tt -138.14 141.44 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.493 -0.558 . . . . 10.0 109.493 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.3 t -121.92 129.98 74.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.202 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -133.21 124.68 27.84 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.437 -0.347 . . . . 10.0 110.128 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 132.88 -72.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.44 -0.886 . . . . 10.0 112.511 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 5.1 t -178.83 162.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.6 pt -146.28 152.17 13.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.158 -0.474 . . . . 10.0 109.914 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -109.96 170.41 8.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.836 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -56.41 -43.8 79.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.03 78.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 10.0 110.807 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -67.86 -37.26 81.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.903 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.66 97.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.0 mt -69.37 -40.92 77.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.782 -0.644 . . . . 10.0 110.5 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.29 -36.71 84.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.067 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.83 -35.75 80.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.933 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.87 -36.81 59.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.343 0.592 . . . . 10.0 109.416 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -70.24 -47.48 61.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.465 -0.789 . . . . 10.0 110.709 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -150.42 112.27 3.23 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.495 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -68.01 -7.32 19.44 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.922 2.415 . . . . 10.0 112.061 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -92.85 -0.27 57.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.932 0.396 . . . . 10.0 111.187 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.39 84.2 7.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.902 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -75.69 147.33 39.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.051 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.977 -1.011 . . . . 10.0 113.108 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.521 ' H3 ' ' CG ' ' B' ' 4' ' ' ASP . 63.2 mtt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.795 0.331 . . . . 10.0 110.837 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.22 -72.61 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.523 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 38.2 tp -78.98 -77.29 0.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . 0.521 ' CG ' ' H3 ' ' B' ' 1' ' ' MET . 75.1 m-20 59.03 36.13 24.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.116 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.95 159.29 42.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.242 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 21.5 m120 64.03 -154.2 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.448 -0.797 . . . . 10.0 111.761 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -107.19 17.54 22.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.965 0.412 . . . . 10.0 111.028 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.35 8.59 4.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.476 0.547 . . . . 10.0 112.476 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.16 132.61 14.74 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.69 -0.232 . . . . 10.0 111.094 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.87 153.93 59.65 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.353 2.702 . . . . 10.0 112.184 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.55 -40.25 54.87 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.591 2.86 . . . . 10.0 113.612 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -65.49 -13.81 59.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -117.13 -1.13 11.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.205 0.526 . . . . 10.0 110.412 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.69 -12.48 23.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.116 -0.493 . . . . 10.0 112.077 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -124.01 128.74 49.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.859 0.362 . . . . 10.0 111.486 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.71 91.11 24.27 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.389 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.52 95.78 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.986 2.458 . . . . 10.0 112.367 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.51 97.74 11.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.93 110.31 20.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.159 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.5 101.92 10.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.158 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.96 130.98 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.186 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.96 176.28 5.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.847 -0.427 . . . . 10.0 109.847 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.22 -34.16 68.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.929 0.395 . . . . 10.0 111.447 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.46 -36.34 53.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.277 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -178.75 -175.93 46.2 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.961 -0.638 . . . . 10.0 111.692 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.09 133.35 40.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 110.228 -0.286 . . . . 10.0 110.228 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -120.28 105.45 10.94 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.967 -0.383 . . . . 10.0 109.967 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 p -93.57 124.19 45.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.128 0.489 . . . . 10.0 110.969 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -127.47 85.77 2.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.91 -0.586 . . . . 10.0 109.947 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -82.71 111.23 18.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.265 0.555 . . . . 10.0 111.004 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 32.5 mtm-85 -75.55 112.5 11.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.453 -0.794 . . . . 10.0 110.194 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -91.65 145.21 7.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.819 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.8 155.06 40.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.148 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.15 88.16 2.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.104 0.478 . . . . 10.0 111.27 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.74 -15.46 0.45 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.538 -0.625 . . . . 10.0 111.538 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -109.66 142.37 40.92 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -133.9 136.98 44.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.86 0.362 . . . . 10.0 110.862 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 41.1 mtt -108.52 147.65 31.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.864 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -88.25 123.82 33.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.853 -0.425 . . . . 10.0 109.853 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -60.08 -32.42 70.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.517 -0.31 . . . . 10.0 111.403 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.67 5.74 20.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.306 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -124.58 -8.42 7.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.461 -0.336 . . . . 10.0 111.836 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 86.9 mt -83.91 99.21 6.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.251 0.548 . . . . 10.0 110.155 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 41.6 t -90.25 112.0 24.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.09 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.73 128.71 3.71 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.893 -0.67 . . . . 10.0 111.545 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -160.56 143.13 13.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.945 0.402 . . . . 10.0 111.444 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 13.4 t -134.6 131.45 37.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.903 -0.59 . . . . 10.0 109.64 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -177.08 158.08 1.37 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.576 -0.284 . . . . 10.0 110.774 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -74.67 -58.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.614 2.209 . . . . 10.0 110.976 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.63 48.53 2.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 10.0 109.795 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.23 36.62 5.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.326 -0.852 . . . . 10.0 111.748 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -97.01 56.69 1.43 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.712 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.8 tp -130.64 152.1 50.38 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.097 -0.705 . . . . 10.0 109.097 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.71 -87.26 0.3 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.542 -0.837 . . . . 10.0 111.726 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -155.93 149.29 18.67 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 110.008 -0.368 . . . . 10.0 110.008 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.45 107.15 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.661 2.24 . . . . 10.0 111.168 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.1 m -79.2 95.38 5.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.154 0.502 . . . . 10.0 110.78 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -78.04 144.57 36.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.528 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.7 m -82.64 -9.38 59.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.566 -0.288 . . . . 10.0 111.318 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? 71.24 166.22 0.3 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.907 -0.588 . . . . 10.0 111.979 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.14 -134.56 1.74 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.463 -0.655 . . . . 10.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -106.44 151.9 24.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.623 0.212 . . . . 10.0 110.558 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -90.89 125.87 35.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -102.16 128.52 48.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.497 -0.32 . . . . 10.0 110.977 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.76 130.62 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.322 -0.621 . . . . 10.0 109.322 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -133.91 163.53 29.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -93.24 -30.28 15.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.822 0.344 . . . . 10.0 111.301 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.27 -39.35 8.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.592 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -89.87 -9.2 49.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.89 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.76 -85.79 0.97 Allowed Glycine 0 C--O 1.227 -0.333 0 C-N-CA 120.758 -0.734 . . . . 10.0 112.673 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -165.24 115.91 1.11 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.645 0.259 . . . . 10.0 110.956 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -138.99 158.72 43.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.288 -0.415 . . . . 10.0 110.447 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 5.6 m -70.79 130.4 41.6 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.425 -0.583 . . . . 10.0 109.425 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.55 150.21 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.377 0.608 . . . . 10.0 112.179 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -110.8 116.36 31.14 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.86 -1.163 . . . . 10.0 107.86 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -103.78 -3.01 25.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.581 0.585 . . . . 10.0 112.581 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.14 -41.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.186 0.517 . . . . 10.0 109.672 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' B' ' 78' ' ' GLU . 1.0 OUTLIER -89.26 100.4 13.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.329 -0.85 . . . . 10.0 110.98 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.49 107.39 8.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.979 0.419 . . . . 10.0 111.397 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -138.43 128.01 24.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.689 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 19.0 t -128.65 129.6 68.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.251 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.72 144.06 31.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.605 -0.271 . . . . 10.0 110.469 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -119.86 100.54 48.57 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.691 0.282 . . . . 10.0 111.684 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.05 118.81 2.39 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.995 2.463 . . . . 10.0 112.01 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -66.4 144.47 56.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 10.0 111.612 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.48 11.66 34.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.23 0.538 . . . . 10.0 109.797 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -164.04 124.93 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.317 -0.856 . . . . 10.0 109.955 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.05 92.55 6.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.06 0.457 . . . . 10.0 110.59 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 12.0 m -121.78 163.7 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.614 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.31 21.02 22.64 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.743 -0.741 . . . . 10.0 111.673 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -93.51 138.04 23.13 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.19 127.75 24.12 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.589 2.193 . . . . 10.0 111.039 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.54 153.78 22.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.435 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -95.69 152.08 18.78 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.691 -0.485 . . . . 10.0 109.691 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 22.7 tp -126.6 124.22 39.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.695 0.283 . . . . 10.0 110.601 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 24.6 t -108.69 123.05 64.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 81.9 mt -126.63 120.26 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 10.0 111.833 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -112.96 117.14 31.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.745 -0.661 . . . . 10.0 109.828 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -99.6 107.17 19.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.627 0.251 . . . . 10.0 111.085 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 14.7 tp60 -121.5 126.02 48.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 10.0 110.936 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.64 -157.76 11.18 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.432 -0.667 . . . . 10.0 111.432 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.3 m -153.51 167.84 28.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.17 144.67 31.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.42 -16.51 60.77 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.107 0.41 . . . . 10.0 112.107 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.27 -12.51 56.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.456 -0.338 . . . . 10.0 111.78 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.48 -14.77 10.77 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.371 -0.918 . . . . 10.0 113.006 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.45 131.8 29.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.94 76.92 1.32 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.961 0.41 . . . . 10.0 110.695 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -66.02 157.14 81.87 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.949 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.8 160.22 10.5 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.778 2.319 . . . . 10.0 112.155 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.31 70.56 7.45 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.743 2.296 . . . . 10.0 111.62 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.6 t -67.04 93.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.775 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.07 150.26 33.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.78 -0.645 . . . . 10.0 111.857 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 10.3 m -137.36 144.99 42.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.513 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -104.29 138.06 41.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.821 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -121.27 153.16 38.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.715 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -114.05 120.58 41.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.985 -0.376 . . . . 10.0 109.985 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 19.8 mm -95.87 79.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.247 0.546 . . . . 10.0 110.328 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -94.01 -14.02 26.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.222 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.44 110.03 2.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.082 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -167.55 -32.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.033 0.444 . . . . 10.0 110.624 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.71 -80.2 0.27 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.924 -0.655 . . . . 10.0 111.552 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 9.1 m -101.01 135.48 42.39 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.083 -0.34 . . . . 10.0 110.083 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -126.04 157.96 36.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.786 0.327 . . . . 10.0 111.217 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.38 148.41 20.97 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.35 137.99 49.19 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.278 1.986 . . . . 10.0 112.565 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -97.49 62.53 1.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.92 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.396 -0.811 . . . . 10.0 110.294 -179.682 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.17 62.61 39.58 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.73 -31.45 48.97 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.192 1.928 . . . . 10.0 111.514 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.89 -40.91 95.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.463 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.68 -40.43 80.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.557 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.1 tp -60.52 -32.89 71.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.207 0.527 . . . . 10.0 110.273 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.8 m -84.44 -15.92 44.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.959 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 45.8 m -79.94 -23.47 41.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.463 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.4 106.55 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.205 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -97.28 148.16 23.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.978 -0.556 . . . . 10.0 110.626 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.6 p -81.11 172.72 13.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.003 -0.544 . . . . 10.0 109.667 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.37 -5.52 19.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 10.0 110.212 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -92.53 5.01 52.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.356 -0.838 . . . . 10.0 109.825 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 73.06 13.59 4.83 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.327 0.862 . . . . 10.0 113.327 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -116.83 139.84 26.15 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.442 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.75 146.31 86.11 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.795 2.33 . . . . 10.0 112.153 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.12 -1.25 7.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 10.0 111.759 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 m -59.42 -20.95 58.96 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.145 -0.48 . . . . 10.0 111.535 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.39 -13.94 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.088 0.47 . . . . 10.0 110.849 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -125.66 20.47 7.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.601 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.7 mt -129.61 40.16 3.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.489 -0.778 . . . . 10.0 110.328 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -138.44 -178.46 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.88 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.2 mttp 69.35 12.31 8.3 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.824 0.675 . . . . 10.0 112.824 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 58.56 28.79 17.55 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.192 0.52 . . . . 10.0 111.486 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -94.51 138.19 22.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.46 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.54 141.79 90.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.87 2.38 . . . . 10.0 111.183 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -108.4 144.21 36.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.855 0.36 . . . . 10.0 111.425 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.0 tp -123.98 104.34 8.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.8 mt -88.23 118.22 33.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.72 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -110.04 116.46 31.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.666 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -90.43 148.27 22.9 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.293 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -150.53 175.88 11.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.527 -0.306 . . . . 10.0 111.32 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.78 146.97 50.04 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.366 -0.605 . . . . 10.0 109.366 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 m -70.88 -63.75 1.04 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 59.31 4.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -135.46 123.34 15.27 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.327 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.61 -49.02 16.06 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.748 2.299 . . . . 10.0 112.568 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mp -59.61 -52.74 64.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.996 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 80.5 m -64.88 -33.07 75.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.846 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 tp -62.2 -48.49 79.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.411 -0.358 . . . . 10.0 110.976 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 m -69.94 -32.46 70.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.535 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.86 -35.3 79.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.563 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.7 -39.8 81.8 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.912 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.4 -29.32 72.94 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.964 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -87.76 -27.54 22.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.873 0.368 . . . . 10.0 110.092 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.2 m -61.11 -47.91 84.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 10.0 110.912 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -37.31 86.49 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.939 0.4 . . . . 10.0 110.221 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.85 -46.85 83.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.883 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -63.2 -42.68 99.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 10.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.41 -4.93 12.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.773 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -113.35 10.64 18.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.765 0.317 . . . . 10.0 111.496 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -93.75 148.7 21.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.735 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.95 -31.85 72.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.41 -46.22 77.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.107 0.479 . . . . 10.0 111.084 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -74.85 -8.02 55.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.639 . . . . 10.0 112.364 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.3 m -70.24 -13.46 62.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.143 0.497 . . . . 10.0 110.86 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 m -69.91 -24.04 63.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.949 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.15 176.45 7.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.453 . . . . 10.0 110.956 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -108.57 98.63 8.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.45 124.22 31.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.631 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.66 138.59 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 10.0 111.508 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.38 109.76 21.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.865 -0.607 . . . . 10.0 109.681 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.9 137.4 42.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.092 0.473 . . . . 10.0 111.656 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.09 147.13 39.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.293 -1.002 . . . . 10.0 108.293 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 m -106.43 98.18 19.04 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 112.268 0.469 . . . . 10.0 112.268 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.43 123.4 11.72 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.674 2.249 . . . . 10.0 111.882 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.88 3.33 73.84 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.817 -0.629 . . . . 10.0 112.706 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.0 148.37 40.2 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.71 -0.288 . . . . 10.0 110.487 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 58.56 27.58 15.87 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 71.52 20.21 4.88 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.716 -0.675 . . . . 10.0 112.371 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -81.72 -172.54 3.93 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.876 0.37 . . . . 10.0 111.155 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -69.37 133.13 47.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.402 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -68.66 158.27 34.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 10.0 112.017 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -55.62 141.57 37.11 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.575 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.46 -60.68 1.53 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.813 -0.915 . . . . 10.0 110.813 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.96 -36.71 78.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 10.0 109.917 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.14 -41.15 97.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.407 -0.815 . . . . 10.0 111.643 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.53 -29.52 69.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.954 0.407 . . . . 10.0 110.558 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -69.93 -28.59 65.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.287 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -66.07 -44.87 83.24 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.941 -0.763 . . . . 10.0 108.941 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -65.0 -38.47 91.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.198 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.77 -20.97 66.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.44 16.16 52.83 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.037 -0.602 . . . . 10.0 112.231 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 mt -118.43 158.38 25.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.658 0.266 . . . . 10.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.416 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 66.1 t30 -82.95 -173.88 4.95 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.45 -0.574 . . . . 10.0 109.45 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.416 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 89.2 m-85 68.88 76.24 0.25 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-O 121.211 0.529 . . . . 10.0 110.207 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.14 8.82 3.03 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.747 2.298 . . . . 10.0 112.473 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -108.13 4.58 25.07 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.116 -0.234 . . . . 10.0 110.903 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.2 mt -78.23 112.52 26.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.714 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.45 71.21 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.959 2.439 . . . . 10.0 111.179 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.69 114.24 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.918 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.0 t -96.53 133.53 37.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.047 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.14 96.01 8.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.012 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -83.37 82.38 8.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.191 0.52 . . . . 10.0 110.058 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -64.31 106.52 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.896 -0.593 . . . . 10.0 111.739 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.61 -24.21 26.24 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.009 -0.615 . . . . 10.0 112.123 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.11 53.41 3.14 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.616 -0.802 . . . . 10.0 111.821 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -47.15 84.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.027 0.441 . . . . 10.0 110.659 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.7 mm -77.05 -40.86 30.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.983 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.44 90.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.851 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -75.39 -42.66 53.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.558 0.218 . . . . 10.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -62.23 -38.42 89.14 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.7 mt -97.1 -2.47 43.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.655 -0.248 . . . . 10.0 111.519 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t30 53.62 58.19 5.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.958 -0.565 . . . . 10.0 111.202 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.1 109.43 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.165 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.13 17.56 14.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.953 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.58 147.83 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.543 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -127.88 160.02 63.44 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.392 -0.596 . . . . 10.0 109.392 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -88.06 124.41 6.96 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.972 -1.262 . . . . 10.0 111.277 -0.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.0 m -105.68 143.07 34.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.124 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -121.47 129.77 53.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.19 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -111.33 114.9 28.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.199 -0.455 . . . . 10.0 111.063 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.5 tp -92.13 117.1 29.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.778 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.24 136.2 38.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.605 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -74.59 -173.43 30.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.227 -0.511 . . . . 10.0 113.401 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -73.6 -12.97 60.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.975 0.417 . . . . 10.0 111.121 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.27 7.48 46.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.865 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.74 24.71 76.32 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.866 -0.683 . . . . 10.0 111.904 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -114.03 153.5 29.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.784 0.326 . . . . 10.0 110.761 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.3 t -67.78 113.99 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.926 0.393 . . . . 10.0 110.199 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -51.15 5.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.228 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -146.8 139.18 24.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.863 0.363 . . . . 10.0 111.587 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.6 tp -110.37 130.93 62.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.065 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.9 t -122.04 132.26 71.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -138.67 136.96 36.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 10.0 111.372 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.56 -80.43 0.36 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.055 -0.593 . . . . 10.0 112.477 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 p -172.62 142.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.604 -0.517 . . . . 10.0 109.604 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -125.49 171.91 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 10.0 110.843 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.33 167.69 18.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.829 -0.434 . . . . 10.0 109.829 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -58.27 -49.96 75.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.5 89.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.368 . . . . 10.0 110.867 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -64.62 -38.79 92.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.041 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.84 92.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 10.0 109.8 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.82 -38.48 91.11 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.962 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.63 90.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 10.0 110.631 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.4 tp -63.92 -34.74 78.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.461 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.98 -33.35 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -70.34 -48.66 55.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.813 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -148.67 117.08 3.95 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.29 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.24 -10.08 19.8 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.01 2.473 . . . . 10.0 112.659 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -81.65 -7.71 59.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.929 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.92 125.4 26.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.785 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -136.1 143.93 44.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.152 -0.477 . . . . 10.0 109.92 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.918 -1.039 . . . . 10.0 112.523 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.754 0.312 . . . . 10.0 110.679 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.07 -85.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.788 0.328 . . . . 10.0 110.685 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 56.0 tp -97.58 -61.75 1.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.228 -0.442 . . . . 10.0 109.984 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.23 35.63 26.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.884 -0.598 . . . . 10.0 111.227 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.37 165.67 27.27 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.902 -0.59 . . . . 10.0 111.006 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.44 -151.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.781 . . . . 10.0 112.235 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -108.47 27.24 9.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.657 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.62 23.07 9.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.739 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -147.99 137.27 11.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.148 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.78 145.41 90.77 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.022 2.482 . . . . 10.0 112.542 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.95 -36.77 76.56 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.464 2.776 . . . . 10.0 113.646 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.8 -4.31 19.47 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -126.59 -8.68 6.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.526 0.679 . . . . 10.0 109.838 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.67 -7.84 59.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 10.0 112.239 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -130.49 123.37 29.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.811 0.338 . . . . 10.0 111.011 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.48 95.62 16.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.327 -0.619 . . . . 10.0 109.327 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.05 93.59 0.96 Allowed 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.186 2.59 . . . . 10.0 113.217 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -90.37 97.36 11.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.59 122.63 29.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.438 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.01 109.37 12.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.199 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 93.7 t -97.57 120.27 46.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.846 0.355 . . . . 10.0 111.082 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.62 169.5 9.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.14 -32.54 72.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.001 0.429 . . . . 10.0 110.975 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -80.28 -37.07 33.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.994 -0.548 . . . . 10.0 111.722 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -175.51 173.82 46.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.532 -0.842 . . . . 10.0 112.444 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -89.38 140.46 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.615 0.245 . . . . 10.0 110.755 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -129.54 111.01 12.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.736 -0.468 . . . . 10.0 109.736 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.02 125.09 44.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.953 0.406 . . . . 10.0 111.182 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -129.18 80.47 1.97 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.365 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -89.72 126.62 35.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.887 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtm-85 -81.76 124.93 30.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.923 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 59.8 mt -99.37 133.7 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.771 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 148.88 33.7 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.517 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.25 74.7 1.82 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.251 0.548 . . . . 10.0 111.675 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.21 -20.77 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.037 -0.825 . . . . 10.0 111.037 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -105.25 153.19 21.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.89 -0.781 . . . . 10.0 108.89 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -145.45 139.62 26.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.005 0.431 . . . . 10.0 111.417 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 40.8 mtt -110.26 156.48 20.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.925 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -97.78 124.06 41.98 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.738 -0.468 . . . . 10.0 109.738 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -60.71 -28.54 68.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.093 0.473 . . . . 10.0 111.465 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.83 15.03 12.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 10.0 111.284 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -130.85 -18.26 3.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.637 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 80.8 mt -77.61 119.82 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.38 . . . . 10.0 110.23 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 56.5 t -98.23 126.65 51.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.023 -0.535 . . . . 10.0 109.565 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -151.55 119.77 1.02 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.733 -0.746 . . . . 10.0 111.909 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 27.4 pttt -150.74 139.67 20.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.733 0.302 . . . . 10.0 110.965 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 4.8 t -138.75 125.37 20.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.587 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 19.9 p30 179.43 162.33 0.78 Allowed Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.267 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.68 -70.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.663 2.242 . . . . 10.0 111.313 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.29 57.21 0.73 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.87 0.366 . . . . 10.0 111.362 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.3 t70 65.19 32.89 9.75 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.268 0.556 . . . . 10.0 112.089 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -96.1 58.43 1.85 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.684 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 36.4 tp -124.49 139.49 53.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.601 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 -72.51 1.11 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.636 -0.792 . . . . 10.0 111.511 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.88 151.57 9.42 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.06 103.03 1.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.583 2.189 . . . . 10.0 110.392 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 49.4 m -76.79 104.78 7.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.021 0.439 . . . . 10.0 111.684 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -85.02 146.2 27.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.044 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 37.3 m -76.8 -11.64 59.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.448 -0.342 . . . . 10.0 111.485 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? 70.82 119.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.638 0.587 . . . . 10.0 112.513 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.81 -136.02 8.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.879 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -112.18 153.7 26.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.68 0.276 . . . . 10.0 111.002 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.62 119.52 26.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.53 -0.545 . . . . 10.0 109.53 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -101.16 139.85 36.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.841 0.353 . . . . 10.0 111.273 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -77.8 133.16 38.27 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.218 -1.031 . . . . 10.0 108.218 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -132.88 168.52 18.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.804 0.335 . . . . 10.0 110.889 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -101.85 -32.09 10.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.198 -0.455 . . . . 10.0 111.232 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -109.69 -38.6 5.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.625 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -84.42 -12.1 55.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.84 0.352 . . . . 10.0 111.015 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.11 -100.56 1.77 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.028 -0.606 . . . . 10.0 112.605 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -136.14 110.24 8.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.522 -0.547 . . . . 10.0 109.522 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -136.39 153.05 51.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.889 0.376 . . . . 10.0 111.588 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.23 127.32 32.3 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.036 -0.727 . . . . 10.0 109.036 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.68 153.6 33.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.509 0.671 . . . . 10.0 112.311 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -110.33 120.65 43.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -106.66 -1.82 22.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.049 0.759 . . . . 10.0 113.049 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -175.83 -37.53 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.219 -0.66 . . . . 10.0 109.219 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.8 OUTLIER -85.43 138.44 32.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.049 -0.978 . . . . 10.0 109.568 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.39 119.43 2.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.781 0.324 . . . . 10.0 110.612 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -159.62 121.9 3.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.347 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.76 126.66 67.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 10.0 109.665 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.63 139.08 34.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.068 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -118.81 98.21 51.03 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 112.207 0.447 . . . . 10.0 112.207 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.44 127.94 6.79 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.063 2.509 . . . . 10.0 110.777 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -74.01 147.82 42.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.442 -0.344 . . . . 10.0 111.277 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.16 -5.8 54.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 10.0 110.538 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -153.02 147.1 25.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.709 -0.678 . . . . 10.0 109.867 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.56 85.37 4.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.911 0.386 . . . . 10.0 111.037 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.75 155.15 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.501 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.12 33.38 6.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.92 -0.657 . . . . 10.0 112.607 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -96.68 139.41 21.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.671 -0.492 . . . . 10.0 109.671 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.58 111.91 1.18 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.731 2.287 . . . . 10.0 111.507 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.12 161.07 21.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.134 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.33 142.44 41.98 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 58.6 tp -116.36 111.67 20.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.867 0.365 . . . . 10.0 110.788 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 41.6 t -101.84 113.49 38.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 96.5 mt -117.48 139.18 51.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.965 0.412 . . . . 10.0 111.414 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 20.9 m -134.36 118.55 17.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.036 -0.727 . . . . 10.0 109.036 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -98.69 112.14 24.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.099 0.407 . . . . 10.0 112.099 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -122.8 118.25 27.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.313 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.19 -160.18 10.22 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.729 -0.748 . . . . 10.0 111.758 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 25.3 m -153.58 -179.57 7.91 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.486 -0.561 . . . . 10.0 109.486 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' B' ' 105' ' ' ALA . . . -120.08 139.29 52.78 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.39 11.66 0.43 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.369 0.418 . . . . 10.0 112.114 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' B' ' 103' ' ' ALA . . . -110.92 6.08 20.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.453 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.92 26.84 9.34 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.431 -0.89 . . . . 10.0 113.436 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 20.3 t -115.27 141.88 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 53.3 t -136.21 89.53 2.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 10.0 110.907 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -78.27 151.09 77.94 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.323 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.38 164.42 35.79 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.718 2.279 . . . . 10.0 111.567 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.01 72.91 5.66 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.707 2.271 . . . . 10.0 112.419 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 24.2 t -62.86 124.4 17.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.622 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -104.87 160.95 14.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.148 0.499 . . . . 10.0 111.694 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.2 m -150.31 119.0 6.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.607 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -92.97 126.63 38.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.052 0.453 . . . . 10.0 111.849 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.55 153.71 28.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.734 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -116.34 124.18 49.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.548 -0.538 . . . . 10.0 109.548 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 17.6 mm -90.21 72.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.234 0.54 . . . . 10.0 110.812 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -78.43 -26.61 46.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.361 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.88 48.55 0.15 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.612 -0.804 . . . . 10.0 113.078 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -107.22 -9.91 15.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.95 0.405 . . . . 10.0 110.639 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.63 -77.6 1.86 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.948 -0.644 . . . . 10.0 111.587 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 11.0 m -97.94 131.92 43.96 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -120.26 155.29 33.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.975 0.417 . . . . 10.0 111.874 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -127.97 143.53 48.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.359 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.8 125.8 16.13 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.644 2.229 . . . . 10.0 111.883 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -85.71 82.61 8.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 179.701 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.92 88.67 31.82 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 10.0 111.603 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.93 -18.2 52.1 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.414 2.076 . . . . 10.0 111.906 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -62.53 -32.73 73.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.911 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -69.75 -41.73 74.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.536 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.29 -31.43 72.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.191 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 m -83.44 -8.43 59.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 10.0 110.636 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.9 m -91.91 -25.88 18.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.645 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -66.46 128.28 35.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.934 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.12 151.92 34.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.39 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 46.0 p -77.95 171.91 14.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.004 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.51 -15.29 63.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.537 0.684 . . . . 10.0 109.785 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -15.58 51.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.977 -1.01 . . . . 10.0 109.593 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.2 t30 97.33 -15.26 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.578 1.151 . . . . 10.0 112.326 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.6 140.25 84.19 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 109.543 -0.54 . . . . 10.0 109.543 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.44 147.12 90.53 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.411 2.074 . . . . 10.0 111.703 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.79 -11.92 42.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.914 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 m -55.41 -24.19 28.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.443 . . . . 10.0 112.155 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 m -62.38 -22.74 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.9 0.381 . . . . 10.0 111.598 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -127.55 29.17 5.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.282 0.563 . . . . 10.0 110.374 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.7 mt -136.22 28.99 3.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.943 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -134.28 -174.61 3.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.37 -0.377 . . . . 10.0 111.864 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt 71.61 11.19 6.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.772 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 56.82 33.9 23.82 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.395 -0.82 . . . . 10.0 111.686 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -101.16 147.53 33.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.46 142.17 95.18 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.061 2.507 . . . . 10.0 111.41 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.0 m -112.66 143.3 44.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.858 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.2 tp -122.14 99.21 6.31 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.7 mt -90.43 120.95 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.803 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.521 ' HZ3' ' CD ' ' A' ' 42' ' ' GLU . 1.1 tmtp? -113.72 124.96 53.53 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.595 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.02 141.74 33.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.514 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -149.02 169.3 20.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.787 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -116.81 135.64 53.59 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -62.42 -59.09 5.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.294 0.85 . . . . 10.0 113.294 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.65 38.49 0.75 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.087 0.773 . . . . 10.0 113.087 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -115.54 126.02 28.18 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.316 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.43 -44.61 21.85 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.829 2.353 . . . . 10.0 113.358 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.9 mt -64.11 -47.0 81.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 10.0 111.589 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.1 m -68.19 -33.73 74.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.507 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.8 mt -64.49 -37.34 87.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 10.0 111.701 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m -72.07 -22.8 61.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.024 0.44 . . . . 10.0 111.157 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -85.24 -6.03 59.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.85 -179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.1 mt -59.3 -49.13 79.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.006 0.431 . . . . 10.0 111.151 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.86 -33.72 87.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.873 -0.68 . . . . 10.0 112.063 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -70.59 -41.58 72.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 10.0 110.665 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.2 m -60.67 -42.46 97.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.537 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -64.46 -41.18 96.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.128 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -64.9 -38.46 91.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.618 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -70.8 -34.39 71.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.467 . . . . 10.0 110.801 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.38 -13.21 62.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.01 0.434 . . . . 10.0 110.813 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -114.63 16.51 17.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 10.0 110.416 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -82.42 148.29 28.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.627 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.36 83.8 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -84.94 -43.09 14.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.537 0.208 . . . . 10.0 111.499 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -66.22 -20.42 66.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 10.0 111.573 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.8 t -69.98 -0.28 7.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.952 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 m -84.62 -5.29 59.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 10.0 110.27 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -134.57 164.65 27.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.653 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -92.3 94.72 9.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.475 -0.329 . . . . 10.0 110.188 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.3 121.64 27.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.966 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.6 pt -138.87 142.32 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 10.0 111.395 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.97 113.78 27.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.566 -0.531 . . . . 10.0 109.566 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.71 138.7 36.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.804 0.335 . . . . 10.0 111.235 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.93 154.48 49.21 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.9 m -112.78 96.16 36.31 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 112.386 0.513 . . . . 10.0 112.386 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.24 131.58 27.12 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.567 2.178 . . . . 10.0 111.437 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.65 10.03 85.68 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.952 -0.642 . . . . 10.0 112.596 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -123.29 138.27 54.66 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 60.39 29.33 18.93 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.184 0.516 . . . . 10.0 111.041 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 t60 74.26 14.97 3.66 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.781 -1.1 . . . . 10.0 113.45 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -70.78 168.11 17.39 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 121.066 -0.254 . . . . 10.0 110.428 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -55.85 136.17 51.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.14 -0.482 . . . . 10.0 111.034 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -67.97 163.06 23.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.156 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.47 137.18 53.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.433 -0.349 . . . . 10.0 110.509 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.05 -49.97 1.94 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.646 -0.981 . . . . 10.0 110.646 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.11 -40.44 71.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.119 0.485 . . . . 10.0 109.829 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -59.59 -48.79 80.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.457 -0.792 . . . . 10.0 111.641 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -66.45 -26.37 67.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 10.0 111.32 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -69.97 -32.69 71.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 10.0 110.289 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -65.6 -45.42 83.25 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -61.86 -36.96 82.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.324 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.41 -24.71 65.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.833 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.33 -0.79 62.89 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.036 -0.602 . . . . 10.0 111.811 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.8 mt -105.05 169.18 8.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.439 . . . . 10.0 110.541 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -90.19 -155.66 0.38 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.998 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 57.54 73.17 0.8 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.954 0.407 . . . . 10.0 110.656 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.36 -9.61 26.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.537 2.158 . . . . 10.0 112.386 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -102.16 20.69 16.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.277 -0.42 . . . . 10.0 111.449 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mt -80.96 115.29 54.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.807 0.337 . . . . 10.0 110.529 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.76 58.13 6.7 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.713 2.275 . . . . 10.0 111.675 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.56 119.96 32.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.052 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.6 t -102.93 142.78 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.078 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 106.28 17.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.291 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -98.36 94.01 6.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.074 0.464 . . . . 10.0 109.911 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.96 108.54 2.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.995 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.26 -17.77 55.16 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.871 -0.681 . . . . 10.0 112.425 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.62 4.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.598 -0.81 . . . . 10.0 112.012 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -62.57 -51.7 66.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.859 0.362 . . . . 10.0 110.377 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.95 -35.84 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.19 97.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.613 -0.722 . . . . 10.0 111.359 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -70.89 -39.8 72.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.407 -0.361 . . . . 10.0 111.224 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 m -58.8 -33.83 70.8 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 68.3 mt -113.02 11.18 18.92 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.997 -0.281 . . . . 10.0 111.691 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 62.3 t30 47.39 60.6 3.37 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.493 0.663 . . . . 10.0 111.421 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mt -86.92 73.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.446 0.641 . . . . 10.0 110.991 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.43 16.94 17.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.392 -0.822 . . . . 10.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.05 147.98 9.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.897 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -127.14 160.73 58.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -81.7 154.12 79.57 Favored 'Cis proline' 0 C--O 1.235 0.33 0 C-N-CA 123.28 -1.55 . . . . 10.0 111.634 -0.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 t -130.45 137.71 49.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.288 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -119.9 116.6 26.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.729 -0.668 . . . . 10.0 110.266 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.31 108.31 20.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.664 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.4 tp -90.94 114.4 26.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.829 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.82 134.6 40.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.373 -0.602 . . . . 10.0 109.373 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -70.01 178.67 29.24 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.281 -0.485 . . . . 10.0 113.423 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.15 7.61 3.23 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.944 0.35 . . . . 10.0 111.944 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.65 -19.48 13.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.073 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 109.97 -1.47 30.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.581 -0.819 . . . . 10.0 112.847 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -101.03 162.21 13.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.745 0.307 . . . . 10.0 110.98 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -71.47 122.29 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 10.0 110.259 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -95.41 -46.85 6.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.422 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -152.28 154.2 35.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.718 0.294 . . . . 10.0 110.729 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 tp -128.32 123.88 60.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.515 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.1 t -113.42 137.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.67 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -141.94 139.03 32.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.006 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.14 -89.92 0.45 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.476 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.4 m -147.68 153.34 39.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 10.0 110.613 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.9 135.85 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.28 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -122.6 179.36 4.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 10.0 111.931 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -64.54 -43.58 93.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 10.0 112.086 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.1 -43.77 95.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.317 . . . . 10.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -62.13 -37.8 86.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.828 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.03 -48.9 76.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.051 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.7 -34.41 78.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.613 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.76 -43.77 87.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.132 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.28 -30.13 71.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.871 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 94.2 mt -70.08 -39.69 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.171 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -79.82 -38.94 31.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.226 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -150.86 103.17 3.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.565 -0.288 . . . . 10.0 110.552 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.7 2.84 6.53 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.77 2.313 . . . . 10.0 112.37 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -90.41 -11.79 39.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 10.0 110.622 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.55 113.64 25.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.01 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -96.91 170.0 9.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.076 -0.511 . . . . 10.0 109.892 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.93 0 N-CA-C 113.977 1.102 . . . . 10.0 113.977 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 111.712 0.264 . . . . 10.0 111.712 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.09 -57.77 3.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.916 0.389 . . . . 10.0 111.73 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 24.9 tp -110.95 -77.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.699 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 60.4 41.91 15.42 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.474 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.67 161.95 38.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.343 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.46 -148.7 0.37 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.33 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -113.56 21.65 14.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.251 0.548 . . . . 10.0 110.16 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -93.3 40.91 1.07 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.092 -0.503 . . . . 10.0 111.409 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.21 138.37 4.39 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.562 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.27 147.11 94.07 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.774 2.316 . . . . 10.0 112.143 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.5 -39.58 74.12 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.467 2.778 . . . . 10.0 113.613 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -64.55 -21.36 66.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 10.0 112.153 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.45 -3.59 19.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.183 0.516 . . . . 10.0 110.358 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.01 -9.73 54.84 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.12 128.76 36.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.931 0.396 . . . . 10.0 111.274 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.48 92.04 15.57 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.42 103.17 1.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.067 2.511 . . . . 10.0 112.924 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -98.36 103.12 15.04 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.376 -0.602 . . . . 10.0 109.376 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -86.76 110.0 19.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.165 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.98 112.9 25.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.944 0.402 . . . . 10.0 109.923 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -102.31 121.8 53.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.897 0.38 . . . . 10.0 111.261 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.76 170.25 8.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.533 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.43 -29.17 68.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.098 0.475 . . . . 10.0 110.554 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -75.44 -39.58 58.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.567 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.92 -179.55 47.81 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.833 -0.699 . . . . 10.0 111.904 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -94.14 135.88 27.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.066 -0.346 . . . . 10.0 110.066 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -124.95 112.04 16.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.856 -0.424 . . . . 10.0 109.856 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 p -92.63 124.75 45.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.969 0.414 . . . . 10.0 110.969 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -126.97 90.77 3.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.554 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -93.81 112.93 24.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.118 0.485 . . . . 10.0 111.238 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mtm-85 -72.45 114.6 10.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.461 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 43.7 mt -91.76 139.56 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.826 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.18 155.74 38.03 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.687 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -75.56 77.49 2.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.106 0.479 . . . . 10.0 111.571 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.0 -20.89 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.568 -0.613 . . . . 10.0 111.568 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -104.55 151.61 23.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -145.44 137.56 25.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.761 0.315 . . . . 10.0 110.724 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 34.4 mtt -107.97 156.18 19.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.964 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -99.59 126.86 45.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.636 -0.505 . . . . 10.0 109.636 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -61.29 -28.56 69.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.909 0.385 . . . . 10.0 111.1 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.96 5.39 37.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.079 -0.51 . . . . 10.0 111.064 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -122.19 -10.85 8.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.289 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 89.9 mt -86.96 118.05 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 10.0 110.453 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.4 t -108.32 121.51 61.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.889 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.91 137.22 6.56 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.688 -0.767 . . . . 10.0 111.705 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -161.69 145.61 12.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.801 0.334 . . . . 10.0 111.209 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 8.8 t -143.97 120.88 11.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.805 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.402 HD21 ' CB ' ' B' ' 53' ' ' LEU . 24.1 p30 -174.07 159.53 2.86 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.832 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -73.87 -77.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.321 2.014 . . . . 10.0 110.843 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.82 44.44 1.03 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.149 0.499 . . . . 10.0 110.251 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t0 66.79 33.33 6.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.297 -0.865 . . . . 10.0 112.269 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.88 70.26 4.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.921 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.402 ' CB ' HD21 ' B' ' 48' ' ' ASN . 28.5 tp -125.04 149.03 48.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.716 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.32 -72.67 1.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.886 -0.673 . . . . 10.0 111.805 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -169.87 146.83 2.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 122.131 0.172 . . . . 10.0 110.552 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.65 109.76 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.378 2.052 . . . . 10.0 110.494 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 6.4 m -89.07 94.24 9.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.157 0.503 . . . . 10.0 111.763 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -77.58 163.53 26.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.202 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 50.2 m -95.0 -3.65 48.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.518 -0.31 . . . . 10.0 111.141 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? 68.71 124.12 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.607 -0.724 . . . . 10.0 111.992 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.27 -139.89 8.4 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.893 -0.67 . . . . 10.0 112.206 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.88 143.92 44.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.732 0.301 . . . . 10.0 110.646 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -81.28 119.92 24.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.213 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -98.95 136.03 39.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.456 -0.338 . . . . 10.0 110.799 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -73.97 126.42 30.45 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.571 -0.9 . . . . 10.0 108.571 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -120.46 -179.53 4.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.765 0.317 . . . . 10.0 110.906 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.23 -25.4 4.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.995 0.426 . . . . 10.0 110.575 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -102.29 -49.12 3.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.853 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -88.6 -4.45 58.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.496 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.79 -76.58 2.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.865 -0.683 . . . . 10.0 112.111 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -173.59 118.96 0.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.026 -0.361 . . . . 10.0 110.026 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -133.52 164.74 26.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.799 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -75.51 125.98 30.1 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.3 m -125.87 163.63 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.455 0.645 . . . . 10.0 112.449 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -120.95 130.91 54.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.815 -1.18 . . . . 10.0 107.815 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -115.22 -10.87 12.06 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.66 0.615 . . . . 10.0 112.66 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.91 -29.31 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.339 0.59 . . . . 10.0 109.653 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.09 142.61 28.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.038 -0.983 . . . . 10.0 109.378 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.79 102.69 0.57 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.793 0.33 . . . . 10.0 110.465 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -148.92 117.71 6.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.13 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.38 120.89 52.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.574 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.91 148.13 23.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.349 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -125.22 102.96 30.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.61 127.46 8.04 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.766 2.311 . . . . 10.0 111.293 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -74.12 143.08 45.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.921 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.0 -4.18 53.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.335 0.588 . . . . 10.0 110.095 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -152.21 136.86 16.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.644 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.9 96.52 10.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.35 140.27 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.487 -0.324 . . . . 10.0 111.457 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.18 58.76 4.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.895 -0.669 . . . . 10.0 111.594 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -116.4 140.67 26.86 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.94 89.55 0.88 Allowed 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.584 2.189 . . . . 10.0 111.485 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.53 160.03 32.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.752 -0.658 . . . . 10.0 111.66 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -103.56 155.23 18.69 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.379 -0.601 . . . . 10.0 109.379 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 42.0 tp -125.89 119.89 29.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.803 0.335 . . . . 10.0 110.762 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.75 123.84 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.525 -0.546 . . . . 10.0 109.525 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 64.2 mt -128.92 131.76 47.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.945 0.403 . . . . 10.0 111.66 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 5.6 m -120.07 117.13 27.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -98.23 104.34 16.37 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.963 0.357 . . . . 10.0 111.963 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -117.47 121.39 40.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.901 0.382 . . . . 10.0 110.981 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.91 -160.41 10.68 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.888 -0.673 . . . . 10.0 111.546 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 18.4 m -152.87 -179.57 7.77 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -121.35 142.99 49.45 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.868 -0.419 . . . . 10.0 109.868 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.55 -10.09 56.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.181 -0.463 . . . . 10.0 112.04 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.33 -4.05 59.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.359 . . . . 10.0 111.769 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.13 38.09 2.96 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.561 -0.828 . . . . 10.0 112.928 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 35.1 t -123.13 141.51 43.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 9.4 t -132.68 86.18 2.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.872 0.368 . . . . 10.0 110.803 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -76.73 152.52 82.99 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.497 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.15 161.38 43.31 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.825 2.35 . . . . 10.0 111.512 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.91 74.65 5.16 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.861 2.374 . . . . 10.0 112.289 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.05 122.78 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.596 -0.52 . . . . 10.0 109.596 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -106.11 156.66 18.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.993 0.425 . . . . 10.0 111.291 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.28 141.09 30.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.17 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -107.73 123.18 48.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 10.0 110.739 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -112.94 148.29 35.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.571 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -105.12 118.96 37.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.517 -0.31 . . . . 10.0 110.221 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 14.9 mm -94.54 71.1 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.295 0.569 . . . . 10.0 110.53 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -83.98 -19.74 34.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.657 -0.701 . . . . 10.0 111.479 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.39 51.7 0.24 Allowed Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.709 -0.758 . . . . 10.0 112.688 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -103.77 -18.13 14.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.166 0.508 . . . . 10.0 110.489 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.19 -78.1 0.67 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.96 -0.856 . . . . 10.0 110.96 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 2.1 m -105.26 141.81 36.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -133.21 156.43 47.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.21 -0.292 . . . . 10.0 110.21 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.3 152.8 54.92 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.91 114.32 2.55 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.448 2.099 . . . . 10.0 112.139 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -81.13 76.9 8.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.566 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 7.7 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.788 -0.625 . . . . 10.0 109.732 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 109.738 -0.467 . . . . 10.0 109.738 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.02 76.32 50.28 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.068 0.461 . . . . 10.0 111.398 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.34 -33.97 88.2 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.702 2.268 . . . . 10.0 112.017 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -43.81 96.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.385 -0.371 . . . . 10.0 111.179 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 -40.01 78.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.307 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.4 tp -62.23 -34.16 75.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.729 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 m -84.57 -8.01 59.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.45 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.2 m -82.51 -20.73 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.192 0.52 . . . . 10.0 109.745 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.4 119.34 5.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.696 -0.683 . . . . 10.0 110.636 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.35 140.42 41.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.43 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.0 p -81.68 168.97 17.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.866 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -11.04 56.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.984 0.421 . . . . 10.0 111.15 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.38 8.22 45.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.381 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.3 t30 68.12 38.14 2.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.6 -0.727 . . . . 10.0 112.108 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -122.51 140.26 32.49 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.658 -0.497 . . . . 10.0 109.658 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.35 143.82 78.04 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.215 1.943 . . . . 10.0 111.422 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -13.23 34.28 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.2 m -56.87 -22.82 39.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 10.0 112.133 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.96 -20.23 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.109 0.48 . . . . 10.0 111.315 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -132.47 28.76 4.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.18 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -138.73 43.94 2.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.131 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -145.81 -171.57 3.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.389 -0.368 . . . . 10.0 111.269 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 mttp 65.84 13.82 9.22 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 58.26 38.4 26.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.944 0.402 . . . . 10.0 111.682 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -103.22 146.43 32.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.941 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.26 135.76 52.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.659 2.239 . . . . 10.0 110.958 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -109.33 146.21 34.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.827 0.346 . . . . 10.0 111.181 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.1 tp -127.34 108.19 10.63 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.872 -0.418 . . . . 10.0 109.872 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.9 mt -96.09 119.75 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.969 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.602 ' HZ3' ' CD ' ' A' ' 42' ' ' GLU . 1.1 tmtp? -113.2 124.82 53.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.679 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -98.0 142.49 29.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.351 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -145.81 170.82 15.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.525 -0.307 . . . . 10.0 110.821 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.9 139.49 49.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.637 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -73.33 -47.19 44.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.994 -0.548 . . . . 10.0 112.443 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.99 29.27 1.4 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.427 0.529 . . . . 10.0 112.427 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.7 t -117.59 121.05 32.39 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.513 0.197 . . . . 10.0 111.288 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.0 -43.54 47.58 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.129 2.553 . . . . 10.0 112.467 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.37 -39.53 90.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.948 0.404 . . . . 10.0 111.279 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 78.2 m -76.08 -31.68 58.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.566 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.02 -46.85 85.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 10.0 112.082 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 m -66.61 -33.66 76.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.055 0.455 . . . . 10.0 110.862 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.602 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -63.49 -26.31 68.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.254 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.28 -34.33 72.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.825 0.345 . . . . 10.0 110.643 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.78 92.34 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.935 -0.65 . . . . 10.0 111.853 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -77.31 -29.65 53.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.911 0.386 . . . . 10.0 110.113 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.7 m -60.44 -47.49 85.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.772 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.68 -36.75 85.28 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -61.69 -50.39 72.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.258 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -64.11 -37.28 86.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.049 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.14 -10.84 59.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.433 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -111.78 16.4 20.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.992 0.425 . . . . 10.0 110.73 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -93.31 139.89 30.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.258 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.38 -32.23 69.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.836 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -71.33 -44.09 65.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 10.0 110.658 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -73.6 -14.76 61.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 10.0 112.198 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.9 m -65.01 -11.63 41.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 10.0 111.216 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -78.87 -15.36 58.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.497 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -123.22 176.33 6.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.418 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -109.69 87.7 2.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.57 117.26 20.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.445 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.2 pt -134.93 147.2 29.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.786 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -109.0 116.41 31.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.167 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.17 137.15 47.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.78 0.324 . . . . 10.0 111.181 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -132.08 138.25 48.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.087 -0.708 . . . . 10.0 109.087 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -100.66 102.35 18.89 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 112.13 0.418 . . . . 10.0 112.13 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -68.63 131.23 22.41 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.994 2.463 . . . . 10.0 111.894 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.57 0.64 90.03 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.942 -0.572 . . . . 10.0 112.448 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -112.02 143.03 43.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 60.81 26.56 16.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.837 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 67.93 26.43 7.48 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.371 -0.831 . . . . 10.0 112.849 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.97 -169.61 2.46 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.451 -0.34 . . . . 10.0 110.187 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -68.35 145.06 54.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.206 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -77.33 162.29 27.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.038 0.447 . . . . 10.0 111.712 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -63.56 150.35 44.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.855 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.56 -40.96 3.03 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.867 -0.893 . . . . 10.0 110.867 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -81.92 -47.62 12.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.913 0.387 . . . . 10.0 110.062 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -57.59 -39.37 76.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.8 -0.637 . . . . 10.0 112.232 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.01 -30.62 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.996 0.427 . . . . 10.0 111.225 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -77.87 -31.72 51.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 10.0 109.866 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -58.16 -45.76 86.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.73 -0.668 . . . . 10.0 109.678 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -66.99 -36.58 82.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.798 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.67 -27.76 69.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.198 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.24 29.21 12.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.889 -0.672 . . . . 10.0 111.998 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.5 mt -121.66 -162.55 0.99 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.042 0.449 . . . . 10.0 111.059 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -116.99 -171.61 2.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.766 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 66.33 84.74 0.17 Allowed Pre-proline 0 N--CA 1.465 0.314 0 CA-C-O 121.381 0.61 . . . . 10.0 110.705 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.0 -11.57 29.39 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.776 2.318 . . . . 10.0 112.549 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -107.09 22.77 15.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.213 0.449 . . . . 10.0 112.213 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 mt -81.34 115.27 55.4 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.627 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.04 63.88 8.24 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.443 2.095 . . . . 10.0 111.705 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 68.7 t -82.31 117.27 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.13 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.7 t -104.97 142.49 18.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.706 -0.679 . . . . 10.0 109.981 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.28 108.45 20.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.05 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -94.72 78.58 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.297 0.57 . . . . 10.0 110.222 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -64.17 116.56 6.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.505 0.557 . . . . 10.0 112.505 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.63 -6.31 67.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.563 -0.827 . . . . 10.0 112.65 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.45 41.36 67.03 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.72 -0.752 . . . . 10.0 111.799 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -43.99 98.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.833 0.349 . . . . 10.0 110.775 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.0 mm -80.39 -42.26 21.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.938 0.399 . . . . 10.0 110.07 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.88 -45.7 89.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.628 -0.714 . . . . 10.0 112.167 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -68.3 -38.01 81.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.8 m -61.2 -35.74 78.0 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.413 0.523 . . . . 10.0 112.413 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -106.37 5.7 29.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.595 0.22 . . . . 10.0 111.595 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.0 t30 53.39 55.71 8.34 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.524 0.678 . . . . 10.0 111.064 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.2 mt -87.06 99.91 9.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.325 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.92 29.19 8.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.749 -0.66 . . . . 10.0 111.277 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.8 p -166.78 152.15 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.211 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -126.83 154.48 76.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -91.71 118.43 3.04 Favored 'Cis proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.619 -1.409 . . . . 10.0 111.403 -1.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.5 m -87.17 136.47 32.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.218 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -113.6 113.47 25.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.749 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.86 116.93 33.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.335 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.3 tp -93.65 116.11 28.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.8 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.65 129.59 56.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.946 -0.57 . . . . 10.0 109.544 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.75 178.17 40.04 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.962 -0.637 . . . . 10.0 112.895 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -69.77 -13.04 62.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.127 0.489 . . . . 10.0 110.617 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.44 -10.68 58.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.263 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.97 43.0 6.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.556 -0.831 . . . . 10.0 112.206 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -149.72 153.67 37.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.636 0.255 . . . . 10.0 110.573 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.5 t -70.23 120.23 17.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.952 0.406 . . . . 10.0 111.323 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -99.95 -28.97 12.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.013 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -156.24 146.65 21.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.585 -0.279 . . . . 10.0 111.004 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.0 tp -131.3 117.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.911 -0.403 . . . . 10.0 109.911 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.62 133.58 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.543 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -120.69 126.45 50.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.195 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.85 -99.21 0.22 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.499 -0.857 . . . . 10.0 112.931 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.4 m -168.14 135.22 2.11 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.122 -0.696 . . . . 10.0 109.122 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.1 pt -119.19 154.86 21.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.969 -0.293 . . . . 10.0 110.664 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -110.37 169.58 8.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.248 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -57.93 -39.32 77.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.114 0.413 . . . . 10.0 112.114 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.55 -40.85 88.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.104 0.478 . . . . 10.0 110.419 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -68.62 -38.21 80.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.22 -0.9 . . . . 10.0 110.146 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.85 91.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.633 -0.712 . . . . 10.0 110.941 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.15 -36.77 85.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.849 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.23 95.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.752 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.2 tp -62.43 -32.09 72.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.077 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.3 mt -72.68 -32.96 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.118 0.485 . . . . 10.0 110.358 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -78.5 -39.78 37.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.649 -0.705 . . . . 10.0 110.82 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -151.75 119.28 3.27 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.603 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.25 -7.25 20.4 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.098 2.532 . . . . 10.0 113.42 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -99.12 4.4 46.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 10.0 111.163 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.2 72.09 9.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.411 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -76.61 150.98 36.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.949 -0.568 . . . . 10.0 111.305 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.146 0 N-CA-C 114.006 1.113 . . . . 10.0 114.006 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.452 0.168 . . . . 10.0 111.08 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.88 70.72 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.08 -0.509 . . . . 10.0 112.087 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 35.1 tp -91.91 -80.03 0.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.674 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 55.16 37.23 28.58 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.448 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.67 157.34 44.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.23 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.17 -172.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.253 -0.885 . . . . 10.0 112.693 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -94.6 27.87 2.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.273 -0.876 . . . . 10.0 110.619 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -84.51 -4.33 58.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.985 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.5 143.98 51.07 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.9 150.89 87.05 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.024 2.483 . . . . 10.0 112.4 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.28 -34.42 88.37 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.413 2.742 . . . . 10.0 113.162 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -68.0 -4.73 14.19 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.118 0.414 . . . . 10.0 112.118 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -129.03 1.43 5.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.4 0.619 . . . . 10.0 110.233 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.42 -10.47 43.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.832 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.95 126.14 33.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.504 -0.317 . . . . 10.0 111.204 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.38 92.55 36.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.49 116.06 4.22 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.169 2.579 . . . . 10.0 113.441 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.1 109.48 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -93.46 118.09 30.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.987 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.16 113.53 22.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.546 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.98 118.91 43.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.025 0.441 . . . . 10.0 111.225 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.0 -164.48 1.14 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.738 -0.665 . . . . 10.0 109.928 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -92.26 -37.29 12.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.789 0.328 . . . . 10.0 111.069 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.64 -37.12 42.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.623 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.01 -170.48 32.81 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.586 -0.816 . . . . 10.0 112.392 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.9 135.1 47.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -120.35 111.89 18.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.753 0.311 . . . . 10.0 110.248 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.01 122.55 46.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.13 0.491 . . . . 10.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -124.27 92.01 3.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.093 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -95.38 122.55 38.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.74 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -79.76 122.33 26.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.625 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 72.1 mt -100.83 130.68 49.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.49 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.65 145.34 55.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.147 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.36 92.99 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.109 0.48 . . . . 10.0 111.675 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.77 -23.86 0.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.663 -0.975 . . . . 10.0 110.663 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -103.51 154.04 19.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -144.63 139.01 27.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.965 0.412 . . . . 10.0 111.101 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 34.4 mtt -110.9 150.63 28.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.432 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -92.6 121.35 33.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -56.81 -37.12 70.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.752 0.31 . . . . 10.0 111.833 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.66 -9.77 58.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.397 . . . . 10.0 111.576 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -104.43 -11.03 17.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.747 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 75.2 mt -82.28 96.59 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.079 0.466 . . . . 10.0 110.314 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 t -91.46 109.04 20.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.203 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.39 141.51 12.57 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.55 -0.834 . . . . 10.0 111.751 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -162.36 147.48 12.51 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.789 0.328 . . . . 10.0 111.475 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 9.9 t -143.47 123.36 13.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.987 -0.552 . . . . 10.0 109.528 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -177.43 157.28 1.24 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.139 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -73.83 -69.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.732 2.288 . . . . 10.0 110.559 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.66 55.43 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.235 0.541 . . . . 10.0 109.769 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 t70 60.95 27.42 17.29 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.251 -0.886 . . . . 10.0 112.453 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.89 59.61 5.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.272 0.558 . . . . 10.0 111.531 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 22.9 tp -122.97 148.84 45.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.729 -0.669 . . . . 10.0 109.516 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.84 -80.21 0.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.596 -0.812 . . . . 10.0 111.45 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -163.0 145.63 8.22 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.402 -0.221 . . . . 10.0 110.402 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.64 107.5 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.606 2.204 . . . . 10.0 110.75 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.0 m -93.65 96.52 9.88 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.224 0.535 . . . . 10.0 111.536 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -80.25 150.25 30.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.718 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.4 m -81.12 -8.1 59.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.778 0.323 . . . . 10.0 110.678 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt 71.39 148.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.44 -0.8 . . . . 10.0 112.813 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.79 -128.33 2.93 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.996 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -121.04 149.57 42.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.526 0.203 . . . . 10.0 110.772 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.94 119.24 28.1 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -101.04 130.91 47.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.944 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -69.13 142.86 54.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -137.93 170.87 15.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.709 0.29 . . . . 10.0 111.16 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -109.85 -13.45 14.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.401 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -121.36 -41.15 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 10.0 111.218 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -90.3 -7.41 53.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.962 0.411 . . . . 10.0 111.207 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.71 -79.46 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.095 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -171.44 110.75 0.31 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.989 0.423 . . . . 10.0 110.678 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -128.29 163.46 24.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.121 -0.491 . . . . 10.0 110.384 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 12.8 m -75.38 125.52 29.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.08 155.28 31.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.397 0.618 . . . . 10.0 112.357 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -112.84 130.34 56.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.611 -1.255 . . . . 10.0 107.611 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -113.03 -10.49 13.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.606 0.595 . . . . 10.0 112.606 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -168.78 -34.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.432 0.634 . . . . 10.0 109.887 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -87.75 134.55 33.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.296 -0.866 . . . . 10.0 109.769 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -159.32 123.79 3.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.883 0.373 . . . . 10.0 111.444 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -160.85 120.72 2.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.328 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 t -125.9 128.33 71.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 10.0 109.998 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.33 138.75 38.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.626 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -122.14 98.39 44.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.51 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.8 126.49 3.98 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.2 2.6 . . . . 10.0 111.027 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.06 149.58 46.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.81 0.338 . . . . 10.0 110.871 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.99 -9.78 41.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.267 0.556 . . . . 10.0 110.107 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -152.24 127.2 9.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.895 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.64 99.32 6.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.143 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -131.83 146.22 33.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.403 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.58 43.63 3.01 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.671 -0.776 . . . . 10.0 111.867 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -104.33 144.44 28.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.43 0.157 . . . . 10.0 110.862 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.39 100.45 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.412 2.075 . . . . 10.0 111.353 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.56 144.13 28.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.923 -0.581 . . . . 10.0 111.208 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -88.81 159.5 17.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.049 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 35.3 tp -131.05 121.8 25.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.046 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.05 125.0 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 49.2 mt -129.56 126.9 39.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.787 0.327 . . . . 10.0 111.549 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 1.7 m -115.62 116.85 28.83 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -100.35 110.94 23.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.314 . . . . 10.0 111.366 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -120.81 121.6 38.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.752 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.99 -157.13 9.84 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.309 -0.717 . . . . 10.0 111.309 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 39.6 m -158.86 -172.98 4.03 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' B' ' 105' ' ' ALA . . . -119.25 146.27 45.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.22 40.35 0.34 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.028 0.442 . . . . 10.0 110.484 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' B' ' 103' ' ' ALA . . . -141.18 1.06 1.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.223 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.05 -32.56 5.73 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.768 -0.729 . . . . 10.0 113.129 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 12.3 t -62.69 133.17 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.353 . . . . 10.0 111.313 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 10.9 t -129.22 100.35 5.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.947 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -89.61 144.81 32.47 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.678 0.275 . . . . 10.0 111.478 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.18 160.83 44.51 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.854 2.37 . . . . 10.0 111.565 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.77 75.83 4.32 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.54 2.16 . . . . 10.0 112.657 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 6.6 t -69.54 104.9 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -72.61 148.51 44.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.846 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.9 m -132.62 128.08 36.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.286 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.59 134.16 49.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.012 0.434 . . . . 10.0 110.616 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -109.17 166.56 10.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.345 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -123.0 117.61 25.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.966 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 18.6 mm -97.23 82.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.152 0.501 . . . . 10.0 110.462 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -97.38 -25.51 15.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.675 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.52 68.16 0.18 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.068 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -128.27 -3.9 5.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.866 0.365 . . . . 10.0 111.363 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.28 -76.72 2.21 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.836 -0.697 . . . . 10.0 111.917 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 135.15 46.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.189 -0.301 . . . . 10.0 110.189 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -123.26 147.21 47.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 10.0 110.925 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.35 145.18 48.54 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.323 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.53 131.61 32.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.592 2.194 . . . . 10.0 111.668 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . 0.418 ' C ' ' HG1' ' B' ' 128' ' ' THR . 61.9 mt-30 -84.24 86.55 7.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.209 0.528 . . . . 10.0 110.476 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' B' ' 127' ' ' GLN . 19.0 m . . . . . 0 C--O 1.245 0.824 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.599 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 109.788 -0.449 . . . . 10.0 109.788 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.53 63.13 63.37 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.337 . . . . 10.0 111.403 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.17 -43.61 10.99 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.411 2.074 . . . . 10.0 111.681 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -58.97 -44.35 91.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.267 -0.424 . . . . 10.0 111.32 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -47.03 80.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.947 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.8 tp -61.21 -36.19 79.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 10.0 111.361 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 m -76.08 -10.43 59.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 10.0 111.685 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.6 m -92.58 -6.33 49.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.035 0.445 . . . . 10.0 110.423 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.37 109.52 2.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.293 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.49 139.43 33.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.931 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.6 p -84.13 172.51 11.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.061 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.29 -9.08 54.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.48 . . . . 10.0 110.263 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -91.71 8.11 38.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.948 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.95 13.33 7.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.258 -0.883 . . . . 10.0 112.956 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.92 143.49 29.2 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.479 -0.328 . . . . 10.0 110.626 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.82 146.79 88.92 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.617 2.211 . . . . 10.0 111.139 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.49 -5.68 25.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.256 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.66 -25.5 53.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.635 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.63 -21.45 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.078 0.466 . . . . 10.0 111.047 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -117.68 20.55 13.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.329 0.585 . . . . 10.0 109.764 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.3 mt -125.76 25.38 6.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.661 -0.699 . . . . 10.0 110.33 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -124.24 -170.6 2.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.204 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 mttm 68.31 8.48 6.63 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.733 0.645 . . . . 10.0 111.692 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.68 34.92 25.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.212 0.529 . . . . 10.0 110.32 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -101.67 150.58 37.44 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 10.0 111.449 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.27 142.87 75.05 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.781 2.321 . . . . 10.0 111.093 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.65 142.37 39.23 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.967 0.413 . . . . 10.0 111.286 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.7 tp -120.76 101.85 8.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.5 mt -87.53 121.92 38.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.817 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.613 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 1.9 tmtp? -114.98 108.91 17.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.253 -0.431 . . . . 10.0 111.192 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -82.86 138.07 34.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.068 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -140.98 171.67 13.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.576 -0.283 . . . . 10.0 111.239 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.46 144.59 49.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.239 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.98 -41.37 18.84 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.611 0.597 . . . . 10.0 112.611 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -88.56 23.81 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.661 0.615 . . . . 10.0 112.661 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.6 t -115.58 128.3 26.07 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 111.854 0.316 . . . . 10.0 111.854 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.49 -43.09 18.69 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.884 2.389 . . . . 10.0 112.297 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.46 -41.69 93.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 10.0 111.171 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.5 m -70.32 -21.27 62.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.252 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.3 tp -68.52 -48.01 65.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.363 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.93 -33.07 74.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.172 0.511 . . . . 10.0 109.827 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.613 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -57.13 -32.62 66.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.354 -0.839 . . . . 10.0 111.534 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.99 -46.71 84.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 10.0 111.091 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.91 -44.19 96.42 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.902 -0.59 . . . . 10.0 112.318 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -65.91 -38.13 87.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 10.0 110.785 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.4 m -63.62 -43.22 97.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.362 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -64.41 -39.71 94.37 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.908 -0.405 . . . . 10.0 109.908 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -60.83 -50.49 73.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.087 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -64.93 -40.16 94.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.753 -0.658 . . . . 10.0 111.528 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.59 -18.74 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.135 0.42 . . . . 10.0 112.135 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -103.7 10.24 36.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.753 0.311 . . . . 10.0 111.418 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -80.9 148.31 29.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.856 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.13 94.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -74.13 -34.85 64.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.885 0.374 . . . . 10.0 110.972 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.82 -10.89 59.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.147 -0.478 . . . . 10.0 111.862 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.5 m -74.72 2.15 10.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.028 0.442 . . . . 10.0 111.532 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -87.82 -9.47 53.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.834 0.349 . . . . 10.0 110.468 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.43 168.23 18.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 10.0 109.945 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -104.53 96.82 6.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.813 0.339 . . . . 10.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.29 125.48 33.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.711 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.3 pt -136.6 132.21 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 10.0 111.532 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.18 131.07 37.7 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.6 p -137.06 147.18 27.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.165 0.507 . . . . 10.0 112.13 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.0 158.55 43.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.257 -1.016 . . . . 10.0 108.257 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 m -110.47 95.1 21.07 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 112.124 0.416 . . . . 10.0 112.124 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.28 119.27 6.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.58 2.187 . . . . 10.0 111.699 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.95 10.02 65.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.93 -0.652 . . . . 10.0 112.48 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -129.03 144.53 51.22 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.3 mt 60.91 27.21 17.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.896 0.379 . . . . 10.0 111.592 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 m170 69.09 19.03 8.17 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.417 -0.811 . . . . 10.0 112.866 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.7 177.66 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.571 -0.286 . . . . 10.0 110.678 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -63.37 148.09 49.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.949 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -74.75 156.39 36.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.993 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.61 143.88 28.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.395 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.24 -52.92 4.12 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.622 -0.991 . . . . 10.0 110.622 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.92 -42.49 76.72 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.22 -47.85 84.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.751 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -66.5 -24.43 66.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 10.0 111.62 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -74.96 -30.87 61.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.434 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -65.67 -48.83 70.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.622 -0.51 . . . . 10.0 109.622 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -62.92 -33.57 75.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.075 0.464 . . . . 10.0 110.852 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.42 -18.62 65.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.351 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.8 30.19 8.65 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.991 -0.844 . . . . 10.0 110.991 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.0 mt -130.85 173.83 10.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.778 0.323 . . . . 10.0 110.27 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.433 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 57.0 t30 -92.87 -165.76 1.4 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.615 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.433 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 41.4 m-85 63.46 68.01 0.95 Allowed Pre-proline 0 C--O 1.233 0.222 0 CA-C-O 121.022 0.439 . . . . 10.0 110.595 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.6 23.82 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.65 2.233 . . . . 10.0 112.698 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.97 13.7 9.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 10.0 110.578 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.3 mt -92.17 118.98 68.4 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 10.0 110.964 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.77 69.08 7.51 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.062 2.508 . . . . 10.0 110.689 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.9 t -79.72 115.86 22.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.204 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -98.87 148.11 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.249 -0.432 . . . . 10.0 109.998 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.02 101.78 11.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.767 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -86.16 88.65 7.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.089 0.471 . . . . 10.0 110.633 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -64.58 106.94 1.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.989 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.91 -2.33 69.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.814 -0.707 . . . . 10.0 112.924 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.98 55.45 19.23 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.355 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.24 -45.01 95.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.023 0.439 . . . . 10.0 110.608 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.8 mm -80.46 -39.09 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.108 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.93 92.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.521 -0.763 . . . . 10.0 111.899 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -75.17 -36.7 61.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.889 0.376 . . . . 10.0 111.294 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.6 m -65.38 -34.66 78.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.559 0.577 . . . . 10.0 112.559 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.19 5.29 42.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.524 0.202 . . . . 10.0 111.5 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 53.05 69.51 0.69 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.578 0.704 . . . . 10.0 111.311 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 86.1 mt -103.47 114.99 44.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.413 -0.812 . . . . 10.0 111.033 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.8 p -121.37 19.48 11.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.46 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.0 p -163.54 149.73 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.838 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -117.33 156.81 48.5 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -91.13 144.95 14.5 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.937 -1.276 . . . . 10.0 111.431 -1.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.8 m -110.08 129.54 55.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.477 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -107.52 107.05 17.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.935 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.05 116.81 29.93 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.484 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.2 tp -94.55 107.38 19.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.823 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.3 127.28 46.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 117' ' ' ASP . . . -66.33 165.38 39.66 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.909 -0.662 . . . . 10.0 112.124 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -69.68 8.94 0.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.225 0.454 . . . . 10.0 112.225 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 115' ' ' GLY . 6.9 t70 -103.92 -20.02 14.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.295 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 100.96 46.28 1.77 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.989 -0.624 . . . . 10.0 112.421 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -154.14 166.71 32.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.436 0.16 . . . . 10.0 110.599 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.5 t -74.66 111.6 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.071 0.462 . . . . 10.0 110.839 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -93.82 -35.97 12.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.989 -0.551 . . . . 10.0 110.689 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -157.53 153.71 27.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.154 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 tp -136.93 121.52 24.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.069 0.461 . . . . 10.0 110.658 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.52 120.13 63.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.358 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -117.1 114.96 24.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.004 -0.369 . . . . 10.0 110.004 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.69 -87.43 0.13 Allowed Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.26 -0.971 . . . . 10.0 112.739 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.6 m -167.18 146.56 5.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.5 pt -127.24 179.99 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.576 0.227 . . . . 10.0 110.821 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -142.99 171.58 13.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.704 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -61.15 -44.5 97.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.927 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.26 95.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.978 0.418 . . . . 10.0 110.236 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -63.56 -39.3 94.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.488 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.85 94.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 10.0 110.349 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.78 -36.66 84.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.422 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.1 70.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.767 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.09 -42.47 89.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.991 -0.55 . . . . 10.0 111.388 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.4 pt -76.0 -10.53 13.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.213 0.53 . . . . 10.0 110.773 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -91.32 -52.11 4.97 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -143.61 110.14 5.27 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.102 -0.954 . . . . 10.0 109.556 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.51 -7.21 17.15 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.964 2.443 . . . . 10.0 112.217 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -86.83 4.88 39.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.304 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.82 109.41 21.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.719 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -115.38 141.48 47.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.166 -0.921 . . . . 10.0 112.56 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.438 ' H3 ' ' CG ' ' B' ' 4' ' ' ASP . 54.2 mtt . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 111.962 0.356 . . . . 10.0 111.962 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.89 -79.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 10.0 111.712 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 59.4 tp -87.89 -69.26 0.7 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.358 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . 0.438 ' CG ' ' H3 ' ' B' ' 1' ' ' MET . 94.1 m-20 60.01 35.11 21.48 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.281 0.562 . . . . 10.0 110.674 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.86 162.76 34.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.275 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 30.3 m120 62.56 -155.95 0.34 Allowed 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.708 0.63 . . . . 10.0 110.897 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -110.22 20.25 18.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.261 0.553 . . . . 10.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -85.39 36.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.801 -0.636 . . . . 10.0 111.629 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -158.93 136.36 7.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.67 148.38 82.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.951 2.434 . . . . 10.0 112.159 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.58 -39.19 76.0 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.344 2.696 . . . . 10.0 113.591 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -68.59 -12.54 61.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 10.0 111.956 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -117.51 -0.15 11.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.249 0.547 . . . . 10.0 110.319 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.78 -19.21 24.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.354 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -127.21 124.79 39.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.448 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 t -109.66 91.17 9.95 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.519 -0.549 . . . . 10.0 109.519 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.51 103.98 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.928 2.419 . . . . 10.0 112.785 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -100.71 115.0 29.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.01 117.06 25.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.673 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.11 99.92 9.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.015 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 65.8 t -94.52 118.29 40.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.961 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.15 -166.48 1.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.915 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -89.15 -36.63 15.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.896 0.379 . . . . 10.0 110.657 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -71.24 -40.26 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.899 -0.592 . . . . 10.0 110.96 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.64 -172.72 42.44 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.784 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.15 135.9 32.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -122.36 114.06 20.24 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.511 -0.551 . . . . 10.0 109.511 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.31 126.79 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.117 0.484 . . . . 10.0 111.273 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -127.5 88.74 2.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.159 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -93.31 115.74 28.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.024 0.44 . . . . 10.0 110.676 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 -75.17 115.71 15.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.554 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mt -94.68 135.8 27.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.911 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.8 150.31 48.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.155 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.53 79.71 2.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.203 0.525 . . . . 10.0 111.757 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.48 -26.65 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -103.77 150.99 23.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.227 -0.657 . . . . 10.0 109.227 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -142.39 146.18 34.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.822 0.344 . . . . 10.0 111.186 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 57.0 mtt -116.51 154.73 29.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.648 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -96.48 129.81 43.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.39 -0.596 . . . . 10.0 109.39 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -60.6 -28.58 68.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.958 0.409 . . . . 10.0 111.255 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.97 9.8 21.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.205 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -127.87 -7.68 5.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 10.0 111.748 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 89.4 mt -83.75 119.69 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.854 0.359 . . . . 10.0 110.188 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 40.3 t -105.19 126.22 60.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.317 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.31 132.39 3.4 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.272 -0.731 . . . . 10.0 111.272 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -159.12 150.46 20.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.863 0.331 . . . . 10.0 111.129 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 10.2 t -153.66 125.27 7.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.34 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -178.54 160.76 1.13 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.344 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.23 -56.54 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.215 1.943 . . . . 10.0 112.093 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.42 69.9 1.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.981 0.42 . . . . 10.0 111.138 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 t70 69.18 9.26 7.27 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.13 0.789 . . . . 10.0 113.13 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -81.24 59.9 4.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.043 0.449 . . . . 10.0 111.945 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 45.0 tp -125.87 138.58 53.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.78 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.57 -79.8 0.44 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.571 -0.823 . . . . 10.0 111.667 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -165.72 145.4 5.38 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.39 107.84 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.545 2.163 . . . . 10.0 111.772 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -83.62 92.65 7.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.467 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -77.27 145.54 37.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.013 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 53.9 m -77.62 -18.01 57.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.811 0.3 . . . . 10.0 111.811 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? 74.54 137.8 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.785 0.678 . . . . 10.0 112.558 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.99 -121.78 2.78 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.817 -0.913 . . . . 10.0 110.817 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -130.15 155.01 46.92 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -87.96 125.55 34.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.075 0.464 . . . . 10.0 110.838 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -102.7 131.9 49.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.452 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -73.79 146.73 44.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -145.2 173.78 11.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.803 0.335 . . . . 10.0 110.918 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -108.86 -29.38 8.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.858 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -108.12 -35.14 6.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -94.11 -6.11 45.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.355 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.81 -79.97 1.52 Allowed Glycine 0 C--O 1.227 -0.296 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.435 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -176.71 122.61 0.15 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 122.698 0.399 . . . . 10.0 110.352 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -143.17 162.27 36.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.551 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 11.5 m -70.77 125.42 26.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.355 -0.609 . . . . 10.0 109.355 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -125.95 156.25 35.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.43 0.634 . . . . 10.0 112.312 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -117.6 132.21 56.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -122.01 6.66 9.79 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.065 0.765 . . . . 10.0 113.065 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -176.25 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.83 -0.804 . . . . 10.0 108.83 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 1.0 OUTLIER -81.46 136.63 35.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.79 -1.095 . . . . 10.0 109.424 179.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -164.05 115.99 1.36 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 10.0 111.053 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -157.3 122.54 4.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.248 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.41 128.68 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.032 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.82 137.59 40.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.438 -0.347 . . . . 10.0 110.234 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -116.4 107.64 46.77 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.802 0.334 . . . . 10.0 111.528 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -91.03 127.47 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.036 2.491 . . . . 10.0 111.335 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -74.46 148.07 41.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.517 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.1 -5.88 57.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.175 0.512 . . . . 10.0 110.312 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -155.7 142.32 18.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.653 -0.703 . . . . 10.0 109.748 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.45 97.78 11.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.984 0.421 . . . . 10.0 110.74 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 13.6 m -128.24 154.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.685 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.26 7.18 72.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.628 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.22 144.7 92.68 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.89 107.06 1.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.444 2.096 . . . . 10.0 111.97 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.32 135.19 36.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -88.7 141.58 28.39 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.605 -0.438 . . . . 10.0 110.328 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 64.6 tp -108.96 114.25 27.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.942 0.401 . . . . 10.0 110.897 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 47.4 t -112.47 122.03 65.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 65.6 mt -127.68 145.83 50.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.006 0.432 . . . . 10.0 111.536 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 24.1 m -147.87 122.93 10.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -107.0 134.78 49.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.875 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -140.61 126.01 18.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.428 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.87 -154.74 8.33 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.229 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.1 m -150.1 175.38 11.78 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.93 145.7 41.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.93 -2.41 12.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.791 0.663 . . . . 10.0 112.791 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.99 0.2 45.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.134 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.2 -21.13 31.8 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.808 -0.71 . . . . 10.0 112.082 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 3.2 t -64.15 145.15 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.79 0.329 . . . . 10.0 110.275 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 t -134.08 106.33 7.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.013 0.435 . . . . 10.0 110.794 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -88.17 146.68 38.71 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.821 0.343 . . . . 10.0 111.735 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.08 163.21 38.83 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.851 2.368 . . . . 10.0 111.782 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.04 94.69 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.223 1.949 . . . . 10.0 111.591 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.56 133.7 30.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.33 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -106.85 149.14 27.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.896 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.6 m -151.4 119.63 6.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.512 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.45 132.16 44.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.272 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -116.04 139.82 49.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.065 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.25 124.74 47.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.644 -0.707 . . . . 10.0 109.781 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.8 66.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.398 0.618 . . . . 10.0 109.925 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -73.19 -24.46 60.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.739 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 122.75 73.41 0.28 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.611 -0.804 . . . . 10.0 112.351 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -140.35 -20.15 0.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.103 0.477 . . . . 10.0 110.496 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.08 -65.29 4.0 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.911 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.99 123.66 33.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.305 -0.257 . . . . 10.0 110.305 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -132.05 156.13 46.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.26 149.22 22.53 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.211 -0.449 . . . . 10.0 109.796 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.12 120.53 7.9 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.422 2.081 . . . . 10.0 112.257 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -80.87 75.28 7.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.19 0.519 . . . . 10.0 110.652 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 71.4 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.357 -0.83 . . . . 10.0 109.971 179.764 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 m -125.39 61.85 37.24 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 112.043 0.386 . . . . 10.0 112.043 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.28 -38.34 12.14 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.932 1.755 . . . . 10.0 111.857 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -62.61 -43.69 98.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.871 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -42.79 95.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.626 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -61.87 -30.3 70.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.034 0.445 . . . . 10.0 110.703 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 m -84.12 -7.14 59.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.187 -0.46 . . . . 10.0 111.456 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -91.24 -8.15 49.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.14 0.495 . . . . 10.0 109.907 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.25 110.7 2.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.418 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.47 140.61 30.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.736 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.2 p -81.2 174.06 11.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.324 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.53 -10.86 58.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.239 0.542 . . . . 10.0 110.135 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -91.95 -4.55 54.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.194 -0.912 . . . . 10.0 109.421 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 79.68 9.98 1.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.067 -0.97 . . . . 10.0 111.836 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 mtt85 -94.64 144.79 28.5 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 10.0 109.998 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.78 148.93 78.16 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.242 1.962 . . . . 10.0 111.387 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.79 -8.52 15.38 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -24.04 52.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.795 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.2 m -61.53 -21.03 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.039 0.447 . . . . 10.0 111.709 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -131.34 23.66 4.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.257 0.551 . . . . 10.0 110.42 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.7 mt -135.33 56.07 1.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.451 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -155.94 -179.71 8.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.36 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 mttp 69.67 14.8 8.16 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.891 0.7 . . . . 10.0 112.891 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.78 39.18 29.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.013 0.435 . . . . 10.0 111.054 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -107.96 145.29 31.1 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.153 -0.476 . . . . 10.0 111.176 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.17 143.74 94.83 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.687 2.258 . . . . 10.0 111.543 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -116.41 143.49 45.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.664 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.3 tp -124.01 105.7 9.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.97 0.414 . . . . 10.0 110.047 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.44 117.52 37.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.867 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HZ1' ' CD ' ' A' ' 42' ' ' GLU . 17.4 ttpt -112.61 119.98 40.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.818 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -88.7 146.92 24.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.569 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -148.94 166.98 26.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.859 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.28 142.81 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.627 -0.509 . . . . 10.0 109.627 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -67.44 -63.85 0.98 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.5 64.16 4.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.494 0.553 . . . . 10.0 112.494 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.6 t -131.94 135.62 26.94 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.076 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.45 -49.54 3.33 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.517 2.145 . . . . 10.0 112.344 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.17 -44.26 95.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.239 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.9 m -66.33 -31.16 71.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 10.0 111.389 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -62.86 -46.78 86.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.99 -38.68 79.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.93 0.395 . . . . 10.0 110.676 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 1.2 tm-20 -66.88 -24.74 66.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.859 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.1 mt -55.27 -44.56 75.74 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.822 0.344 . . . . 10.0 111.416 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.48 -33.42 81.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.577 -0.821 . . . . 10.0 111.128 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -68.85 -40.01 79.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.355 -0.423 . . . . 10.0 110.662 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.4 m -55.19 -47.55 75.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.424 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.86 -44.14 86.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.061 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -60.63 -44.49 96.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.03 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -71.35 -37.89 71.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 10.0 111.698 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.91 -22.08 66.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.041 0.448 . . . . 10.0 111.234 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -88.55 -6.69 57.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.629 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.2 135.5 50.69 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.769 0.319 . . . . 10.0 110.369 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.42 -33.93 68.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.925 -0.579 . . . . 10.0 112.214 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -73.53 -37.75 65.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.968 0.413 . . . . 10.0 110.919 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -78.21 -10.32 59.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.925 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m -75.64 5.36 6.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.913 0.387 . . . . 10.0 111.53 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -87.04 -15.22 39.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.047 0.451 . . . . 10.0 110.52 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.44 148.4 51.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 10.0 109.814 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -82.87 88.19 6.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.763 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.48 121.54 26.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.542 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.2 pt -133.73 157.62 42.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.991 0.424 . . . . 10.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.83 117.55 33.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.166 -0.47 . . . . 10.0 109.811 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.96 143.35 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.863 0.364 . . . . 10.0 111.337 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.39 146.76 38.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -104.17 100.9 23.28 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.75 118.51 5.41 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.758 2.305 . . . . 10.0 112.067 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.88 -12.71 67.01 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.965 -0.636 . . . . 10.0 112.539 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -96.92 144.43 26.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.158 -0.312 . . . . 10.0 110.158 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 60.4 30.41 19.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.737 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t60 66.37 19.0 10.97 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.653 -0.703 . . . . 10.0 112.811 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -77.6 -175.58 3.91 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -65.45 127.89 33.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.795 0.331 . . . . 10.0 111.039 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -66.46 163.41 18.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.961 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.96 125.62 24.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.549 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.97 -17.32 35.38 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -107.23 -41.68 5.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.029 0.442 . . . . 10.0 109.867 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -62.62 -50.92 69.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.594 . . . . 10.0 112.496 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.91 -28.07 69.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.047 0.451 . . . . 10.0 110.687 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -75.55 -30.69 59.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.681 -0.691 . . . . 10.0 109.911 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -65.25 -50.04 67.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.526 -0.761 . . . . 10.0 109.499 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -63.89 -30.02 71.15 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.079 -0.51 . . . . 10.0 111.107 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.46 -24.1 67.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.178 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.14 8.15 41.51 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.105 -0.569 . . . . 10.0 111.98 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 mt -95.19 -179.65 4.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.797 0.332 . . . . 10.0 110.879 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -97.93 -178.48 4.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.678 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 66.97 84.06 0.17 Allowed Pre-proline 0 N--CA 1.464 0.269 0 O-C-N 123.647 0.592 . . . . 10.0 112.053 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.1 37.96 0.72 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.633 2.222 . . . . 10.0 111.663 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -150.02 25.08 0.83 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.694 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -93.36 117.9 67.51 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.545 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.56 66.97 5.59 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.745 2.297 . . . . 10.0 111.489 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.08 117.91 31.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.772 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.3 t -103.2 142.45 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.64 106.4 17.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.123 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -93.48 91.35 7.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.243 0.545 . . . . 10.0 110.267 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.03 113.72 4.67 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.22 -24.64 26.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.857 -0.687 . . . . 10.0 113.06 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.81 44.15 3.98 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.513 -0.851 . . . . 10.0 111.413 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -33.72 74.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 10.0 110.627 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.2 mm -92.27 -43.45 13.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.224 -0.444 . . . . 10.0 109.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.51 -44.95 95.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.688 -0.687 . . . . 10.0 112.394 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -68.15 -40.77 82.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.9 m -66.54 -22.12 66.16 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.57 5.06 24.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.464 -0.334 . . . . 10.0 110.669 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.3 t30 52.37 50.08 19.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.665 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 98.3 mt -75.26 109.38 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.258 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.4 p -115.59 -10.32 11.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.586 -0.733 . . . . 10.0 112.025 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.14 142.1 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.562 0.22 . . . . 10.0 111.293 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -107.24 153.99 40.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.653 -0.499 . . . . 10.0 109.653 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.07 159.16 83.63 Favored 'Cis proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.339 -1.525 . . . . 10.0 112.058 -0.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 m -122.18 124.3 43.53 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -108.76 104.2 13.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.02 0.438 . . . . 10.0 110.898 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.47 29.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.164 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.0 tp -95.69 112.62 24.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.584 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.5 127.25 51.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.3 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.79 171.98 29.66 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 116.016 -0.538 . . . . 10.0 112.618 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -65.58 -14.42 61.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.256 0.465 . . . . 10.0 112.256 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.24 0.95 57.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 10.0 111.87 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.89 37.74 15.41 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.82 -0.705 . . . . 10.0 113.191 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -132.99 146.96 52.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.785 -0.244 . . . . 10.0 110.666 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.6 111.48 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.098 -0.334 . . . . 10.0 110.098 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -96.44 -35.87 11.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.357 -0.383 . . . . 10.0 111.512 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.35 150.27 40.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.628 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 tp -144.21 116.94 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 t -119.48 130.76 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.844 0.354 . . . . 10.0 111.637 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -101.96 107.23 18.31 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.158 -0.682 . . . . 10.0 109.158 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.42 -141.93 11.92 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.488 -0.645 . . . . 10.0 111.488 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.7 m -119.5 147.22 44.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.84 0.352 . . . . 10.0 111.066 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.9 pt -104.72 176.57 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.264 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -146.6 171.67 14.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.443 -0.344 . . . . 10.0 110.57 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -61.53 -46.88 88.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.932 0.345 . . . . 10.0 111.932 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.65 88.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 10.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -66.8 -39.19 87.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.351 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.64 -42.88 99.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 10.0 109.75 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.75 -35.92 82.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.603 . . . . 10.0 110.41 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.7 -39.29 88.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 10.0 109.975 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -64.38 -36.32 83.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.585 -0.734 . . . . 10.0 110.523 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.2 mt -67.11 -29.44 46.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.022 -0.536 . . . . 10.0 109.763 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -83.38 -50.34 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.793 -0.64 . . . . 10.0 111.246 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -144.43 120.67 6.24 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.8 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.24 -6.29 18.88 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.004 2.469 . . . . 10.0 112.707 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -94.11 -3.15 51.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.925 0.393 . . . . 10.0 110.897 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.13 73.44 6.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.526 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -74.2 155.43 38.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.25 -0.881 . . . . 10.0 111.513 -179.522 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.438 ' H3 ' ' CG ' ' B' ' 4' ' ' ASP . 58.6 mtt . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 112.203 0.446 . . . . 10.0 112.203 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.3 -10.14 45.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 25.2 tp -142.41 -77.92 0.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.126 -0.23 . . . . 10.0 111.143 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . 0.438 ' CG ' ' H3 ' ' B' ' 1' ' ' MET . 25.2 m-20 57.71 39.09 27.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.827 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.13 166.3 31.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.793 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.3 m120 68.4 -172.32 0.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.776 0.673 . . . . 10.0 111.865 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -99.69 13.9 32.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.36 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.43 -13.94 59.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.446 0.535 . . . . 10.0 112.446 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.08 133.27 23.44 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.673 0.273 . . . . 10.0 111.734 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.4 151.41 85.63 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 123.097 2.532 . . . . 10.0 112.453 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.86 -33.75 72.84 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.746 2.964 . . . . 10.0 113.707 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -55.75 -28.15 54.44 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.38 -11.4 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 10.0 111.075 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.01 -7.61 54.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.275 -0.421 . . . . 10.0 111.932 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -122.19 129.84 52.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.944 0.402 . . . . 10.0 111.364 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.16 92.06 25.41 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.13 102.0 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.5 2.133 . . . . 10.0 113.428 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -95.81 110.56 22.71 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -92.57 120.55 33.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.477 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.26 100.8 8.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.614 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.11 118.29 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.194 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.67 -170.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 10.0 110.347 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.65 -22.32 20.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.009 0.433 . . . . 10.0 111.608 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -86.73 -39.23 16.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.156 0.503 . . . . 10.0 110.272 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.91 -171.4 36.89 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.663 -0.699 . . . . 10.0 111.629 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -107.75 129.59 61.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.338 -0.616 . . . . 10.0 109.338 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -115.89 117.98 31.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.813 0.339 . . . . 10.0 110.186 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.88 118.02 48.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.277 0.56 . . . . 10.0 110.553 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -121.63 90.96 3.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.545 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -94.2 119.18 32.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.204 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 62.4 mtm-85 -77.0 118.38 19.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.232 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.06 136.49 24.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.354 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 146.07 51.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.403 -0.362 . . . . 10.0 110.284 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.21 92.76 0.57 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.991 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.49 -16.71 1.12 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.404 -0.678 . . . . 10.0 111.404 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -105.78 151.95 23.83 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -143.98 139.9 29.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.945 0.402 . . . . 10.0 111.191 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 43.8 mtt -110.41 150.5 28.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.99 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -92.09 116.52 29.0 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.77 -0.456 . . . . 10.0 109.77 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -61.32 -23.02 65.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.208 0.528 . . . . 10.0 111.331 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.8 -6.82 59.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.522 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -123.8 0.05 8.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.494 -0.321 . . . . 10.0 111.631 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 92.9 mt -78.87 117.77 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.024 0.44 . . . . 10.0 109.817 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.56 123.41 52.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.826 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -153.81 120.57 1.05 Allowed Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.643 -0.789 . . . . 10.0 111.995 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -160.46 140.47 11.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.808 0.337 . . . . 10.0 111.015 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 11.6 t -139.72 126.23 20.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.134 -0.484 . . . . 10.0 109.893 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -174.56 158.36 2.45 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.426 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -74.26 -66.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.256 1.97 . . . . 10.0 111.072 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.64 53.79 1.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.129 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.45 51.0 6.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.608 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.18 43.58 1.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.8 -0.637 . . . . 10.0 110.422 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 18.6 tp -107.45 144.64 34.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.092 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.63 -66.72 1.89 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.418 -0.896 . . . . 10.0 111.284 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -171.63 149.7 2.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 122.596 0.358 . . . . 10.0 110.179 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.81 106.47 1.86 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.495 2.13 . . . . 10.0 110.434 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -86.67 99.58 11.85 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.061 0.458 . . . . 10.0 111.376 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -84.59 157.91 21.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.799 -0.637 . . . . 10.0 110.352 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 50.2 m -86.72 -20.4 27.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.645 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? 70.57 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.711 -0.677 . . . . 10.0 112.292 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.87 -127.8 6.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.21 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -116.69 158.88 23.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.624 0.249 . . . . 10.0 110.873 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.24 132.81 34.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -114.47 127.01 55.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.508 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.88 149.56 46.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.548 -0.908 . . . . 10.0 108.548 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -146.56 171.02 15.72 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.935 -0.306 . . . . 10.0 111.382 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.98 -23.55 14.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.284 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -114.76 -40.74 3.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.887 0.375 . . . . 10.0 110.949 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -87.68 -6.13 58.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.185 -0.462 . . . . 10.0 111.616 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.7 -73.55 2.07 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 121.105 -0.569 . . . . 10.0 112.16 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -173.92 122.89 0.33 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.862 0.465 . . . . 10.0 109.968 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -139.88 162.98 33.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.438 -0.346 . . . . 10.0 110.545 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -74.28 127.2 32.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.96 159.75 38.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.354 0.597 . . . . 10.0 112.091 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -114.5 127.33 55.76 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.404 -1.332 . . . . 10.0 107.404 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -113.58 -3.79 13.58 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -173.89 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.599 . . . . 10.0 109.472 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -91.19 126.41 36.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.774 -1.103 . . . . 10.0 109.712 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -153.42 112.87 3.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.889 0.376 . . . . 10.0 111.173 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -145.94 119.41 9.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.381 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -127.87 120.95 55.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.069 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.19 134.57 44.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.66 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -113.81 98.91 48.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.092 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.14 127.96 3.54 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.949 2.433 . . . . 10.0 111.782 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -74.04 148.29 42.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.881 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.66 -5.19 32.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.465 0.65 . . . . 10.0 109.754 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -134.95 129.48 34.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.166 -0.925 . . . . 10.0 108.785 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.9 80.41 4.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.237 0.542 . . . . 10.0 111.307 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 4.1 m -128.4 143.26 41.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.557 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.19 54.04 4.67 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.336 -0.706 . . . . 10.0 111.336 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -105.78 153.84 39.74 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.68 -0.26 . . . . 10.0 110.47 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.7 141.91 42.52 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.44 2.093 . . . . 10.0 110.436 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -132.57 154.14 50.31 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.232 0.456 . . . . 10.0 112.232 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -98.25 150.83 21.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 10.0 109.658 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.97 114.32 22.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.584 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 42.0 t -104.19 114.82 44.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.058 -0.519 . . . . 10.0 109.987 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 93.0 mt -125.1 136.77 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.402 . . . . 10.0 111.154 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 19.1 m -133.69 118.04 17.67 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.132 -0.485 . . . . 10.0 109.839 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -98.62 109.38 22.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.462 -0.335 . . . . 10.0 111.335 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.94 128.87 50.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.444 -0.344 . . . . 10.0 110.945 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.49 -155.64 12.58 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.851 -0.69 . . . . 10.0 111.617 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 73.5 m -155.56 176.99 11.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.3 -0.259 . . . . 10.0 110.3 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -116.98 145.03 43.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.89 -10.68 22.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.442 0.534 . . . . 10.0 112.442 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.45 -0.76 55.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.517 -0.31 . . . . 10.0 111.785 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.7 20.63 23.8 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.669 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 4.6 t -103.27 136.73 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.436 -0.579 . . . . 10.0 109.436 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 17.4 t -122.57 97.97 5.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.683 0.277 . . . . 10.0 110.767 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -84.23 143.94 43.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.859 0.361 . . . . 10.0 111.361 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.31 163.64 33.67 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.586 2.191 . . . . 10.0 111.241 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -75.74 80.56 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.372 2.048 . . . . 10.0 111.86 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 12.8 t -60.84 108.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.69 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -100.41 130.41 46.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.514 0.673 . . . . 10.0 111.833 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.6 124.86 36.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.393 -0.822 . . . . 10.0 109.951 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.39 130.26 49.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.077 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -114.86 149.17 37.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.452 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.02 114.28 28.26 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.98 -0.748 . . . . 10.0 108.98 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 23.3 mm -85.61 99.86 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.212 0.529 . . . . 10.0 111.057 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -108.75 -6.66 15.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.529 -0.76 . . . . 10.0 110.195 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.7 97.57 2.51 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.509 -0.769 . . . . 10.0 111.191 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -153.48 -15.94 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.824 0.345 . . . . 10.0 111.504 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.95 -76.91 1.49 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.697 -0.763 . . . . 10.0 111.891 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.76 145.83 28.61 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.311 -0.255 . . . . 10.0 110.311 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -136.88 146.37 45.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 10.0 111.024 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.21 147.71 38.43 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.098 -0.501 . . . . 10.0 109.695 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.9 136.92 43.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.401 2.067 . . . . 10.0 111.74 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -91.86 70.28 5.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.137 0.494 . . . . 10.0 111.304 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.602 -0.713 . . . . 10.0 109.741 179.733 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 110.067 -0.346 . . . . 10.0 110.067 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 m -132.05 65.89 76.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 111.981 0.363 . . . . 10.0 111.981 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.91 -40.29 45.13 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.38 2.053 . . . . 10.0 111.617 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -60.54 -38.35 84.19 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 115.949 -0.568 . . . . 10.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.9 m -67.45 -47.22 70.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.703 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.55 -35.25 75.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 10.0 111.005 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m -84.27 -4.73 59.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.437 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.6 m -90.15 -18.6 25.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.384 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.59 124.42 23.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.706 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -107.77 151.91 25.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.089 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.8 p -84.74 174.32 9.99 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.474 -0.565 . . . . 10.0 109.474 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.12 -7.87 33.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.129 0.49 . . . . 10.0 110.515 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -95.96 1.71 53.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.351 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.0 t30 75.45 16.5 2.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -103.89 135.42 19.36 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.037 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.61 145.26 95.22 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.782 2.321 . . . . 10.0 111.551 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.37 -9.7 27.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 10.0 112.043 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.73 -19.9 44.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.394 -0.367 . . . . 10.0 111.817 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.21 -16.02 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.027 0.441 . . . . 10.0 111.383 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -127.07 22.55 6.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.572 0.701 . . . . 10.0 109.34 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.1 mt -134.02 34.12 3.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.405 -0.816 . . . . 10.0 110.428 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -127.7 176.08 7.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.478 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt 68.18 17.39 9.38 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.504 -0.771 . . . . 10.0 112.53 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 51.51 43.39 29.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.509 -0.768 . . . . 10.0 112.077 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -103.28 145.5 30.72 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.832 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.19 131.83 47.51 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.715 2.277 . . . . 10.0 111.066 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -99.79 136.22 40.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.905 0.384 . . . . 10.0 111.226 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.1 tp -117.74 99.58 7.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.7 mt -91.87 122.88 43.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 10.0 111.147 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.486 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 3.9 tmmm? -117.24 121.82 42.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.495 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -95.92 134.49 38.85 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.594 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -134.97 -179.11 5.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.064 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.09 150.05 51.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.223 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.99 -40.86 16.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.066 0.46 . . . . 10.0 110.497 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -86.75 65.61 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.98 -0.555 . . . . 10.0 111.466 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.1 t -161.18 129.34 2.87 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.223 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.13 -41.76 2.43 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.571 2.181 . . . . 10.0 112.094 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.57 -43.21 97.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.928 0.394 . . . . 10.0 111.495 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.8 m -69.29 -23.1 63.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.269 -0.423 . . . . 10.0 111.077 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.6 tp -66.64 -40.54 88.78 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.112 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.45 -34.85 68.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.105 0.479 . . . . 10.0 110.308 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -61.67 -32.21 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.634 -0.712 . . . . 10.0 111.115 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.2 mt -56.25 -42.51 77.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.787 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.77 -36.82 92.75 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.909 -0.662 . . . . 10.0 111.475 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -69.9 -39.59 76.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.361 . . . . 10.0 110.073 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.6 m -61.61 -45.07 95.64 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.431 -0.581 . . . . 10.0 109.431 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.1 -35.13 76.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.519 -0.764 . . . . 10.0 110.375 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -72.33 -46.03 57.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.729 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -63.71 -33.12 74.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 10.0 111.421 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.06 -13.39 57.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.7 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -105.57 -3.41 22.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.375 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.39 144.66 53.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.093 0.473 . . . . 10.0 111.822 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.02 84.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.719 -0.673 . . . . 10.0 112.13 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -74.58 -43.75 54.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 10.0 110.943 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -61.04 -20.44 62.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 10.0 112.13 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -67.73 -5.41 15.95 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.863 0.363 . . . . 10.0 111.826 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 m -77.06 -17.01 59.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 10.0 110.561 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.24 169.42 15.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.923 -0.58 . . . . 10.0 109.998 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.84 98.1 8.0 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.233 -0.284 . . . . 10.0 110.233 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.0 tp -86.15 127.6 34.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.291 -0.413 . . . . 10.0 111.39 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.41 144.94 30.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.497 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.57 110.99 23.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.025 -0.534 . . . . 10.0 109.702 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -109.24 137.39 41.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.052 0.454 . . . . 10.0 111.548 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.39 146.89 52.47 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -109.91 96.11 23.43 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 112.222 0.453 . . . . 10.0 112.222 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.31 132.25 30.92 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.365 2.043 . . . . 10.0 111.357 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.98 6.08 88.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.072 -0.585 . . . . 10.0 112.534 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -121.72 148.49 44.54 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.155 -0.313 . . . . 10.0 110.155 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 59.92 21.17 10.17 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.5 t60 69.57 27.73 4.74 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.462 -0.79 . . . . 10.0 112.287 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -88.26 -168.35 2.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -63.57 145.08 56.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.711 0.291 . . . . 10.0 111.033 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -80.9 161.78 24.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.806 0.336 . . . . 10.0 111.367 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.44 150.17 27.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.533 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.03 -47.13 3.76 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.273 -0.731 . . . . 10.0 111.273 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -76.65 -39.72 51.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.676 -0.49 . . . . 10.0 109.676 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -63.05 -36.32 83.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.485 -0.779 . . . . 10.0 111.891 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -66.11 -32.14 73.42 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.775 -0.37 . . . . 10.0 111.021 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.92 -27.49 63.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.04 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -61.32 -57.71 11.2 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.503 -0.772 . . . . 10.0 109.707 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -65.93 -36.32 83.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.102 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.82 -20.78 58.95 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.224 0.453 . . . . 10.0 112.224 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.21 5.23 38.59 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.592 -0.813 . . . . 10.0 112.192 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.2 mt -100.46 -178.29 3.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.895 0.378 . . . . 10.0 111.185 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -103.54 -177.78 3.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.136 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 69.0 78.56 0.23 Allowed Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 123.007 0.523 . . . . 10.0 111.035 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.15 12.25 1.83 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.736 2.29 . . . . 10.0 112.063 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -108.57 11.25 26.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.402 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.9 mt -88.5 111.13 41.83 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.574 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.56 69.83 5.85 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.465 2.11 . . . . 10.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.1 t -78.56 107.78 11.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.844 -0.616 . . . . 10.0 111.305 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.5 t -92.34 137.34 22.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.762 -0.653 . . . . 10.0 109.918 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.47 100.44 11.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.59 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -94.81 85.35 4.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.171 0.51 . . . . 10.0 110.05 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -62.38 114.75 3.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.655 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.71 -11.92 67.86 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.653 -0.784 . . . . 10.0 112.897 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.53 55.95 7.14 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.632 -0.794 . . . . 10.0 112.269 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.84 -44.15 81.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.178 0.514 . . . . 10.0 110.253 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.5 mm -77.74 -41.14 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.295 -0.631 . . . . 10.0 109.295 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.48 86.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.714 -0.676 . . . . 10.0 111.338 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -70.84 -41.74 71.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.985 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.9 m -65.92 -27.89 68.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.097 0.406 . . . . 10.0 112.097 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.72 -2.74 31.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.723 0.297 . . . . 10.0 110.898 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t30 54.21 55.88 7.66 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.686 -0.688 . . . . 10.0 111.471 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 87.5 mt -80.65 126.15 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.659 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 p -127.34 -1.99 6.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.898 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.9 p -154.18 151.72 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.575 0.226 . . . . 10.0 111.007 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -117.3 156.21 49.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -87.33 130.16 11.0 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.734 -1.361 . . . . 10.0 111.585 -0.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.4 m -94.35 130.73 40.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.135 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 19.3 m95 -112.84 115.34 28.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.462 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.09 116.91 32.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.346 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.4 tp -97.12 111.88 23.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.133 0.492 . . . . 10.0 110.939 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.1 129.31 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.62 -0.881 . . . . 10.0 108.62 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.59 175.58 33.45 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.859 -0.686 . . . . 10.0 112.262 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -72.21 -1.95 17.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.019 0.438 . . . . 10.0 111.176 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.46 -14.02 33.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.135 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.47 21.44 31.93 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.869 -0.682 . . . . 10.0 112.607 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -126.63 166.1 17.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.855 0.36 . . . . 10.0 111.289 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.22 125.33 31.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.688 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -113.76 -39.6 3.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.818 0.342 . . . . 10.0 111.848 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.53 151.3 43.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.688 0.28 . . . . 10.0 110.891 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.12 128.51 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 10.0 110.629 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.11 128.93 74.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.578 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -129.39 114.8 16.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.272 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.79 -85.58 0.19 Allowed Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.415 -0.898 . . . . 10.0 112.757 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.9 m -160.75 163.21 32.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.077 -0.342 . . . . 10.0 110.077 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.03 170.73 18.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.557 0.218 . . . . 10.0 111.294 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -147.17 163.34 36.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.007 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -57.66 -45.89 84.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.613 0.598 . . . . 10.0 112.613 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.8 95.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.847 0.356 . . . . 10.0 111.097 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -65.0 -40.9 95.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.176 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.91 -47.56 85.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.848 -0.615 . . . . 10.0 110.644 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.56 -37.81 88.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.713 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.41 97.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.742 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.1 tp -62.73 -36.11 81.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.134 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.8 mt -73.12 -26.78 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.077 0.465 . . . . 10.0 110.048 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -80.88 -40.99 23.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.311 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -154.15 113.9 2.51 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.177 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.06 -7.88 18.38 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.003 2.469 . . . . 10.0 112.449 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -86.36 -6.69 58.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.876 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.55 96.59 4.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.345 -0.389 . . . . 10.0 111.474 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -102.08 128.38 48.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.417 -0.586 . . . . 10.0 109.417 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 36.2 tp . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.108 -0.948 . . . . 10.0 111.633 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.909 0.385 . . . . 10.0 110.773 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.71 -60.41 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 61.7 tp -113.91 -65.31 1.2 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.847 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 52.79 41.12 31.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.446 0.641 . . . . 10.0 111.246 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.1 170.68 18.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.449 -0.796 . . . . 10.0 110.278 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.39 -159.34 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.855 0.722 . . . . 10.0 111.921 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -105.63 16.19 25.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.482 -0.781 . . . . 10.0 109.757 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -81.04 2.87 25.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 10.0 112.374 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.85 132.77 16.25 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.43 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.89 145.64 96.23 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.031 2.487 . . . . 10.0 112.35 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.37 -36.25 68.18 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.532 2.822 . . . . 10.0 113.136 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -62.71 -14.23 41.73 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.07 0.462 . . . . 10.0 111.96 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -121.17 -3.08 9.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.633 0.73 . . . . 10.0 109.93 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.6 -3.78 54.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 10.0 112.25 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -122.29 125.14 45.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.888 0.375 . . . . 10.0 111.165 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.03 90.82 10.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.275 -0.639 . . . . 10.0 109.275 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.73 96.28 0.99 Allowed 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.955 2.436 . . . . 10.0 112.879 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.42 98.17 10.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.05 116.34 27.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.819 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.26 109.95 19.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.703 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.87 114.81 30.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.275 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.96 170.49 7.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.23 -0.656 . . . . 10.0 109.23 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.51 -42.84 77.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.98 0.363 . . . . 10.0 111.98 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.9 -15.03 59.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.567 0.58 . . . . 10.0 112.567 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 165.11 166.4 24.02 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.424 -0.893 . . . . 10.0 112.228 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -90.52 137.43 21.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.18 -0.304 . . . . 10.0 110.18 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -120.53 112.15 18.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.922 -0.399 . . . . 10.0 109.922 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 6.8 p -91.79 121.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.051 0.453 . . . . 10.0 110.956 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -124.53 79.32 1.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.039 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -87.27 112.5 22.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 10.0 111.057 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -76.47 118.9 19.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.414 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 45.9 mt -92.65 140.19 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.719 -0.673 . . . . 10.0 110.33 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.94 149.79 39.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.396 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.08 77.74 1.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.168 0.509 . . . . 10.0 111.486 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 169.57 -21.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.376 -0.69 . . . . 10.0 111.376 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.41 150.17 24.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.221 -0.659 . . . . 10.0 109.221 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -142.15 136.54 30.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.048 0.452 . . . . 10.0 111.597 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 48.4 mtt -108.27 152.92 23.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.653 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -95.1 126.81 40.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.527 -0.546 . . . . 10.0 109.527 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -60.51 -28.96 68.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.051 0.453 . . . . 10.0 111.841 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.16 -0.94 51.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.994 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -113.06 -26.11 8.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.35 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.87 115.41 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.24 0.543 . . . . 10.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.51 122.98 59.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.871 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.28 129.37 3.45 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.685 -0.769 . . . . 10.0 111.909 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -157.76 138.24 12.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.806 0.336 . . . . 10.0 111.26 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 4.7 t -139.25 126.9 21.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.732 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -178.3 164.13 1.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.365 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.11 -76.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.244 1.962 . . . . 10.0 111.148 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.32 49.19 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.983 0.421 . . . . 10.0 110.651 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 t0 63.24 56.2 1.75 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.501 -0.772 . . . . 10.0 112.101 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -117.61 57.24 0.82 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.126 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.5 tp -115.6 147.62 40.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.134 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.5 -74.07 0.98 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.627 -0.797 . . . . 10.0 111.563 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.36 145.49 4.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.58 108.61 1.45 Allowed 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.472 2.115 . . . . 10.0 111.236 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 16.7 m -79.15 98.54 6.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.257 -0.429 . . . . 10.0 111.629 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -80.21 144.64 32.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.787 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -86.23 -9.33 56.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt 71.66 127.77 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.864 0.727 . . . . 10.0 112.542 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.77 -127.61 4.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.528 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -119.77 145.4 46.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.647 0.223 . . . . 10.0 110.412 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -85.87 125.61 33.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -111.4 134.56 52.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.038 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -77.14 128.37 34.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -116.17 174.49 6.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.983 0.421 . . . . 10.0 111.241 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -101.09 -26.83 13.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.015 -0.539 . . . . 10.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -118.95 -39.36 2.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.703 0.287 . . . . 10.0 111.487 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -79.47 -14.0 59.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 10.0 111.405 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.55 -89.71 1.63 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.863 -0.684 . . . . 10.0 112.053 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -159.03 115.45 2.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.029 -0.36 . . . . 10.0 110.029 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -137.23 164.35 28.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.866 0.365 . . . . 10.0 111.209 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -78.11 127.92 33.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.971 -0.751 . . . . 10.0 108.971 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.5 155.72 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.394 0.516 . . . . 10.0 112.394 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -117.0 128.6 55.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.556 -1.276 . . . . 10.0 107.556 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -118.3 5.87 11.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.397 0.517 . . . . 10.0 112.397 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 179.25 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -87.47 112.06 21.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.677 -1.147 . . . . 10.0 110.867 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.7 120.21 11.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.863 0.363 . . . . 10.0 110.871 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -155.36 120.77 4.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.15 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.04 124.46 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.348 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.72 144.93 28.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.235 -0.439 . . . . 10.0 109.897 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -120.66 100.28 46.84 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.41 121.59 3.87 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.8 2.334 . . . . 10.0 111.346 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.97 151.35 35.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.019 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.63 -2.41 48.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.293 0.568 . . . . 10.0 109.817 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -152.63 111.23 3.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.325 -0.852 . . . . 10.0 109.266 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.85 92.29 6.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.982 0.42 . . . . 10.0 110.64 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.48 158.05 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.137 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.91 51.96 2.25 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.124 -0.56 . . . . 10.0 111.846 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -117.02 145.84 36.59 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.87 117.06 4.63 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.247 1.965 . . . . 10.0 110.513 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.06 151.95 20.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.329 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -100.35 148.92 24.16 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.4 -0.592 . . . . 10.0 109.4 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 35.5 tp -122.32 125.65 46.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.78 0.324 . . . . 10.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 39.9 t -111.02 122.28 65.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 87.0 mt -127.42 123.84 37.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.856 0.36 . . . . 10.0 111.318 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 17.5 m -113.62 121.69 44.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -102.63 107.5 18.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.759 0.314 . . . . 10.0 111.47 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.04 125.33 42.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.91 0.386 . . . . 10.0 110.211 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.83 -159.09 13.67 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.675 -0.774 . . . . 10.0 111.359 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 10.3 m -152.7 -177.77 6.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' B' ' 105' ' ' ALA . . . -118.66 149.24 41.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -75.06 21.69 0.12 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.973 0.416 . . . . 10.0 111.502 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' B' ' 103' ' ' ALA . . . -122.78 -1.03 8.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.864 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.95 -26.03 12.1 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.754 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.9 t -62.12 140.19 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.616 0.246 . . . . 10.0 110.77 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 47.5 t -137.2 99.31 3.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.888 0.375 . . . . 10.0 110.465 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -80.58 151.79 71.96 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.779 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.12 161.17 45.57 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.861 2.374 . . . . 10.0 111.651 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.75 52.6 3.76 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.864 2.376 . . . . 10.0 113.077 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 33.5 t -56.57 131.44 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.028 0.442 . . . . 10.0 110.784 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -113.21 168.34 9.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.49 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.0 m -147.79 138.44 23.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.499 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -100.49 131.08 46.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.508 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -112.85 143.22 44.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.286 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -105.98 111.3 23.88 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.38 88.14 2.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.28 0.562 . . . . 10.0 110.846 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -102.92 -11.37 18.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.62 -0.718 . . . . 10.0 110.695 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.09 83.77 1.4 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.037 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -140.2 7.11 2.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.996 0.426 . . . . 10.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.73 -80.0 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.112 -0.565 . . . . 10.0 112.367 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 1.7 m -105.91 145.85 30.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -130.51 152.41 49.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.711 0.291 . . . . 10.0 111.328 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.15 138.72 15.15 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.708 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.81 138.61 23.75 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.467 2.112 . . . . 10.0 112.335 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -92.01 92.72 8.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.519 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 34.0 m . . . . . 0 C--O 1.252 1.202 0 CA-C-O 118.856 -0.593 . . . . 10.0 109.644 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.54 69.35 79.76 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 120.762 0.315 . . . . 10.0 110.798 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.1 -30.13 90.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.866 2.377 . . . . 10.0 112.877 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -61.71 -39.57 91.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.752 0.311 . . . . 10.0 110.91 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -71.08 -37.69 72.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 10.0 110.1 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 tp -65.04 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.904 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.1 m -84.86 -24.82 28.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.605 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 m -67.04 -28.43 68.21 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.069 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.06 112.51 1.37 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.83 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.01 138.9 40.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.08 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.0 p -77.53 168.72 19.53 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.041 -0.527 . . . . 10.0 109.671 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.28 -8.05 42.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.393 0.616 . . . . 10.0 110.029 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -91.1 2.16 56.54 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.247 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 t30 69.21 30.26 4.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.952 -1.022 . . . . 10.0 111.466 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtt85 -119.08 137.22 24.91 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.931 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.31 144.83 95.82 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.372 2.048 . . . . 10.0 110.899 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.96 -9.93 18.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.024 0.379 . . . . 10.0 112.024 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.5 m -56.17 -21.85 25.34 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.435 0.531 . . . . 10.0 112.435 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 m -64.9 -24.61 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.02 0.438 . . . . 10.0 111.138 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -118.97 17.38 13.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.487 0.661 . . . . 10.0 109.699 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 91.5 mt -125.22 43.66 2.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.313 -0.858 . . . . 10.0 109.618 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -141.65 -179.36 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.142 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.5 mttp 72.48 3.61 4.74 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.988 0.805 . . . . 10.0 112.179 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 54.0 47.77 22.64 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.881 -0.599 . . . . 10.0 111.071 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -116.36 150.09 44.77 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.441 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.82 127.41 26.09 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.053 2.502 . . . . 10.0 112.028 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -102.09 137.07 40.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.242 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.2 tp -118.7 106.09 12.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.84 -0.43 . . . . 10.0 109.84 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.7 mt -97.37 123.26 49.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.759 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.511 ' HZ1' ' CD ' ' A' ' 42' ' ' GLU . 19.6 ttpt -116.03 126.03 53.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.361 -0.382 . . . . 10.0 110.644 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.33 144.85 26.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.494 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -145.67 166.93 24.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.613 -0.267 . . . . 10.0 111.155 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.51 144.34 39.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.139 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 m -70.51 -52.46 21.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.585 0.587 . . . . 10.0 112.585 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -90.89 44.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.96 0.409 . . . . 10.0 111.694 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.7 t -119.84 119.67 30.99 Favored Pre-proline 0 C--N 1.317 -0.826 0 C-N-CA 120.88 -0.328 . . . . 10.0 111.368 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.95 -38.23 48.46 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.687 2.258 . . . . 10.0 111.793 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.47 -44.98 81.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.343 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.6 m -72.19 -24.72 61.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.235 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -55.31 31.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 10.0 111.474 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.09 -34.03 77.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.024 0.44 . . . . 10.0 110.496 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.511 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 2.5 tm-20 -65.13 -27.95 69.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.679 -0.692 . . . . 10.0 111.569 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -56.39 -40.64 74.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.914 0.388 . . . . 10.0 110.864 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.76 -32.6 78.28 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.147 -0.781 . . . . 10.0 111.147 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -71.57 -36.63 70.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.936 -0.394 . . . . 10.0 109.936 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -61.35 -47.7 84.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.037 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -64.77 -37.6 88.15 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.522 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -60.12 -46.16 90.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.23 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -66.5 -32.53 73.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.023 -0.535 . . . . 10.0 111.025 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.51 -16.12 63.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.21 0.528 . . . . 10.0 111.111 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -99.2 -3.57 34.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.472 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.5 147.16 29.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.376 -0.375 . . . . 10.0 110.653 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 -31.13 72.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.862 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -66.61 -51.51 55.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 10.0 111.035 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -75.67 -10.25 59.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.674 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -75.74 -7.37 54.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.192 0.52 . . . . 10.0 110.195 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.89 4.62 52.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.836 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.78 173.29 11.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.85 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -106.58 89.36 3.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.899 0.38 . . . . 10.0 110.299 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -88.51 127.01 35.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.879 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.8 pt -142.28 152.28 18.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.985 0.421 . . . . 10.0 111.27 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.09 126.3 52.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.299 -0.63 . . . . 10.0 109.299 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.6 t -122.08 141.99 40.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.835 0.35 . . . . 10.0 111.474 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.36 148.28 52.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.8 m -110.74 97.42 33.16 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.663 0.268 . . . . 10.0 111.624 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -60.17 123.69 13.68 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.882 2.388 . . . . 10.0 112.525 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.7 -21.5 29.46 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.797 -0.638 . . . . 10.0 112.86 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.0 143.68 28.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.648 0.261 . . . . 10.0 110.508 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 60.02 22.81 11.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.911 -0.586 . . . . 10.0 112.385 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 71.12 24.54 3.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.78 -0.645 . . . . 10.0 112.561 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.55 -175.34 5.74 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.54 0.21 . . . . 10.0 110.798 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -58.57 136.16 57.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.494 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -76.25 174.37 10.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.875 0.369 . . . . 10.0 111.866 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.8 144.26 55.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.736 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 -47.02 3.59 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.014 -0.835 . . . . 10.0 111.014 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -47.21 81.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 10.0 109.908 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.78 -32.1 73.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.471 -0.786 . . . . 10.0 110.907 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.12 -44.57 94.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.666 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -71.28 -31.39 67.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.782 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -58.87 -47.06 86.24 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.864 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -73.6 -40.94 63.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.366 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.49 68.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 10.0 111.395 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.44 23.08 36.59 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.955 -0.641 . . . . 10.0 112.623 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 mt -117.53 170.11 9.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.833 0.349 . . . . 10.0 110.766 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -89.58 176.02 7.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.798 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 71.09 73.81 0.26 Allowed Pre-proline 0 N--CA 1.465 0.3 0 O-C-N 123.883 0.739 . . . . 10.0 111.448 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.45 -1.57 11.21 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.482 2.122 . . . . 10.0 112.188 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.88 -0.81 44.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.895 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.69 114.97 39.5 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.764 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.86 77.65 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.62 2.213 . . . . 10.0 111.581 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.1 t -92.32 118.66 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.094 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 t -100.75 144.62 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.74 -0.663 . . . . 10.0 109.963 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.43 117.38 33.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.499 -0.319 . . . . 10.0 111.125 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -108.18 96.03 6.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 10.0 110.044 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -67.62 112.52 4.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.766 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.59 -9.45 62.43 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.995 -0.622 . . . . 10.0 112.242 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.21 50.92 41.8 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.964 -0.636 . . . . 10.0 112.187 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -46.8 88.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.9 0.381 . . . . 10.0 111.262 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.85 -42.47 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.96 90.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.541 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -69.64 -36.72 76.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.812 0.339 . . . . 10.0 111.409 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -64.6 -33.51 76.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.215 0.45 . . . . 10.0 112.215 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -100.82 -2.86 31.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.673 0.273 . . . . 10.0 110.919 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 43.7 t30 60.58 61.44 1.72 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.92 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.8 mt -97.84 105.37 17.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.422 -0.808 . . . . 10.0 110.956 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.77 13.24 14.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.926 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 p -147.0 150.5 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.617 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -124.18 153.64 68.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -89.74 128.17 7.67 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 124.0 -1.25 . . . . 10.0 111.689 -0.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.9 m -96.21 136.27 36.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.361 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -114.14 110.99 20.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.214 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.21 110.23 22.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.51 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.1 tp -91.72 112.7 24.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.688 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 84.4 mt -99.74 137.72 26.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.82 173.25 55.12 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.64 -0.791 . . . . 10.0 112.799 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -65.2 -14.49 60.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 10.0 111.716 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.35 -19.72 29.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.151 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 105.06 -0.08 41.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.82 -0.705 . . . . 10.0 111.945 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -96.57 158.48 15.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.232 -0.285 . . . . 10.0 110.232 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.14 118.87 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.921 0.391 . . . . 10.0 111.171 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -51.53 6.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.695 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -156.87 142.26 17.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.119 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -116.25 119.25 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.051 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.9 t -107.92 120.51 59.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.786 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -126.39 125.1 41.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.626 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 142.33 -97.22 0.2 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.722 -0.751 . . . . 10.0 111.829 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.7 t -160.35 138.2 9.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.022 -0.362 . . . . 10.0 110.022 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.9 pt -121.71 150.64 25.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.001 0.429 . . . . 10.0 110.875 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -114.28 174.92 5.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.649 . . . . 10.0 110.256 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.18 -45.3 91.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.71 0.263 . . . . 10.0 111.71 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.16 -41.97 84.96 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.515 -0.312 . . . . 10.0 110.59 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.18 -44.46 88.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.868 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.07 92.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.672 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.93 -34.34 75.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.765 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.2 85.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.383 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.44 -33.89 75.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.52 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 76.5 mt -67.44 -31.83 54.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.669 -0.493 . . . . 10.0 109.669 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.45 -61.24 2.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.772 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -127.64 117.31 21.12 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.341 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.26 -3.55 12.57 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.087 2.525 . . . . 10.0 112.574 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -95.81 -2.52 47.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.624 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.64 116.99 10.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.041 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -122.53 160.25 26.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.633 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.283 0.989 . . . . 10.0 112.972 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.422 ' H3 ' ' CG ' ' B' ' 4' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.622 0.248 . . . . 10.0 111.354 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.24 -65.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.198 0.444 . . . . 10.0 112.198 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 54.9 tp -85.37 -82.57 0.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . 0.422 ' CG ' ' H3 ' ' B' ' 1' ' ' MET . 76.3 m-20 62.24 45.82 6.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.619 0.724 . . . . 10.0 110.899 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.08 154.05 38.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.374 -0.83 . . . . 10.0 110.13 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.76 -163.63 0.23 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.79 0.681 . . . . 10.0 112.145 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -98.78 29.7 3.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.968 0.413 . . . . 10.0 111.085 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.65 15.27 14.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.146 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.63 137.61 11.53 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.789 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.11 151.05 86.78 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.931 2.421 . . . . 10.0 112.356 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.29 -36.03 85.38 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.302 2.668 . . . . 10.0 113.152 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -69.06 -2.86 11.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.932 0.396 . . . . 10.0 112.023 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -131.82 5.86 4.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.473 0.654 . . . . 10.0 109.623 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.74 -1.84 31.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.702 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -134.19 128.97 35.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.814 0.34 . . . . 10.0 110.96 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.6 91.38 20.55 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.67 105.26 1.27 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.679 2.253 . . . . 10.0 112.727 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.12 99.4 12.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.236 -0.653 . . . . 10.0 109.236 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -89.33 102.99 15.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.882 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.26 101.78 10.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.52 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 81.1 t -89.82 119.59 37.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.616 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.1 -176.37 3.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.175 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.48 -35.9 34.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.403 -0.362 . . . . 10.0 111.29 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.35 -34.95 28.28 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.22 -178.61 40.14 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.762 -0.733 . . . . 10.0 112.077 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.86 135.88 38.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -123.48 114.87 20.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.954 0.407 . . . . 10.0 110.524 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.69 122.56 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.403 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -125.03 80.35 1.87 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.951 0.405 . . . . 10.0 110.315 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -77.35 111.71 13.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 10.0 111.141 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 -72.35 112.73 8.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.372 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 63.4 mt -90.23 135.73 25.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.975 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.41 149.27 50.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.21 92.65 1.02 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.059 0.457 . . . . 10.0 111.576 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.95 -22.06 0.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.369 -0.692 . . . . 10.0 111.369 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -105.37 154.28 20.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -146.6 139.23 25.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.983 0.42 . . . . 10.0 111.184 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 37.8 mtt -110.99 159.04 18.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.849 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -100.91 127.36 47.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -59.31 -30.7 68.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.183 0.438 . . . . 10.0 112.183 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.68 3.84 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.94 0.4 . . . . 10.0 111.181 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -116.83 -20.47 9.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.336 -0.393 . . . . 10.0 111.801 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 60.8 mt -77.22 96.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.092 0.472 . . . . 10.0 110.724 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.21 108.88 20.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.315 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.59 138.66 10.21 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.846 -0.692 . . . . 10.0 111.562 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -160.98 145.52 13.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.608 0.242 . . . . 10.0 111.066 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 15.1 t -141.51 125.63 17.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.191 -0.459 . . . . 10.0 109.879 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -179.0 161.75 1.02 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.154 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -73.92 -63.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.435 2.09 . . . . 10.0 110.909 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.36 58.49 1.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 10.0 109.809 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 5.5 t70 61.96 33.62 17.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.53 -0.759 . . . . 10.0 112.455 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -90.16 55.09 2.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.4 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 19.0 tp -121.5 145.47 47.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.104 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.46 -76.8 0.85 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.587 -0.816 . . . . 10.0 111.309 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -161.17 143.46 9.18 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.9 108.52 1.11 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.526 2.151 . . . . 10.0 111.18 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.6 m -82.46 103.55 12.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.849 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.4 158.91 18.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 51.0 m -91.79 -14.06 30.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.622 -0.263 . . . . 10.0 110.831 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? 71.82 127.9 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.76 -0.655 . . . . 10.0 112.284 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.81 -133.0 5.61 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.135 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -117.41 140.24 49.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.527 0.203 . . . . 10.0 110.564 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.31 121.65 24.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.457 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -98.72 139.91 33.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -78.56 141.54 38.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.39 170.49 15.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.636 0.255 . . . . 10.0 110.495 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -24.83 10.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.961 0.41 . . . . 10.0 110.994 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -102.82 -44.75 5.19 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.202 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -89.61 -9.62 49.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.583 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.08 -77.78 1.89 Allowed Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.827 -0.624 . . . . 10.0 112.296 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -173.81 117.91 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.752 0.31 . . . . 10.0 110.496 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -141.02 162.16 36.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.144 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.6 m -68.83 127.24 32.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.812 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.2 m -127.3 161.8 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 10.0 111.731 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -118.24 128.1 54.36 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.868 -1.16 . . . . 10.0 107.868 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -112.27 -3.8 14.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.768 0.655 . . . . 10.0 112.768 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -175.93 -36.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.987 -0.746 . . . . 10.0 108.987 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -86.26 125.04 33.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.086 -0.961 . . . . 10.0 109.767 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.37 116.77 4.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.323 . . . . 10.0 111.523 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -153.61 125.38 7.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.163 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.3 t -129.99 131.75 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.252 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.56 142.01 39.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.704 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -120.22 112.26 34.7 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.263 0.468 . . . . 10.0 112.263 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -93.08 124.62 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.521 2.814 . . . . 10.0 111.55 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.01 148.04 40.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.988 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.3 -3.21 53.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.324 0.583 . . . . 10.0 109.73 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -153.47 124.7 7.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.867 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.75 89.77 8.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.04 0.448 . . . . 10.0 110.352 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.64 147.15 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.71 47.33 3.83 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.073 -0.584 . . . . 10.0 112.344 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -106.67 145.44 31.07 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.53 116.02 4.54 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.319 2.013 . . . . 10.0 111.288 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.77 165.4 11.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.967 0.413 . . . . 10.0 111.832 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -109.2 151.76 26.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.979 -0.555 . . . . 10.0 109.828 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 56.0 tp -120.54 115.55 23.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.974 0.416 . . . . 10.0 110.664 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.88 126.44 64.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.535 -0.542 . . . . 10.0 109.535 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 66.8 mt -133.13 121.06 22.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.925 0.393 . . . . 10.0 111.895 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 5.0 m -108.8 119.22 38.91 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -100.58 109.48 21.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.777 0.322 . . . . 10.0 111.561 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -124.32 119.35 29.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.968 0.413 . . . . 10.0 110.533 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.36 -160.79 11.08 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.603 -0.808 . . . . 10.0 111.877 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 13.1 m -151.21 -172.42 4.2 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.22 147.73 52.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.259 -0.274 . . . . 10.0 110.259 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.47 6.08 2.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 10.0 111.753 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.19 5.33 29.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.892 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.52 -7.74 56.2 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.626 -0.797 . . . . 10.0 113.087 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.33 142.75 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.739 0.304 . . . . 10.0 110.471 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 47.9 t -142.52 85.56 1.91 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.941 0.401 . . . . 10.0 110.068 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -74.09 152.35 88.44 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.79 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.82 165.18 31.9 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.827 2.351 . . . . 10.0 111.377 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.42 68.11 5.28 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.657 2.238 . . . . 10.0 112.947 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 4.8 t -62.65 120.78 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 10.0 109.943 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -108.03 153.91 22.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.094 0.473 . . . . 10.0 111.37 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.68 138.77 41.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.822 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.19 124.45 50.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.82 0.343 . . . . 10.0 110.571 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -111.57 142.73 43.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.618 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -103.98 121.41 43.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.263 -0.426 . . . . 10.0 109.877 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 23.1 mm -94.66 88.83 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.967 0.413 . . . . 10.0 110.787 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -95.03 -35.02 12.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.549 . . . . 10.0 111.45 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.4 60.78 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.43 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -120.0 -0.89 10.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.81 0.338 . . . . 10.0 111.101 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.26 -76.14 1.5 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.002 -0.618 . . . . 10.0 111.658 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 3.9 m -103.21 140.25 37.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.565 -0.531 . . . . 10.0 109.565 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -129.86 161.36 30.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.142 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.18 146.97 24.67 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.26 121.56 9.43 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.557 2.171 . . . . 10.0 112.42 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -82.64 62.89 6.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.355 0.598 . . . . 10.0 110.01 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.091 -179.285 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 tpt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.098 -0.334 . . . . 10.0 110.098 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.65 82.64 48.26 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.562 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.01 -25.71 58.97 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.55 2.167 . . . . 10.0 111.566 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -46.83 87.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.833 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -60.56 -42.54 96.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.302 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.97 -32.84 74.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.806 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.0 m -81.91 -25.6 34.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.054 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.3 m -65.68 -26.71 67.9 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.756 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -55.69 128.0 32.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.878 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -115.47 149.55 37.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.638 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.4 p -89.34 174.96 7.53 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.046 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.56 -19.36 65.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.411 . . . . 10.0 111.008 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.31 9.13 27.16 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 64.84 30.57 12.11 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.703 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 mtp85 -112.27 137.65 21.59 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.932 -0.577 . . . . 10.0 109.93 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.32 139.48 90.21 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.615 2.21 . . . . 10.0 111.409 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.14 -10.08 20.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 10.0 112.008 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 t -59.85 -18.41 43.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.647 -0.252 . . . . 10.0 111.494 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.18 -15.54 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-O 120.788 0.328 . . . . 10.0 111.018 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -127.06 22.92 6.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.56 . . . . 10.0 109.714 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.4 mt -133.0 27.28 4.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.024 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -118.97 174.6 6.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.6 mttp 69.32 15.7 8.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.127 -0.942 . . . . 10.0 112.902 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.18 51.21 14.89 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.512 0.507 . . . . 10.0 111.242 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -112.65 143.37 28.86 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.218 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.26 134.08 56.81 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.725 2.283 . . . . 10.0 110.956 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -106.78 143.91 34.19 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.967 0.413 . . . . 10.0 111.22 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tp -121.47 97.94 5.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.156 -0.683 . . . . 10.0 109.156 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.0 mt -89.39 112.22 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.025 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.5 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 5.7 tmmm? -106.59 120.88 43.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.88 0.371 . . . . 10.0 110.826 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -90.33 127.9 36.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.208 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -121.37 173.89 7.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.078 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.83 138.48 54.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.102 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -77.49 -47.43 19.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.36 29.1 1.0 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.077 0.769 . . . . 10.0 113.077 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -119.65 125.98 27.18 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 111.665 0.246 . . . . 10.0 111.665 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.01 -43.85 17.92 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.832 2.355 . . . . 10.0 112.457 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.97 -44.52 96.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.167 0.508 . . . . 10.0 111.135 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.9 -28.52 67.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.888 -0.596 . . . . 10.0 111.496 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.7 mt -63.62 -44.77 92.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.845 0.355 . . . . 10.0 110.464 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.6 m -69.63 -31.61 69.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.668 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.5 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -63.93 -28.82 70.09 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.057 -0.52 . . . . 10.0 110.646 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.91 -42.48 84.83 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.442 -0.345 . . . . 10.0 111.321 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.04 -44.46 97.3 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.796 -0.716 . . . . 10.0 111.421 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -65.49 -34.67 78.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.867 0.365 . . . . 10.0 110.192 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.3 m -61.33 -46.88 88.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.161 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.56 -40.93 98.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.955 0.407 . . . . 10.0 110.429 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.22 -47.66 78.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 10.0 111.003 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -65.01 -33.93 77.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.576 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.44 -6.28 34.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.918 0.389 . . . . 10.0 111.283 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -113.11 9.07 18.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.207 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -85.63 146.54 26.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.439 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.32 73.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.856 0.687 . . . . 10.0 112.856 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -74.67 -39.2 62.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.835 0.35 . . . . 10.0 111.155 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -75.5 -20.3 58.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.495 0.554 . . . . 10.0 112.495 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.8 m -65.93 -6.54 12.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.34 . . . . 10.0 111.902 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -77.3 -18.37 57.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 10.0 110.147 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -125.91 -178.67 4.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.701 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -113.39 100.36 8.48 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.182 -0.303 . . . . 10.0 110.182 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.07 129.29 35.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.598 -0.273 . . . . 10.0 111.022 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.3 pt -138.22 155.73 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.988 0.423 . . . . 10.0 111.415 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.97 109.43 18.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 10.0 109.648 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.0 t -111.14 140.99 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.94 0.4 . . . . 10.0 111.482 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -135.44 149.63 49.64 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 m -110.03 97.97 32.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.39 126.63 21.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.942 2.428 . . . . 10.0 112.507 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.61 -36.8 3.3 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.8 -0.637 . . . . 10.0 113.171 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -66.44 134.36 52.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.621 0.248 . . . . 10.0 110.999 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.14 29.7 19.32 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.639 0.607 . . . . 10.0 112.639 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.08 21.14 3.24 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.299 0.852 . . . . 10.0 113.299 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.34 178.3 5.95 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -61.52 124.93 22.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -61.73 156.95 18.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.913 0.387 . . . . 10.0 111.734 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -59.27 151.47 23.17 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.403 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.58 -44.97 3.3 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.22 -39.51 17.71 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -57.44 -46.2 83.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.584 -0.735 . . . . 10.0 112.136 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -63.48 -31.69 72.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.9 0.381 . . . . 10.0 111.541 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -75.6 -22.62 56.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.142 0.496 . . . . 10.0 110.464 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -65.47 -46.69 78.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.493 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -72.43 -32.71 66.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.819 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.49 -31.71 68.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.963 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.39 23.89 34.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.398 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.5 mt -115.71 -161.82 0.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.408 . . . . 10.0 111.361 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -118.59 -168.89 1.62 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 63.24 76.3 0.37 Allowed Pre-proline 0 C--O 1.234 0.24 0 O-C-N 123.456 0.472 . . . . 10.0 111.559 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.4 0.76 9.12 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.666 2.244 . . . . 10.0 112.272 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -104.43 6.47 34.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.089 0.471 . . . . 10.0 110.428 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.2 mt -84.81 115.21 59.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.125 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.06 76.9 3.98 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.658 2.239 . . . . 10.0 111.393 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.25 118.47 30.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.982 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.9 t -103.88 142.8 16.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.861 -0.609 . . . . 10.0 109.95 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.9 m -107.58 107.51 18.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.145 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -97.86 92.32 5.77 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.251 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -63.08 107.91 1.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.918 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.54 -10.53 68.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.823 -0.703 . . . . 10.0 112.872 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.9 55.9 6.91 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.263 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.96 -45.1 87.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.937 0.399 . . . . 10.0 110.642 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.3 mm -78.67 -37.85 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.485 -0.561 . . . . 10.0 109.485 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.23 95.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.586 -0.734 . . . . 10.0 111.599 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -70.08 -37.22 75.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.762 0.315 . . . . 10.0 111.529 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.2 m -62.84 -23.44 67.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.447 -0.342 . . . . 10.0 111.833 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.2 mt -111.87 4.4 18.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.659 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.8 t30 54.3 44.4 29.07 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.429 0.633 . . . . 10.0 111.631 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.8 mt -80.41 101.53 5.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.839 -0.619 . . . . 10.0 111.551 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.9 m -118.95 29.88 7.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.87 -0.605 . . . . 10.0 110.564 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.4 p -160.71 151.14 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.281 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -130.89 155.29 81.67 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.74 141.97 30.55 Favored 'Cis proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.355 -1.519 . . . . 10.0 111.26 -1.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.7 m -118.23 126.76 52.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.654 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -107.72 108.39 19.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.91 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.01 115.68 27.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.154 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.4 tp -90.94 115.78 28.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.595 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.9 135.68 41.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.211 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.69 178.95 38.47 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.03 -0.605 . . . . 10.0 112.63 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -71.45 -4.59 27.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.906 0.384 . . . . 10.0 111.984 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -98.92 -4.43 32.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.993 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 86.06 16.79 62.32 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.815 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -109.09 163.09 13.64 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.162 -0.31 . . . . 10.0 110.162 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.34 122.75 25.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.855 0.36 . . . . 10.0 110.418 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.18 -40.92 6.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.95 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -160.78 161.89 32.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.498 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -138.03 120.76 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.013 0.435 . . . . 10.0 110.484 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.4 t -115.66 107.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 10.0 109.872 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -115.21 133.62 55.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.452 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.65 -75.72 0.42 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.415 -0.897 . . . . 10.0 112.96 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.9 m -159.88 159.26 32.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.018 -0.364 . . . . 10.0 110.018 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.38 170.6 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.311 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -156.0 174.33 15.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.643 -0.253 . . . . 10.0 111.132 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.19 -40.01 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.57 -46.23 87.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 10.0 110.902 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -67.94 -37.74 81.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.953 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.51 80.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.38 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.78 -38.97 92.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.739 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.17 91.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.262 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.1 tp -62.88 -35.65 80.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 10.0 111.646 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.2 mt -70.1 -27.89 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.214 0.53 . . . . 10.0 110.552 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -89.11 -47.33 8.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.077 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -137.15 110.61 9.14 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.622 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.48 3.45 4.2 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.306 2.67 . . . . 10.0 112.812 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -93.1 -7.27 46.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.458 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.04 131.34 44.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.005 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -133.31 136.9 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.465 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.092 0 N-CA-C 113.944 1.09 . . . . 10.0 113.944 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.716 0.293 . . . . 10.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.75 -53.1 59.49 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.314 -0.403 . . . . 10.0 112.086 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 49.6 tp -89.73 -73.09 0.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.131 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 57.59 35.46 25.76 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.214 0.531 . . . . 10.0 110.918 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.67 167.81 27.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.778 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.8 m120 65.68 -170.36 0.19 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.721 0.638 . . . . 10.0 112.398 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -101.17 19.44 17.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.124 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -88.97 20.24 3.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.614 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.3 136.56 13.26 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.279 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -61.42 150.23 86.0 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.166 2.577 . . . . 10.0 112.11 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.18 -40.09 60.83 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.682 2.921 . . . . 10.0 113.365 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -65.24 -19.65 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.009 0.374 . . . . 10.0 112.009 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -106.91 -10.53 15.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.367 0.604 . . . . 10.0 110.041 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.49 -8.22 59.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.539 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -134.08 131.53 38.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.923 0.392 . . . . 10.0 111.571 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.59 91.57 42.12 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.37 108.74 2.58 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.12 2.547 . . . . 10.0 113.32 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -104.43 107.93 19.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.963 -0.755 . . . . 10.0 108.963 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.19 120.45 35.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.57 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.71 108.66 14.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.354 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 85.1 t -98.86 128.13 50.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.218 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.69 -166.94 1.34 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.291 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.31 -38.03 27.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.533 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.09 -41.66 85.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.216 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 178.12 -168.28 39.48 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.664 -0.779 . . . . 10.0 112.274 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 86.1 t -101.92 131.74 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.79 -0.448 . . . . 10.0 109.79 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -121.42 118.96 30.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.956 0.408 . . . . 10.0 110.765 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 p -103.47 116.96 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.12 0.486 . . . . 10.0 110.439 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -123.91 82.25 2.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.484 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -87.62 134.25 33.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.79 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 71.6 mtm-85 -85.52 129.36 34.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.298 -0.41 . . . . 10.0 111.034 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 76.9 mt -101.78 132.58 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.003 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.38 144.33 57.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.441 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.35 91.79 0.26 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.458 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.43 -23.06 0.95 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.427 -0.669 . . . . 10.0 111.427 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -100.74 159.24 15.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.103 -0.702 . . . . 10.0 109.103 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -150.32 136.57 18.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.131 0.491 . . . . 10.0 111.581 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 23.7 mtt -107.48 153.22 23.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.389 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -96.16 127.07 41.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.071 -0.714 . . . . 10.0 109.071 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -59.06 -33.79 71.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.849 0.356 . . . . 10.0 111.402 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.04 1.3 32.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.229 -0.442 . . . . 10.0 111.302 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -116.53 -6.72 11.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 10.0 111.427 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 81.0 mt -87.97 96.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 10.0 110.055 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 39.1 t -91.34 117.95 35.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.304 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.71 140.89 9.55 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.614 -0.803 . . . . 10.0 111.847 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -163.71 147.46 10.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.789 0.328 . . . . 10.0 110.713 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 9.4 t -144.18 120.41 10.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.143 -0.48 . . . . 10.0 109.854 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -174.96 155.19 1.83 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.47 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.13 -66.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.837 2.358 . . . . 10.0 111.52 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.42 36.18 2.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.48 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 13.8 t0 64.58 33.16 11.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.495 -0.775 . . . . 10.0 112.611 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.78 76.6 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.92 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -131.98 155.51 47.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.681 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.04 -80.46 0.64 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.094 -0.803 . . . . 10.0 111.094 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -168.99 147.8 3.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.841 -0.429 . . . . 10.0 109.841 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.02 110.53 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.637 2.225 . . . . 10.0 110.919 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.9 m -95.25 100.62 12.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.016 0.436 . . . . 10.0 111.401 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -80.58 168.16 19.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.98 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 42.4 m -97.67 -7.2 31.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.713 -0.221 . . . . 10.0 111.39 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt 69.41 117.6 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.829 0.677 . . . . 10.0 112.829 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.53 -125.34 5.57 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.914 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.21 158.4 28.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -94.31 123.31 37.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.932 0.396 . . . . 10.0 110.667 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -100.97 130.02 46.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.982 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.41 120.83 23.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.392 -0.966 . . . . 10.0 108.392 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -110.2 176.05 5.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.104 0.478 . . . . 10.0 111.432 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -110.06 -25.1 10.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.214 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.61 -42.68 3.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.054 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -88.32 4.55 45.65 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.072 0.397 . . . . 10.0 112.072 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.98 -89.57 1.18 Allowed Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.715 -0.755 . . . . 10.0 111.859 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -171.09 123.9 0.61 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -136.57 167.3 21.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.337 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 15.2 m -75.34 128.78 36.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.521 -0.918 . . . . 10.0 108.521 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.65 162.69 32.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.433 0.635 . . . . 10.0 112.46 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -122.09 129.09 52.07 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.718 -1.216 . . . . 10.0 107.718 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -110.39 -15.54 13.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.721 0.637 . . . . 10.0 112.721 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -159.88 -35.24 0.06 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.6 OUTLIER -83.98 144.33 29.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.031 -0.986 . . . . 10.0 108.779 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -170.13 101.57 0.29 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.857 0.36 . . . . 10.0 111.042 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -140.57 120.37 13.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.118 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.36 123.54 62.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.155 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.27 141.28 36.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.723 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -119.82 104.35 44.59 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.539 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.4 126.12 3.07 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.781 2.321 . . . . 10.0 111.448 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -70.14 151.27 45.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.918 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.05 -11.74 25.95 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -149.35 122.29 8.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.166 -0.924 . . . . 10.0 109.075 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.84 85.95 6.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.087 0.47 . . . . 10.0 110.651 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 m -114.63 160.55 13.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.858 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.63 2.38 82.54 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.77 -0.728 . . . . 10.0 111.695 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.68 125.45 82.78 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.572 -0.314 . . . . 10.0 110.893 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.13 101.31 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.407 2.071 . . . . 10.0 110.6 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.63 163.91 18.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.673 0.619 . . . . 10.0 112.673 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -114.04 160.65 18.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.298 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 18.6 tp -127.42 135.84 51.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.922 0.391 . . . . 10.0 110.772 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.37 126.1 71.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 79.9 mt -129.99 126.62 38.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.889 0.376 . . . . 10.0 112.004 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 4.0 m -111.52 117.87 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -98.52 100.29 11.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.945 0.35 . . . . 10.0 111.945 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -117.61 122.05 42.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.104 0.478 . . . . 10.0 110.894 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.79 -162.33 12.46 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.937 -0.649 . . . . 10.0 111.685 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.5 m -151.95 -175.13 5.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.43 -0.582 . . . . 10.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.07 144.56 51.11 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -69.37 -4.05 16.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.156 0.503 . . . . 10.0 111.202 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.52 -13.37 43.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.982 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 118.1 -18.15 11.43 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.975 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 6.3 t -66.61 141.99 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.606 0.241 . . . . 10.0 110.473 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 13.8 t -137.49 87.74 2.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.14 0.495 . . . . 10.0 110.005 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -76.1 151.95 84.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.875 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.35 163.72 34.04 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.8 2.333 . . . . 10.0 111.521 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.0 79.15 3.2 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.623 2.215 . . . . 10.0 112.247 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.0 101.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -86.67 149.47 24.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.127 0.489 . . . . 10.0 111.701 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.09 140.89 44.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.205 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.48 137.64 38.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.007 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.81 135.54 53.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.662 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -95.13 119.48 33.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.302 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 16.5 mm -95.74 76.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 10.0 110.665 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -88.75 -24.55 22.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.005 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.54 53.89 0.17 Allowed Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.925 -0.655 . . . . 10.0 112.406 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -104.6 -4.69 22.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.246 0.546 . . . . 10.0 109.955 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.85 -77.11 1.94 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.276 -0.73 . . . . 10.0 111.276 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 2.3 m -101.81 140.03 36.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -128.09 152.72 47.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.926 0.393 . . . . 10.0 110.817 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.3 151.72 70.05 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.147 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.0 116.23 3.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.468 2.112 . . . . 10.0 111.75 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -82.77 81.47 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.241 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.927 -0.559 . . . . 10.0 109.964 -179.801 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.88 71.1 14.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.861 0.362 . . . . 10.0 111.597 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.97 -31.98 55.08 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.387 2.058 . . . . 10.0 112.256 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -61.88 -41.97 98.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.722 0.296 . . . . 10.0 110.874 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.75 -43.06 80.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.614 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.0 tp -61.95 -34.69 76.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.831 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -80.48 -13.74 58.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.236 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.4 m -84.86 -12.31 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 10.0 110.535 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -59.38 120.79 9.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.254 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.73 133.24 51.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.563 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.9 p -74.09 171.17 14.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.638 -0.504 . . . . 10.0 109.638 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.96 -12.24 60.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.432 0.634 . . . . 10.0 110.542 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -96.03 7.92 45.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.291 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 71.01 19.03 5.77 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.399 -0.819 . . . . 10.0 112.401 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -102.79 143.93 27.6 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.918 -0.401 . . . . 10.0 109.918 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.48 142.1 76.77 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.404 2.07 . . . . 10.0 111.318 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.76 -8.52 28.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.429 -0.35 . . . . 10.0 111.783 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.66 -24.27 55.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.637 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 m -63.16 -18.73 22.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.932 0.396 . . . . 10.0 111.579 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -126.03 24.27 6.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.433 0.635 . . . . 10.0 109.927 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -138.6 58.82 1.65 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.269 -0.878 . . . . 10.0 109.441 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -154.37 -178.7 7.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.98 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? 66.85 12.78 9.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.598 -0.728 . . . . 10.0 112.316 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 55.3 38.31 30.17 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.075 0.464 . . . . 10.0 111.689 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -107.51 151.56 41.03 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.704 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.84 152.16 59.39 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.009 2.472 . . . . 10.0 112.153 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.88 141.71 48.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.64 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.7 tp -122.33 94.97 4.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.6 mt -93.38 122.51 44.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.613 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.509 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 3.6 tmmt? -123.08 129.7 51.82 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.978 0.418 . . . . 10.0 111.134 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -92.8 137.88 31.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.307 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -132.57 171.91 13.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.145 -0.48 . . . . 10.0 110.475 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.67 137.54 54.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.756 0.312 . . . . 10.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.28 -39.99 46.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.928 -0.578 . . . . 10.0 112.12 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -91.64 25.02 2.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.404 0.52 . . . . 10.0 112.404 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.3 t -115.6 124.33 30.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.24 -41.96 24.92 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.771 2.314 . . . . 10.0 112.142 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.72 -31.53 72.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.988 0.423 . . . . 10.0 111.07 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.1 m -84.19 -14.95 48.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.568 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 mt -71.55 -45.79 61.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.556 -0.293 . . . . 10.0 111.752 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -22.04 62.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.426 0.631 . . . . 10.0 110.559 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.509 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -70.67 -23.69 62.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.353 -0.84 . . . . 10.0 111.458 -179.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -58.55 -53.93 52.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.118 0.414 . . . . 10.0 112.118 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.56 -35.76 89.9 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.047 -0.597 . . . . 10.0 111.943 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -66.95 -41.68 86.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.791 0.329 . . . . 10.0 110.46 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.9 m -61.72 -43.92 97.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.96 -0.563 . . . . 10.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -39.82 92.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.774 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.56 -40.09 95.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.114 0.483 . . . . 10.0 110.337 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -73.64 -34.12 64.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.891 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.06 -13.78 60.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.001 0.429 . . . . 10.0 111.623 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -113.01 10.62 18.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.131 0.491 . . . . 10.0 110.699 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -81.1 140.31 35.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.911 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.64 -33.36 74.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.159 0.429 . . . . 10.0 112.159 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -77.31 -37.86 51.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.721 0.296 . . . . 10.0 111.519 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -77.58 -10.26 59.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.017 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.5 t -69.18 -12.32 61.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 10.0 111.521 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 m -80.16 -2.96 46.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.918 0.389 . . . . 10.0 111.167 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.27 159.36 41.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.222 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -94.89 92.4 6.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.816 0.341 . . . . 10.0 110.339 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.76 124.48 30.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.791 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 pt -140.94 141.63 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.915 0.388 . . . . 10.0 111.434 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.49 113.33 26.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.563 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.65 142.81 22.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.886 0.374 . . . . 10.0 111.621 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -137.41 140.44 41.32 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 m -98.19 104.99 25.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.774 0.321 . . . . 10.0 111.854 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.9 121.56 8.93 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.745 2.297 . . . . 10.0 112.261 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.05 -4.78 83.22 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.577 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -111.15 148.98 31.56 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.302 -0.259 . . . . 10.0 110.302 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.6 mt 60.61 29.15 18.8 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.412 0.445 . . . . 10.0 111.667 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.0 19.24 9.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.465 -0.788 . . . . 10.0 112.105 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -80.95 179.95 7.61 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.689 0.28 . . . . 10.0 110.893 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.8 mmtt -69.18 142.24 54.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.902 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -73.19 165.69 24.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.476 -0.329 . . . . 10.0 111.303 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -55.16 147.18 16.79 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.763 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.44 -57.24 4.73 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.586 -1.006 . . . . 10.0 110.586 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.86 -44.94 95.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.401 0.619 . . . . 10.0 109.424 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -67.43 -39.01 85.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.258 -0.883 . . . . 10.0 111.33 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -65.14 -42.83 93.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.839 0.352 . . . . 10.0 111.075 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -65.55 -24.67 67.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.402 . . . . 10.0 110.854 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -64.9 -47.15 78.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.658 -0.868 . . . . 10.0 108.658 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -66.27 -41.22 90.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.714 -0.676 . . . . 10.0 110.732 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.23 -31.22 65.3 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.993 -0.549 . . . . 10.0 111.002 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.38 35.33 5.04 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.835 -0.698 . . . . 10.0 112.067 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mt -118.3 -178.22 3.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.81 0.338 . . . . 10.0 110.814 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -100.31 171.44 7.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 66.6 82.11 0.2 Allowed Pre-proline 0 N--CA 1.466 0.326 0 O-C-N 123.556 0.535 . . . . 10.0 111.41 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.73 1.36 6.45 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.45 2.1 . . . . 10.0 112.915 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -104.73 6.24 34.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.534 0.207 . . . . 10.0 111.108 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -69.05 116.84 45.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.755 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.94 69.01 8.07 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.543 2.162 . . . . 10.0 111.696 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.51 124.78 41.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.717 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 t -112.03 142.53 24.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.31 104.3 16.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.814 0.34 . . . . 10.0 110.986 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -85.77 79.92 9.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.137 0.494 . . . . 10.0 110.039 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -65.67 110.26 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.601 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.34 -25.18 27.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.875 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.27 51.51 2.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.651 -0.785 . . . . 10.0 111.654 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -51.6 66.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.009 0.433 . . . . 10.0 110.45 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.5 mm -81.89 -38.18 15.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.021 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.51 83.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.281 -0.872 . . . . 10.0 111.787 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -80.57 -28.28 37.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 10.0 111.184 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -63.02 -47.03 84.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.57 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -101.37 -5.76 24.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.849 0.314 . . . . 10.0 111.849 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 t30 65.79 70.82 0.43 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.57 0.7 . . . . 10.0 111.638 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -86.47 126.44 40.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.433 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.41 23.52 2.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.877 0.37 . . . . 10.0 111.245 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.5 p -172.05 157.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.409 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -123.51 150.49 61.25 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.511 -0.552 . . . . 10.0 109.511 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -90.09 132.38 9.18 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.315 -1.535 . . . . 10.0 111.978 -0.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.7 m -93.61 121.45 35.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.189 -0.46 . . . . 10.0 109.939 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -106.62 108.47 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.829 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.13 110.12 22.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.208 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 38.6 tp -90.81 112.01 23.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.699 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.0 133.11 45.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -71.38 -179.51 30.96 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.056 -0.592 . . . . 10.0 113.121 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -75.56 -4.9 42.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 10.0 111.405 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.98 -12.39 25.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.236 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 99.95 5.08 55.25 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.754 -0.736 . . . . 10.0 113.216 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -106.5 152.91 23.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.686 0.279 . . . . 10.0 111.24 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.92 118.67 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.094 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.53 -48.72 7.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.554 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -147.75 141.79 25.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.592 -0.277 . . . . 10.0 111.132 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -121.89 121.64 64.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.307 -0.406 . . . . 10.0 109.999 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.0 t -113.22 125.89 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.688 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -126.17 110.58 13.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.427 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 157.79 -87.47 0.12 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.173 -1.013 . . . . 10.0 113.2 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.5 t -170.57 131.17 0.89 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt -116.01 158.05 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.726 0.298 . . . . 10.0 110.796 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -108.23 171.48 7.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.473 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.53 -40.4 96.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.021 0.378 . . . . 10.0 112.021 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.4 88.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.556 -0.293 . . . . 10.0 110.767 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -61.89 -41.8 98.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.746 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.3 96.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 10.0 110.364 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.8 mt -71.52 -26.5 62.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.972 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.93 -34.35 29.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.504 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.5 tp -62.86 -33.95 76.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.25 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 13.3 pt -83.03 15.91 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.124 0.487 . . . . 10.0 111.31 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -133.69 -48.33 0.82 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.655 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -138.25 97.36 9.63 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.302 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.94 2.57 4.05 Favored 'Trans proline' 0 CA--C 1.526 0.092 0 C-N-CA 123.014 2.476 . . . . 10.0 112.83 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -95.36 -5.32 43.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.825 0.345 . . . . 10.0 110.132 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.17 134.6 36.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.836 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -126.09 155.08 42.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.16 -0.682 . . . . 10.0 109.16 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.98 0 N-CA-C 113.57 0.952 . . . . 10.0 113.57 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 47.4 mtt . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.599 0.238 . . . . 10.0 111.32 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.65 -83.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.462 -0.335 . . . . 10.0 111.287 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 34.8 tp -93.32 -55.04 3.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.005 -0.278 . . . . 10.0 110.896 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 53.6 35.58 21.33 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.672 0.608 . . . . 10.0 111.518 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.93 166.44 27.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.441 -0.8 . . . . 10.0 110.555 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.91 -160.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.413 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -107.16 28.46 8.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.302 0.572 . . . . 10.0 109.925 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -92.95 7.68 42.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.96 -0.564 . . . . 10.0 111.391 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -133.17 140.81 38.53 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.772 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.88 148.7 93.14 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.125 2.55 . . . . 10.0 112.333 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.28 -37.76 81.18 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.46 2.773 . . . . 10.0 113.456 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -63.98 -20.89 66.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 10.0 111.936 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -111.57 -6.32 14.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.253 0.549 . . . . 10.0 110.468 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.12 -17.36 46.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.042 -0.527 . . . . 10.0 111.793 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -127.54 125.81 41.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.711 0.291 . . . . 10.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.76 89.8 16.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.114 -0.494 . . . . 10.0 109.757 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.26 106.5 2.18 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.996 2.464 . . . . 10.0 112.707 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -101.57 110.23 22.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.665 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -92.73 117.08 29.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.152 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.68 98.03 6.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.284 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 t -82.18 117.12 27.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.204 -0.453 . . . . 10.0 109.94 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.27 -174.32 2.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.476 -0.329 . . . . 10.0 110.808 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.14 -37.88 53.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.422 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.3 -36.68 39.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.788 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.52 -179.75 45.32 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.521 -0.847 . . . . 10.0 112.432 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.44 128.74 42.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -114.94 110.23 19.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.94 124.11 47.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.904 0.383 . . . . 10.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -127.03 87.94 2.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.195 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -91.55 118.04 30.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.94 0.4 . . . . 10.0 110.765 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 mtm-85 -78.2 126.18 30.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.702 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 23.7 mt -101.93 141.25 18.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.263 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.42 151.21 47.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.039 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.92 81.68 2.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.142 0.496 . . . . 10.0 111.381 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.05 -21.22 0.13 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.063 -0.815 . . . . 10.0 111.063 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.23 147.15 28.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -139.78 136.08 33.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.094 0.474 . . . . 10.0 111.009 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 43.2 mtt -106.91 152.18 24.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.973 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -92.11 125.59 36.85 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.903 -0.777 . . . . 10.0 108.903 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -59.85 -29.66 68.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.716 0.293 . . . . 10.0 111.668 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.39 -8.62 59.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.36 . . . . 10.0 111.17 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -107.45 -13.81 15.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.838 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 85.3 mt -80.84 102.24 6.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.022 0.439 . . . . 10.0 109.847 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.77 129.85 44.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.683 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.6 129.04 2.64 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.686 -0.769 . . . . 10.0 111.911 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -156.47 137.81 13.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.818 0.342 . . . . 10.0 111.097 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 13.2 t -138.49 125.11 20.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.494 -0.558 . . . . 10.0 109.494 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -177.9 160.1 1.27 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.316 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.08 -76.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.687 2.258 . . . . 10.0 110.635 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.57 48.62 0.83 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.447 0.641 . . . . 10.0 109.839 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 6.7 t0 63.63 35.82 11.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.998 -1.001 . . . . 10.0 112.427 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.65 67.57 6.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.79 -0.641 . . . . 10.0 111.075 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 19.1 tp -125.28 144.45 50.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 10.0 109.798 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.46 -64.94 1.91 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.561 -0.828 . . . . 10.0 112.254 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -169.29 157.71 7.07 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.0 -0.37 . . . . 10.0 110.0 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.99 97.72 1.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.514 2.143 . . . . 10.0 110.427 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m -78.97 100.37 7.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.971 0.415 . . . . 10.0 111.611 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -87.96 149.48 24.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.095 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m -79.98 -14.13 58.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.701 0.286 . . . . 10.0 110.755 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? 72.72 136.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.672 -0.695 . . . . 10.0 112.332 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.38 -133.24 4.33 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.003 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -116.18 149.38 39.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -86.66 136.27 33.09 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -114.8 130.85 56.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.636 0.255 . . . . 10.0 110.791 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.18 119.75 18.82 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.14 -177.76 3.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.79 -0.641 . . . . 10.0 109.429 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -112.2 -51.6 2.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.683 0.277 . . . . 10.0 111.097 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -84.49 -30.13 25.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.253 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -95.91 -10.11 29.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.997 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.23 -92.66 1.39 Allowed Glycine 0 C--O 1.224 -0.488 0 C-N-CA 120.853 -0.689 . . . . 10.0 112.734 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -165.2 115.57 1.1 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.758 0.313 . . . . 10.0 110.615 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -144.06 170.53 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.258 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 3.4 m -74.14 134.35 42.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.548 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.65 161.02 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.97 0.414 . . . . 10.0 111.131 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -115.98 130.98 57.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.185 -1.043 . . . . 10.0 108.185 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -114.22 -6.84 13.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.793 0.664 . . . . 10.0 112.793 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -173.17 -37.0 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.26 135.49 34.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.918 -1.037 . . . . 10.0 109.537 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.7 110.98 1.54 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.002 0.43 . . . . 10.0 111.382 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -151.39 121.25 7.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.254 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 t -125.89 131.96 71.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.56 135.74 48.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.875 0.369 . . . . 10.0 110.435 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -113.73 108.28 51.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.374 -0.376 . . . . 10.0 111.626 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.41 131.08 4.02 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.836 2.358 . . . . 10.0 111.655 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -76.34 142.77 41.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 10.0 109.942 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.9 11.22 38.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.096 0.474 . . . . 10.0 110.661 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -166.69 128.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.697 -0.683 . . . . 10.0 109.656 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.38 81.41 5.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.995 0.426 . . . . 10.0 111.337 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.5 126.72 73.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.996 -0.547 . . . . 10.0 110.74 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.46 58.26 4.87 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.045 -0.598 . . . . 10.0 111.77 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -113.78 149.17 41.34 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.93 95.23 0.48 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.138 1.892 . . . . 10.0 111.472 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.28 140.16 38.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.262 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -91.86 147.3 23.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 35.9 tp -118.6 127.79 53.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.881 0.372 . . . . 10.0 110.887 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.37 121.15 66.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.031 -0.729 . . . . 10.0 109.031 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.14 137.61 53.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 10.0 111.324 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 7.3 m -129.02 121.0 27.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -104.77 118.5 36.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.919 0.39 . . . . 10.0 111.457 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 11.3 tp60 -132.9 123.71 26.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.32 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.88 -158.33 9.43 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.66 -0.781 . . . . 10.0 111.737 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 20.3 m -152.05 175.57 12.41 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.283 -0.636 . . . . 10.0 109.283 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -115.71 148.81 39.35 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.142 -0.318 . . . . 10.0 110.142 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.39 -10.55 44.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.237 0.458 . . . . 10.0 112.237 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.52 6.98 46.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 10.0 111.507 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.82 -6.8 67.4 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.761 -0.733 . . . . 10.0 112.549 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 5.7 t -68.35 136.26 26.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.843 -0.429 . . . . 10.0 109.843 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 21.6 t -127.31 107.98 10.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.692 0.282 . . . . 10.0 110.744 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -97.72 148.34 34.31 Favored Pre-proline 0 C--N 1.327 -0.402 0 O-C-N 122.226 -0.296 . . . . 10.0 111.625 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.53 159.49 52.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.927 2.418 . . . . 10.0 111.666 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.51 83.59 1.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.583 2.189 . . . . 10.0 111.72 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.17 122.86 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.01 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -104.71 150.32 24.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.03 0.443 . . . . 10.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -141.5 138.78 33.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.004 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -107.78 134.93 50.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.556 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -122.38 150.02 43.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.853 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -116.42 116.21 27.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.751 0.31 . . . . 10.0 110.171 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 19.9 mm -94.15 93.13 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.044 0.45 . . . . 10.0 111.06 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -102.08 -13.45 17.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.319 0.58 . . . . 10.0 110.926 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 122.5 110.87 2.07 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.634 -0.793 . . . . 10.0 112.095 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -176.02 -22.13 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 10.0 110.565 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.92 -74.3 2.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.707 -0.758 . . . . 10.0 111.861 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.62 129.45 35.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 10.0 111.238 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -132.84 150.26 52.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.327 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.65 146.99 34.18 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.239 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.74 118.62 5.63 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.487 2.125 . . . . 10.0 112.407 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -75.51 82.57 2.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.489 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.877 -0.582 . . . . 10.0 109.995 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 m -127.49 64.81 64.32 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 112.229 0.455 . . . . 10.0 112.229 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.58 -36.63 63.38 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.062 1.841 . . . . 10.0 111.973 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -65.89 -37.17 85.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.734 0.302 . . . . 10.0 110.985 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -70.33 -31.45 68.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.651 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.34 -32.04 73.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.221 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 m -86.79 -8.24 57.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.833 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 m -76.5 -23.08 53.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.593 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -73.52 118.14 16.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.284 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -111.19 147.55 34.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.386 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 p -71.3 178.26 3.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.084 -0.507 . . . . 10.0 111.332 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.17 -14.98 62.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.05 0.453 . . . . 10.0 110.465 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -89.0 -2.2 58.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.632 -0.713 . . . . 10.0 109.319 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.6 t30 75.22 19.67 2.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.854 -1.066 . . . . 10.0 110.554 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -101.13 126.54 34.5 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.226 -0.897 . . . . 10.0 109.278 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.49 140.49 35.49 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.132 2.555 . . . . 10.0 112.397 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.41 -2.56 8.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.302 0.482 . . . . 10.0 112.302 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.12 -16.13 29.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 10.0 111.439 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.73 -23.97 34.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.991 0.425 . . . . 10.0 111.052 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -120.42 4.27 10.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.686 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.6 mt -108.81 26.65 10.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.267 0.556 . . . . 10.0 110.348 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -128.97 -174.94 3.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.913 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt 68.92 11.15 8.26 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.72 0.638 . . . . 10.0 111.151 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.37 41.54 32.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.36 -0.837 . . . . 10.0 111.82 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -110.42 138.89 21.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.95 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.23 125.67 19.94 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.962 2.441 . . . . 10.0 111.713 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.8 117.86 34.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.757 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tp -89.23 110.03 20.84 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.4 mt -93.58 118.53 39.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 10.0 111.992 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.557 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 14.8 tttt -119.92 129.64 54.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.482 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -99.07 135.35 40.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.465 -0.334 . . . . 10.0 111.085 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -122.42 -178.6 3.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 10.0 110.812 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.22 146.38 35.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.571 0.225 . . . . 10.0 111.133 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.7 -31.34 14.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.705 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -82.32 11.0 5.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.189 0.44 . . . . 10.0 112.189 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.89 125.82 27.19 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.74 0.305 . . . . 10.0 111.449 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.8 -35.44 9.59 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.533 2.156 . . . . 10.0 112.63 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.7 mt -64.52 -47.04 80.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.38 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 76.7 m -69.46 -20.1 63.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.275 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 tp -69.09 -41.73 77.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.594 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.99 -32.88 69.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.129 0.49 . . . . 10.0 110.223 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.557 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -63.12 -23.41 67.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.622 -0.717 . . . . 10.0 110.978 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.9 mt -59.5 -36.73 76.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 10.0 110.352 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.78 -37.09 88.3 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.564 -1.014 . . . . 10.0 110.564 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.33 -36.01 73.99 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -61.87 -41.62 98.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.806 -0.634 . . . . 10.0 109.852 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -61.55 -39.18 90.18 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 120.962 0.41 . . . . 10.0 109.945 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -63.08 -44.14 96.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.705 -0.68 . . . . 10.0 109.727 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -68.52 -33.5 74.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.983 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.43 -2.73 20.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.123 0.487 . . . . 10.0 110.821 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -125.3 14.82 8.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.74 -0.663 . . . . 10.0 109.603 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -87.05 140.92 29.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.447 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.73 94.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.165 0.431 . . . . 10.0 112.165 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -76.39 -37.81 56.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.77 0.319 . . . . 10.0 111.321 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -71.16 -16.0 62.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.322 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.9 t -72.26 -0.28 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 10.0 111.673 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -75.49 -22.05 57.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 10.0 110.222 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.96 169.05 15.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 10.0 109.72 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -100.08 97.5 8.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.673 0.273 . . . . 10.0 110.315 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.2 tp -83.29 130.81 35.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.442 -0.344 . . . . 10.0 110.944 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.6 pt -135.9 146.71 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.966 0.413 . . . . 10.0 111.156 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.03 105.98 16.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.236 -0.438 . . . . 10.0 109.908 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.4 t -103.31 146.51 10.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.124 0.487 . . . . 10.0 111.71 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.44 146.25 33.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.205 -1.035 . . . . 10.0 108.205 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.1 m -106.46 98.63 20.68 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 112.196 0.443 . . . . 10.0 112.196 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.0 123.51 13.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.944 2.429 . . . . 10.0 112.27 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.98 -13.36 66.37 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.944 -0.646 . . . . 10.0 112.954 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -94.42 139.05 31.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.822 0.311 . . . . 10.0 110.469 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.03 35.55 26.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.08 -0.509 . . . . 10.0 112.183 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.36 20.73 8.56 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.026 0.75 . . . . 10.0 113.026 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.69 -179.07 4.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.718 0.294 . . . . 10.0 110.723 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -67.39 121.3 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.218 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -66.5 155.56 37.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.706 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.09 130.79 47.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.176 -0.466 . . . . 10.0 111.173 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.16 -40.41 2.53 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.586 -1.406 . . . . 10.0 109.586 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -97.4 -34.84 10.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.965 0.412 . . . . 10.0 110.103 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.26 -50.97 69.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.706 . . . . 10.0 112.432 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -35.31 76.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.457 -0.338 . . . . 10.0 111.482 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -70.65 -28.9 65.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.765 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -60.99 -49.74 76.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.623 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -73.93 -32.06 63.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.605 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.88 -18.99 63.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.6 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.74 5.88 43.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.938 -0.648 . . . . 10.0 111.689 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.0 mt -106.49 177.48 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.958 0.408 . . . . 10.0 111.042 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.427 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 49.3 t30 -98.22 -162.65 0.97 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.765 -0.652 . . . . 10.0 109.942 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.427 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 13.5 m-85 65.43 78.28 0.26 Allowed Pre-proline 0 N--CA 1.464 0.258 0 C-N-CA 122.829 0.451 . . . . 10.0 111.356 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.05 -0.69 10.57 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.616 2.211 . . . . 10.0 112.3 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -101.22 10.55 40.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.5 mt -85.76 112.56 45.71 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.019 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.03 63.44 8.71 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.571 2.181 . . . . 10.0 111.051 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.3 t -73.38 117.89 17.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.825 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.28 138.98 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.439 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 107.09 19.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.119 -0.492 . . . . 10.0 110.922 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -103.18 84.33 2.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.894 0.378 . . . . 10.0 110.237 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -63.9 116.87 6.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 10.0 112.109 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.96 -19.66 53.91 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.825 -0.703 . . . . 10.0 112.629 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.77 50.71 5.13 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.106 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.12 99.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.976 0.417 . . . . 10.0 110.523 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.9 mm -82.88 -40.2 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.889 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.63 -45.12 95.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.759 -0.655 . . . . 10.0 111.655 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -72.0 -30.04 64.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -65.86 -38.53 89.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.948 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.13 7.2 44.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.947 0.404 . . . . 10.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.3 t30 50.48 60.98 3.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.421 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.9 mt -87.14 98.46 7.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.752 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.21 8.62 25.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.914 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.0 p -149.17 154.53 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.67 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -131.05 152.63 81.01 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.252 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.39 161.7 76.75 Favored 'Cis proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.935 -1.694 . . . . 10.0 111.372 -1.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 m -127.67 131.34 49.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.698 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -118.82 125.12 48.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.19 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.54 113.08 26.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.843 0.354 . . . . 10.0 110.332 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.1 tp -89.51 101.12 13.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.168 0.509 . . . . 10.0 111.293 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.28 133.13 32.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.666 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.26 -177.43 49.96 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.088 -0.577 . . . . 10.0 113.244 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -67.86 -11.4 58.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.265 0.469 . . . . 10.0 112.265 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.36 -7.94 30.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 10.0 111.382 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.38 -7.0 63.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.684 -0.769 . . . . 10.0 112.626 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -89.0 156.0 19.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.734 0.302 . . . . 10.0 110.844 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.6 t -78.55 107.75 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.149 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -81.99 -41.52 20.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.263 -0.426 . . . . 10.0 111.507 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -148.76 160.01 43.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.372 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.9 tt -138.14 141.44 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.493 -0.558 . . . . 10.0 109.493 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.3 t -121.92 129.98 74.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.202 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -133.21 124.68 27.84 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.437 -0.347 . . . . 10.0 110.128 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 132.88 -72.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.44 -0.886 . . . . 10.0 112.511 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 5.1 t -178.83 162.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.6 pt -146.28 152.17 13.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.158 -0.474 . . . . 10.0 109.914 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -109.96 170.41 8.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.836 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -56.41 -43.8 79.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.03 78.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 10.0 110.807 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -67.86 -37.26 81.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.903 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.66 97.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.0 mt -69.37 -40.92 77.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.782 -0.644 . . . . 10.0 110.5 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.29 -36.71 84.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.067 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.83 -35.75 80.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.933 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.87 -36.81 59.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.343 0.592 . . . . 10.0 109.416 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -70.24 -47.48 61.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.465 -0.789 . . . . 10.0 110.709 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -150.42 112.27 3.23 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.495 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -68.01 -7.32 19.44 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.922 2.415 . . . . 10.0 112.061 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -92.85 -0.27 57.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.932 0.396 . . . . 10.0 111.187 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.39 84.2 7.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.902 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -75.69 147.33 39.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.051 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.977 -1.011 . . . . 10.0 113.108 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.521 ' H3 ' ' CG ' ' B' ' 4' ' ' ASP . 63.2 mtt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.795 0.331 . . . . 10.0 110.837 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.22 -72.61 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.523 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 38.2 tp -78.98 -77.29 0.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . 0.521 ' CG ' ' H3 ' ' B' ' 1' ' ' MET . 75.1 m-20 59.03 36.13 24.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.116 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.95 159.29 42.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.242 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 21.5 m120 64.03 -154.2 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.448 -0.797 . . . . 10.0 111.761 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -107.19 17.54 22.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.965 0.412 . . . . 10.0 111.028 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.35 8.59 4.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.476 0.547 . . . . 10.0 112.476 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.16 132.61 14.74 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.69 -0.232 . . . . 10.0 111.094 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.87 153.93 59.65 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.353 2.702 . . . . 10.0 112.184 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.55 -40.25 54.87 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.591 2.86 . . . . 10.0 113.612 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -65.49 -13.81 59.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -117.13 -1.13 11.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.205 0.526 . . . . 10.0 110.412 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.69 -12.48 23.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.116 -0.493 . . . . 10.0 112.077 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -124.01 128.74 49.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.859 0.362 . . . . 10.0 111.486 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.71 91.11 24.27 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.389 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.52 95.78 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.986 2.458 . . . . 10.0 112.367 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.51 97.74 11.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.93 110.31 20.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.159 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.5 101.92 10.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.158 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.96 130.98 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.186 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.96 176.28 5.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.847 -0.427 . . . . 10.0 109.847 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.22 -34.16 68.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.929 0.395 . . . . 10.0 111.447 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.46 -36.34 53.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.277 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -178.75 -175.93 46.2 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.961 -0.638 . . . . 10.0 111.692 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.09 133.35 40.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 110.228 -0.286 . . . . 10.0 110.228 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -120.28 105.45 10.94 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.967 -0.383 . . . . 10.0 109.967 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 p -93.57 124.19 45.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.128 0.489 . . . . 10.0 110.969 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -127.47 85.77 2.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.91 -0.586 . . . . 10.0 109.947 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -82.71 111.23 18.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.265 0.555 . . . . 10.0 111.004 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 32.5 mtm-85 -75.55 112.5 11.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.453 -0.794 . . . . 10.0 110.194 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -91.65 145.21 7.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.819 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.8 155.06 40.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.148 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.15 88.16 2.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.104 0.478 . . . . 10.0 111.27 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.74 -15.46 0.45 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.538 -0.625 . . . . 10.0 111.538 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -109.66 142.37 40.92 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -133.9 136.98 44.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.86 0.362 . . . . 10.0 110.862 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 41.1 mtt -108.52 147.65 31.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.864 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -88.25 123.82 33.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.853 -0.425 . . . . 10.0 109.853 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -60.08 -32.42 70.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.517 -0.31 . . . . 10.0 111.403 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.67 5.74 20.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.306 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -124.58 -8.42 7.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.461 -0.336 . . . . 10.0 111.836 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 86.9 mt -83.91 99.21 6.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.251 0.548 . . . . 10.0 110.155 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 41.6 t -90.25 112.0 24.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.09 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.73 128.71 3.71 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.893 -0.67 . . . . 10.0 111.545 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -160.56 143.13 13.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.945 0.402 . . . . 10.0 111.444 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 13.4 t -134.6 131.45 37.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.903 -0.59 . . . . 10.0 109.64 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -177.08 158.08 1.37 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.576 -0.284 . . . . 10.0 110.774 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -74.67 -58.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.614 2.209 . . . . 10.0 110.976 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.63 48.53 2.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 10.0 109.795 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.23 36.62 5.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.326 -0.852 . . . . 10.0 111.748 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -97.01 56.69 1.43 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.712 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.8 tp -130.64 152.1 50.38 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.097 -0.705 . . . . 10.0 109.097 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.71 -87.26 0.3 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.542 -0.837 . . . . 10.0 111.726 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -155.93 149.29 18.67 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 110.008 -0.368 . . . . 10.0 110.008 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.45 107.15 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.661 2.24 . . . . 10.0 111.168 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.1 m -79.2 95.38 5.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.154 0.502 . . . . 10.0 110.78 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -78.04 144.57 36.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.528 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.7 m -82.64 -9.38 59.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.566 -0.288 . . . . 10.0 111.318 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? 71.24 166.22 0.3 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.907 -0.588 . . . . 10.0 111.979 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.14 -134.56 1.74 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.463 -0.655 . . . . 10.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -106.44 151.9 24.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.623 0.212 . . . . 10.0 110.558 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -90.89 125.87 35.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -102.16 128.52 48.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.497 -0.32 . . . . 10.0 110.977 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.76 130.62 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.322 -0.621 . . . . 10.0 109.322 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -133.91 163.53 29.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -93.24 -30.28 15.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.822 0.344 . . . . 10.0 111.301 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.27 -39.35 8.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.592 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -89.87 -9.2 49.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.89 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.76 -85.79 0.97 Allowed Glycine 0 C--O 1.227 -0.333 0 C-N-CA 120.758 -0.734 . . . . 10.0 112.673 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -165.24 115.91 1.11 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.645 0.259 . . . . 10.0 110.956 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -138.99 158.72 43.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.288 -0.415 . . . . 10.0 110.447 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 5.6 m -70.79 130.4 41.6 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.425 -0.583 . . . . 10.0 109.425 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.55 150.21 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.377 0.608 . . . . 10.0 112.179 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -110.8 116.36 31.14 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.86 -1.163 . . . . 10.0 107.86 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -103.78 -3.01 25.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.581 0.585 . . . . 10.0 112.581 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.14 -41.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.186 0.517 . . . . 10.0 109.672 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' B' ' 78' ' ' GLU . 1.0 OUTLIER -89.26 100.4 13.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.329 -0.85 . . . . 10.0 110.98 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.49 107.39 8.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.979 0.419 . . . . 10.0 111.397 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -138.43 128.01 24.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.689 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 19.0 t -128.65 129.6 68.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.251 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.72 144.06 31.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.605 -0.271 . . . . 10.0 110.469 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -119.86 100.54 48.57 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.691 0.282 . . . . 10.0 111.684 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.05 118.81 2.39 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.995 2.463 . . . . 10.0 112.01 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -66.4 144.47 56.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 10.0 111.612 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.48 11.66 34.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.23 0.538 . . . . 10.0 109.797 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -164.04 124.93 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.317 -0.856 . . . . 10.0 109.955 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.05 92.55 6.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.06 0.457 . . . . 10.0 110.59 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 12.0 m -121.78 163.7 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.614 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.31 21.02 22.64 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.743 -0.741 . . . . 10.0 111.673 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -93.51 138.04 23.13 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.19 127.75 24.12 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.589 2.193 . . . . 10.0 111.039 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.54 153.78 22.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.435 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -95.69 152.08 18.78 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.691 -0.485 . . . . 10.0 109.691 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 22.7 tp -126.6 124.22 39.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.695 0.283 . . . . 10.0 110.601 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 24.6 t -108.69 123.05 64.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 81.9 mt -126.63 120.26 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 10.0 111.833 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -112.96 117.14 31.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.745 -0.661 . . . . 10.0 109.828 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -99.6 107.17 19.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.627 0.251 . . . . 10.0 111.085 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 14.7 tp60 -121.5 126.02 48.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 10.0 110.936 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.64 -157.76 11.18 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.432 -0.667 . . . . 10.0 111.432 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.3 m -153.51 167.84 28.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -105.17 144.67 31.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.42 -16.51 60.77 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.107 0.41 . . . . 10.0 112.107 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.27 -12.51 56.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.456 -0.338 . . . . 10.0 111.78 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.48 -14.77 10.77 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.371 -0.918 . . . . 10.0 113.006 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.45 131.8 29.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.94 76.92 1.32 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.961 0.41 . . . . 10.0 110.695 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -66.02 157.14 81.87 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.949 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.8 160.22 10.5 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.778 2.319 . . . . 10.0 112.155 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.31 70.56 7.45 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.743 2.296 . . . . 10.0 111.62 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.6 t -67.04 93.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.775 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.07 150.26 33.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.78 -0.645 . . . . 10.0 111.857 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 10.3 m -137.36 144.99 42.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.513 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -104.29 138.06 41.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.821 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -121.27 153.16 38.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.715 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -114.05 120.58 41.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.985 -0.376 . . . . 10.0 109.985 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 19.8 mm -95.87 79.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.247 0.546 . . . . 10.0 110.328 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -94.01 -14.02 26.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.222 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.44 110.03 2.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.082 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -167.55 -32.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.033 0.444 . . . . 10.0 110.624 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.71 -80.2 0.27 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.924 -0.655 . . . . 10.0 111.552 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 9.1 m -101.01 135.48 42.39 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.083 -0.34 . . . . 10.0 110.083 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -126.04 157.96 36.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.786 0.327 . . . . 10.0 111.217 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.38 148.41 20.97 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.35 137.99 49.19 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.278 1.986 . . . . 10.0 112.565 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -97.49 62.53 1.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.92 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.396 -0.811 . . . . 10.0 110.294 -179.682 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.17 62.61 39.58 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.73 -31.45 48.97 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.192 1.928 . . . . 10.0 111.514 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.89 -40.91 95.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.463 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.68 -40.43 80.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.557 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.1 tp -60.52 -32.89 71.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.207 0.527 . . . . 10.0 110.273 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.8 m -84.44 -15.92 44.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.959 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 45.8 m -79.94 -23.47 41.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.463 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.4 106.55 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.205 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -97.28 148.16 23.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.978 -0.556 . . . . 10.0 110.626 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.6 p -81.11 172.72 13.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.003 -0.544 . . . . 10.0 109.667 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.37 -5.52 19.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 10.0 110.212 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -92.53 5.01 52.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.356 -0.838 . . . . 10.0 109.825 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 73.06 13.59 4.83 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.327 0.862 . . . . 10.0 113.327 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -116.83 139.84 26.15 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.442 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.75 146.31 86.11 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.795 2.33 . . . . 10.0 112.153 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.12 -1.25 7.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 10.0 111.759 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 m -59.42 -20.95 58.96 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.145 -0.48 . . . . 10.0 111.535 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.39 -13.94 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.088 0.47 . . . . 10.0 110.849 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -125.66 20.47 7.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.601 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.7 mt -129.61 40.16 3.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.489 -0.778 . . . . 10.0 110.328 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -138.44 -178.46 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.88 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.2 mttp 69.35 12.31 8.3 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.824 0.675 . . . . 10.0 112.824 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 58.56 28.79 17.55 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.192 0.52 . . . . 10.0 111.486 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -94.51 138.19 22.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.46 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.54 141.79 90.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.87 2.38 . . . . 10.0 111.183 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -108.4 144.21 36.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.855 0.36 . . . . 10.0 111.425 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.0 tp -123.98 104.34 8.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.8 mt -88.23 118.22 33.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.72 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -110.04 116.46 31.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.666 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -90.43 148.27 22.9 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.293 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -150.53 175.88 11.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.527 -0.306 . . . . 10.0 111.32 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.78 146.97 50.04 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.366 -0.605 . . . . 10.0 109.366 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 m -70.88 -63.75 1.04 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 59.31 4.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -135.46 123.34 15.27 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.327 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.61 -49.02 16.06 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.748 2.299 . . . . 10.0 112.568 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mp -59.61 -52.74 64.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.996 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 80.5 m -64.88 -33.07 75.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.846 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 tp -62.2 -48.49 79.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.411 -0.358 . . . . 10.0 110.976 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 m -69.94 -32.46 70.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.535 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.86 -35.3 79.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.563 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.7 -39.8 81.8 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.912 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.4 -29.32 72.94 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.964 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -87.76 -27.54 22.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.873 0.368 . . . . 10.0 110.092 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.2 m -61.11 -47.91 84.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 10.0 110.912 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -37.31 86.49 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.939 0.4 . . . . 10.0 110.221 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.85 -46.85 83.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.883 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -63.2 -42.68 99.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 10.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.41 -4.93 12.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.773 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -113.35 10.64 18.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.765 0.317 . . . . 10.0 111.496 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -93.75 148.7 21.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.735 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.95 -31.85 72.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.41 -46.22 77.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.107 0.479 . . . . 10.0 111.084 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -74.85 -8.02 55.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.639 . . . . 10.0 112.364 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.3 m -70.24 -13.46 62.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.143 0.497 . . . . 10.0 110.86 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 m -69.91 -24.04 63.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.949 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.15 176.45 7.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.453 . . . . 10.0 110.956 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -108.57 98.63 8.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.45 124.22 31.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.631 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.66 138.59 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 10.0 111.508 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.38 109.76 21.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.865 -0.607 . . . . 10.0 109.681 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.9 137.4 42.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.092 0.473 . . . . 10.0 111.656 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.09 147.13 39.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.293 -1.002 . . . . 10.0 108.293 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 m -106.43 98.18 19.04 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 112.268 0.469 . . . . 10.0 112.268 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.43 123.4 11.72 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.674 2.249 . . . . 10.0 111.882 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.88 3.33 73.84 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.817 -0.629 . . . . 10.0 112.706 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.0 148.37 40.2 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.71 -0.288 . . . . 10.0 110.487 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 58.56 27.58 15.87 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 71.52 20.21 4.88 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.716 -0.675 . . . . 10.0 112.371 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -81.72 -172.54 3.93 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.876 0.37 . . . . 10.0 111.155 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -69.37 133.13 47.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.402 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -68.66 158.27 34.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 10.0 112.017 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -55.62 141.57 37.11 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.575 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.46 -60.68 1.53 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.813 -0.915 . . . . 10.0 110.813 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.96 -36.71 78.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 10.0 109.917 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.14 -41.15 97.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.407 -0.815 . . . . 10.0 111.643 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.53 -29.52 69.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.954 0.407 . . . . 10.0 110.558 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -69.93 -28.59 65.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.287 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -66.07 -44.87 83.24 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.941 -0.763 . . . . 10.0 108.941 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -65.0 -38.47 91.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.198 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.77 -20.97 66.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.44 16.16 52.83 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.037 -0.602 . . . . 10.0 112.231 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 mt -118.43 158.38 25.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.658 0.266 . . . . 10.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.416 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 66.1 t30 -82.95 -173.88 4.95 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.45 -0.574 . . . . 10.0 109.45 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.416 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 89.2 m-85 68.88 76.24 0.25 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-O 121.211 0.529 . . . . 10.0 110.207 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.14 8.82 3.03 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.747 2.298 . . . . 10.0 112.473 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -108.13 4.58 25.07 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.116 -0.234 . . . . 10.0 110.903 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.2 mt -78.23 112.52 26.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.714 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.45 71.21 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.959 2.439 . . . . 10.0 111.179 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.69 114.24 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.918 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.0 t -96.53 133.53 37.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.047 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.14 96.01 8.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.012 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -83.37 82.38 8.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.191 0.52 . . . . 10.0 110.058 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -64.31 106.52 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.896 -0.593 . . . . 10.0 111.739 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.61 -24.21 26.24 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.009 -0.615 . . . . 10.0 112.123 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.11 53.41 3.14 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.616 -0.802 . . . . 10.0 111.821 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -47.15 84.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.027 0.441 . . . . 10.0 110.659 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.7 mm -77.05 -40.86 30.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.983 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.44 90.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.851 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -75.39 -42.66 53.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.558 0.218 . . . . 10.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -62.23 -38.42 89.14 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.7 mt -97.1 -2.47 43.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.655 -0.248 . . . . 10.0 111.519 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t30 53.62 58.19 5.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.958 -0.565 . . . . 10.0 111.202 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.1 109.43 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.165 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.13 17.56 14.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.953 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.58 147.83 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.543 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -127.88 160.02 63.44 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.392 -0.596 . . . . 10.0 109.392 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -88.06 124.41 6.96 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.972 -1.262 . . . . 10.0 111.277 -0.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.0 m -105.68 143.07 34.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.124 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -121.47 129.77 53.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.19 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -111.33 114.9 28.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.199 -0.455 . . . . 10.0 111.063 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.5 tp -92.13 117.1 29.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.778 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.24 136.2 38.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.605 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -74.59 -173.43 30.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.227 -0.511 . . . . 10.0 113.401 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -73.6 -12.97 60.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.975 0.417 . . . . 10.0 111.121 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.27 7.48 46.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.865 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.74 24.71 76.32 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.866 -0.683 . . . . 10.0 111.904 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -114.03 153.5 29.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.784 0.326 . . . . 10.0 110.761 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.3 t -67.78 113.99 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.926 0.393 . . . . 10.0 110.199 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -51.15 5.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.228 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -146.8 139.18 24.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.863 0.363 . . . . 10.0 111.587 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.6 tp -110.37 130.93 62.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.065 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.9 t -122.04 132.26 71.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -138.67 136.96 36.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 10.0 111.372 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.56 -80.43 0.36 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.055 -0.593 . . . . 10.0 112.477 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 p -172.62 142.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.604 -0.517 . . . . 10.0 109.604 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -125.49 171.91 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 10.0 110.843 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.33 167.69 18.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.829 -0.434 . . . . 10.0 109.829 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -58.27 -49.96 75.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.5 89.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.368 . . . . 10.0 110.867 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -64.62 -38.79 92.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.041 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.84 92.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 10.0 109.8 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.82 -38.48 91.11 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.962 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.63 90.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 10.0 110.631 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.4 tp -63.92 -34.74 78.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.461 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.98 -33.35 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -70.34 -48.66 55.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.813 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -148.67 117.08 3.95 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.29 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.24 -10.08 19.8 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.01 2.473 . . . . 10.0 112.659 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -81.65 -7.71 59.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.929 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.92 125.4 26.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.785 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -136.1 143.93 44.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.152 -0.477 . . . . 10.0 109.92 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.918 -1.039 . . . . 10.0 112.523 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.754 0.312 . . . . 10.0 110.679 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.07 -85.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.788 0.328 . . . . 10.0 110.685 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 56.0 tp -97.58 -61.75 1.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.228 -0.442 . . . . 10.0 109.984 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.23 35.63 26.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.884 -0.598 . . . . 10.0 111.227 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.37 165.67 27.27 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.902 -0.59 . . . . 10.0 111.006 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.44 -151.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.781 . . . . 10.0 112.235 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -108.47 27.24 9.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.657 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.62 23.07 9.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.739 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -147.99 137.27 11.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.148 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.78 145.41 90.77 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.022 2.482 . . . . 10.0 112.542 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.95 -36.77 76.56 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.464 2.776 . . . . 10.0 113.646 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.8 -4.31 19.47 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -126.59 -8.68 6.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.526 0.679 . . . . 10.0 109.838 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.67 -7.84 59.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 10.0 112.239 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -130.49 123.37 29.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.811 0.338 . . . . 10.0 111.011 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.48 95.62 16.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.327 -0.619 . . . . 10.0 109.327 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.05 93.59 0.96 Allowed 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.186 2.59 . . . . 10.0 113.217 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -90.37 97.36 11.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.59 122.63 29.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.438 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.01 109.37 12.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.199 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 93.7 t -97.57 120.27 46.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.846 0.355 . . . . 10.0 111.082 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.62 169.5 9.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.14 -32.54 72.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.001 0.429 . . . . 10.0 110.975 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -80.28 -37.07 33.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.994 -0.548 . . . . 10.0 111.722 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -175.51 173.82 46.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.532 -0.842 . . . . 10.0 112.444 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -89.38 140.46 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.615 0.245 . . . . 10.0 110.755 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -129.54 111.01 12.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.736 -0.468 . . . . 10.0 109.736 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.02 125.09 44.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.953 0.406 . . . . 10.0 111.182 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -129.18 80.47 1.97 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.365 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -89.72 126.62 35.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.887 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtm-85 -81.76 124.93 30.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.923 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 59.8 mt -99.37 133.7 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.771 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 148.88 33.7 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.517 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.25 74.7 1.82 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.251 0.548 . . . . 10.0 111.675 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.21 -20.77 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.037 -0.825 . . . . 10.0 111.037 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -105.25 153.19 21.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.89 -0.781 . . . . 10.0 108.89 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -145.45 139.62 26.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.005 0.431 . . . . 10.0 111.417 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 40.8 mtt -110.26 156.48 20.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.925 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -97.78 124.06 41.98 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.738 -0.468 . . . . 10.0 109.738 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -60.71 -28.54 68.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.093 0.473 . . . . 10.0 111.465 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.83 15.03 12.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 10.0 111.284 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -130.85 -18.26 3.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.637 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 80.8 mt -77.61 119.82 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.38 . . . . 10.0 110.23 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 56.5 t -98.23 126.65 51.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.023 -0.535 . . . . 10.0 109.565 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -151.55 119.77 1.02 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.733 -0.746 . . . . 10.0 111.909 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 27.4 pttt -150.74 139.67 20.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.733 0.302 . . . . 10.0 110.965 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 4.8 t -138.75 125.37 20.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.587 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 19.9 p30 179.43 162.33 0.78 Allowed Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.267 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.68 -70.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.663 2.242 . . . . 10.0 111.313 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.29 57.21 0.73 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.87 0.366 . . . . 10.0 111.362 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.3 t70 65.19 32.89 9.75 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.268 0.556 . . . . 10.0 112.089 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -96.1 58.43 1.85 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.684 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 36.4 tp -124.49 139.49 53.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.601 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 -72.51 1.11 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.636 -0.792 . . . . 10.0 111.511 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.88 151.57 9.42 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.06 103.03 1.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.583 2.189 . . . . 10.0 110.392 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 49.4 m -76.79 104.78 7.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.021 0.439 . . . . 10.0 111.684 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -85.02 146.2 27.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.044 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 37.3 m -76.8 -11.64 59.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.448 -0.342 . . . . 10.0 111.485 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? 70.82 119.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.638 0.587 . . . . 10.0 112.513 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.81 -136.02 8.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.879 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -112.18 153.7 26.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.68 0.276 . . . . 10.0 111.002 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.62 119.52 26.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.53 -0.545 . . . . 10.0 109.53 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -101.16 139.85 36.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.841 0.353 . . . . 10.0 111.273 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -77.8 133.16 38.27 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.218 -1.031 . . . . 10.0 108.218 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -132.88 168.52 18.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.804 0.335 . . . . 10.0 110.889 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -101.85 -32.09 10.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.198 -0.455 . . . . 10.0 111.232 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -109.69 -38.6 5.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.625 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -84.42 -12.1 55.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.84 0.352 . . . . 10.0 111.015 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.11 -100.56 1.77 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.028 -0.606 . . . . 10.0 112.605 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -136.14 110.24 8.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.522 -0.547 . . . . 10.0 109.522 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -136.39 153.05 51.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.889 0.376 . . . . 10.0 111.588 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.23 127.32 32.3 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.036 -0.727 . . . . 10.0 109.036 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.68 153.6 33.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.509 0.671 . . . . 10.0 112.311 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -110.33 120.65 43.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -106.66 -1.82 22.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.049 0.759 . . . . 10.0 113.049 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -175.83 -37.53 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.219 -0.66 . . . . 10.0 109.219 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.8 OUTLIER -85.43 138.44 32.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.049 -0.978 . . . . 10.0 109.568 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.39 119.43 2.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.781 0.324 . . . . 10.0 110.612 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -159.62 121.9 3.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.347 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.76 126.66 67.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 10.0 109.665 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.63 139.08 34.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.068 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -118.81 98.21 51.03 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 112.207 0.447 . . . . 10.0 112.207 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.44 127.94 6.79 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.063 2.509 . . . . 10.0 110.777 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -74.01 147.82 42.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.442 -0.344 . . . . 10.0 111.277 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.16 -5.8 54.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 10.0 110.538 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -153.02 147.1 25.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.709 -0.678 . . . . 10.0 109.867 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.56 85.37 4.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.911 0.386 . . . . 10.0 111.037 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.75 155.15 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.501 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.12 33.38 6.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.92 -0.657 . . . . 10.0 112.607 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -96.68 139.41 21.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.671 -0.492 . . . . 10.0 109.671 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.58 111.91 1.18 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.731 2.287 . . . . 10.0 111.507 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.12 161.07 21.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.134 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.33 142.44 41.98 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 58.6 tp -116.36 111.67 20.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.867 0.365 . . . . 10.0 110.788 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 41.6 t -101.84 113.49 38.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 96.5 mt -117.48 139.18 51.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.965 0.412 . . . . 10.0 111.414 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 20.9 m -134.36 118.55 17.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.036 -0.727 . . . . 10.0 109.036 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -98.69 112.14 24.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.099 0.407 . . . . 10.0 112.099 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -122.8 118.25 27.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.313 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.19 -160.18 10.22 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.729 -0.748 . . . . 10.0 111.758 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 25.3 m -153.58 -179.57 7.91 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.486 -0.561 . . . . 10.0 109.486 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' B' ' 105' ' ' ALA . . . -120.08 139.29 52.78 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.39 11.66 0.43 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.369 0.418 . . . . 10.0 112.114 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' B' ' 103' ' ' ALA . . . -110.92 6.08 20.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.453 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.92 26.84 9.34 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.431 -0.89 . . . . 10.0 113.436 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 20.3 t -115.27 141.88 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 53.3 t -136.21 89.53 2.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 10.0 110.907 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -78.27 151.09 77.94 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.323 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.38 164.42 35.79 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.718 2.279 . . . . 10.0 111.567 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.01 72.91 5.66 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.707 2.271 . . . . 10.0 112.419 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 24.2 t -62.86 124.4 17.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.622 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -104.87 160.95 14.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.148 0.499 . . . . 10.0 111.694 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.2 m -150.31 119.0 6.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.607 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -92.97 126.63 38.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.052 0.453 . . . . 10.0 111.849 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.55 153.71 28.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.734 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -116.34 124.18 49.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.548 -0.538 . . . . 10.0 109.548 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 17.6 mm -90.21 72.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.234 0.54 . . . . 10.0 110.812 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -78.43 -26.61 46.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.361 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.88 48.55 0.15 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.612 -0.804 . . . . 10.0 113.078 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -107.22 -9.91 15.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.95 0.405 . . . . 10.0 110.639 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.63 -77.6 1.86 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.948 -0.644 . . . . 10.0 111.587 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 11.0 m -97.94 131.92 43.96 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -120.26 155.29 33.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.975 0.417 . . . . 10.0 111.874 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -127.97 143.53 48.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.359 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.8 125.8 16.13 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.644 2.229 . . . . 10.0 111.883 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -85.71 82.61 8.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 179.701 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.92 88.67 31.82 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 10.0 111.603 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.93 -18.2 52.1 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.414 2.076 . . . . 10.0 111.906 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -62.53 -32.73 73.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.911 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -69.75 -41.73 74.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.536 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.29 -31.43 72.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.191 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 m -83.44 -8.43 59.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 10.0 110.636 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.9 m -91.91 -25.88 18.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.645 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -66.46 128.28 35.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.934 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.12 151.92 34.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.39 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 46.0 p -77.95 171.91 14.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.004 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.51 -15.29 63.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.537 0.684 . . . . 10.0 109.785 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -15.58 51.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.977 -1.01 . . . . 10.0 109.593 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.2 t30 97.33 -15.26 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.578 1.151 . . . . 10.0 112.326 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.6 140.25 84.19 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 109.543 -0.54 . . . . 10.0 109.543 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.44 147.12 90.53 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.411 2.074 . . . . 10.0 111.703 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.79 -11.92 42.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.914 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 m -55.41 -24.19 28.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.443 . . . . 10.0 112.155 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 m -62.38 -22.74 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.9 0.381 . . . . 10.0 111.598 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -127.55 29.17 5.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.282 0.563 . . . . 10.0 110.374 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.7 mt -136.22 28.99 3.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.943 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -134.28 -174.61 3.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.37 -0.377 . . . . 10.0 111.864 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt 71.61 11.19 6.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.772 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 56.82 33.9 23.82 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.395 -0.82 . . . . 10.0 111.686 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -101.16 147.53 33.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.46 142.17 95.18 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.061 2.507 . . . . 10.0 111.41 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.0 m -112.66 143.3 44.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.858 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.2 tp -122.14 99.21 6.31 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.7 mt -90.43 120.95 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.803 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.521 ' HZ3' ' CD ' ' A' ' 42' ' ' GLU . 1.1 tmtp? -113.72 124.96 53.53 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.595 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.02 141.74 33.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.514 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -149.02 169.3 20.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.787 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -116.81 135.64 53.59 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -62.42 -59.09 5.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.294 0.85 . . . . 10.0 113.294 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.65 38.49 0.75 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.087 0.773 . . . . 10.0 113.087 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -115.54 126.02 28.18 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.316 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.43 -44.61 21.85 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.829 2.353 . . . . 10.0 113.358 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.9 mt -64.11 -47.0 81.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 10.0 111.589 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.1 m -68.19 -33.73 74.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.507 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.8 mt -64.49 -37.34 87.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 10.0 111.701 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m -72.07 -22.8 61.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.024 0.44 . . . . 10.0 111.157 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -85.24 -6.03 59.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.85 -179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.1 mt -59.3 -49.13 79.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.006 0.431 . . . . 10.0 111.151 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.86 -33.72 87.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.873 -0.68 . . . . 10.0 112.063 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -70.59 -41.58 72.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 10.0 110.665 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.2 m -60.67 -42.46 97.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.537 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -64.46 -41.18 96.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.128 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -64.9 -38.46 91.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.618 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -70.8 -34.39 71.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.467 . . . . 10.0 110.801 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.38 -13.21 62.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.01 0.434 . . . . 10.0 110.813 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -114.63 16.51 17.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 10.0 110.416 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -82.42 148.29 28.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.627 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.36 83.8 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -84.94 -43.09 14.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.537 0.208 . . . . 10.0 111.499 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -66.22 -20.42 66.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 10.0 111.573 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.8 t -69.98 -0.28 7.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.952 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 m -84.62 -5.29 59.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 10.0 110.27 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -134.57 164.65 27.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.653 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -92.3 94.72 9.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.475 -0.329 . . . . 10.0 110.188 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.3 121.64 27.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.966 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.6 pt -138.87 142.32 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 10.0 111.395 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.97 113.78 27.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.566 -0.531 . . . . 10.0 109.566 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.71 138.7 36.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.804 0.335 . . . . 10.0 111.235 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.93 154.48 49.21 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.9 m -112.78 96.16 36.31 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 112.386 0.513 . . . . 10.0 112.386 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.24 131.58 27.12 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.567 2.178 . . . . 10.0 111.437 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.65 10.03 85.68 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.952 -0.642 . . . . 10.0 112.596 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -123.29 138.27 54.66 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 60.39 29.33 18.93 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.184 0.516 . . . . 10.0 111.041 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 t60 74.26 14.97 3.66 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.781 -1.1 . . . . 10.0 113.45 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -70.78 168.11 17.39 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 121.066 -0.254 . . . . 10.0 110.428 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -55.85 136.17 51.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.14 -0.482 . . . . 10.0 111.034 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -67.97 163.06 23.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.156 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.47 137.18 53.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.433 -0.349 . . . . 10.0 110.509 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.05 -49.97 1.94 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.646 -0.981 . . . . 10.0 110.646 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.11 -40.44 71.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.119 0.485 . . . . 10.0 109.829 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -59.59 -48.79 80.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.457 -0.792 . . . . 10.0 111.641 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -66.45 -26.37 67.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 10.0 111.32 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -69.97 -32.69 71.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 10.0 110.289 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -65.6 -45.42 83.25 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -61.86 -36.96 82.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.324 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.41 -24.71 65.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.833 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.33 -0.79 62.89 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.036 -0.602 . . . . 10.0 111.811 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.8 mt -105.05 169.18 8.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.439 . . . . 10.0 110.541 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -90.19 -155.66 0.38 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.998 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 57.54 73.17 0.8 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.954 0.407 . . . . 10.0 110.656 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.36 -9.61 26.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.537 2.158 . . . . 10.0 112.386 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -102.16 20.69 16.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.277 -0.42 . . . . 10.0 111.449 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mt -80.96 115.29 54.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.807 0.337 . . . . 10.0 110.529 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.76 58.13 6.7 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.713 2.275 . . . . 10.0 111.675 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.56 119.96 32.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.052 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.6 t -102.93 142.78 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.078 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 106.28 17.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.291 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -98.36 94.01 6.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.074 0.464 . . . . 10.0 109.911 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.96 108.54 2.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.995 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.26 -17.77 55.16 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.871 -0.681 . . . . 10.0 112.425 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.62 4.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.598 -0.81 . . . . 10.0 112.012 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -62.57 -51.7 66.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.859 0.362 . . . . 10.0 110.377 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.95 -35.84 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.19 97.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.613 -0.722 . . . . 10.0 111.359 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -70.89 -39.8 72.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.407 -0.361 . . . . 10.0 111.224 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 m -58.8 -33.83 70.8 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 68.3 mt -113.02 11.18 18.92 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.997 -0.281 . . . . 10.0 111.691 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 62.3 t30 47.39 60.6 3.37 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.493 0.663 . . . . 10.0 111.421 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mt -86.92 73.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.446 0.641 . . . . 10.0 110.991 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.43 16.94 17.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.392 -0.822 . . . . 10.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.05 147.98 9.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.897 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -127.14 160.73 58.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -81.7 154.12 79.57 Favored 'Cis proline' 0 C--O 1.235 0.33 0 C-N-CA 123.28 -1.55 . . . . 10.0 111.634 -0.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 t -130.45 137.71 49.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.288 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -119.9 116.6 26.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.729 -0.668 . . . . 10.0 110.266 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.31 108.31 20.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.664 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.4 tp -90.94 114.4 26.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.829 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.82 134.6 40.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.373 -0.602 . . . . 10.0 109.373 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -70.01 178.67 29.24 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.281 -0.485 . . . . 10.0 113.423 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.15 7.61 3.23 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.944 0.35 . . . . 10.0 111.944 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.65 -19.48 13.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.073 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 109.97 -1.47 30.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.581 -0.819 . . . . 10.0 112.847 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -101.03 162.21 13.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.745 0.307 . . . . 10.0 110.98 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -71.47 122.29 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 10.0 110.259 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -95.41 -46.85 6.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.422 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -152.28 154.2 35.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.718 0.294 . . . . 10.0 110.729 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 tp -128.32 123.88 60.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.515 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.1 t -113.42 137.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.67 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -141.94 139.03 32.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.006 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.14 -89.92 0.45 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.476 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.4 m -147.68 153.34 39.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 10.0 110.613 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.9 135.85 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.28 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -122.6 179.36 4.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 10.0 111.931 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -64.54 -43.58 93.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 10.0 112.086 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.1 -43.77 95.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.317 . . . . 10.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -62.13 -37.8 86.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.828 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.03 -48.9 76.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.051 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.7 -34.41 78.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.613 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.76 -43.77 87.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.132 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.28 -30.13 71.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.871 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 94.2 mt -70.08 -39.69 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.171 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -79.82 -38.94 31.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.226 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -150.86 103.17 3.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.565 -0.288 . . . . 10.0 110.552 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.7 2.84 6.53 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.77 2.313 . . . . 10.0 112.37 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -90.41 -11.79 39.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 10.0 110.622 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.55 113.64 25.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.01 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -96.91 170.0 9.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.076 -0.511 . . . . 10.0 109.892 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.93 0 N-CA-C 113.977 1.102 . . . . 10.0 113.977 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 111.712 0.264 . . . . 10.0 111.712 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.09 -57.77 3.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.916 0.389 . . . . 10.0 111.73 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 24.9 tp -110.95 -77.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.699 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 60.4 41.91 15.42 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.474 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.67 161.95 38.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.343 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.46 -148.7 0.37 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.33 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -113.56 21.65 14.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.251 0.548 . . . . 10.0 110.16 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -93.3 40.91 1.07 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.092 -0.503 . . . . 10.0 111.409 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.21 138.37 4.39 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.562 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.27 147.11 94.07 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.774 2.316 . . . . 10.0 112.143 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.5 -39.58 74.12 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.467 2.778 . . . . 10.0 113.613 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -64.55 -21.36 66.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 10.0 112.153 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.45 -3.59 19.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.183 0.516 . . . . 10.0 110.358 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.01 -9.73 54.84 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.12 128.76 36.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.931 0.396 . . . . 10.0 111.274 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.48 92.04 15.57 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.42 103.17 1.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.067 2.511 . . . . 10.0 112.924 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -98.36 103.12 15.04 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.376 -0.602 . . . . 10.0 109.376 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -86.76 110.0 19.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.165 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.98 112.9 25.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.944 0.402 . . . . 10.0 109.923 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -102.31 121.8 53.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.897 0.38 . . . . 10.0 111.261 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.76 170.25 8.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.533 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.43 -29.17 68.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.098 0.475 . . . . 10.0 110.554 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -75.44 -39.58 58.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.567 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.92 -179.55 47.81 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.833 -0.699 . . . . 10.0 111.904 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -94.14 135.88 27.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.066 -0.346 . . . . 10.0 110.066 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -124.95 112.04 16.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.856 -0.424 . . . . 10.0 109.856 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 p -92.63 124.75 45.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.969 0.414 . . . . 10.0 110.969 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -126.97 90.77 3.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.554 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -93.81 112.93 24.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.118 0.485 . . . . 10.0 111.238 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mtm-85 -72.45 114.6 10.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.461 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 43.7 mt -91.76 139.56 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.826 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.18 155.74 38.03 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.687 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -75.56 77.49 2.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.106 0.479 . . . . 10.0 111.571 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.0 -20.89 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.568 -0.613 . . . . 10.0 111.568 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -104.55 151.61 23.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -145.44 137.56 25.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.761 0.315 . . . . 10.0 110.724 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 34.4 mtt -107.97 156.18 19.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.964 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -99.59 126.86 45.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.636 -0.505 . . . . 10.0 109.636 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -61.29 -28.56 69.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.909 0.385 . . . . 10.0 111.1 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.96 5.39 37.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.079 -0.51 . . . . 10.0 111.064 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -122.19 -10.85 8.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.289 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 89.9 mt -86.96 118.05 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 10.0 110.453 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.4 t -108.32 121.51 61.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.889 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.91 137.22 6.56 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.688 -0.767 . . . . 10.0 111.705 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -161.69 145.61 12.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.801 0.334 . . . . 10.0 111.209 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 8.8 t -143.97 120.88 11.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.805 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.402 HD21 ' CB ' ' B' ' 53' ' ' LEU . 24.1 p30 -174.07 159.53 2.86 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.832 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -73.87 -77.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.321 2.014 . . . . 10.0 110.843 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.82 44.44 1.03 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.149 0.499 . . . . 10.0 110.251 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t0 66.79 33.33 6.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.297 -0.865 . . . . 10.0 112.269 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.88 70.26 4.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.921 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.402 ' CB ' HD21 ' B' ' 48' ' ' ASN . 28.5 tp -125.04 149.03 48.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.716 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.32 -72.67 1.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.886 -0.673 . . . . 10.0 111.805 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -169.87 146.83 2.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 122.131 0.172 . . . . 10.0 110.552 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.65 109.76 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.378 2.052 . . . . 10.0 110.494 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 6.4 m -89.07 94.24 9.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.157 0.503 . . . . 10.0 111.763 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -77.58 163.53 26.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.202 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 50.2 m -95.0 -3.65 48.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.518 -0.31 . . . . 10.0 111.141 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? 68.71 124.12 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.607 -0.724 . . . . 10.0 111.992 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.27 -139.89 8.4 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.893 -0.67 . . . . 10.0 112.206 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.88 143.92 44.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.732 0.301 . . . . 10.0 110.646 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -81.28 119.92 24.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.213 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -98.95 136.03 39.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.456 -0.338 . . . . 10.0 110.799 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -73.97 126.42 30.45 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.571 -0.9 . . . . 10.0 108.571 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -120.46 -179.53 4.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.765 0.317 . . . . 10.0 110.906 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.23 -25.4 4.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.995 0.426 . . . . 10.0 110.575 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -102.29 -49.12 3.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.853 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -88.6 -4.45 58.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.496 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.79 -76.58 2.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.865 -0.683 . . . . 10.0 112.111 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -173.59 118.96 0.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.026 -0.361 . . . . 10.0 110.026 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -133.52 164.74 26.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.799 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -75.51 125.98 30.1 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.3 m -125.87 163.63 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.455 0.645 . . . . 10.0 112.449 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -120.95 130.91 54.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.815 -1.18 . . . . 10.0 107.815 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -115.22 -10.87 12.06 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.66 0.615 . . . . 10.0 112.66 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.91 -29.31 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.339 0.59 . . . . 10.0 109.653 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.09 142.61 28.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.038 -0.983 . . . . 10.0 109.378 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.79 102.69 0.57 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.793 0.33 . . . . 10.0 110.465 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -148.92 117.71 6.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.13 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.38 120.89 52.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.574 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.91 148.13 23.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.349 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -125.22 102.96 30.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.61 127.46 8.04 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.766 2.311 . . . . 10.0 111.293 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -74.12 143.08 45.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.921 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.0 -4.18 53.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.335 0.588 . . . . 10.0 110.095 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -152.21 136.86 16.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.644 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.9 96.52 10.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.35 140.27 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.487 -0.324 . . . . 10.0 111.457 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.18 58.76 4.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.895 -0.669 . . . . 10.0 111.594 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -116.4 140.67 26.86 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.94 89.55 0.88 Allowed 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.584 2.189 . . . . 10.0 111.485 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.53 160.03 32.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.752 -0.658 . . . . 10.0 111.66 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -103.56 155.23 18.69 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.379 -0.601 . . . . 10.0 109.379 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 42.0 tp -125.89 119.89 29.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.803 0.335 . . . . 10.0 110.762 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.75 123.84 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.525 -0.546 . . . . 10.0 109.525 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 64.2 mt -128.92 131.76 47.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.945 0.403 . . . . 10.0 111.66 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 5.6 m -120.07 117.13 27.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -98.23 104.34 16.37 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.963 0.357 . . . . 10.0 111.963 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -117.47 121.39 40.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.901 0.382 . . . . 10.0 110.981 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.91 -160.41 10.68 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.888 -0.673 . . . . 10.0 111.546 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 18.4 m -152.87 -179.57 7.77 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -121.35 142.99 49.45 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.868 -0.419 . . . . 10.0 109.868 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.55 -10.09 56.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.181 -0.463 . . . . 10.0 112.04 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.33 -4.05 59.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.359 . . . . 10.0 111.769 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.13 38.09 2.96 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.561 -0.828 . . . . 10.0 112.928 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 35.1 t -123.13 141.51 43.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 9.4 t -132.68 86.18 2.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.872 0.368 . . . . 10.0 110.803 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -76.73 152.52 82.99 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.497 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.15 161.38 43.31 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.825 2.35 . . . . 10.0 111.512 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.91 74.65 5.16 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.861 2.374 . . . . 10.0 112.289 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.05 122.78 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.596 -0.52 . . . . 10.0 109.596 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -106.11 156.66 18.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.993 0.425 . . . . 10.0 111.291 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.28 141.09 30.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.17 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -107.73 123.18 48.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 10.0 110.739 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -112.94 148.29 35.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.571 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -105.12 118.96 37.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.517 -0.31 . . . . 10.0 110.221 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 14.9 mm -94.54 71.1 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.295 0.569 . . . . 10.0 110.53 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -83.98 -19.74 34.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.657 -0.701 . . . . 10.0 111.479 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.39 51.7 0.24 Allowed Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.709 -0.758 . . . . 10.0 112.688 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -103.77 -18.13 14.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.166 0.508 . . . . 10.0 110.489 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.19 -78.1 0.67 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.96 -0.856 . . . . 10.0 110.96 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 2.1 m -105.26 141.81 36.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -133.21 156.43 47.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.21 -0.292 . . . . 10.0 110.21 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.3 152.8 54.92 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.91 114.32 2.55 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.448 2.099 . . . . 10.0 112.139 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -81.13 76.9 8.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.566 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 7.7 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.788 -0.625 . . . . 10.0 109.732 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 109.738 -0.467 . . . . 10.0 109.738 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.02 76.32 50.28 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.068 0.461 . . . . 10.0 111.398 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.34 -33.97 88.2 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.702 2.268 . . . . 10.0 112.017 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -43.81 96.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.385 -0.371 . . . . 10.0 111.179 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 -40.01 78.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.307 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.4 tp -62.23 -34.16 75.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.729 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 m -84.57 -8.01 59.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.45 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.2 m -82.51 -20.73 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.192 0.52 . . . . 10.0 109.745 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.4 119.34 5.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.696 -0.683 . . . . 10.0 110.636 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.35 140.42 41.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.43 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.0 p -81.68 168.97 17.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.866 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -11.04 56.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.984 0.421 . . . . 10.0 111.15 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.38 8.22 45.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.381 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.3 t30 68.12 38.14 2.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.6 -0.727 . . . . 10.0 112.108 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -122.51 140.26 32.49 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.658 -0.497 . . . . 10.0 109.658 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.35 143.82 78.04 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.215 1.943 . . . . 10.0 111.422 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -13.23 34.28 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.2 m -56.87 -22.82 39.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 10.0 112.133 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.96 -20.23 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.109 0.48 . . . . 10.0 111.315 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -132.47 28.76 4.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.18 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -138.73 43.94 2.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.131 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -145.81 -171.57 3.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.389 -0.368 . . . . 10.0 111.269 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 mttp 65.84 13.82 9.22 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 58.26 38.4 26.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.944 0.402 . . . . 10.0 111.682 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -103.22 146.43 32.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.941 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.26 135.76 52.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.659 2.239 . . . . 10.0 110.958 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -109.33 146.21 34.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.827 0.346 . . . . 10.0 111.181 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.1 tp -127.34 108.19 10.63 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.872 -0.418 . . . . 10.0 109.872 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.9 mt -96.09 119.75 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.969 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.602 ' HZ3' ' CD ' ' A' ' 42' ' ' GLU . 1.1 tmtp? -113.2 124.82 53.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.679 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -98.0 142.49 29.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.351 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -145.81 170.82 15.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.525 -0.307 . . . . 10.0 110.821 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.9 139.49 49.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.637 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -73.33 -47.19 44.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.994 -0.548 . . . . 10.0 112.443 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.99 29.27 1.4 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.427 0.529 . . . . 10.0 112.427 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.7 t -117.59 121.05 32.39 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.513 0.197 . . . . 10.0 111.288 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.0 -43.54 47.58 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.129 2.553 . . . . 10.0 112.467 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.37 -39.53 90.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.948 0.404 . . . . 10.0 111.279 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 78.2 m -76.08 -31.68 58.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.566 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.02 -46.85 85.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 10.0 112.082 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 m -66.61 -33.66 76.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.055 0.455 . . . . 10.0 110.862 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.602 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -63.49 -26.31 68.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.254 -179.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.28 -34.33 72.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.825 0.345 . . . . 10.0 110.643 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.78 92.34 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.935 -0.65 . . . . 10.0 111.853 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -77.31 -29.65 53.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.911 0.386 . . . . 10.0 110.113 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.7 m -60.44 -47.49 85.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.772 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.68 -36.75 85.28 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -61.69 -50.39 72.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.258 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -64.11 -37.28 86.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.049 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.14 -10.84 59.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.433 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -111.78 16.4 20.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.992 0.425 . . . . 10.0 110.73 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -93.31 139.89 30.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.258 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.38 -32.23 69.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.836 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -71.33 -44.09 65.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 10.0 110.658 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -73.6 -14.76 61.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 10.0 112.198 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.9 m -65.01 -11.63 41.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 10.0 111.216 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -78.87 -15.36 58.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.497 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -123.22 176.33 6.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.418 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -109.69 87.7 2.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.57 117.26 20.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.445 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.2 pt -134.93 147.2 29.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.786 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -109.0 116.41 31.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.167 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.17 137.15 47.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.78 0.324 . . . . 10.0 111.181 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -132.08 138.25 48.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.087 -0.708 . . . . 10.0 109.087 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -100.66 102.35 18.89 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 112.13 0.418 . . . . 10.0 112.13 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -68.63 131.23 22.41 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.994 2.463 . . . . 10.0 111.894 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.57 0.64 90.03 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.942 -0.572 . . . . 10.0 112.448 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -112.02 143.03 43.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 60.81 26.56 16.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.837 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 67.93 26.43 7.48 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.371 -0.831 . . . . 10.0 112.849 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.97 -169.61 2.46 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.451 -0.34 . . . . 10.0 110.187 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -68.35 145.06 54.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.206 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -77.33 162.29 27.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.038 0.447 . . . . 10.0 111.712 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -63.56 150.35 44.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.855 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.56 -40.96 3.03 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.867 -0.893 . . . . 10.0 110.867 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -81.92 -47.62 12.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.913 0.387 . . . . 10.0 110.062 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -57.59 -39.37 76.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.8 -0.637 . . . . 10.0 112.232 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.01 -30.62 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.996 0.427 . . . . 10.0 111.225 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -77.87 -31.72 51.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 10.0 109.866 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -58.16 -45.76 86.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.73 -0.668 . . . . 10.0 109.678 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -66.99 -36.58 82.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.798 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.67 -27.76 69.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.198 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.24 29.21 12.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.889 -0.672 . . . . 10.0 111.998 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.5 mt -121.66 -162.55 0.99 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.042 0.449 . . . . 10.0 111.059 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -116.99 -171.61 2.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.766 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 66.33 84.74 0.17 Allowed Pre-proline 0 N--CA 1.465 0.314 0 CA-C-O 121.381 0.61 . . . . 10.0 110.705 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.0 -11.57 29.39 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.776 2.318 . . . . 10.0 112.549 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -107.09 22.77 15.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.213 0.449 . . . . 10.0 112.213 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 mt -81.34 115.27 55.4 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.627 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.04 63.88 8.24 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.443 2.095 . . . . 10.0 111.705 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 68.7 t -82.31 117.27 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.13 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.7 t -104.97 142.49 18.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.706 -0.679 . . . . 10.0 109.981 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.28 108.45 20.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.05 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -94.72 78.58 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.297 0.57 . . . . 10.0 110.222 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -64.17 116.56 6.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.505 0.557 . . . . 10.0 112.505 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.63 -6.31 67.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.563 -0.827 . . . . 10.0 112.65 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.45 41.36 67.03 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.72 -0.752 . . . . 10.0 111.799 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -43.99 98.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.833 0.349 . . . . 10.0 110.775 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.0 mm -80.39 -42.26 21.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.938 0.399 . . . . 10.0 110.07 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.88 -45.7 89.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.628 -0.714 . . . . 10.0 112.167 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -68.3 -38.01 81.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.8 m -61.2 -35.74 78.0 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.413 0.523 . . . . 10.0 112.413 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -106.37 5.7 29.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.595 0.22 . . . . 10.0 111.595 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.0 t30 53.39 55.71 8.34 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.524 0.678 . . . . 10.0 111.064 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.2 mt -87.06 99.91 9.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.325 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.92 29.19 8.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.749 -0.66 . . . . 10.0 111.277 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.8 p -166.78 152.15 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.211 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -126.83 154.48 76.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -91.71 118.43 3.04 Favored 'Cis proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.619 -1.409 . . . . 10.0 111.403 -1.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.5 m -87.17 136.47 32.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.218 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -113.6 113.47 25.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.749 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.86 116.93 33.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.335 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.3 tp -93.65 116.11 28.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.8 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.65 129.59 56.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.946 -0.57 . . . . 10.0 109.544 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.75 178.17 40.04 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.962 -0.637 . . . . 10.0 112.895 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -69.77 -13.04 62.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.127 0.489 . . . . 10.0 110.617 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.44 -10.68 58.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.263 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.97 43.0 6.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.556 -0.831 . . . . 10.0 112.206 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -149.72 153.67 37.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.636 0.255 . . . . 10.0 110.573 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.5 t -70.23 120.23 17.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.952 0.406 . . . . 10.0 111.323 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -99.95 -28.97 12.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.013 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -156.24 146.65 21.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.585 -0.279 . . . . 10.0 111.004 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.0 tp -131.3 117.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.911 -0.403 . . . . 10.0 109.911 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.62 133.58 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.543 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -120.69 126.45 50.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.195 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.85 -99.21 0.22 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.499 -0.857 . . . . 10.0 112.931 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.4 m -168.14 135.22 2.11 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.122 -0.696 . . . . 10.0 109.122 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.1 pt -119.19 154.86 21.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.969 -0.293 . . . . 10.0 110.664 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -110.37 169.58 8.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.248 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -57.93 -39.32 77.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.114 0.413 . . . . 10.0 112.114 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.55 -40.85 88.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.104 0.478 . . . . 10.0 110.419 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -68.62 -38.21 80.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.22 -0.9 . . . . 10.0 110.146 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.85 91.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.633 -0.712 . . . . 10.0 110.941 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.15 -36.77 85.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.849 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.23 95.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.752 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.2 tp -62.43 -32.09 72.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.077 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.3 mt -72.68 -32.96 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.118 0.485 . . . . 10.0 110.358 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -78.5 -39.78 37.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.649 -0.705 . . . . 10.0 110.82 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -151.75 119.28 3.27 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.603 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.25 -7.25 20.4 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.098 2.532 . . . . 10.0 113.42 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -99.12 4.4 46.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 10.0 111.163 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.2 72.09 9.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.411 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -76.61 150.98 36.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.949 -0.568 . . . . 10.0 111.305 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.146 0 N-CA-C 114.006 1.113 . . . . 10.0 114.006 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.452 0.168 . . . . 10.0 111.08 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.88 70.72 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.08 -0.509 . . . . 10.0 112.087 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 35.1 tp -91.91 -80.03 0.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.674 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 55.16 37.23 28.58 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.448 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.67 157.34 44.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.23 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.17 -172.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.253 -0.885 . . . . 10.0 112.693 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -94.6 27.87 2.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.273 -0.876 . . . . 10.0 110.619 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -84.51 -4.33 58.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.985 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.5 143.98 51.07 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.9 150.89 87.05 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.024 2.483 . . . . 10.0 112.4 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.28 -34.42 88.37 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.413 2.742 . . . . 10.0 113.162 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -68.0 -4.73 14.19 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.118 0.414 . . . . 10.0 112.118 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -129.03 1.43 5.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.4 0.619 . . . . 10.0 110.233 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.42 -10.47 43.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.832 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.95 126.14 33.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.504 -0.317 . . . . 10.0 111.204 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.38 92.55 36.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.49 116.06 4.22 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.169 2.579 . . . . 10.0 113.441 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.1 109.48 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -93.46 118.09 30.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.987 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.16 113.53 22.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.546 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.98 118.91 43.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.025 0.441 . . . . 10.0 111.225 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.0 -164.48 1.14 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.738 -0.665 . . . . 10.0 109.928 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -92.26 -37.29 12.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.789 0.328 . . . . 10.0 111.069 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.64 -37.12 42.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.623 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.01 -170.48 32.81 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.586 -0.816 . . . . 10.0 112.392 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.9 135.1 47.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -120.35 111.89 18.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.753 0.311 . . . . 10.0 110.248 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.01 122.55 46.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.13 0.491 . . . . 10.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -124.27 92.01 3.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.093 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -95.38 122.55 38.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.74 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -79.76 122.33 26.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.625 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 72.1 mt -100.83 130.68 49.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.49 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.65 145.34 55.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.147 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.36 92.99 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.109 0.48 . . . . 10.0 111.675 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.77 -23.86 0.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.663 -0.975 . . . . 10.0 110.663 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -103.51 154.04 19.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -144.63 139.01 27.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.965 0.412 . . . . 10.0 111.101 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 34.4 mtt -110.9 150.63 28.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.432 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -92.6 121.35 33.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -56.81 -37.12 70.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.752 0.31 . . . . 10.0 111.833 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.66 -9.77 58.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.397 . . . . 10.0 111.576 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -104.43 -11.03 17.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.747 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 75.2 mt -82.28 96.59 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.079 0.466 . . . . 10.0 110.314 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 t -91.46 109.04 20.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.203 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.39 141.51 12.57 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.55 -0.834 . . . . 10.0 111.751 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -162.36 147.48 12.51 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.789 0.328 . . . . 10.0 111.475 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 9.9 t -143.47 123.36 13.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.987 -0.552 . . . . 10.0 109.528 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -177.43 157.28 1.24 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.139 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -73.83 -69.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.732 2.288 . . . . 10.0 110.559 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.66 55.43 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.235 0.541 . . . . 10.0 109.769 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 t70 60.95 27.42 17.29 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.251 -0.886 . . . . 10.0 112.453 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.89 59.61 5.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.272 0.558 . . . . 10.0 111.531 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 22.9 tp -122.97 148.84 45.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.729 -0.669 . . . . 10.0 109.516 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.84 -80.21 0.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.596 -0.812 . . . . 10.0 111.45 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -163.0 145.63 8.22 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.402 -0.221 . . . . 10.0 110.402 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.64 107.5 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.606 2.204 . . . . 10.0 110.75 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.0 m -93.65 96.52 9.88 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.224 0.535 . . . . 10.0 111.536 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -80.25 150.25 30.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.718 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.4 m -81.12 -8.1 59.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.778 0.323 . . . . 10.0 110.678 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt 71.39 148.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.44 -0.8 . . . . 10.0 112.813 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.79 -128.33 2.93 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.996 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -121.04 149.57 42.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.526 0.203 . . . . 10.0 110.772 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.94 119.24 28.1 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -101.04 130.91 47.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.944 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -69.13 142.86 54.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -137.93 170.87 15.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.709 0.29 . . . . 10.0 111.16 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -109.85 -13.45 14.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.401 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -121.36 -41.15 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 10.0 111.218 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -90.3 -7.41 53.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.962 0.411 . . . . 10.0 111.207 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.71 -79.46 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.095 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -171.44 110.75 0.31 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.989 0.423 . . . . 10.0 110.678 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -128.29 163.46 24.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.121 -0.491 . . . . 10.0 110.384 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 12.8 m -75.38 125.52 29.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.08 155.28 31.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.397 0.618 . . . . 10.0 112.357 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -112.84 130.34 56.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.611 -1.255 . . . . 10.0 107.611 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -113.03 -10.49 13.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.606 0.595 . . . . 10.0 112.606 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -168.78 -34.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.432 0.634 . . . . 10.0 109.887 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -87.75 134.55 33.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.296 -0.866 . . . . 10.0 109.769 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -159.32 123.79 3.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.883 0.373 . . . . 10.0 111.444 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -160.85 120.72 2.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.328 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 t -125.9 128.33 71.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 10.0 109.998 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.33 138.75 38.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.626 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -122.14 98.39 44.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.51 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.8 126.49 3.98 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.2 2.6 . . . . 10.0 111.027 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.06 149.58 46.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.81 0.338 . . . . 10.0 110.871 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.99 -9.78 41.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.267 0.556 . . . . 10.0 110.107 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -152.24 127.2 9.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.895 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.64 99.32 6.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.143 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -131.83 146.22 33.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.403 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.58 43.63 3.01 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.671 -0.776 . . . . 10.0 111.867 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -104.33 144.44 28.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.43 0.157 . . . . 10.0 110.862 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.39 100.45 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.412 2.075 . . . . 10.0 111.353 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.56 144.13 28.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.923 -0.581 . . . . 10.0 111.208 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -88.81 159.5 17.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.049 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 35.3 tp -131.05 121.8 25.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.046 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.05 125.0 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 49.2 mt -129.56 126.9 39.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.787 0.327 . . . . 10.0 111.549 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 1.7 m -115.62 116.85 28.83 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -100.35 110.94 23.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.314 . . . . 10.0 111.366 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -120.81 121.6 38.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.752 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.99 -157.13 9.84 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.309 -0.717 . . . . 10.0 111.309 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 39.6 m -158.86 -172.98 4.03 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' B' ' 105' ' ' ALA . . . -119.25 146.27 45.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.22 40.35 0.34 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.028 0.442 . . . . 10.0 110.484 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' B' ' 103' ' ' ALA . . . -141.18 1.06 1.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.223 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.05 -32.56 5.73 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.768 -0.729 . . . . 10.0 113.129 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 12.3 t -62.69 133.17 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.353 . . . . 10.0 111.313 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 10.9 t -129.22 100.35 5.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.947 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -89.61 144.81 32.47 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.678 0.275 . . . . 10.0 111.478 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.18 160.83 44.51 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.854 2.37 . . . . 10.0 111.565 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.77 75.83 4.32 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.54 2.16 . . . . 10.0 112.657 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 6.6 t -69.54 104.9 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -72.61 148.51 44.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.846 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.9 m -132.62 128.08 36.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.286 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.59 134.16 49.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.012 0.434 . . . . 10.0 110.616 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -109.17 166.56 10.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.345 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -123.0 117.61 25.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.966 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 18.6 mm -97.23 82.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.152 0.501 . . . . 10.0 110.462 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -97.38 -25.51 15.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.675 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.52 68.16 0.18 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.068 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -128.27 -3.9 5.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.866 0.365 . . . . 10.0 111.363 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.28 -76.72 2.21 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.836 -0.697 . . . . 10.0 111.917 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 135.15 46.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.189 -0.301 . . . . 10.0 110.189 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -123.26 147.21 47.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 10.0 110.925 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.35 145.18 48.54 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.323 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.53 131.61 32.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.592 2.194 . . . . 10.0 111.668 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . 0.418 ' C ' ' HG1' ' B' ' 128' ' ' THR . 61.9 mt-30 -84.24 86.55 7.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.209 0.528 . . . . 10.0 110.476 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' B' ' 127' ' ' GLN . 19.0 m . . . . . 0 C--O 1.245 0.824 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.599 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 109.788 -0.449 . . . . 10.0 109.788 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.53 63.13 63.37 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.337 . . . . 10.0 111.403 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.17 -43.61 10.99 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.411 2.074 . . . . 10.0 111.681 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -58.97 -44.35 91.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.267 -0.424 . . . . 10.0 111.32 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -47.03 80.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.947 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.8 tp -61.21 -36.19 79.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 10.0 111.361 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 m -76.08 -10.43 59.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 10.0 111.685 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.6 m -92.58 -6.33 49.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.035 0.445 . . . . 10.0 110.423 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.37 109.52 2.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.293 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.49 139.43 33.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.931 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.6 p -84.13 172.51 11.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.061 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.29 -9.08 54.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.48 . . . . 10.0 110.263 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -91.71 8.11 38.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.948 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.95 13.33 7.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.258 -0.883 . . . . 10.0 112.956 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.92 143.49 29.2 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.479 -0.328 . . . . 10.0 110.626 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.82 146.79 88.92 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.617 2.211 . . . . 10.0 111.139 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.49 -5.68 25.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.256 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.66 -25.5 53.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.635 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.63 -21.45 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.078 0.466 . . . . 10.0 111.047 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -117.68 20.55 13.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.329 0.585 . . . . 10.0 109.764 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.3 mt -125.76 25.38 6.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.661 -0.699 . . . . 10.0 110.33 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -124.24 -170.6 2.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.204 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 mttm 68.31 8.48 6.63 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.733 0.645 . . . . 10.0 111.692 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.68 34.92 25.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.212 0.529 . . . . 10.0 110.32 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -101.67 150.58 37.44 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 10.0 111.449 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.27 142.87 75.05 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.781 2.321 . . . . 10.0 111.093 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.65 142.37 39.23 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.967 0.413 . . . . 10.0 111.286 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.7 tp -120.76 101.85 8.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.5 mt -87.53 121.92 38.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.817 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.613 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 1.9 tmtp? -114.98 108.91 17.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.253 -0.431 . . . . 10.0 111.192 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -82.86 138.07 34.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.068 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -140.98 171.67 13.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.576 -0.283 . . . . 10.0 111.239 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.46 144.59 49.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.239 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.98 -41.37 18.84 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.611 0.597 . . . . 10.0 112.611 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -88.56 23.81 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.661 0.615 . . . . 10.0 112.661 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.6 t -115.58 128.3 26.07 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 111.854 0.316 . . . . 10.0 111.854 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.49 -43.09 18.69 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.884 2.389 . . . . 10.0 112.297 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.46 -41.69 93.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 10.0 111.171 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.5 m -70.32 -21.27 62.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.252 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.3 tp -68.52 -48.01 65.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.363 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.93 -33.07 74.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.172 0.511 . . . . 10.0 109.827 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.613 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -57.13 -32.62 66.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.354 -0.839 . . . . 10.0 111.534 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.99 -46.71 84.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 10.0 111.091 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.91 -44.19 96.42 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.902 -0.59 . . . . 10.0 112.318 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -65.91 -38.13 87.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 10.0 110.785 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.4 m -63.62 -43.22 97.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.362 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -64.41 -39.71 94.37 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.908 -0.405 . . . . 10.0 109.908 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -60.83 -50.49 73.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.087 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -64.93 -40.16 94.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.753 -0.658 . . . . 10.0 111.528 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.59 -18.74 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.135 0.42 . . . . 10.0 112.135 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -103.7 10.24 36.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.753 0.311 . . . . 10.0 111.418 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -80.9 148.31 29.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.856 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.13 94.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -74.13 -34.85 64.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.885 0.374 . . . . 10.0 110.972 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.82 -10.89 59.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.147 -0.478 . . . . 10.0 111.862 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.5 m -74.72 2.15 10.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.028 0.442 . . . . 10.0 111.532 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -87.82 -9.47 53.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.834 0.349 . . . . 10.0 110.468 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.43 168.23 18.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 10.0 109.945 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -104.53 96.82 6.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.813 0.339 . . . . 10.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.29 125.48 33.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.711 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.3 pt -136.6 132.21 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 10.0 111.532 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.18 131.07 37.7 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.6 p -137.06 147.18 27.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.165 0.507 . . . . 10.0 112.13 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.0 158.55 43.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.257 -1.016 . . . . 10.0 108.257 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 m -110.47 95.1 21.07 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 112.124 0.416 . . . . 10.0 112.124 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.28 119.27 6.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.58 2.187 . . . . 10.0 111.699 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.95 10.02 65.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.93 -0.652 . . . . 10.0 112.48 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -129.03 144.53 51.22 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.3 mt 60.91 27.21 17.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.896 0.379 . . . . 10.0 111.592 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 m170 69.09 19.03 8.17 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.417 -0.811 . . . . 10.0 112.866 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.7 177.66 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.571 -0.286 . . . . 10.0 110.678 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -63.37 148.09 49.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.949 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -74.75 156.39 36.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.993 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.61 143.88 28.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.395 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.24 -52.92 4.12 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.622 -0.991 . . . . 10.0 110.622 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.92 -42.49 76.72 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.22 -47.85 84.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.751 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -66.5 -24.43 66.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 10.0 111.62 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -74.96 -30.87 61.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.434 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -65.67 -48.83 70.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.622 -0.51 . . . . 10.0 109.622 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -62.92 -33.57 75.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.075 0.464 . . . . 10.0 110.852 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.42 -18.62 65.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.351 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.8 30.19 8.65 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.991 -0.844 . . . . 10.0 110.991 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.0 mt -130.85 173.83 10.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.778 0.323 . . . . 10.0 110.27 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.433 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 57.0 t30 -92.87 -165.76 1.4 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.615 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.433 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 41.4 m-85 63.46 68.01 0.95 Allowed Pre-proline 0 C--O 1.233 0.222 0 CA-C-O 121.022 0.439 . . . . 10.0 110.595 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.6 23.82 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.65 2.233 . . . . 10.0 112.698 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.97 13.7 9.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 10.0 110.578 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.3 mt -92.17 118.98 68.4 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 10.0 110.964 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.77 69.08 7.51 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.062 2.508 . . . . 10.0 110.689 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.9 t -79.72 115.86 22.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.204 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -98.87 148.11 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.249 -0.432 . . . . 10.0 109.998 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.02 101.78 11.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.767 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -86.16 88.65 7.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.089 0.471 . . . . 10.0 110.633 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -64.58 106.94 1.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.989 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.91 -2.33 69.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.814 -0.707 . . . . 10.0 112.924 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.98 55.45 19.23 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.355 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.24 -45.01 95.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.023 0.439 . . . . 10.0 110.608 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.8 mm -80.46 -39.09 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.108 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.93 92.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.521 -0.763 . . . . 10.0 111.899 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -75.17 -36.7 61.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.889 0.376 . . . . 10.0 111.294 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.6 m -65.38 -34.66 78.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.559 0.577 . . . . 10.0 112.559 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.19 5.29 42.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.524 0.202 . . . . 10.0 111.5 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 53.05 69.51 0.69 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.578 0.704 . . . . 10.0 111.311 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 86.1 mt -103.47 114.99 44.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.413 -0.812 . . . . 10.0 111.033 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.8 p -121.37 19.48 11.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.46 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.0 p -163.54 149.73 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.838 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -117.33 156.81 48.5 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -91.13 144.95 14.5 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.937 -1.276 . . . . 10.0 111.431 -1.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.8 m -110.08 129.54 55.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.477 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -107.52 107.05 17.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.935 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.05 116.81 29.93 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.484 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.2 tp -94.55 107.38 19.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.823 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.3 127.28 46.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 117' ' ' ASP . . . -66.33 165.38 39.66 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.909 -0.662 . . . . 10.0 112.124 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -69.68 8.94 0.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.225 0.454 . . . . 10.0 112.225 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 115' ' ' GLY . 6.9 t70 -103.92 -20.02 14.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.295 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 100.96 46.28 1.77 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.989 -0.624 . . . . 10.0 112.421 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -154.14 166.71 32.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.436 0.16 . . . . 10.0 110.599 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.5 t -74.66 111.6 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.071 0.462 . . . . 10.0 110.839 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -93.82 -35.97 12.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.989 -0.551 . . . . 10.0 110.689 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -157.53 153.71 27.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.154 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 tp -136.93 121.52 24.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.069 0.461 . . . . 10.0 110.658 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.52 120.13 63.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.358 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -117.1 114.96 24.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.004 -0.369 . . . . 10.0 110.004 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.69 -87.43 0.13 Allowed Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.26 -0.971 . . . . 10.0 112.739 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.6 m -167.18 146.56 5.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.5 pt -127.24 179.99 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.576 0.227 . . . . 10.0 110.821 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -142.99 171.58 13.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.704 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -61.15 -44.5 97.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.927 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.26 95.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.978 0.418 . . . . 10.0 110.236 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -63.56 -39.3 94.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.488 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.85 94.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 10.0 110.349 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.78 -36.66 84.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.422 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.1 70.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.767 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.09 -42.47 89.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.991 -0.55 . . . . 10.0 111.388 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.4 pt -76.0 -10.53 13.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.213 0.53 . . . . 10.0 110.773 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -91.32 -52.11 4.97 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -143.61 110.14 5.27 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.102 -0.954 . . . . 10.0 109.556 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.51 -7.21 17.15 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.964 2.443 . . . . 10.0 112.217 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -86.83 4.88 39.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.304 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.82 109.41 21.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.719 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -115.38 141.48 47.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.166 -0.921 . . . . 10.0 112.56 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.438 ' H3 ' ' CG ' ' B' ' 4' ' ' ASP . 54.2 mtt . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 111.962 0.356 . . . . 10.0 111.962 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.89 -79.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 10.0 111.712 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 59.4 tp -87.89 -69.26 0.7 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.358 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . 0.438 ' CG ' ' H3 ' ' B' ' 1' ' ' MET . 94.1 m-20 60.01 35.11 21.48 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.281 0.562 . . . . 10.0 110.674 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.86 162.76 34.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.275 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 30.3 m120 62.56 -155.95 0.34 Allowed 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.708 0.63 . . . . 10.0 110.897 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -110.22 20.25 18.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.261 0.553 . . . . 10.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -85.39 36.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.801 -0.636 . . . . 10.0 111.629 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -158.93 136.36 7.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.67 148.38 82.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.951 2.434 . . . . 10.0 112.159 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.58 -39.19 76.0 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.344 2.696 . . . . 10.0 113.591 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -68.59 -12.54 61.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 10.0 111.956 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -117.51 -0.15 11.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.249 0.547 . . . . 10.0 110.319 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.78 -19.21 24.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.354 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -127.21 124.79 39.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.448 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 t -109.66 91.17 9.95 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.519 -0.549 . . . . 10.0 109.519 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.51 103.98 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.928 2.419 . . . . 10.0 112.785 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -100.71 115.0 29.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.01 117.06 25.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.673 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.11 99.92 9.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.015 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 65.8 t -94.52 118.29 40.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.961 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.15 -166.48 1.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.915 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -89.15 -36.63 15.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.896 0.379 . . . . 10.0 110.657 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -71.24 -40.26 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.899 -0.592 . . . . 10.0 110.96 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.64 -172.72 42.44 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.784 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.15 135.9 32.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -122.36 114.06 20.24 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.511 -0.551 . . . . 10.0 109.511 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.31 126.79 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.117 0.484 . . . . 10.0 111.273 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -127.5 88.74 2.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.159 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -93.31 115.74 28.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.024 0.44 . . . . 10.0 110.676 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 -75.17 115.71 15.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.554 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mt -94.68 135.8 27.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.911 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.8 150.31 48.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.155 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.53 79.71 2.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.203 0.525 . . . . 10.0 111.757 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.48 -26.65 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -103.77 150.99 23.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.227 -0.657 . . . . 10.0 109.227 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -142.39 146.18 34.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.822 0.344 . . . . 10.0 111.186 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 57.0 mtt -116.51 154.73 29.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.648 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -96.48 129.81 43.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.39 -0.596 . . . . 10.0 109.39 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -60.6 -28.58 68.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.958 0.409 . . . . 10.0 111.255 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.97 9.8 21.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.205 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -127.87 -7.68 5.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 10.0 111.748 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 89.4 mt -83.75 119.69 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.854 0.359 . . . . 10.0 110.188 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 40.3 t -105.19 126.22 60.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.317 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.31 132.39 3.4 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.272 -0.731 . . . . 10.0 111.272 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -159.12 150.46 20.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.863 0.331 . . . . 10.0 111.129 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 10.2 t -153.66 125.27 7.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.34 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -178.54 160.76 1.13 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.344 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.23 -56.54 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.215 1.943 . . . . 10.0 112.093 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.42 69.9 1.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.981 0.42 . . . . 10.0 111.138 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 t70 69.18 9.26 7.27 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.13 0.789 . . . . 10.0 113.13 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -81.24 59.9 4.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.043 0.449 . . . . 10.0 111.945 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 45.0 tp -125.87 138.58 53.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.78 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.57 -79.8 0.44 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.571 -0.823 . . . . 10.0 111.667 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -165.72 145.4 5.38 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.39 107.84 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.545 2.163 . . . . 10.0 111.772 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -83.62 92.65 7.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.467 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -77.27 145.54 37.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.013 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 53.9 m -77.62 -18.01 57.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.811 0.3 . . . . 10.0 111.811 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? 74.54 137.8 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.785 0.678 . . . . 10.0 112.558 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.99 -121.78 2.78 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.817 -0.913 . . . . 10.0 110.817 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -130.15 155.01 46.92 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -87.96 125.55 34.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.075 0.464 . . . . 10.0 110.838 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -102.7 131.9 49.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.452 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -73.79 146.73 44.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -145.2 173.78 11.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.803 0.335 . . . . 10.0 110.918 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -108.86 -29.38 8.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.858 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -108.12 -35.14 6.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -94.11 -6.11 45.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.355 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.81 -79.97 1.52 Allowed Glycine 0 C--O 1.227 -0.296 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.435 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -176.71 122.61 0.15 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 122.698 0.399 . . . . 10.0 110.352 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -143.17 162.27 36.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.551 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 11.5 m -70.77 125.42 26.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.355 -0.609 . . . . 10.0 109.355 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -125.95 156.25 35.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.43 0.634 . . . . 10.0 112.312 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -117.6 132.21 56.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -122.01 6.66 9.79 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.065 0.765 . . . . 10.0 113.065 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -176.25 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.83 -0.804 . . . . 10.0 108.83 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 1.0 OUTLIER -81.46 136.63 35.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.79 -1.095 . . . . 10.0 109.424 179.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -164.05 115.99 1.36 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 10.0 111.053 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -157.3 122.54 4.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.248 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.41 128.68 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.032 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.82 137.59 40.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.438 -0.347 . . . . 10.0 110.234 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -116.4 107.64 46.77 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.802 0.334 . . . . 10.0 111.528 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -91.03 127.47 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.036 2.491 . . . . 10.0 111.335 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -74.46 148.07 41.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.517 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.1 -5.88 57.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.175 0.512 . . . . 10.0 110.312 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -155.7 142.32 18.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.653 -0.703 . . . . 10.0 109.748 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.45 97.78 11.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.984 0.421 . . . . 10.0 110.74 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 13.6 m -128.24 154.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.685 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.26 7.18 72.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.628 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.22 144.7 92.68 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.89 107.06 1.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.444 2.096 . . . . 10.0 111.97 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.32 135.19 36.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -88.7 141.58 28.39 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.605 -0.438 . . . . 10.0 110.328 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 64.6 tp -108.96 114.25 27.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.942 0.401 . . . . 10.0 110.897 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 47.4 t -112.47 122.03 65.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 65.6 mt -127.68 145.83 50.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.006 0.432 . . . . 10.0 111.536 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 24.1 m -147.87 122.93 10.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -107.0 134.78 49.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.875 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -140.61 126.01 18.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.428 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.87 -154.74 8.33 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.229 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.1 m -150.1 175.38 11.78 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.93 145.7 41.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.93 -2.41 12.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.791 0.663 . . . . 10.0 112.791 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.99 0.2 45.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.134 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.2 -21.13 31.8 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.808 -0.71 . . . . 10.0 112.082 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 3.2 t -64.15 145.15 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.79 0.329 . . . . 10.0 110.275 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 t -134.08 106.33 7.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.013 0.435 . . . . 10.0 110.794 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -88.17 146.68 38.71 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.821 0.343 . . . . 10.0 111.735 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.08 163.21 38.83 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.851 2.368 . . . . 10.0 111.782 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.04 94.69 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.223 1.949 . . . . 10.0 111.591 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.56 133.7 30.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.33 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -106.85 149.14 27.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.896 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.6 m -151.4 119.63 6.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.512 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.45 132.16 44.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.272 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -116.04 139.82 49.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.065 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.25 124.74 47.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.644 -0.707 . . . . 10.0 109.781 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.8 66.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.398 0.618 . . . . 10.0 109.925 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -73.19 -24.46 60.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.739 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 122.75 73.41 0.28 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.611 -0.804 . . . . 10.0 112.351 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -140.35 -20.15 0.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.103 0.477 . . . . 10.0 110.496 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.08 -65.29 4.0 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.911 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.99 123.66 33.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.305 -0.257 . . . . 10.0 110.305 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -132.05 156.13 46.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.26 149.22 22.53 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.211 -0.449 . . . . 10.0 109.796 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.12 120.53 7.9 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.422 2.081 . . . . 10.0 112.257 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -80.87 75.28 7.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.19 0.519 . . . . 10.0 110.652 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 71.4 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.357 -0.83 . . . . 10.0 109.971 179.764 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 m -125.39 61.85 37.24 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 112.043 0.386 . . . . 10.0 112.043 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.28 -38.34 12.14 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.932 1.755 . . . . 10.0 111.857 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -62.61 -43.69 98.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.871 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -42.79 95.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.626 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -61.87 -30.3 70.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.034 0.445 . . . . 10.0 110.703 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 m -84.12 -7.14 59.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.187 -0.46 . . . . 10.0 111.456 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -91.24 -8.15 49.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.14 0.495 . . . . 10.0 109.907 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.25 110.7 2.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.418 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.47 140.61 30.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.736 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.8 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 25.2 p -81.2 174.06 11.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.324 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.53 -10.86 58.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.239 0.542 . . . . 10.0 110.135 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -91.95 -4.55 54.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.194 -0.912 . . . . 10.0 109.421 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 79.68 9.98 1.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.067 -0.97 . . . . 10.0 111.836 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 15' ' ' ARG . 32.8 mtt85 -94.64 144.79 28.5 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 10.0 109.998 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.78 148.93 78.16 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.242 1.962 . . . . 10.0 111.387 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.79 -8.52 15.38 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -24.04 52.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.795 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.631 HG23 ' HD1' ' A' ' 20' ' ' TYR . 19.2 m -61.53 -21.03 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.039 0.447 . . . . 10.0 111.709 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.631 ' HD1' HG23 ' A' ' 19' ' ' VAL . 35.5 m-85 -131.34 23.66 4.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.257 0.551 . . . . 10.0 110.42 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.7 mt -135.33 56.07 1.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.451 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HG2' ' H ' ' A' ' 23' ' ' LYS . 31.6 tttp -155.94 -179.71 8.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.36 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.484 ' H ' ' HG2' ' A' ' 22' ' ' LYS . 30.2 mttp 69.67 14.8 8.16 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.891 0.7 . . . . 10.0 112.891 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.78 39.18 29.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.013 0.435 . . . . 10.0 111.054 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -107.96 145.29 31.1 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.153 -0.476 . . . . 10.0 111.176 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.17 143.74 94.83 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.687 2.258 . . . . 10.0 111.543 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.516 ' HB ' ' HB ' ' A' ' 114' ' ' ILE . 1.6 m -116.41 143.49 45.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.664 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.636 HD23 ' HG ' ' A' ' 60' ' ' LEU . 28.3 tp -124.01 105.7 9.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.97 0.414 . . . . 10.0 110.047 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 67.6 mt -93.44 117.52 37.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.867 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.736 ' HE2' HG22 ' A' ' 62' ' ' THR . 17.4 ttpt -112.61 119.98 40.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.818 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 110' ' ' SER . 3.9 m-85 -88.7 146.92 24.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.569 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -148.94 166.98 26.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.859 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.28 142.81 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.627 -0.509 . . . . 10.0 109.627 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -67.44 -63.85 0.98 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.561 ' CZ2' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.5 64.16 4.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.494 0.553 . . . . 10.0 112.494 -178.5 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.6 t -131.94 135.62 26.94 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.076 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.709 ' HD3' ' HE1' ' B' ' 69' ' ' PHE . 33.3 Cg_endo -64.45 -49.54 3.33 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.517 2.145 . . . . 10.0 112.344 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' B' ' 108' ' ' CYS . 78.0 mt -63.17 -44.26 95.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.239 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.434 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 74.9 m -66.33 -31.16 71.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 10.0 111.389 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -62.86 -46.78 86.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.99 -38.68 79.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.93 0.395 . . . . 10.0 110.676 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -66.88 -24.74 66.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.859 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 39' ' ' CYS . 24.1 mt -55.27 -44.56 75.74 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.822 0.344 . . . . 10.0 111.416 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.48 -33.42 81.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.577 -0.821 . . . . 10.0 111.128 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -68.85 -40.01 79.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.355 -0.423 . . . . 10.0 110.662 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.4 m -55.19 -47.55 75.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.424 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.86 -44.14 86.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.061 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -60.63 -44.49 96.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.03 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -71.35 -37.89 71.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 10.0 111.698 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.91 -22.08 66.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.041 0.448 . . . . 10.0 111.234 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -88.55 -6.69 57.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.629 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.2 135.5 50.69 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.769 0.319 . . . . 10.0 110.369 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.42 -33.93 68.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.925 -0.579 . . . . 10.0 112.214 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -73.53 -37.75 65.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.968 0.413 . . . . 10.0 110.919 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -78.21 -10.32 59.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.925 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m -75.64 5.36 6.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.913 0.387 . . . . 10.0 111.53 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -87.04 -15.22 39.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.047 0.451 . . . . 10.0 110.52 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.44 148.4 51.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 10.0 109.814 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -82.87 88.19 6.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.763 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.636 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -81.48 121.54 26.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.542 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.2 pt -133.73 157.62 42.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.991 0.424 . . . . 10.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.736 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -111.83 117.55 33.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.166 -0.47 . . . . 10.0 109.811 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 92' ' ' VAL . 21.5 t -115.96 143.35 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.863 0.364 . . . . 10.0 111.337 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.39 146.76 38.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 4.7 m -104.17 100.9 23.28 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.639 ' HG3' HG22 ' A' ' 93' ' ' THR . 29.9 Cg_endo -62.75 118.51 5.41 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.758 2.305 . . . . 10.0 112.067 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.88 -12.71 67.01 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.965 -0.636 . . . . 10.0 112.539 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.593 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 7.5 t80 -96.92 144.43 26.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.158 -0.312 . . . . 10.0 110.158 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.481 HD11 HG22 ' B' ' 112' ' ' VAL . 0.8 OUTLIER 60.4 30.41 19.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.737 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.7 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 2.6 t60 66.37 19.0 10.97 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.653 -0.703 . . . . 10.0 112.811 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.561 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 2.1 mm-40 -77.6 -175.58 3.91 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 72' ' ' LYS . 48.1 mmtt -65.45 127.89 33.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.795 0.331 . . . . 10.0 111.039 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -66.46 163.41 18.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.961 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.96 125.62 24.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.549 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.97 -17.32 35.38 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -107.23 -41.68 5.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.029 0.442 . . . . 10.0 109.867 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -62.62 -50.92 69.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.594 . . . . 10.0 112.496 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.91 -28.07 69.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.047 0.451 . . . . 10.0 110.687 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 8.1 mmmt -75.55 -30.69 59.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.681 -0.691 . . . . 10.0 109.911 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.436 ' HZ3' ' HE3' ' A' ' 72' ' ' LYS . 5.2 t-105 -65.25 -50.04 67.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.526 -0.761 . . . . 10.0 109.499 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.405 ' HA ' HD12 ' A' ' 84' ' ' LEU . 74.9 t80 -63.89 -30.02 71.15 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.079 -0.51 . . . . 10.0 111.107 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.46 -24.1 67.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.178 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.14 8.15 41.51 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.105 -0.569 . . . . 10.0 111.98 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 81' ' ' TYR . 35.5 mt -95.19 -179.65 4.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.797 0.332 . . . . 10.0 110.879 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -97.93 -178.48 4.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.678 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 66.97 84.06 0.17 Allowed Pre-proline 0 N--CA 1.464 0.269 0 O-C-N 123.647 0.592 . . . . 10.0 112.053 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.1 37.96 0.72 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.633 2.222 . . . . 10.0 111.663 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -150.02 25.08 0.83 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.694 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 19.4 mt -93.36 117.9 67.51 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.545 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 89' ' ' LEU . 6.1 Cg_exo -74.56 66.97 5.59 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.745 2.297 . . . . 10.0 111.489 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 62' ' ' THR . 60.7 t -86.08 117.91 31.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.772 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.8 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 8.3 t -103.2 142.45 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.131 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.639 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -101.64 106.4 17.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.123 -179.474 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.456 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 40.3 t0 -93.48 91.35 7.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.243 0.545 . . . . 10.0 110.267 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.03 113.72 4.67 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.22 -24.64 26.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.857 -0.687 . . . . 10.0 113.06 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.81 44.15 3.98 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.513 -0.851 . . . . 10.0 111.413 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -33.72 74.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 10.0 110.627 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.2 mm -92.27 -43.45 13.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.224 -0.444 . . . . 10.0 109.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.831 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -60.51 -44.95 95.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.688 -0.687 . . . . 10.0 112.394 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -68.15 -40.77 82.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.9 m -66.54 -22.12 66.16 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.57 5.06 24.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.464 -0.334 . . . . 10.0 110.669 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.3 t30 52.37 50.08 19.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.665 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.831 HD12 ' HA ' ' A' ' 100' ' ' ALA . 98.3 mt -75.26 109.38 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.258 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.4 p -115.59 -10.32 11.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.586 -0.733 . . . . 10.0 112.025 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.859 HG23 ' HB3' ' B' ' 109' ' ' TYR . 7.4 p -147.14 142.1 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.562 0.22 . . . . 10.0 111.293 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' B' ' 108' ' ' CYS . 22.1 m-85 -107.24 153.99 40.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.653 -0.499 . . . . 10.0 109.653 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.07 159.16 83.63 Favored 'Cis proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.339 -1.525 . . . . 10.0 112.058 -0.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 13.0 m -122.18 124.3 43.53 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -108.76 104.2 13.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.02 0.438 . . . . 10.0 110.898 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.19 115.47 29.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.164 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 25.0 tp -95.69 112.62 24.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.584 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 27' ' ' THR . 3.4 mp -98.5 127.25 51.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.3 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.79 171.98 29.66 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 116.016 -0.538 . . . . 10.0 112.618 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -65.58 -14.42 61.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.256 0.465 . . . . 10.0 112.256 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.24 0.95 57.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 10.0 111.87 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.89 37.74 15.41 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.82 -0.705 . . . . 10.0 113.191 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -132.99 146.96 52.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.785 -0.244 . . . . 10.0 110.666 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.6 111.48 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.098 -0.334 . . . . 10.0 110.098 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -96.44 -35.87 11.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.357 -0.383 . . . . 10.0 111.512 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -142.35 150.27 40.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.628 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 tp -144.21 116.94 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 t -119.48 130.76 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.844 0.354 . . . . 10.0 111.637 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -101.96 107.23 18.31 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.158 -0.682 . . . . 10.0 109.158 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.42 -141.93 11.92 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.488 -0.645 . . . . 10.0 111.488 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.7 m -119.5 147.22 44.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.84 0.352 . . . . 10.0 111.066 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.9 pt -104.72 176.57 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.264 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -146.6 171.67 14.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.443 -0.344 . . . . 10.0 110.57 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -61.53 -46.88 88.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.932 0.345 . . . . 10.0 111.932 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.65 88.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 10.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -66.8 -39.19 87.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.351 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.426 ' O ' HG13 ' A' ' 137' ' ' ILE . . . -61.64 -42.88 99.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 10.0 109.75 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.75 -35.92 82.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.603 . . . . 10.0 110.41 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.7 -39.29 88.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 10.0 109.975 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 140' ' ' PRO . 27.5 tp -64.38 -36.32 83.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.585 -0.734 . . . . 10.0 110.523 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 133' ' ' ALA . 85.2 mt -67.11 -29.44 46.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.022 -0.536 . . . . 10.0 109.763 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -83.38 -50.34 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.793 -0.64 . . . . 10.0 111.246 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.491 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 2.8 t70 -144.43 120.67 6.24 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.8 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 139' ' ' ASP . 13.5 Cg_exo -71.24 -6.29 18.88 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.004 2.469 . . . . 10.0 112.707 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -94.11 -3.15 51.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.925 0.393 . . . . 10.0 110.897 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.13 73.44 6.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.526 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -74.2 155.43 38.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.25 -0.881 . . . . 10.0 111.513 -179.522 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 112.203 0.446 . . . . 10.0 112.203 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.3 -10.14 45.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 25.2 tp -142.41 -77.92 0.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.126 -0.23 . . . . 10.0 111.143 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 57.71 39.09 27.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.827 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.13 166.3 31.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.793 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.3 m120 68.4 -172.32 0.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.776 0.673 . . . . 10.0 111.865 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -99.69 13.9 32.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.36 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.43 -13.94 59.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.446 0.535 . . . . 10.0 112.446 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.08 133.27 23.44 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.673 0.273 . . . . 10.0 111.734 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.4 151.41 85.63 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 123.097 2.532 . . . . 10.0 112.453 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.677 ' HG3' ' HB ' ' A' ' 107' ' ' VAL . 11.3 Cg_endo -53.86 -33.75 72.84 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.746 2.964 . . . . 10.0 113.707 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -55.75 -28.15 54.44 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.38 -11.4 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 10.0 111.075 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' B' ' 11' ' ' PRO . . . -75.01 -7.61 54.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.275 -0.421 . . . . 10.0 111.932 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.468 ' HE1' HG23 ' B' ' 32' ' ' ILE . 21.4 m-85 -122.19 129.84 52.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.944 0.402 . . . . 10.0 111.364 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' B' ' 31' ' ' ARG . 42.1 t -114.16 92.06 25.41 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.13 102.0 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.5 2.133 . . . . 10.0 113.428 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -95.81 110.56 22.71 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' B' ' 19' ' ' LEU . 2.8 mm? -92.57 120.55 33.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.477 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.26 100.8 8.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.614 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.11 118.29 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.194 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.67 -170.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 10.0 110.347 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.65 -22.32 20.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.009 0.433 . . . . 10.0 111.608 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -86.73 -39.23 16.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.156 0.503 . . . . 10.0 110.272 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.91 -171.4 36.89 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.663 -0.699 . . . . 10.0 111.629 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -107.75 129.59 61.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.338 -0.616 . . . . 10.0 109.338 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -115.89 117.98 31.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.813 0.339 . . . . 10.0 110.186 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.509 HG22 ' HD1' ' B' ' 30' ' ' PHE . 7.8 p -101.88 118.02 48.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.277 0.56 . . . . 10.0 110.553 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -121.63 90.96 3.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.545 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.509 ' HD1' HG22 ' B' ' 28' ' ' VAL . 4.1 p90 -94.2 119.18 32.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.204 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.448 ' HB2' ' HB ' ' B' ' 16' ' ' VAL . 62.4 mtm-85 -77.0 118.38 19.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.232 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.468 HG23 ' HE1' ' B' ' 15' ' ' PHE . 53.8 mt -92.06 136.49 24.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.354 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 146.07 51.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.403 -0.362 . . . . 10.0 110.284 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.21 92.76 0.57 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.991 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.49 -16.71 1.12 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.404 -0.678 . . . . 10.0 111.404 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -105.78 151.95 23.83 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' B' ' 75' ' ' TYR . 33.0 p90 -143.98 139.9 29.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.945 0.402 . . . . 10.0 111.191 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' MET . . . . . 0.415 ' HA ' ' HA3' ' B' ' 101' ' ' GLY . 43.8 mtt -110.41 150.5 28.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.99 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.549 ' O ' HG13 ' B' ' 43' ' ' ILE . 90.9 m-85 -92.09 116.52 29.0 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.77 -0.456 . . . . 10.0 109.77 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.424 ' OE1' ' HA ' ' B' ' 60' ' ' LYS . 21.7 tt0 -61.32 -23.02 65.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.208 0.528 . . . . 10.0 111.331 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.8 -6.82 59.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.522 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -123.8 0.05 8.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.494 -0.321 . . . . 10.0 111.631 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.549 HG13 ' O ' ' B' ' 39' ' ' TYR . 92.9 mt -78.87 117.77 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.024 0.44 . . . . 10.0 109.817 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' B' ' 98' ' ' THR . 21.7 t -99.56 123.41 52.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.826 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -153.81 120.57 1.05 Allowed Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.643 -0.789 . . . . 10.0 111.995 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -160.46 140.47 11.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.808 0.337 . . . . 10.0 111.015 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' B' ' 94' ' ' LYS . 11.6 t -139.72 126.23 20.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.134 -0.484 . . . . 10.0 109.893 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.502 ' HB2' ' H ' ' B' ' 52' ' ' LEU . 28.2 p30 -174.56 158.36 2.45 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.426 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -74.26 -66.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.256 1.97 . . . . 10.0 111.072 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.64 53.79 1.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.129 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.489 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 0.3 OUTLIER 59.45 51.0 6.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.608 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.502 ' H ' ' HB2' ' B' ' 48' ' ' ASN . 0.6 OUTLIER -108.18 43.58 1.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.8 -0.637 . . . . 10.0 110.422 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' B' ' 83' ' ' PHE . 18.6 tp -107.45 144.64 34.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.092 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.63 -66.72 1.89 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.418 -0.896 . . . . 10.0 111.284 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 2.7 pp0? -171.63 149.7 2.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 122.596 0.358 . . . . 10.0 110.179 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 15.2 Cg_exo -70.81 106.47 1.86 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.495 2.13 . . . . 10.0 110.434 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -86.67 99.58 11.85 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.061 0.458 . . . . 10.0 111.376 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -84.59 157.91 21.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.799 -0.637 . . . . 10.0 110.352 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 50.2 m -86.72 -20.4 27.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.645 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.424 ' HA ' ' OE1' ' B' ' 40' ' ' GLN . 12.8 tmtt? 70.57 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.711 -0.677 . . . . 10.0 112.292 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.87 -127.8 6.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.21 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -116.69 158.88 23.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.624 0.249 . . . . 10.0 110.873 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.24 132.81 34.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' B' ' 71' ' ' ARG . 11.3 ttpp -114.47 127.01 55.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.508 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.88 149.56 46.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.548 -0.908 . . . . 10.0 108.548 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -146.56 171.02 15.72 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.935 -0.306 . . . . 10.0 111.382 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.98 -23.55 14.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.284 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -114.76 -40.74 3.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.887 0.375 . . . . 10.0 110.949 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.709 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 85.5 m-85 -87.68 -6.13 58.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.185 -0.462 . . . . 10.0 111.616 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.7 -73.55 2.07 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 121.105 -0.569 . . . . 10.0 112.16 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' B' ' 64' ' ' LYS . 5.9 ptp180 -173.92 122.89 0.33 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.862 0.465 . . . . 10.0 109.968 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -139.88 162.98 33.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.438 -0.346 . . . . 10.0 110.545 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -74.28 127.2 32.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.96 159.75 38.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.354 0.597 . . . . 10.0 112.091 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' B' ' 37' ' ' TYR . 16.7 m-85 -114.5 127.33 55.76 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.404 -1.332 . . . . 10.0 107.404 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -113.58 -3.79 13.58 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -173.89 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.599 . . . . 10.0 109.472 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -91.19 126.41 36.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.774 -1.103 . . . . 10.0 109.712 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -153.42 112.87 3.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.889 0.376 . . . . 10.0 111.173 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -145.94 119.41 9.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.381 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -127.87 120.95 55.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.069 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.19 134.57 44.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.66 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' PHE . . . . . 0.459 ' HB3' HD11 ' B' ' 53' ' ' LEU . 29.8 m-85 -113.81 98.91 48.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.092 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.14 127.96 3.54 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.949 2.433 . . . . 10.0 111.782 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -74.04 148.29 42.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.881 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.66 -5.19 32.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.465 0.65 . . . . 10.0 109.754 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -134.95 129.48 34.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.166 -0.925 . . . . 10.0 108.785 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.9 80.41 4.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.237 0.542 . . . . 10.0 111.307 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 4.1 m -128.4 143.26 41.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.557 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.19 54.04 4.67 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.336 -0.706 . . . . 10.0 111.336 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -105.78 153.84 39.74 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.68 -0.26 . . . . 10.0 110.47 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.7 141.91 42.52 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.44 2.093 . . . . 10.0 110.436 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -132.57 154.14 50.31 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.232 0.456 . . . . 10.0 112.232 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' B' ' 47' ' ' THR . 43.1 tttt -98.25 150.83 21.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 10.0 109.658 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' B' ' 47' ' ' THR . 60.4 tp -118.97 114.32 22.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.584 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 42.0 t -104.19 114.82 44.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.058 -0.519 . . . . 10.0 109.987 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 93.0 mt -125.1 136.77 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.402 . . . . 10.0 111.154 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' THR . . . . . 0.566 HG23 ' HB3' ' B' ' 113' ' ' ASP . 19.1 m -133.69 118.04 17.67 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.132 -0.485 . . . . 10.0 109.839 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 39.5 m-85 -98.62 109.38 22.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.462 -0.335 . . . . 10.0 111.335 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.73 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 0.8 OUTLIER -123.94 128.87 50.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.444 -0.344 . . . . 10.0 110.945 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 101' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -174.49 -155.64 12.58 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.851 -0.69 . . . . 10.0 111.617 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 73.5 m -155.56 176.99 11.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.3 -0.259 . . . . 10.0 110.3 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -116.98 145.03 43.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.89 -10.68 22.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.442 0.534 . . . . 10.0 112.442 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.45 -0.76 55.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.517 -0.31 . . . . 10.0 111.785 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.7 20.63 23.8 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.669 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 4.6 t -103.27 136.73 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.436 -0.579 . . . . 10.0 109.436 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 17.4 t -122.57 97.97 5.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.683 0.277 . . . . 10.0 110.767 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.859 ' HB3' HG23 ' A' ' 107' ' ' VAL . 53.2 p90 -84.23 143.94 43.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.859 0.361 . . . . 10.0 111.361 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.622 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 42.4 Cg_endo -67.31 163.64 33.67 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.586 2.191 . . . . 10.0 111.241 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.73 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 63.7 Cg_endo -75.74 80.56 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.372 2.048 . . . . 10.0 111.86 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.481 HG22 HD11 ' A' ' 69' ' ' LEU . 12.8 t -60.84 108.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.69 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ASP . . . . . 0.566 ' HB3' HG23 ' B' ' 98' ' ' THR . 20.9 p-10 -100.41 130.41 46.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.514 0.673 . . . . 10.0 111.833 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.456 HG21 ' HB3' ' B' ' 126' ' ' PRO . 0.2 OUTLIER -128.6 124.86 36.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.393 -0.822 . . . . 10.0 109.951 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.39 130.26 49.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.077 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -114.86 149.17 37.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.452 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.02 114.28 28.26 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.98 -0.748 . . . . 10.0 108.98 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 23.3 mm -85.61 99.86 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.212 0.529 . . . . 10.0 111.057 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -108.75 -6.66 15.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.529 -0.76 . . . . 10.0 110.195 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.7 97.57 2.51 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.509 -0.769 . . . . 10.0 111.191 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -153.48 -15.94 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.824 0.345 . . . . 10.0 111.504 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.95 -76.91 1.49 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.697 -0.763 . . . . 10.0 111.891 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.76 145.83 28.61 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.311 -0.255 . . . . 10.0 110.311 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -136.88 146.37 45.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 10.0 111.024 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.21 147.71 38.43 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.098 -0.501 . . . . 10.0 109.695 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' PRO . . . . . 0.456 ' HB3' HG21 ' B' ' 114' ' ' THR . 36.7 Cg_endo -66.9 136.92 43.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.401 2.067 . . . . 10.0 111.74 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -91.86 70.28 5.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.137 0.494 . . . . 10.0 111.304 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.602 -0.713 . . . . 10.0 109.741 179.733 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 110.067 -0.346 . . . . 10.0 110.067 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 m -132.05 65.89 76.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 111.981 0.363 . . . . 10.0 111.981 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.91 -40.29 45.13 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.38 2.053 . . . . 10.0 111.617 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -60.54 -38.35 84.19 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 115.949 -0.568 . . . . 10.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.9 m -67.45 -47.22 70.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.703 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.55 -35.25 75.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 10.0 111.005 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m -84.27 -4.73 59.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.437 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.6 m -90.15 -18.6 25.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.384 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -67.59 124.42 23.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.706 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 10' ' ' LYS . 2.1 mppt? -107.77 151.91 25.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.089 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 24.8 p -84.74 174.32 9.99 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.474 -0.565 . . . . 10.0 109.474 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.12 -7.87 33.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.129 0.49 . . . . 10.0 110.515 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.496 ' OD2' ' HD2' ' A' ' 15' ' ' ARG . 28.2 t70 -95.96 1.71 53.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.351 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.0 t30 75.45 16.5 2.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.496 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 24.6 mtt180 -103.89 135.42 19.36 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.037 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.61 145.26 95.22 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.782 2.321 . . . . 10.0 111.551 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.37 -9.7 27.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 10.0 112.043 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.519 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -58.73 -19.9 44.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.394 -0.367 . . . . 10.0 111.817 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.499 HG23 ' HD2' ' A' ' 20' ' ' TYR . 31.3 m -66.21 -16.02 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.027 0.441 . . . . 10.0 111.383 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.499 ' HD2' HG23 ' A' ' 19' ' ' VAL . 19.7 m-85 -127.07 22.55 6.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.572 0.701 . . . . 10.0 109.34 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 17.1 mt -134.02 34.12 3.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.405 -0.816 . . . . 10.0 110.428 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -127.7 176.08 7.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.478 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt 68.18 17.39 9.38 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.504 -0.771 . . . . 10.0 112.53 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 51.51 43.39 29.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.509 -0.768 . . . . 10.0 112.077 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -103.28 145.5 30.72 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.832 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.19 131.83 47.51 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.715 2.277 . . . . 10.0 111.066 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 114' ' ' ILE . 1.3 m -99.79 136.22 40.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.905 0.384 . . . . 10.0 111.226 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.444 HD21 ' HZ3' ' A' ' 111' ' ' TRP . 12.1 tp -117.74 99.58 7.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 70.7 mt -91.87 122.88 43.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 10.0 111.147 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' HE2' HG22 ' A' ' 62' ' ' THR . 3.9 tmmm? -117.24 121.82 42.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.495 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.548 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 5.7 m-85 -95.92 134.49 38.85 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.594 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -134.97 -179.11 5.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.064 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 108' ' ' TYR . . . -134.09 150.05 51.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.223 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.99 -40.86 16.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.066 0.46 . . . . 10.0 110.497 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.473 ' HZ2' ' HE2' ' A' ' 72' ' ' LYS . 27.3 m0 -86.75 65.61 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.98 -0.555 . . . . 10.0 111.466 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.1 t -161.18 129.34 2.87 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.223 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 41.8 Cg_endo -71.13 -41.76 2.43 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.571 2.181 . . . . 10.0 112.094 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.57 -43.21 97.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.928 0.394 . . . . 10.0 111.495 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.8 m -69.29 -23.1 63.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.269 -0.423 . . . . 10.0 111.077 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.6 tp -66.64 -40.54 88.78 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.112 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.45 -34.85 68.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.105 0.479 . . . . 10.0 110.308 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.67 -32.21 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.634 -0.712 . . . . 10.0 111.115 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.2 mt -56.25 -42.51 77.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.787 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.77 -36.82 92.75 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.909 -0.662 . . . . 10.0 111.475 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -69.9 -39.59 76.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.361 . . . . 10.0 110.073 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.6 m -61.61 -45.07 95.64 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.431 -0.581 . . . . 10.0 109.431 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HG3' ' HB3' ' A' ' 86' ' ' TYR . 4.3 tm-20 -61.1 -35.13 76.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.519 -0.764 . . . . 10.0 110.375 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -72.33 -46.03 57.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.729 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -63.71 -33.12 74.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 10.0 111.421 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.06 -13.39 57.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.7 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -105.57 -3.41 22.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.375 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 18.0 t70 -69.39 144.66 53.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.093 0.473 . . . . 10.0 111.822 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.02 84.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.719 -0.673 . . . . 10.0 112.13 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 27.4 mmmt -74.58 -43.75 54.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 10.0 110.943 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.437 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 3.0 m-85 -61.04 -20.44 62.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 10.0 112.13 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -67.73 -5.41 15.95 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.863 0.363 . . . . 10.0 111.826 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 m -77.06 -17.01 59.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 10.0 110.561 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.24 169.42 15.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.923 -0.58 . . . . 10.0 109.998 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.84 98.1 8.0 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.233 -0.284 . . . . 10.0 110.233 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.0 tp -86.15 127.6 34.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.291 -0.413 . . . . 10.0 111.39 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.491 HG22 ' HB2' ' A' ' 90' ' ' PRO . 5.8 pt -137.41 144.94 30.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.497 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.488 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -102.57 110.99 23.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.025 -0.534 . . . . 10.0 109.702 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -109.24 137.39 41.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.052 0.454 . . . . 10.0 111.548 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.39 146.89 52.47 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.437 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 19.2 m -109.91 96.11 23.43 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 112.222 0.453 . . . . 10.0 112.222 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 65' ' ' SER . 33.3 Cg_endo -65.31 132.25 30.92 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.365 2.043 . . . . 10.0 111.357 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.98 6.08 88.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.072 -0.585 . . . . 10.0 112.534 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -121.72 148.49 44.54 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.155 -0.313 . . . . 10.0 110.155 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER 59.92 21.17 10.17 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.5 t60 69.57 27.73 4.74 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.462 -0.79 . . . . 10.0 112.287 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -88.26 -168.35 2.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.487 ' HE3' ' CZ3' ' A' ' 80' ' ' TRP . 23.0 mmtt -63.57 145.08 56.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.711 0.291 . . . . 10.0 111.033 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -80.9 161.78 24.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.806 0.336 . . . . 10.0 111.367 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.44 150.17 27.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.533 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 78' ' ' GLN . . . 83.03 -47.13 3.76 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.273 -0.731 . . . . 10.0 111.273 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -76.65 -39.72 51.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.676 -0.49 . . . . 10.0 109.676 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -63.05 -36.32 83.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.485 -0.779 . . . . 10.0 111.891 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 17.1 pt20 -66.11 -32.14 73.42 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.775 -0.37 . . . . 10.0 111.021 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.92 -27.49 63.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.04 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.537 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.7 t-105 -61.32 -57.71 11.2 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.503 -0.772 . . . . 10.0 109.707 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -65.93 -36.32 83.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.102 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.82 -20.78 58.95 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.224 0.453 . . . . 10.0 112.224 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.21 5.23 38.59 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.592 -0.813 . . . . 10.0 112.192 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 80' ' ' TRP . 88.2 mt -100.46 -178.29 3.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.895 0.378 . . . . 10.0 111.185 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -103.54 -177.78 3.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.136 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.55 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 12.8 m-85 69.0 78.56 0.23 Allowed Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 123.007 0.523 . . . . 10.0 111.035 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.15 12.25 1.83 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.736 2.29 . . . . 10.0 112.063 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -108.57 11.25 26.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.402 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.9 mt -88.5 111.13 41.83 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.574 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.491 ' HB2' HG22 ' A' ' 61' ' ' ILE . 66.5 Cg_endo -75.56 69.83 5.85 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.465 2.11 . . . . 10.0 111.234 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 62' ' ' THR . 57.1 t -78.56 107.78 11.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.844 -0.616 . . . . 10.0 111.305 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 16.5 t -92.34 137.34 22.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.762 -0.653 . . . . 10.0 109.918 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -100.47 100.44 11.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.59 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -94.81 85.35 4.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.171 0.51 . . . . 10.0 110.05 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -62.38 114.75 3.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.655 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.71 -11.92 67.86 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.653 -0.784 . . . . 10.0 112.897 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.53 55.95 7.14 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.632 -0.794 . . . . 10.0 112.269 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.84 -44.15 81.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.178 0.514 . . . . 10.0 110.253 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.5 mm -77.74 -41.14 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.295 -0.631 . . . . 10.0 109.295 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.714 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.67 -41.48 86.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.714 -0.676 . . . . 10.0 111.338 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -70.84 -41.74 71.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.985 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.9 m -65.92 -27.89 68.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.097 0.406 . . . . 10.0 112.097 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.72 -2.74 31.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.723 0.297 . . . . 10.0 110.898 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t30 54.21 55.88 7.66 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.686 -0.688 . . . . 10.0 111.471 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 100' ' ' ALA . 87.5 mt -80.65 126.15 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.659 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 p -127.34 -1.99 6.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.898 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.838 HG23 ' HB3' ' B' ' 109' ' ' TYR . 14.9 p -154.18 151.72 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.575 0.226 . . . . 10.0 111.007 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.548 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 25.3 m-85 -117.3 156.21 49.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -87.33 130.16 11.0 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.734 -1.361 . . . . 10.0 111.585 -0.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.4 m -94.35 130.73 40.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.135 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.693 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 19.3 m95 -112.84 115.34 28.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.462 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -107.09 116.91 32.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.346 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.53 HD22 HD11 ' A' ' 136' ' ' LEU . 52.4 tp -97.12 111.88 23.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.133 0.492 . . . . 10.0 110.939 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 27' ' ' THR . 2.4 mp -98.1 129.31 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.62 -0.881 . . . . 10.0 108.62 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.59 175.58 33.45 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.859 -0.686 . . . . 10.0 112.262 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -72.21 -1.95 17.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.019 0.438 . . . . 10.0 111.176 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.46 -14.02 33.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.135 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.47 21.44 31.93 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.869 -0.682 . . . . 10.0 112.607 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -126.63 166.1 17.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.855 0.36 . . . . 10.0 111.289 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.22 125.33 31.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.688 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -113.76 -39.6 3.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.818 0.342 . . . . 10.0 111.848 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 122' ' ' ARG . 0.1 OUTLIER -141.53 151.3 43.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.688 0.28 . . . . 10.0 110.891 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.12 128.51 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 10.0 110.629 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.693 ' HB ' ' HB2' ' A' ' 111' ' ' TRP . 46.3 t -117.11 128.93 74.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.578 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -129.39 114.8 16.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.272 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.79 -85.58 0.19 Allowed Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.415 -0.898 . . . . 10.0 112.757 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.9 m -160.75 163.21 32.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.077 -0.342 . . . . 10.0 110.077 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.49 HG12 ' CE2' ' A' ' 111' ' ' TRP . 1.5 pp -130.03 170.73 18.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.557 0.218 . . . . 10.0 111.294 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 132' ' ' GLN . 9.6 p30 -147.17 163.34 36.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.007 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -57.66 -45.89 84.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.613 0.598 . . . . 10.0 112.613 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.8 95.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.847 0.356 . . . . 10.0 111.097 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.417 ' HB2' ' ND2' ' A' ' 129' ' ' ASN . 8.9 tt0 -65.0 -40.9 95.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 55' ' ' PHE . . . -60.91 -47.56 85.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.848 -0.615 . . . . 10.0 110.644 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.56 -37.81 88.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.713 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.41 97.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.742 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.53 HD11 HD22 ' A' ' 113' ' ' LEU . 19.1 tp -62.73 -36.11 81.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.134 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.8 mt -73.12 -26.78 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.077 0.465 . . . . 10.0 110.048 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -80.88 -40.99 23.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.311 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 50.4 t0 -154.15 113.9 2.51 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.177 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 36.7 Cg_endo -66.06 -7.88 18.38 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.003 2.469 . . . . 10.0 112.449 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -86.36 -6.69 58.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.876 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.55 96.59 4.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.345 -0.389 . . . . 10.0 111.474 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -102.08 128.38 48.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.417 -0.586 . . . . 10.0 109.417 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 36.2 tp . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.108 -0.948 . . . . 10.0 111.633 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.909 0.385 . . . . 10.0 110.773 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.71 -60.41 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 61.7 tp -113.91 -65.31 1.2 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.847 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 52.79 41.12 31.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.446 0.641 . . . . 10.0 111.246 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.1 170.68 18.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.449 -0.796 . . . . 10.0 110.278 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.39 -159.34 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.855 0.722 . . . . 10.0 111.921 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -105.63 16.19 25.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.482 -0.781 . . . . 10.0 109.757 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -81.04 2.87 25.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 10.0 112.374 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.85 132.77 16.25 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.43 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.89 145.64 96.23 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.031 2.487 . . . . 10.0 112.35 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' B' ' 14' ' ' ALA . 9.4 Cg_endo -52.37 -36.25 68.18 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.532 2.822 . . . . 10.0 113.136 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -62.71 -14.23 41.73 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.07 0.462 . . . . 10.0 111.96 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -121.17 -3.08 9.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.633 0.73 . . . . 10.0 109.93 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' B' ' 11' ' ' PRO . . . -92.6 -3.78 54.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 10.0 112.25 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.529 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 15.4 m-85 -122.29 125.14 45.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.888 0.375 . . . . 10.0 111.165 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.03 90.82 10.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.275 -0.639 . . . . 10.0 109.275 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 6.4 Cg_exo -74.73 96.28 0.99 Allowed 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.955 2.436 . . . . 10.0 112.879 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.42 98.17 10.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 123' ' ' THR . 3.2 mm? -89.05 116.34 27.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.819 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.26 109.95 19.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.703 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.602 HG13 HG22 ' B' ' 26' ' ' VAL . 61.4 t -92.87 114.81 30.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.275 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.96 170.49 7.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.23 -0.656 . . . . 10.0 109.23 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.51 -42.84 77.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.98 0.363 . . . . 10.0 111.98 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.9 -15.03 59.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.567 0.58 . . . . 10.0 112.567 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 165.11 166.4 24.02 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.424 -0.893 . . . . 10.0 112.228 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.602 HG22 HG13 ' B' ' 21' ' ' VAL . 58.7 t -90.52 137.43 21.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.18 -0.304 . . . . 10.0 110.18 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -120.53 112.15 18.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.922 -0.399 . . . . 10.0 109.922 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.573 HG22 ' HD1' ' B' ' 30' ' ' PHE . 6.8 p -91.79 121.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.051 0.453 . . . . 10.0 110.956 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -124.53 79.32 1.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.039 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.573 ' HD1' HG22 ' B' ' 28' ' ' VAL . 12.8 p90 -87.27 112.5 22.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 10.0 111.057 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -76.47 118.9 19.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.414 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 45.9 mt -92.65 140.19 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.719 -0.673 . . . . 10.0 110.33 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.94 149.79 39.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.396 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.08 77.74 1.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.168 0.509 . . . . 10.0 111.486 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 169.57 -21.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.376 -0.69 . . . . 10.0 111.376 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.41 150.17 24.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.221 -0.659 . . . . 10.0 109.221 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' B' ' 75' ' ' TYR . 8.3 p90 -142.15 136.54 30.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.048 0.452 . . . . 10.0 111.597 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 48.4 mtt -108.27 152.92 23.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.653 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 23.8 m-85 -95.1 126.81 40.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.527 -0.546 . . . . 10.0 109.527 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -60.51 -28.96 68.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.051 0.453 . . . . 10.0 111.841 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.16 -0.94 51.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.994 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.55 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 41.4 mmtt -113.06 -26.11 8.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.35 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.426 HG13 ' O ' ' B' ' 39' ' ' TYR . 73.3 mt -70.87 115.41 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.24 0.543 . . . . 10.0 110.882 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.51 122.98 59.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.871 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' B' ' 96' ' ' VAL . . . -145.28 129.37 3.45 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.685 -0.769 . . . . 10.0 111.909 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -157.76 138.24 12.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.806 0.336 . . . . 10.0 111.26 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.598 ' HB ' HD13 ' B' ' 95' ' ' LEU . 4.7 t -139.25 126.9 21.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.732 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.551 ' ND2' ' HA ' ' B' ' 51' ' ' ASP . 29.2 p30 -178.3 164.13 1.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.365 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.11 -76.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.244 1.962 . . . . 10.0 111.148 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.32 49.19 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.983 0.421 . . . . 10.0 110.651 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.551 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 2.8 t0 63.24 56.2 1.75 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.501 -0.772 . . . . 10.0 112.101 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.416 ' H ' ' HB2' ' B' ' 48' ' ' ASN . 1.7 mm? -117.61 57.24 0.82 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.126 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' B' ' 83' ' ' PHE . 21.5 tp -115.6 147.62 40.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.134 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.5 -74.07 0.98 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.627 -0.797 . . . . 10.0 111.563 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.36 145.49 4.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.58 108.61 1.45 Allowed 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.472 2.115 . . . . 10.0 111.236 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 16.7 m -79.15 98.54 6.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.257 -0.429 . . . . 10.0 111.629 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -80.21 144.64 32.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.787 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -86.23 -9.33 56.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt 71.66 127.77 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.864 0.727 . . . . 10.0 112.542 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.77 -127.61 4.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.528 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -119.77 145.4 46.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.647 0.223 . . . . 10.0 110.412 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -85.87 125.61 33.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -111.4 134.56 52.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.038 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -77.14 128.37 34.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -116.17 174.49 6.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.983 0.421 . . . . 10.0 111.241 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -101.09 -26.83 13.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.015 -0.539 . . . . 10.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -118.95 -39.36 2.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.703 0.287 . . . . 10.0 111.487 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.422 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 4.3 m-30 -79.47 -14.0 59.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 10.0 111.405 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.55 -89.71 1.63 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.863 -0.684 . . . . 10.0 112.053 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -159.03 115.45 2.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.029 -0.36 . . . . 10.0 110.029 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -137.23 164.35 28.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.866 0.365 . . . . 10.0 111.209 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -78.11 127.92 33.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.971 -0.751 . . . . 10.0 108.971 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.5 155.72 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.394 0.516 . . . . 10.0 112.394 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' B' ' 37' ' ' TYR . 21.2 m-85 -117.0 128.6 55.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.556 -1.276 . . . . 10.0 107.556 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -118.3 5.87 11.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.397 0.517 . . . . 10.0 112.397 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 179.25 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -87.47 112.06 21.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.677 -1.147 . . . . 10.0 110.867 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 30' ' ' PHE . . . -142.7 120.21 11.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.863 0.363 . . . . 10.0 110.871 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -155.36 120.77 4.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.15 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.04 124.46 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.348 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.72 144.93 28.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.235 -0.439 . . . . 10.0 109.897 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' PHE . . . . . 0.474 ' HB3' HD11 ' B' ' 53' ' ' LEU . 64.1 m-85 -120.66 100.28 46.84 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.41 121.59 3.87 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.8 2.334 . . . . 10.0 111.346 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.97 151.35 35.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.019 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.63 -2.41 48.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.293 0.568 . . . . 10.0 109.817 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.415 ' HG3' HG13 ' B' ' 89' ' ' VAL . 12.9 tppt? -152.63 111.23 3.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.325 -0.852 . . . . 10.0 109.266 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.85 92.29 6.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.982 0.42 . . . . 10.0 110.64 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.415 HG13 ' HG3' ' B' ' 87' ' ' LYS . 15.7 m -119.48 158.05 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.137 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.91 51.96 2.25 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.124 -0.56 . . . . 10.0 111.846 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -117.02 145.84 36.59 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.87 117.06 4.63 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.247 1.965 . . . . 10.0 110.513 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.06 151.95 20.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.329 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 47' ' ' THR . 34.9 tttt -100.35 148.92 24.16 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.4 -0.592 . . . . 10.0 109.4 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.598 HD13 ' HB ' ' B' ' 47' ' ' THR . 35.5 tp -122.32 125.65 46.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.78 0.324 . . . . 10.0 110.852 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.445 ' O ' ' HA2' ' B' ' 45' ' ' GLY . 39.9 t -111.02 122.28 65.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 87.0 mt -127.42 123.84 37.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.856 0.36 . . . . 10.0 111.318 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 17.5 m -113.62 121.69 44.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -102.63 107.5 18.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.759 0.314 . . . . 10.0 111.47 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.645 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 0.4 OUTLIER -126.04 125.33 42.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.91 0.386 . . . . 10.0 110.211 178.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.83 -159.09 13.67 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.675 -0.774 . . . . 10.0 111.359 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 10.3 m -152.7 -177.77 6.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' B' ' 105' ' ' ALA . . . -118.66 149.24 41.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -75.06 21.69 0.12 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.973 0.416 . . . . 10.0 111.502 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' B' ' 103' ' ' ALA . . . -122.78 -1.03 8.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.864 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.95 -26.03 12.1 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.754 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.9 t -62.12 140.19 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.616 0.246 . . . . 10.0 110.77 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 47.5 t -137.2 99.31 3.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.888 0.375 . . . . 10.0 110.465 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.838 ' HB3' HG23 ' A' ' 107' ' ' VAL . 50.5 p90 -80.58 151.79 71.96 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.779 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 43.9 Cg_endo -68.12 161.17 45.57 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.861 2.374 . . . . 10.0 111.651 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.645 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 73.7 Cg_endo -76.75 52.6 3.76 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.864 2.376 . . . . 10.0 113.077 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 33.5 t -56.57 131.44 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.028 0.442 . . . . 10.0 110.784 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -113.21 168.34 9.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.49 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.0 m -147.79 138.44 23.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.499 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -100.49 131.08 46.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.508 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' B' ' 95' ' ' LEU . 76.2 m-85 -112.85 143.22 44.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.286 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -105.98 111.3 23.88 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.38 88.14 2.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.28 0.562 . . . . 10.0 110.846 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -102.92 -11.37 18.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.62 -0.718 . . . . 10.0 110.695 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.09 83.77 1.4 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.037 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -140.2 7.11 2.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.996 0.426 . . . . 10.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.73 -80.0 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.112 -0.565 . . . . 10.0 112.367 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 1.7 m -105.91 145.85 30.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -130.51 152.41 49.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.711 0.291 . . . . 10.0 111.328 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.15 138.72 15.15 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.708 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' PRO . . . . . 0.439 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 61.3 Cg_endo -74.81 138.61 23.75 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.467 2.112 . . . . 10.0 112.335 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -92.01 92.72 8.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.519 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 34.0 m . . . . . 0 C--O 1.252 1.202 0 CA-C-O 118.856 -0.593 . . . . 10.0 109.644 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.54 69.35 79.76 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 120.762 0.315 . . . . 10.0 110.798 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.1 -30.13 90.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.866 2.377 . . . . 10.0 112.877 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -61.71 -39.57 91.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.752 0.311 . . . . 10.0 110.91 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.472 HG21 HG21 ' A' ' 98' ' ' THR . 1.2 m -71.08 -37.69 72.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 10.0 110.1 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 tp -65.04 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.904 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.1 m -84.86 -24.82 28.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.605 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 m -67.04 -28.43 68.21 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.069 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.06 112.51 1.37 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.83 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.01 138.9 40.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.08 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.817 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 33.0 p -77.53 168.72 19.53 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.041 -0.527 . . . . 10.0 109.671 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.28 -8.05 42.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.393 0.616 . . . . 10.0 110.029 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -91.1 2.16 56.54 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.247 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 t30 69.21 30.26 4.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.952 -1.022 . . . . 10.0 111.466 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 30.6 mtt85 -119.08 137.22 24.91 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.931 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 15' ' ' ARG . 38.5 Cg_exo -62.31 144.83 95.82 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.372 2.048 . . . . 10.0 110.899 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.96 -9.93 18.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.024 0.379 . . . . 10.0 112.024 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.612 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 4.5 m -56.17 -21.85 25.34 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.435 0.531 . . . . 10.0 112.435 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 m -64.9 -24.61 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.02 0.438 . . . . 10.0 111.138 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -118.97 17.38 13.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.487 0.661 . . . . 10.0 109.699 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 91.5 mt -125.22 43.66 2.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.313 -0.858 . . . . 10.0 109.618 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -141.65 -179.36 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.142 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.5 mttp 72.48 3.61 4.74 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.988 0.805 . . . . 10.0 112.179 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 54.0 47.77 22.64 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.881 -0.599 . . . . 10.0 111.071 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -116.36 150.09 44.77 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.441 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.82 127.41 26.09 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.053 2.502 . . . . 10.0 112.028 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.406 ' HB ' HD12 ' A' ' 114' ' ' ILE . 2.7 m -102.09 137.07 40.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.242 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.654 HD23 HD12 ' A' ' 60' ' ' LEU . 22.2 tp -118.7 106.09 12.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.84 -0.43 . . . . 10.0 109.84 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 75.7 mt -97.37 123.26 49.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.759 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.768 ' HE2' HG22 ' A' ' 62' ' ' THR . 19.6 ttpt -116.03 126.03 53.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.361 -0.382 . . . . 10.0 110.644 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.51 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 19.2 m-85 -96.33 144.85 26.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.494 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -145.67 166.93 24.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.613 -0.267 . . . . 10.0 111.155 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.51 144.34 39.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.139 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 m -70.51 -52.46 21.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.585 0.587 . . . . 10.0 112.585 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.649 ' HZ2' ' HE3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -90.89 44.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.96 0.409 . . . . 10.0 111.694 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.7 t -119.84 119.67 30.99 Favored Pre-proline 0 C--N 1.317 -0.826 0 C-N-CA 120.88 -0.328 . . . . 10.0 111.368 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 25.6 Cg_endo -62.95 -38.23 48.46 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.687 2.258 . . . . 10.0 111.793 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.536 HD12 ' HG2' ' A' ' 37' ' ' PRO . 6.6 mp -66.47 -44.98 81.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.343 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.436 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 73.6 m -72.19 -24.72 61.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.235 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.57 ' HB3' ' CZ ' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -61.9 -55.31 31.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 10.0 111.474 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.09 -34.03 77.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.024 0.44 . . . . 10.0 110.496 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -65.13 -27.95 69.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.679 -0.692 . . . . 10.0 111.569 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 39' ' ' CYS . 37.3 mt -56.39 -40.64 74.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.914 0.388 . . . . 10.0 110.864 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.76 -32.6 78.28 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.147 -0.781 . . . . 10.0 111.147 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -71.57 -36.63 70.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.936 -0.394 . . . . 10.0 109.936 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.559 HG22 HD21 ' A' ' 60' ' ' LEU . 1.7 m -61.35 -47.7 84.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.037 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -64.77 -37.6 88.15 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.522 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -60.12 -46.16 90.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.23 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.451 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 37.0 m0 -66.5 -32.53 73.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.023 -0.535 . . . . 10.0 111.025 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.51 -16.12 63.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.21 0.528 . . . . 10.0 111.111 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -99.2 -3.57 34.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.472 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.5 147.16 29.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.376 -0.375 . . . . 10.0 110.653 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 -31.13 72.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.862 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -66.61 -51.51 55.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 10.0 111.035 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 49' ' ' TRP . 92.7 m-85 -75.67 -10.25 59.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.674 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -75.74 -7.37 54.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.192 0.52 . . . . 10.0 110.195 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.89 4.62 52.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.836 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.78 173.29 11.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.85 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -106.58 89.36 3.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.899 0.38 . . . . 10.0 110.299 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.654 HD12 HD23 ' A' ' 28' ' ' LEU . 1.2 tt -88.51 127.01 35.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.879 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.528 HG22 ' HB2' ' A' ' 90' ' ' PRO . 7.8 pt -142.28 152.28 18.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.985 0.421 . . . . 10.0 111.27 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.768 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -107.09 126.3 52.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.299 -0.63 . . . . 10.0 109.299 179.058 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.583 HG22 ' HB ' ' A' ' 92' ' ' VAL . 44.6 t -122.08 141.99 40.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.835 0.35 . . . . 10.0 111.474 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.36 148.28 52.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.46 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 13.8 m -110.74 97.42 33.16 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.663 0.268 . . . . 10.0 111.624 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 23.3 Cg_endo -60.17 123.69 13.68 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.882 2.388 . . . . 10.0 112.525 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.7 -21.5 29.46 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.797 -0.638 . . . . 10.0 112.86 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.0 143.68 28.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.648 0.261 . . . . 10.0 110.508 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.844 HD12 HG22 ' B' ' 112' ' ' VAL . 2.3 mm? 60.02 22.81 11.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.911 -0.586 . . . . 10.0 112.385 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.638 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.9 OUTLIER 71.12 24.54 3.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.78 -0.645 . . . . 10.0 112.561 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.55 -175.34 5.74 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.54 0.21 . . . . 10.0 110.798 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.649 ' HE3' ' HZ2' ' A' ' 35' ' ' TRP . 3.7 mmpt? -58.57 136.16 57.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.494 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -76.25 174.37 10.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.875 0.369 . . . . 10.0 111.866 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.8 144.26 55.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.736 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 -47.02 3.59 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.014 -0.835 . . . . 10.0 111.014 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -47.21 81.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 10.0 109.908 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.78 -32.1 73.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.471 -0.786 . . . . 10.0 110.907 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.12 -44.57 94.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.666 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -71.28 -31.39 67.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.782 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -58.87 -47.06 86.24 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.864 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -73.6 -40.94 63.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.366 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.49 68.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 10.0 111.395 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.44 23.08 36.59 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.955 -0.641 . . . . 10.0 112.623 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 mt -117.53 170.11 9.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.833 0.349 . . . . 10.0 110.766 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -89.58 176.02 7.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.798 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 71.09 73.81 0.26 Allowed Pre-proline 0 N--CA 1.465 0.3 0 O-C-N 123.883 0.739 . . . . 10.0 111.448 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.45 -1.57 11.21 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.482 2.122 . . . . 10.0 112.188 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.88 -0.81 44.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.895 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.69 114.97 39.5 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.764 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.528 ' HB2' HG22 ' A' ' 61' ' ' ILE . 73.0 Cg_endo -78.86 77.65 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.62 2.213 . . . . 10.0 111.581 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 62' ' ' THR . 43.1 t -92.32 118.66 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.094 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.817 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 4.6 t -100.75 144.62 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.74 -0.663 . . . . 10.0 109.963 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.455 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -107.43 117.38 33.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.499 -0.319 . . . . 10.0 111.125 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.483 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 62.3 t0 -108.18 96.03 6.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 10.0 110.044 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.437 ' HA ' ' HG2' ' A' ' 66' ' ' PRO . 13.2 t-20 -67.62 112.52 4.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.766 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.59 -9.45 62.43 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.995 -0.622 . . . . 10.0 112.242 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.21 50.92 41.8 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.964 -0.636 . . . . 10.0 112.187 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.472 HG21 HG21 ' A' ' 5' ' ' THR . 0.2 OUTLIER -60.66 -46.8 88.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.9 0.381 . . . . 10.0 111.262 -179.538 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.85 -42.47 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.77 -44.96 90.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.541 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -69.64 -36.72 76.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.812 0.339 . . . . 10.0 111.409 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -64.6 -33.51 76.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.215 0.45 . . . . 10.0 112.215 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.418 HD13 HD13 ' A' ' 123' ' ' ILE . 95.9 mt -100.82 -2.86 31.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.673 0.273 . . . . 10.0 110.919 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 43.7 t30 60.58 61.44 1.72 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.92 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 100' ' ' ALA . 94.8 mt -97.84 105.37 17.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.422 -0.808 . . . . 10.0 110.956 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.77 13.24 14.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.926 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.915 HG23 ' HB3' ' B' ' 109' ' ' TYR . 12.4 p -147.0 150.5 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.617 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' B' ' 108' ' ' CYS . 22.5 m-85 -124.18 153.64 68.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -89.74 128.17 7.67 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 124.0 -1.25 . . . . 10.0 111.689 -0.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.9 m -96.21 136.27 36.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.361 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -114.14 110.99 20.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.214 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.21 110.23 22.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.51 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.1 tp -91.72 112.7 24.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.688 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 27' ' ' THR . 84.4 mt -99.74 137.72 26.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.82 173.25 55.12 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.64 -0.791 . . . . 10.0 112.799 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -65.2 -14.49 60.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 10.0 111.716 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.35 -19.72 29.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.151 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 105.06 -0.08 41.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.82 -0.705 . . . . 10.0 111.945 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -96.57 158.48 15.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.232 -0.285 . . . . 10.0 110.232 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.14 118.87 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.921 0.391 . . . . 10.0 111.171 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -51.53 6.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.695 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -156.87 142.26 17.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.119 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.418 HD13 HD13 ' A' ' 103' ' ' LEU . 4.3 tp -116.25 119.25 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.051 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.9 t -107.92 120.51 59.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.786 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -126.39 125.1 41.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.626 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 142.33 -97.22 0.2 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.722 -0.751 . . . . 10.0 111.829 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.766 ' HB2' HG22 ' B' ' 107' ' ' VAL . 3.7 t -160.35 138.2 9.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.022 -0.362 . . . . 10.0 110.022 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.532 ' HA ' ' OE1' ' A' ' 132' ' ' GLN . 12.9 pt -121.71 150.64 25.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.001 0.429 . . . . 10.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -114.28 174.92 5.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.649 . . . . 10.0 110.256 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.18 -45.3 91.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.71 0.263 . . . . 10.0 111.71 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.16 -41.97 84.96 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.515 -0.312 . . . . 10.0 110.59 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.532 ' OE1' ' HA ' ' A' ' 128' ' ' ILE . 41.1 mt-30 -65.18 -44.46 88.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.868 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 137' ' ' ILE . . . -59.31 -45.07 92.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.93 -34.34 75.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.765 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.2 85.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.383 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.44 -33.89 75.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.52 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 133' ' ' ALA . 76.5 mt -67.44 -31.83 54.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.669 -0.493 . . . . 10.0 109.669 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.45 -61.24 2.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.772 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 23.3 t70 -127.64 117.31 21.12 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.341 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 139' ' ' ASP . 14.6 Cg_exo -70.26 -3.55 12.57 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.087 2.525 . . . . 10.0 112.574 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -95.81 -2.52 47.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.624 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.64 116.99 10.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.041 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.7 t70 -122.53 160.25 26.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.633 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.283 0.989 . . . . 10.0 112.972 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.622 0.248 . . . . 10.0 111.354 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.24 -65.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.198 0.444 . . . . 10.0 112.198 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 54.9 tp -85.37 -82.57 0.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 62.24 45.82 6.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.619 0.724 . . . . 10.0 110.899 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.08 154.05 38.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.374 -0.83 . . . . 10.0 110.13 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.76 -163.63 0.23 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.79 0.681 . . . . 10.0 112.145 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -98.78 29.7 3.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.968 0.413 . . . . 10.0 111.085 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.65 15.27 14.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.146 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.63 137.61 11.53 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.789 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.11 151.05 86.78 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.931 2.421 . . . . 10.0 112.356 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.635 ' HG3' ' HB ' ' A' ' 107' ' ' VAL . 11.3 Cg_endo -54.29 -36.03 85.38 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.302 2.668 . . . . 10.0 113.152 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -69.06 -2.86 11.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.932 0.396 . . . . 10.0 112.023 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -131.82 5.86 4.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.473 0.654 . . . . 10.0 109.623 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.74 -1.84 31.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.702 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.509 ' HE1' HG23 ' B' ' 32' ' ' ILE . 43.9 m-85 -134.19 128.97 35.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.814 0.34 . . . . 10.0 110.96 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.6 91.38 20.55 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.539 ' HG2' ' HG3' ' B' ' 126' ' ' PRO . 17.1 Cg_exo -68.67 105.26 1.27 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.679 2.253 . . . . 10.0 112.727 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.12 99.4 12.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.236 -0.653 . . . . 10.0 109.236 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.2 mm? -89.33 102.99 15.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.882 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.26 101.78 10.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.52 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.479 HG13 HG22 ' B' ' 26' ' ' VAL . 81.1 t -89.82 119.59 37.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.616 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.1 -176.37 3.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.175 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.48 -35.9 34.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.403 -0.362 . . . . 10.0 111.29 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.35 -34.95 28.28 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.22 -178.61 40.14 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.762 -0.733 . . . . 10.0 112.077 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.479 HG22 HG13 ' B' ' 21' ' ' VAL . 60.7 t -102.86 135.88 38.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -123.48 114.87 20.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.954 0.407 . . . . 10.0 110.524 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.401 HG22 ' HD1' ' B' ' 30' ' ' PHE . 2.6 p -101.69 122.56 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.403 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -125.03 80.35 1.87 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.951 0.405 . . . . 10.0 110.315 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 7.4 p90 -77.35 111.71 13.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 10.0 111.141 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 -72.35 112.73 8.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.372 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.509 HG23 ' HE1' ' B' ' 15' ' ' PHE . 63.4 mt -90.23 135.73 25.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.975 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.41 149.27 50.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.21 92.65 1.02 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.059 0.457 . . . . 10.0 111.576 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.95 -22.06 0.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.369 -0.692 . . . . 10.0 111.369 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -105.37 154.28 20.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -146.6 139.23 25.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.983 0.42 . . . . 10.0 111.184 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 37.8 mtt -110.99 159.04 18.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.849 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.438 ' O ' HG13 ' B' ' 43' ' ' ILE . 24.2 m-85 -100.91 127.36 47.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -59.31 -30.7 68.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.183 0.438 . . . . 10.0 112.183 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.68 3.84 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.94 0.4 . . . . 10.0 111.181 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' B' ' 100' ' ' GLN . 71.1 mmtt -116.83 -20.47 9.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.336 -0.393 . . . . 10.0 111.801 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.456 HD13 ' HZ ' ' B' ' 30' ' ' PHE . 60.8 mt -77.22 96.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.092 0.472 . . . . 10.0 110.724 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.21 108.88 20.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.315 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.59 138.66 10.21 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.846 -0.692 . . . . 10.0 111.562 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -160.98 145.52 13.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.608 0.242 . . . . 10.0 111.066 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.598 ' HB ' HD13 ' B' ' 95' ' ' LEU . 15.1 t -141.51 125.63 17.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.191 -0.459 . . . . 10.0 109.879 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' B' ' 51' ' ' ASP . 28.1 p30 -179.0 161.75 1.02 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.154 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' B' ' 52' ' ' LEU . 11.3 Cg_exo -73.92 -63.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.435 2.09 . . . . 10.0 110.909 178.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.36 58.49 1.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 10.0 109.809 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.534 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 5.5 t70 61.96 33.62 17.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.53 -0.759 . . . . 10.0 112.455 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.495 ' HA ' HD13 ' B' ' 52' ' ' LEU . 1.4 mm? -90.16 55.09 2.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.4 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.492 ' HB2' HD22 ' B' ' 48' ' ' ASN . 19.0 tp -121.5 145.47 47.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.104 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.46 -76.8 0.85 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.587 -0.816 . . . . 10.0 111.309 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 3.6 pp0? -161.17 143.46 9.18 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 24.5 Cg_exo -64.9 108.52 1.11 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.526 2.151 . . . . 10.0 111.18 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 5.6 m -82.46 103.55 12.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.849 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.4 158.91 18.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 51.0 m -91.79 -14.06 30.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.622 -0.263 . . . . 10.0 110.831 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? 71.82 127.9 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.76 -0.655 . . . . 10.0 112.284 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.81 -133.0 5.61 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.135 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -117.41 140.24 49.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.527 0.203 . . . . 10.0 110.564 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.31 121.65 24.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.457 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -98.72 139.91 33.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -78.56 141.54 38.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.39 170.49 15.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.636 0.255 . . . . 10.0 110.495 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -24.83 10.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.961 0.41 . . . . 10.0 110.994 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 40' ' ' LEU . 11.9 m-85 -102.82 -44.75 5.19 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.202 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.569 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 14.6 m-30 -89.61 -9.62 49.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.583 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.08 -77.78 1.89 Allowed Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.827 -0.624 . . . . 10.0 112.296 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -173.81 117.91 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.752 0.31 . . . . 10.0 110.496 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -141.02 162.16 36.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.144 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.6 m -68.83 127.24 32.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.812 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.2 m -127.3 161.8 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 10.0 111.731 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -118.24 128.1 54.36 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.868 -1.16 . . . . 10.0 107.868 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -112.27 -3.8 14.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.768 0.655 . . . . 10.0 112.768 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -175.93 -36.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.987 -0.746 . . . . 10.0 108.987 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -86.26 125.04 33.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.086 -0.961 . . . . 10.0 109.767 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.37 116.77 4.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.323 . . . . 10.0 111.523 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -153.61 125.38 7.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.163 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.3 t -129.99 131.75 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.252 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' B' ' 57' ' ' SER . . . -108.56 142.01 39.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.704 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' PHE . . . . . 0.44 ' HB3' HD11 ' B' ' 53' ' ' LEU . 67.1 m-85 -120.22 112.26 34.7 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.263 0.468 . . . . 10.0 112.263 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -93.08 124.62 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.521 2.814 . . . . 10.0 111.55 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.01 148.04 40.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.988 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.3 -3.21 53.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.324 0.583 . . . . 10.0 109.73 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.412 ' HB2' ' HE2' ' B' ' 87' ' ' LYS . 6.2 tppt? -153.47 124.7 7.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.867 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.75 89.77 8.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.04 0.448 . . . . 10.0 110.352 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.64 147.15 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.71 47.33 3.83 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.073 -0.584 . . . . 10.0 112.344 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -106.67 145.44 31.07 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.53 116.02 4.54 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.319 2.013 . . . . 10.0 111.288 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.77 165.4 11.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.967 0.413 . . . . 10.0 111.832 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 47' ' ' THR . 67.6 tttt -109.2 151.76 26.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.979 -0.555 . . . . 10.0 109.828 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.598 HD13 ' HB ' ' B' ' 47' ' ' THR . 56.0 tp -120.54 115.55 23.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.974 0.416 . . . . 10.0 110.664 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.88 126.44 64.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.535 -0.542 . . . . 10.0 109.535 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 66.8 mt -133.13 121.06 22.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.925 0.393 . . . . 10.0 111.895 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' THR . . . . . 0.602 HG23 ' HB3' ' B' ' 113' ' ' ASP . 5.0 m -108.8 119.22 38.91 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -100.58 109.48 21.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.777 0.322 . . . . 10.0 111.561 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' B' ' 42' ' ' LYS . 11.6 tp60 -124.32 119.35 29.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.968 0.413 . . . . 10.0 110.533 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.36 -160.79 11.08 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.603 -0.808 . . . . 10.0 111.877 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 13.1 m -151.21 -172.42 4.2 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -131.22 147.73 52.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.259 -0.274 . . . . 10.0 110.259 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.47 6.08 2.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 10.0 111.753 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.19 5.33 29.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.892 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.52 -7.74 56.2 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.626 -0.797 . . . . 10.0 113.087 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.766 HG22 ' HB2' ' A' ' 127' ' ' SER . 2.9 t -74.33 142.75 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.739 0.304 . . . . 10.0 110.471 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 47.9 t -142.52 85.56 1.91 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.941 0.401 . . . . 10.0 110.068 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.915 ' HB3' HG23 ' A' ' 107' ' ' VAL . 52.4 p90 -74.09 152.35 88.44 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.79 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 55.3 Cg_endo -69.82 165.18 31.9 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.827 2.351 . . . . 10.0 111.377 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 70' ' ' HIS . 67.3 Cg_endo -74.42 68.11 5.28 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.657 2.238 . . . . 10.0 112.947 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.844 HG22 HD12 ' A' ' 69' ' ' LEU . 4.8 t -62.65 120.78 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 10.0 109.943 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ASP . . . . . 0.602 ' HB3' HG23 ' B' ' 98' ' ' THR . 4.0 p-10 -108.03 153.91 22.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.094 0.473 . . . . 10.0 111.37 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.68 138.77 41.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.822 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.19 124.45 50.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.82 0.343 . . . . 10.0 110.571 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -111.57 142.73 43.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.618 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -103.98 121.41 43.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.263 -0.426 . . . . 10.0 109.877 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 23.1 mm -94.66 88.83 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.967 0.413 . . . . 10.0 110.787 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' B' ' 121' ' ' ASN . 14.8 p90 -95.03 -35.02 12.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.549 . . . . 10.0 111.45 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.4 60.78 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.43 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' B' ' 119' ' ' PHE . 8.3 t30 -120.0 -0.89 10.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.81 0.338 . . . . 10.0 111.101 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.26 -76.14 1.5 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.002 -0.618 . . . . 10.0 111.658 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 3.9 m -103.21 140.25 37.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.565 -0.531 . . . . 10.0 109.565 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -129.86 161.36 30.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.142 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.18 146.97 24.67 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' PRO . . . . . 0.539 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 28.6 Cg_endo -63.26 121.56 9.43 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.557 2.171 . . . . 10.0 112.42 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -82.64 62.89 6.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.355 0.598 . . . . 10.0 110.01 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.091 -179.285 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 tpt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.098 -0.334 . . . . 10.0 110.098 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.65 82.64 48.26 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.562 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.01 -25.71 58.97 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.55 2.167 . . . . 10.0 111.566 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -46.83 87.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.833 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -60.56 -42.54 96.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.302 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.97 -32.84 74.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.806 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.0 m -81.91 -25.6 34.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.054 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.3 m -65.68 -26.71 67.9 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.756 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 9' ' ' LEU . 2.1 mm? -55.69 128.0 32.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.878 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -115.47 149.55 37.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.638 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 19.4 p -89.34 174.96 7.53 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.046 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.56 -19.36 65.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.411 . . . . 10.0 111.008 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.549 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.0 t70 -89.31 9.13 27.16 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 64.84 30.57 12.11 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.703 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.549 ' HG3' ' HB3' ' A' ' 13' ' ' ASP . 16.4 mtp85 -112.27 137.65 21.59 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.932 -0.577 . . . . 10.0 109.93 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 15' ' ' ARG . 50.3 Cg_exo -57.32 139.48 90.21 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.615 2.21 . . . . 10.0 111.409 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.14 -10.08 20.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 10.0 112.008 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 1.7 t -59.85 -18.41 43.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.647 -0.252 . . . . 10.0 111.494 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.18 -15.54 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-O 120.788 0.328 . . . . 10.0 111.018 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -127.06 22.92 6.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.56 . . . . 10.0 109.714 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 57.4 mt -133.0 27.28 4.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.024 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 18' ' ' SER . 53.7 mttm -118.97 174.6 6.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.6 mttp 69.32 15.7 8.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.127 -0.942 . . . . 10.0 112.902 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.18 51.21 14.89 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.512 0.507 . . . . 10.0 111.242 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.547 ' HD2' ' HD2' ' A' ' 26' ' ' PRO . 16.8 mmtp -112.65 143.37 28.86 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.218 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.547 ' HD2' ' HD2' ' A' ' 25' ' ' LYS . 19.6 Cg_endo -59.26 134.08 56.81 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.725 2.283 . . . . 10.0 110.956 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -106.78 143.91 34.19 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.967 0.413 . . . . 10.0 111.22 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 28' ' ' LEU . 9.5 tp -121.47 97.94 5.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.156 -0.683 . . . . 10.0 109.156 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.571 HG12 HD11 ' A' ' 61' ' ' ILE . 66.0 mt -89.39 112.22 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.025 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HG3' ' CE2' ' A' ' 111' ' ' TRP . 5.7 tmmm? -106.59 120.88 43.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.88 0.371 . . . . 10.0 110.826 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 14.1 m-85 -90.33 127.9 36.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.208 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -121.37 173.89 7.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.078 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB1' ' CZ3' ' A' ' 35' ' ' TRP . . . -124.83 138.48 54.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.102 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -77.49 -47.43 19.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.522 ' CZ3' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -88.36 29.1 1.0 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.077 0.769 . . . . 10.0 113.077 -178.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 5.0 t -119.65 125.98 27.18 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 111.665 0.246 . . . . 10.0 111.665 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 26.2 Cg_endo -63.01 -43.85 17.92 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.832 2.355 . . . . 10.0 112.457 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.97 -44.52 96.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.167 0.508 . . . . 10.0 111.135 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.9 -28.52 67.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.888 -0.596 . . . . 10.0 111.496 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.7 mt -63.62 -44.77 92.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.845 0.355 . . . . 10.0 110.464 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.6 m -69.63 -31.61 69.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.668 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -28.82 70.09 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.057 -0.52 . . . . 10.0 110.646 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.91 -42.48 84.83 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.442 -0.345 . . . . 10.0 111.321 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.04 -44.46 97.3 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.796 -0.716 . . . . 10.0 111.421 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -65.49 -34.67 78.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.867 0.365 . . . . 10.0 110.192 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.3 m -61.33 -46.88 88.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.161 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.56 -40.93 98.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.955 0.407 . . . . 10.0 110.429 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.22 -47.66 78.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 10.0 111.003 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -65.01 -33.93 77.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.576 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.44 -6.28 34.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.918 0.389 . . . . 10.0 111.283 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -113.11 9.07 18.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.207 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.664 ' HB3' ' HD2' ' A' ' 55' ' ' PHE . 14.3 t70 -85.63 146.54 26.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.439 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.32 73.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.856 0.687 . . . . 10.0 112.856 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.479 ' HB3' HD13 ' A' ' 137' ' ' ILE . 32.5 mmmt -74.67 -39.2 62.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.835 0.35 . . . . 10.0 111.155 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.664 ' HD2' ' HB3' ' A' ' 52' ' ' ASP . 94.8 m-85 -75.5 -20.3 58.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.495 0.554 . . . . 10.0 112.495 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.8 m -65.93 -6.54 12.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.34 . . . . 10.0 111.902 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -77.3 -18.37 57.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 10.0 110.147 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -125.91 -178.67 4.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.701 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -113.39 100.36 8.48 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.182 -0.303 . . . . 10.0 110.182 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.07 129.29 35.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.598 -0.273 . . . . 10.0 111.022 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.571 HD11 HG12 ' A' ' 29' ' ' ILE . 10.3 pt -138.22 155.73 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.988 0.423 . . . . 10.0 111.415 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.97 109.43 18.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 10.0 109.648 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 92' ' ' VAL . 36.0 t -111.14 140.99 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.94 0.4 . . . . 10.0 111.482 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . . . -135.44 149.63 49.64 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.498 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 12.3 m -110.03 97.97 32.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 94' ' ' ASP . 18.9 Cg_endo -58.39 126.63 21.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.942 2.428 . . . . 10.0 112.507 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.61 -36.8 3.3 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.8 -0.637 . . . . 10.0 113.171 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -66.44 134.36 52.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.621 0.248 . . . . 10.0 110.999 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD11 HG22 ' B' ' 112' ' ' VAL . 0.4 OUTLIER 59.14 29.7 19.32 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.639 0.607 . . . . 10.0 112.639 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.735 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.1 OUTLIER 73.08 21.14 3.24 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.299 0.852 . . . . 10.0 113.299 178.529 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.34 178.3 5.95 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 28.2 mmtt -61.52 124.93 22.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -61.73 156.95 18.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.913 0.387 . . . . 10.0 111.734 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -59.27 151.47 23.17 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.403 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.58 -44.97 3.3 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.22 -39.51 17.71 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 80' ' ' TRP . 50.6 t80 -57.44 -46.2 83.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.584 -0.735 . . . . 10.0 112.136 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -63.48 -31.69 72.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.9 0.381 . . . . 10.0 111.541 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -75.6 -22.62 56.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.142 0.496 . . . . 10.0 110.464 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.43 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 65.6 t-105 -65.47 -46.69 78.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.493 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -72.43 -32.71 66.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.819 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.49 -31.71 68.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.963 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.39 23.89 34.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.398 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 80' ' ' TRP . 42.5 mt -115.71 -161.82 0.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.408 . . . . 10.0 111.361 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.4 ' H ' ' HB3' ' A' ' 84' ' ' LEU . 11.2 t-20 -118.59 -168.89 1.62 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 63.24 76.3 0.37 Allowed Pre-proline 0 C--O 1.234 0.24 0 O-C-N 123.456 0.472 . . . . 10.0 111.559 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.4 0.76 9.12 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.666 2.244 . . . . 10.0 112.272 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -104.43 6.47 34.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.089 0.471 . . . . 10.0 110.428 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 89' ' ' LEU . 10.2 mt -84.81 115.21 59.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.125 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HG2' ' HA ' ' A' ' 61' ' ' ILE . 69.2 Cg_endo -77.06 76.9 3.98 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.658 2.239 . . . . 10.0 111.393 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.25 118.47 30.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.982 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 15.9 t -103.88 142.8 16.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.861 -0.609 . . . . 10.0 109.95 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.9 m -107.58 107.51 18.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.145 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 61.9 t0 -97.86 92.32 5.77 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.251 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -63.08 107.91 1.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.918 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.54 -10.53 68.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.823 -0.703 . . . . 10.0 112.872 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.9 55.9 6.91 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.263 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.96 -45.1 87.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.937 0.399 . . . . 10.0 110.642 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.3 mm -78.67 -37.85 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.485 -0.561 . . . . 10.0 109.485 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.23 95.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.586 -0.734 . . . . 10.0 111.599 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -70.08 -37.22 75.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.762 0.315 . . . . 10.0 111.529 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.2 m -62.84 -23.44 67.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.447 -0.342 . . . . 10.0 111.833 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.2 mt -111.87 4.4 18.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.659 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.8 t30 54.3 44.4 29.07 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.429 0.633 . . . . 10.0 111.631 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.8 mt -80.41 101.53 5.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.839 -0.619 . . . . 10.0 111.551 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.9 m -118.95 29.88 7.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.87 -0.605 . . . . 10.0 110.564 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.715 HG23 ' HB3' ' B' ' 109' ' ' TYR . 11.4 p -160.71 151.14 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.281 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -130.89 155.29 81.67 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 126' ' ' GLY . 97.7 Cg_endo -85.74 141.97 30.55 Favored 'Cis proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.355 -1.519 . . . . 10.0 111.26 -1.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.7 m -118.23 126.76 52.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.654 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.421 ' CE2' ' HG3' ' A' ' 30' ' ' LYS . 23.5 m95 -107.72 108.39 19.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.91 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -95.01 115.68 27.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 136' ' ' LEU . 55.4 tp -90.94 115.78 28.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.595 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.9 135.68 41.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.211 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.69 178.95 38.47 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.03 -0.605 . . . . 10.0 112.63 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -71.45 -4.59 27.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.906 0.384 . . . . 10.0 111.984 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -98.92 -4.43 32.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.993 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 86.06 16.79 62.32 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.815 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -109.09 163.09 13.64 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.162 -0.31 . . . . 10.0 110.162 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.34 122.75 25.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.855 0.36 . . . . 10.0 110.418 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.18 -40.92 6.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.95 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 122' ' ' ARG . 14.8 tpt180 -160.78 161.89 32.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.498 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -138.03 120.76 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.013 0.435 . . . . 10.0 110.484 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.4 t -115.66 107.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 10.0 109.872 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -115.21 133.62 55.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.452 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 130.65 -75.72 0.42 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.415 -0.897 . . . . 10.0 112.96 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.9 m -159.88 159.26 32.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.018 -0.364 . . . . 10.0 110.018 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.38 170.6 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.311 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -156.0 174.33 15.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.643 -0.253 . . . . 10.0 111.132 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.19 -40.01 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.57 -46.23 87.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 10.0 110.902 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -67.94 -37.74 81.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.953 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 137' ' ' ILE . . . -61.93 -48.51 80.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.38 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.78 -38.97 92.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.739 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.17 91.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.262 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.619 HD11 HD22 ' A' ' 113' ' ' LEU . 15.1 tp -62.88 -35.65 80.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 10.0 111.646 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.479 HD13 ' HB3' ' A' ' 54' ' ' LYS . 74.2 mt -70.1 -27.89 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.214 0.53 . . . . 10.0 110.552 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -89.11 -47.33 8.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.077 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 24.7 t70 -137.15 110.61 9.14 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.622 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 139' ' ' ASP . 11.8 Cg_exo -72.48 3.45 4.2 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.306 2.67 . . . . 10.0 112.812 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -93.1 -7.27 46.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.458 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.04 131.34 44.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.005 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -133.31 136.9 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.465 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.092 0 N-CA-C 113.944 1.09 . . . . 10.0 113.944 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.716 0.293 . . . . 10.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.75 -53.1 59.49 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.314 -0.403 . . . . 10.0 112.086 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' B' ' 5' ' ' ALA . 49.6 tp -89.73 -73.09 0.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.131 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 57.59 35.46 25.76 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.214 0.531 . . . . 10.0 110.918 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ALA . . . . . 0.423 ' H ' ' HG ' ' B' ' 3' ' ' LEU . . . -152.67 167.81 27.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.778 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.8 m120 65.68 -170.36 0.19 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.721 0.638 . . . . 10.0 112.398 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -101.17 19.44 17.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.124 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -88.97 20.24 3.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.614 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.3 136.56 13.26 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.279 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' PRO . . . . . 0.451 ' HB2' ' OE1' ' B' ' 12' ' ' GLU . 27.9 Cg_endo -61.42 150.23 86.0 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.166 2.577 . . . . 10.0 112.11 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.18 -40.09 60.83 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.682 2.921 . . . . 10.0 113.365 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.451 ' OE1' ' HB2' ' B' ' 10' ' ' PRO . 8.8 pm0 -65.24 -19.65 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.009 0.374 . . . . 10.0 112.009 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -106.91 -10.53 15.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.367 0.604 . . . . 10.0 110.041 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.49 -8.22 59.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.539 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.701 ' HE1' HG23 ' B' ' 32' ' ' ILE . 56.2 m-85 -134.08 131.53 38.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.923 0.392 . . . . 10.0 111.571 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.59 91.57 42.12 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' B' ' 30' ' ' PHE . 12.2 Cg_exo -72.37 108.74 2.58 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.12 2.547 . . . . 10.0 113.32 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -104.43 107.93 19.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.963 -0.755 . . . . 10.0 108.963 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' B' ' 19' ' ' LEU . 2.9 mm? -95.19 120.45 35.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.57 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.71 108.66 14.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.354 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.46 HG22 HG13 ' B' ' 26' ' ' VAL . 85.1 t -98.86 128.13 50.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.218 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.69 -166.94 1.34 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.291 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.31 -38.03 27.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.533 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.09 -41.66 85.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.216 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 178.12 -168.28 39.48 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.664 -0.779 . . . . 10.0 112.274 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.46 HG13 HG22 ' B' ' 21' ' ' VAL . 86.1 t -101.92 131.74 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.79 -0.448 . . . . 10.0 109.79 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -121.42 118.96 30.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.956 0.408 . . . . 10.0 110.765 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 p -103.47 116.96 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.12 0.486 . . . . 10.0 110.439 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' B' ' 79' ' ' ALA . 1.1 tmm_? -123.91 82.25 2.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.484 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.521 ' HB3' ' HA ' ' B' ' 17' ' ' PRO . 33.0 p90 -87.62 134.25 33.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.79 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 71.6 mtm-85 -85.52 129.36 34.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.298 -0.41 . . . . 10.0 111.034 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.701 HG23 ' HE1' ' B' ' 15' ' ' PHE . 76.9 mt -101.78 132.58 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.003 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.38 144.33 57.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.441 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.35 91.79 0.26 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.458 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.43 -23.06 0.95 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.427 -0.669 . . . . 10.0 111.427 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -100.74 159.24 15.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.103 -0.702 . . . . 10.0 109.103 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -150.32 136.57 18.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.131 0.491 . . . . 10.0 111.581 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 23.7 mtt -107.48 153.22 23.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.389 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.473 ' O ' HG13 ' B' ' 43' ' ' ILE . 20.0 m-85 -96.16 127.07 41.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.071 -0.714 . . . . 10.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -59.06 -33.79 71.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.849 0.356 . . . . 10.0 111.402 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.04 1.3 32.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.229 -0.442 . . . . 10.0 111.302 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.497 ' HE3' ' HE2' ' B' ' 69' ' ' PHE . 69.2 mmtt -116.53 -6.72 11.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 10.0 111.427 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.473 HG13 ' O ' ' B' ' 39' ' ' TYR . 81.0 mt -87.97 96.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 10.0 110.055 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 39.1 t -91.34 117.95 35.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.304 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.71 140.89 9.55 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.614 -0.803 . . . . 10.0 111.847 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -163.71 147.46 10.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.789 0.328 . . . . 10.0 110.713 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.457 ' HB ' HD13 ' B' ' 95' ' ' LEU . 9.4 t -144.18 120.41 10.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.143 -0.48 . . . . 10.0 109.854 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.6 ' CG ' ' HA ' ' B' ' 51' ' ' ASP . 0.3 OUTLIER -174.96 155.19 1.83 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.47 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 48' ' ' ASN . 6.0 Cg_exo -80.13 -66.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.837 2.358 . . . . 10.0 111.52 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.42 36.18 2.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.48 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.6 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 13.8 t0 64.58 33.16 11.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.495 -0.775 . . . . 10.0 112.611 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' B' ' 52' ' ' LEU . 2.0 mm? -96.78 76.6 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.92 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.445 HD13 ' O ' ' B' ' 47' ' ' THR . 17.6 tp -131.98 155.51 47.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.681 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.04 -80.46 0.64 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.094 -0.803 . . . . 10.0 111.094 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -168.99 147.8 3.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.841 -0.429 . . . . 10.0 109.841 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.02 110.53 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.637 2.225 . . . . 10.0 110.919 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.9 m -95.25 100.62 12.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.016 0.436 . . . . 10.0 111.401 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -80.58 168.16 19.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.98 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 42.4 m -97.67 -7.2 31.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.713 -0.221 . . . . 10.0 111.39 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt 69.41 117.6 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.829 0.677 . . . . 10.0 112.829 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.53 -125.34 5.57 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.914 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.21 158.4 28.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -94.31 123.31 37.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.932 0.396 . . . . 10.0 110.667 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -100.97 130.02 46.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.982 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.41 120.83 23.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.392 -0.966 . . . . 10.0 108.392 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -110.2 176.05 5.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.104 0.478 . . . . 10.0 111.432 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -110.06 -25.1 10.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.214 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.61 -42.68 3.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.054 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.497 ' HE2' ' HE3' ' B' ' 42' ' ' LYS . 4.3 m-30 -88.32 4.55 45.65 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.072 0.397 . . . . 10.0 112.072 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.98 -89.57 1.18 Allowed Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.715 -0.755 . . . . 10.0 111.859 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -171.09 123.9 0.61 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -136.57 167.3 21.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.337 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 15.2 m -75.34 128.78 36.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.521 -0.918 . . . . 10.0 108.521 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.65 162.69 32.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.433 0.635 . . . . 10.0 112.46 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.539 ' HB3' ' O ' ' B' ' 78' ' ' GLU . 40.6 m-85 -122.09 129.09 52.07 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.718 -1.216 . . . . 10.0 107.718 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -110.39 -15.54 13.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.721 0.637 . . . . 10.0 112.721 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.57 ' HA ' ' HB ' ' B' ' 32' ' ' ILE . 1.7 t60 -159.88 -35.24 0.06 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' B' ' 75' ' ' TYR . 0.6 OUTLIER -83.98 144.33 29.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.031 -0.986 . . . . 10.0 108.779 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' B' ' 29' ' ' ARG . . . -170.13 101.57 0.29 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.857 0.36 . . . . 10.0 111.042 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -140.57 120.37 13.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.118 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.36 123.54 62.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.155 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.27 141.28 36.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.723 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -119.82 104.35 44.59 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.539 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.4 126.12 3.07 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.781 2.321 . . . . 10.0 111.448 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -70.14 151.27 45.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.918 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.05 -11.74 25.95 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' B' ' 87' ' ' LYS . 8.8 tppt? -149.35 122.29 8.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.166 -0.924 . . . . 10.0 109.075 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.84 85.95 6.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.087 0.47 . . . . 10.0 110.651 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.419 ' HB ' ' HG2' ' B' ' 91' ' ' GLU . 10.8 m -114.63 160.55 13.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.858 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.63 2.38 82.54 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.77 -0.728 . . . . 10.0 111.695 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.419 ' HG2' ' HB ' ' B' ' 89' ' ' VAL . 35.3 mm-40 -60.68 125.45 82.78 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.572 -0.314 . . . . 10.0 110.893 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.13 101.31 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.407 2.071 . . . . 10.0 110.6 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.63 163.91 18.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.673 0.619 . . . . 10.0 112.673 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 47' ' ' THR . 63.1 tttt -114.04 160.65 18.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.298 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.457 HD13 ' HB ' ' B' ' 47' ' ' THR . 18.6 tp -127.42 135.84 51.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.922 0.391 . . . . 10.0 110.772 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.37 126.1 71.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 79.9 mt -129.99 126.62 38.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.889 0.376 . . . . 10.0 112.004 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' THR . . . . . 0.679 HG23 ' HB3' ' B' ' 113' ' ' ASP . 4.0 m -111.52 117.87 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 53.4 m-85 -98.52 100.29 11.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.945 0.35 . . . . 10.0 111.945 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.918 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 15.0 tp60 -117.61 122.05 42.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.104 0.478 . . . . 10.0 110.894 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.79 -162.33 12.46 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.937 -0.649 . . . . 10.0 111.685 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.5 m -151.95 -175.13 5.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.43 -0.582 . . . . 10.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.07 144.56 51.11 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -69.37 -4.05 16.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.156 0.503 . . . . 10.0 111.202 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.52 -13.37 43.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.982 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 118.1 -18.15 11.43 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.975 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' GLY . 6.3 t -66.61 141.99 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.606 0.241 . . . . 10.0 110.473 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 13.8 t -137.49 87.74 2.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.14 0.495 . . . . 10.0 110.005 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.715 ' HB3' HG23 ' A' ' 107' ' ' VAL . 55.3 p90 -76.1 151.95 84.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.875 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.451 ' CD ' ' HA ' ' A' ' 107' ' ' VAL . 67.6 Cg_endo -75.35 163.72 34.04 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.8 2.333 . . . . 10.0 111.521 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.918 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 67.5 Cg_endo -77.0 79.15 3.2 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.623 2.215 . . . . 10.0 112.247 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.635 HG22 HD11 ' A' ' 69' ' ' LEU . 3.1 t -68.0 101.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ASP . . . . . 0.679 ' HB3' HG23 ' B' ' 98' ' ' THR . 4.9 p-10 -86.67 149.47 24.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.127 0.489 . . . . 10.0 111.701 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.09 140.89 44.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.205 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.48 137.64 38.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.007 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.81 135.54 53.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.662 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -95.13 119.48 33.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.302 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 16.5 mm -95.74 76.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 10.0 110.665 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' PHE . . . . . 0.468 ' CZ ' ' HB2' ' B' ' 121' ' ' ASN . 43.3 p90 -88.75 -24.55 22.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.005 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.54 53.89 0.17 Allowed Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.925 -0.655 . . . . 10.0 112.406 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' ASN . . . . . 0.468 ' HB2' ' CZ ' ' B' ' 119' ' ' PHE . 7.3 t30 -104.6 -4.69 22.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.246 0.546 . . . . 10.0 109.955 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.85 -77.11 1.94 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.276 -0.73 . . . . 10.0 111.276 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 2.3 m -101.81 140.03 36.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' B' ' 19' ' ' LEU . 78.4 m-85 -128.09 152.72 47.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.926 0.393 . . . . 10.0 110.817 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.3 151.72 70.05 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.147 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' PRO . . . . . 0.41 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 30.3 Cg_endo -64.0 116.23 3.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.468 2.112 . . . . 10.0 111.75 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -82.77 81.47 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.241 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.927 -0.559 . . . . 10.0 109.964 -179.801 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.88 71.1 14.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.861 0.362 . . . . 10.0 111.597 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.97 -31.98 55.08 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.387 2.058 . . . . 10.0 112.256 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -61.88 -41.97 98.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.722 0.296 . . . . 10.0 110.874 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.75 -43.06 80.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.614 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.0 tp -61.95 -34.69 76.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.831 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -80.48 -13.74 58.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.236 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.4 m -84.86 -12.31 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 10.0 110.535 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -59.38 120.79 9.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.254 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.73 133.24 51.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.563 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.869 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 34.9 p -74.09 171.17 14.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.638 -0.504 . . . . 10.0 109.638 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.96 -12.24 60.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.432 0.634 . . . . 10.0 110.542 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.555 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 6.2 t70 -96.03 7.92 45.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.291 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 71.01 19.03 5.77 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.399 -0.819 . . . . 10.0 112.401 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.555 ' HG3' ' HB3' ' A' ' 13' ' ' ASP . 11.6 mtp180 -102.79 143.93 27.6 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.918 -0.401 . . . . 10.0 109.918 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.48 142.1 76.77 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.404 2.07 . . . . 10.0 111.318 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.76 -8.52 28.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.429 -0.35 . . . . 10.0 111.783 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -57.66 -24.27 55.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.637 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.569 HG23 ' HD1' ' A' ' 20' ' ' TYR . 29.5 m -63.16 -18.73 22.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.932 0.396 . . . . 10.0 111.579 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.569 ' HD1' HG23 ' A' ' 19' ' ' VAL . 15.4 m-85 -126.03 24.27 6.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.433 0.635 . . . . 10.0 109.927 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 68.9 mt -138.6 58.82 1.65 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.269 -0.878 . . . . 10.0 109.441 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -154.37 -178.7 7.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.98 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? 66.85 12.78 9.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.598 -0.728 . . . . 10.0 112.316 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 55.3 38.31 30.17 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.075 0.464 . . . . 10.0 111.689 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -107.51 151.56 41.03 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.704 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.84 152.16 59.39 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.009 2.472 . . . . 10.0 112.153 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.88 141.71 48.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.64 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD23 ' HG ' ' A' ' 60' ' ' LEU . 19.7 tp -122.33 94.97 4.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.6 mt -93.38 122.51 44.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.613 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HG3' ' CE2' ' A' ' 111' ' ' TRP . 3.6 tmmt? -123.08 129.7 51.82 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.978 0.418 . . . . 10.0 111.134 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.497 ' HB2' ' HB2' ' A' ' 110' ' ' SER . 23.7 m-85 -92.8 137.88 31.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.307 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -132.57 171.91 13.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.145 -0.48 . . . . 10.0 110.475 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.67 137.54 54.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.756 0.312 . . . . 10.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.28 -39.99 46.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.928 -0.578 . . . . 10.0 112.12 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.699 ' HE1' ' HA ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -91.64 25.02 2.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.404 0.52 . . . . 10.0 112.404 -179.025 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.506 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 46.3 t -115.6 124.33 30.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HA ' HD12 ' A' ' 40' ' ' LEU . 28.0 Cg_endo -63.24 -41.96 24.92 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.771 2.314 . . . . 10.0 112.142 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.72 -31.53 72.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.988 0.423 . . . . 10.0 111.07 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.1 m -84.19 -14.95 48.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.568 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 37' ' ' PRO . 53.1 mt -71.55 -45.79 61.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.556 -0.293 . . . . 10.0 111.752 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -22.04 62.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.426 0.631 . . . . 10.0 110.559 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -23.69 62.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.353 -0.84 . . . . 10.0 111.458 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -58.55 -53.93 52.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.118 0.414 . . . . 10.0 112.118 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.56 -35.76 89.9 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.047 -0.597 . . . . 10.0 111.943 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -66.95 -41.68 86.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.791 0.329 . . . . 10.0 110.46 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.9 m -61.72 -43.92 97.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.96 -0.563 . . . . 10.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.506 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -65.58 -39.82 92.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.774 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.56 -40.09 95.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.114 0.483 . . . . 10.0 110.337 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -73.64 -34.12 64.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.891 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.06 -13.78 60.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.001 0.429 . . . . 10.0 111.623 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -113.01 10.62 18.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.131 0.491 . . . . 10.0 110.699 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -81.1 140.31 35.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.911 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.64 -33.36 74.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.159 0.429 . . . . 10.0 112.159 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.799 ' HB3' HD12 ' A' ' 137' ' ' ILE . 17.5 mmmt -77.31 -37.86 51.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.721 0.296 . . . . 10.0 111.519 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -77.58 -10.26 59.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.017 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.5 t -69.18 -12.32 61.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 10.0 111.521 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 m -80.16 -2.96 46.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.918 0.389 . . . . 10.0 111.167 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.27 159.36 41.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.222 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -94.89 92.4 6.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.816 0.341 . . . . 10.0 110.339 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.501 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -83.76 124.48 30.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.791 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.583 HG22 ' HB2' ' A' ' 90' ' ' PRO . 3.3 pt -140.94 141.63 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.915 0.388 . . . . 10.0 111.434 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -104.49 113.33 26.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.563 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.551 HG22 ' HB ' ' A' ' 92' ' ' VAL . 17.6 t -110.65 142.81 22.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.886 0.374 . . . . 10.0 111.621 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -137.41 140.44 41.32 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 1.7 m -98.19 104.99 25.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.774 0.321 . . . . 10.0 111.854 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.666 ' HG3' HG22 ' A' ' 93' ' ' THR . 39.6 Cg_endo -65.9 121.56 8.93 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.745 2.297 . . . . 10.0 112.261 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.05 -4.78 83.22 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.577 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 25.8 t80 -111.15 148.98 31.56 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.302 -0.259 . . . . 10.0 110.302 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.6 mt 60.61 29.15 18.8 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.412 0.445 . . . . 10.0 111.667 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.528 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.1 OUTLIER 68.0 19.24 9.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.465 -0.788 . . . . 10.0 112.105 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.699 ' HA ' ' HE1' ' A' ' 35' ' ' TRP . 2.7 mm-40 -80.95 179.95 7.61 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.689 0.28 . . . . 10.0 110.893 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 42.8 mmtt -69.18 142.24 54.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 74' ' ' ASP . 77.3 tttt -73.19 165.69 24.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.476 -0.329 . . . . 10.0 111.303 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 73' ' ' LYS . 16.9 t70 -55.16 147.18 16.79 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.763 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.44 -57.24 4.73 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.586 -1.006 . . . . 10.0 110.586 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.86 -44.94 95.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.401 0.619 . . . . 10.0 109.424 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -67.43 -39.01 85.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.258 -0.883 . . . . 10.0 111.33 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -65.14 -42.83 93.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.839 0.352 . . . . 10.0 111.075 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -65.55 -24.67 67.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.402 . . . . 10.0 110.854 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.422 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 2.9 t90 -64.9 -47.15 78.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.658 -0.868 . . . . 10.0 108.658 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -66.27 -41.22 90.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.714 -0.676 . . . . 10.0 110.732 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.23 -31.22 65.3 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.993 -0.549 . . . . 10.0 111.002 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.38 35.33 5.04 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.835 -0.698 . . . . 10.0 112.067 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 84' ' ' LEU . 10.8 mt -118.3 -178.22 3.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.81 0.338 . . . . 10.0 110.814 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -100.31 171.44 7.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.413 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 90.7 m-85 66.6 82.11 0.2 Allowed Pre-proline 0 N--CA 1.466 0.326 0 O-C-N 123.556 0.535 . . . . 10.0 111.41 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.73 1.36 6.45 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.45 2.1 . . . . 10.0 112.915 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 88' ' ' LYS . 16.3 mtpp -104.73 6.24 34.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.534 0.207 . . . . 10.0 111.108 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.506 ' HG ' ' HG3' ' A' ' 47' ' ' GLU . 9.0 mt -69.05 116.84 45.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.755 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.583 ' HB2' HG22 ' A' ' 61' ' ' ILE . 71.8 Cg_endo -78.94 69.01 8.07 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.543 2.162 . . . . 10.0 111.696 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' THR . 44.3 t -87.51 124.78 41.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.717 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.869 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 6.4 t -112.03 142.53 24.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.666 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -98.31 104.3 16.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.814 0.34 . . . . 10.0 110.986 -179.369 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 57.3 t0 -85.77 79.92 9.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.137 0.494 . . . . 10.0 110.039 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -65.67 110.26 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.601 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.34 -25.18 27.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.875 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.27 51.51 2.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.651 -0.785 . . . . 10.0 111.654 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 102' ' ' SER . 0.5 OUTLIER -62.52 -51.6 66.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.009 0.433 . . . . 10.0 110.45 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.454 ' HB ' ' HZ ' ' A' ' 31' ' ' PHE . 31.5 mm -81.89 -38.18 15.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.021 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.773 ' HA ' HD13 ' A' ' 105' ' ' ILE . . . -57.12 -44.51 83.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.281 -0.872 . . . . 10.0 111.787 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -80.57 -28.28 37.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 10.0 111.184 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 98' ' ' THR . 4.4 t -63.02 -47.03 84.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.57 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -101.37 -5.76 24.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.849 0.314 . . . . 10.0 111.849 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 t30 65.79 70.82 0.43 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.57 0.7 . . . . 10.0 111.638 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.773 HD13 ' HA ' ' A' ' 100' ' ' ALA . 2.6 mp -86.47 126.44 40.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.433 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.41 23.52 2.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.877 0.37 . . . . 10.0 111.245 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.503 HG23 ' HB3' ' B' ' 109' ' ' TYR . 5.5 p -172.05 157.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.409 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -123.51 150.49 61.25 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.511 -0.552 . . . . 10.0 109.511 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -90.09 132.38 9.18 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.315 -1.535 . . . . 10.0 111.978 -0.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 25.7 m -93.61 121.45 35.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.189 -0.46 . . . . 10.0 109.939 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.525 ' CE2' ' HG3' ' A' ' 30' ' ' LYS . 69.0 m95 -106.62 108.47 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.829 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.13 110.12 22.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.208 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 136' ' ' LEU . 38.6 tp -90.81 112.01 23.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.699 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.0 133.11 45.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -71.38 -179.51 30.96 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.056 -0.592 . . . . 10.0 113.121 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -75.56 -4.9 42.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 10.0 111.405 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.98 -12.39 25.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.236 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 99.95 5.08 55.25 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.754 -0.736 . . . . 10.0 113.216 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -106.5 152.91 23.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.686 0.279 . . . . 10.0 111.24 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.92 118.67 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.094 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.53 -48.72 7.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.554 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -147.75 141.79 25.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.592 -0.277 . . . . 10.0 111.132 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -121.89 121.64 64.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.307 -0.406 . . . . 10.0 109.999 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.0 t -113.22 125.89 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.688 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -126.17 110.58 13.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.427 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 157.79 -87.47 0.12 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.173 -1.013 . . . . 10.0 113.2 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.5 t -170.57 131.17 0.89 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt -116.01 158.05 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.726 0.298 . . . . 10.0 110.796 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -108.23 171.48 7.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.473 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.53 -40.4 96.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.021 0.378 . . . . 10.0 112.021 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.4 88.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.556 -0.293 . . . . 10.0 110.767 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -61.89 -41.8 98.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.746 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.3 96.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 10.0 110.364 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.8 mt -71.52 -26.5 62.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.972 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.93 -34.35 29.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.504 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 140' ' ' PRO . 19.5 tp -62.86 -33.95 76.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.25 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.799 HD12 ' HB3' ' A' ' 54' ' ' LYS . 13.3 pt -83.03 15.91 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.124 0.487 . . . . 10.0 111.31 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -133.69 -48.33 0.82 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.655 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -138.25 97.36 9.63 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.302 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.545 ' HA ' HD12 ' A' ' 136' ' ' LEU . 57.7 Cg_endo -70.94 2.57 4.05 Favored 'Trans proline' 0 CA--C 1.526 0.092 0 C-N-CA 123.014 2.476 . . . . 10.0 112.83 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -95.36 -5.32 43.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.825 0.345 . . . . 10.0 110.132 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.17 134.6 36.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.836 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -126.09 155.08 42.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.16 -0.682 . . . . 10.0 109.16 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.98 0 N-CA-C 113.57 0.952 . . . . 10.0 113.57 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 47.4 mtt . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.599 0.238 . . . . 10.0 111.32 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.65 -83.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.462 -0.335 . . . . 10.0 111.287 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 34.8 tp -93.32 -55.04 3.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.005 -0.278 . . . . 10.0 110.896 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ASP . . . . . 0.525 ' HA ' HD13 ' B' ' 9' ' ' LEU . 0.6 OUTLIER 53.6 35.58 21.33 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.672 0.608 . . . . 10.0 111.518 -179.511 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.93 166.44 27.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.441 -0.8 . . . . 10.0 110.555 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.91 -160.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.413 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -107.16 28.46 8.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.302 0.572 . . . . 10.0 109.925 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -92.95 7.68 42.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.96 -0.564 . . . . 10.0 111.391 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.591 HD12 ' HD3' ' B' ' 13' ' ' LYS . 2.6 pt? -133.17 140.81 38.53 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.772 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.88 148.7 93.14 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.125 2.55 . . . . 10.0 112.333 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.28 -37.76 81.18 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.46 2.773 . . . . 10.0 113.456 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -63.98 -20.89 66.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 10.0 111.936 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.591 ' HD3' HD12 ' B' ' 9' ' ' LEU . 2.5 tmtm? -111.57 -6.32 14.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.253 0.549 . . . . 10.0 110.468 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.12 -17.36 46.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.042 -0.527 . . . . 10.0 111.793 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.438 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 13.7 m-85 -127.54 125.81 41.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.711 0.291 . . . . 10.0 110.934 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.76 89.8 16.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.114 -0.494 . . . . 10.0 109.757 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.511 ' HG2' ' HG3' ' B' ' 126' ' ' PRO . 9.5 Cg_exo -73.26 106.5 2.18 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.996 2.464 . . . . 10.0 112.707 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -101.57 110.23 22.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.665 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' B' ' 19' ' ' LEU . 3.5 mm? -92.73 117.08 29.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.152 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.68 98.03 6.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.284 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.528 HG13 HG22 ' B' ' 26' ' ' VAL . 29.2 t -82.18 117.12 27.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.204 -0.453 . . . . 10.0 109.94 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.27 -174.32 2.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.476 -0.329 . . . . 10.0 110.808 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.14 -37.88 53.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.422 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.3 -36.68 39.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.788 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.498 ' HA2' ' CZ ' ' B' ' 85' ' ' TYR . . . -174.52 -179.75 45.32 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.521 -0.847 . . . . 10.0 112.432 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.528 HG22 HG13 ' B' ' 21' ' ' VAL . 46.9 t -90.44 128.74 42.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -114.94 110.23 19.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' B' ' 81' ' ' VAL . 3.8 p -94.94 124.11 47.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.904 0.383 . . . . 10.0 110.944 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -127.03 87.94 2.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.195 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 10.4 p90 -91.55 118.04 30.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.94 0.4 . . . . 10.0 110.765 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 mtm-85 -78.2 126.18 30.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.702 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 23.7 mt -101.93 141.25 18.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.263 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.42 151.21 47.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.039 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.92 81.68 2.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.142 0.496 . . . . 10.0 111.381 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.05 -21.22 0.13 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.063 -0.815 . . . . 10.0 111.063 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.23 147.15 28.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -139.78 136.08 33.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.094 0.474 . . . . 10.0 111.009 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' MET . . . . . 0.408 ' HA ' ' HA3' ' B' ' 101' ' ' GLY . 43.2 mtt -106.91 152.18 24.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.973 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.619 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 38.4 m-85 -92.11 125.59 36.85 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.903 -0.777 . . . . 10.0 108.903 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -59.85 -29.66 68.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.716 0.293 . . . . 10.0 111.668 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.39 -8.62 59.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.36 . . . . 10.0 111.17 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' B' ' 100' ' ' GLN . 37.2 mmtt -107.45 -13.81 15.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.838 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 39' ' ' TYR . 85.3 mt -80.84 102.24 6.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.022 0.439 . . . . 10.0 109.847 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.77 129.85 44.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.683 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.6 129.04 2.64 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.686 -0.769 . . . . 10.0 111.911 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -156.47 137.81 13.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.818 0.342 . . . . 10.0 111.097 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.661 ' HB ' HD13 ' B' ' 95' ' ' LEU . 13.2 t -138.49 125.11 20.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.494 -0.558 . . . . 10.0 109.494 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.54 ' CG ' ' HA ' ' B' ' 51' ' ' ASP . 0.3 OUTLIER -177.9 160.1 1.27 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.316 -178.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.08 -76.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.687 2.258 . . . . 10.0 110.635 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.57 48.62 0.83 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.447 0.641 . . . . 10.0 109.839 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.54 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 6.7 t0 63.63 35.82 11.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.998 -1.001 . . . . 10.0 112.427 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.49 ' HA ' HD13 ' B' ' 52' ' ' LEU . 2.3 mm? -90.65 67.57 6.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.79 -0.641 . . . . 10.0 111.075 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 19.1 tp -125.28 144.45 50.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 10.0 109.798 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.46 -64.94 1.91 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.561 -0.828 . . . . 10.0 112.254 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -169.29 157.71 7.07 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.0 -0.37 . . . . 10.0 110.0 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.99 97.72 1.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.514 2.143 . . . . 10.0 110.427 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m -78.97 100.37 7.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.971 0.415 . . . . 10.0 111.611 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -87.96 149.48 24.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.095 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m -79.98 -14.13 58.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.701 0.286 . . . . 10.0 110.755 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? 72.72 136.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.672 -0.695 . . . . 10.0 112.332 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.38 -133.24 4.33 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.003 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -116.18 149.38 39.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -86.66 136.27 33.09 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -114.8 130.85 56.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.636 0.255 . . . . 10.0 110.791 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.18 119.75 18.82 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.14 -177.76 3.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.79 -0.641 . . . . 10.0 109.429 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -112.2 -51.6 2.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.683 0.277 . . . . 10.0 111.097 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -84.49 -30.13 25.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.253 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.495 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 5.8 m-30 -95.91 -10.11 29.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.997 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.23 -92.66 1.39 Allowed Glycine 0 C--O 1.224 -0.488 0 C-N-CA 120.853 -0.689 . . . . 10.0 112.734 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -165.2 115.57 1.1 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.758 0.313 . . . . 10.0 110.615 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -144.06 170.53 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.258 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 3.4 m -74.14 134.35 42.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.548 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.65 161.02 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.97 0.414 . . . . 10.0 111.131 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -115.98 130.98 57.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.185 -1.043 . . . . 10.0 108.185 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -114.22 -6.84 13.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.793 0.664 . . . . 10.0 112.793 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -173.17 -37.0 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -83.26 135.49 34.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.918 -1.037 . . . . 10.0 109.537 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' B' ' 30' ' ' PHE . . . -161.7 110.98 1.54 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.002 0.43 . . . . 10.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 25.9 tt0 -151.39 121.25 7.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.254 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.421 ' HB ' ' CG1' ' B' ' 28' ' ' VAL . 9.3 t -125.89 131.96 71.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.56 135.74 48.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.875 0.369 . . . . 10.0 110.435 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -113.73 108.28 51.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.374 -0.376 . . . . 10.0 111.626 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.41 131.08 4.02 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.836 2.358 . . . . 10.0 111.655 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' TYR . . . . . 0.498 ' CZ ' ' HA2' ' B' ' 25' ' ' GLY . 14.9 m-85 -76.34 142.77 41.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 10.0 109.942 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.9 11.22 38.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.096 0.474 . . . . 10.0 110.661 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -166.69 128.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.697 -0.683 . . . . 10.0 109.656 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.38 81.41 5.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.995 0.426 . . . . 10.0 111.337 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.5 126.72 73.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.996 -0.547 . . . . 10.0 110.74 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.46 58.26 4.87 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.045 -0.598 . . . . 10.0 111.77 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -113.78 149.17 41.34 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.93 95.23 0.48 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.138 1.892 . . . . 10.0 111.472 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.28 140.16 38.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.262 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' B' ' 47' ' ' THR . 70.6 tttt -91.86 147.3 23.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.661 HD13 ' HB ' ' B' ' 47' ' ' THR . 35.9 tp -118.6 127.79 53.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.881 0.372 . . . . 10.0 110.887 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.37 121.15 66.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.031 -0.729 . . . . 10.0 109.031 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.14 137.61 53.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 10.0 111.324 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 7.3 m -129.02 121.0 27.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 38.2 m-85 -104.77 118.5 36.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.919 0.39 . . . . 10.0 111.457 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.716 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 11.3 tp60 -132.9 123.71 26.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.32 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -161.88 -158.33 9.43 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.66 -0.781 . . . . 10.0 111.737 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 20.3 m -152.05 175.57 12.41 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.283 -0.636 . . . . 10.0 109.283 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -115.71 148.81 39.35 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.142 -0.318 . . . . 10.0 110.142 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.39 -10.55 44.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.237 0.458 . . . . 10.0 112.237 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.52 6.98 46.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 10.0 111.507 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.82 -6.8 67.4 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.761 -0.733 . . . . 10.0 112.549 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 5.7 t -68.35 136.26 26.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.843 -0.429 . . . . 10.0 109.843 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 21.6 t -127.31 107.98 10.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.692 0.282 . . . . 10.0 110.744 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.503 ' HB3' HG23 ' A' ' 107' ' ' VAL . 35.8 p90 -97.72 148.34 34.31 Favored Pre-proline 0 C--N 1.327 -0.402 0 O-C-N 122.226 -0.296 . . . . 10.0 111.625 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.53 159.49 52.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.927 2.418 . . . . 10.0 111.666 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.716 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 59.1 Cg_endo -74.51 83.59 1.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.583 2.189 . . . . 10.0 111.72 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.17 122.86 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.01 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -104.71 150.32 24.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.03 0.443 . . . . 10.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -141.5 138.78 33.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.004 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' B' ' 94' ' ' LYS . 47.4 mt-10 -107.78 134.93 50.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.556 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' B' ' 95' ' ' LEU . 75.6 m-85 -122.38 150.02 43.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.853 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -116.42 116.21 27.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.751 0.31 . . . . 10.0 110.171 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 19.9 mm -94.15 93.13 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.044 0.45 . . . . 10.0 111.06 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -102.08 -13.45 17.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.319 0.58 . . . . 10.0 110.926 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 122.5 110.87 2.07 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.634 -0.793 . . . . 10.0 112.095 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -176.02 -22.13 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 10.0 110.565 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.92 -74.3 2.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.707 -0.758 . . . . 10.0 111.861 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.62 129.45 35.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 10.0 111.238 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -132.84 150.26 52.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.327 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.65 146.99 34.18 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.239 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' PRO . . . . . 0.511 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 34.7 Cg_endo -65.74 118.62 5.63 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.487 2.125 . . . . 10.0 112.407 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -75.51 82.57 2.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.489 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.877 -0.582 . . . . 10.0 109.995 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.463 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 3.6 m -127.49 64.81 64.32 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 112.229 0.455 . . . . 10.0 112.229 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.58 -36.63 63.38 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.062 1.841 . . . . 10.0 111.973 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -65.89 -37.17 85.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.734 0.302 . . . . 10.0 110.985 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 2' ' ' VAL . 1.3 m -70.33 -31.45 68.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.651 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.608 ' HG ' HD13 ' A' ' 21' ' ' LEU . 15.6 tp -63.34 -32.04 73.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.221 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 m -86.79 -8.24 57.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.833 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 5' ' ' THR . 6.8 m -76.5 -23.08 53.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.593 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 94' ' ' ASP . 1.1 mm? -73.52 118.14 16.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.284 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -111.19 147.55 34.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.386 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.799 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 25.1 p -71.3 178.26 3.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.084 -0.507 . . . . 10.0 111.332 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.17 -14.98 62.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.05 0.453 . . . . 10.0 110.465 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -89.0 -2.2 58.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.632 -0.713 . . . . 10.0 109.319 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.6 t30 75.22 19.67 2.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.854 -1.066 . . . . 10.0 110.554 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -101.13 126.54 34.5 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.226 -0.897 . . . . 10.0 109.278 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.49 140.49 35.49 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.132 2.555 . . . . 10.0 112.397 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.41 -2.56 8.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.302 0.482 . . . . 10.0 112.302 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.592 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -60.12 -16.13 29.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 10.0 111.439 179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.73 -23.97 34.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.991 0.425 . . . . 10.0 111.052 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.401 ' HB3' ' HB3' ' A' ' 59' ' ' ASN . 45.3 m-85 -120.42 4.27 10.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.686 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.608 HD13 ' HG ' ' A' ' 6' ' ' LEU . 73.6 mt -108.81 26.65 10.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.267 0.556 . . . . 10.0 110.348 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -128.97 -174.94 3.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.913 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt 68.92 11.15 8.26 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.72 0.638 . . . . 10.0 111.151 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.37 41.54 32.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.36 -0.837 . . . . 10.0 111.82 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -110.42 138.89 21.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.95 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.23 125.67 19.94 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.962 2.441 . . . . 10.0 111.713 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.8 117.86 34.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.757 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.469 HD23 HD13 ' A' ' 60' ' ' LEU . 10.0 tp -89.23 110.03 20.84 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.4 mt -93.58 118.53 39.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 10.0 111.992 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.497 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 14.8 tttt -119.92 129.64 54.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.482 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.656 ' HB3' ' HE1' ' A' ' 108' ' ' TYR . 6.5 m-85 -99.07 135.35 40.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.465 -0.334 . . . . 10.0 111.085 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -122.42 -178.6 3.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 10.0 110.812 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.22 146.38 35.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.571 0.225 . . . . 10.0 111.133 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.7 -31.34 14.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.705 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.544 ' CH2' ' HA ' ' B' ' 110' ' ' PRO . 0.9 OUTLIER -82.32 11.0 5.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.189 0.44 . . . . 10.0 112.189 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.89 125.82 27.19 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.74 0.305 . . . . 10.0 111.449 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.8 -35.44 9.59 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.533 2.156 . . . . 10.0 112.63 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.7 mt -64.52 -47.04 80.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.38 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 76.7 m -69.46 -20.1 63.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.275 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HB3' ' CE2' ' B' ' 68' ' ' PHE . 1.5 tp -69.09 -41.73 77.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.594 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.99 -32.88 69.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.129 0.49 . . . . 10.0 110.223 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -63.12 -23.41 67.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.622 -0.717 . . . . 10.0 110.978 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' HD11 ' A' ' 89' ' ' LEU . 86.9 mt -59.5 -36.73 76.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 10.0 110.352 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.78 -37.09 88.3 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.564 -1.014 . . . . 10.0 110.564 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.33 -36.01 73.99 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -61.87 -41.62 98.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.806 -0.634 . . . . 10.0 109.852 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 88' ' ' LYS . 31.3 tt0 -61.55 -39.18 90.18 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 120.962 0.41 . . . . 10.0 109.945 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -63.08 -44.14 96.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.705 -0.68 . . . . 10.0 109.727 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -68.52 -33.5 74.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.983 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.43 -2.73 20.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.123 0.487 . . . . 10.0 110.821 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -125.3 14.82 8.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.74 -0.663 . . . . 10.0 109.603 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 15.2 t70 -87.05 140.92 29.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.447 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.73 94.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.165 0.431 . . . . 10.0 112.165 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -76.39 -37.81 56.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.77 0.319 . . . . 10.0 111.321 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.702 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 27.7 m-85 -71.16 -16.0 62.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.322 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.9 t -72.26 -0.28 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 10.0 111.673 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -75.49 -22.05 57.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 10.0 110.222 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.96 169.05 15.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 10.0 109.72 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 87.5 m-20 -100.08 97.5 8.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.673 0.273 . . . . 10.0 110.315 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.469 HD13 HD23 ' A' ' 28' ' ' LEU . 54.2 tp -83.29 130.81 35.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.442 -0.344 . . . . 10.0 110.944 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.487 ' HA ' ' HG2' ' A' ' 90' ' ' PRO . 21.6 pt -135.9 146.71 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.966 0.413 . . . . 10.0 111.156 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -107.03 105.98 16.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.236 -0.438 . . . . 10.0 109.908 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.407 HG13 ' HB ' ' A' ' 92' ' ' VAL . 5.4 t -103.31 146.51 10.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.124 0.487 . . . . 10.0 111.71 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . . . -143.44 146.25 33.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.205 -1.035 . . . . 10.0 108.205 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 7.1 m -106.46 98.63 20.68 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 112.196 0.443 . . . . 10.0 112.196 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.582 ' HG3' HG22 ' A' ' 93' ' ' THR . 17.8 Cg_endo -60.0 123.51 13.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.944 2.429 . . . . 10.0 112.27 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.98 -13.36 66.37 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.944 -0.646 . . . . 10.0 112.954 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 52.9 t80 -94.42 139.05 31.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.822 0.311 . . . . 10.0 110.469 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.766 HD11 HG22 ' B' ' 112' ' ' VAL . 0.2 OUTLIER 57.03 35.55 26.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.08 -0.509 . . . . 10.0 112.183 179.509 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.36 20.73 8.56 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.026 0.75 . . . . 10.0 113.026 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 2.7 mm-40 -75.69 -179.07 4.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.718 0.294 . . . . 10.0 110.723 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -67.39 121.3 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.218 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -66.5 155.56 37.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.706 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.09 130.79 47.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.176 -0.466 . . . . 10.0 111.173 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.16 -40.41 2.53 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.586 -1.406 . . . . 10.0 109.586 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.484 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 2.2 t70 -97.4 -34.84 10.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.965 0.412 . . . . 10.0 110.103 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 64' ' ' ALA . 76.0 t80 -56.26 -50.97 69.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.706 . . . . 10.0 112.432 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -35.31 76.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.457 -0.338 . . . . 10.0 111.482 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 20.5 mtmt -70.65 -28.9 65.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.765 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -60.99 -49.74 76.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.623 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -73.93 -32.06 63.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.605 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.88 -18.99 63.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.6 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.74 5.88 43.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.938 -0.648 . . . . 10.0 111.689 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.0 mt -106.49 177.48 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.958 0.408 . . . . 10.0 111.042 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.405 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 49.3 t30 -98.22 -162.65 0.97 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.765 -0.652 . . . . 10.0 109.942 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.405 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 13.5 m-85 65.43 78.28 0.26 Allowed Pre-proline 0 N--CA 1.464 0.258 0 C-N-CA 122.829 0.451 . . . . 10.0 111.356 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.05 -0.69 10.57 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.616 2.211 . . . . 10.0 112.3 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 4.4 mmpt? -101.22 10.55 40.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.155 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 43' ' ' LEU . 16.5 mt -85.76 112.56 45.71 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.019 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.487 ' HG2' ' HA ' ' A' ' 61' ' ' ILE . 72.9 Cg_endo -79.03 63.44 8.71 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.571 2.181 . . . . 10.0 111.051 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 62' ' ' THR . 99.3 t -73.38 117.89 17.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.825 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.799 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 21.7 t -103.28 138.98 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.439 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -97.68 107.09 19.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.119 -0.492 . . . . 10.0 110.922 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 54.0 t0 -103.18 84.33 2.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.894 0.378 . . . . 10.0 110.237 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.424 ' HA ' ' HG2' ' A' ' 66' ' ' PRO . 28.2 t-20 -63.9 116.87 6.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 10.0 112.109 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.96 -19.66 53.91 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.825 -0.703 . . . . 10.0 112.629 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.77 50.71 5.13 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.106 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 102' ' ' SER . 0.2 OUTLIER -62.46 -42.12 99.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.976 0.417 . . . . 10.0 110.523 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.9 mm -82.88 -40.2 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.889 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.576 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -60.63 -45.12 95.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.759 -0.655 . . . . 10.0 111.655 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -72.0 -30.04 64.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 98' ' ' THR . 1.4 t -65.86 -38.53 89.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.948 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.13 7.2 44.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.947 0.404 . . . . 10.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.3 t30 50.48 60.98 3.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.421 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 100' ' ' ALA . 79.9 mt -87.14 98.46 7.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.752 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.21 8.62 25.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.914 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.617 ' HA ' ' CD ' ' B' ' 110' ' ' PRO . 7.0 p -149.17 154.53 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.67 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.656 ' HE1' ' HB3' ' A' ' 31' ' ' PHE . 57.1 m-85 -131.05 152.63 81.01 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.252 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 126' ' ' GLY . 97.8 Cg_endo -82.39 161.7 76.75 Favored 'Cis proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.935 -1.694 . . . . 10.0 111.372 -1.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 m -127.67 131.34 49.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.698 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -118.82 125.12 48.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.19 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.54 113.08 26.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.843 0.354 . . . . 10.0 110.332 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 140' ' ' PRO . 44.1 tp -89.51 101.12 13.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.168 0.509 . . . . 10.0 111.293 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.28 133.13 32.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.666 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.26 -177.43 49.96 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.088 -0.577 . . . . 10.0 113.244 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -67.86 -11.4 58.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.265 0.469 . . . . 10.0 112.265 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.36 -7.94 30.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 10.0 111.382 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.38 -7.0 63.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.684 -0.769 . . . . 10.0 112.626 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -89.0 156.0 19.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.734 0.302 . . . . 10.0 110.844 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.6 t -78.55 107.75 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.149 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -81.99 -41.52 20.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.263 -0.426 . . . . 10.0 111.507 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -148.76 160.01 43.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.372 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.9 tt -138.14 141.44 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.493 -0.558 . . . . 10.0 109.493 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.3 t -121.92 129.98 74.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.202 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -133.21 124.68 27.84 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.437 -0.347 . . . . 10.0 110.128 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.598 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 132.88 -72.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.44 -0.886 . . . . 10.0 112.511 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.79 ' HB2' HG22 ' B' ' 107' ' ' VAL . 5.1 t -178.83 162.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.6 pt -146.28 152.17 13.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.158 -0.474 . . . . 10.0 109.914 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -109.96 170.41 8.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.836 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -56.41 -43.8 79.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.03 78.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 10.0 110.807 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -67.86 -37.26 81.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.903 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.66 97.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.0 mt -69.37 -40.92 77.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.782 -0.644 . . . . 10.0 110.5 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.29 -36.71 84.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.067 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.604 HD11 HD22 ' A' ' 113' ' ' LEU . 16.8 tp -62.83 -35.75 80.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.933 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.87 -36.81 59.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.343 0.592 . . . . 10.0 109.416 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -70.24 -47.48 61.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.465 -0.789 . . . . 10.0 110.709 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 23.3 t0 -150.42 112.27 3.23 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.495 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.688 ' HB3' HD21 ' A' ' 113' ' ' LEU . 19.3 Cg_exo -68.01 -7.32 19.44 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.922 2.415 . . . . 10.0 112.061 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -92.85 -0.27 57.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.932 0.396 . . . . 10.0 111.187 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.39 84.2 7.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.902 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.546 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 17.0 t70 -75.69 147.33 39.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.051 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.977 -1.011 . . . . 10.0 113.108 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.795 0.331 . . . . 10.0 110.837 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.22 -72.61 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.523 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 38.2 tp -78.98 -77.29 0.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 59.03 36.13 24.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.116 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.95 159.29 42.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.242 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 21.5 m120 64.03 -154.2 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.448 -0.797 . . . . 10.0 111.761 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -107.19 17.54 22.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.965 0.412 . . . . 10.0 111.028 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.35 8.59 4.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.476 0.547 . . . . 10.0 112.476 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.16 132.61 14.74 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.69 -0.232 . . . . 10.0 111.094 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' PRO . . . . . 0.522 ' HB2' ' OE1' ' B' ' 12' ' ' GLU . 24.1 Cg_endo -60.87 153.93 59.65 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.353 2.702 . . . . 10.0 112.184 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.55 -40.25 54.87 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.591 2.86 . . . . 10.0 113.612 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.522 ' OE1' ' HB2' ' B' ' 10' ' ' PRO . 3.0 pm0 -65.49 -13.81 59.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -117.13 -1.13 11.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.205 0.526 . . . . 10.0 110.412 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.69 -12.48 23.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.116 -0.493 . . . . 10.0 112.077 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -124.01 128.74 49.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.859 0.362 . . . . 10.0 111.486 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' B' ' 31' ' ' ARG . 40.6 t -114.71 91.11 24.27 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.389 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.509 ' HG2' ' HG3' ' B' ' 126' ' ' PRO . 14.2 Cg_exo -70.52 95.78 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.986 2.458 . . . . 10.0 112.367 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.51 97.74 11.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' B' ' 123' ' ' THR . 3.3 mm? -87.93 110.31 20.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.159 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.5 101.92 10.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.158 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.491 HG13 HG22 ' B' ' 26' ' ' VAL . 47.8 t -88.96 130.98 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.186 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.96 176.28 5.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.847 -0.427 . . . . 10.0 109.847 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.22 -34.16 68.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.929 0.395 . . . . 10.0 111.447 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.46 -36.34 53.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.277 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' B' ' 85' ' ' TYR . . . -178.75 -175.93 46.2 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.961 -0.638 . . . . 10.0 111.692 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.491 HG22 HG13 ' B' ' 21' ' ' VAL . 54.5 t -98.09 133.35 40.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 110.228 -0.286 . . . . 10.0 110.228 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -120.28 105.45 10.94 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.967 -0.383 . . . . 10.0 109.967 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.472 HG22 ' HD1' ' B' ' 30' ' ' PHE . 6.3 p -93.57 124.19 45.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.128 0.489 . . . . 10.0 110.969 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -127.47 85.77 2.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.91 -0.586 . . . . 10.0 109.947 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.472 ' HD1' HG22 ' B' ' 28' ' ' VAL . 1.9 p90 -82.71 111.23 18.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.265 0.555 . . . . 10.0 111.004 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.435 ' HB2' ' HB ' ' B' ' 16' ' ' VAL . 32.5 mtm-85 -75.55 112.5 11.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.453 -0.794 . . . . 10.0 110.194 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -91.65 145.21 7.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.819 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.8 155.06 40.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.148 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.15 88.16 2.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.104 0.478 . . . . 10.0 111.27 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.74 -15.46 0.45 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.538 -0.625 . . . . 10.0 111.538 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -109.66 142.37 40.92 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -133.9 136.98 44.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.86 0.362 . . . . 10.0 110.862 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' MET . . . . . 0.48 ' HA ' ' HA3' ' B' ' 101' ' ' GLY . 41.1 mtt -108.52 147.65 31.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.864 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.474 ' O ' HG13 ' B' ' 43' ' ' ILE . 50.0 m-85 -88.25 123.82 33.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.853 -0.425 . . . . 10.0 109.853 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -60.08 -32.42 70.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.517 -0.31 . . . . 10.0 111.403 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.67 5.74 20.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.306 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.446 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 24.0 mmtt -124.58 -8.42 7.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.461 -0.336 . . . . 10.0 111.836 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 39' ' ' TYR . 86.9 mt -83.91 99.21 6.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.251 0.548 . . . . 10.0 110.155 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 41.6 t -90.25 112.0 24.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.09 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' B' ' 96' ' ' VAL . . . -141.73 128.71 3.71 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.893 -0.67 . . . . 10.0 111.545 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -160.56 143.13 13.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.945 0.402 . . . . 10.0 111.444 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.635 ' HB ' HD13 ' B' ' 95' ' ' LEU . 13.4 t -134.6 131.45 37.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.903 -0.59 . . . . 10.0 109.64 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.482 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 9.2 p30 -177.08 158.08 1.37 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.576 -0.284 . . . . 10.0 110.774 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.418 ' HG3' ' HD2' ' B' ' 93' ' ' TYR . 9.3 Cg_exo -74.67 -58.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.614 2.209 . . . . 10.0 110.976 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.63 48.53 2.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 10.0 109.795 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.414 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 0.4 OUTLIER 66.23 36.62 5.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.326 -0.852 . . . . 10.0 111.748 -178.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' B' ' 52' ' ' LEU . 2.4 mm? -97.01 56.69 1.43 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.712 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' B' ' 48' ' ' ASN . 11.8 tp -130.64 152.1 50.38 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.097 -0.705 . . . . 10.0 109.097 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.71 -87.26 0.3 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.542 -0.837 . . . . 10.0 111.726 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.41 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 3.5 pp0? -155.93 149.29 18.67 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 110.008 -0.368 . . . . 10.0 110.008 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 26.4 Cg_exo -63.45 107.15 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.661 2.24 . . . . 10.0 111.168 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 3.1 m -79.2 95.38 5.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.154 0.502 . . . . 10.0 110.78 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -78.04 144.57 36.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.528 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.7 m -82.64 -9.38 59.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.566 -0.288 . . . . 10.0 111.318 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? 71.24 166.22 0.3 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.907 -0.588 . . . . 10.0 111.979 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.14 -134.56 1.74 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.463 -0.655 . . . . 10.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -106.44 151.9 24.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.623 0.212 . . . . 10.0 110.558 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -90.89 125.87 35.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -102.16 128.52 48.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.497 -0.32 . . . . 10.0 110.977 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.76 130.62 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.322 -0.621 . . . . 10.0 109.322 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -133.91 163.53 29.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -93.24 -30.28 15.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.822 0.344 . . . . 10.0 111.301 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -100.27 -39.35 8.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.592 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -89.87 -9.2 49.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.89 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.76 -85.79 0.97 Allowed Glycine 0 C--O 1.227 -0.333 0 C-N-CA 120.758 -0.734 . . . . 10.0 112.673 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -165.24 115.91 1.11 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.645 0.259 . . . . 10.0 110.956 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -138.99 158.72 43.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.288 -0.415 . . . . 10.0 110.447 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 5.6 m -70.79 130.4 41.6 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.425 -0.583 . . . . 10.0 109.425 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.55 150.21 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.377 0.608 . . . . 10.0 112.179 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -110.8 116.36 31.14 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.86 -1.163 . . . . 10.0 107.86 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -103.78 -3.01 25.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.581 0.585 . . . . 10.0 112.581 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.14 -41.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.186 0.517 . . . . 10.0 109.672 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 1.0 OUTLIER -89.26 100.4 13.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.329 -0.85 . . . . 10.0 110.98 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.49 107.39 8.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.979 0.419 . . . . 10.0 111.397 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -138.43 128.01 24.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.689 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 19.0 t -128.65 129.6 68.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.251 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' B' ' 57' ' ' SER . . . -102.72 144.06 31.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.605 -0.271 . . . . 10.0 110.469 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' PHE . . . . . 0.435 ' HD2' ' HB ' ' B' ' 26' ' ' VAL . 58.2 m-85 -119.86 100.54 48.57 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.691 0.282 . . . . 10.0 111.684 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.05 118.81 2.39 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.995 2.463 . . . . 10.0 112.01 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' TYR . . . . . 0.425 ' CE2' ' HA2' ' B' ' 25' ' ' GLY . 36.7 m-85 -66.4 144.47 56.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 10.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.48 11.66 34.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.23 0.538 . . . . 10.0 109.797 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -164.04 124.93 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.317 -0.856 . . . . 10.0 109.955 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.05 92.55 6.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.06 0.457 . . . . 10.0 110.59 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 12.0 m -121.78 163.7 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.614 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.31 21.02 22.64 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.743 -0.741 . . . . 10.0 111.673 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -93.51 138.04 23.13 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.19 127.75 24.12 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.589 2.193 . . . . 10.0 111.039 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' TYR . . . . . 0.418 ' HD2' ' HG3' ' B' ' 49' ' ' PRO . 0.1 OUTLIER -108.54 153.78 22.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.435 -179.001 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -95.69 152.08 18.78 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.691 -0.485 . . . . 10.0 109.691 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.635 HD13 ' HB ' ' B' ' 47' ' ' THR . 22.7 tp -126.6 124.22 39.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.695 0.283 . . . . 10.0 110.601 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.475 ' O ' ' HA2' ' B' ' 45' ' ' GLY . 24.6 t -108.69 123.05 64.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 81.9 mt -126.63 120.26 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 10.0 111.833 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' THR . . . . . 0.675 HG23 ' HB3' ' B' ' 113' ' ' ASP . 5.5 m -112.96 117.14 31.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.745 -0.661 . . . . 10.0 109.828 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 24.2 m-85 -99.6 107.17 19.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.627 0.251 . . . . 10.0 111.085 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 14.7 tp60 -121.5 126.02 48.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 10.0 110.936 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -167.64 -157.76 11.18 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.432 -0.667 . . . . 10.0 111.432 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.3 m -153.51 167.84 28.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -105.17 144.67 31.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.42 -16.51 60.77 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.107 0.41 . . . . 10.0 112.107 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.27 -12.51 56.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.456 -0.338 . . . . 10.0 111.78 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.48 -14.77 10.77 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.371 -0.918 . . . . 10.0 113.006 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 127' ' ' SER . 46.2 t -63.45 131.8 29.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.94 76.92 1.32 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.961 0.41 . . . . 10.0 110.695 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -66.02 157.14 81.87 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.949 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.649 ' HD3' ' H ' ' A' ' 108' ' ' TYR . 93.8 Cg_endo -85.8 160.22 10.5 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.778 2.319 . . . . 10.0 112.155 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.751 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 85.6 Cg_endo -79.31 70.56 7.45 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.743 2.296 . . . . 10.0 111.62 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.766 HG22 HD11 ' A' ' 69' ' ' LEU . 16.6 t -67.04 93.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.775 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ASP . . . . . 0.675 ' HB3' HG23 ' B' ' 98' ' ' THR . 6.3 p-10 -78.07 150.26 33.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.78 -0.645 . . . . 10.0 111.857 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 10.3 m -137.36 144.99 42.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.513 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -104.29 138.06 41.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.821 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -121.27 153.16 38.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.715 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -114.05 120.58 41.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.985 -0.376 . . . . 10.0 109.985 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 19.8 mm -95.87 79.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.247 0.546 . . . . 10.0 110.328 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -94.01 -14.02 26.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.222 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.44 110.03 2.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.082 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -167.55 -32.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.033 0.444 . . . . 10.0 110.624 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.71 -80.2 0.27 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.924 -0.655 . . . . 10.0 111.552 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 9.1 m -101.01 135.48 42.39 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.083 -0.34 . . . . 10.0 110.083 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -126.04 157.96 36.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.786 0.327 . . . . 10.0 111.217 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.38 148.41 20.97 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' PRO . . . . . 0.509 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 35.7 Cg_endo -66.35 137.99 49.19 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.278 1.986 . . . . 10.0 112.565 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -97.49 62.53 1.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.92 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.396 -0.811 . . . . 10.0 110.294 -179.682 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.17 62.61 39.58 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.73 -31.45 48.97 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.192 1.928 . . . . 10.0 111.514 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.89 -40.91 95.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.463 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.68 -40.43 80.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.557 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.1 tp -60.52 -32.89 71.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.207 0.527 . . . . 10.0 110.273 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.8 m -84.44 -15.92 44.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.959 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 45.8 m -79.94 -23.47 41.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.463 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -64.4 106.55 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.205 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 58.6 mttp -97.28 148.16 23.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.978 -0.556 . . . . 10.0 110.626 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.746 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 39.6 p -81.11 172.72 13.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.003 -0.544 . . . . 10.0 109.667 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.37 -5.52 19.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 10.0 110.212 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -92.53 5.01 52.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.356 -0.838 . . . . 10.0 109.825 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 73.06 13.59 4.83 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.327 0.862 . . . . 10.0 113.327 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -116.83 139.84 26.15 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.442 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 18.1 Cg_endo -57.75 146.31 86.11 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.795 2.33 . . . . 10.0 112.153 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.12 -1.25 7.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 10.0 111.759 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.568 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 4.4 m -59.42 -20.95 58.96 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.145 -0.48 . . . . 10.0 111.535 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 20' ' ' TYR . 21.7 m -65.39 -13.94 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.088 0.47 . . . . 10.0 110.849 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.416 ' HD2' HG23 ' A' ' 19' ' ' VAL . 22.7 m-85 -125.66 20.47 7.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.601 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 70.7 mt -129.61 40.16 3.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.489 -0.778 . . . . 10.0 110.328 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -138.44 -178.46 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.88 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.2 mttp 69.35 12.31 8.3 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.824 0.675 . . . . 10.0 112.824 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 58.56 28.79 17.55 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.192 0.52 . . . . 10.0 111.486 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -94.51 138.19 22.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.46 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.54 141.79 90.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.87 2.38 . . . . 10.0 111.183 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -108.4 144.21 36.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.855 0.36 . . . . 10.0 111.425 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.435 HD23 ' HG ' ' A' ' 60' ' ' LEU . 21.0 tp -123.98 104.34 8.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.697 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 77.8 mt -88.23 118.22 33.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.72 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.541 ' HD2' HG22 ' A' ' 62' ' ' THR . 7.9 tmtm? -110.04 116.46 31.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.666 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -90.43 148.27 22.9 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.293 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -150.53 175.88 11.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.527 -0.306 . . . . 10.0 111.32 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.78 146.97 50.04 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.366 -0.605 . . . . 10.0 109.366 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 m -70.88 -63.75 1.04 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.51 ' CZ2' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.41 59.31 4.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -178.346 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 1.6 t -135.46 123.34 15.27 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.327 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 52.3 Cg_exo -56.61 -49.02 16.06 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.748 2.299 . . . . 10.0 112.568 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 38' ' ' LEU . 5.7 mp -59.61 -52.74 64.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.996 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 80.5 m -64.88 -33.07 75.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.846 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.483 ' HB3' ' CE2' ' B' ' 68' ' ' PHE . 10.7 tp -62.2 -48.49 79.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.411 -0.358 . . . . 10.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 m -69.94 -32.46 70.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.535 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.86 -35.3 79.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.563 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.7 -39.8 81.8 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.912 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.4 -29.32 72.94 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.964 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -87.76 -27.54 22.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.873 0.368 . . . . 10.0 110.092 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.2 m -61.11 -47.91 84.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 10.0 110.912 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.658 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -62.91 -37.31 86.49 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.939 0.4 . . . . 10.0 110.221 179.424 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.85 -46.85 83.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.883 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -63.2 -42.68 99.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 10.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.41 -4.93 12.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.773 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -113.35 10.64 18.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.765 0.317 . . . . 10.0 111.496 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' HB3' ' HD1' ' A' ' 55' ' ' PHE . 11.5 t70 -93.75 148.7 21.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.735 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.95 -31.85 72.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.41 -46.22 77.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.107 0.479 . . . . 10.0 111.084 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.405 ' HD1' ' HB3' ' A' ' 52' ' ' ASP . 76.5 m-85 -74.85 -8.02 55.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.639 . . . . 10.0 112.364 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.3 m -70.24 -13.46 62.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.143 0.497 . . . . 10.0 110.86 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 m -69.91 -24.04 63.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.949 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.15 176.45 7.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.453 . . . . 10.0 110.956 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -108.57 98.63 8.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HG ' HD23 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -84.45 124.22 31.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.631 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.66 138.59 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 10.0 111.508 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.541 HG22 ' HD2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -92.38 109.76 21.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.865 -0.607 . . . . 10.0 109.681 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.9 137.4 42.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.092 0.473 . . . . 10.0 111.656 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.09 147.13 39.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.293 -1.002 . . . . 10.0 108.293 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 4.8 m -106.43 98.18 19.04 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 112.268 0.469 . . . . 10.0 112.268 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HG3' HG22 ' A' ' 93' ' ' THR . 30.2 Cg_endo -64.43 123.4 11.72 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.674 2.249 . . . . 10.0 111.882 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.88 3.33 73.84 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.817 -0.629 . . . . 10.0 112.706 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 3.0 t80 -116.0 148.37 40.2 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.71 -0.288 . . . . 10.0 110.487 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER 58.56 27.58 15.87 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.828 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.6 OUTLIER 71.52 20.21 4.88 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.716 -0.675 . . . . 10.0 112.371 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.51 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 2.3 mm-40 -81.72 -172.54 3.93 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.876 0.37 . . . . 10.0 111.155 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.666 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 9.4 mmpt? -69.37 133.13 47.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.402 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -68.66 158.27 34.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 10.0 112.017 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -55.62 141.57 37.11 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.575 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 78' ' ' GLN . . . 95.46 -60.68 1.53 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.813 -0.915 . . . . 10.0 110.813 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.96 -36.71 78.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 10.0 109.917 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.14 -41.15 97.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.407 -0.815 . . . . 10.0 111.643 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 10.9 pt20 -66.53 -29.52 69.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.954 0.407 . . . . 10.0 110.558 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -69.93 -28.59 65.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.287 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -66.07 -44.87 83.24 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.941 -0.763 . . . . 10.0 108.941 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -65.0 -38.47 91.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.198 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.77 -20.97 66.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.44 16.16 52.83 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.037 -0.602 . . . . 10.0 112.231 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 mt -118.43 158.38 25.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.658 0.266 . . . . 10.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.402 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 66.1 t30 -82.95 -173.88 4.95 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.45 -0.574 . . . . 10.0 109.45 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.402 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 89.2 m-85 68.88 76.24 0.25 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-O 121.211 0.529 . . . . 10.0 110.207 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.14 8.82 3.03 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.747 2.298 . . . . 10.0 112.473 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -108.13 4.58 25.07 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.116 -0.234 . . . . 10.0 110.903 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.658 ' HG ' ' HG3' ' A' ' 47' ' ' GLU . 13.2 mt -78.23 112.52 26.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.714 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 89' ' ' LEU . 2.9 Cg_exo -76.45 71.21 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.959 2.439 . . . . 10.0 111.179 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.69 114.24 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.918 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.746 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 20.0 t -96.53 133.53 37.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.047 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.701 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.14 96.01 8.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.012 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -83.37 82.38 8.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.191 0.52 . . . . 10.0 110.058 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -64.31 106.52 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.896 -0.593 . . . . 10.0 111.739 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.61 -24.21 26.24 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.009 -0.615 . . . . 10.0 112.123 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.11 53.41 3.14 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.616 -0.802 . . . . 10.0 111.821 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -47.15 84.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.027 0.441 . . . . 10.0 110.659 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.7 mm -77.05 -40.86 30.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.983 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.44 90.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.851 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -75.39 -42.66 53.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.558 0.218 . . . . 10.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -62.23 -38.42 89.14 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.7 mt -97.1 -2.47 43.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.655 -0.248 . . . . 10.0 111.519 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t30 53.62 58.19 5.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.958 -0.565 . . . . 10.0 111.202 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.1 109.43 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.165 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.13 17.56 14.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.953 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.842 HG23 ' HB3' ' B' ' 109' ' ' TYR . 11.4 p -149.58 147.83 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.543 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.5 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 27.5 m-85 -127.88 160.02 63.44 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.392 -0.596 . . . . 10.0 109.392 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.5 ' HA ' ' HB3' ' A' ' 108' ' ' TYR . 2.1 Cg_endo -88.06 124.41 6.96 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.972 -1.262 . . . . 10.0 111.277 -0.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.0 m -105.68 143.07 34.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.124 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -121.47 129.77 53.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.19 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.697 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -111.33 114.9 28.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.199 -0.455 . . . . 10.0 111.063 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.419 HD22 HD11 ' A' ' 136' ' ' LEU . 24.5 tp -92.13 117.1 29.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.778 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.24 136.2 38.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.605 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -74.59 -173.43 30.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.227 -0.511 . . . . 10.0 113.401 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 116' ' ' LYS . 5.7 mtmt -73.6 -12.97 60.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.975 0.417 . . . . 10.0 111.121 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.27 7.48 46.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.865 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.74 24.71 76.32 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.866 -0.683 . . . . 10.0 111.904 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -114.03 153.5 29.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.784 0.326 . . . . 10.0 110.761 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.3 t -67.78 113.99 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.926 0.393 . . . . 10.0 110.199 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -51.15 5.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.228 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -146.8 139.18 24.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.863 0.363 . . . . 10.0 111.587 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.6 tp -110.37 130.93 62.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.065 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.9 t -122.04 132.26 71.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -138.67 136.96 36.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 10.0 111.372 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.467 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 127.56 -80.43 0.36 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.055 -0.593 . . . . 10.0 112.477 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 p -172.62 142.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.604 -0.517 . . . . 10.0 109.604 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -125.49 171.91 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 10.0 110.843 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 132' ' ' GLN . 11.4 p30 -130.33 167.69 18.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.829 -0.434 . . . . 10.0 109.829 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -58.27 -49.96 75.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.5 89.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.368 . . . . 10.0 110.867 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.402 ' HB2' ' ND2' ' A' ' 129' ' ' ASN . 38.0 tt0 -64.62 -38.79 92.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.041 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.84 92.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 10.0 109.8 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.82 -38.48 91.11 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.962 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.63 90.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 10.0 110.631 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.419 HD11 HD22 ' A' ' 113' ' ' LEU . 15.4 tp -63.92 -34.74 78.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.461 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.98 -33.35 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -70.34 -48.66 55.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.813 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 49.4 t0 -148.67 117.08 3.95 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.29 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 29.1 Cg_endo -63.24 -10.08 19.8 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.01 2.473 . . . . 10.0 112.659 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -81.65 -7.71 59.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.929 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.92 125.4 26.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.785 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.534 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 19.5 t70 -136.1 143.93 44.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.152 -0.477 . . . . 10.0 109.92 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.918 -1.039 . . . . 10.0 112.523 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.754 0.312 . . . . 10.0 110.679 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.07 -85.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.788 0.328 . . . . 10.0 110.685 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.416 ' HG ' ' H ' ' B' ' 5' ' ' ALA . 56.0 tp -97.58 -61.75 1.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.228 -0.442 . . . . 10.0 109.984 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ASP . . . . . 0.573 ' HA ' HD13 ' B' ' 9' ' ' LEU . 1.7 m-20 57.23 35.63 26.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.884 -0.598 . . . . 10.0 111.227 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ALA . . . . . 0.416 ' H ' ' HG ' ' B' ' 3' ' ' LEU . . . -144.37 165.67 27.27 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.902 -0.59 . . . . 10.0 111.006 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' B' ' 7' ' ' ASP . 0.7 OUTLIER 62.44 -151.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.781 . . . . 10.0 112.235 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 7' ' ' ASP . . . . . 0.456 ' H ' ' HB3' ' B' ' 6' ' ' ASN . 11.7 p-10 -108.47 27.24 9.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.657 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.62 23.07 9.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.739 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' B' ' 4' ' ' ASP . 2.7 pt? -147.99 137.27 11.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.148 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' PRO . . . . . 0.402 ' HB2' ' OE1' ' B' ' 12' ' ' GLU . 33.6 Cg_endo -63.78 145.41 90.77 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.022 2.482 . . . . 10.0 112.542 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.95 -36.77 76.56 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.464 2.776 . . . . 10.0 113.646 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' B' ' 10' ' ' PRO . 1.5 pm0 -69.8 -4.31 19.47 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.409 ' HD3' HD12 ' B' ' 9' ' ' LEU . 1.8 tmtm? -126.59 -8.68 6.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.526 0.679 . . . . 10.0 109.838 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.67 -7.84 59.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 10.0 112.239 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.475 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 27.7 m-85 -130.49 123.37 29.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.811 0.338 . . . . 10.0 111.011 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.48 95.62 16.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.327 -0.619 . . . . 10.0 109.327 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' B' ' 30' ' ' PHE . 2.9 Cg_exo -75.05 93.59 0.96 Allowed 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.186 2.59 . . . . 10.0 113.217 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -90.37 97.36 11.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.9 mm? -84.59 122.63 29.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.438 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.01 109.37 12.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.199 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.479 HG21 ' HE2' ' B' ' 124' ' ' TYR . 93.7 t -97.57 120.27 46.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.846 0.355 . . . . 10.0 111.082 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.62 169.5 9.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.14 -32.54 72.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.001 0.429 . . . . 10.0 110.975 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -80.28 -37.07 33.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.994 -0.548 . . . . 10.0 111.722 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -175.51 173.82 46.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.532 -0.842 . . . . 10.0 112.444 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.455 HG13 HG22 ' B' ' 21' ' ' VAL . 47.2 t -89.38 140.46 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.615 0.245 . . . . 10.0 110.755 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -129.54 111.01 12.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.736 -0.468 . . . . 10.0 109.736 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' B' ' 80' ' ' GLN . 7.3 p -92.02 125.09 44.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.953 0.406 . . . . 10.0 111.182 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -129.18 80.47 1.97 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.365 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' B' ' 17' ' ' PRO . 21.5 p90 -89.72 126.62 35.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.887 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtm-85 -81.76 124.93 30.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.923 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.494 ' HB ' ' HA ' ' B' ' 77' ' ' HIS . 59.8 mt -99.37 133.7 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.771 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 148.88 33.7 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.517 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.25 74.7 1.82 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.251 0.548 . . . . 10.0 111.675 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.21 -20.77 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.037 -0.825 . . . . 10.0 111.037 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -105.25 153.19 21.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.89 -0.781 . . . . 10.0 108.89 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -145.45 139.62 26.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.005 0.431 . . . . 10.0 111.417 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 40.8 mtt -110.26 156.48 20.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.925 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.679 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 31.3 m-85 -97.78 124.06 41.98 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.738 -0.468 . . . . 10.0 109.738 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -60.71 -28.54 68.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.093 0.473 . . . . 10.0 111.465 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.83 15.03 12.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 10.0 111.284 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.679 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 6.5 mmtm -130.85 -18.26 3.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.637 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.453 HG13 ' O ' ' B' ' 39' ' ' TYR . 80.8 mt -77.61 119.82 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.38 . . . . 10.0 110.23 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' B' ' 98' ' ' THR . 56.5 t -98.23 126.65 51.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.023 -0.535 . . . . 10.0 109.565 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -151.55 119.77 1.02 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.733 -0.746 . . . . 10.0 111.909 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 27.4 pttt -150.74 139.67 20.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.733 0.302 . . . . 10.0 110.965 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.63 ' HB ' HD13 ' B' ' 95' ' ' LEU . 4.8 t -138.75 125.37 20.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.587 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 19.9 p30 179.43 162.33 0.78 Allowed Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.267 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.68 -70.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.663 2.242 . . . . 10.0 111.313 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.29 57.21 0.73 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.87 0.366 . . . . 10.0 111.362 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.3 t70 65.19 32.89 9.75 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.268 0.556 . . . . 10.0 112.089 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' B' ' 52' ' ' LEU . 1.2 mm? -96.1 58.43 1.85 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.684 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 36.4 tp -124.49 139.49 53.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.601 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 -72.51 1.11 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.636 -0.792 . . . . 10.0 111.511 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.88 151.57 9.42 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.06 103.03 1.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.583 2.189 . . . . 10.0 110.392 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 49.4 m -76.79 104.78 7.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.021 0.439 . . . . 10.0 111.684 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -85.02 146.2 27.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.044 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 37.3 m -76.8 -11.64 59.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.448 -0.342 . . . . 10.0 111.485 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? 70.82 119.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.638 0.587 . . . . 10.0 112.513 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.81 -136.02 8.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.879 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -112.18 153.7 26.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.68 0.276 . . . . 10.0 111.002 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.62 119.52 26.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.53 -0.545 . . . . 10.0 109.53 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -101.16 139.85 36.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.841 0.353 . . . . 10.0 111.273 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -77.8 133.16 38.27 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.218 -1.031 . . . . 10.0 108.218 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -132.88 168.52 18.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.804 0.335 . . . . 10.0 110.889 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -101.85 -32.09 10.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.198 -0.455 . . . . 10.0 111.232 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 1.6 m-85 -109.69 -38.6 5.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.625 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.405 ' HD1' ' HA ' ' B' ' 69' ' ' PHE . 8.3 m-30 -84.42 -12.1 55.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.84 0.352 . . . . 10.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.11 -100.56 1.77 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.028 -0.606 . . . . 10.0 112.605 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -136.14 110.24 8.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.522 -0.547 . . . . 10.0 109.522 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -136.39 153.05 51.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.889 0.376 . . . . 10.0 111.588 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.23 127.32 32.3 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.036 -0.727 . . . . 10.0 109.036 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.68 153.6 33.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.509 0.671 . . . . 10.0 112.311 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -110.33 120.65 43.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -106.66 -1.82 22.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.049 0.759 . . . . 10.0 113.049 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.494 ' HA ' ' HB ' ' B' ' 32' ' ' ILE . 2.4 t60 -175.83 -37.53 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.219 -0.66 . . . . 10.0 109.219 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.8 OUTLIER -85.43 138.44 32.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.049 -0.978 . . . . 10.0 109.568 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 30' ' ' PHE . . . -160.39 119.43 2.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.781 0.324 . . . . 10.0 110.612 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 24.3 tt0 -159.62 121.9 3.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.347 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.76 126.66 67.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 10.0 109.665 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' B' ' 57' ' ' SER . . . -98.63 139.08 34.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.068 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -118.81 98.21 51.03 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 112.207 0.447 . . . . 10.0 112.207 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.44 127.94 6.79 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.063 2.509 . . . . 10.0 110.777 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -74.01 147.82 42.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.442 -0.344 . . . . 10.0 111.277 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.16 -5.8 54.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 10.0 110.538 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -153.02 147.1 25.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.709 -0.678 . . . . 10.0 109.867 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.56 85.37 4.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.911 0.386 . . . . 10.0 111.037 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.75 155.15 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.501 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.12 33.38 6.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.92 -0.657 . . . . 10.0 112.607 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -96.68 139.41 21.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.671 -0.492 . . . . 10.0 109.671 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.58 111.91 1.18 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.731 2.287 . . . . 10.0 111.507 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.12 161.07 21.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.134 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' B' ' 47' ' ' THR . 78.9 tttt -110.33 142.44 41.98 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.63 HD13 ' HB ' ' B' ' 47' ' ' THR . 58.6 tp -116.36 111.67 20.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.867 0.365 . . . . 10.0 110.788 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 41.6 t -101.84 113.49 38.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 96.5 mt -117.48 139.18 51.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.965 0.412 . . . . 10.0 111.414 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' THR . . . . . 0.604 ' HB ' ' HB ' ' B' ' 44' ' ' VAL . 20.9 m -134.36 118.55 17.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.036 -0.727 . . . . 10.0 109.036 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 50.6 m-85 -98.69 112.14 24.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.099 0.407 . . . . 10.0 112.099 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.67 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 15.8 tp60 -122.8 118.25 27.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.313 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.19 -160.18 10.22 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.729 -0.748 . . . . 10.0 111.758 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 25.3 m -153.58 -179.57 7.91 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.486 -0.561 . . . . 10.0 109.486 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' ALA . . . . . 0.67 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -120.08 139.29 52.78 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.39 11.66 0.43 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.369 0.418 . . . . 10.0 112.114 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.92 6.08 20.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.453 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.92 26.84 9.34 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.431 -0.89 . . . . 10.0 113.436 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 20.3 t -115.27 141.88 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 53.3 t -136.21 89.53 2.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 10.0 110.907 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.842 ' HB3' HG23 ' A' ' 107' ' ' VAL . 53.3 p90 -78.27 151.09 77.94 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.323 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.566 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 57.9 Cg_endo -71.38 164.42 35.79 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.718 2.279 . . . . 10.0 111.567 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.828 ' HG2' ' HB3' ' A' ' 70' ' ' HIS . 71.9 Cg_endo -77.01 72.91 5.66 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.707 2.271 . . . . 10.0 112.419 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.401 HG22 ' CD1' ' A' ' 69' ' ' LEU . 24.2 t -62.86 124.4 17.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.622 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -104.87 160.95 14.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.148 0.499 . . . . 10.0 111.694 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.2 m -150.31 119.0 6.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.607 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' GLU . . . . . 0.457 ' HB3' ' HE2' ' B' ' 94' ' ' LYS . 31.6 mt-10 -92.97 126.63 38.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.052 0.453 . . . . 10.0 111.849 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.55 153.71 28.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.734 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -116.34 124.18 49.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.548 -0.538 . . . . 10.0 109.548 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 17.6 mm -90.21 72.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.234 0.54 . . . . 10.0 110.812 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -78.43 -26.61 46.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.361 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.88 48.55 0.15 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.612 -0.804 . . . . 10.0 113.078 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -107.22 -9.91 15.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.95 0.405 . . . . 10.0 110.639 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.63 -77.6 1.86 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.948 -0.644 . . . . 10.0 111.587 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 11.0 m -97.94 131.92 43.96 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.479 ' HE2' HG21 ' B' ' 21' ' ' VAL . 89.9 m-85 -120.26 155.29 33.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.975 0.417 . . . . 10.0 111.874 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -127.97 143.53 48.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.359 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.8 125.8 16.13 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.644 2.229 . . . . 10.0 111.883 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -85.71 82.61 8.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 179.701 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.92 88.67 31.82 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 10.0 111.603 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.93 -18.2 52.1 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.414 2.076 . . . . 10.0 111.906 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -62.53 -32.73 73.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.911 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 98' ' ' THR . 2.0 m -69.75 -41.73 74.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.536 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.29 -31.43 72.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.191 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 m -83.44 -8.43 59.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 10.0 110.636 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.9 m -91.91 -25.88 18.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.645 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -66.46 128.28 35.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.934 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.509 ' HG3' ' HA ' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -116.12 151.92 34.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.39 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.796 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 46.0 p -77.95 171.91 14.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.004 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.51 -15.29 63.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.537 0.684 . . . . 10.0 109.785 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.474 ' OD1' ' HB2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -82.55 -15.58 51.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.977 -1.01 . . . . 10.0 109.593 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.2 t30 97.33 -15.26 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.578 1.151 . . . . 10.0 112.326 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.557 ' HG3' ' HD2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -71.6 140.25 84.19 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 109.543 -0.54 . . . . 10.0 109.543 178.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HD2' ' HG3' ' A' ' 15' ' ' ARG . 34.6 Cg_endo -64.44 147.12 90.53 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.411 2.074 . . . . 10.0 111.703 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.79 -11.92 42.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.914 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 m -55.41 -24.19 28.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.443 . . . . 10.0 112.155 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 m -62.38 -22.74 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.9 0.381 . . . . 10.0 111.598 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.402 ' HB3' ' HB3' ' A' ' 59' ' ' ASN . 60.1 m-85 -127.55 29.17 5.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.282 0.563 . . . . 10.0 110.374 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.7 mt -136.22 28.99 3.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.943 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -134.28 -174.61 3.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.37 -0.377 . . . . 10.0 111.864 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt 71.61 11.19 6.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.772 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 56.82 33.9 23.82 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.395 -0.82 . . . . 10.0 111.686 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -101.16 147.53 33.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.46 142.17 95.18 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.061 2.507 . . . . 10.0 111.41 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 114' ' ' ILE . 2.0 m -112.66 143.3 44.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.858 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.411 HD23 ' HG ' ' A' ' 60' ' ' LEU . 15.2 tp -122.14 99.21 6.31 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.657 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 86.7 mt -90.43 120.95 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.803 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.502 ' HD2' HG22 ' A' ' 62' ' ' THR . 1.1 tmtp? -113.72 124.96 53.53 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.595 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.441 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 3.2 m-85 -101.02 141.74 33.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.514 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -149.02 169.3 20.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.787 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.405 ' HB1' ' CZ3' ' A' ' 35' ' ' TRP . . . -116.81 135.64 53.59 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -62.42 -59.09 5.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.294 0.85 . . . . 10.0 113.294 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.782 ' HZ2' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -85.65 38.49 0.75 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.087 0.773 . . . . 10.0 113.087 -178.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -115.54 126.02 28.18 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.316 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 28.1 Cg_endo -61.43 -44.61 21.85 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.829 2.353 . . . . 10.0 113.358 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.574 HD12 ' HB2' ' B' ' 108' ' ' CYS . 65.9 mt -64.11 -47.0 81.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 10.0 111.589 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.1 m -68.19 -33.73 74.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.507 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB3' ' CZ ' ' B' ' 68' ' ' PHE . 25.8 mt -64.49 -37.34 87.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 10.0 111.701 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m -72.07 -22.8 61.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.024 0.44 . . . . 10.0 111.157 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.24 -6.03 59.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.85 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.1 mt -59.3 -49.13 79.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.006 0.431 . . . . 10.0 111.151 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.86 -33.72 87.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.873 -0.68 . . . . 10.0 112.063 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -70.59 -41.58 72.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 10.0 110.665 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.2 m -60.67 -42.46 97.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.537 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -64.46 -41.18 96.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.128 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -64.9 -38.46 91.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.618 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -70.8 -34.39 71.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.467 . . . . 10.0 110.801 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.38 -13.21 62.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.01 0.434 . . . . 10.0 110.813 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -114.63 16.51 17.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 10.0 110.416 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 18.4 t70 -82.42 148.29 28.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.627 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.36 83.8 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -84.94 -43.09 14.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.537 0.208 . . . . 10.0 111.499 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.633 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 49.7 m-85 -66.22 -20.42 66.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 10.0 111.573 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 13.8 t -69.98 -0.28 7.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.952 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 m -84.62 -5.29 59.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 10.0 110.27 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -134.57 164.65 27.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.653 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 72.4 m-20 -92.3 94.72 9.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.475 -0.329 . . . . 10.0 110.188 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -84.3 121.64 27.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.966 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.6 pt -138.87 142.32 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 10.0 111.395 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.502 HG22 ' HD2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -100.97 113.78 27.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.566 -0.531 . . . . 10.0 109.566 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 92' ' ' VAL . 24.7 t -109.71 138.7 36.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.804 0.335 . . . . 10.0 111.235 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.93 154.48 49.21 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.444 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 9.9 m -112.78 96.16 36.31 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 112.386 0.513 . . . . 10.0 112.386 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.783 ' HG3' HG22 ' A' ' 93' ' ' THR . 38.1 Cg_endo -66.24 131.58 27.12 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.567 2.178 . . . . 10.0 111.437 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.65 10.03 85.68 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.952 -0.642 . . . . 10.0 112.596 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 2.7 t80 -123.29 138.27 54.66 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.577 HD12 HG22 ' B' ' 112' ' ' VAL . 2.1 mm? 60.39 29.33 18.93 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.184 0.516 . . . . 10.0 111.041 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.754 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 2.0 t60 74.26 14.97 3.66 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.781 -1.1 . . . . 10.0 113.45 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.782 ' HA ' ' HZ2' ' A' ' 35' ' ' TRP . 1.5 mm-40 -70.78 168.11 17.39 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 121.066 -0.254 . . . . 10.0 110.428 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' HE3' ' A' ' 80' ' ' TRP . 44.5 mmtt -55.85 136.17 51.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.14 -0.482 . . . . 10.0 111.034 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -67.97 163.06 23.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.156 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.47 137.18 53.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.433 -0.349 . . . . 10.0 110.509 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.05 -49.97 1.94 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.646 -0.981 . . . . 10.0 110.646 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.11 -40.44 71.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.119 0.485 . . . . 10.0 109.829 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -59.59 -48.79 80.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.457 -0.792 . . . . 10.0 111.641 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -66.45 -26.37 67.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 10.0 111.32 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -69.97 -32.69 71.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 10.0 110.289 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.585 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 3.2 t90 -65.6 -45.42 83.25 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -61.86 -36.96 82.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.324 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.41 -24.71 65.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.833 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.33 -0.79 62.89 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.036 -0.602 . . . . 10.0 111.811 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 80' ' ' TRP . 44.8 mt -105.05 169.18 8.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.439 . . . . 10.0 110.541 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -90.19 -155.66 0.38 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.998 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.446 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 55.8 m-85 57.54 73.17 0.8 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.954 0.407 . . . . 10.0 110.656 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.36 -9.61 26.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.537 2.158 . . . . 10.0 112.386 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 88' ' ' LYS . 28.4 mtpp -102.16 20.69 16.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.277 -0.42 . . . . 10.0 111.449 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.547 ' HB3' HG23 ' A' ' 91' ' ' VAL . 7.8 mt -80.96 115.29 54.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.807 0.337 . . . . 10.0 110.529 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.76 58.13 6.7 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.713 2.275 . . . . 10.0 111.675 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.547 HG23 ' HB3' ' A' ' 89' ' ' LEU . 48.5 t -81.56 119.96 32.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.052 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.796 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 12.6 t -102.93 142.78 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.078 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.783 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -101.24 106.28 17.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.291 -179.125 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 64.1 t0 -98.36 94.01 6.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.074 0.464 . . . . 10.0 109.911 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.96 108.54 2.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.995 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.26 -17.77 55.16 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.871 -0.681 . . . . 10.0 112.425 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.62 4.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.598 -0.81 . . . . 10.0 112.012 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 5' ' ' THR . 1.2 m -62.57 -51.7 66.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.859 0.362 . . . . 10.0 110.377 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.95 -35.84 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -61.99 -41.19 97.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.613 -0.722 . . . . 10.0 111.359 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -70.89 -39.8 72.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.407 -0.361 . . . . 10.0 111.224 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 m -58.8 -33.83 70.8 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.566 HD13 HD13 ' A' ' 123' ' ' ILE . 68.3 mt -113.02 11.18 18.92 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.997 -0.281 . . . . 10.0 111.691 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 62.3 t30 47.39 60.6 3.37 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.493 0.663 . . . . 10.0 111.421 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 100' ' ' ALA . 30.4 mt -86.92 73.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.446 0.641 . . . . 10.0 110.991 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.43 16.94 17.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.392 -0.822 . . . . 10.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.729 HG23 ' HB3' ' B' ' 109' ' ' TYR . 14.8 p -158.05 147.98 9.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.897 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 64.9 m-85 -127.14 160.73 58.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 108' ' ' TYR . 91.2 Cg_endo -81.7 154.12 79.57 Favored 'Cis proline' 0 C--O 1.235 0.33 0 C-N-CA 123.28 -1.55 . . . . 10.0 111.634 -0.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 t -130.45 137.71 49.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.288 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -119.9 116.6 26.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.729 -0.668 . . . . 10.0 110.266 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.657 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.31 108.31 20.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.664 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.4 tp -90.94 114.4 26.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.829 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 27' ' ' THR . 2.0 mp -100.82 134.6 40.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.373 -0.602 . . . . 10.0 109.373 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -70.01 178.67 29.24 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.281 -0.485 . . . . 10.0 113.423 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.15 7.61 3.23 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.944 0.35 . . . . 10.0 111.944 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.65 -19.48 13.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.073 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 109.97 -1.47 30.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.581 -0.819 . . . . 10.0 112.847 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -101.03 162.21 13.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.745 0.307 . . . . 10.0 110.98 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -71.47 122.29 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 10.0 110.259 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -95.41 -46.85 6.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.422 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 122' ' ' ARG . 9.3 tpt180 -152.28 154.2 35.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.718 0.294 . . . . 10.0 110.729 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.566 HD13 HD13 ' A' ' 103' ' ' LEU . 4.8 tp -128.32 123.88 60.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.515 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.1 t -113.42 137.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.67 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -141.94 139.03 32.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.006 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 121.14 -89.92 0.45 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.476 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.4 m -147.68 153.34 39.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 10.0 110.613 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.9 135.85 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.28 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -122.6 179.36 4.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 10.0 111.931 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -64.54 -43.58 93.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 10.0 112.086 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.1 -43.77 95.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.317 . . . . 10.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -62.13 -37.8 86.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.828 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.03 -48.9 76.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.051 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.7 -34.41 78.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.613 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.76 -43.77 87.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.132 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 140' ' ' PRO . 14.4 tp -64.28 -30.13 71.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.871 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 94.2 mt -70.08 -39.69 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.171 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -79.82 -38.94 31.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.226 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -150.86 103.17 3.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.565 -0.288 . . . . 10.0 110.552 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 136' ' ' LEU . 72.5 Cg_endo -75.7 2.84 6.53 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.77 2.313 . . . . 10.0 112.37 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -90.41 -11.79 39.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 10.0 110.622 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.55 113.64 25.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.01 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.419 ' HB3' HD23 ' A' ' 144' ' ' LEU . 4.6 t0 -96.91 170.0 9.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.076 -0.511 . . . . 10.0 109.892 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.419 HD23 ' HB3' ' A' ' 143' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.93 0 N-CA-C 113.977 1.102 . . . . 10.0 113.977 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 111.712 0.264 . . . . 10.0 111.712 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.09 -57.77 3.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.916 0.389 . . . . 10.0 111.73 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 24.9 tp -110.95 -77.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.699 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ASP . . . . . 0.575 ' HA ' HD13 ' B' ' 9' ' ' LEU . 2.5 m-20 60.4 41.91 15.42 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.474 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.67 161.95 38.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.343 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.46 -148.7 0.37 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.33 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -113.56 21.65 14.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.251 0.548 . . . . 10.0 110.16 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -93.3 40.91 1.07 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.092 -0.503 . . . . 10.0 111.409 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.575 HD13 ' HA ' ' B' ' 4' ' ' ASP . 2.6 pt? -164.21 138.37 4.39 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.562 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.27 147.11 94.07 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.774 2.316 . . . . 10.0 112.143 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.476 ' HG3' ' HB ' ' A' ' 107' ' ' VAL . 9.6 Cg_endo -52.5 -39.58 74.12 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.467 2.778 . . . . 10.0 113.613 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -64.55 -21.36 66.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 10.0 112.153 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.45 -3.59 19.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.183 0.516 . . . . 10.0 110.358 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.01 -9.73 54.84 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.463 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 19.8 m-85 -133.12 128.76 36.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.931 0.396 . . . . 10.0 111.274 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.48 92.04 15.57 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 3.0 Cg_exo -75.42 103.17 1.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.067 2.511 . . . . 10.0 112.924 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -98.36 103.12 15.04 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.376 -0.602 . . . . 10.0 109.376 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.9 mm? -86.76 110.0 19.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.165 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.98 112.9 25.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.944 0.402 . . . . 10.0 109.923 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.497 HG22 HG13 ' B' ' 26' ' ' VAL . 95.6 t -102.31 121.8 53.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.897 0.38 . . . . 10.0 111.261 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.76 170.25 8.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.533 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.43 -29.17 68.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.098 0.475 . . . . 10.0 110.554 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -75.44 -39.58 58.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.567 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.92 -179.55 47.81 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.833 -0.699 . . . . 10.0 111.904 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.497 HG13 HG22 ' B' ' 21' ' ' VAL . 60.0 t -94.14 135.88 27.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.066 -0.346 . . . . 10.0 110.066 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.428 ' OD1' ' HG3' ' B' ' 80' ' ' GLN . 52.5 t30 -124.95 112.04 16.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.856 -0.424 . . . . 10.0 109.856 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.49 HG22 ' HD1' ' B' ' 30' ' ' PHE . 2.8 p -92.63 124.75 45.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.969 0.414 . . . . 10.0 110.969 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' B' ' 79' ' ' ALA . 2.0 tmm_? -126.97 90.77 3.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.554 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.49 ' HD1' HG22 ' B' ' 28' ' ' VAL . 6.2 p90 -93.81 112.93 24.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.118 0.485 . . . . 10.0 111.238 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mtm-85 -72.45 114.6 10.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.461 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 43.7 mt -91.76 139.56 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.826 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.18 155.74 38.03 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.687 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -75.56 77.49 2.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.106 0.479 . . . . 10.0 111.571 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.0 -20.89 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.568 -0.613 . . . . 10.0 111.568 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -104.55 151.61 23.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -145.44 137.56 25.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.761 0.315 . . . . 10.0 110.724 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 34.4 mtt -107.97 156.18 19.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.964 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.616 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 18.3 m-85 -99.59 126.86 45.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.636 -0.505 . . . . 10.0 109.636 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -61.29 -28.56 69.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.909 0.385 . . . . 10.0 111.1 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.96 5.39 37.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.079 -0.51 . . . . 10.0 111.064 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.616 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 53.2 mmtt -122.19 -10.85 8.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.289 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.454 HG13 ' O ' ' B' ' 39' ' ' TYR . 89.9 mt -86.96 118.05 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 10.0 110.453 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.4 t -108.32 121.51 61.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.889 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.91 137.22 6.56 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.688 -0.767 . . . . 10.0 111.705 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -161.69 145.61 12.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.801 0.334 . . . . 10.0 111.209 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.635 ' HB ' HD13 ' B' ' 95' ' ' LEU . 8.8 t -143.97 120.88 11.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.805 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.535 ' CG ' ' HA ' ' B' ' 51' ' ' ASP . 0.3 OUTLIER -174.07 159.53 2.86 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.832 -178.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -73.87 -77.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.321 2.014 . . . . 10.0 110.843 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.82 44.44 1.03 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.149 0.499 . . . . 10.0 110.251 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.535 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 9.9 t0 66.79 33.33 6.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.297 -0.865 . . . . 10.0 112.269 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.88 70.26 4.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.921 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' B' ' 83' ' ' PHE . 28.5 tp -125.04 149.03 48.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.716 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.32 -72.67 1.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.886 -0.673 . . . . 10.0 111.805 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -169.87 146.83 2.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 122.131 0.172 . . . . 10.0 110.552 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.65 109.76 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.378 2.052 . . . . 10.0 110.494 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 6.4 m -89.07 94.24 9.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.157 0.503 . . . . 10.0 111.763 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -77.58 163.53 26.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.202 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 50.2 m -95.0 -3.65 48.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.518 -0.31 . . . . 10.0 111.141 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? 68.71 124.12 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.607 -0.724 . . . . 10.0 111.992 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.27 -139.89 8.4 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.893 -0.67 . . . . 10.0 112.206 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.88 143.92 44.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.732 0.301 . . . . 10.0 110.646 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -81.28 119.92 24.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.213 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' B' ' 65' ' ' GLU . 14.2 ttpt -98.95 136.03 39.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.456 -0.338 . . . . 10.0 110.799 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.405 ' O ' ' HE3' ' B' ' 64' ' ' LYS . 4.6 tp10 -73.97 126.42 30.45 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.571 -0.9 . . . . 10.0 108.571 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -120.46 -179.53 4.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.765 0.317 . . . . 10.0 110.906 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.23 -25.4 4.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.995 0.426 . . . . 10.0 110.575 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 40' ' ' LEU . 1.1 t80 -102.29 -49.12 3.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.853 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.437 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 22.1 m-30 -88.6 -4.45 58.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.496 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.79 -76.58 2.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.865 -0.683 . . . . 10.0 112.111 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -173.59 118.96 0.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.026 -0.361 . . . . 10.0 110.026 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -133.52 164.74 26.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.799 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -75.51 125.98 30.1 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.3 m -125.87 163.63 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.455 0.645 . . . . 10.0 112.449 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' B' ' 78' ' ' GLU . 28.8 m-85 -120.95 130.91 54.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.815 -1.18 . . . . 10.0 107.815 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -115.22 -10.87 12.06 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.66 0.615 . . . . 10.0 112.66 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.91 -29.31 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.339 0.59 . . . . 10.0 109.653 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.8 OUTLIER -86.09 142.61 28.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.038 -0.983 . . . . 10.0 109.378 178.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' B' ' 29' ' ' ARG . . . -166.79 102.69 0.57 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.793 0.33 . . . . 10.0 110.465 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.428 ' HG3' ' OD1' ' B' ' 27' ' ' ASN . 27.3 tt0 -148.92 117.71 6.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.13 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.38 120.89 52.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.574 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.91 148.13 23.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.349 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' PHE . . . . . 0.562 ' HB3' HD11 ' B' ' 53' ' ' LEU . 77.1 m-85 -125.22 102.96 30.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.61 127.46 8.04 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.766 2.311 . . . . 10.0 111.293 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -74.12 143.08 45.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.921 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.0 -4.18 53.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.335 0.588 . . . . 10.0 110.095 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -152.21 136.86 16.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.644 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.9 96.52 10.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.35 140.27 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.487 -0.324 . . . . 10.0 111.457 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.18 58.76 4.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.895 -0.669 . . . . 10.0 111.594 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -116.4 140.67 26.86 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.94 89.55 0.88 Allowed 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.584 2.189 . . . . 10.0 111.485 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.53 160.03 32.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.752 -0.658 . . . . 10.0 111.66 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 47' ' ' THR . 27.3 tttt -103.56 155.23 18.69 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.379 -0.601 . . . . 10.0 109.379 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.635 HD13 ' HB ' ' B' ' 47' ' ' THR . 42.0 tp -125.89 119.89 29.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.803 0.335 . . . . 10.0 110.762 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.75 123.84 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.525 -0.546 . . . . 10.0 109.525 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 64.2 mt -128.92 131.76 47.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.945 0.403 . . . . 10.0 111.66 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' THR . . . . . 0.416 HG22 ' HB2' ' B' ' 111' ' ' PRO . 5.6 m -120.07 117.13 27.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 34.1 m-85 -98.23 104.34 16.37 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.963 0.357 . . . . 10.0 111.963 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.883 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 11.1 tp60 -117.47 121.39 40.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.901 0.382 . . . . 10.0 110.981 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.91 -160.41 10.68 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.888 -0.673 . . . . 10.0 111.546 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 18.4 m -152.87 -179.57 7.77 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' ALA . . . . . 0.625 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -121.35 142.99 49.45 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.868 -0.419 . . . . 10.0 109.868 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.55 -10.09 56.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.181 -0.463 . . . . 10.0 112.04 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.33 -4.05 59.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.359 . . . . 10.0 111.769 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.13 38.09 2.96 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.561 -0.828 . . . . 10.0 112.928 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.625 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 35.1 t -123.13 141.51 43.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.574 ' HB2' HD12 ' A' ' 38' ' ' LEU . 9.4 t -132.68 86.18 2.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.872 0.368 . . . . 10.0 110.803 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.729 ' HB3' HG23 ' A' ' 107' ' ' VAL . 55.2 p90 -76.73 152.52 82.99 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.497 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.15 161.38 43.31 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.825 2.35 . . . . 10.0 111.512 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.883 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 84.0 Cg_endo -77.91 74.65 5.16 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.861 2.374 . . . . 10.0 112.289 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.577 HG22 HD12 ' A' ' 69' ' ' LEU . 4.5 t -61.05 122.78 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.596 -0.52 . . . . 10.0 109.596 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ASP . . . . . 0.409 ' HB3' HG23 ' B' ' 98' ' ' THR . 4.6 p-10 -106.11 156.66 18.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.993 0.425 . . . . 10.0 111.291 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.28 141.09 30.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.17 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -107.73 123.18 48.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 10.0 110.739 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -112.94 148.29 35.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.571 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -105.12 118.96 37.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.517 -0.31 . . . . 10.0 110.221 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 14.9 mm -94.54 71.1 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.295 0.569 . . . . 10.0 110.53 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' B' ' 121' ' ' ASN . 44.0 p90 -83.98 -19.74 34.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.657 -0.701 . . . . 10.0 111.479 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.39 51.7 0.24 Allowed Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.709 -0.758 . . . . 10.0 112.688 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' ASN . . . . . 0.44 ' HB2' ' CZ ' ' B' ' 119' ' ' PHE . 21.3 t30 -103.77 -18.13 14.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.166 0.508 . . . . 10.0 110.489 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.19 -78.1 0.67 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.96 -0.856 . . . . 10.0 110.96 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 2.1 m -105.26 141.81 36.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -133.21 156.43 47.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.21 -0.292 . . . . 10.0 110.21 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.3 152.8 54.92 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' PRO . . . . . 0.434 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 28.5 Cg_endo -63.91 114.32 2.55 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.448 2.099 . . . . 10.0 112.139 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -81.13 76.9 8.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.566 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 7.7 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.788 -0.625 . . . . 10.0 109.732 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 109.738 -0.467 . . . . 10.0 109.738 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.503 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 1.4 m -123.02 76.32 50.28 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.068 0.461 . . . . 10.0 111.398 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.34 -33.97 88.2 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.702 2.268 . . . . 10.0 112.017 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -43.81 96.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.385 -0.371 . . . . 10.0 111.179 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -69.27 -40.01 78.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.307 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.4 tp -62.23 -34.16 75.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.729 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 m -84.57 -8.01 59.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.45 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.2 m -82.51 -20.73 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.192 0.52 . . . . 10.0 109.745 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 9' ' ' LEU . 3.2 mm? -56.4 119.34 5.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.696 -0.683 . . . . 10.0 110.636 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.35 140.42 41.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.43 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 22.0 p -81.68 168.97 17.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.866 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -11.04 56.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.984 0.421 . . . . 10.0 111.15 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.38 8.22 45.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.381 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.3 t30 68.12 38.14 2.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.6 -0.727 . . . . 10.0 112.108 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -122.51 140.26 32.49 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.658 -0.497 . . . . 10.0 109.658 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.35 143.82 78.04 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.215 1.943 . . . . 10.0 111.422 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -13.23 34.28 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.2 m -56.87 -22.82 39.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 10.0 112.133 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.96 -20.23 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.109 0.48 . . . . 10.0 111.315 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -132.47 28.76 4.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.18 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -138.73 43.94 2.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.131 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -145.81 -171.57 3.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.389 -0.368 . . . . 10.0 111.269 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 mttp 65.84 13.82 9.22 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 58.26 38.4 26.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.944 0.402 . . . . 10.0 111.682 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -103.22 146.43 32.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.941 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.622 ' HD3' ' HG2' ' A' ' 116' ' ' LYS . 27.1 Cg_endo -63.26 135.76 52.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.659 2.239 . . . . 10.0 110.958 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 114' ' ' ILE . 4.2 m -109.33 146.21 34.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.827 0.346 . . . . 10.0 111.181 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.1 tp -127.34 108.19 10.63 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.872 -0.418 . . . . 10.0 109.872 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 70.9 mt -96.09 119.75 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.969 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.714 ' HD2' HG22 ' A' ' 62' ' ' THR . 1.1 tmtp? -113.2 124.82 53.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.679 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -98.0 142.49 29.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.351 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.426 ' HE1' ' HB ' ' A' ' 62' ' ' THR . 32.7 p-90 -145.81 170.82 15.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.525 -0.307 . . . . 10.0 110.821 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . . . -114.9 139.49 49.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.637 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -73.33 -47.19 44.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.994 -0.548 . . . . 10.0 112.443 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.429 ' CH2' ' HD3' ' B' ' 111' ' ' PRO . 0.0 OUTLIER -90.99 29.27 1.4 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.427 0.529 . . . . 10.0 112.427 -178.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 33.7 t -117.59 121.05 32.39 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.513 0.197 . . . . 10.0 111.288 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.765 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 14.6 Cg_endo -58.0 -43.54 47.58 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.129 2.553 . . . . 10.0 112.467 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.37 -39.53 90.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.948 0.404 . . . . 10.0 111.279 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 78.2 m -76.08 -31.68 58.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.566 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.02 -46.85 85.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 10.0 112.082 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 m -66.61 -33.66 76.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.055 0.455 . . . . 10.0 110.862 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -26.31 68.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.254 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.28 -34.33 72.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.825 0.345 . . . . 10.0 110.643 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.78 92.34 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.935 -0.65 . . . . 10.0 111.853 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -77.31 -29.65 53.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.911 0.386 . . . . 10.0 110.113 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.7 m -60.44 -47.49 85.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.772 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.68 -36.75 85.28 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -61.69 -50.39 72.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.258 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -64.11 -37.28 86.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.049 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.14 -10.84 59.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.433 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -111.78 16.4 20.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.992 0.425 . . . . 10.0 110.73 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -93.31 139.89 30.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.258 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.38 -32.23 69.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.836 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -71.33 -44.09 65.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 10.0 110.658 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.42 ' CZ ' ' HB1' ' A' ' 133' ' ' ALA . 1.7 m-85 -73.6 -14.76 61.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 10.0 112.198 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.9 m -65.01 -11.63 41.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 10.0 111.216 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -78.87 -15.36 58.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.497 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -123.22 176.33 6.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.418 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.437 ' HB2' HG23 ' A' ' 27' ' ' THR . 78.9 m-20 -109.69 87.7 2.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.57 117.26 20.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.445 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.2 pt -134.93 147.2 29.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.786 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.714 HG22 ' HD2' ' A' ' 30' ' ' LYS . 1.6 p -109.0 116.41 31.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.167 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.462 HG22 ' HB ' ' A' ' 92' ' ' VAL . 18.7 t -113.17 137.15 47.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.78 0.324 . . . . 10.0 111.181 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.522 ' O ' ' HD3' ' A' ' 66' ' ' PRO . . . -132.08 138.25 48.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.087 -0.708 . . . . 10.0 109.087 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -100.66 102.35 18.89 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 112.13 0.418 . . . . 10.0 112.13 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 18.4 Cg_exo -68.63 131.23 22.41 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.994 2.463 . . . . 10.0 111.894 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.57 0.64 90.03 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.942 -0.572 . . . . 10.0 112.448 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -112.02 143.03 43.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.499 HD12 HG22 ' B' ' 112' ' ' VAL . 2.0 mm? 60.81 26.56 16.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.837 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.904 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.1 OUTLIER 67.93 26.43 7.48 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.371 -0.831 . . . . 10.0 112.849 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 2.1 mm-40 -81.97 -169.61 2.46 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.451 -0.34 . . . . 10.0 110.187 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -68.35 145.06 54.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.206 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -77.33 162.29 27.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.038 0.447 . . . . 10.0 111.712 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -63.56 150.35 44.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.855 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.56 -40.96 3.03 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.867 -0.893 . . . . 10.0 110.867 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -81.92 -47.62 12.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.913 0.387 . . . . 10.0 110.062 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -57.59 -39.37 76.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.8 -0.637 . . . . 10.0 112.232 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.01 -30.62 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.996 0.427 . . . . 10.0 111.225 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -77.87 -31.72 51.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 10.0 109.866 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -58.16 -45.76 86.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.73 -0.668 . . . . 10.0 109.678 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -66.99 -36.58 82.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.798 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.67 -27.76 69.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.198 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.24 29.21 12.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.889 -0.672 . . . . 10.0 111.998 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HB3' ' H ' ' A' ' 85' ' ' ASN . 38.5 mt -121.66 -162.55 0.99 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.042 0.449 . . . . 10.0 111.059 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.437 ' H ' ' HB3' ' A' ' 84' ' ' LEU . 45.8 t30 -116.99 -171.61 2.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.766 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 66.33 84.74 0.17 Allowed Pre-proline 0 N--CA 1.465 0.314 0 CA-C-O 121.381 0.61 . . . . 10.0 110.705 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.0 -11.57 29.39 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.776 2.318 . . . . 10.0 112.549 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -107.09 22.77 15.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.213 0.449 . . . . 10.0 112.213 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.454 ' HB3' HG23 ' A' ' 91' ' ' VAL . 5.2 mt -81.34 115.27 55.4 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.627 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.04 63.88 8.24 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.443 2.095 . . . . 10.0 111.705 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 89' ' ' LEU . 68.7 t -82.31 117.27 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.13 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.77 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 9.7 t -104.97 142.49 18.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.706 -0.679 . . . . 10.0 109.981 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -99.28 108.45 20.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.05 -179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -94.72 78.58 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.297 0.57 . . . . 10.0 110.222 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -64.17 116.56 6.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.505 0.557 . . . . 10.0 112.505 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.63 -6.31 67.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.563 -0.827 . . . . 10.0 112.65 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.45 41.36 67.03 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.72 -0.752 . . . . 10.0 111.799 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -43.99 98.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.833 0.349 . . . . 10.0 110.775 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.0 mm -80.39 -42.26 21.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.938 0.399 . . . . 10.0 110.07 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.436 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.88 -45.7 89.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.628 -0.714 . . . . 10.0 112.167 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -68.3 -38.01 81.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.8 m -61.2 -35.74 78.0 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.413 0.523 . . . . 10.0 112.413 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -106.37 5.7 29.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.595 0.22 . . . . 10.0 111.595 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.0 t30 53.39 55.71 8.34 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.524 0.678 . . . . 10.0 111.064 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 100' ' ' ALA . 78.2 mt -87.06 99.91 9.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.325 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.92 29.19 8.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.749 -0.66 . . . . 10.0 111.277 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.525 ' HA ' ' CD ' ' B' ' 110' ' ' PRO . 10.8 p -166.78 152.15 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.211 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -126.83 154.48 76.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -91.71 118.43 3.04 Favored 'Cis proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.619 -1.409 . . . . 10.0 111.403 -1.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.5 m -87.17 136.47 32.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.218 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -113.6 113.47 25.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.749 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.86 116.93 33.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.335 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 136' ' ' LEU . 37.3 tp -93.65 116.11 28.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.8 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 27' ' ' THR . 2.9 mp -104.65 129.59 56.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.946 -0.57 . . . . 10.0 109.544 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.75 178.17 40.04 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.962 -0.637 . . . . 10.0 112.895 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.622 ' HG2' ' HD3' ' A' ' 26' ' ' PRO . 3.3 mtmp? -69.77 -13.04 62.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.127 0.489 . . . . 10.0 110.617 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.44 -10.68 58.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.263 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.97 43.0 6.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.556 -0.831 . . . . 10.0 112.206 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -149.72 153.67 37.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.636 0.255 . . . . 10.0 110.573 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.5 t -70.23 120.23 17.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.952 0.406 . . . . 10.0 111.323 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -99.95 -28.97 12.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.013 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -156.24 146.65 21.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.585 -0.279 . . . . 10.0 111.004 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.0 tp -131.3 117.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.911 -0.403 . . . . 10.0 109.911 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.62 133.58 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.543 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -120.69 126.45 50.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.195 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.85 -99.21 0.22 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.499 -0.857 . . . . 10.0 112.931 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.4 m -168.14 135.22 2.11 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.122 -0.696 . . . . 10.0 109.122 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.1 pt -119.19 154.86 21.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.969 -0.293 . . . . 10.0 110.664 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -110.37 169.58 8.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.248 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -57.93 -39.32 77.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.114 0.413 . . . . 10.0 112.114 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.55 -40.85 88.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.104 0.478 . . . . 10.0 110.419 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -68.62 -38.21 80.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.22 -0.9 . . . . 10.0 110.146 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.42 ' HB1' ' CZ ' ' A' ' 55' ' ' PHE . . . -59.77 -45.85 91.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.633 -0.712 . . . . 10.0 110.941 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.15 -36.77 85.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.849 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.23 95.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.752 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.534 HD11 HD22 ' A' ' 113' ' ' LEU . 21.2 tp -62.43 -32.09 72.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.077 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.3 mt -72.68 -32.96 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.118 0.485 . . . . 10.0 110.358 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -78.5 -39.78 37.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.649 -0.705 . . . . 10.0 110.82 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.6 t70 -151.75 119.28 3.27 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.603 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.509 ' HB3' HD21 ' A' ' 113' ' ' LEU . 16.5 Cg_exo -69.25 -7.25 20.4 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.098 2.532 . . . . 10.0 113.42 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -99.12 4.4 46.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 10.0 111.163 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.2 72.09 9.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.411 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -76.61 150.98 36.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.949 -0.568 . . . . 10.0 111.305 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.146 0 N-CA-C 114.006 1.113 . . . . 10.0 114.006 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.452 0.168 . . . . 10.0 111.08 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.88 70.72 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.08 -0.509 . . . . 10.0 112.087 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 35.1 tp -91.91 -80.03 0.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.674 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 55.16 37.23 28.58 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.448 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.67 157.34 44.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.23 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.17 -172.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.253 -0.885 . . . . 10.0 112.693 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -94.6 27.87 2.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.273 -0.876 . . . . 10.0 110.619 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -84.51 -4.33 58.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.985 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.5 143.98 51.07 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.9 150.89 87.05 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.024 2.483 . . . . 10.0 112.4 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.28 -34.42 88.37 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.413 2.742 . . . . 10.0 113.162 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -68.0 -4.73 14.19 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.118 0.414 . . . . 10.0 112.118 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -129.03 1.43 5.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.4 0.619 . . . . 10.0 110.233 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.42 -10.47 43.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.832 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.4 ' HE1' HG23 ' B' ' 32' ' ' ILE . 23.6 m-85 -131.95 126.14 33.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.504 -0.317 . . . . 10.0 111.204 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.38 92.55 36.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' B' ' 30' ' ' PHE . 3.1 Cg_exo -76.49 116.06 4.22 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.169 2.579 . . . . 10.0 113.441 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.1 109.48 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.1 mm? -93.46 118.09 30.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.987 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.16 113.53 22.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.546 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.98 118.91 43.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.025 0.441 . . . . 10.0 111.225 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.0 -164.48 1.14 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.738 -0.665 . . . . 10.0 109.928 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -92.26 -37.29 12.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.789 0.328 . . . . 10.0 111.069 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.64 -37.12 42.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.623 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CZ ' ' B' ' 85' ' ' TYR . . . -168.01 -170.48 32.81 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.586 -0.816 . . . . 10.0 112.392 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.9 135.1 47.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -120.35 111.89 18.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.753 0.311 . . . . 10.0 110.248 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.488 HG22 ' HD1' ' B' ' 30' ' ' PHE . 3.9 p -95.01 122.55 46.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.13 0.491 . . . . 10.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -124.27 92.01 3.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.093 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 6.1 p90 -95.38 122.55 38.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.74 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -79.76 122.33 26.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.625 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.4 HG23 ' HE1' ' B' ' 15' ' ' PHE . 72.1 mt -100.83 130.68 49.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.49 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.65 145.34 55.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.147 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.36 92.99 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.109 0.48 . . . . 10.0 111.675 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.77 -23.86 0.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.663 -0.975 . . . . 10.0 110.663 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 103' ' ' ALA . 37.5 m-85 -103.51 154.04 19.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -144.63 139.01 27.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.965 0.412 . . . . 10.0 111.101 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 34.4 mtt -110.9 150.63 28.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.432 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.695 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 59.7 m-85 -92.6 121.35 33.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' B' ' 60' ' ' LYS . 21.1 tt0 -56.81 -37.12 70.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.752 0.31 . . . . 10.0 111.833 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.66 -9.77 58.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.397 . . . . 10.0 111.576 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.695 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 43.6 mmtt -104.43 -11.03 17.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.747 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.482 HG13 ' O ' ' B' ' 39' ' ' TYR . 75.2 mt -82.28 96.59 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.079 0.466 . . . . 10.0 110.314 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 t -91.46 109.04 20.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.203 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.39 141.51 12.57 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.55 -0.834 . . . . 10.0 111.751 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -162.36 147.48 12.51 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.789 0.328 . . . . 10.0 111.475 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.578 ' HB ' HD13 ' B' ' 95' ' ' LEU . 9.9 t -143.47 123.36 13.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.987 -0.552 . . . . 10.0 109.528 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' B' ' 51' ' ' ASP . 28.0 p30 -177.43 157.28 1.24 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.139 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 48' ' ' ASN . 11.7 Cg_exo -73.83 -69.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.732 2.288 . . . . 10.0 110.559 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.66 55.43 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.235 0.541 . . . . 10.0 109.769 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.564 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 4.9 t70 60.95 27.42 17.29 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.251 -0.886 . . . . 10.0 112.453 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' B' ' 52' ' ' LEU . 1.2 mm? -86.89 59.61 5.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.272 0.558 . . . . 10.0 111.531 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.434 ' HB2' ' HB3' ' B' ' 48' ' ' ASN . 22.9 tp -122.97 148.84 45.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.729 -0.669 . . . . 10.0 109.516 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.84 -80.21 0.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.596 -0.812 . . . . 10.0 111.45 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.447 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 1.5 pp0? -163.0 145.63 8.22 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.402 -0.221 . . . . 10.0 110.402 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 31.9 Cg_exo -63.64 107.5 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.606 2.204 . . . . 10.0 110.75 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.0 m -93.65 96.52 9.88 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.224 0.535 . . . . 10.0 111.536 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -80.25 150.25 30.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.718 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.4 m -81.12 -8.1 59.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.778 0.323 . . . . 10.0 110.678 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.408 ' HA ' ' OE1' ' B' ' 40' ' ' GLN . 3.3 mmtt 71.39 148.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.44 -0.8 . . . . 10.0 112.813 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.79 -128.33 2.93 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.996 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -121.04 149.57 42.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.526 0.203 . . . . 10.0 110.772 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.94 119.24 28.1 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -101.04 130.91 47.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.944 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -69.13 142.86 54.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -137.93 170.87 15.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.709 0.29 . . . . 10.0 111.16 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -109.85 -13.45 14.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.401 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.765 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 10.7 m-85 -121.36 -41.15 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 10.0 111.218 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -90.3 -7.41 53.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.962 0.411 . . . . 10.0 111.207 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.71 -79.46 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.095 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -171.44 110.75 0.31 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.989 0.423 . . . . 10.0 110.678 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -128.29 163.46 24.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.121 -0.491 . . . . 10.0 110.384 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 12.8 m -75.38 125.52 29.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.08 155.28 31.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.397 0.618 . . . . 10.0 112.357 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -112.84 130.34 56.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.611 -1.255 . . . . 10.0 107.611 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -113.03 -10.49 13.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.606 0.595 . . . . 10.0 112.606 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -168.78 -34.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.432 0.634 . . . . 10.0 109.887 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -87.75 134.55 33.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.296 -0.866 . . . . 10.0 109.769 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -159.32 123.79 3.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.883 0.373 . . . . 10.0 111.444 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -160.85 120.72 2.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.328 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 t -125.9 128.33 71.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 10.0 109.998 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.33 138.75 38.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.626 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' PHE . . . . . 0.416 ' HB3' HD11 ' B' ' 53' ' ' LEU . 62.7 m-85 -122.14 98.39 44.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.51 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.8 126.49 3.98 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.2 2.6 . . . . 10.0 111.027 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' TYR . . . . . 0.433 ' CZ ' ' HA2' ' B' ' 25' ' ' GLY . 7.1 m-85 -71.06 149.58 46.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.81 0.338 . . . . 10.0 110.871 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.99 -9.78 41.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.267 0.556 . . . . 10.0 110.107 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -152.24 127.2 9.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.895 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.64 99.32 6.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.143 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -131.83 146.22 33.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.403 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.58 43.63 3.01 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.671 -0.776 . . . . 10.0 111.867 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -104.33 144.44 28.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.43 0.157 . . . . 10.0 110.862 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.39 100.45 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.412 2.075 . . . . 10.0 111.353 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.56 144.13 28.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.923 -0.581 . . . . 10.0 111.208 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -88.81 159.5 17.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.049 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.578 HD13 ' HB ' ' B' ' 47' ' ' THR . 35.3 tp -131.05 121.8 25.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.046 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.42 HG22 ' HG2' ' B' ' 115' ' ' GLU . 40.6 t -117.05 125.0 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 49.2 mt -129.56 126.9 39.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.787 0.327 . . . . 10.0 111.549 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' THR . . . . . 0.497 HG23 ' HB3' ' B' ' 113' ' ' ASP . 1.7 m -115.62 116.85 28.83 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 41.9 m-85 -100.35 110.94 23.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.314 . . . . 10.0 111.366 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.91 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 6.1 tp60 -120.81 121.6 38.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.752 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.99 -157.13 9.84 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.309 -0.717 . . . . 10.0 111.309 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 39.6 m -158.86 -172.98 4.03 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' B' ' 36' ' ' TYR . . . -119.25 146.27 45.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.22 40.35 0.34 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.028 0.442 . . . . 10.0 110.484 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.18 1.06 1.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.223 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.05 -32.56 5.73 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.768 -0.729 . . . . 10.0 113.129 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 12.3 t -62.69 133.17 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.353 . . . . 10.0 111.313 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 10.9 t -129.22 100.35 5.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.947 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.414 ' CB ' HG23 ' A' ' 107' ' ' VAL . 15.3 p90 -89.61 144.81 32.47 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.678 0.275 . . . . 10.0 111.478 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.525 ' CD ' ' HA ' ' A' ' 107' ' ' VAL . 59.4 Cg_endo -73.18 160.83 44.51 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.854 2.37 . . . . 10.0 111.565 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.91 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 72.4 Cg_endo -76.77 75.83 4.32 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.54 2.16 . . . . 10.0 112.657 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.499 HG22 HD12 ' A' ' 69' ' ' LEU . 6.6 t -69.54 104.9 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' B' ' 98' ' ' THR . 5.5 p-10 -72.61 148.51 44.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.846 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.9 m -132.62 128.08 36.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.286 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' GLU . . . . . 0.42 ' HG2' HG22 ' B' ' 96' ' ' VAL . 39.1 mt-10 -105.59 134.16 49.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.012 0.434 . . . . 10.0 110.616 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.439 ' HB2' HD23 ' B' ' 95' ' ' LEU . 79.9 m-85 -109.17 166.56 10.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.345 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -123.0 117.61 25.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.966 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 18.6 mm -97.23 82.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.152 0.501 . . . . 10.0 110.462 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -97.38 -25.51 15.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.675 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.52 68.16 0.18 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.068 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -128.27 -3.9 5.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.866 0.365 . . . . 10.0 111.363 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.28 -76.72 2.21 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.836 -0.697 . . . . 10.0 111.917 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 0.2 OUTLIER -105.01 135.15 46.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.189 -0.301 . . . . 10.0 110.189 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -123.26 147.21 47.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 10.0 110.925 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.35 145.18 48.54 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.323 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.53 131.61 32.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.592 2.194 . . . . 10.0 111.668 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -84.24 86.55 7.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.209 0.528 . . . . 10.0 110.476 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.245 0.824 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.599 179.777 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.436 ' C ' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 109.788 -0.449 . . . . 10.0 109.788 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.53 63.13 63.37 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.337 . . . . 10.0 111.403 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HD3' ' C ' ' A' ' 1' ' ' MET . 23.0 Cg_exo -65.17 -43.61 10.99 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.411 2.074 . . . . 10.0 111.681 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -58.97 -44.35 91.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.267 -0.424 . . . . 10.0 111.32 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -47.03 80.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.947 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' A' ' 9' ' ' LEU . 28.8 tp -61.21 -36.19 79.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 10.0 111.361 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 m -76.08 -10.43 59.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 10.0 111.685 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.6 m -92.58 -6.33 49.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.035 0.445 . . . . 10.0 110.423 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 6' ' ' LEU . 2.3 mm? -66.37 109.52 2.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.293 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.49 139.43 33.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.931 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.78 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 71.6 p -84.13 172.51 11.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.061 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.29 -9.08 54.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.48 . . . . 10.0 110.263 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -91.71 8.11 38.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.948 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.95 13.33 7.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.258 -0.883 . . . . 10.0 112.956 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.92 143.49 29.2 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.479 -0.328 . . . . 10.0 110.626 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.82 146.79 88.92 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.617 2.211 . . . . 10.0 111.139 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.49 -5.68 25.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.256 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.556 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -56.66 -25.5 53.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.635 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.408 HG23 ' HD2' ' A' ' 20' ' ' TYR . 15.5 m -62.63 -21.45 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.078 0.466 . . . . 10.0 111.047 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.408 ' HD2' HG23 ' A' ' 19' ' ' VAL . 34.8 m-85 -117.68 20.55 13.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.329 0.585 . . . . 10.0 109.764 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 73.3 mt -125.76 25.38 6.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.661 -0.699 . . . . 10.0 110.33 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 18' ' ' SER . 26.4 mtpp -124.24 -170.6 2.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.204 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 mttm 68.31 8.48 6.63 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.733 0.645 . . . . 10.0 111.692 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.68 34.92 25.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.212 0.529 . . . . 10.0 110.32 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -101.67 150.58 37.44 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 10.0 111.449 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.27 142.87 75.05 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.781 2.321 . . . . 10.0 111.093 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.65 142.37 39.23 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.967 0.413 . . . . 10.0 111.286 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.563 HD23 ' HG ' ' A' ' 60' ' ' LEU . 24.7 tp -120.76 101.85 8.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 39.5 mt -87.53 121.92 38.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.817 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' HD2' HG22 ' A' ' 62' ' ' THR . 1.9 tmtp? -114.98 108.91 17.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.253 -0.431 . . . . 10.0 111.192 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 10.3 m-85 -82.86 138.07 34.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.068 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -140.98 171.67 13.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.576 -0.283 . . . . 10.0 111.239 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.46 144.59 49.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.239 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.98 -41.37 18.84 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.611 0.597 . . . . 10.0 112.611 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.572 ' HE1' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -88.56 23.81 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.661 0.615 . . . . 10.0 112.661 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.6 t -115.58 128.3 26.07 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 111.854 0.316 . . . . 10.0 111.854 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 27.2 Cg_endo -63.49 -43.09 18.69 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.884 2.389 . . . . 10.0 112.297 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.46 -41.69 93.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 10.0 111.171 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.5 m -70.32 -21.27 62.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.252 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.3 tp -68.52 -48.01 65.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.363 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.93 -33.07 74.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.172 0.511 . . . . 10.0 109.827 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -32.62 66.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.354 -0.839 . . . . 10.0 111.534 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.99 -46.71 84.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 10.0 111.091 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.91 -44.19 96.42 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.902 -0.59 . . . . 10.0 112.318 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -65.91 -38.13 87.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 10.0 110.785 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.4 m -63.62 -43.22 97.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.362 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -64.41 -39.71 94.37 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.908 -0.405 . . . . 10.0 109.908 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -60.83 -50.49 73.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.087 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -64.93 -40.16 94.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.753 -0.658 . . . . 10.0 111.528 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.59 -18.74 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.135 0.42 . . . . 10.0 112.135 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -103.7 10.24 36.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.753 0.311 . . . . 10.0 111.418 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 23.4 t70 -80.9 148.31 29.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.856 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.13 94.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 54' ' ' LYS . 25.1 mmmt -74.13 -34.85 64.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.885 0.374 . . . . 10.0 110.972 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.419 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -76.82 -10.89 59.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.147 -0.478 . . . . 10.0 111.862 -179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.5 m -74.72 2.15 10.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.028 0.442 . . . . 10.0 111.532 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -87.82 -9.47 53.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.834 0.349 . . . . 10.0 110.468 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.43 168.23 18.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 10.0 109.945 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -104.53 96.82 6.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.813 0.339 . . . . 10.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.563 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -86.29 125.48 33.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.711 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.3 pt -136.6 132.21 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 10.0 111.532 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.487 HG22 ' HD2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -92.18 131.07 37.7 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 179.168 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' A' ' 92' ' ' VAL . 13.6 p -137.06 147.18 27.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.165 0.507 . . . . 10.0 112.13 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.0 158.55 43.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.257 -1.016 . . . . 10.0 108.257 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 4.8 m -110.47 95.1 21.07 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 112.124 0.416 . . . . 10.0 112.124 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.753 ' HG3' HG22 ' A' ' 93' ' ' THR . 28.5 Cg_endo -63.28 119.27 6.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.58 2.187 . . . . 10.0 111.699 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.95 10.02 65.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.93 -0.652 . . . . 10.0 112.48 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 19.5 t80 -129.03 144.53 51.22 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.407 HD11 ' O ' ' A' ' 105' ' ' ILE . 44.3 mt 60.91 27.21 17.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.896 0.379 . . . . 10.0 111.592 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.587 ' HE1' ' HB3' ' B' ' 113' ' ' ASP . 4.2 m170 69.09 19.03 8.17 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.417 -0.811 . . . . 10.0 112.866 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.572 ' HA ' ' HE1' ' A' ' 35' ' ' TRP . 2.9 mm-40 -75.7 177.66 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.571 -0.286 . . . . 10.0 110.678 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 33.1 mmtt -63.37 148.09 49.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.949 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HD3' ' H ' ' A' ' 74' ' ' ASP . 6.2 tmtt? -74.75 156.39 36.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.993 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.548 ' H ' ' HD3' ' A' ' 73' ' ' LYS . 5.1 t70 -55.61 143.88 28.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.395 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.24 -52.92 4.12 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.622 -0.991 . . . . 10.0 110.622 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.92 -42.49 76.72 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.22 -47.85 84.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.751 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -66.5 -24.43 66.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 10.0 111.62 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -74.96 -30.87 61.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.434 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -65.67 -48.83 70.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.622 -0.51 . . . . 10.0 109.622 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -62.92 -33.57 75.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.075 0.464 . . . . 10.0 110.852 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.42 -18.62 65.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.351 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.8 30.19 8.65 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.991 -0.844 . . . . 10.0 110.991 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.0 mt -130.85 173.83 10.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.778 0.323 . . . . 10.0 110.27 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.408 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 57.0 t30 -92.87 -165.76 1.4 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.615 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.408 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 41.4 m-85 63.46 68.01 0.95 Allowed Pre-proline 0 C--O 1.233 0.222 0 CA-C-O 121.022 0.439 . . . . 10.0 110.595 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.6 23.82 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.65 2.233 . . . . 10.0 112.698 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.97 13.7 9.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 10.0 110.578 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 20.3 mt -92.17 118.98 68.4 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 10.0 110.964 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 89' ' ' LEU . 3.8 Cg_exo -77.77 69.08 7.51 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.062 2.508 . . . . 10.0 110.689 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 62' ' ' THR . 66.9 t -79.72 115.86 22.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.204 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 3.2 t -98.87 148.11 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.249 -0.432 . . . . 10.0 109.998 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.753 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -105.02 101.78 11.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.767 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 55.5 t0 -86.16 88.65 7.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.089 0.471 . . . . 10.0 110.633 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -64.58 106.94 1.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.989 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.91 -2.33 69.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.814 -0.707 . . . . 10.0 112.924 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.98 55.45 19.23 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.355 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.24 -45.01 95.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.023 0.439 . . . . 10.0 110.608 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.452 ' HB ' ' HZ ' ' A' ' 31' ' ' PHE . 31.8 mm -80.46 -39.09 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.108 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -59.33 -43.93 92.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.521 -0.763 . . . . 10.0 111.899 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -75.17 -36.7 61.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.889 0.376 . . . . 10.0 111.294 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.6 m -65.38 -34.66 78.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.559 0.577 . . . . 10.0 112.559 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.421 HD21 HG21 ' A' ' 120' ' ' VAL . 93.6 mt -101.19 5.29 42.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.524 0.202 . . . . 10.0 111.5 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 53.05 69.51 0.69 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.578 0.704 . . . . 10.0 111.311 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 100' ' ' ALA . 86.1 mt -103.47 114.99 44.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.413 -0.812 . . . . 10.0 111.033 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.8 p -121.37 19.48 11.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.46 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' B' ' 109' ' ' TYR . 11.0 p -163.54 149.73 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.838 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 31' ' ' PHE . 72.0 m-85 -117.33 156.81 48.5 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 126' ' ' GLY . 7.0 Cg_endo -91.13 144.95 14.5 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.937 -1.276 . . . . 10.0 111.431 -1.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.8 m -110.08 129.54 55.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.477 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -107.52 107.05 17.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.935 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.797 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -97.05 116.81 29.93 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.484 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.2 tp -94.55 107.38 19.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.823 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.3 127.28 46.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 117' ' ' ASP . . . -66.33 165.38 39.66 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.909 -0.662 . . . . 10.0 112.124 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -69.68 8.94 0.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.225 0.454 . . . . 10.0 112.225 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 115' ' ' GLY . 6.9 t70 -103.92 -20.02 14.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.295 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 100.96 46.28 1.77 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.989 -0.624 . . . . 10.0 112.421 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -154.14 166.71 32.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.436 0.16 . . . . 10.0 110.599 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.421 HG21 HD21 ' A' ' 103' ' ' LEU . 16.5 t -74.66 111.6 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.071 0.462 . . . . 10.0 110.839 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -93.82 -35.97 12.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.989 -0.551 . . . . 10.0 110.689 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -157.53 153.71 27.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.154 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 tp -136.93 121.52 24.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.069 0.461 . . . . 10.0 110.658 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.52 120.13 63.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.358 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -117.1 114.96 24.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.004 -0.369 . . . . 10.0 110.004 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.52 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 154.69 -87.43 0.13 Allowed Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.26 -0.971 . . . . 10.0 112.739 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.6 m -167.18 146.56 5.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.5 pt -127.24 179.99 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.576 0.227 . . . . 10.0 110.821 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -142.99 171.58 13.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.704 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -61.15 -44.5 97.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.927 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.26 95.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.978 0.418 . . . . 10.0 110.236 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -63.56 -39.3 94.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.488 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.85 94.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 10.0 110.349 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.78 -36.66 84.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.422 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.1 70.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.767 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.09 -42.47 89.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.991 -0.55 . . . . 10.0 111.388 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.4 pt -76.0 -10.53 13.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.213 0.53 . . . . 10.0 110.773 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -91.32 -52.11 4.97 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 25.7 t0 -143.61 110.14 5.27 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.102 -0.954 . . . . 10.0 109.556 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 38.4 Cg_endo -66.51 -7.21 17.15 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.964 2.443 . . . . 10.0 112.217 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -86.83 4.88 39.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.304 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.82 109.41 21.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.719 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.495 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 4.9 t70 -115.38 141.48 47.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.166 -0.921 . . . . 10.0 112.56 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtt . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 111.962 0.356 . . . . 10.0 111.962 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.89 -79.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 10.0 111.712 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 59.4 tp -87.89 -69.26 0.7 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.358 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 60.01 35.11 21.48 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.281 0.562 . . . . 10.0 110.674 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.86 162.76 34.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.275 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 30.3 m120 62.56 -155.95 0.34 Allowed 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.708 0.63 . . . . 10.0 110.897 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -110.22 20.25 18.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.261 0.553 . . . . 10.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -85.39 36.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.801 -0.636 . . . . 10.0 111.629 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -158.93 136.36 7.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.67 148.38 82.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.951 2.434 . . . . 10.0 112.159 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.58 -39.19 76.0 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.344 2.696 . . . . 10.0 113.591 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -68.59 -12.54 61.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 10.0 111.956 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -117.51 -0.15 11.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.249 0.547 . . . . 10.0 110.319 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.78 -19.21 24.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.354 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.54 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 16.5 m-85 -127.21 124.79 39.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.448 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 t -109.66 91.17 9.95 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.519 -0.549 . . . . 10.0 109.519 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 3.4 Cg_exo -75.51 103.98 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.928 2.419 . . . . 10.0 112.785 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -100.71 115.0 29.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.01 117.06 25.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.673 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.11 99.92 9.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.015 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.519 HG21 ' HE2' ' B' ' 124' ' ' TYR . 65.8 t -94.52 118.29 40.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.961 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.15 -166.48 1.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.915 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -89.15 -36.63 15.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.896 0.379 . . . . 10.0 110.657 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -71.24 -40.26 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.899 -0.592 . . . . 10.0 110.96 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.428 ' HA2' ' CE2' ' B' ' 85' ' ' TYR . . . -177.64 -172.72 42.44 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.784 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.15 135.9 32.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -122.36 114.06 20.24 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.511 -0.551 . . . . 10.0 109.511 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.435 HG22 ' HD1' ' B' ' 30' ' ' PHE . 7.7 p -92.31 126.79 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.117 0.484 . . . . 10.0 111.273 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -127.5 88.74 2.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.159 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 5.0 p90 -93.31 115.74 28.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.024 0.44 . . . . 10.0 110.676 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 -75.17 115.71 15.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.554 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mt -94.68 135.8 27.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.911 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.8 150.31 48.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.155 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.53 79.71 2.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.203 0.525 . . . . 10.0 111.757 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.48 -26.65 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -103.77 150.99 23.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.227 -0.657 . . . . 10.0 109.227 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -142.39 146.18 34.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.822 0.344 . . . . 10.0 111.186 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' B' ' 99' ' ' TYR . 57.0 mtt -116.51 154.73 29.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.648 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.631 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 59.2 m-85 -96.48 129.81 43.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.39 -0.596 . . . . 10.0 109.39 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -60.6 -28.58 68.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.958 0.409 . . . . 10.0 111.255 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.97 9.8 21.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.205 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.631 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 38.9 mmtt -127.87 -7.68 5.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 10.0 111.748 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 89.4 mt -83.75 119.69 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.854 0.359 . . . . 10.0 110.188 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' B' ' 98' ' ' THR . 40.3 t -105.19 126.22 60.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.317 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.31 132.39 3.4 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.272 -0.731 . . . . 10.0 111.272 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -159.12 150.46 20.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.863 0.331 . . . . 10.0 111.129 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' B' ' 94' ' ' LYS . 10.2 t -153.66 125.27 7.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.34 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.451 ' HB2' ' HD2' ' B' ' 49' ' ' PRO . 13.3 p30 -178.54 160.76 1.13 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.344 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.464 ' HG3' HG21 ' B' ' 89' ' ' VAL . 55.3 Cg_endo -74.23 -56.54 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.215 1.943 . . . . 10.0 112.093 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.42 69.9 1.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.981 0.42 . . . . 10.0 111.138 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 t70 69.18 9.26 7.27 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.13 0.789 . . . . 10.0 113.13 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.443 ' HA ' HD13 ' B' ' 52' ' ' LEU . 1.4 mm? -81.24 59.9 4.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.043 0.449 . . . . 10.0 111.945 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 45.0 tp -125.87 138.58 53.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.78 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.57 -79.8 0.44 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.571 -0.823 . . . . 10.0 111.667 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 12.3 pt20 -165.72 145.4 5.38 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 23.7 Cg_exo -65.39 107.84 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.545 2.163 . . . . 10.0 111.772 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -83.62 92.65 7.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.467 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -77.27 145.54 37.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.013 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 53.9 m -77.62 -18.01 57.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.811 0.3 . . . . 10.0 111.811 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? 74.54 137.8 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.785 0.678 . . . . 10.0 112.558 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.99 -121.78 2.78 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.817 -0.913 . . . . 10.0 110.817 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -130.15 155.01 46.92 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -87.96 125.55 34.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.075 0.464 . . . . 10.0 110.838 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 71' ' ' ARG . 12.8 ttpp -102.7 131.9 49.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.452 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -73.79 146.73 44.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -145.2 173.78 11.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.803 0.335 . . . . 10.0 110.918 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -108.86 -29.38 8.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.858 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -108.12 -35.14 6.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 4.1 m-30 -94.11 -6.11 45.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.355 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.81 -79.97 1.52 Allowed Glycine 0 C--O 1.227 -0.296 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.435 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' B' ' 64' ' ' LYS . 5.9 ptp180 -176.71 122.61 0.15 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 122.698 0.399 . . . . 10.0 110.352 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -143.17 162.27 36.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.551 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 11.5 m -70.77 125.42 26.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.355 -0.609 . . . . 10.0 109.355 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -125.95 156.25 35.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.43 0.634 . . . . 10.0 112.312 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' TYR . . . . . 0.473 ' HB3' ' O ' ' B' ' 78' ' ' GLU . 53.7 m-85 -117.6 132.21 56.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -122.01 6.66 9.79 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.065 0.765 . . . . 10.0 113.065 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -176.25 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.83 -0.804 . . . . 10.0 108.83 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 1.0 OUTLIER -81.46 136.63 35.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.79 -1.095 . . . . 10.0 109.424 179.451 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -164.05 115.99 1.36 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 10.0 111.053 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -157.3 122.54 4.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.248 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.41 128.68 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.032 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.82 137.59 40.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.438 -0.347 . . . . 10.0 110.234 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -116.4 107.64 46.77 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.802 0.334 . . . . 10.0 111.528 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -91.03 127.47 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.036 2.491 . . . . 10.0 111.335 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' TYR . . . . . 0.428 ' CE2' ' HA2' ' B' ' 25' ' ' GLY . 21.9 m-85 -74.46 148.07 41.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.517 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.1 -5.88 57.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.175 0.512 . . . . 10.0 110.312 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -155.7 142.32 18.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.653 -0.703 . . . . 10.0 109.748 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.45 97.78 11.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.984 0.421 . . . . 10.0 110.74 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.464 HG21 ' HG3' ' B' ' 49' ' ' PRO . 13.6 m -128.24 154.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.685 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.26 7.18 72.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.628 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.22 144.7 92.68 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.89 107.06 1.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.444 2.096 . . . . 10.0 111.97 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.32 135.19 36.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' B' ' 47' ' ' THR . 40.7 tttt -88.7 141.58 28.39 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.605 -0.438 . . . . 10.0 110.328 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 64.6 tp -108.96 114.25 27.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.942 0.401 . . . . 10.0 110.897 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 47.4 t -112.47 122.03 65.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 65.6 mt -127.68 145.83 50.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.006 0.432 . . . . 10.0 111.536 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' THR . . . . . 0.744 ' HB ' ' HB ' ' B' ' 44' ' ' VAL . 24.1 m -147.87 122.93 10.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 16.4 m-85 -107.0 134.78 49.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.875 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 9.2 tp60 -140.61 126.01 18.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.428 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -165.87 -154.74 8.33 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.229 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.1 m -150.1 175.38 11.78 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -113.93 145.7 41.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.93 -2.41 12.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.791 0.663 . . . . 10.0 112.791 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.99 0.2 45.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.134 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.2 -21.13 31.8 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.808 -0.71 . . . . 10.0 112.082 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 3.2 t -64.15 145.15 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.79 0.329 . . . . 10.0 110.275 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 t -134.08 106.33 7.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.013 0.435 . . . . 10.0 110.794 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.5 ' HA ' HG23 ' A' ' 107' ' ' VAL . 31.3 p90 -88.17 146.68 38.71 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.821 0.343 . . . . 10.0 111.735 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 107' ' ' VAL . 63.7 Cg_endo -73.08 163.21 38.83 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.851 2.368 . . . . 10.0 111.782 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' B' ' 99' ' ' TYR . 57.0 Cg_endo -73.04 94.69 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.223 1.949 . . . . 10.0 111.591 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.56 133.7 30.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.33 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ASP . . . . . 0.587 ' HB3' ' HE1' ' A' ' 70' ' ' HIS . 4.8 p-10 -106.85 149.14 27.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.896 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.6 m -151.4 119.63 6.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.512 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.45 132.16 44.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.272 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -116.04 139.82 49.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.065 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.25 124.74 47.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.644 -0.707 . . . . 10.0 109.781 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.8 66.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.398 0.618 . . . . 10.0 109.925 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -73.19 -24.46 60.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.739 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 122.75 73.41 0.28 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.611 -0.804 . . . . 10.0 112.351 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -140.35 -20.15 0.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.103 0.477 . . . . 10.0 110.496 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.08 -65.29 4.0 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.911 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.99 123.66 33.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.305 -0.257 . . . . 10.0 110.305 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.519 ' HE2' HG21 ' B' ' 21' ' ' VAL . 56.4 m-85 -132.05 156.13 46.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.26 149.22 22.53 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.211 -0.449 . . . . 10.0 109.796 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.12 120.53 7.9 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.422 2.081 . . . . 10.0 112.257 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -80.87 75.28 7.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.19 0.519 . . . . 10.0 110.652 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 71.4 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.357 -0.83 . . . . 10.0 109.971 179.764 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 m -125.39 61.85 37.24 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 112.043 0.386 . . . . 10.0 112.043 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.28 -38.34 12.14 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.932 1.755 . . . . 10.0 111.857 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -62.61 -43.69 98.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.871 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -42.79 95.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.626 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -61.87 -30.3 70.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.034 0.445 . . . . 10.0 110.703 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 m -84.12 -7.14 59.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.187 -0.46 . . . . 10.0 111.456 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -91.24 -8.15 49.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.14 0.495 . . . . 10.0 109.907 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.25 110.7 2.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.418 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.47 140.61 30.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.736 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.8 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 25.2 p -81.2 174.06 11.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.324 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.53 -10.86 58.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.239 0.542 . . . . 10.0 110.135 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -91.95 -4.55 54.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.194 -0.912 . . . . 10.0 109.421 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 79.68 9.98 1.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.067 -0.97 . . . . 10.0 111.836 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 15' ' ' ARG . 32.8 mtt85 -94.64 144.79 28.5 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 10.0 109.998 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.78 148.93 78.16 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.242 1.962 . . . . 10.0 111.387 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.79 -8.52 15.38 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -24.04 52.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.795 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.631 HG23 ' HD1' ' A' ' 20' ' ' TYR . 19.2 m -61.53 -21.03 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.039 0.447 . . . . 10.0 111.709 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.631 ' HD1' HG23 ' A' ' 19' ' ' VAL . 35.5 m-85 -131.34 23.66 4.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.257 0.551 . . . . 10.0 110.42 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.7 mt -135.33 56.07 1.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.451 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HG2' ' H ' ' A' ' 23' ' ' LYS . 31.6 tttp -155.94 -179.71 8.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.36 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.484 ' H ' ' HG2' ' A' ' 22' ' ' LYS . 30.2 mttp 69.67 14.8 8.16 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.891 0.7 . . . . 10.0 112.891 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.78 39.18 29.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.013 0.435 . . . . 10.0 111.054 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -107.96 145.29 31.1 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.153 -0.476 . . . . 10.0 111.176 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.17 143.74 94.83 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.687 2.258 . . . . 10.0 111.543 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.516 ' HB ' ' HB ' ' A' ' 114' ' ' ILE . 1.6 m -116.41 143.49 45.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.664 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.636 HD23 ' HG ' ' A' ' 60' ' ' LEU . 28.3 tp -124.01 105.7 9.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.97 0.414 . . . . 10.0 110.047 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 67.6 mt -93.44 117.52 37.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.867 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.736 ' HE2' HG22 ' A' ' 62' ' ' THR . 17.4 ttpt -112.61 119.98 40.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.818 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 110' ' ' SER . 3.9 m-85 -88.7 146.92 24.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.569 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -148.94 166.98 26.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.859 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.28 142.81 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.627 -0.509 . . . . 10.0 109.627 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -67.44 -63.85 0.98 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.561 ' CZ2' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.5 64.16 4.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.494 0.553 . . . . 10.0 112.494 -178.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.6 t -131.94 135.62 26.94 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.076 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.709 ' HD3' ' HE1' ' B' ' 69' ' ' PHE . 33.3 Cg_endo -64.45 -49.54 3.33 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.517 2.145 . . . . 10.0 112.344 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' B' ' 108' ' ' CYS . 78.0 mt -63.17 -44.26 95.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.239 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.434 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 74.9 m -66.33 -31.16 71.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 10.0 111.389 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -62.86 -46.78 86.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.99 -38.68 79.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.93 0.395 . . . . 10.0 110.676 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -66.88 -24.74 66.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.859 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 39' ' ' CYS . 24.1 mt -55.27 -44.56 75.74 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.822 0.344 . . . . 10.0 111.416 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.48 -33.42 81.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.577 -0.821 . . . . 10.0 111.128 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -68.85 -40.01 79.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.355 -0.423 . . . . 10.0 110.662 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.4 m -55.19 -47.55 75.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.424 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.86 -44.14 86.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.061 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -60.63 -44.49 96.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.03 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -71.35 -37.89 71.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 10.0 111.698 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.91 -22.08 66.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.041 0.448 . . . . 10.0 111.234 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -88.55 -6.69 57.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.629 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.2 135.5 50.69 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.769 0.319 . . . . 10.0 110.369 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.42 -33.93 68.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.925 -0.579 . . . . 10.0 112.214 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -73.53 -37.75 65.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.968 0.413 . . . . 10.0 110.919 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -78.21 -10.32 59.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.925 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m -75.64 5.36 6.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.913 0.387 . . . . 10.0 111.53 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -87.04 -15.22 39.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.047 0.451 . . . . 10.0 110.52 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.44 148.4 51.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 10.0 109.814 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -82.87 88.19 6.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.763 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.636 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -81.48 121.54 26.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.542 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.2 pt -133.73 157.62 42.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.991 0.424 . . . . 10.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.736 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -111.83 117.55 33.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.166 -0.47 . . . . 10.0 109.811 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 92' ' ' VAL . 21.5 t -115.96 143.35 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.863 0.364 . . . . 10.0 111.337 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.39 146.76 38.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 4.7 m -104.17 100.9 23.28 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.639 ' HG3' HG22 ' A' ' 93' ' ' THR . 29.9 Cg_endo -62.75 118.51 5.41 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.758 2.305 . . . . 10.0 112.067 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.88 -12.71 67.01 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.965 -0.636 . . . . 10.0 112.539 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.593 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 7.5 t80 -96.92 144.43 26.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.158 -0.312 . . . . 10.0 110.158 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.481 HD11 HG22 ' B' ' 112' ' ' VAL . 0.8 OUTLIER 60.4 30.41 19.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.737 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.7 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 2.6 t60 66.37 19.0 10.97 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.653 -0.703 . . . . 10.0 112.811 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.561 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 2.1 mm-40 -77.6 -175.58 3.91 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 72' ' ' LYS . 48.1 mmtt -65.45 127.89 33.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.795 0.331 . . . . 10.0 111.039 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -66.46 163.41 18.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.961 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.96 125.62 24.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.549 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.97 -17.32 35.38 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -107.23 -41.68 5.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.029 0.442 . . . . 10.0 109.867 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -62.62 -50.92 69.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.594 . . . . 10.0 112.496 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.91 -28.07 69.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.047 0.451 . . . . 10.0 110.687 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 8.1 mmmt -75.55 -30.69 59.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.681 -0.691 . . . . 10.0 109.911 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.436 ' HZ3' ' HE3' ' A' ' 72' ' ' LYS . 5.2 t-105 -65.25 -50.04 67.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.526 -0.761 . . . . 10.0 109.499 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.405 ' HA ' HD12 ' A' ' 84' ' ' LEU . 74.9 t80 -63.89 -30.02 71.15 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.079 -0.51 . . . . 10.0 111.107 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.46 -24.1 67.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.178 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.14 8.15 41.51 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.105 -0.569 . . . . 10.0 111.98 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 81' ' ' TYR . 35.5 mt -95.19 -179.65 4.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.797 0.332 . . . . 10.0 110.879 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -97.93 -178.48 4.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.678 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 66.97 84.06 0.17 Allowed Pre-proline 0 N--CA 1.464 0.269 0 O-C-N 123.647 0.592 . . . . 10.0 112.053 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.1 37.96 0.72 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.633 2.222 . . . . 10.0 111.663 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -150.02 25.08 0.83 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.694 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 19.4 mt -93.36 117.9 67.51 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.545 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 89' ' ' LEU . 6.1 Cg_exo -74.56 66.97 5.59 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.745 2.297 . . . . 10.0 111.489 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 62' ' ' THR . 60.7 t -86.08 117.91 31.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.772 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.8 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 8.3 t -103.2 142.45 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.131 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.639 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -101.64 106.4 17.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.123 -179.474 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.456 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 40.3 t0 -93.48 91.35 7.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.243 0.545 . . . . 10.0 110.267 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.03 113.72 4.67 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.22 -24.64 26.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.857 -0.687 . . . . 10.0 113.06 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.81 44.15 3.98 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.513 -0.851 . . . . 10.0 111.413 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -33.72 74.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 10.0 110.627 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.2 mm -92.27 -43.45 13.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.224 -0.444 . . . . 10.0 109.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.831 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -60.51 -44.95 95.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.688 -0.687 . . . . 10.0 112.394 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -68.15 -40.77 82.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.9 m -66.54 -22.12 66.16 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.57 5.06 24.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.464 -0.334 . . . . 10.0 110.669 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.3 t30 52.37 50.08 19.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.665 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.831 HD12 ' HA ' ' A' ' 100' ' ' ALA . 98.3 mt -75.26 109.38 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.258 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.4 p -115.59 -10.32 11.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.586 -0.733 . . . . 10.0 112.025 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.859 HG23 ' HB3' ' B' ' 109' ' ' TYR . 7.4 p -147.14 142.1 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.562 0.22 . . . . 10.0 111.293 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' B' ' 108' ' ' CYS . 22.1 m-85 -107.24 153.99 40.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.653 -0.499 . . . . 10.0 109.653 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.07 159.16 83.63 Favored 'Cis proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.339 -1.525 . . . . 10.0 112.058 -0.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 13.0 m -122.18 124.3 43.53 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -108.76 104.2 13.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.02 0.438 . . . . 10.0 110.898 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.19 115.47 29.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.164 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 25.0 tp -95.69 112.62 24.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.584 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 27' ' ' THR . 3.4 mp -98.5 127.25 51.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.3 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.79 171.98 29.66 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 116.016 -0.538 . . . . 10.0 112.618 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -65.58 -14.42 61.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.256 0.465 . . . . 10.0 112.256 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.24 0.95 57.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 10.0 111.87 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.89 37.74 15.41 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.82 -0.705 . . . . 10.0 113.191 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -132.99 146.96 52.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.785 -0.244 . . . . 10.0 110.666 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.6 111.48 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.098 -0.334 . . . . 10.0 110.098 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -96.44 -35.87 11.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.357 -0.383 . . . . 10.0 111.512 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -142.35 150.27 40.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.628 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 tp -144.21 116.94 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 t -119.48 130.76 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.844 0.354 . . . . 10.0 111.637 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -101.96 107.23 18.31 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.158 -0.682 . . . . 10.0 109.158 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.42 -141.93 11.92 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.488 -0.645 . . . . 10.0 111.488 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.7 m -119.5 147.22 44.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.84 0.352 . . . . 10.0 111.066 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.9 pt -104.72 176.57 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.264 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -146.6 171.67 14.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.443 -0.344 . . . . 10.0 110.57 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -61.53 -46.88 88.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.932 0.345 . . . . 10.0 111.932 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.65 88.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 10.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -66.8 -39.19 87.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.351 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.426 ' O ' HG13 ' A' ' 137' ' ' ILE . . . -61.64 -42.88 99.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 10.0 109.75 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.75 -35.92 82.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.603 . . . . 10.0 110.41 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.7 -39.29 88.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 10.0 109.975 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 140' ' ' PRO . 27.5 tp -64.38 -36.32 83.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.585 -0.734 . . . . 10.0 110.523 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 133' ' ' ALA . 85.2 mt -67.11 -29.44 46.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.022 -0.536 . . . . 10.0 109.763 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -83.38 -50.34 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.793 -0.64 . . . . 10.0 111.246 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.491 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 2.8 t70 -144.43 120.67 6.24 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.8 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 139' ' ' ASP . 13.5 Cg_exo -71.24 -6.29 18.88 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.004 2.469 . . . . 10.0 112.707 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -94.11 -3.15 51.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.925 0.393 . . . . 10.0 110.897 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.13 73.44 6.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.526 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -74.2 155.43 38.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.25 -0.881 . . . . 10.0 111.513 -179.522 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 112.203 0.446 . . . . 10.0 112.203 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.3 -10.14 45.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 25.2 tp -142.41 -77.92 0.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.126 -0.23 . . . . 10.0 111.143 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 57.71 39.09 27.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.827 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.13 166.3 31.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.793 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.3 m120 68.4 -172.32 0.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.776 0.673 . . . . 10.0 111.865 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -99.69 13.9 32.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.36 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.43 -13.94 59.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.446 0.535 . . . . 10.0 112.446 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.08 133.27 23.44 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.673 0.273 . . . . 10.0 111.734 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.4 151.41 85.63 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 123.097 2.532 . . . . 10.0 112.453 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.677 ' HG3' ' HB ' ' A' ' 107' ' ' VAL . 11.3 Cg_endo -53.86 -33.75 72.84 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.746 2.964 . . . . 10.0 113.707 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -55.75 -28.15 54.44 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.38 -11.4 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 10.0 111.075 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' B' ' 11' ' ' PRO . . . -75.01 -7.61 54.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.275 -0.421 . . . . 10.0 111.932 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.468 ' HE1' HG23 ' B' ' 32' ' ' ILE . 21.4 m-85 -122.19 129.84 52.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.944 0.402 . . . . 10.0 111.364 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' B' ' 31' ' ' ARG . 42.1 t -114.16 92.06 25.41 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.13 102.0 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.5 2.133 . . . . 10.0 113.428 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -95.81 110.56 22.71 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' B' ' 19' ' ' LEU . 2.8 mm? -92.57 120.55 33.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.477 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.26 100.8 8.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.614 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.11 118.29 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.194 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.67 -170.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 10.0 110.347 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.65 -22.32 20.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.009 0.433 . . . . 10.0 111.608 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -86.73 -39.23 16.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.156 0.503 . . . . 10.0 110.272 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.91 -171.4 36.89 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.663 -0.699 . . . . 10.0 111.629 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -107.75 129.59 61.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.338 -0.616 . . . . 10.0 109.338 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -115.89 117.98 31.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.813 0.339 . . . . 10.0 110.186 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.509 HG22 ' HD1' ' B' ' 30' ' ' PHE . 7.8 p -101.88 118.02 48.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.277 0.56 . . . . 10.0 110.553 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -121.63 90.96 3.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.545 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.509 ' HD1' HG22 ' B' ' 28' ' ' VAL . 4.1 p90 -94.2 119.18 32.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.204 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.448 ' HB2' ' HB ' ' B' ' 16' ' ' VAL . 62.4 mtm-85 -77.0 118.38 19.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.232 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.468 HG23 ' HE1' ' B' ' 15' ' ' PHE . 53.8 mt -92.06 136.49 24.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.354 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 146.07 51.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.403 -0.362 . . . . 10.0 110.284 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.21 92.76 0.57 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.991 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.49 -16.71 1.12 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.404 -0.678 . . . . 10.0 111.404 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -105.78 151.95 23.83 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' B' ' 75' ' ' TYR . 33.0 p90 -143.98 139.9 29.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.945 0.402 . . . . 10.0 111.191 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' MET . . . . . 0.415 ' HA ' ' HA3' ' B' ' 101' ' ' GLY . 43.8 mtt -110.41 150.5 28.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.99 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.549 ' O ' HG13 ' B' ' 43' ' ' ILE . 90.9 m-85 -92.09 116.52 29.0 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.77 -0.456 . . . . 10.0 109.77 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.424 ' OE1' ' HA ' ' B' ' 60' ' ' LYS . 21.7 tt0 -61.32 -23.02 65.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.208 0.528 . . . . 10.0 111.331 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.8 -6.82 59.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.522 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -123.8 0.05 8.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.494 -0.321 . . . . 10.0 111.631 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.549 HG13 ' O ' ' B' ' 39' ' ' TYR . 92.9 mt -78.87 117.77 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.024 0.44 . . . . 10.0 109.817 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' B' ' 98' ' ' THR . 21.7 t -99.56 123.41 52.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.826 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -153.81 120.57 1.05 Allowed Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.643 -0.789 . . . . 10.0 111.995 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -160.46 140.47 11.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.808 0.337 . . . . 10.0 111.015 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' B' ' 94' ' ' LYS . 11.6 t -139.72 126.23 20.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.134 -0.484 . . . . 10.0 109.893 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.502 ' HB2' ' H ' ' B' ' 52' ' ' LEU . 28.2 p30 -174.56 158.36 2.45 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.426 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -74.26 -66.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.256 1.97 . . . . 10.0 111.072 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.64 53.79 1.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.129 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.489 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 0.3 OUTLIER 59.45 51.0 6.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.608 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.502 ' H ' ' HB2' ' B' ' 48' ' ' ASN . 0.6 OUTLIER -108.18 43.58 1.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.8 -0.637 . . . . 10.0 110.422 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' B' ' 83' ' ' PHE . 18.6 tp -107.45 144.64 34.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.092 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.63 -66.72 1.89 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.418 -0.896 . . . . 10.0 111.284 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 2.7 pp0? -171.63 149.7 2.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 122.596 0.358 . . . . 10.0 110.179 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 15.2 Cg_exo -70.81 106.47 1.86 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.495 2.13 . . . . 10.0 110.434 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -86.67 99.58 11.85 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.061 0.458 . . . . 10.0 111.376 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -84.59 157.91 21.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.799 -0.637 . . . . 10.0 110.352 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 50.2 m -86.72 -20.4 27.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.645 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.424 ' HA ' ' OE1' ' B' ' 40' ' ' GLN . 12.8 tmtt? 70.57 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.711 -0.677 . . . . 10.0 112.292 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.87 -127.8 6.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.21 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -116.69 158.88 23.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.624 0.249 . . . . 10.0 110.873 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.24 132.81 34.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' B' ' 71' ' ' ARG . 11.3 ttpp -114.47 127.01 55.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.508 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.88 149.56 46.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.548 -0.908 . . . . 10.0 108.548 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -146.56 171.02 15.72 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.935 -0.306 . . . . 10.0 111.382 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.98 -23.55 14.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.284 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -114.76 -40.74 3.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.887 0.375 . . . . 10.0 110.949 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.709 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 85.5 m-85 -87.68 -6.13 58.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.185 -0.462 . . . . 10.0 111.616 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.7 -73.55 2.07 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 121.105 -0.569 . . . . 10.0 112.16 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' B' ' 64' ' ' LYS . 5.9 ptp180 -173.92 122.89 0.33 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.862 0.465 . . . . 10.0 109.968 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -139.88 162.98 33.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.438 -0.346 . . . . 10.0 110.545 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -74.28 127.2 32.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.96 159.75 38.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.354 0.597 . . . . 10.0 112.091 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' B' ' 37' ' ' TYR . 16.7 m-85 -114.5 127.33 55.76 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.404 -1.332 . . . . 10.0 107.404 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -113.58 -3.79 13.58 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -173.89 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.599 . . . . 10.0 109.472 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -91.19 126.41 36.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.774 -1.103 . . . . 10.0 109.712 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -153.42 112.87 3.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.889 0.376 . . . . 10.0 111.173 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -145.94 119.41 9.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.381 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -127.87 120.95 55.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.069 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.19 134.57 44.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.66 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' PHE . . . . . 0.459 ' HB3' HD11 ' B' ' 53' ' ' LEU . 29.8 m-85 -113.81 98.91 48.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.092 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.14 127.96 3.54 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.949 2.433 . . . . 10.0 111.782 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -74.04 148.29 42.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.881 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.66 -5.19 32.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.465 0.65 . . . . 10.0 109.754 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -134.95 129.48 34.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.166 -0.925 . . . . 10.0 108.785 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.9 80.41 4.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.237 0.542 . . . . 10.0 111.307 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 4.1 m -128.4 143.26 41.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.557 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.19 54.04 4.67 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.336 -0.706 . . . . 10.0 111.336 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -105.78 153.84 39.74 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.68 -0.26 . . . . 10.0 110.47 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.7 141.91 42.52 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.44 2.093 . . . . 10.0 110.436 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -132.57 154.14 50.31 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.232 0.456 . . . . 10.0 112.232 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' B' ' 47' ' ' THR . 43.1 tttt -98.25 150.83 21.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 10.0 109.658 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' B' ' 47' ' ' THR . 60.4 tp -118.97 114.32 22.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.584 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 42.0 t -104.19 114.82 44.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.058 -0.519 . . . . 10.0 109.987 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 93.0 mt -125.1 136.77 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.402 . . . . 10.0 111.154 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' THR . . . . . 0.566 HG23 ' HB3' ' B' ' 113' ' ' ASP . 19.1 m -133.69 118.04 17.67 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.132 -0.485 . . . . 10.0 109.839 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 39.5 m-85 -98.62 109.38 22.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.462 -0.335 . . . . 10.0 111.335 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.73 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 0.8 OUTLIER -123.94 128.87 50.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.444 -0.344 . . . . 10.0 110.945 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -174.49 -155.64 12.58 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.851 -0.69 . . . . 10.0 111.617 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 73.5 m -155.56 176.99 11.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.3 -0.259 . . . . 10.0 110.3 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -116.98 145.03 43.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.89 -10.68 22.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.442 0.534 . . . . 10.0 112.442 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.45 -0.76 55.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.517 -0.31 . . . . 10.0 111.785 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.7 20.63 23.8 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.669 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 4.6 t -103.27 136.73 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.436 -0.579 . . . . 10.0 109.436 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 17.4 t -122.57 97.97 5.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.683 0.277 . . . . 10.0 110.767 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.859 ' HB3' HG23 ' A' ' 107' ' ' VAL . 53.2 p90 -84.23 143.94 43.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.859 0.361 . . . . 10.0 111.361 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.622 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 42.4 Cg_endo -67.31 163.64 33.67 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.586 2.191 . . . . 10.0 111.241 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.73 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 63.7 Cg_endo -75.74 80.56 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.372 2.048 . . . . 10.0 111.86 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.481 HG22 HD11 ' A' ' 69' ' ' LEU . 12.8 t -60.84 108.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.69 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ASP . . . . . 0.566 ' HB3' HG23 ' B' ' 98' ' ' THR . 20.9 p-10 -100.41 130.41 46.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.514 0.673 . . . . 10.0 111.833 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.456 HG21 ' HB3' ' B' ' 126' ' ' PRO . 0.2 OUTLIER -128.6 124.86 36.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.393 -0.822 . . . . 10.0 109.951 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.39 130.26 49.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.077 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -114.86 149.17 37.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.452 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.02 114.28 28.26 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.98 -0.748 . . . . 10.0 108.98 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 23.3 mm -85.61 99.86 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.212 0.529 . . . . 10.0 111.057 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -108.75 -6.66 15.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.529 -0.76 . . . . 10.0 110.195 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.7 97.57 2.51 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.509 -0.769 . . . . 10.0 111.191 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -153.48 -15.94 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.824 0.345 . . . . 10.0 111.504 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.95 -76.91 1.49 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.697 -0.763 . . . . 10.0 111.891 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.76 145.83 28.61 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.311 -0.255 . . . . 10.0 110.311 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -136.88 146.37 45.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 10.0 111.024 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.21 147.71 38.43 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.098 -0.501 . . . . 10.0 109.695 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' PRO . . . . . 0.456 ' HB3' HG21 ' B' ' 114' ' ' THR . 36.7 Cg_endo -66.9 136.92 43.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.401 2.067 . . . . 10.0 111.74 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -91.86 70.28 5.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.137 0.494 . . . . 10.0 111.304 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.602 -0.713 . . . . 10.0 109.741 179.733 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 110.067 -0.346 . . . . 10.0 110.067 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 m -132.05 65.89 76.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 111.981 0.363 . . . . 10.0 111.981 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.91 -40.29 45.13 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.38 2.053 . . . . 10.0 111.617 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -60.54 -38.35 84.19 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 115.949 -0.568 . . . . 10.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.9 m -67.45 -47.22 70.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.703 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.55 -35.25 75.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 10.0 111.005 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m -84.27 -4.73 59.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.437 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.6 m -90.15 -18.6 25.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.384 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -67.59 124.42 23.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.706 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 10' ' ' LYS . 2.1 mppt? -107.77 151.91 25.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.089 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 24.8 p -84.74 174.32 9.99 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.474 -0.565 . . . . 10.0 109.474 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.12 -7.87 33.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.129 0.49 . . . . 10.0 110.515 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.496 ' OD2' ' HD2' ' A' ' 15' ' ' ARG . 28.2 t70 -95.96 1.71 53.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.351 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.0 t30 75.45 16.5 2.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.496 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 24.6 mtt180 -103.89 135.42 19.36 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.037 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.61 145.26 95.22 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.782 2.321 . . . . 10.0 111.551 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.37 -9.7 27.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 10.0 112.043 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.519 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -58.73 -19.9 44.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.394 -0.367 . . . . 10.0 111.817 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.499 HG23 ' HD2' ' A' ' 20' ' ' TYR . 31.3 m -66.21 -16.02 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.027 0.441 . . . . 10.0 111.383 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.499 ' HD2' HG23 ' A' ' 19' ' ' VAL . 19.7 m-85 -127.07 22.55 6.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.572 0.701 . . . . 10.0 109.34 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 17.1 mt -134.02 34.12 3.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.405 -0.816 . . . . 10.0 110.428 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -127.7 176.08 7.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.478 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt 68.18 17.39 9.38 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.504 -0.771 . . . . 10.0 112.53 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 51.51 43.39 29.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.509 -0.768 . . . . 10.0 112.077 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -103.28 145.5 30.72 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.832 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.19 131.83 47.51 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.715 2.277 . . . . 10.0 111.066 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 114' ' ' ILE . 1.3 m -99.79 136.22 40.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.905 0.384 . . . . 10.0 111.226 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.444 HD21 ' HZ3' ' A' ' 111' ' ' TRP . 12.1 tp -117.74 99.58 7.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 70.7 mt -91.87 122.88 43.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 10.0 111.147 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' HE2' HG22 ' A' ' 62' ' ' THR . 3.9 tmmm? -117.24 121.82 42.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.495 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.548 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 5.7 m-85 -95.92 134.49 38.85 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.594 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -134.97 -179.11 5.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.064 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 108' ' ' TYR . . . -134.09 150.05 51.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.223 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.99 -40.86 16.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.066 0.46 . . . . 10.0 110.497 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.473 ' HZ2' ' HE2' ' A' ' 72' ' ' LYS . 27.3 m0 -86.75 65.61 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.98 -0.555 . . . . 10.0 111.466 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.1 t -161.18 129.34 2.87 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.223 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 41.8 Cg_endo -71.13 -41.76 2.43 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.571 2.181 . . . . 10.0 112.094 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.57 -43.21 97.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.928 0.394 . . . . 10.0 111.495 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.8 m -69.29 -23.1 63.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.269 -0.423 . . . . 10.0 111.077 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.6 tp -66.64 -40.54 88.78 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.112 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.45 -34.85 68.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.105 0.479 . . . . 10.0 110.308 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.67 -32.21 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.634 -0.712 . . . . 10.0 111.115 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.2 mt -56.25 -42.51 77.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.787 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.77 -36.82 92.75 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.909 -0.662 . . . . 10.0 111.475 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -69.9 -39.59 76.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.361 . . . . 10.0 110.073 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.6 m -61.61 -45.07 95.64 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.431 -0.581 . . . . 10.0 109.431 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HG3' ' HB3' ' A' ' 86' ' ' TYR . 4.3 tm-20 -61.1 -35.13 76.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.519 -0.764 . . . . 10.0 110.375 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -72.33 -46.03 57.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.729 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -63.71 -33.12 74.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 10.0 111.421 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.06 -13.39 57.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.7 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -105.57 -3.41 22.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.375 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 18.0 t70 -69.39 144.66 53.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.093 0.473 . . . . 10.0 111.822 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.02 84.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.719 -0.673 . . . . 10.0 112.13 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 27.4 mmmt -74.58 -43.75 54.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 10.0 110.943 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.437 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 3.0 m-85 -61.04 -20.44 62.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 10.0 112.13 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -67.73 -5.41 15.95 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.863 0.363 . . . . 10.0 111.826 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 m -77.06 -17.01 59.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 10.0 110.561 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.24 169.42 15.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.923 -0.58 . . . . 10.0 109.998 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.84 98.1 8.0 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.233 -0.284 . . . . 10.0 110.233 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.0 tp -86.15 127.6 34.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.291 -0.413 . . . . 10.0 111.39 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.491 HG22 ' HB2' ' A' ' 90' ' ' PRO . 5.8 pt -137.41 144.94 30.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.497 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.488 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -102.57 110.99 23.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.025 -0.534 . . . . 10.0 109.702 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -109.24 137.39 41.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.052 0.454 . . . . 10.0 111.548 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.39 146.89 52.47 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.437 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 19.2 m -109.91 96.11 23.43 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 112.222 0.453 . . . . 10.0 112.222 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 65' ' ' SER . 33.3 Cg_endo -65.31 132.25 30.92 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.365 2.043 . . . . 10.0 111.357 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.98 6.08 88.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.072 -0.585 . . . . 10.0 112.534 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -121.72 148.49 44.54 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.155 -0.313 . . . . 10.0 110.155 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER 59.92 21.17 10.17 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.5 t60 69.57 27.73 4.74 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.462 -0.79 . . . . 10.0 112.287 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -88.26 -168.35 2.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.487 ' HE3' ' CZ3' ' A' ' 80' ' ' TRP . 23.0 mmtt -63.57 145.08 56.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.711 0.291 . . . . 10.0 111.033 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -80.9 161.78 24.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.806 0.336 . . . . 10.0 111.367 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.44 150.17 27.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.533 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 78' ' ' GLN . . . 83.03 -47.13 3.76 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.273 -0.731 . . . . 10.0 111.273 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -76.65 -39.72 51.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.676 -0.49 . . . . 10.0 109.676 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -63.05 -36.32 83.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.485 -0.779 . . . . 10.0 111.891 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 17.1 pt20 -66.11 -32.14 73.42 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.775 -0.37 . . . . 10.0 111.021 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.92 -27.49 63.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.04 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.537 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.7 t-105 -61.32 -57.71 11.2 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.503 -0.772 . . . . 10.0 109.707 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -65.93 -36.32 83.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.102 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.82 -20.78 58.95 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.224 0.453 . . . . 10.0 112.224 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.21 5.23 38.59 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.592 -0.813 . . . . 10.0 112.192 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 80' ' ' TRP . 88.2 mt -100.46 -178.29 3.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.895 0.378 . . . . 10.0 111.185 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -103.54 -177.78 3.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.136 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.55 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 12.8 m-85 69.0 78.56 0.23 Allowed Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 123.007 0.523 . . . . 10.0 111.035 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.15 12.25 1.83 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.736 2.29 . . . . 10.0 112.063 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -108.57 11.25 26.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.402 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.9 mt -88.5 111.13 41.83 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.574 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.491 ' HB2' HG22 ' A' ' 61' ' ' ILE . 66.5 Cg_endo -75.56 69.83 5.85 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.465 2.11 . . . . 10.0 111.234 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 62' ' ' THR . 57.1 t -78.56 107.78 11.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.844 -0.616 . . . . 10.0 111.305 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 16.5 t -92.34 137.34 22.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.762 -0.653 . . . . 10.0 109.918 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -100.47 100.44 11.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.59 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -94.81 85.35 4.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.171 0.51 . . . . 10.0 110.05 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -62.38 114.75 3.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.655 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.71 -11.92 67.86 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.653 -0.784 . . . . 10.0 112.897 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.53 55.95 7.14 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.632 -0.794 . . . . 10.0 112.269 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.84 -44.15 81.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.178 0.514 . . . . 10.0 110.253 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.5 mm -77.74 -41.14 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.295 -0.631 . . . . 10.0 109.295 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.714 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.67 -41.48 86.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.714 -0.676 . . . . 10.0 111.338 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -70.84 -41.74 71.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.985 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.9 m -65.92 -27.89 68.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.097 0.406 . . . . 10.0 112.097 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.72 -2.74 31.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.723 0.297 . . . . 10.0 110.898 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t30 54.21 55.88 7.66 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.686 -0.688 . . . . 10.0 111.471 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 100' ' ' ALA . 87.5 mt -80.65 126.15 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.659 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 p -127.34 -1.99 6.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.898 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.838 HG23 ' HB3' ' B' ' 109' ' ' TYR . 14.9 p -154.18 151.72 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.575 0.226 . . . . 10.0 111.007 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.548 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 25.3 m-85 -117.3 156.21 49.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -87.33 130.16 11.0 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.734 -1.361 . . . . 10.0 111.585 -0.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.4 m -94.35 130.73 40.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.135 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.693 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 19.3 m95 -112.84 115.34 28.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.462 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -107.09 116.91 32.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.346 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.53 HD22 HD11 ' A' ' 136' ' ' LEU . 52.4 tp -97.12 111.88 23.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.133 0.492 . . . . 10.0 110.939 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 27' ' ' THR . 2.4 mp -98.1 129.31 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.62 -0.881 . . . . 10.0 108.62 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.59 175.58 33.45 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.859 -0.686 . . . . 10.0 112.262 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -72.21 -1.95 17.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.019 0.438 . . . . 10.0 111.176 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.46 -14.02 33.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.135 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.47 21.44 31.93 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.869 -0.682 . . . . 10.0 112.607 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -126.63 166.1 17.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.855 0.36 . . . . 10.0 111.289 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.22 125.33 31.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.688 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -113.76 -39.6 3.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.818 0.342 . . . . 10.0 111.848 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 122' ' ' ARG . 0.1 OUTLIER -141.53 151.3 43.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.688 0.28 . . . . 10.0 110.891 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.12 128.51 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 10.0 110.629 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.693 ' HB ' ' HB2' ' A' ' 111' ' ' TRP . 46.3 t -117.11 128.93 74.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.578 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -129.39 114.8 16.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.272 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.79 -85.58 0.19 Allowed Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.415 -0.898 . . . . 10.0 112.757 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.9 m -160.75 163.21 32.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.077 -0.342 . . . . 10.0 110.077 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.49 HG12 ' CE2' ' A' ' 111' ' ' TRP . 1.5 pp -130.03 170.73 18.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.557 0.218 . . . . 10.0 111.294 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 132' ' ' GLN . 9.6 p30 -147.17 163.34 36.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.007 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -57.66 -45.89 84.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.613 0.598 . . . . 10.0 112.613 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.8 95.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.847 0.356 . . . . 10.0 111.097 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.417 ' HB2' ' ND2' ' A' ' 129' ' ' ASN . 8.9 tt0 -65.0 -40.9 95.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 55' ' ' PHE . . . -60.91 -47.56 85.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.848 -0.615 . . . . 10.0 110.644 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.56 -37.81 88.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.713 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.41 97.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.742 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.53 HD11 HD22 ' A' ' 113' ' ' LEU . 19.1 tp -62.73 -36.11 81.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.134 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.8 mt -73.12 -26.78 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.077 0.465 . . . . 10.0 110.048 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -80.88 -40.99 23.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.311 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 50.4 t0 -154.15 113.9 2.51 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.177 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 36.7 Cg_endo -66.06 -7.88 18.38 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.003 2.469 . . . . 10.0 112.449 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -86.36 -6.69 58.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.876 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.55 96.59 4.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.345 -0.389 . . . . 10.0 111.474 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -102.08 128.38 48.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.417 -0.586 . . . . 10.0 109.417 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 36.2 tp . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.108 -0.948 . . . . 10.0 111.633 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.909 0.385 . . . . 10.0 110.773 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.71 -60.41 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 61.7 tp -113.91 -65.31 1.2 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.847 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 52.79 41.12 31.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.446 0.641 . . . . 10.0 111.246 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.1 170.68 18.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.449 -0.796 . . . . 10.0 110.278 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.39 -159.34 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.855 0.722 . . . . 10.0 111.921 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -105.63 16.19 25.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.482 -0.781 . . . . 10.0 109.757 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -81.04 2.87 25.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 10.0 112.374 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.85 132.77 16.25 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.43 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.89 145.64 96.23 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.031 2.487 . . . . 10.0 112.35 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' B' ' 14' ' ' ALA . 9.4 Cg_endo -52.37 -36.25 68.18 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.532 2.822 . . . . 10.0 113.136 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -62.71 -14.23 41.73 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.07 0.462 . . . . 10.0 111.96 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -121.17 -3.08 9.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.633 0.73 . . . . 10.0 109.93 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' B' ' 11' ' ' PRO . . . -92.6 -3.78 54.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 10.0 112.25 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.529 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 15.4 m-85 -122.29 125.14 45.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.888 0.375 . . . . 10.0 111.165 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.03 90.82 10.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.275 -0.639 . . . . 10.0 109.275 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 6.4 Cg_exo -74.73 96.28 0.99 Allowed 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.955 2.436 . . . . 10.0 112.879 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.42 98.17 10.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 123' ' ' THR . 3.2 mm? -89.05 116.34 27.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.819 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.26 109.95 19.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.703 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.602 HG13 HG22 ' B' ' 26' ' ' VAL . 61.4 t -92.87 114.81 30.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.275 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.96 170.49 7.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.23 -0.656 . . . . 10.0 109.23 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.51 -42.84 77.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.98 0.363 . . . . 10.0 111.98 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.9 -15.03 59.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.567 0.58 . . . . 10.0 112.567 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 165.11 166.4 24.02 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.424 -0.893 . . . . 10.0 112.228 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.602 HG22 HG13 ' B' ' 21' ' ' VAL . 58.7 t -90.52 137.43 21.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.18 -0.304 . . . . 10.0 110.18 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -120.53 112.15 18.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.922 -0.399 . . . . 10.0 109.922 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.573 HG22 ' HD1' ' B' ' 30' ' ' PHE . 6.8 p -91.79 121.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.051 0.453 . . . . 10.0 110.956 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -124.53 79.32 1.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.039 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.573 ' HD1' HG22 ' B' ' 28' ' ' VAL . 12.8 p90 -87.27 112.5 22.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 10.0 111.057 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -76.47 118.9 19.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.414 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 45.9 mt -92.65 140.19 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.719 -0.673 . . . . 10.0 110.33 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.94 149.79 39.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.396 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.08 77.74 1.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.168 0.509 . . . . 10.0 111.486 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 169.57 -21.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.376 -0.69 . . . . 10.0 111.376 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.41 150.17 24.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.221 -0.659 . . . . 10.0 109.221 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' B' ' 75' ' ' TYR . 8.3 p90 -142.15 136.54 30.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.048 0.452 . . . . 10.0 111.597 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 48.4 mtt -108.27 152.92 23.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.653 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 23.8 m-85 -95.1 126.81 40.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.527 -0.546 . . . . 10.0 109.527 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -60.51 -28.96 68.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.051 0.453 . . . . 10.0 111.841 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.16 -0.94 51.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.994 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.55 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 41.4 mmtt -113.06 -26.11 8.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.35 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.426 HG13 ' O ' ' B' ' 39' ' ' TYR . 73.3 mt -70.87 115.41 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.24 0.543 . . . . 10.0 110.882 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.51 122.98 59.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.871 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' B' ' 96' ' ' VAL . . . -145.28 129.37 3.45 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.685 -0.769 . . . . 10.0 111.909 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -157.76 138.24 12.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.806 0.336 . . . . 10.0 111.26 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.598 ' HB ' HD13 ' B' ' 95' ' ' LEU . 4.7 t -139.25 126.9 21.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.732 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.551 ' ND2' ' HA ' ' B' ' 51' ' ' ASP . 29.2 p30 -178.3 164.13 1.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.365 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.11 -76.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.244 1.962 . . . . 10.0 111.148 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.32 49.19 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.983 0.421 . . . . 10.0 110.651 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.551 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 2.8 t0 63.24 56.2 1.75 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.501 -0.772 . . . . 10.0 112.101 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.416 ' H ' ' HB2' ' B' ' 48' ' ' ASN . 1.7 mm? -117.61 57.24 0.82 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.126 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' B' ' 83' ' ' PHE . 21.5 tp -115.6 147.62 40.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.134 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.5 -74.07 0.98 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.627 -0.797 . . . . 10.0 111.563 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.36 145.49 4.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.58 108.61 1.45 Allowed 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.472 2.115 . . . . 10.0 111.236 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 16.7 m -79.15 98.54 6.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.257 -0.429 . . . . 10.0 111.629 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -80.21 144.64 32.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.787 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -86.23 -9.33 56.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt 71.66 127.77 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.864 0.727 . . . . 10.0 112.542 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.77 -127.61 4.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.528 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -119.77 145.4 46.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.647 0.223 . . . . 10.0 110.412 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -85.87 125.61 33.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -111.4 134.56 52.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.038 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -77.14 128.37 34.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -116.17 174.49 6.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.983 0.421 . . . . 10.0 111.241 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -101.09 -26.83 13.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.015 -0.539 . . . . 10.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -118.95 -39.36 2.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.703 0.287 . . . . 10.0 111.487 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.422 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 4.3 m-30 -79.47 -14.0 59.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 10.0 111.405 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.55 -89.71 1.63 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.863 -0.684 . . . . 10.0 112.053 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -159.03 115.45 2.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.029 -0.36 . . . . 10.0 110.029 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -137.23 164.35 28.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.866 0.365 . . . . 10.0 111.209 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -78.11 127.92 33.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.971 -0.751 . . . . 10.0 108.971 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.5 155.72 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.394 0.516 . . . . 10.0 112.394 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' B' ' 37' ' ' TYR . 21.2 m-85 -117.0 128.6 55.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.556 -1.276 . . . . 10.0 107.556 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -118.3 5.87 11.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.397 0.517 . . . . 10.0 112.397 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 179.25 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -87.47 112.06 21.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.677 -1.147 . . . . 10.0 110.867 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 30' ' ' PHE . . . -142.7 120.21 11.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.863 0.363 . . . . 10.0 110.871 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -155.36 120.77 4.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.15 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.04 124.46 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.348 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.72 144.93 28.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.235 -0.439 . . . . 10.0 109.897 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' PHE . . . . . 0.474 ' HB3' HD11 ' B' ' 53' ' ' LEU . 64.1 m-85 -120.66 100.28 46.84 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.41 121.59 3.87 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.8 2.334 . . . . 10.0 111.346 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.97 151.35 35.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.019 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.63 -2.41 48.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.293 0.568 . . . . 10.0 109.817 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.415 ' HG3' HG13 ' B' ' 89' ' ' VAL . 12.9 tppt? -152.63 111.23 3.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.325 -0.852 . . . . 10.0 109.266 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.85 92.29 6.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.982 0.42 . . . . 10.0 110.64 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.415 HG13 ' HG3' ' B' ' 87' ' ' LYS . 15.7 m -119.48 158.05 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.137 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.91 51.96 2.25 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.124 -0.56 . . . . 10.0 111.846 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -117.02 145.84 36.59 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.87 117.06 4.63 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.247 1.965 . . . . 10.0 110.513 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.06 151.95 20.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.329 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 47' ' ' THR . 34.9 tttt -100.35 148.92 24.16 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.4 -0.592 . . . . 10.0 109.4 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.598 HD13 ' HB ' ' B' ' 47' ' ' THR . 35.5 tp -122.32 125.65 46.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.78 0.324 . . . . 10.0 110.852 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.445 ' O ' ' HA2' ' B' ' 45' ' ' GLY . 39.9 t -111.02 122.28 65.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 87.0 mt -127.42 123.84 37.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.856 0.36 . . . . 10.0 111.318 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 17.5 m -113.62 121.69 44.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -102.63 107.5 18.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.759 0.314 . . . . 10.0 111.47 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.645 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 0.4 OUTLIER -126.04 125.33 42.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.91 0.386 . . . . 10.0 110.211 178.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.83 -159.09 13.67 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.675 -0.774 . . . . 10.0 111.359 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 10.3 m -152.7 -177.77 6.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' B' ' 105' ' ' ALA . . . -118.66 149.24 41.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -75.06 21.69 0.12 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.973 0.416 . . . . 10.0 111.502 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' B' ' 103' ' ' ALA . . . -122.78 -1.03 8.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.864 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.95 -26.03 12.1 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.754 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.9 t -62.12 140.19 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.616 0.246 . . . . 10.0 110.77 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 47.5 t -137.2 99.31 3.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.888 0.375 . . . . 10.0 110.465 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.838 ' HB3' HG23 ' A' ' 107' ' ' VAL . 50.5 p90 -80.58 151.79 71.96 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.779 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 43.9 Cg_endo -68.12 161.17 45.57 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.861 2.374 . . . . 10.0 111.651 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.645 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 73.7 Cg_endo -76.75 52.6 3.76 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.864 2.376 . . . . 10.0 113.077 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 33.5 t -56.57 131.44 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.028 0.442 . . . . 10.0 110.784 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -113.21 168.34 9.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.49 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.0 m -147.79 138.44 23.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.499 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -100.49 131.08 46.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.508 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' B' ' 95' ' ' LEU . 76.2 m-85 -112.85 143.22 44.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.286 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -105.98 111.3 23.88 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.38 88.14 2.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.28 0.562 . . . . 10.0 110.846 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -102.92 -11.37 18.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.62 -0.718 . . . . 10.0 110.695 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.09 83.77 1.4 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.037 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -140.2 7.11 2.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.996 0.426 . . . . 10.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.73 -80.0 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.112 -0.565 . . . . 10.0 112.367 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 1.7 m -105.91 145.85 30.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -130.51 152.41 49.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.711 0.291 . . . . 10.0 111.328 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.15 138.72 15.15 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.708 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' PRO . . . . . 0.439 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 61.3 Cg_endo -74.81 138.61 23.75 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.467 2.112 . . . . 10.0 112.335 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -92.01 92.72 8.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.519 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 34.0 m . . . . . 0 C--O 1.252 1.202 0 CA-C-O 118.856 -0.593 . . . . 10.0 109.644 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.54 69.35 79.76 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 120.762 0.315 . . . . 10.0 110.798 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.1 -30.13 90.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.866 2.377 . . . . 10.0 112.877 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -61.71 -39.57 91.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.752 0.311 . . . . 10.0 110.91 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.472 HG21 HG21 ' A' ' 98' ' ' THR . 1.2 m -71.08 -37.69 72.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 10.0 110.1 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 tp -65.04 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.904 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.1 m -84.86 -24.82 28.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.605 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 m -67.04 -28.43 68.21 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.069 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.06 112.51 1.37 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.83 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.01 138.9 40.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.08 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.817 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 33.0 p -77.53 168.72 19.53 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.041 -0.527 . . . . 10.0 109.671 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.28 -8.05 42.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.393 0.616 . . . . 10.0 110.029 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -91.1 2.16 56.54 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.247 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 t30 69.21 30.26 4.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.952 -1.022 . . . . 10.0 111.466 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 30.6 mtt85 -119.08 137.22 24.91 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.931 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 15' ' ' ARG . 38.5 Cg_exo -62.31 144.83 95.82 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.372 2.048 . . . . 10.0 110.899 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.96 -9.93 18.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.024 0.379 . . . . 10.0 112.024 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.612 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 4.5 m -56.17 -21.85 25.34 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.435 0.531 . . . . 10.0 112.435 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 m -64.9 -24.61 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.02 0.438 . . . . 10.0 111.138 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -118.97 17.38 13.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.487 0.661 . . . . 10.0 109.699 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 91.5 mt -125.22 43.66 2.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.313 -0.858 . . . . 10.0 109.618 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -141.65 -179.36 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.142 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.5 mttp 72.48 3.61 4.74 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.988 0.805 . . . . 10.0 112.179 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 54.0 47.77 22.64 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.881 -0.599 . . . . 10.0 111.071 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -116.36 150.09 44.77 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.441 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.82 127.41 26.09 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.053 2.502 . . . . 10.0 112.028 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.406 ' HB ' HD12 ' A' ' 114' ' ' ILE . 2.7 m -102.09 137.07 40.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.242 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.654 HD23 HD12 ' A' ' 60' ' ' LEU . 22.2 tp -118.7 106.09 12.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.84 -0.43 . . . . 10.0 109.84 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 75.7 mt -97.37 123.26 49.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.759 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.768 ' HE2' HG22 ' A' ' 62' ' ' THR . 19.6 ttpt -116.03 126.03 53.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.361 -0.382 . . . . 10.0 110.644 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.51 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 19.2 m-85 -96.33 144.85 26.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.494 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -145.67 166.93 24.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.613 -0.267 . . . . 10.0 111.155 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.51 144.34 39.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.139 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 m -70.51 -52.46 21.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.585 0.587 . . . . 10.0 112.585 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.649 ' HZ2' ' HE3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -90.89 44.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.96 0.409 . . . . 10.0 111.694 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.7 t -119.84 119.67 30.99 Favored Pre-proline 0 C--N 1.317 -0.826 0 C-N-CA 120.88 -0.328 . . . . 10.0 111.368 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 25.6 Cg_endo -62.95 -38.23 48.46 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.687 2.258 . . . . 10.0 111.793 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.536 HD12 ' HG2' ' A' ' 37' ' ' PRO . 6.6 mp -66.47 -44.98 81.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.343 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.436 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 73.6 m -72.19 -24.72 61.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.235 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.57 ' HB3' ' CZ ' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -61.9 -55.31 31.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 10.0 111.474 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.09 -34.03 77.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.024 0.44 . . . . 10.0 110.496 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -65.13 -27.95 69.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.679 -0.692 . . . . 10.0 111.569 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 39' ' ' CYS . 37.3 mt -56.39 -40.64 74.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.914 0.388 . . . . 10.0 110.864 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.76 -32.6 78.28 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.147 -0.781 . . . . 10.0 111.147 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -71.57 -36.63 70.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.936 -0.394 . . . . 10.0 109.936 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.559 HG22 HD21 ' A' ' 60' ' ' LEU . 1.7 m -61.35 -47.7 84.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.037 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -64.77 -37.6 88.15 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.522 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -60.12 -46.16 90.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.23 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.451 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 37.0 m0 -66.5 -32.53 73.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.023 -0.535 . . . . 10.0 111.025 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.51 -16.12 63.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.21 0.528 . . . . 10.0 111.111 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -99.2 -3.57 34.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.472 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.5 147.16 29.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.376 -0.375 . . . . 10.0 110.653 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 -31.13 72.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.862 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -66.61 -51.51 55.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 10.0 111.035 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 49' ' ' TRP . 92.7 m-85 -75.67 -10.25 59.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.674 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -75.74 -7.37 54.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.192 0.52 . . . . 10.0 110.195 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.89 4.62 52.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.836 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.78 173.29 11.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.85 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -106.58 89.36 3.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.899 0.38 . . . . 10.0 110.299 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.654 HD12 HD23 ' A' ' 28' ' ' LEU . 1.2 tt -88.51 127.01 35.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.879 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.528 HG22 ' HB2' ' A' ' 90' ' ' PRO . 7.8 pt -142.28 152.28 18.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.985 0.421 . . . . 10.0 111.27 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.768 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -107.09 126.3 52.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.299 -0.63 . . . . 10.0 109.299 179.058 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.583 HG22 ' HB ' ' A' ' 92' ' ' VAL . 44.6 t -122.08 141.99 40.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.835 0.35 . . . . 10.0 111.474 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.36 148.28 52.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.46 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 13.8 m -110.74 97.42 33.16 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.663 0.268 . . . . 10.0 111.624 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 23.3 Cg_endo -60.17 123.69 13.68 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.882 2.388 . . . . 10.0 112.525 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.7 -21.5 29.46 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.797 -0.638 . . . . 10.0 112.86 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.0 143.68 28.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.648 0.261 . . . . 10.0 110.508 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.844 HD12 HG22 ' B' ' 112' ' ' VAL . 2.3 mm? 60.02 22.81 11.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.911 -0.586 . . . . 10.0 112.385 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.638 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.9 OUTLIER 71.12 24.54 3.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.78 -0.645 . . . . 10.0 112.561 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.55 -175.34 5.74 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.54 0.21 . . . . 10.0 110.798 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.649 ' HE3' ' HZ2' ' A' ' 35' ' ' TRP . 3.7 mmpt? -58.57 136.16 57.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.494 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -76.25 174.37 10.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.875 0.369 . . . . 10.0 111.866 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.8 144.26 55.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.736 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 -47.02 3.59 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.014 -0.835 . . . . 10.0 111.014 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -47.21 81.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 10.0 109.908 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.78 -32.1 73.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.471 -0.786 . . . . 10.0 110.907 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.12 -44.57 94.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.666 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -71.28 -31.39 67.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.782 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -58.87 -47.06 86.24 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.864 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -73.6 -40.94 63.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.366 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.49 68.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 10.0 111.395 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.44 23.08 36.59 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.955 -0.641 . . . . 10.0 112.623 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 mt -117.53 170.11 9.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.833 0.349 . . . . 10.0 110.766 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -89.58 176.02 7.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.798 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 71.09 73.81 0.26 Allowed Pre-proline 0 N--CA 1.465 0.3 0 O-C-N 123.883 0.739 . . . . 10.0 111.448 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.45 -1.57 11.21 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.482 2.122 . . . . 10.0 112.188 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.88 -0.81 44.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.895 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.69 114.97 39.5 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.764 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.528 ' HB2' HG22 ' A' ' 61' ' ' ILE . 73.0 Cg_endo -78.86 77.65 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.62 2.213 . . . . 10.0 111.581 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 62' ' ' THR . 43.1 t -92.32 118.66 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.094 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.817 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 4.6 t -100.75 144.62 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.74 -0.663 . . . . 10.0 109.963 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.455 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -107.43 117.38 33.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.499 -0.319 . . . . 10.0 111.125 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.483 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 62.3 t0 -108.18 96.03 6.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 10.0 110.044 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.437 ' HA ' ' HG2' ' A' ' 66' ' ' PRO . 13.2 t-20 -67.62 112.52 4.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.766 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.59 -9.45 62.43 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.995 -0.622 . . . . 10.0 112.242 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.21 50.92 41.8 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.964 -0.636 . . . . 10.0 112.187 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.472 HG21 HG21 ' A' ' 5' ' ' THR . 0.2 OUTLIER -60.66 -46.8 88.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.9 0.381 . . . . 10.0 111.262 -179.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.85 -42.47 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.77 -44.96 90.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.541 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -69.64 -36.72 76.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.812 0.339 . . . . 10.0 111.409 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -64.6 -33.51 76.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.215 0.45 . . . . 10.0 112.215 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.418 HD13 HD13 ' A' ' 123' ' ' ILE . 95.9 mt -100.82 -2.86 31.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.673 0.273 . . . . 10.0 110.919 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 43.7 t30 60.58 61.44 1.72 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.92 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 100' ' ' ALA . 94.8 mt -97.84 105.37 17.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.422 -0.808 . . . . 10.0 110.956 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.77 13.24 14.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.926 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.915 HG23 ' HB3' ' B' ' 109' ' ' TYR . 12.4 p -147.0 150.5 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.617 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' B' ' 108' ' ' CYS . 22.5 m-85 -124.18 153.64 68.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -89.74 128.17 7.67 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 124.0 -1.25 . . . . 10.0 111.689 -0.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.9 m -96.21 136.27 36.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.361 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -114.14 110.99 20.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.214 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.21 110.23 22.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.51 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.1 tp -91.72 112.7 24.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.688 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 27' ' ' THR . 84.4 mt -99.74 137.72 26.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.82 173.25 55.12 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.64 -0.791 . . . . 10.0 112.799 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -65.2 -14.49 60.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 10.0 111.716 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.35 -19.72 29.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.151 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 105.06 -0.08 41.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.82 -0.705 . . . . 10.0 111.945 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -96.57 158.48 15.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.232 -0.285 . . . . 10.0 110.232 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.14 118.87 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.921 0.391 . . . . 10.0 111.171 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -51.53 6.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.695 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -156.87 142.26 17.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.119 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.418 HD13 HD13 ' A' ' 103' ' ' LEU . 4.3 tp -116.25 119.25 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.051 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.9 t -107.92 120.51 59.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.786 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -126.39 125.1 41.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.626 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 142.33 -97.22 0.2 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.722 -0.751 . . . . 10.0 111.829 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.766 ' HB2' HG22 ' B' ' 107' ' ' VAL . 3.7 t -160.35 138.2 9.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.022 -0.362 . . . . 10.0 110.022 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.532 ' HA ' ' OE1' ' A' ' 132' ' ' GLN . 12.9 pt -121.71 150.64 25.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.001 0.429 . . . . 10.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -114.28 174.92 5.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.649 . . . . 10.0 110.256 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.18 -45.3 91.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.71 0.263 . . . . 10.0 111.71 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.16 -41.97 84.96 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.515 -0.312 . . . . 10.0 110.59 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.532 ' OE1' ' HA ' ' A' ' 128' ' ' ILE . 41.1 mt-30 -65.18 -44.46 88.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.868 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 137' ' ' ILE . . . -59.31 -45.07 92.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.93 -34.34 75.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.765 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.2 85.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.383 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.44 -33.89 75.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.52 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 133' ' ' ALA . 76.5 mt -67.44 -31.83 54.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.669 -0.493 . . . . 10.0 109.669 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.45 -61.24 2.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.772 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 23.3 t70 -127.64 117.31 21.12 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.341 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 139' ' ' ASP . 14.6 Cg_exo -70.26 -3.55 12.57 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.087 2.525 . . . . 10.0 112.574 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -95.81 -2.52 47.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.624 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.64 116.99 10.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.041 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.7 t70 -122.53 160.25 26.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.633 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.283 0.989 . . . . 10.0 112.972 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.622 0.248 . . . . 10.0 111.354 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.24 -65.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.198 0.444 . . . . 10.0 112.198 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 54.9 tp -85.37 -82.57 0.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 62.24 45.82 6.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.619 0.724 . . . . 10.0 110.899 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.08 154.05 38.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.374 -0.83 . . . . 10.0 110.13 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.76 -163.63 0.23 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.79 0.681 . . . . 10.0 112.145 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -98.78 29.7 3.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.968 0.413 . . . . 10.0 111.085 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.65 15.27 14.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.146 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.63 137.61 11.53 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.789 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.11 151.05 86.78 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.931 2.421 . . . . 10.0 112.356 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.635 ' HG3' ' HB ' ' A' ' 107' ' ' VAL . 11.3 Cg_endo -54.29 -36.03 85.38 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.302 2.668 . . . . 10.0 113.152 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -69.06 -2.86 11.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.932 0.396 . . . . 10.0 112.023 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -131.82 5.86 4.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.473 0.654 . . . . 10.0 109.623 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.74 -1.84 31.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.702 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.509 ' HE1' HG23 ' B' ' 32' ' ' ILE . 43.9 m-85 -134.19 128.97 35.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.814 0.34 . . . . 10.0 110.96 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.6 91.38 20.55 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.539 ' HG2' ' HG3' ' B' ' 126' ' ' PRO . 17.1 Cg_exo -68.67 105.26 1.27 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.679 2.253 . . . . 10.0 112.727 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.12 99.4 12.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.236 -0.653 . . . . 10.0 109.236 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.2 mm? -89.33 102.99 15.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.882 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.26 101.78 10.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.52 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.479 HG13 HG22 ' B' ' 26' ' ' VAL . 81.1 t -89.82 119.59 37.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.616 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.1 -176.37 3.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.175 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.48 -35.9 34.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.403 -0.362 . . . . 10.0 111.29 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.35 -34.95 28.28 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.22 -178.61 40.14 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.762 -0.733 . . . . 10.0 112.077 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.479 HG22 HG13 ' B' ' 21' ' ' VAL . 60.7 t -102.86 135.88 38.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -123.48 114.87 20.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.954 0.407 . . . . 10.0 110.524 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.401 HG22 ' HD1' ' B' ' 30' ' ' PHE . 2.6 p -101.69 122.56 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.403 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -125.03 80.35 1.87 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.951 0.405 . . . . 10.0 110.315 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 7.4 p90 -77.35 111.71 13.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 10.0 111.141 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 -72.35 112.73 8.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.372 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.509 HG23 ' HE1' ' B' ' 15' ' ' PHE . 63.4 mt -90.23 135.73 25.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.975 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.41 149.27 50.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.21 92.65 1.02 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.059 0.457 . . . . 10.0 111.576 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.95 -22.06 0.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.369 -0.692 . . . . 10.0 111.369 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -105.37 154.28 20.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -146.6 139.23 25.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.983 0.42 . . . . 10.0 111.184 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 37.8 mtt -110.99 159.04 18.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.849 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.438 ' O ' HG13 ' B' ' 43' ' ' ILE . 24.2 m-85 -100.91 127.36 47.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -59.31 -30.7 68.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.183 0.438 . . . . 10.0 112.183 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.68 3.84 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.94 0.4 . . . . 10.0 111.181 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' B' ' 100' ' ' GLN . 71.1 mmtt -116.83 -20.47 9.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.336 -0.393 . . . . 10.0 111.801 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.456 HD13 ' HZ ' ' B' ' 30' ' ' PHE . 60.8 mt -77.22 96.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.092 0.472 . . . . 10.0 110.724 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.21 108.88 20.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.315 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.59 138.66 10.21 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.846 -0.692 . . . . 10.0 111.562 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -160.98 145.52 13.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.608 0.242 . . . . 10.0 111.066 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.598 ' HB ' HD13 ' B' ' 95' ' ' LEU . 15.1 t -141.51 125.63 17.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.191 -0.459 . . . . 10.0 109.879 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' B' ' 51' ' ' ASP . 28.1 p30 -179.0 161.75 1.02 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.154 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' B' ' 52' ' ' LEU . 11.3 Cg_exo -73.92 -63.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.435 2.09 . . . . 10.0 110.909 178.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.36 58.49 1.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 10.0 109.809 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.534 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 5.5 t70 61.96 33.62 17.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.53 -0.759 . . . . 10.0 112.455 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.495 ' HA ' HD13 ' B' ' 52' ' ' LEU . 1.4 mm? -90.16 55.09 2.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.4 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.492 ' HB2' HD22 ' B' ' 48' ' ' ASN . 19.0 tp -121.5 145.47 47.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.104 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.46 -76.8 0.85 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.587 -0.816 . . . . 10.0 111.309 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 3.6 pp0? -161.17 143.46 9.18 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 24.5 Cg_exo -64.9 108.52 1.11 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.526 2.151 . . . . 10.0 111.18 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 5.6 m -82.46 103.55 12.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.849 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.4 158.91 18.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 51.0 m -91.79 -14.06 30.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.622 -0.263 . . . . 10.0 110.831 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? 71.82 127.9 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.76 -0.655 . . . . 10.0 112.284 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.81 -133.0 5.61 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.135 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -117.41 140.24 49.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.527 0.203 . . . . 10.0 110.564 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.31 121.65 24.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.457 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -98.72 139.91 33.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -78.56 141.54 38.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.39 170.49 15.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.636 0.255 . . . . 10.0 110.495 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -24.83 10.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.961 0.41 . . . . 10.0 110.994 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 40' ' ' LEU . 11.9 m-85 -102.82 -44.75 5.19 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.202 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.569 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 14.6 m-30 -89.61 -9.62 49.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.583 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.08 -77.78 1.89 Allowed Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.827 -0.624 . . . . 10.0 112.296 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -173.81 117.91 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.752 0.31 . . . . 10.0 110.496 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -141.02 162.16 36.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.144 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.6 m -68.83 127.24 32.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.812 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.2 m -127.3 161.8 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 10.0 111.731 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -118.24 128.1 54.36 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.868 -1.16 . . . . 10.0 107.868 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -112.27 -3.8 14.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.768 0.655 . . . . 10.0 112.768 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -175.93 -36.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.987 -0.746 . . . . 10.0 108.987 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -86.26 125.04 33.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.086 -0.961 . . . . 10.0 109.767 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.37 116.77 4.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.323 . . . . 10.0 111.523 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -153.61 125.38 7.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.163 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.3 t -129.99 131.75 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.252 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' B' ' 57' ' ' SER . . . -108.56 142.01 39.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.704 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' PHE . . . . . 0.44 ' HB3' HD11 ' B' ' 53' ' ' LEU . 67.1 m-85 -120.22 112.26 34.7 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.263 0.468 . . . . 10.0 112.263 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -93.08 124.62 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.521 2.814 . . . . 10.0 111.55 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.01 148.04 40.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.988 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.3 -3.21 53.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.324 0.583 . . . . 10.0 109.73 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.412 ' HB2' ' HE2' ' B' ' 87' ' ' LYS . 6.2 tppt? -153.47 124.7 7.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.867 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.75 89.77 8.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.04 0.448 . . . . 10.0 110.352 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.64 147.15 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.71 47.33 3.83 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.073 -0.584 . . . . 10.0 112.344 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -106.67 145.44 31.07 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.53 116.02 4.54 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.319 2.013 . . . . 10.0 111.288 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.77 165.4 11.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.967 0.413 . . . . 10.0 111.832 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 47' ' ' THR . 67.6 tttt -109.2 151.76 26.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.979 -0.555 . . . . 10.0 109.828 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.598 HD13 ' HB ' ' B' ' 47' ' ' THR . 56.0 tp -120.54 115.55 23.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.974 0.416 . . . . 10.0 110.664 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.88 126.44 64.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.535 -0.542 . . . . 10.0 109.535 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 66.8 mt -133.13 121.06 22.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.925 0.393 . . . . 10.0 111.895 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' THR . . . . . 0.602 HG23 ' HB3' ' B' ' 113' ' ' ASP . 5.0 m -108.8 119.22 38.91 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -100.58 109.48 21.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.777 0.322 . . . . 10.0 111.561 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' B' ' 42' ' ' LYS . 11.6 tp60 -124.32 119.35 29.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.968 0.413 . . . . 10.0 110.533 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.36 -160.79 11.08 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.603 -0.808 . . . . 10.0 111.877 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 13.1 m -151.21 -172.42 4.2 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -131.22 147.73 52.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.259 -0.274 . . . . 10.0 110.259 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.47 6.08 2.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 10.0 111.753 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.19 5.33 29.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.892 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.52 -7.74 56.2 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.626 -0.797 . . . . 10.0 113.087 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.766 HG22 ' HB2' ' A' ' 127' ' ' SER . 2.9 t -74.33 142.75 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.739 0.304 . . . . 10.0 110.471 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 47.9 t -142.52 85.56 1.91 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.941 0.401 . . . . 10.0 110.068 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.915 ' HB3' HG23 ' A' ' 107' ' ' VAL . 52.4 p90 -74.09 152.35 88.44 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.79 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 55.3 Cg_endo -69.82 165.18 31.9 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.827 2.351 . . . . 10.0 111.377 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 70' ' ' HIS . 67.3 Cg_endo -74.42 68.11 5.28 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.657 2.238 . . . . 10.0 112.947 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.844 HG22 HD12 ' A' ' 69' ' ' LEU . 4.8 t -62.65 120.78 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 10.0 109.943 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ASP . . . . . 0.602 ' HB3' HG23 ' B' ' 98' ' ' THR . 4.0 p-10 -108.03 153.91 22.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.094 0.473 . . . . 10.0 111.37 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.68 138.77 41.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.822 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.19 124.45 50.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.82 0.343 . . . . 10.0 110.571 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -111.57 142.73 43.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.618 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -103.98 121.41 43.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.263 -0.426 . . . . 10.0 109.877 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 23.1 mm -94.66 88.83 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.967 0.413 . . . . 10.0 110.787 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' B' ' 121' ' ' ASN . 14.8 p90 -95.03 -35.02 12.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.549 . . . . 10.0 111.45 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.4 60.78 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.43 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' B' ' 119' ' ' PHE . 8.3 t30 -120.0 -0.89 10.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.81 0.338 . . . . 10.0 111.101 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.26 -76.14 1.5 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.002 -0.618 . . . . 10.0 111.658 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 3.9 m -103.21 140.25 37.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.565 -0.531 . . . . 10.0 109.565 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -129.86 161.36 30.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.142 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.18 146.97 24.67 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' PRO . . . . . 0.539 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 28.6 Cg_endo -63.26 121.56 9.43 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.557 2.171 . . . . 10.0 112.42 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -82.64 62.89 6.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.355 0.598 . . . . 10.0 110.01 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.091 -179.285 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 tpt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.098 -0.334 . . . . 10.0 110.098 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.65 82.64 48.26 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.562 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.01 -25.71 58.97 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.55 2.167 . . . . 10.0 111.566 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -46.83 87.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.833 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -60.56 -42.54 96.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.302 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.97 -32.84 74.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.806 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.0 m -81.91 -25.6 34.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.054 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.3 m -65.68 -26.71 67.9 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.756 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 9' ' ' LEU . 2.1 mm? -55.69 128.0 32.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.878 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -115.47 149.55 37.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.638 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 19.4 p -89.34 174.96 7.53 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.046 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.56 -19.36 65.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.411 . . . . 10.0 111.008 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.549 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.0 t70 -89.31 9.13 27.16 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 64.84 30.57 12.11 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.703 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.549 ' HG3' ' HB3' ' A' ' 13' ' ' ASP . 16.4 mtp85 -112.27 137.65 21.59 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.932 -0.577 . . . . 10.0 109.93 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 15' ' ' ARG . 50.3 Cg_exo -57.32 139.48 90.21 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.615 2.21 . . . . 10.0 111.409 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.14 -10.08 20.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 10.0 112.008 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 1.7 t -59.85 -18.41 43.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.647 -0.252 . . . . 10.0 111.494 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.18 -15.54 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-O 120.788 0.328 . . . . 10.0 111.018 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -127.06 22.92 6.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.56 . . . . 10.0 109.714 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 57.4 mt -133.0 27.28 4.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.024 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 18' ' ' SER . 53.7 mttm -118.97 174.6 6.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.6 mttp 69.32 15.7 8.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.127 -0.942 . . . . 10.0 112.902 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.18 51.21 14.89 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.512 0.507 . . . . 10.0 111.242 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.547 ' HD2' ' HD2' ' A' ' 26' ' ' PRO . 16.8 mmtp -112.65 143.37 28.86 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.218 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.547 ' HD2' ' HD2' ' A' ' 25' ' ' LYS . 19.6 Cg_endo -59.26 134.08 56.81 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.725 2.283 . . . . 10.0 110.956 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -106.78 143.91 34.19 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.967 0.413 . . . . 10.0 111.22 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 28' ' ' LEU . 9.5 tp -121.47 97.94 5.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.156 -0.683 . . . . 10.0 109.156 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.571 HG12 HD11 ' A' ' 61' ' ' ILE . 66.0 mt -89.39 112.22 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.025 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HG3' ' CE2' ' A' ' 111' ' ' TRP . 5.7 tmmm? -106.59 120.88 43.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.88 0.371 . . . . 10.0 110.826 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 14.1 m-85 -90.33 127.9 36.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.208 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -121.37 173.89 7.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.078 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB1' ' CZ3' ' A' ' 35' ' ' TRP . . . -124.83 138.48 54.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.102 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -77.49 -47.43 19.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.522 ' CZ3' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -88.36 29.1 1.0 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.077 0.769 . . . . 10.0 113.077 -178.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 5.0 t -119.65 125.98 27.18 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 111.665 0.246 . . . . 10.0 111.665 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 26.2 Cg_endo -63.01 -43.85 17.92 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.832 2.355 . . . . 10.0 112.457 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.97 -44.52 96.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.167 0.508 . . . . 10.0 111.135 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.9 -28.52 67.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.888 -0.596 . . . . 10.0 111.496 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.7 mt -63.62 -44.77 92.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.845 0.355 . . . . 10.0 110.464 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.6 m -69.63 -31.61 69.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.668 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -28.82 70.09 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.057 -0.52 . . . . 10.0 110.646 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.91 -42.48 84.83 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.442 -0.345 . . . . 10.0 111.321 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.04 -44.46 97.3 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.796 -0.716 . . . . 10.0 111.421 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -65.49 -34.67 78.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.867 0.365 . . . . 10.0 110.192 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.3 m -61.33 -46.88 88.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.161 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.56 -40.93 98.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.955 0.407 . . . . 10.0 110.429 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.22 -47.66 78.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 10.0 111.003 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -65.01 -33.93 77.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.576 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.44 -6.28 34.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.918 0.389 . . . . 10.0 111.283 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -113.11 9.07 18.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.207 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.664 ' HB3' ' HD2' ' A' ' 55' ' ' PHE . 14.3 t70 -85.63 146.54 26.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.439 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.32 73.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.856 0.687 . . . . 10.0 112.856 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.479 ' HB3' HD13 ' A' ' 137' ' ' ILE . 32.5 mmmt -74.67 -39.2 62.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.835 0.35 . . . . 10.0 111.155 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.664 ' HD2' ' HB3' ' A' ' 52' ' ' ASP . 94.8 m-85 -75.5 -20.3 58.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.495 0.554 . . . . 10.0 112.495 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.8 m -65.93 -6.54 12.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.34 . . . . 10.0 111.902 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -77.3 -18.37 57.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 10.0 110.147 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -125.91 -178.67 4.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.701 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -113.39 100.36 8.48 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.182 -0.303 . . . . 10.0 110.182 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.07 129.29 35.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.598 -0.273 . . . . 10.0 111.022 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.571 HD11 HG12 ' A' ' 29' ' ' ILE . 10.3 pt -138.22 155.73 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.988 0.423 . . . . 10.0 111.415 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.97 109.43 18.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 10.0 109.648 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 92' ' ' VAL . 36.0 t -111.14 140.99 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.94 0.4 . . . . 10.0 111.482 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . . . -135.44 149.63 49.64 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.498 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 12.3 m -110.03 97.97 32.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 94' ' ' ASP . 18.9 Cg_endo -58.39 126.63 21.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.942 2.428 . . . . 10.0 112.507 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.61 -36.8 3.3 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.8 -0.637 . . . . 10.0 113.171 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -66.44 134.36 52.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.621 0.248 . . . . 10.0 110.999 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD11 HG22 ' B' ' 112' ' ' VAL . 0.4 OUTLIER 59.14 29.7 19.32 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.639 0.607 . . . . 10.0 112.639 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.735 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.1 OUTLIER 73.08 21.14 3.24 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.299 0.852 . . . . 10.0 113.299 178.529 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.34 178.3 5.95 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 28.2 mmtt -61.52 124.93 22.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -61.73 156.95 18.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.913 0.387 . . . . 10.0 111.734 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -59.27 151.47 23.17 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.403 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.58 -44.97 3.3 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.22 -39.51 17.71 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 80' ' ' TRP . 50.6 t80 -57.44 -46.2 83.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.584 -0.735 . . . . 10.0 112.136 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -63.48 -31.69 72.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.9 0.381 . . . . 10.0 111.541 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -75.6 -22.62 56.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.142 0.496 . . . . 10.0 110.464 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.43 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 65.6 t-105 -65.47 -46.69 78.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.493 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -72.43 -32.71 66.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.819 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.49 -31.71 68.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.963 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.39 23.89 34.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.398 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 80' ' ' TRP . 42.5 mt -115.71 -161.82 0.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.408 . . . . 10.0 111.361 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.4 ' H ' ' HB3' ' A' ' 84' ' ' LEU . 11.2 t-20 -118.59 -168.89 1.62 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 63.24 76.3 0.37 Allowed Pre-proline 0 C--O 1.234 0.24 0 O-C-N 123.456 0.472 . . . . 10.0 111.559 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.4 0.76 9.12 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.666 2.244 . . . . 10.0 112.272 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -104.43 6.47 34.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.089 0.471 . . . . 10.0 110.428 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 89' ' ' LEU . 10.2 mt -84.81 115.21 59.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.125 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HG2' ' HA ' ' A' ' 61' ' ' ILE . 69.2 Cg_endo -77.06 76.9 3.98 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.658 2.239 . . . . 10.0 111.393 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.25 118.47 30.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.982 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 15.9 t -103.88 142.8 16.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.861 -0.609 . . . . 10.0 109.95 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.9 m -107.58 107.51 18.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.145 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 61.9 t0 -97.86 92.32 5.77 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.251 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -63.08 107.91 1.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.918 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.54 -10.53 68.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.823 -0.703 . . . . 10.0 112.872 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.9 55.9 6.91 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.263 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.96 -45.1 87.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.937 0.399 . . . . 10.0 110.642 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.3 mm -78.67 -37.85 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.485 -0.561 . . . . 10.0 109.485 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.23 95.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.586 -0.734 . . . . 10.0 111.599 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -70.08 -37.22 75.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.762 0.315 . . . . 10.0 111.529 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.2 m -62.84 -23.44 67.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.447 -0.342 . . . . 10.0 111.833 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.2 mt -111.87 4.4 18.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.659 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.8 t30 54.3 44.4 29.07 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.429 0.633 . . . . 10.0 111.631 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.8 mt -80.41 101.53 5.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.839 -0.619 . . . . 10.0 111.551 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.9 m -118.95 29.88 7.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.87 -0.605 . . . . 10.0 110.564 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.715 HG23 ' HB3' ' B' ' 109' ' ' TYR . 11.4 p -160.71 151.14 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.281 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -130.89 155.29 81.67 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 126' ' ' GLY . 97.7 Cg_endo -85.74 141.97 30.55 Favored 'Cis proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.355 -1.519 . . . . 10.0 111.26 -1.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.7 m -118.23 126.76 52.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.654 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.421 ' CE2' ' HG3' ' A' ' 30' ' ' LYS . 23.5 m95 -107.72 108.39 19.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.91 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -95.01 115.68 27.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 136' ' ' LEU . 55.4 tp -90.94 115.78 28.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.595 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.9 135.68 41.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.211 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.69 178.95 38.47 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.03 -0.605 . . . . 10.0 112.63 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -71.45 -4.59 27.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.906 0.384 . . . . 10.0 111.984 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -98.92 -4.43 32.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.993 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 86.06 16.79 62.32 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.815 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -109.09 163.09 13.64 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.162 -0.31 . . . . 10.0 110.162 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.34 122.75 25.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.855 0.36 . . . . 10.0 110.418 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.18 -40.92 6.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.95 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 122' ' ' ARG . 14.8 tpt180 -160.78 161.89 32.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.498 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -138.03 120.76 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.013 0.435 . . . . 10.0 110.484 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.4 t -115.66 107.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 10.0 109.872 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -115.21 133.62 55.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.452 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 130.65 -75.72 0.42 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.415 -0.897 . . . . 10.0 112.96 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.9 m -159.88 159.26 32.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.018 -0.364 . . . . 10.0 110.018 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.38 170.6 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.311 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -156.0 174.33 15.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.643 -0.253 . . . . 10.0 111.132 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.19 -40.01 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.57 -46.23 87.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 10.0 110.902 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -67.94 -37.74 81.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.953 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 137' ' ' ILE . . . -61.93 -48.51 80.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.38 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.78 -38.97 92.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.739 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.17 91.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.262 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.619 HD11 HD22 ' A' ' 113' ' ' LEU . 15.1 tp -62.88 -35.65 80.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 10.0 111.646 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.479 HD13 ' HB3' ' A' ' 54' ' ' LYS . 74.2 mt -70.1 -27.89 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.214 0.53 . . . . 10.0 110.552 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -89.11 -47.33 8.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.077 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 24.7 t70 -137.15 110.61 9.14 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.622 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 139' ' ' ASP . 11.8 Cg_exo -72.48 3.45 4.2 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.306 2.67 . . . . 10.0 112.812 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -93.1 -7.27 46.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.458 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.04 131.34 44.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.005 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -133.31 136.9 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.465 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.092 0 N-CA-C 113.944 1.09 . . . . 10.0 113.944 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.716 0.293 . . . . 10.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.75 -53.1 59.49 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.314 -0.403 . . . . 10.0 112.086 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' B' ' 5' ' ' ALA . 49.6 tp -89.73 -73.09 0.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.131 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 57.59 35.46 25.76 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.214 0.531 . . . . 10.0 110.918 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.423 ' H ' ' HG ' ' B' ' 3' ' ' LEU . . . -152.67 167.81 27.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.778 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.8 m120 65.68 -170.36 0.19 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.721 0.638 . . . . 10.0 112.398 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -101.17 19.44 17.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.124 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -88.97 20.24 3.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.614 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.3 136.56 13.26 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.279 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' PRO . . . . . 0.451 ' HB2' ' OE1' ' B' ' 12' ' ' GLU . 27.9 Cg_endo -61.42 150.23 86.0 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.166 2.577 . . . . 10.0 112.11 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.18 -40.09 60.83 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.682 2.921 . . . . 10.0 113.365 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.451 ' OE1' ' HB2' ' B' ' 10' ' ' PRO . 8.8 pm0 -65.24 -19.65 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.009 0.374 . . . . 10.0 112.009 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -106.91 -10.53 15.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.367 0.604 . . . . 10.0 110.041 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.49 -8.22 59.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.539 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.701 ' HE1' HG23 ' B' ' 32' ' ' ILE . 56.2 m-85 -134.08 131.53 38.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.923 0.392 . . . . 10.0 111.571 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.59 91.57 42.12 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' B' ' 30' ' ' PHE . 12.2 Cg_exo -72.37 108.74 2.58 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.12 2.547 . . . . 10.0 113.32 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -104.43 107.93 19.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.963 -0.755 . . . . 10.0 108.963 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' B' ' 19' ' ' LEU . 2.9 mm? -95.19 120.45 35.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.57 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.71 108.66 14.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.354 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.46 HG22 HG13 ' B' ' 26' ' ' VAL . 85.1 t -98.86 128.13 50.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.218 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.69 -166.94 1.34 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.291 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.31 -38.03 27.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.533 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.09 -41.66 85.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.216 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 178.12 -168.28 39.48 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.664 -0.779 . . . . 10.0 112.274 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.46 HG13 HG22 ' B' ' 21' ' ' VAL . 86.1 t -101.92 131.74 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.79 -0.448 . . . . 10.0 109.79 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -121.42 118.96 30.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.956 0.408 . . . . 10.0 110.765 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 p -103.47 116.96 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.12 0.486 . . . . 10.0 110.439 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' B' ' 79' ' ' ALA . 1.1 tmm_? -123.91 82.25 2.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.484 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.521 ' HB3' ' HA ' ' B' ' 17' ' ' PRO . 33.0 p90 -87.62 134.25 33.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.79 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 71.6 mtm-85 -85.52 129.36 34.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.298 -0.41 . . . . 10.0 111.034 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.701 HG23 ' HE1' ' B' ' 15' ' ' PHE . 76.9 mt -101.78 132.58 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.003 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.38 144.33 57.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.441 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.35 91.79 0.26 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.458 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.43 -23.06 0.95 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.427 -0.669 . . . . 10.0 111.427 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -100.74 159.24 15.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.103 -0.702 . . . . 10.0 109.103 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -150.32 136.57 18.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.131 0.491 . . . . 10.0 111.581 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 23.7 mtt -107.48 153.22 23.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.389 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.473 ' O ' HG13 ' B' ' 43' ' ' ILE . 20.0 m-85 -96.16 127.07 41.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.071 -0.714 . . . . 10.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -59.06 -33.79 71.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.849 0.356 . . . . 10.0 111.402 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.04 1.3 32.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.229 -0.442 . . . . 10.0 111.302 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.497 ' HE3' ' HE2' ' B' ' 69' ' ' PHE . 69.2 mmtt -116.53 -6.72 11.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 10.0 111.427 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.473 HG13 ' O ' ' B' ' 39' ' ' TYR . 81.0 mt -87.97 96.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 10.0 110.055 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 39.1 t -91.34 117.95 35.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.304 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.71 140.89 9.55 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.614 -0.803 . . . . 10.0 111.847 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -163.71 147.46 10.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.789 0.328 . . . . 10.0 110.713 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.457 ' HB ' HD13 ' B' ' 95' ' ' LEU . 9.4 t -144.18 120.41 10.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.143 -0.48 . . . . 10.0 109.854 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.6 ' CG ' ' HA ' ' B' ' 51' ' ' ASP . 0.3 OUTLIER -174.96 155.19 1.83 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.47 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 48' ' ' ASN . 6.0 Cg_exo -80.13 -66.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.837 2.358 . . . . 10.0 111.52 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.42 36.18 2.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.48 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.6 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 13.8 t0 64.58 33.16 11.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.495 -0.775 . . . . 10.0 112.611 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' B' ' 52' ' ' LEU . 2.0 mm? -96.78 76.6 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.92 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.445 HD13 ' O ' ' B' ' 47' ' ' THR . 17.6 tp -131.98 155.51 47.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.681 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.04 -80.46 0.64 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.094 -0.803 . . . . 10.0 111.094 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -168.99 147.8 3.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.841 -0.429 . . . . 10.0 109.841 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.02 110.53 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.637 2.225 . . . . 10.0 110.919 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.9 m -95.25 100.62 12.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.016 0.436 . . . . 10.0 111.401 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -80.58 168.16 19.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.98 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 42.4 m -97.67 -7.2 31.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.713 -0.221 . . . . 10.0 111.39 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt 69.41 117.6 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.829 0.677 . . . . 10.0 112.829 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.53 -125.34 5.57 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.914 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.21 158.4 28.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -94.31 123.31 37.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.932 0.396 . . . . 10.0 110.667 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -100.97 130.02 46.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.982 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.41 120.83 23.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.392 -0.966 . . . . 10.0 108.392 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -110.2 176.05 5.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.104 0.478 . . . . 10.0 111.432 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -110.06 -25.1 10.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.214 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.61 -42.68 3.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.054 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.497 ' HE2' ' HE3' ' B' ' 42' ' ' LYS . 4.3 m-30 -88.32 4.55 45.65 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.072 0.397 . . . . 10.0 112.072 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.98 -89.57 1.18 Allowed Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.715 -0.755 . . . . 10.0 111.859 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -171.09 123.9 0.61 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -136.57 167.3 21.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.337 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 15.2 m -75.34 128.78 36.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.521 -0.918 . . . . 10.0 108.521 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.65 162.69 32.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.433 0.635 . . . . 10.0 112.46 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.539 ' HB3' ' O ' ' B' ' 78' ' ' GLU . 40.6 m-85 -122.09 129.09 52.07 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.718 -1.216 . . . . 10.0 107.718 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -110.39 -15.54 13.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.721 0.637 . . . . 10.0 112.721 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.57 ' HA ' ' HB ' ' B' ' 32' ' ' ILE . 1.7 t60 -159.88 -35.24 0.06 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' B' ' 75' ' ' TYR . 0.6 OUTLIER -83.98 144.33 29.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.031 -0.986 . . . . 10.0 108.779 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' B' ' 29' ' ' ARG . . . -170.13 101.57 0.29 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.857 0.36 . . . . 10.0 111.042 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -140.57 120.37 13.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.118 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.36 123.54 62.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.155 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.27 141.28 36.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.723 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -119.82 104.35 44.59 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.539 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.4 126.12 3.07 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.781 2.321 . . . . 10.0 111.448 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -70.14 151.27 45.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.918 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.05 -11.74 25.95 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' B' ' 87' ' ' LYS . 8.8 tppt? -149.35 122.29 8.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.166 -0.924 . . . . 10.0 109.075 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.84 85.95 6.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.087 0.47 . . . . 10.0 110.651 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.419 ' HB ' ' HG2' ' B' ' 91' ' ' GLU . 10.8 m -114.63 160.55 13.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.858 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.63 2.38 82.54 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.77 -0.728 . . . . 10.0 111.695 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.419 ' HG2' ' HB ' ' B' ' 89' ' ' VAL . 35.3 mm-40 -60.68 125.45 82.78 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.572 -0.314 . . . . 10.0 110.893 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.13 101.31 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.407 2.071 . . . . 10.0 110.6 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.63 163.91 18.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.673 0.619 . . . . 10.0 112.673 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 47' ' ' THR . 63.1 tttt -114.04 160.65 18.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.298 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.457 HD13 ' HB ' ' B' ' 47' ' ' THR . 18.6 tp -127.42 135.84 51.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.922 0.391 . . . . 10.0 110.772 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.37 126.1 71.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 79.9 mt -129.99 126.62 38.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.889 0.376 . . . . 10.0 112.004 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' THR . . . . . 0.679 HG23 ' HB3' ' B' ' 113' ' ' ASP . 4.0 m -111.52 117.87 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 53.4 m-85 -98.52 100.29 11.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.945 0.35 . . . . 10.0 111.945 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.918 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 15.0 tp60 -117.61 122.05 42.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.104 0.478 . . . . 10.0 110.894 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.79 -162.33 12.46 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.937 -0.649 . . . . 10.0 111.685 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.5 m -151.95 -175.13 5.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.43 -0.582 . . . . 10.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.07 144.56 51.11 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -69.37 -4.05 16.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.156 0.503 . . . . 10.0 111.202 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.52 -13.37 43.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.982 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 118.1 -18.15 11.43 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.975 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' GLY . 6.3 t -66.61 141.99 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.606 0.241 . . . . 10.0 110.473 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 13.8 t -137.49 87.74 2.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.14 0.495 . . . . 10.0 110.005 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.715 ' HB3' HG23 ' A' ' 107' ' ' VAL . 55.3 p90 -76.1 151.95 84.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.875 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.451 ' CD ' ' HA ' ' A' ' 107' ' ' VAL . 67.6 Cg_endo -75.35 163.72 34.04 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.8 2.333 . . . . 10.0 111.521 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.918 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 67.5 Cg_endo -77.0 79.15 3.2 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.623 2.215 . . . . 10.0 112.247 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.635 HG22 HD11 ' A' ' 69' ' ' LEU . 3.1 t -68.0 101.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ASP . . . . . 0.679 ' HB3' HG23 ' B' ' 98' ' ' THR . 4.9 p-10 -86.67 149.47 24.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.127 0.489 . . . . 10.0 111.701 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.09 140.89 44.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.205 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.48 137.64 38.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.007 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.81 135.54 53.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.662 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -95.13 119.48 33.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.302 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 16.5 mm -95.74 76.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 10.0 110.665 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' PHE . . . . . 0.468 ' CZ ' ' HB2' ' B' ' 121' ' ' ASN . 43.3 p90 -88.75 -24.55 22.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.005 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.54 53.89 0.17 Allowed Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.925 -0.655 . . . . 10.0 112.406 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' ASN . . . . . 0.468 ' HB2' ' CZ ' ' B' ' 119' ' ' PHE . 7.3 t30 -104.6 -4.69 22.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.246 0.546 . . . . 10.0 109.955 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.85 -77.11 1.94 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.276 -0.73 . . . . 10.0 111.276 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 2.3 m -101.81 140.03 36.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' B' ' 19' ' ' LEU . 78.4 m-85 -128.09 152.72 47.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.926 0.393 . . . . 10.0 110.817 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.3 151.72 70.05 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.147 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' PRO . . . . . 0.41 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 30.3 Cg_endo -64.0 116.23 3.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.468 2.112 . . . . 10.0 111.75 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -82.77 81.47 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.241 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.927 -0.559 . . . . 10.0 109.964 -179.801 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.88 71.1 14.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.861 0.362 . . . . 10.0 111.597 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.97 -31.98 55.08 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.387 2.058 . . . . 10.0 112.256 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -61.88 -41.97 98.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.722 0.296 . . . . 10.0 110.874 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.75 -43.06 80.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.614 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.0 tp -61.95 -34.69 76.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.831 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -80.48 -13.74 58.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.236 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.4 m -84.86 -12.31 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 10.0 110.535 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -59.38 120.79 9.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.254 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.73 133.24 51.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.563 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.869 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 34.9 p -74.09 171.17 14.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.638 -0.504 . . . . 10.0 109.638 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.96 -12.24 60.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.432 0.634 . . . . 10.0 110.542 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.555 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 6.2 t70 -96.03 7.92 45.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.291 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 71.01 19.03 5.77 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.399 -0.819 . . . . 10.0 112.401 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.555 ' HG3' ' HB3' ' A' ' 13' ' ' ASP . 11.6 mtp180 -102.79 143.93 27.6 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.918 -0.401 . . . . 10.0 109.918 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.48 142.1 76.77 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.404 2.07 . . . . 10.0 111.318 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.76 -8.52 28.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.429 -0.35 . . . . 10.0 111.783 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -57.66 -24.27 55.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.637 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.569 HG23 ' HD1' ' A' ' 20' ' ' TYR . 29.5 m -63.16 -18.73 22.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.932 0.396 . . . . 10.0 111.579 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.569 ' HD1' HG23 ' A' ' 19' ' ' VAL . 15.4 m-85 -126.03 24.27 6.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.433 0.635 . . . . 10.0 109.927 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 68.9 mt -138.6 58.82 1.65 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.269 -0.878 . . . . 10.0 109.441 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -154.37 -178.7 7.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.98 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? 66.85 12.78 9.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.598 -0.728 . . . . 10.0 112.316 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 55.3 38.31 30.17 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.075 0.464 . . . . 10.0 111.689 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -107.51 151.56 41.03 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.704 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.84 152.16 59.39 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.009 2.472 . . . . 10.0 112.153 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.88 141.71 48.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.64 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD23 ' HG ' ' A' ' 60' ' ' LEU . 19.7 tp -122.33 94.97 4.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.6 mt -93.38 122.51 44.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.613 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HG3' ' CE2' ' A' ' 111' ' ' TRP . 3.6 tmmt? -123.08 129.7 51.82 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.978 0.418 . . . . 10.0 111.134 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.497 ' HB2' ' HB2' ' A' ' 110' ' ' SER . 23.7 m-85 -92.8 137.88 31.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.307 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -132.57 171.91 13.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.145 -0.48 . . . . 10.0 110.475 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.67 137.54 54.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.756 0.312 . . . . 10.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.28 -39.99 46.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.928 -0.578 . . . . 10.0 112.12 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.699 ' HE1' ' HA ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -91.64 25.02 2.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.404 0.52 . . . . 10.0 112.404 -179.025 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.506 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 46.3 t -115.6 124.33 30.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HA ' HD12 ' A' ' 40' ' ' LEU . 28.0 Cg_endo -63.24 -41.96 24.92 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.771 2.314 . . . . 10.0 112.142 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.72 -31.53 72.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.988 0.423 . . . . 10.0 111.07 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.1 m -84.19 -14.95 48.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.568 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 37' ' ' PRO . 53.1 mt -71.55 -45.79 61.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.556 -0.293 . . . . 10.0 111.752 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -22.04 62.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.426 0.631 . . . . 10.0 110.559 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -23.69 62.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.353 -0.84 . . . . 10.0 111.458 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -58.55 -53.93 52.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.118 0.414 . . . . 10.0 112.118 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.56 -35.76 89.9 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.047 -0.597 . . . . 10.0 111.943 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -66.95 -41.68 86.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.791 0.329 . . . . 10.0 110.46 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.9 m -61.72 -43.92 97.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.96 -0.563 . . . . 10.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.506 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -65.58 -39.82 92.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.774 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.56 -40.09 95.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.114 0.483 . . . . 10.0 110.337 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -73.64 -34.12 64.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.891 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.06 -13.78 60.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.001 0.429 . . . . 10.0 111.623 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -113.01 10.62 18.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.131 0.491 . . . . 10.0 110.699 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -81.1 140.31 35.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.911 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.64 -33.36 74.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.159 0.429 . . . . 10.0 112.159 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.799 ' HB3' HD12 ' A' ' 137' ' ' ILE . 17.5 mmmt -77.31 -37.86 51.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.721 0.296 . . . . 10.0 111.519 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -77.58 -10.26 59.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.017 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.5 t -69.18 -12.32 61.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 10.0 111.521 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 m -80.16 -2.96 46.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.918 0.389 . . . . 10.0 111.167 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.27 159.36 41.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.222 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -94.89 92.4 6.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.816 0.341 . . . . 10.0 110.339 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.501 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -83.76 124.48 30.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.791 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.583 HG22 ' HB2' ' A' ' 90' ' ' PRO . 3.3 pt -140.94 141.63 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.915 0.388 . . . . 10.0 111.434 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -104.49 113.33 26.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.563 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.551 HG22 ' HB ' ' A' ' 92' ' ' VAL . 17.6 t -110.65 142.81 22.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.886 0.374 . . . . 10.0 111.621 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -137.41 140.44 41.32 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 1.7 m -98.19 104.99 25.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.774 0.321 . . . . 10.0 111.854 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.666 ' HG3' HG22 ' A' ' 93' ' ' THR . 39.6 Cg_endo -65.9 121.56 8.93 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.745 2.297 . . . . 10.0 112.261 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.05 -4.78 83.22 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.577 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 25.8 t80 -111.15 148.98 31.56 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.302 -0.259 . . . . 10.0 110.302 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.6 mt 60.61 29.15 18.8 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.412 0.445 . . . . 10.0 111.667 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.528 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.1 OUTLIER 68.0 19.24 9.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.465 -0.788 . . . . 10.0 112.105 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.699 ' HA ' ' HE1' ' A' ' 35' ' ' TRP . 2.7 mm-40 -80.95 179.95 7.61 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.689 0.28 . . . . 10.0 110.893 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 42.8 mmtt -69.18 142.24 54.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 74' ' ' ASP . 77.3 tttt -73.19 165.69 24.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.476 -0.329 . . . . 10.0 111.303 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 73' ' ' LYS . 16.9 t70 -55.16 147.18 16.79 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.763 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.44 -57.24 4.73 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.586 -1.006 . . . . 10.0 110.586 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.86 -44.94 95.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.401 0.619 . . . . 10.0 109.424 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -67.43 -39.01 85.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.258 -0.883 . . . . 10.0 111.33 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -65.14 -42.83 93.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.839 0.352 . . . . 10.0 111.075 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -65.55 -24.67 67.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.402 . . . . 10.0 110.854 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.422 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 2.9 t90 -64.9 -47.15 78.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.658 -0.868 . . . . 10.0 108.658 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -66.27 -41.22 90.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.714 -0.676 . . . . 10.0 110.732 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.23 -31.22 65.3 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.993 -0.549 . . . . 10.0 111.002 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.38 35.33 5.04 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.835 -0.698 . . . . 10.0 112.067 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 84' ' ' LEU . 10.8 mt -118.3 -178.22 3.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.81 0.338 . . . . 10.0 110.814 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -100.31 171.44 7.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.413 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 90.7 m-85 66.6 82.11 0.2 Allowed Pre-proline 0 N--CA 1.466 0.326 0 O-C-N 123.556 0.535 . . . . 10.0 111.41 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.73 1.36 6.45 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.45 2.1 . . . . 10.0 112.915 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 88' ' ' LYS . 16.3 mtpp -104.73 6.24 34.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.534 0.207 . . . . 10.0 111.108 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.506 ' HG ' ' HG3' ' A' ' 47' ' ' GLU . 9.0 mt -69.05 116.84 45.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.755 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.583 ' HB2' HG22 ' A' ' 61' ' ' ILE . 71.8 Cg_endo -78.94 69.01 8.07 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.543 2.162 . . . . 10.0 111.696 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' THR . 44.3 t -87.51 124.78 41.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.717 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.869 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 6.4 t -112.03 142.53 24.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.666 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -98.31 104.3 16.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.814 0.34 . . . . 10.0 110.986 -179.369 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 57.3 t0 -85.77 79.92 9.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.137 0.494 . . . . 10.0 110.039 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -65.67 110.26 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.601 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.34 -25.18 27.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.875 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.27 51.51 2.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.651 -0.785 . . . . 10.0 111.654 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 102' ' ' SER . 0.5 OUTLIER -62.52 -51.6 66.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.009 0.433 . . . . 10.0 110.45 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.454 ' HB ' ' HZ ' ' A' ' 31' ' ' PHE . 31.5 mm -81.89 -38.18 15.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.021 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.773 ' HA ' HD13 ' A' ' 105' ' ' ILE . . . -57.12 -44.51 83.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.281 -0.872 . . . . 10.0 111.787 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -80.57 -28.28 37.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 10.0 111.184 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 98' ' ' THR . 4.4 t -63.02 -47.03 84.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.57 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -101.37 -5.76 24.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.849 0.314 . . . . 10.0 111.849 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 t30 65.79 70.82 0.43 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.57 0.7 . . . . 10.0 111.638 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.773 HD13 ' HA ' ' A' ' 100' ' ' ALA . 2.6 mp -86.47 126.44 40.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.433 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.41 23.52 2.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.877 0.37 . . . . 10.0 111.245 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.503 HG23 ' HB3' ' B' ' 109' ' ' TYR . 5.5 p -172.05 157.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.409 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -123.51 150.49 61.25 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.511 -0.552 . . . . 10.0 109.511 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -90.09 132.38 9.18 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.315 -1.535 . . . . 10.0 111.978 -0.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 25.7 m -93.61 121.45 35.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.189 -0.46 . . . . 10.0 109.939 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.525 ' CE2' ' HG3' ' A' ' 30' ' ' LYS . 69.0 m95 -106.62 108.47 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.829 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.13 110.12 22.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.208 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 136' ' ' LEU . 38.6 tp -90.81 112.01 23.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.699 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.0 133.11 45.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -71.38 -179.51 30.96 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.056 -0.592 . . . . 10.0 113.121 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -75.56 -4.9 42.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 10.0 111.405 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.98 -12.39 25.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.236 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 99.95 5.08 55.25 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.754 -0.736 . . . . 10.0 113.216 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -106.5 152.91 23.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.686 0.279 . . . . 10.0 111.24 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.92 118.67 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.094 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.53 -48.72 7.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.554 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -147.75 141.79 25.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.592 -0.277 . . . . 10.0 111.132 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -121.89 121.64 64.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.307 -0.406 . . . . 10.0 109.999 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.0 t -113.22 125.89 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.688 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -126.17 110.58 13.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.427 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 157.79 -87.47 0.12 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.173 -1.013 . . . . 10.0 113.2 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.5 t -170.57 131.17 0.89 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt -116.01 158.05 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.726 0.298 . . . . 10.0 110.796 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -108.23 171.48 7.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.473 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.53 -40.4 96.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.021 0.378 . . . . 10.0 112.021 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.4 88.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.556 -0.293 . . . . 10.0 110.767 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -61.89 -41.8 98.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.746 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.3 96.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 10.0 110.364 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.8 mt -71.52 -26.5 62.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.972 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.93 -34.35 29.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.504 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 140' ' ' PRO . 19.5 tp -62.86 -33.95 76.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.25 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.799 HD12 ' HB3' ' A' ' 54' ' ' LYS . 13.3 pt -83.03 15.91 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.124 0.487 . . . . 10.0 111.31 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -133.69 -48.33 0.82 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.655 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -138.25 97.36 9.63 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.302 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.545 ' HA ' HD12 ' A' ' 136' ' ' LEU . 57.7 Cg_endo -70.94 2.57 4.05 Favored 'Trans proline' 0 CA--C 1.526 0.092 0 C-N-CA 123.014 2.476 . . . . 10.0 112.83 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -95.36 -5.32 43.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.825 0.345 . . . . 10.0 110.132 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.17 134.6 36.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.836 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -126.09 155.08 42.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.16 -0.682 . . . . 10.0 109.16 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.98 0 N-CA-C 113.57 0.952 . . . . 10.0 113.57 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 47.4 mtt . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.599 0.238 . . . . 10.0 111.32 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.65 -83.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.462 -0.335 . . . . 10.0 111.287 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 34.8 tp -93.32 -55.04 3.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.005 -0.278 . . . . 10.0 110.896 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ASP . . . . . 0.525 ' HA ' HD13 ' B' ' 9' ' ' LEU . 0.6 OUTLIER 53.6 35.58 21.33 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.672 0.608 . . . . 10.0 111.518 -179.511 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.93 166.44 27.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.441 -0.8 . . . . 10.0 110.555 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.91 -160.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.413 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -107.16 28.46 8.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.302 0.572 . . . . 10.0 109.925 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -92.95 7.68 42.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.96 -0.564 . . . . 10.0 111.391 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.591 HD12 ' HD3' ' B' ' 13' ' ' LYS . 2.6 pt? -133.17 140.81 38.53 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.772 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.88 148.7 93.14 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.125 2.55 . . . . 10.0 112.333 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.28 -37.76 81.18 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.46 2.773 . . . . 10.0 113.456 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -63.98 -20.89 66.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 10.0 111.936 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.591 ' HD3' HD12 ' B' ' 9' ' ' LEU . 2.5 tmtm? -111.57 -6.32 14.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.253 0.549 . . . . 10.0 110.468 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.12 -17.36 46.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.042 -0.527 . . . . 10.0 111.793 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.438 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 13.7 m-85 -127.54 125.81 41.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.711 0.291 . . . . 10.0 110.934 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.76 89.8 16.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.114 -0.494 . . . . 10.0 109.757 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.511 ' HG2' ' HG3' ' B' ' 126' ' ' PRO . 9.5 Cg_exo -73.26 106.5 2.18 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.996 2.464 . . . . 10.0 112.707 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -101.57 110.23 22.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.665 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' B' ' 19' ' ' LEU . 3.5 mm? -92.73 117.08 29.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.152 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.68 98.03 6.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.284 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.528 HG13 HG22 ' B' ' 26' ' ' VAL . 29.2 t -82.18 117.12 27.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.204 -0.453 . . . . 10.0 109.94 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.27 -174.32 2.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.476 -0.329 . . . . 10.0 110.808 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.14 -37.88 53.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.422 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.3 -36.68 39.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.788 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.498 ' HA2' ' CZ ' ' B' ' 85' ' ' TYR . . . -174.52 -179.75 45.32 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.521 -0.847 . . . . 10.0 112.432 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.528 HG22 HG13 ' B' ' 21' ' ' VAL . 46.9 t -90.44 128.74 42.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -114.94 110.23 19.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' B' ' 81' ' ' VAL . 3.8 p -94.94 124.11 47.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.904 0.383 . . . . 10.0 110.944 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -127.03 87.94 2.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.195 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 10.4 p90 -91.55 118.04 30.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.94 0.4 . . . . 10.0 110.765 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 mtm-85 -78.2 126.18 30.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.702 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 23.7 mt -101.93 141.25 18.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.263 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.42 151.21 47.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.039 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.92 81.68 2.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.142 0.496 . . . . 10.0 111.381 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.05 -21.22 0.13 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.063 -0.815 . . . . 10.0 111.063 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.23 147.15 28.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -139.78 136.08 33.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.094 0.474 . . . . 10.0 111.009 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' MET . . . . . 0.408 ' HA ' ' HA3' ' B' ' 101' ' ' GLY . 43.2 mtt -106.91 152.18 24.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.973 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.619 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 38.4 m-85 -92.11 125.59 36.85 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.903 -0.777 . . . . 10.0 108.903 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -59.85 -29.66 68.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.716 0.293 . . . . 10.0 111.668 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.39 -8.62 59.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.36 . . . . 10.0 111.17 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' B' ' 100' ' ' GLN . 37.2 mmtt -107.45 -13.81 15.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.838 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 39' ' ' TYR . 85.3 mt -80.84 102.24 6.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.022 0.439 . . . . 10.0 109.847 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.77 129.85 44.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.683 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.6 129.04 2.64 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.686 -0.769 . . . . 10.0 111.911 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -156.47 137.81 13.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.818 0.342 . . . . 10.0 111.097 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.661 ' HB ' HD13 ' B' ' 95' ' ' LEU . 13.2 t -138.49 125.11 20.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.494 -0.558 . . . . 10.0 109.494 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.54 ' CG ' ' HA ' ' B' ' 51' ' ' ASP . 0.3 OUTLIER -177.9 160.1 1.27 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.316 -178.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.08 -76.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.687 2.258 . . . . 10.0 110.635 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.57 48.62 0.83 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.447 0.641 . . . . 10.0 109.839 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.54 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 6.7 t0 63.63 35.82 11.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.998 -1.001 . . . . 10.0 112.427 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.49 ' HA ' HD13 ' B' ' 52' ' ' LEU . 2.3 mm? -90.65 67.57 6.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.79 -0.641 . . . . 10.0 111.075 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 19.1 tp -125.28 144.45 50.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 10.0 109.798 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.46 -64.94 1.91 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.561 -0.828 . . . . 10.0 112.254 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -169.29 157.71 7.07 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.0 -0.37 . . . . 10.0 110.0 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.99 97.72 1.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.514 2.143 . . . . 10.0 110.427 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m -78.97 100.37 7.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.971 0.415 . . . . 10.0 111.611 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -87.96 149.48 24.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.095 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m -79.98 -14.13 58.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.701 0.286 . . . . 10.0 110.755 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? 72.72 136.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.672 -0.695 . . . . 10.0 112.332 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.38 -133.24 4.33 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.003 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -116.18 149.38 39.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -86.66 136.27 33.09 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -114.8 130.85 56.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.636 0.255 . . . . 10.0 110.791 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.18 119.75 18.82 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.14 -177.76 3.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.79 -0.641 . . . . 10.0 109.429 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -112.2 -51.6 2.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.683 0.277 . . . . 10.0 111.097 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -84.49 -30.13 25.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.253 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.495 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 5.8 m-30 -95.91 -10.11 29.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.997 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.23 -92.66 1.39 Allowed Glycine 0 C--O 1.224 -0.488 0 C-N-CA 120.853 -0.689 . . . . 10.0 112.734 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -165.2 115.57 1.1 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.758 0.313 . . . . 10.0 110.615 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -144.06 170.53 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.258 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 3.4 m -74.14 134.35 42.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.548 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.65 161.02 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.97 0.414 . . . . 10.0 111.131 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -115.98 130.98 57.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.185 -1.043 . . . . 10.0 108.185 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -114.22 -6.84 13.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.793 0.664 . . . . 10.0 112.793 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -173.17 -37.0 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -83.26 135.49 34.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.918 -1.037 . . . . 10.0 109.537 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' B' ' 30' ' ' PHE . . . -161.7 110.98 1.54 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.002 0.43 . . . . 10.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 25.9 tt0 -151.39 121.25 7.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.254 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.421 ' HB ' ' CG1' ' B' ' 28' ' ' VAL . 9.3 t -125.89 131.96 71.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.56 135.74 48.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.875 0.369 . . . . 10.0 110.435 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -113.73 108.28 51.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.374 -0.376 . . . . 10.0 111.626 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.41 131.08 4.02 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.836 2.358 . . . . 10.0 111.655 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' TYR . . . . . 0.498 ' CZ ' ' HA2' ' B' ' 25' ' ' GLY . 14.9 m-85 -76.34 142.77 41.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 10.0 109.942 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.9 11.22 38.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.096 0.474 . . . . 10.0 110.661 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -166.69 128.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.697 -0.683 . . . . 10.0 109.656 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.38 81.41 5.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.995 0.426 . . . . 10.0 111.337 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.5 126.72 73.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.996 -0.547 . . . . 10.0 110.74 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.46 58.26 4.87 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.045 -0.598 . . . . 10.0 111.77 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -113.78 149.17 41.34 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.93 95.23 0.48 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.138 1.892 . . . . 10.0 111.472 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.28 140.16 38.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.262 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' B' ' 47' ' ' THR . 70.6 tttt -91.86 147.3 23.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.661 HD13 ' HB ' ' B' ' 47' ' ' THR . 35.9 tp -118.6 127.79 53.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.881 0.372 . . . . 10.0 110.887 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.37 121.15 66.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.031 -0.729 . . . . 10.0 109.031 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.14 137.61 53.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 10.0 111.324 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 7.3 m -129.02 121.0 27.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 38.2 m-85 -104.77 118.5 36.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.919 0.39 . . . . 10.0 111.457 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.716 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 11.3 tp60 -132.9 123.71 26.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.32 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -161.88 -158.33 9.43 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.66 -0.781 . . . . 10.0 111.737 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 20.3 m -152.05 175.57 12.41 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.283 -0.636 . . . . 10.0 109.283 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -115.71 148.81 39.35 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.142 -0.318 . . . . 10.0 110.142 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.39 -10.55 44.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.237 0.458 . . . . 10.0 112.237 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.52 6.98 46.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 10.0 111.507 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.82 -6.8 67.4 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.761 -0.733 . . . . 10.0 112.549 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 5.7 t -68.35 136.26 26.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.843 -0.429 . . . . 10.0 109.843 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 21.6 t -127.31 107.98 10.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.692 0.282 . . . . 10.0 110.744 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.503 ' HB3' HG23 ' A' ' 107' ' ' VAL . 35.8 p90 -97.72 148.34 34.31 Favored Pre-proline 0 C--N 1.327 -0.402 0 O-C-N 122.226 -0.296 . . . . 10.0 111.625 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.53 159.49 52.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.927 2.418 . . . . 10.0 111.666 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.716 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 59.1 Cg_endo -74.51 83.59 1.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.583 2.189 . . . . 10.0 111.72 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.17 122.86 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.01 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -104.71 150.32 24.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.03 0.443 . . . . 10.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -141.5 138.78 33.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.004 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' B' ' 94' ' ' LYS . 47.4 mt-10 -107.78 134.93 50.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.556 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' B' ' 95' ' ' LEU . 75.6 m-85 -122.38 150.02 43.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.853 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -116.42 116.21 27.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.751 0.31 . . . . 10.0 110.171 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 19.9 mm -94.15 93.13 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.044 0.45 . . . . 10.0 111.06 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -102.08 -13.45 17.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.319 0.58 . . . . 10.0 110.926 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 122.5 110.87 2.07 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.634 -0.793 . . . . 10.0 112.095 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -176.02 -22.13 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 10.0 110.565 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.92 -74.3 2.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.707 -0.758 . . . . 10.0 111.861 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.62 129.45 35.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 10.0 111.238 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -132.84 150.26 52.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.327 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.65 146.99 34.18 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.239 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' PRO . . . . . 0.511 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 34.7 Cg_endo -65.74 118.62 5.63 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.487 2.125 . . . . 10.0 112.407 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -75.51 82.57 2.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.489 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.877 -0.582 . . . . 10.0 109.995 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.463 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 3.6 m -127.49 64.81 64.32 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 112.229 0.455 . . . . 10.0 112.229 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.58 -36.63 63.38 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.062 1.841 . . . . 10.0 111.973 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -65.89 -37.17 85.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.734 0.302 . . . . 10.0 110.985 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 2' ' ' VAL . 1.3 m -70.33 -31.45 68.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.651 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.608 ' HG ' HD13 ' A' ' 21' ' ' LEU . 15.6 tp -63.34 -32.04 73.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.221 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 m -86.79 -8.24 57.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.833 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 5' ' ' THR . 6.8 m -76.5 -23.08 53.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.593 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 94' ' ' ASP . 1.1 mm? -73.52 118.14 16.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.284 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -111.19 147.55 34.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.386 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.799 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 25.1 p -71.3 178.26 3.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.084 -0.507 . . . . 10.0 111.332 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.17 -14.98 62.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.05 0.453 . . . . 10.0 110.465 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -89.0 -2.2 58.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.632 -0.713 . . . . 10.0 109.319 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.6 t30 75.22 19.67 2.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.854 -1.066 . . . . 10.0 110.554 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -101.13 126.54 34.5 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.226 -0.897 . . . . 10.0 109.278 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.49 140.49 35.49 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.132 2.555 . . . . 10.0 112.397 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.41 -2.56 8.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.302 0.482 . . . . 10.0 112.302 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.592 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -60.12 -16.13 29.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 10.0 111.439 179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.73 -23.97 34.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.991 0.425 . . . . 10.0 111.052 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.401 ' HB3' ' HB3' ' A' ' 59' ' ' ASN . 45.3 m-85 -120.42 4.27 10.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.686 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.608 HD13 ' HG ' ' A' ' 6' ' ' LEU . 73.6 mt -108.81 26.65 10.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.267 0.556 . . . . 10.0 110.348 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -128.97 -174.94 3.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.913 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt 68.92 11.15 8.26 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.72 0.638 . . . . 10.0 111.151 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.37 41.54 32.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.36 -0.837 . . . . 10.0 111.82 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -110.42 138.89 21.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.95 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.23 125.67 19.94 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.962 2.441 . . . . 10.0 111.713 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.8 117.86 34.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.757 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD23 HD13 ' A' ' 60' ' ' LEU . 10.0 tp -89.23 110.03 20.84 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.4 mt -93.58 118.53 39.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 10.0 111.992 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.497 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 14.8 tttt -119.92 129.64 54.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.482 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.656 ' HB3' ' HE1' ' A' ' 108' ' ' TYR . 6.5 m-85 -99.07 135.35 40.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.465 -0.334 . . . . 10.0 111.085 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -122.42 -178.6 3.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 10.0 110.812 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.22 146.38 35.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.571 0.225 . . . . 10.0 111.133 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.7 -31.34 14.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.705 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.544 ' CH2' ' HA ' ' B' ' 110' ' ' PRO . 0.9 OUTLIER -82.32 11.0 5.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.189 0.44 . . . . 10.0 112.189 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.89 125.82 27.19 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.74 0.305 . . . . 10.0 111.449 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.8 -35.44 9.59 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.533 2.156 . . . . 10.0 112.63 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.7 mt -64.52 -47.04 80.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.38 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 76.7 m -69.46 -20.1 63.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.275 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HB3' ' CE2' ' B' ' 68' ' ' PHE . 1.5 tp -69.09 -41.73 77.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.594 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.99 -32.88 69.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.129 0.49 . . . . 10.0 110.223 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -63.12 -23.41 67.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.622 -0.717 . . . . 10.0 110.978 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' HD11 ' A' ' 89' ' ' LEU . 86.9 mt -59.5 -36.73 76.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 10.0 110.352 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.78 -37.09 88.3 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.564 -1.014 . . . . 10.0 110.564 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.33 -36.01 73.99 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -61.87 -41.62 98.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.806 -0.634 . . . . 10.0 109.852 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 88' ' ' LYS . 31.3 tt0 -61.55 -39.18 90.18 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 120.962 0.41 . . . . 10.0 109.945 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -63.08 -44.14 96.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.705 -0.68 . . . . 10.0 109.727 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -68.52 -33.5 74.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.983 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.43 -2.73 20.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.123 0.487 . . . . 10.0 110.821 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -125.3 14.82 8.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.74 -0.663 . . . . 10.0 109.603 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 15.2 t70 -87.05 140.92 29.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.447 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.73 94.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.165 0.431 . . . . 10.0 112.165 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -76.39 -37.81 56.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.77 0.319 . . . . 10.0 111.321 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.702 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 27.7 m-85 -71.16 -16.0 62.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.322 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.9 t -72.26 -0.28 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 10.0 111.673 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -75.49 -22.05 57.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 10.0 110.222 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.96 169.05 15.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 10.0 109.72 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 87.5 m-20 -100.08 97.5 8.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.673 0.273 . . . . 10.0 110.315 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.469 HD13 HD23 ' A' ' 28' ' ' LEU . 54.2 tp -83.29 130.81 35.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.442 -0.344 . . . . 10.0 110.944 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.487 ' HA ' ' HG2' ' A' ' 90' ' ' PRO . 21.6 pt -135.9 146.71 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.966 0.413 . . . . 10.0 111.156 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -107.03 105.98 16.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.236 -0.438 . . . . 10.0 109.908 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.407 HG13 ' HB ' ' A' ' 92' ' ' VAL . 5.4 t -103.31 146.51 10.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.124 0.487 . . . . 10.0 111.71 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . . . -143.44 146.25 33.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.205 -1.035 . . . . 10.0 108.205 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 7.1 m -106.46 98.63 20.68 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 112.196 0.443 . . . . 10.0 112.196 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.582 ' HG3' HG22 ' A' ' 93' ' ' THR . 17.8 Cg_endo -60.0 123.51 13.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.944 2.429 . . . . 10.0 112.27 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.98 -13.36 66.37 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.944 -0.646 . . . . 10.0 112.954 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 52.9 t80 -94.42 139.05 31.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.822 0.311 . . . . 10.0 110.469 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.766 HD11 HG22 ' B' ' 112' ' ' VAL . 0.2 OUTLIER 57.03 35.55 26.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.08 -0.509 . . . . 10.0 112.183 179.509 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.36 20.73 8.56 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.026 0.75 . . . . 10.0 113.026 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 2.7 mm-40 -75.69 -179.07 4.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.718 0.294 . . . . 10.0 110.723 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -67.39 121.3 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.218 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -66.5 155.56 37.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.706 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.09 130.79 47.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.176 -0.466 . . . . 10.0 111.173 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.16 -40.41 2.53 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.586 -1.406 . . . . 10.0 109.586 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.484 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 2.2 t70 -97.4 -34.84 10.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.965 0.412 . . . . 10.0 110.103 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 64' ' ' ALA . 76.0 t80 -56.26 -50.97 69.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.706 . . . . 10.0 112.432 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -35.31 76.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.457 -0.338 . . . . 10.0 111.482 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 20.5 mtmt -70.65 -28.9 65.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.765 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -60.99 -49.74 76.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.623 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -73.93 -32.06 63.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.605 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.88 -18.99 63.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.6 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.74 5.88 43.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.938 -0.648 . . . . 10.0 111.689 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.0 mt -106.49 177.48 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.958 0.408 . . . . 10.0 111.042 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.405 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 49.3 t30 -98.22 -162.65 0.97 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.765 -0.652 . . . . 10.0 109.942 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.405 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 13.5 m-85 65.43 78.28 0.26 Allowed Pre-proline 0 N--CA 1.464 0.258 0 C-N-CA 122.829 0.451 . . . . 10.0 111.356 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.05 -0.69 10.57 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.616 2.211 . . . . 10.0 112.3 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 4.4 mmpt? -101.22 10.55 40.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.155 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 43' ' ' LEU . 16.5 mt -85.76 112.56 45.71 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.019 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.487 ' HG2' ' HA ' ' A' ' 61' ' ' ILE . 72.9 Cg_endo -79.03 63.44 8.71 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.571 2.181 . . . . 10.0 111.051 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 62' ' ' THR . 99.3 t -73.38 117.89 17.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.825 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.799 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 21.7 t -103.28 138.98 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.439 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -97.68 107.09 19.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.119 -0.492 . . . . 10.0 110.922 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 54.0 t0 -103.18 84.33 2.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.894 0.378 . . . . 10.0 110.237 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.424 ' HA ' ' HG2' ' A' ' 66' ' ' PRO . 28.2 t-20 -63.9 116.87 6.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 10.0 112.109 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.96 -19.66 53.91 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.825 -0.703 . . . . 10.0 112.629 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.77 50.71 5.13 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.106 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 102' ' ' SER . 0.2 OUTLIER -62.46 -42.12 99.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.976 0.417 . . . . 10.0 110.523 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.9 mm -82.88 -40.2 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.889 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.576 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -60.63 -45.12 95.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.759 -0.655 . . . . 10.0 111.655 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -72.0 -30.04 64.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 98' ' ' THR . 1.4 t -65.86 -38.53 89.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.948 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.13 7.2 44.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.947 0.404 . . . . 10.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.3 t30 50.48 60.98 3.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.421 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 100' ' ' ALA . 79.9 mt -87.14 98.46 7.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.752 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.21 8.62 25.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.914 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.617 ' HA ' ' CD ' ' B' ' 110' ' ' PRO . 7.0 p -149.17 154.53 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.67 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.656 ' HE1' ' HB3' ' A' ' 31' ' ' PHE . 57.1 m-85 -131.05 152.63 81.01 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.252 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 126' ' ' GLY . 97.8 Cg_endo -82.39 161.7 76.75 Favored 'Cis proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.935 -1.694 . . . . 10.0 111.372 -1.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 m -127.67 131.34 49.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.698 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -118.82 125.12 48.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.19 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.54 113.08 26.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.843 0.354 . . . . 10.0 110.332 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 140' ' ' PRO . 44.1 tp -89.51 101.12 13.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.168 0.509 . . . . 10.0 111.293 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.28 133.13 32.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.666 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.26 -177.43 49.96 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.088 -0.577 . . . . 10.0 113.244 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -67.86 -11.4 58.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.265 0.469 . . . . 10.0 112.265 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.36 -7.94 30.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 10.0 111.382 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.38 -7.0 63.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.684 -0.769 . . . . 10.0 112.626 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -89.0 156.0 19.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.734 0.302 . . . . 10.0 110.844 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.6 t -78.55 107.75 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.149 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -81.99 -41.52 20.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.263 -0.426 . . . . 10.0 111.507 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -148.76 160.01 43.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.372 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.9 tt -138.14 141.44 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.493 -0.558 . . . . 10.0 109.493 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.3 t -121.92 129.98 74.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.202 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -133.21 124.68 27.84 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.437 -0.347 . . . . 10.0 110.128 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.598 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 132.88 -72.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.44 -0.886 . . . . 10.0 112.511 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.79 ' HB2' HG22 ' B' ' 107' ' ' VAL . 5.1 t -178.83 162.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.6 pt -146.28 152.17 13.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.158 -0.474 . . . . 10.0 109.914 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -109.96 170.41 8.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.836 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -56.41 -43.8 79.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.03 78.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 10.0 110.807 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -67.86 -37.26 81.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.903 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.66 97.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.0 mt -69.37 -40.92 77.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.782 -0.644 . . . . 10.0 110.5 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.29 -36.71 84.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.067 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.604 HD11 HD22 ' A' ' 113' ' ' LEU . 16.8 tp -62.83 -35.75 80.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.933 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.87 -36.81 59.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.343 0.592 . . . . 10.0 109.416 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -70.24 -47.48 61.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.465 -0.789 . . . . 10.0 110.709 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 23.3 t0 -150.42 112.27 3.23 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.495 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.688 ' HB3' HD21 ' A' ' 113' ' ' LEU . 19.3 Cg_exo -68.01 -7.32 19.44 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.922 2.415 . . . . 10.0 112.061 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -92.85 -0.27 57.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.932 0.396 . . . . 10.0 111.187 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.39 84.2 7.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.902 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.546 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 17.0 t70 -75.69 147.33 39.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.051 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.977 -1.011 . . . . 10.0 113.108 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.795 0.331 . . . . 10.0 110.837 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.22 -72.61 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.523 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 38.2 tp -78.98 -77.29 0.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 59.03 36.13 24.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.116 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.95 159.29 42.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.242 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 21.5 m120 64.03 -154.2 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.448 -0.797 . . . . 10.0 111.761 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -107.19 17.54 22.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.965 0.412 . . . . 10.0 111.028 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.35 8.59 4.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.476 0.547 . . . . 10.0 112.476 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.16 132.61 14.74 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.69 -0.232 . . . . 10.0 111.094 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' PRO . . . . . 0.522 ' HB2' ' OE1' ' B' ' 12' ' ' GLU . 24.1 Cg_endo -60.87 153.93 59.65 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.353 2.702 . . . . 10.0 112.184 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.55 -40.25 54.87 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.591 2.86 . . . . 10.0 113.612 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.522 ' OE1' ' HB2' ' B' ' 10' ' ' PRO . 3.0 pm0 -65.49 -13.81 59.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -117.13 -1.13 11.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.205 0.526 . . . . 10.0 110.412 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.69 -12.48 23.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.116 -0.493 . . . . 10.0 112.077 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -124.01 128.74 49.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.859 0.362 . . . . 10.0 111.486 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' B' ' 31' ' ' ARG . 40.6 t -114.71 91.11 24.27 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.389 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.509 ' HG2' ' HG3' ' B' ' 126' ' ' PRO . 14.2 Cg_exo -70.52 95.78 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.986 2.458 . . . . 10.0 112.367 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.51 97.74 11.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' B' ' 123' ' ' THR . 3.3 mm? -87.93 110.31 20.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.159 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.5 101.92 10.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.158 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.491 HG13 HG22 ' B' ' 26' ' ' VAL . 47.8 t -88.96 130.98 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.186 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.96 176.28 5.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.847 -0.427 . . . . 10.0 109.847 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.22 -34.16 68.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.929 0.395 . . . . 10.0 111.447 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.46 -36.34 53.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.277 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' B' ' 85' ' ' TYR . . . -178.75 -175.93 46.2 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.961 -0.638 . . . . 10.0 111.692 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.491 HG22 HG13 ' B' ' 21' ' ' VAL . 54.5 t -98.09 133.35 40.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 110.228 -0.286 . . . . 10.0 110.228 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -120.28 105.45 10.94 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.967 -0.383 . . . . 10.0 109.967 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.472 HG22 ' HD1' ' B' ' 30' ' ' PHE . 6.3 p -93.57 124.19 45.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.128 0.489 . . . . 10.0 110.969 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -127.47 85.77 2.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.91 -0.586 . . . . 10.0 109.947 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.472 ' HD1' HG22 ' B' ' 28' ' ' VAL . 1.9 p90 -82.71 111.23 18.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.265 0.555 . . . . 10.0 111.004 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.435 ' HB2' ' HB ' ' B' ' 16' ' ' VAL . 32.5 mtm-85 -75.55 112.5 11.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.453 -0.794 . . . . 10.0 110.194 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -91.65 145.21 7.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.819 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.8 155.06 40.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.148 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.15 88.16 2.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.104 0.478 . . . . 10.0 111.27 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.74 -15.46 0.45 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.538 -0.625 . . . . 10.0 111.538 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -109.66 142.37 40.92 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -133.9 136.98 44.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.86 0.362 . . . . 10.0 110.862 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' MET . . . . . 0.48 ' HA ' ' HA3' ' B' ' 101' ' ' GLY . 41.1 mtt -108.52 147.65 31.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.864 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.474 ' O ' HG13 ' B' ' 43' ' ' ILE . 50.0 m-85 -88.25 123.82 33.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.853 -0.425 . . . . 10.0 109.853 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -60.08 -32.42 70.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.517 -0.31 . . . . 10.0 111.403 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.67 5.74 20.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.306 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.446 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 24.0 mmtt -124.58 -8.42 7.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.461 -0.336 . . . . 10.0 111.836 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 39' ' ' TYR . 86.9 mt -83.91 99.21 6.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.251 0.548 . . . . 10.0 110.155 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 41.6 t -90.25 112.0 24.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.09 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' B' ' 96' ' ' VAL . . . -141.73 128.71 3.71 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.893 -0.67 . . . . 10.0 111.545 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -160.56 143.13 13.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.945 0.402 . . . . 10.0 111.444 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.635 ' HB ' HD13 ' B' ' 95' ' ' LEU . 13.4 t -134.6 131.45 37.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.903 -0.59 . . . . 10.0 109.64 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.482 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 9.2 p30 -177.08 158.08 1.37 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.576 -0.284 . . . . 10.0 110.774 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.418 ' HG3' ' HD2' ' B' ' 93' ' ' TYR . 9.3 Cg_exo -74.67 -58.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.614 2.209 . . . . 10.0 110.976 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.63 48.53 2.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 10.0 109.795 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.414 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 0.4 OUTLIER 66.23 36.62 5.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.326 -0.852 . . . . 10.0 111.748 -178.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' B' ' 52' ' ' LEU . 2.4 mm? -97.01 56.69 1.43 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.712 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' B' ' 48' ' ' ASN . 11.8 tp -130.64 152.1 50.38 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.097 -0.705 . . . . 10.0 109.097 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.71 -87.26 0.3 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.542 -0.837 . . . . 10.0 111.726 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.41 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 3.5 pp0? -155.93 149.29 18.67 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 110.008 -0.368 . . . . 10.0 110.008 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 26.4 Cg_exo -63.45 107.15 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.661 2.24 . . . . 10.0 111.168 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 3.1 m -79.2 95.38 5.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.154 0.502 . . . . 10.0 110.78 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -78.04 144.57 36.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.528 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.7 m -82.64 -9.38 59.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.566 -0.288 . . . . 10.0 111.318 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? 71.24 166.22 0.3 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.907 -0.588 . . . . 10.0 111.979 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.14 -134.56 1.74 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.463 -0.655 . . . . 10.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -106.44 151.9 24.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.623 0.212 . . . . 10.0 110.558 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -90.89 125.87 35.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -102.16 128.52 48.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.497 -0.32 . . . . 10.0 110.977 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.76 130.62 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.322 -0.621 . . . . 10.0 109.322 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -133.91 163.53 29.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -93.24 -30.28 15.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.822 0.344 . . . . 10.0 111.301 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -100.27 -39.35 8.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.592 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -89.87 -9.2 49.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.89 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.76 -85.79 0.97 Allowed Glycine 0 C--O 1.227 -0.333 0 C-N-CA 120.758 -0.734 . . . . 10.0 112.673 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -165.24 115.91 1.11 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.645 0.259 . . . . 10.0 110.956 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -138.99 158.72 43.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.288 -0.415 . . . . 10.0 110.447 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 5.6 m -70.79 130.4 41.6 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.425 -0.583 . . . . 10.0 109.425 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.55 150.21 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.377 0.608 . . . . 10.0 112.179 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -110.8 116.36 31.14 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.86 -1.163 . . . . 10.0 107.86 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -103.78 -3.01 25.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.581 0.585 . . . . 10.0 112.581 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.14 -41.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.186 0.517 . . . . 10.0 109.672 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 1.0 OUTLIER -89.26 100.4 13.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.329 -0.85 . . . . 10.0 110.98 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.49 107.39 8.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.979 0.419 . . . . 10.0 111.397 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -138.43 128.01 24.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.689 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 19.0 t -128.65 129.6 68.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.251 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' B' ' 57' ' ' SER . . . -102.72 144.06 31.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.605 -0.271 . . . . 10.0 110.469 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' PHE . . . . . 0.435 ' HD2' ' HB ' ' B' ' 26' ' ' VAL . 58.2 m-85 -119.86 100.54 48.57 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.691 0.282 . . . . 10.0 111.684 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.05 118.81 2.39 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.995 2.463 . . . . 10.0 112.01 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' TYR . . . . . 0.425 ' CE2' ' HA2' ' B' ' 25' ' ' GLY . 36.7 m-85 -66.4 144.47 56.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 10.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.48 11.66 34.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.23 0.538 . . . . 10.0 109.797 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -164.04 124.93 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.317 -0.856 . . . . 10.0 109.955 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.05 92.55 6.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.06 0.457 . . . . 10.0 110.59 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 12.0 m -121.78 163.7 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.614 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.31 21.02 22.64 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.743 -0.741 . . . . 10.0 111.673 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -93.51 138.04 23.13 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.19 127.75 24.12 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.589 2.193 . . . . 10.0 111.039 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' TYR . . . . . 0.418 ' HD2' ' HG3' ' B' ' 49' ' ' PRO . 0.1 OUTLIER -108.54 153.78 22.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.435 -179.001 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -95.69 152.08 18.78 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.691 -0.485 . . . . 10.0 109.691 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.635 HD13 ' HB ' ' B' ' 47' ' ' THR . 22.7 tp -126.6 124.22 39.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.695 0.283 . . . . 10.0 110.601 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.475 ' O ' ' HA2' ' B' ' 45' ' ' GLY . 24.6 t -108.69 123.05 64.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 81.9 mt -126.63 120.26 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 10.0 111.833 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' THR . . . . . 0.675 HG23 ' HB3' ' B' ' 113' ' ' ASP . 5.5 m -112.96 117.14 31.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.745 -0.661 . . . . 10.0 109.828 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 24.2 m-85 -99.6 107.17 19.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.627 0.251 . . . . 10.0 111.085 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 14.7 tp60 -121.5 126.02 48.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 10.0 110.936 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -167.64 -157.76 11.18 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.432 -0.667 . . . . 10.0 111.432 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.3 m -153.51 167.84 28.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -105.17 144.67 31.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.42 -16.51 60.77 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.107 0.41 . . . . 10.0 112.107 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.27 -12.51 56.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.456 -0.338 . . . . 10.0 111.78 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.48 -14.77 10.77 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.371 -0.918 . . . . 10.0 113.006 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 127' ' ' SER . 46.2 t -63.45 131.8 29.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.94 76.92 1.32 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.961 0.41 . . . . 10.0 110.695 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -66.02 157.14 81.87 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.949 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.649 ' HD3' ' H ' ' A' ' 108' ' ' TYR . 93.8 Cg_endo -85.8 160.22 10.5 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.778 2.319 . . . . 10.0 112.155 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.751 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 85.6 Cg_endo -79.31 70.56 7.45 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.743 2.296 . . . . 10.0 111.62 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.766 HG22 HD11 ' A' ' 69' ' ' LEU . 16.6 t -67.04 93.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.775 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ASP . . . . . 0.675 ' HB3' HG23 ' B' ' 98' ' ' THR . 6.3 p-10 -78.07 150.26 33.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.78 -0.645 . . . . 10.0 111.857 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 10.3 m -137.36 144.99 42.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.513 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -104.29 138.06 41.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.821 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -121.27 153.16 38.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.715 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -114.05 120.58 41.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.985 -0.376 . . . . 10.0 109.985 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 19.8 mm -95.87 79.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.247 0.546 . . . . 10.0 110.328 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -94.01 -14.02 26.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.222 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.44 110.03 2.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.082 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -167.55 -32.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.033 0.444 . . . . 10.0 110.624 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.71 -80.2 0.27 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.924 -0.655 . . . . 10.0 111.552 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 9.1 m -101.01 135.48 42.39 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.083 -0.34 . . . . 10.0 110.083 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -126.04 157.96 36.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.786 0.327 . . . . 10.0 111.217 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.38 148.41 20.97 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' PRO . . . . . 0.509 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 35.7 Cg_endo -66.35 137.99 49.19 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.278 1.986 . . . . 10.0 112.565 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -97.49 62.53 1.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.92 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.396 -0.811 . . . . 10.0 110.294 -179.682 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.17 62.61 39.58 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.73 -31.45 48.97 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.192 1.928 . . . . 10.0 111.514 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.89 -40.91 95.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.463 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.68 -40.43 80.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.557 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.1 tp -60.52 -32.89 71.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.207 0.527 . . . . 10.0 110.273 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.8 m -84.44 -15.92 44.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.959 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 45.8 m -79.94 -23.47 41.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.463 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -64.4 106.55 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.205 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 58.6 mttp -97.28 148.16 23.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.978 -0.556 . . . . 10.0 110.626 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.746 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 39.6 p -81.11 172.72 13.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.003 -0.544 . . . . 10.0 109.667 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.37 -5.52 19.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 10.0 110.212 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -92.53 5.01 52.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.356 -0.838 . . . . 10.0 109.825 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 73.06 13.59 4.83 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.327 0.862 . . . . 10.0 113.327 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -116.83 139.84 26.15 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.442 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 18.1 Cg_endo -57.75 146.31 86.11 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.795 2.33 . . . . 10.0 112.153 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.12 -1.25 7.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 10.0 111.759 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.568 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 4.4 m -59.42 -20.95 58.96 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.145 -0.48 . . . . 10.0 111.535 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 20' ' ' TYR . 21.7 m -65.39 -13.94 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.088 0.47 . . . . 10.0 110.849 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.416 ' HD2' HG23 ' A' ' 19' ' ' VAL . 22.7 m-85 -125.66 20.47 7.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.601 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 70.7 mt -129.61 40.16 3.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.489 -0.778 . . . . 10.0 110.328 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -138.44 -178.46 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.88 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.2 mttp 69.35 12.31 8.3 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.824 0.675 . . . . 10.0 112.824 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 58.56 28.79 17.55 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.192 0.52 . . . . 10.0 111.486 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -94.51 138.19 22.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.46 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.54 141.79 90.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.87 2.38 . . . . 10.0 111.183 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -108.4 144.21 36.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.855 0.36 . . . . 10.0 111.425 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.435 HD23 ' HG ' ' A' ' 60' ' ' LEU . 21.0 tp -123.98 104.34 8.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.697 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 77.8 mt -88.23 118.22 33.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.72 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.541 ' HD2' HG22 ' A' ' 62' ' ' THR . 7.9 tmtm? -110.04 116.46 31.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.666 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -90.43 148.27 22.9 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.293 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -150.53 175.88 11.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.527 -0.306 . . . . 10.0 111.32 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.78 146.97 50.04 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.366 -0.605 . . . . 10.0 109.366 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 m -70.88 -63.75 1.04 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.51 ' CZ2' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.41 59.31 4.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -178.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 1.6 t -135.46 123.34 15.27 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.327 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 52.3 Cg_exo -56.61 -49.02 16.06 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.748 2.299 . . . . 10.0 112.568 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 38' ' ' LEU . 5.7 mp -59.61 -52.74 64.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.996 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 80.5 m -64.88 -33.07 75.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.846 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.483 ' HB3' ' CE2' ' B' ' 68' ' ' PHE . 10.7 tp -62.2 -48.49 79.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.411 -0.358 . . . . 10.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 m -69.94 -32.46 70.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.535 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.86 -35.3 79.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.563 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.7 -39.8 81.8 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.912 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.4 -29.32 72.94 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.964 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -87.76 -27.54 22.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.873 0.368 . . . . 10.0 110.092 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.2 m -61.11 -47.91 84.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 10.0 110.912 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.658 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -62.91 -37.31 86.49 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.939 0.4 . . . . 10.0 110.221 179.424 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.85 -46.85 83.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.883 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -63.2 -42.68 99.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 10.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.41 -4.93 12.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.773 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -113.35 10.64 18.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.765 0.317 . . . . 10.0 111.496 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' HB3' ' HD1' ' A' ' 55' ' ' PHE . 11.5 t70 -93.75 148.7 21.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.735 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.95 -31.85 72.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.41 -46.22 77.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.107 0.479 . . . . 10.0 111.084 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.405 ' HD1' ' HB3' ' A' ' 52' ' ' ASP . 76.5 m-85 -74.85 -8.02 55.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.639 . . . . 10.0 112.364 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.3 m -70.24 -13.46 62.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.143 0.497 . . . . 10.0 110.86 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 m -69.91 -24.04 63.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.949 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.15 176.45 7.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.453 . . . . 10.0 110.956 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -108.57 98.63 8.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HG ' HD23 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -84.45 124.22 31.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.631 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.66 138.59 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 10.0 111.508 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.541 HG22 ' HD2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -92.38 109.76 21.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.865 -0.607 . . . . 10.0 109.681 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.9 137.4 42.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.092 0.473 . . . . 10.0 111.656 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.09 147.13 39.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.293 -1.002 . . . . 10.0 108.293 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 4.8 m -106.43 98.18 19.04 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 112.268 0.469 . . . . 10.0 112.268 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HG3' HG22 ' A' ' 93' ' ' THR . 30.2 Cg_endo -64.43 123.4 11.72 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.674 2.249 . . . . 10.0 111.882 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.88 3.33 73.84 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.817 -0.629 . . . . 10.0 112.706 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 3.0 t80 -116.0 148.37 40.2 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.71 -0.288 . . . . 10.0 110.487 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER 58.56 27.58 15.87 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.828 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.6 OUTLIER 71.52 20.21 4.88 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.716 -0.675 . . . . 10.0 112.371 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.51 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 2.3 mm-40 -81.72 -172.54 3.93 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.876 0.37 . . . . 10.0 111.155 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.666 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 9.4 mmpt? -69.37 133.13 47.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.402 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -68.66 158.27 34.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 10.0 112.017 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -55.62 141.57 37.11 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.575 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 78' ' ' GLN . . . 95.46 -60.68 1.53 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.813 -0.915 . . . . 10.0 110.813 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.96 -36.71 78.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 10.0 109.917 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.14 -41.15 97.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.407 -0.815 . . . . 10.0 111.643 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 10.9 pt20 -66.53 -29.52 69.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.954 0.407 . . . . 10.0 110.558 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -69.93 -28.59 65.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.287 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -66.07 -44.87 83.24 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.941 -0.763 . . . . 10.0 108.941 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -65.0 -38.47 91.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.198 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.77 -20.97 66.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.44 16.16 52.83 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.037 -0.602 . . . . 10.0 112.231 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 mt -118.43 158.38 25.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.658 0.266 . . . . 10.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.402 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 66.1 t30 -82.95 -173.88 4.95 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.45 -0.574 . . . . 10.0 109.45 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.402 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 89.2 m-85 68.88 76.24 0.25 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-O 121.211 0.529 . . . . 10.0 110.207 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.14 8.82 3.03 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.747 2.298 . . . . 10.0 112.473 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -108.13 4.58 25.07 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.116 -0.234 . . . . 10.0 110.903 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.658 ' HG ' ' HG3' ' A' ' 47' ' ' GLU . 13.2 mt -78.23 112.52 26.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.714 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 89' ' ' LEU . 2.9 Cg_exo -76.45 71.21 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.959 2.439 . . . . 10.0 111.179 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.69 114.24 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.918 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.746 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 20.0 t -96.53 133.53 37.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.047 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.701 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.14 96.01 8.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.012 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -83.37 82.38 8.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.191 0.52 . . . . 10.0 110.058 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -64.31 106.52 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.896 -0.593 . . . . 10.0 111.739 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.61 -24.21 26.24 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.009 -0.615 . . . . 10.0 112.123 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.11 53.41 3.14 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.616 -0.802 . . . . 10.0 111.821 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -47.15 84.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.027 0.441 . . . . 10.0 110.659 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.7 mm -77.05 -40.86 30.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.983 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.44 90.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.851 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -75.39 -42.66 53.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.558 0.218 . . . . 10.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -62.23 -38.42 89.14 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.7 mt -97.1 -2.47 43.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.655 -0.248 . . . . 10.0 111.519 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t30 53.62 58.19 5.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.958 -0.565 . . . . 10.0 111.202 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.1 109.43 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.165 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.13 17.56 14.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.953 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.842 HG23 ' HB3' ' B' ' 109' ' ' TYR . 11.4 p -149.58 147.83 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.543 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.5 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 27.5 m-85 -127.88 160.02 63.44 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.392 -0.596 . . . . 10.0 109.392 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.5 ' HA ' ' HB3' ' A' ' 108' ' ' TYR . 2.1 Cg_endo -88.06 124.41 6.96 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.972 -1.262 . . . . 10.0 111.277 -0.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.0 m -105.68 143.07 34.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.124 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -121.47 129.77 53.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.19 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.697 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -111.33 114.9 28.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.199 -0.455 . . . . 10.0 111.063 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.419 HD22 HD11 ' A' ' 136' ' ' LEU . 24.5 tp -92.13 117.1 29.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.778 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.24 136.2 38.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.605 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -74.59 -173.43 30.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.227 -0.511 . . . . 10.0 113.401 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 116' ' ' LYS . 5.7 mtmt -73.6 -12.97 60.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.975 0.417 . . . . 10.0 111.121 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.27 7.48 46.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.865 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.74 24.71 76.32 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.866 -0.683 . . . . 10.0 111.904 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -114.03 153.5 29.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.784 0.326 . . . . 10.0 110.761 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.3 t -67.78 113.99 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.926 0.393 . . . . 10.0 110.199 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -51.15 5.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.228 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -146.8 139.18 24.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.863 0.363 . . . . 10.0 111.587 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.6 tp -110.37 130.93 62.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.065 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.9 t -122.04 132.26 71.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -138.67 136.96 36.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 10.0 111.372 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.467 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 127.56 -80.43 0.36 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.055 -0.593 . . . . 10.0 112.477 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 p -172.62 142.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.604 -0.517 . . . . 10.0 109.604 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -125.49 171.91 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 10.0 110.843 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 132' ' ' GLN . 11.4 p30 -130.33 167.69 18.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.829 -0.434 . . . . 10.0 109.829 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -58.27 -49.96 75.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.5 89.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.368 . . . . 10.0 110.867 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.402 ' HB2' ' ND2' ' A' ' 129' ' ' ASN . 38.0 tt0 -64.62 -38.79 92.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.041 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.84 92.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 10.0 109.8 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.82 -38.48 91.11 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.962 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.63 90.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 10.0 110.631 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.419 HD11 HD22 ' A' ' 113' ' ' LEU . 15.4 tp -63.92 -34.74 78.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.461 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.98 -33.35 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -70.34 -48.66 55.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.813 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 49.4 t0 -148.67 117.08 3.95 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.29 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 29.1 Cg_endo -63.24 -10.08 19.8 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.01 2.473 . . . . 10.0 112.659 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -81.65 -7.71 59.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.929 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.92 125.4 26.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.785 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.534 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 19.5 t70 -136.1 143.93 44.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.152 -0.477 . . . . 10.0 109.92 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.918 -1.039 . . . . 10.0 112.523 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.754 0.312 . . . . 10.0 110.679 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.07 -85.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.788 0.328 . . . . 10.0 110.685 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.416 ' HG ' ' H ' ' B' ' 5' ' ' ALA . 56.0 tp -97.58 -61.75 1.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.228 -0.442 . . . . 10.0 109.984 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ASP . . . . . 0.573 ' HA ' HD13 ' B' ' 9' ' ' LEU . 1.7 m-20 57.23 35.63 26.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.884 -0.598 . . . . 10.0 111.227 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.416 ' H ' ' HG ' ' B' ' 3' ' ' LEU . . . -144.37 165.67 27.27 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.902 -0.59 . . . . 10.0 111.006 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' B' ' 7' ' ' ASP . 0.7 OUTLIER 62.44 -151.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.781 . . . . 10.0 112.235 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ASP . . . . . 0.456 ' H ' ' HB3' ' B' ' 6' ' ' ASN . 11.7 p-10 -108.47 27.24 9.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.657 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.62 23.07 9.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.739 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' B' ' 4' ' ' ASP . 2.7 pt? -147.99 137.27 11.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.148 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' PRO . . . . . 0.402 ' HB2' ' OE1' ' B' ' 12' ' ' GLU . 33.6 Cg_endo -63.78 145.41 90.77 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.022 2.482 . . . . 10.0 112.542 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.95 -36.77 76.56 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.464 2.776 . . . . 10.0 113.646 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' B' ' 10' ' ' PRO . 1.5 pm0 -69.8 -4.31 19.47 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.409 ' HD3' HD12 ' B' ' 9' ' ' LEU . 1.8 tmtm? -126.59 -8.68 6.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.526 0.679 . . . . 10.0 109.838 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.67 -7.84 59.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 10.0 112.239 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.475 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 27.7 m-85 -130.49 123.37 29.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.811 0.338 . . . . 10.0 111.011 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.48 95.62 16.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.327 -0.619 . . . . 10.0 109.327 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' B' ' 30' ' ' PHE . 2.9 Cg_exo -75.05 93.59 0.96 Allowed 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.186 2.59 . . . . 10.0 113.217 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -90.37 97.36 11.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.9 mm? -84.59 122.63 29.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.438 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.01 109.37 12.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.199 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.479 HG21 ' HE2' ' B' ' 124' ' ' TYR . 93.7 t -97.57 120.27 46.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.846 0.355 . . . . 10.0 111.082 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.62 169.5 9.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.14 -32.54 72.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.001 0.429 . . . . 10.0 110.975 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -80.28 -37.07 33.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.994 -0.548 . . . . 10.0 111.722 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -175.51 173.82 46.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.532 -0.842 . . . . 10.0 112.444 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.455 HG13 HG22 ' B' ' 21' ' ' VAL . 47.2 t -89.38 140.46 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.615 0.245 . . . . 10.0 110.755 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -129.54 111.01 12.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.736 -0.468 . . . . 10.0 109.736 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' B' ' 80' ' ' GLN . 7.3 p -92.02 125.09 44.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.953 0.406 . . . . 10.0 111.182 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -129.18 80.47 1.97 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.365 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' B' ' 17' ' ' PRO . 21.5 p90 -89.72 126.62 35.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.887 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtm-85 -81.76 124.93 30.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.923 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.494 ' HB ' ' HA ' ' B' ' 77' ' ' HIS . 59.8 mt -99.37 133.7 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.771 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 148.88 33.7 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.517 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.25 74.7 1.82 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.251 0.548 . . . . 10.0 111.675 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.21 -20.77 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.037 -0.825 . . . . 10.0 111.037 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -105.25 153.19 21.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.89 -0.781 . . . . 10.0 108.89 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -145.45 139.62 26.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.005 0.431 . . . . 10.0 111.417 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 40.8 mtt -110.26 156.48 20.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.925 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.679 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 31.3 m-85 -97.78 124.06 41.98 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.738 -0.468 . . . . 10.0 109.738 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -60.71 -28.54 68.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.093 0.473 . . . . 10.0 111.465 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.83 15.03 12.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 10.0 111.284 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.679 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 6.5 mmtm -130.85 -18.26 3.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.637 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.453 HG13 ' O ' ' B' ' 39' ' ' TYR . 80.8 mt -77.61 119.82 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.38 . . . . 10.0 110.23 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' B' ' 98' ' ' THR . 56.5 t -98.23 126.65 51.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.023 -0.535 . . . . 10.0 109.565 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -151.55 119.77 1.02 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.733 -0.746 . . . . 10.0 111.909 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 27.4 pttt -150.74 139.67 20.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.733 0.302 . . . . 10.0 110.965 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.63 ' HB ' HD13 ' B' ' 95' ' ' LEU . 4.8 t -138.75 125.37 20.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.587 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 19.9 p30 179.43 162.33 0.78 Allowed Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.267 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.68 -70.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.663 2.242 . . . . 10.0 111.313 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.29 57.21 0.73 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.87 0.366 . . . . 10.0 111.362 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.3 t70 65.19 32.89 9.75 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.268 0.556 . . . . 10.0 112.089 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' B' ' 52' ' ' LEU . 1.2 mm? -96.1 58.43 1.85 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.684 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 36.4 tp -124.49 139.49 53.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.601 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 -72.51 1.11 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.636 -0.792 . . . . 10.0 111.511 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.88 151.57 9.42 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.06 103.03 1.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.583 2.189 . . . . 10.0 110.392 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 49.4 m -76.79 104.78 7.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.021 0.439 . . . . 10.0 111.684 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -85.02 146.2 27.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.044 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 37.3 m -76.8 -11.64 59.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.448 -0.342 . . . . 10.0 111.485 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? 70.82 119.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.638 0.587 . . . . 10.0 112.513 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.81 -136.02 8.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.879 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -112.18 153.7 26.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.68 0.276 . . . . 10.0 111.002 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.62 119.52 26.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.53 -0.545 . . . . 10.0 109.53 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -101.16 139.85 36.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.841 0.353 . . . . 10.0 111.273 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -77.8 133.16 38.27 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.218 -1.031 . . . . 10.0 108.218 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -132.88 168.52 18.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.804 0.335 . . . . 10.0 110.889 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -101.85 -32.09 10.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.198 -0.455 . . . . 10.0 111.232 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 1.6 m-85 -109.69 -38.6 5.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.625 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.405 ' HD1' ' HA ' ' B' ' 69' ' ' PHE . 8.3 m-30 -84.42 -12.1 55.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.84 0.352 . . . . 10.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.11 -100.56 1.77 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.028 -0.606 . . . . 10.0 112.605 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -136.14 110.24 8.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.522 -0.547 . . . . 10.0 109.522 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -136.39 153.05 51.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.889 0.376 . . . . 10.0 111.588 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.23 127.32 32.3 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.036 -0.727 . . . . 10.0 109.036 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.68 153.6 33.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.509 0.671 . . . . 10.0 112.311 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -110.33 120.65 43.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -106.66 -1.82 22.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.049 0.759 . . . . 10.0 113.049 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.494 ' HA ' ' HB ' ' B' ' 32' ' ' ILE . 2.4 t60 -175.83 -37.53 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.219 -0.66 . . . . 10.0 109.219 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.8 OUTLIER -85.43 138.44 32.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.049 -0.978 . . . . 10.0 109.568 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 30' ' ' PHE . . . -160.39 119.43 2.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.781 0.324 . . . . 10.0 110.612 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 24.3 tt0 -159.62 121.9 3.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.347 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.76 126.66 67.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 10.0 109.665 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' B' ' 57' ' ' SER . . . -98.63 139.08 34.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.068 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -118.81 98.21 51.03 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 112.207 0.447 . . . . 10.0 112.207 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.44 127.94 6.79 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.063 2.509 . . . . 10.0 110.777 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -74.01 147.82 42.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.442 -0.344 . . . . 10.0 111.277 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.16 -5.8 54.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 10.0 110.538 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -153.02 147.1 25.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.709 -0.678 . . . . 10.0 109.867 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.56 85.37 4.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.911 0.386 . . . . 10.0 111.037 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.75 155.15 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.501 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.12 33.38 6.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.92 -0.657 . . . . 10.0 112.607 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -96.68 139.41 21.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.671 -0.492 . . . . 10.0 109.671 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.58 111.91 1.18 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.731 2.287 . . . . 10.0 111.507 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.12 161.07 21.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.134 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' B' ' 47' ' ' THR . 78.9 tttt -110.33 142.44 41.98 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.63 HD13 ' HB ' ' B' ' 47' ' ' THR . 58.6 tp -116.36 111.67 20.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.867 0.365 . . . . 10.0 110.788 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 41.6 t -101.84 113.49 38.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 96.5 mt -117.48 139.18 51.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.965 0.412 . . . . 10.0 111.414 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' THR . . . . . 0.604 ' HB ' ' HB ' ' B' ' 44' ' ' VAL . 20.9 m -134.36 118.55 17.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.036 -0.727 . . . . 10.0 109.036 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 50.6 m-85 -98.69 112.14 24.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.099 0.407 . . . . 10.0 112.099 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.67 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 15.8 tp60 -122.8 118.25 27.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.313 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.19 -160.18 10.22 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.729 -0.748 . . . . 10.0 111.758 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 25.3 m -153.58 -179.57 7.91 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.486 -0.561 . . . . 10.0 109.486 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ALA . . . . . 0.67 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -120.08 139.29 52.78 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.39 11.66 0.43 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.369 0.418 . . . . 10.0 112.114 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.92 6.08 20.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.453 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.92 26.84 9.34 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.431 -0.89 . . . . 10.0 113.436 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 20.3 t -115.27 141.88 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 53.3 t -136.21 89.53 2.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 10.0 110.907 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.842 ' HB3' HG23 ' A' ' 107' ' ' VAL . 53.3 p90 -78.27 151.09 77.94 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.323 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.566 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 57.9 Cg_endo -71.38 164.42 35.79 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.718 2.279 . . . . 10.0 111.567 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.828 ' HG2' ' HB3' ' A' ' 70' ' ' HIS . 71.9 Cg_endo -77.01 72.91 5.66 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.707 2.271 . . . . 10.0 112.419 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.401 HG22 ' CD1' ' A' ' 69' ' ' LEU . 24.2 t -62.86 124.4 17.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.622 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -104.87 160.95 14.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.148 0.499 . . . . 10.0 111.694 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.2 m -150.31 119.0 6.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.607 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' GLU . . . . . 0.457 ' HB3' ' HE2' ' B' ' 94' ' ' LYS . 31.6 mt-10 -92.97 126.63 38.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.052 0.453 . . . . 10.0 111.849 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.55 153.71 28.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.734 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -116.34 124.18 49.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.548 -0.538 . . . . 10.0 109.548 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 17.6 mm -90.21 72.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.234 0.54 . . . . 10.0 110.812 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -78.43 -26.61 46.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.361 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.88 48.55 0.15 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.612 -0.804 . . . . 10.0 113.078 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -107.22 -9.91 15.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.95 0.405 . . . . 10.0 110.639 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.63 -77.6 1.86 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.948 -0.644 . . . . 10.0 111.587 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 11.0 m -97.94 131.92 43.96 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.479 ' HE2' HG21 ' B' ' 21' ' ' VAL . 89.9 m-85 -120.26 155.29 33.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.975 0.417 . . . . 10.0 111.874 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -127.97 143.53 48.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.359 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.8 125.8 16.13 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.644 2.229 . . . . 10.0 111.883 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -85.71 82.61 8.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 179.701 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.92 88.67 31.82 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 10.0 111.603 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.93 -18.2 52.1 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.414 2.076 . . . . 10.0 111.906 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -62.53 -32.73 73.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.911 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 98' ' ' THR . 2.0 m -69.75 -41.73 74.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.536 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.29 -31.43 72.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.191 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 m -83.44 -8.43 59.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 10.0 110.636 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.9 m -91.91 -25.88 18.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.645 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -66.46 128.28 35.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.934 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.509 ' HG3' ' HA ' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -116.12 151.92 34.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.39 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.796 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 46.0 p -77.95 171.91 14.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.004 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.51 -15.29 63.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.537 0.684 . . . . 10.0 109.785 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.474 ' OD1' ' HB2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -82.55 -15.58 51.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.977 -1.01 . . . . 10.0 109.593 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.2 t30 97.33 -15.26 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.578 1.151 . . . . 10.0 112.326 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.557 ' HG3' ' HD2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -71.6 140.25 84.19 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 109.543 -0.54 . . . . 10.0 109.543 178.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HD2' ' HG3' ' A' ' 15' ' ' ARG . 34.6 Cg_endo -64.44 147.12 90.53 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.411 2.074 . . . . 10.0 111.703 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.79 -11.92 42.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.914 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 m -55.41 -24.19 28.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.443 . . . . 10.0 112.155 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 m -62.38 -22.74 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.9 0.381 . . . . 10.0 111.598 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.402 ' HB3' ' HB3' ' A' ' 59' ' ' ASN . 60.1 m-85 -127.55 29.17 5.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.282 0.563 . . . . 10.0 110.374 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.7 mt -136.22 28.99 3.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.943 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -134.28 -174.61 3.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.37 -0.377 . . . . 10.0 111.864 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt 71.61 11.19 6.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.772 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 56.82 33.9 23.82 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.395 -0.82 . . . . 10.0 111.686 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -101.16 147.53 33.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.46 142.17 95.18 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.061 2.507 . . . . 10.0 111.41 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 114' ' ' ILE . 2.0 m -112.66 143.3 44.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.858 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.411 HD23 ' HG ' ' A' ' 60' ' ' LEU . 15.2 tp -122.14 99.21 6.31 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.657 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 86.7 mt -90.43 120.95 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.803 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.502 ' HD2' HG22 ' A' ' 62' ' ' THR . 1.1 tmtp? -113.72 124.96 53.53 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.595 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.441 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 3.2 m-85 -101.02 141.74 33.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.514 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -149.02 169.3 20.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.787 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.405 ' HB1' ' CZ3' ' A' ' 35' ' ' TRP . . . -116.81 135.64 53.59 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -62.42 -59.09 5.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.294 0.85 . . . . 10.0 113.294 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.782 ' HZ2' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -85.65 38.49 0.75 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.087 0.773 . . . . 10.0 113.087 -178.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -115.54 126.02 28.18 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.316 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 28.1 Cg_endo -61.43 -44.61 21.85 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.829 2.353 . . . . 10.0 113.358 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.574 HD12 ' HB2' ' B' ' 108' ' ' CYS . 65.9 mt -64.11 -47.0 81.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 10.0 111.589 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.1 m -68.19 -33.73 74.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.507 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB3' ' CZ ' ' B' ' 68' ' ' PHE . 25.8 mt -64.49 -37.34 87.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 10.0 111.701 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m -72.07 -22.8 61.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.024 0.44 . . . . 10.0 111.157 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.24 -6.03 59.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.85 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.1 mt -59.3 -49.13 79.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.006 0.431 . . . . 10.0 111.151 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.86 -33.72 87.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.873 -0.68 . . . . 10.0 112.063 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -70.59 -41.58 72.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 10.0 110.665 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.2 m -60.67 -42.46 97.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.537 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -64.46 -41.18 96.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.128 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -64.9 -38.46 91.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.618 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -70.8 -34.39 71.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.467 . . . . 10.0 110.801 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.38 -13.21 62.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.01 0.434 . . . . 10.0 110.813 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -114.63 16.51 17.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 10.0 110.416 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 18.4 t70 -82.42 148.29 28.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.627 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.36 83.8 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -84.94 -43.09 14.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.537 0.208 . . . . 10.0 111.499 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.633 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 49.7 m-85 -66.22 -20.42 66.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 10.0 111.573 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 13.8 t -69.98 -0.28 7.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.952 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 m -84.62 -5.29 59.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 10.0 110.27 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -134.57 164.65 27.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.653 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 72.4 m-20 -92.3 94.72 9.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.475 -0.329 . . . . 10.0 110.188 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -84.3 121.64 27.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.966 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.6 pt -138.87 142.32 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 10.0 111.395 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.502 HG22 ' HD2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -100.97 113.78 27.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.566 -0.531 . . . . 10.0 109.566 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 92' ' ' VAL . 24.7 t -109.71 138.7 36.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.804 0.335 . . . . 10.0 111.235 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.93 154.48 49.21 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.444 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 9.9 m -112.78 96.16 36.31 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 112.386 0.513 . . . . 10.0 112.386 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.783 ' HG3' HG22 ' A' ' 93' ' ' THR . 38.1 Cg_endo -66.24 131.58 27.12 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.567 2.178 . . . . 10.0 111.437 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.65 10.03 85.68 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.952 -0.642 . . . . 10.0 112.596 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 2.7 t80 -123.29 138.27 54.66 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.577 HD12 HG22 ' B' ' 112' ' ' VAL . 2.1 mm? 60.39 29.33 18.93 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.184 0.516 . . . . 10.0 111.041 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.754 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 2.0 t60 74.26 14.97 3.66 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.781 -1.1 . . . . 10.0 113.45 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.782 ' HA ' ' HZ2' ' A' ' 35' ' ' TRP . 1.5 mm-40 -70.78 168.11 17.39 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 121.066 -0.254 . . . . 10.0 110.428 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' HE3' ' A' ' 80' ' ' TRP . 44.5 mmtt -55.85 136.17 51.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.14 -0.482 . . . . 10.0 111.034 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -67.97 163.06 23.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.156 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.47 137.18 53.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.433 -0.349 . . . . 10.0 110.509 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.05 -49.97 1.94 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.646 -0.981 . . . . 10.0 110.646 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.11 -40.44 71.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.119 0.485 . . . . 10.0 109.829 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -59.59 -48.79 80.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.457 -0.792 . . . . 10.0 111.641 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -66.45 -26.37 67.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 10.0 111.32 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -69.97 -32.69 71.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 10.0 110.289 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.585 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 3.2 t90 -65.6 -45.42 83.25 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -61.86 -36.96 82.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.324 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.41 -24.71 65.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.833 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.33 -0.79 62.89 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.036 -0.602 . . . . 10.0 111.811 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 80' ' ' TRP . 44.8 mt -105.05 169.18 8.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.439 . . . . 10.0 110.541 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -90.19 -155.66 0.38 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.998 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.446 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 55.8 m-85 57.54 73.17 0.8 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.954 0.407 . . . . 10.0 110.656 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.36 -9.61 26.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.537 2.158 . . . . 10.0 112.386 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 88' ' ' LYS . 28.4 mtpp -102.16 20.69 16.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.277 -0.42 . . . . 10.0 111.449 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.547 ' HB3' HG23 ' A' ' 91' ' ' VAL . 7.8 mt -80.96 115.29 54.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.807 0.337 . . . . 10.0 110.529 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.76 58.13 6.7 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.713 2.275 . . . . 10.0 111.675 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.547 HG23 ' HB3' ' A' ' 89' ' ' LEU . 48.5 t -81.56 119.96 32.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.052 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.796 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 12.6 t -102.93 142.78 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.078 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.783 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -101.24 106.28 17.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.291 -179.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 64.1 t0 -98.36 94.01 6.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.074 0.464 . . . . 10.0 109.911 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.96 108.54 2.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.995 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.26 -17.77 55.16 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.871 -0.681 . . . . 10.0 112.425 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.62 4.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.598 -0.81 . . . . 10.0 112.012 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 5' ' ' THR . 1.2 m -62.57 -51.7 66.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.859 0.362 . . . . 10.0 110.377 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.95 -35.84 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -61.99 -41.19 97.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.613 -0.722 . . . . 10.0 111.359 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -70.89 -39.8 72.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.407 -0.361 . . . . 10.0 111.224 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 m -58.8 -33.83 70.8 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.566 HD13 HD13 ' A' ' 123' ' ' ILE . 68.3 mt -113.02 11.18 18.92 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.997 -0.281 . . . . 10.0 111.691 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 62.3 t30 47.39 60.6 3.37 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.493 0.663 . . . . 10.0 111.421 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 100' ' ' ALA . 30.4 mt -86.92 73.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.446 0.641 . . . . 10.0 110.991 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.43 16.94 17.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.392 -0.822 . . . . 10.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.729 HG23 ' HB3' ' B' ' 109' ' ' TYR . 14.8 p -158.05 147.98 9.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.897 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 64.9 m-85 -127.14 160.73 58.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 108' ' ' TYR . 91.2 Cg_endo -81.7 154.12 79.57 Favored 'Cis proline' 0 C--O 1.235 0.33 0 C-N-CA 123.28 -1.55 . . . . 10.0 111.634 -0.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 t -130.45 137.71 49.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.288 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -119.9 116.6 26.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.729 -0.668 . . . . 10.0 110.266 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.657 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.31 108.31 20.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.664 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.4 tp -90.94 114.4 26.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.829 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 27' ' ' THR . 2.0 mp -100.82 134.6 40.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.373 -0.602 . . . . 10.0 109.373 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -70.01 178.67 29.24 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.281 -0.485 . . . . 10.0 113.423 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.15 7.61 3.23 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.944 0.35 . . . . 10.0 111.944 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.65 -19.48 13.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.073 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 109.97 -1.47 30.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.581 -0.819 . . . . 10.0 112.847 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -101.03 162.21 13.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.745 0.307 . . . . 10.0 110.98 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -71.47 122.29 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 10.0 110.259 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -95.41 -46.85 6.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.422 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 122' ' ' ARG . 9.3 tpt180 -152.28 154.2 35.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.718 0.294 . . . . 10.0 110.729 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.566 HD13 HD13 ' A' ' 103' ' ' LEU . 4.8 tp -128.32 123.88 60.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.515 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.1 t -113.42 137.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.67 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -141.94 139.03 32.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.006 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 121.14 -89.92 0.45 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.476 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.4 m -147.68 153.34 39.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 10.0 110.613 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.9 135.85 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.28 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -122.6 179.36 4.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 10.0 111.931 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -64.54 -43.58 93.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 10.0 112.086 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.1 -43.77 95.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.317 . . . . 10.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -62.13 -37.8 86.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.828 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.03 -48.9 76.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.051 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.7 -34.41 78.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.613 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.76 -43.77 87.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.132 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 140' ' ' PRO . 14.4 tp -64.28 -30.13 71.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.871 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 94.2 mt -70.08 -39.69 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.171 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -79.82 -38.94 31.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.226 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -150.86 103.17 3.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.565 -0.288 . . . . 10.0 110.552 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 136' ' ' LEU . 72.5 Cg_endo -75.7 2.84 6.53 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.77 2.313 . . . . 10.0 112.37 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -90.41 -11.79 39.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 10.0 110.622 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.55 113.64 25.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.01 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.419 ' HB3' HD23 ' A' ' 144' ' ' LEU . 4.6 t0 -96.91 170.0 9.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.076 -0.511 . . . . 10.0 109.892 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.419 HD23 ' HB3' ' A' ' 143' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.93 0 N-CA-C 113.977 1.102 . . . . 10.0 113.977 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 111.712 0.264 . . . . 10.0 111.712 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.09 -57.77 3.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.916 0.389 . . . . 10.0 111.73 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 24.9 tp -110.95 -77.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.699 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ASP . . . . . 0.575 ' HA ' HD13 ' B' ' 9' ' ' LEU . 2.5 m-20 60.4 41.91 15.42 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.474 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.67 161.95 38.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.343 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.46 -148.7 0.37 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.33 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -113.56 21.65 14.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.251 0.548 . . . . 10.0 110.16 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -93.3 40.91 1.07 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.092 -0.503 . . . . 10.0 111.409 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.575 HD13 ' HA ' ' B' ' 4' ' ' ASP . 2.6 pt? -164.21 138.37 4.39 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.562 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.27 147.11 94.07 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.774 2.316 . . . . 10.0 112.143 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.476 ' HG3' ' HB ' ' A' ' 107' ' ' VAL . 9.6 Cg_endo -52.5 -39.58 74.12 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.467 2.778 . . . . 10.0 113.613 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -64.55 -21.36 66.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 10.0 112.153 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.45 -3.59 19.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.183 0.516 . . . . 10.0 110.358 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.01 -9.73 54.84 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.463 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 19.8 m-85 -133.12 128.76 36.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.931 0.396 . . . . 10.0 111.274 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.48 92.04 15.57 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 3.0 Cg_exo -75.42 103.17 1.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.067 2.511 . . . . 10.0 112.924 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -98.36 103.12 15.04 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.376 -0.602 . . . . 10.0 109.376 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.9 mm? -86.76 110.0 19.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.165 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.98 112.9 25.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.944 0.402 . . . . 10.0 109.923 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.497 HG22 HG13 ' B' ' 26' ' ' VAL . 95.6 t -102.31 121.8 53.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.897 0.38 . . . . 10.0 111.261 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.76 170.25 8.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.533 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.43 -29.17 68.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.098 0.475 . . . . 10.0 110.554 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -75.44 -39.58 58.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.567 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.92 -179.55 47.81 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.833 -0.699 . . . . 10.0 111.904 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.497 HG13 HG22 ' B' ' 21' ' ' VAL . 60.0 t -94.14 135.88 27.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.066 -0.346 . . . . 10.0 110.066 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.428 ' OD1' ' HG3' ' B' ' 80' ' ' GLN . 52.5 t30 -124.95 112.04 16.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.856 -0.424 . . . . 10.0 109.856 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.49 HG22 ' HD1' ' B' ' 30' ' ' PHE . 2.8 p -92.63 124.75 45.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.969 0.414 . . . . 10.0 110.969 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' B' ' 79' ' ' ALA . 2.0 tmm_? -126.97 90.77 3.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.554 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.49 ' HD1' HG22 ' B' ' 28' ' ' VAL . 6.2 p90 -93.81 112.93 24.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.118 0.485 . . . . 10.0 111.238 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mtm-85 -72.45 114.6 10.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.461 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 43.7 mt -91.76 139.56 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.826 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.18 155.74 38.03 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.687 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -75.56 77.49 2.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.106 0.479 . . . . 10.0 111.571 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.0 -20.89 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.568 -0.613 . . . . 10.0 111.568 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -104.55 151.61 23.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -145.44 137.56 25.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.761 0.315 . . . . 10.0 110.724 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 34.4 mtt -107.97 156.18 19.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.964 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.616 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 18.3 m-85 -99.59 126.86 45.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.636 -0.505 . . . . 10.0 109.636 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -61.29 -28.56 69.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.909 0.385 . . . . 10.0 111.1 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.96 5.39 37.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.079 -0.51 . . . . 10.0 111.064 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.616 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 53.2 mmtt -122.19 -10.85 8.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.289 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.454 HG13 ' O ' ' B' ' 39' ' ' TYR . 89.9 mt -86.96 118.05 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 10.0 110.453 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.4 t -108.32 121.51 61.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.889 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.91 137.22 6.56 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.688 -0.767 . . . . 10.0 111.705 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -161.69 145.61 12.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.801 0.334 . . . . 10.0 111.209 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.635 ' HB ' HD13 ' B' ' 95' ' ' LEU . 8.8 t -143.97 120.88 11.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.805 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.535 ' CG ' ' HA ' ' B' ' 51' ' ' ASP . 0.3 OUTLIER -174.07 159.53 2.86 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.832 -178.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -73.87 -77.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.321 2.014 . . . . 10.0 110.843 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.82 44.44 1.03 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.149 0.499 . . . . 10.0 110.251 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.535 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 9.9 t0 66.79 33.33 6.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.297 -0.865 . . . . 10.0 112.269 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.88 70.26 4.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.921 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' B' ' 83' ' ' PHE . 28.5 tp -125.04 149.03 48.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.716 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.32 -72.67 1.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.886 -0.673 . . . . 10.0 111.805 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -169.87 146.83 2.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 122.131 0.172 . . . . 10.0 110.552 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.65 109.76 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.378 2.052 . . . . 10.0 110.494 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 6.4 m -89.07 94.24 9.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.157 0.503 . . . . 10.0 111.763 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -77.58 163.53 26.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.202 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 50.2 m -95.0 -3.65 48.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.518 -0.31 . . . . 10.0 111.141 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? 68.71 124.12 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.607 -0.724 . . . . 10.0 111.992 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.27 -139.89 8.4 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.893 -0.67 . . . . 10.0 112.206 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.88 143.92 44.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.732 0.301 . . . . 10.0 110.646 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -81.28 119.92 24.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.213 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' B' ' 65' ' ' GLU . 14.2 ttpt -98.95 136.03 39.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.456 -0.338 . . . . 10.0 110.799 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.405 ' O ' ' HE3' ' B' ' 64' ' ' LYS . 4.6 tp10 -73.97 126.42 30.45 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.571 -0.9 . . . . 10.0 108.571 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -120.46 -179.53 4.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.765 0.317 . . . . 10.0 110.906 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.23 -25.4 4.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.995 0.426 . . . . 10.0 110.575 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 40' ' ' LEU . 1.1 t80 -102.29 -49.12 3.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.853 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.437 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 22.1 m-30 -88.6 -4.45 58.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.496 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.79 -76.58 2.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.865 -0.683 . . . . 10.0 112.111 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -173.59 118.96 0.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.026 -0.361 . . . . 10.0 110.026 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -133.52 164.74 26.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.799 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -75.51 125.98 30.1 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.3 m -125.87 163.63 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.455 0.645 . . . . 10.0 112.449 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' B' ' 78' ' ' GLU . 28.8 m-85 -120.95 130.91 54.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.815 -1.18 . . . . 10.0 107.815 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -115.22 -10.87 12.06 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.66 0.615 . . . . 10.0 112.66 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.91 -29.31 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.339 0.59 . . . . 10.0 109.653 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.8 OUTLIER -86.09 142.61 28.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.038 -0.983 . . . . 10.0 109.378 178.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' B' ' 29' ' ' ARG . . . -166.79 102.69 0.57 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.793 0.33 . . . . 10.0 110.465 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.428 ' HG3' ' OD1' ' B' ' 27' ' ' ASN . 27.3 tt0 -148.92 117.71 6.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.13 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.38 120.89 52.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.574 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.91 148.13 23.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.349 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' PHE . . . . . 0.562 ' HB3' HD11 ' B' ' 53' ' ' LEU . 77.1 m-85 -125.22 102.96 30.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.61 127.46 8.04 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.766 2.311 . . . . 10.0 111.293 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -74.12 143.08 45.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.921 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.0 -4.18 53.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.335 0.588 . . . . 10.0 110.095 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -152.21 136.86 16.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.644 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.9 96.52 10.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.35 140.27 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.487 -0.324 . . . . 10.0 111.457 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.18 58.76 4.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.895 -0.669 . . . . 10.0 111.594 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -116.4 140.67 26.86 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.94 89.55 0.88 Allowed 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.584 2.189 . . . . 10.0 111.485 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.53 160.03 32.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.752 -0.658 . . . . 10.0 111.66 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 47' ' ' THR . 27.3 tttt -103.56 155.23 18.69 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.379 -0.601 . . . . 10.0 109.379 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.635 HD13 ' HB ' ' B' ' 47' ' ' THR . 42.0 tp -125.89 119.89 29.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.803 0.335 . . . . 10.0 110.762 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.75 123.84 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.525 -0.546 . . . . 10.0 109.525 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 64.2 mt -128.92 131.76 47.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.945 0.403 . . . . 10.0 111.66 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' THR . . . . . 0.416 HG22 ' HB2' ' B' ' 111' ' ' PRO . 5.6 m -120.07 117.13 27.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 34.1 m-85 -98.23 104.34 16.37 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.963 0.357 . . . . 10.0 111.963 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.883 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 11.1 tp60 -117.47 121.39 40.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.901 0.382 . . . . 10.0 110.981 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.91 -160.41 10.68 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.888 -0.673 . . . . 10.0 111.546 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 18.4 m -152.87 -179.57 7.77 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ALA . . . . . 0.625 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -121.35 142.99 49.45 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.868 -0.419 . . . . 10.0 109.868 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.55 -10.09 56.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.181 -0.463 . . . . 10.0 112.04 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.33 -4.05 59.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.359 . . . . 10.0 111.769 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.13 38.09 2.96 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.561 -0.828 . . . . 10.0 112.928 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.625 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 35.1 t -123.13 141.51 43.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.574 ' HB2' HD12 ' A' ' 38' ' ' LEU . 9.4 t -132.68 86.18 2.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.872 0.368 . . . . 10.0 110.803 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.729 ' HB3' HG23 ' A' ' 107' ' ' VAL . 55.2 p90 -76.73 152.52 82.99 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.497 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.15 161.38 43.31 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.825 2.35 . . . . 10.0 111.512 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.883 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 84.0 Cg_endo -77.91 74.65 5.16 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.861 2.374 . . . . 10.0 112.289 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.577 HG22 HD12 ' A' ' 69' ' ' LEU . 4.5 t -61.05 122.78 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.596 -0.52 . . . . 10.0 109.596 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ASP . . . . . 0.409 ' HB3' HG23 ' B' ' 98' ' ' THR . 4.6 p-10 -106.11 156.66 18.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.993 0.425 . . . . 10.0 111.291 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.28 141.09 30.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.17 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -107.73 123.18 48.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 10.0 110.739 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -112.94 148.29 35.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.571 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -105.12 118.96 37.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.517 -0.31 . . . . 10.0 110.221 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 14.9 mm -94.54 71.1 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.295 0.569 . . . . 10.0 110.53 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' B' ' 121' ' ' ASN . 44.0 p90 -83.98 -19.74 34.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.657 -0.701 . . . . 10.0 111.479 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.39 51.7 0.24 Allowed Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.709 -0.758 . . . . 10.0 112.688 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' ASN . . . . . 0.44 ' HB2' ' CZ ' ' B' ' 119' ' ' PHE . 21.3 t30 -103.77 -18.13 14.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.166 0.508 . . . . 10.0 110.489 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.19 -78.1 0.67 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.96 -0.856 . . . . 10.0 110.96 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 2.1 m -105.26 141.81 36.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -133.21 156.43 47.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.21 -0.292 . . . . 10.0 110.21 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.3 152.8 54.92 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' PRO . . . . . 0.434 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 28.5 Cg_endo -63.91 114.32 2.55 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.448 2.099 . . . . 10.0 112.139 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -81.13 76.9 8.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.566 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 7.7 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.788 -0.625 . . . . 10.0 109.732 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 109.738 -0.467 . . . . 10.0 109.738 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.503 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 1.4 m -123.02 76.32 50.28 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.068 0.461 . . . . 10.0 111.398 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.34 -33.97 88.2 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.702 2.268 . . . . 10.0 112.017 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -43.81 96.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.385 -0.371 . . . . 10.0 111.179 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -69.27 -40.01 78.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.307 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.4 tp -62.23 -34.16 75.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.729 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 m -84.57 -8.01 59.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.45 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.2 m -82.51 -20.73 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.192 0.52 . . . . 10.0 109.745 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 9' ' ' LEU . 3.2 mm? -56.4 119.34 5.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.696 -0.683 . . . . 10.0 110.636 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.35 140.42 41.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.43 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 22.0 p -81.68 168.97 17.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.866 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -11.04 56.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.984 0.421 . . . . 10.0 111.15 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.38 8.22 45.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.381 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.3 t30 68.12 38.14 2.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.6 -0.727 . . . . 10.0 112.108 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -122.51 140.26 32.49 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.658 -0.497 . . . . 10.0 109.658 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.35 143.82 78.04 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.215 1.943 . . . . 10.0 111.422 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -13.23 34.28 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.2 m -56.87 -22.82 39.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 10.0 112.133 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.96 -20.23 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.109 0.48 . . . . 10.0 111.315 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -132.47 28.76 4.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.18 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -138.73 43.94 2.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.131 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -145.81 -171.57 3.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.389 -0.368 . . . . 10.0 111.269 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 mttp 65.84 13.82 9.22 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 58.26 38.4 26.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.944 0.402 . . . . 10.0 111.682 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -103.22 146.43 32.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.941 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.622 ' HD3' ' HG2' ' A' ' 116' ' ' LYS . 27.1 Cg_endo -63.26 135.76 52.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.659 2.239 . . . . 10.0 110.958 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 114' ' ' ILE . 4.2 m -109.33 146.21 34.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.827 0.346 . . . . 10.0 111.181 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.1 tp -127.34 108.19 10.63 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.872 -0.418 . . . . 10.0 109.872 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 70.9 mt -96.09 119.75 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.969 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.714 ' HD2' HG22 ' A' ' 62' ' ' THR . 1.1 tmtp? -113.2 124.82 53.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.679 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -98.0 142.49 29.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.351 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.426 ' HE1' ' HB ' ' A' ' 62' ' ' THR . 32.7 p-90 -145.81 170.82 15.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.525 -0.307 . . . . 10.0 110.821 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . . . -114.9 139.49 49.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.637 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -73.33 -47.19 44.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.994 -0.548 . . . . 10.0 112.443 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.429 ' CH2' ' HD3' ' B' ' 111' ' ' PRO . 0.0 OUTLIER -90.99 29.27 1.4 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.427 0.529 . . . . 10.0 112.427 -178.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 33.7 t -117.59 121.05 32.39 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.513 0.197 . . . . 10.0 111.288 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.765 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 14.6 Cg_endo -58.0 -43.54 47.58 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.129 2.553 . . . . 10.0 112.467 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.37 -39.53 90.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.948 0.404 . . . . 10.0 111.279 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 78.2 m -76.08 -31.68 58.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.566 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.02 -46.85 85.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 10.0 112.082 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 m -66.61 -33.66 76.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.055 0.455 . . . . 10.0 110.862 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -26.31 68.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.254 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.28 -34.33 72.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.825 0.345 . . . . 10.0 110.643 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.78 92.34 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.935 -0.65 . . . . 10.0 111.853 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -77.31 -29.65 53.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.911 0.386 . . . . 10.0 110.113 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.7 m -60.44 -47.49 85.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.772 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.68 -36.75 85.28 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -61.69 -50.39 72.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.258 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -64.11 -37.28 86.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.049 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.14 -10.84 59.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.433 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -111.78 16.4 20.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.992 0.425 . . . . 10.0 110.73 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -93.31 139.89 30.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.258 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.38 -32.23 69.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.836 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -71.33 -44.09 65.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 10.0 110.658 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.42 ' CZ ' ' HB1' ' A' ' 133' ' ' ALA . 1.7 m-85 -73.6 -14.76 61.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 10.0 112.198 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.9 m -65.01 -11.63 41.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 10.0 111.216 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -78.87 -15.36 58.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.497 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -123.22 176.33 6.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.418 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.437 ' HB2' HG23 ' A' ' 27' ' ' THR . 78.9 m-20 -109.69 87.7 2.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.57 117.26 20.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.445 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.2 pt -134.93 147.2 29.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.786 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.714 HG22 ' HD2' ' A' ' 30' ' ' LYS . 1.6 p -109.0 116.41 31.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.167 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.462 HG22 ' HB ' ' A' ' 92' ' ' VAL . 18.7 t -113.17 137.15 47.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.78 0.324 . . . . 10.0 111.181 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.522 ' O ' ' HD3' ' A' ' 66' ' ' PRO . . . -132.08 138.25 48.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.087 -0.708 . . . . 10.0 109.087 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -100.66 102.35 18.89 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 112.13 0.418 . . . . 10.0 112.13 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 18.4 Cg_exo -68.63 131.23 22.41 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.994 2.463 . . . . 10.0 111.894 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.57 0.64 90.03 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.942 -0.572 . . . . 10.0 112.448 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -112.02 143.03 43.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.499 HD12 HG22 ' B' ' 112' ' ' VAL . 2.0 mm? 60.81 26.56 16.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.837 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.904 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.1 OUTLIER 67.93 26.43 7.48 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.371 -0.831 . . . . 10.0 112.849 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 2.1 mm-40 -81.97 -169.61 2.46 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.451 -0.34 . . . . 10.0 110.187 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -68.35 145.06 54.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.206 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -77.33 162.29 27.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.038 0.447 . . . . 10.0 111.712 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -63.56 150.35 44.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.855 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.56 -40.96 3.03 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.867 -0.893 . . . . 10.0 110.867 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -81.92 -47.62 12.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.913 0.387 . . . . 10.0 110.062 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -57.59 -39.37 76.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.8 -0.637 . . . . 10.0 112.232 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.01 -30.62 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.996 0.427 . . . . 10.0 111.225 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -77.87 -31.72 51.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 10.0 109.866 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -58.16 -45.76 86.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.73 -0.668 . . . . 10.0 109.678 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -66.99 -36.58 82.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.798 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.67 -27.76 69.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.198 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.24 29.21 12.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.889 -0.672 . . . . 10.0 111.998 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HB3' ' H ' ' A' ' 85' ' ' ASN . 38.5 mt -121.66 -162.55 0.99 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.042 0.449 . . . . 10.0 111.059 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.437 ' H ' ' HB3' ' A' ' 84' ' ' LEU . 45.8 t30 -116.99 -171.61 2.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.766 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 66.33 84.74 0.17 Allowed Pre-proline 0 N--CA 1.465 0.314 0 CA-C-O 121.381 0.61 . . . . 10.0 110.705 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.0 -11.57 29.39 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.776 2.318 . . . . 10.0 112.549 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -107.09 22.77 15.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.213 0.449 . . . . 10.0 112.213 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.454 ' HB3' HG23 ' A' ' 91' ' ' VAL . 5.2 mt -81.34 115.27 55.4 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.627 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.04 63.88 8.24 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.443 2.095 . . . . 10.0 111.705 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 89' ' ' LEU . 68.7 t -82.31 117.27 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.13 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.77 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 9.7 t -104.97 142.49 18.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.706 -0.679 . . . . 10.0 109.981 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -99.28 108.45 20.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.05 -179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -94.72 78.58 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.297 0.57 . . . . 10.0 110.222 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -64.17 116.56 6.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.505 0.557 . . . . 10.0 112.505 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.63 -6.31 67.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.563 -0.827 . . . . 10.0 112.65 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.45 41.36 67.03 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.72 -0.752 . . . . 10.0 111.799 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -43.99 98.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.833 0.349 . . . . 10.0 110.775 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.0 mm -80.39 -42.26 21.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.938 0.399 . . . . 10.0 110.07 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.436 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.88 -45.7 89.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.628 -0.714 . . . . 10.0 112.167 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -68.3 -38.01 81.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.8 m -61.2 -35.74 78.0 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.413 0.523 . . . . 10.0 112.413 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -106.37 5.7 29.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.595 0.22 . . . . 10.0 111.595 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.0 t30 53.39 55.71 8.34 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.524 0.678 . . . . 10.0 111.064 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 100' ' ' ALA . 78.2 mt -87.06 99.91 9.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.325 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.92 29.19 8.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.749 -0.66 . . . . 10.0 111.277 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.525 ' HA ' ' CD ' ' B' ' 110' ' ' PRO . 10.8 p -166.78 152.15 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.211 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -126.83 154.48 76.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -91.71 118.43 3.04 Favored 'Cis proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.619 -1.409 . . . . 10.0 111.403 -1.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.5 m -87.17 136.47 32.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.218 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -113.6 113.47 25.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.749 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.86 116.93 33.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.335 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 136' ' ' LEU . 37.3 tp -93.65 116.11 28.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.8 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 27' ' ' THR . 2.9 mp -104.65 129.59 56.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.946 -0.57 . . . . 10.0 109.544 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.75 178.17 40.04 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.962 -0.637 . . . . 10.0 112.895 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.622 ' HG2' ' HD3' ' A' ' 26' ' ' PRO . 3.3 mtmp? -69.77 -13.04 62.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.127 0.489 . . . . 10.0 110.617 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.44 -10.68 58.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.263 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.97 43.0 6.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.556 -0.831 . . . . 10.0 112.206 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -149.72 153.67 37.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.636 0.255 . . . . 10.0 110.573 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.5 t -70.23 120.23 17.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.952 0.406 . . . . 10.0 111.323 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -99.95 -28.97 12.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.013 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -156.24 146.65 21.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.585 -0.279 . . . . 10.0 111.004 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.0 tp -131.3 117.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.911 -0.403 . . . . 10.0 109.911 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.62 133.58 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.543 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -120.69 126.45 50.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.195 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.85 -99.21 0.22 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.499 -0.857 . . . . 10.0 112.931 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.4 m -168.14 135.22 2.11 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.122 -0.696 . . . . 10.0 109.122 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.1 pt -119.19 154.86 21.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.969 -0.293 . . . . 10.0 110.664 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -110.37 169.58 8.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.248 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -57.93 -39.32 77.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.114 0.413 . . . . 10.0 112.114 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.55 -40.85 88.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.104 0.478 . . . . 10.0 110.419 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -68.62 -38.21 80.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.22 -0.9 . . . . 10.0 110.146 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.42 ' HB1' ' CZ ' ' A' ' 55' ' ' PHE . . . -59.77 -45.85 91.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.633 -0.712 . . . . 10.0 110.941 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.15 -36.77 85.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.849 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.23 95.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.752 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.534 HD11 HD22 ' A' ' 113' ' ' LEU . 21.2 tp -62.43 -32.09 72.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.077 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.3 mt -72.68 -32.96 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.118 0.485 . . . . 10.0 110.358 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -78.5 -39.78 37.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.649 -0.705 . . . . 10.0 110.82 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.6 t70 -151.75 119.28 3.27 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.603 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.509 ' HB3' HD21 ' A' ' 113' ' ' LEU . 16.5 Cg_exo -69.25 -7.25 20.4 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.098 2.532 . . . . 10.0 113.42 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -99.12 4.4 46.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 10.0 111.163 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.2 72.09 9.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.411 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -76.61 150.98 36.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.949 -0.568 . . . . 10.0 111.305 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.146 0 N-CA-C 114.006 1.113 . . . . 10.0 114.006 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.452 0.168 . . . . 10.0 111.08 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.88 70.72 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.08 -0.509 . . . . 10.0 112.087 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 35.1 tp -91.91 -80.03 0.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.674 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 55.16 37.23 28.58 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.448 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.67 157.34 44.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.23 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.17 -172.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.253 -0.885 . . . . 10.0 112.693 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -94.6 27.87 2.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.273 -0.876 . . . . 10.0 110.619 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -84.51 -4.33 58.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.985 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.5 143.98 51.07 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.9 150.89 87.05 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.024 2.483 . . . . 10.0 112.4 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.28 -34.42 88.37 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.413 2.742 . . . . 10.0 113.162 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -68.0 -4.73 14.19 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.118 0.414 . . . . 10.0 112.118 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -129.03 1.43 5.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.4 0.619 . . . . 10.0 110.233 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.42 -10.47 43.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.832 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.4 ' HE1' HG23 ' B' ' 32' ' ' ILE . 23.6 m-85 -131.95 126.14 33.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.504 -0.317 . . . . 10.0 111.204 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.38 92.55 36.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' B' ' 30' ' ' PHE . 3.1 Cg_exo -76.49 116.06 4.22 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.169 2.579 . . . . 10.0 113.441 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.1 109.48 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.1 mm? -93.46 118.09 30.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.987 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.16 113.53 22.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.546 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.98 118.91 43.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.025 0.441 . . . . 10.0 111.225 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.0 -164.48 1.14 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.738 -0.665 . . . . 10.0 109.928 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -92.26 -37.29 12.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.789 0.328 . . . . 10.0 111.069 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.64 -37.12 42.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.623 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CZ ' ' B' ' 85' ' ' TYR . . . -168.01 -170.48 32.81 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.586 -0.816 . . . . 10.0 112.392 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.9 135.1 47.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -120.35 111.89 18.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.753 0.311 . . . . 10.0 110.248 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.488 HG22 ' HD1' ' B' ' 30' ' ' PHE . 3.9 p -95.01 122.55 46.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.13 0.491 . . . . 10.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -124.27 92.01 3.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.093 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 6.1 p90 -95.38 122.55 38.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.74 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -79.76 122.33 26.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.625 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.4 HG23 ' HE1' ' B' ' 15' ' ' PHE . 72.1 mt -100.83 130.68 49.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.49 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.65 145.34 55.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.147 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.36 92.99 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.109 0.48 . . . . 10.0 111.675 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.77 -23.86 0.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.663 -0.975 . . . . 10.0 110.663 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 103' ' ' ALA . 37.5 m-85 -103.51 154.04 19.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -144.63 139.01 27.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.965 0.412 . . . . 10.0 111.101 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 34.4 mtt -110.9 150.63 28.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.432 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.695 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 59.7 m-85 -92.6 121.35 33.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' B' ' 60' ' ' LYS . 21.1 tt0 -56.81 -37.12 70.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.752 0.31 . . . . 10.0 111.833 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.66 -9.77 58.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.397 . . . . 10.0 111.576 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.695 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 43.6 mmtt -104.43 -11.03 17.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.747 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.482 HG13 ' O ' ' B' ' 39' ' ' TYR . 75.2 mt -82.28 96.59 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.079 0.466 . . . . 10.0 110.314 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 t -91.46 109.04 20.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.203 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.39 141.51 12.57 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.55 -0.834 . . . . 10.0 111.751 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -162.36 147.48 12.51 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.789 0.328 . . . . 10.0 111.475 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.578 ' HB ' HD13 ' B' ' 95' ' ' LEU . 9.9 t -143.47 123.36 13.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.987 -0.552 . . . . 10.0 109.528 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' B' ' 51' ' ' ASP . 28.0 p30 -177.43 157.28 1.24 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.139 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 48' ' ' ASN . 11.7 Cg_exo -73.83 -69.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.732 2.288 . . . . 10.0 110.559 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.66 55.43 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.235 0.541 . . . . 10.0 109.769 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.564 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 4.9 t70 60.95 27.42 17.29 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.251 -0.886 . . . . 10.0 112.453 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' B' ' 52' ' ' LEU . 1.2 mm? -86.89 59.61 5.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.272 0.558 . . . . 10.0 111.531 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.434 ' HB2' ' HB3' ' B' ' 48' ' ' ASN . 22.9 tp -122.97 148.84 45.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.729 -0.669 . . . . 10.0 109.516 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.84 -80.21 0.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.596 -0.812 . . . . 10.0 111.45 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.447 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 1.5 pp0? -163.0 145.63 8.22 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.402 -0.221 . . . . 10.0 110.402 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 31.9 Cg_exo -63.64 107.5 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.606 2.204 . . . . 10.0 110.75 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.0 m -93.65 96.52 9.88 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.224 0.535 . . . . 10.0 111.536 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -80.25 150.25 30.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.718 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.4 m -81.12 -8.1 59.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.778 0.323 . . . . 10.0 110.678 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.408 ' HA ' ' OE1' ' B' ' 40' ' ' GLN . 3.3 mmtt 71.39 148.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.44 -0.8 . . . . 10.0 112.813 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.79 -128.33 2.93 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.996 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -121.04 149.57 42.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.526 0.203 . . . . 10.0 110.772 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.94 119.24 28.1 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -101.04 130.91 47.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.944 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -69.13 142.86 54.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -137.93 170.87 15.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.709 0.29 . . . . 10.0 111.16 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -109.85 -13.45 14.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.401 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.765 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 10.7 m-85 -121.36 -41.15 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 10.0 111.218 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -90.3 -7.41 53.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.962 0.411 . . . . 10.0 111.207 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.71 -79.46 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.095 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -171.44 110.75 0.31 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.989 0.423 . . . . 10.0 110.678 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -128.29 163.46 24.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.121 -0.491 . . . . 10.0 110.384 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 12.8 m -75.38 125.52 29.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.08 155.28 31.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.397 0.618 . . . . 10.0 112.357 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -112.84 130.34 56.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.611 -1.255 . . . . 10.0 107.611 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -113.03 -10.49 13.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.606 0.595 . . . . 10.0 112.606 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -168.78 -34.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.432 0.634 . . . . 10.0 109.887 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -87.75 134.55 33.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.296 -0.866 . . . . 10.0 109.769 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -159.32 123.79 3.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.883 0.373 . . . . 10.0 111.444 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -160.85 120.72 2.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.328 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 t -125.9 128.33 71.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 10.0 109.998 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.33 138.75 38.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.626 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' PHE . . . . . 0.416 ' HB3' HD11 ' B' ' 53' ' ' LEU . 62.7 m-85 -122.14 98.39 44.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.51 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.8 126.49 3.98 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.2 2.6 . . . . 10.0 111.027 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' TYR . . . . . 0.433 ' CZ ' ' HA2' ' B' ' 25' ' ' GLY . 7.1 m-85 -71.06 149.58 46.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.81 0.338 . . . . 10.0 110.871 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.99 -9.78 41.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.267 0.556 . . . . 10.0 110.107 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -152.24 127.2 9.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.895 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.64 99.32 6.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.143 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -131.83 146.22 33.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.403 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.58 43.63 3.01 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.671 -0.776 . . . . 10.0 111.867 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -104.33 144.44 28.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.43 0.157 . . . . 10.0 110.862 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.39 100.45 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.412 2.075 . . . . 10.0 111.353 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.56 144.13 28.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.923 -0.581 . . . . 10.0 111.208 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -88.81 159.5 17.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.049 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.578 HD13 ' HB ' ' B' ' 47' ' ' THR . 35.3 tp -131.05 121.8 25.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.046 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.42 HG22 ' HG2' ' B' ' 115' ' ' GLU . 40.6 t -117.05 125.0 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 49.2 mt -129.56 126.9 39.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.787 0.327 . . . . 10.0 111.549 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' THR . . . . . 0.497 HG23 ' HB3' ' B' ' 113' ' ' ASP . 1.7 m -115.62 116.85 28.83 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 41.9 m-85 -100.35 110.94 23.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.314 . . . . 10.0 111.366 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.91 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 6.1 tp60 -120.81 121.6 38.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.752 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.99 -157.13 9.84 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.309 -0.717 . . . . 10.0 111.309 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 39.6 m -158.86 -172.98 4.03 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' B' ' 36' ' ' TYR . . . -119.25 146.27 45.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.22 40.35 0.34 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.028 0.442 . . . . 10.0 110.484 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.18 1.06 1.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.223 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.05 -32.56 5.73 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.768 -0.729 . . . . 10.0 113.129 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 12.3 t -62.69 133.17 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.353 . . . . 10.0 111.313 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 10.9 t -129.22 100.35 5.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.947 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.414 ' CB ' HG23 ' A' ' 107' ' ' VAL . 15.3 p90 -89.61 144.81 32.47 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.678 0.275 . . . . 10.0 111.478 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.525 ' CD ' ' HA ' ' A' ' 107' ' ' VAL . 59.4 Cg_endo -73.18 160.83 44.51 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.854 2.37 . . . . 10.0 111.565 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.91 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 72.4 Cg_endo -76.77 75.83 4.32 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.54 2.16 . . . . 10.0 112.657 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.499 HG22 HD12 ' A' ' 69' ' ' LEU . 6.6 t -69.54 104.9 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' B' ' 98' ' ' THR . 5.5 p-10 -72.61 148.51 44.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.846 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.9 m -132.62 128.08 36.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.286 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' GLU . . . . . 0.42 ' HG2' HG22 ' B' ' 96' ' ' VAL . 39.1 mt-10 -105.59 134.16 49.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.012 0.434 . . . . 10.0 110.616 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.439 ' HB2' HD23 ' B' ' 95' ' ' LEU . 79.9 m-85 -109.17 166.56 10.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.345 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -123.0 117.61 25.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.966 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 18.6 mm -97.23 82.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.152 0.501 . . . . 10.0 110.462 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -97.38 -25.51 15.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.675 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.52 68.16 0.18 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.068 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -128.27 -3.9 5.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.866 0.365 . . . . 10.0 111.363 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.28 -76.72 2.21 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.836 -0.697 . . . . 10.0 111.917 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 0.2 OUTLIER -105.01 135.15 46.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.189 -0.301 . . . . 10.0 110.189 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -123.26 147.21 47.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 10.0 110.925 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.35 145.18 48.54 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.323 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.53 131.61 32.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.592 2.194 . . . . 10.0 111.668 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -84.24 86.55 7.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.209 0.528 . . . . 10.0 110.476 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.245 0.824 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.599 179.777 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' C ' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 109.788 -0.449 . . . . 10.0 109.788 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.53 63.13 63.37 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.337 . . . . 10.0 111.403 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HD3' ' C ' ' A' ' 1' ' ' MET . 23.0 Cg_exo -65.17 -43.61 10.99 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.411 2.074 . . . . 10.0 111.681 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -58.97 -44.35 91.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.267 -0.424 . . . . 10.0 111.32 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -47.03 80.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.947 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' A' ' 9' ' ' LEU . 28.8 tp -61.21 -36.19 79.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 10.0 111.361 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 m -76.08 -10.43 59.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 10.0 111.685 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.6 m -92.58 -6.33 49.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.035 0.445 . . . . 10.0 110.423 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 6' ' ' LEU . 2.3 mm? -66.37 109.52 2.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.293 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.49 139.43 33.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.931 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.78 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 71.6 p -84.13 172.51 11.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.061 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.29 -9.08 54.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.48 . . . . 10.0 110.263 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -91.71 8.11 38.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.948 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.95 13.33 7.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.258 -0.883 . . . . 10.0 112.956 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.92 143.49 29.2 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.479 -0.328 . . . . 10.0 110.626 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.82 146.79 88.92 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.617 2.211 . . . . 10.0 111.139 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.49 -5.68 25.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.256 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.556 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -56.66 -25.5 53.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.635 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.408 HG23 ' HD2' ' A' ' 20' ' ' TYR . 15.5 m -62.63 -21.45 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.078 0.466 . . . . 10.0 111.047 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.408 ' HD2' HG23 ' A' ' 19' ' ' VAL . 34.8 m-85 -117.68 20.55 13.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.329 0.585 . . . . 10.0 109.764 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 73.3 mt -125.76 25.38 6.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.661 -0.699 . . . . 10.0 110.33 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 18' ' ' SER . 26.4 mtpp -124.24 -170.6 2.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.204 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 mttm 68.31 8.48 6.63 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.733 0.645 . . . . 10.0 111.692 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.68 34.92 25.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.212 0.529 . . . . 10.0 110.32 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -101.67 150.58 37.44 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 10.0 111.449 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.27 142.87 75.05 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.781 2.321 . . . . 10.0 111.093 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.65 142.37 39.23 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.967 0.413 . . . . 10.0 111.286 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.563 HD23 ' HG ' ' A' ' 60' ' ' LEU . 24.7 tp -120.76 101.85 8.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 39.5 mt -87.53 121.92 38.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.817 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' HD2' HG22 ' A' ' 62' ' ' THR . 1.9 tmtp? -114.98 108.91 17.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.253 -0.431 . . . . 10.0 111.192 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 10.3 m-85 -82.86 138.07 34.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.068 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -140.98 171.67 13.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.576 -0.283 . . . . 10.0 111.239 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.46 144.59 49.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.239 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.98 -41.37 18.84 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.611 0.597 . . . . 10.0 112.611 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.572 ' HE1' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -88.56 23.81 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.661 0.615 . . . . 10.0 112.661 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.6 t -115.58 128.3 26.07 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 111.854 0.316 . . . . 10.0 111.854 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 27.2 Cg_endo -63.49 -43.09 18.69 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.884 2.389 . . . . 10.0 112.297 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.46 -41.69 93.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 10.0 111.171 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.5 m -70.32 -21.27 62.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.252 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.3 tp -68.52 -48.01 65.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.363 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.93 -33.07 74.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.172 0.511 . . . . 10.0 109.827 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -32.62 66.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.354 -0.839 . . . . 10.0 111.534 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.99 -46.71 84.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 10.0 111.091 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.91 -44.19 96.42 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.902 -0.59 . . . . 10.0 112.318 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -65.91 -38.13 87.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 10.0 110.785 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.4 m -63.62 -43.22 97.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.362 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -64.41 -39.71 94.37 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.908 -0.405 . . . . 10.0 109.908 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -60.83 -50.49 73.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.087 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -64.93 -40.16 94.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.753 -0.658 . . . . 10.0 111.528 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.59 -18.74 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.135 0.42 . . . . 10.0 112.135 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -103.7 10.24 36.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.753 0.311 . . . . 10.0 111.418 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 23.4 t70 -80.9 148.31 29.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.856 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.13 94.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 54' ' ' LYS . 25.1 mmmt -74.13 -34.85 64.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.885 0.374 . . . . 10.0 110.972 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.419 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -76.82 -10.89 59.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.147 -0.478 . . . . 10.0 111.862 -179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.5 m -74.72 2.15 10.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.028 0.442 . . . . 10.0 111.532 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -87.82 -9.47 53.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.834 0.349 . . . . 10.0 110.468 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.43 168.23 18.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 10.0 109.945 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -104.53 96.82 6.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.813 0.339 . . . . 10.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.563 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -86.29 125.48 33.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.711 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.3 pt -136.6 132.21 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 10.0 111.532 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.487 HG22 ' HD2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -92.18 131.07 37.7 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 179.168 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' A' ' 92' ' ' VAL . 13.6 p -137.06 147.18 27.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.165 0.507 . . . . 10.0 112.13 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.0 158.55 43.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.257 -1.016 . . . . 10.0 108.257 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 4.8 m -110.47 95.1 21.07 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 112.124 0.416 . . . . 10.0 112.124 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.753 ' HG3' HG22 ' A' ' 93' ' ' THR . 28.5 Cg_endo -63.28 119.27 6.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.58 2.187 . . . . 10.0 111.699 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.95 10.02 65.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.93 -0.652 . . . . 10.0 112.48 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 19.5 t80 -129.03 144.53 51.22 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.407 HD11 ' O ' ' A' ' 105' ' ' ILE . 44.3 mt 60.91 27.21 17.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.896 0.379 . . . . 10.0 111.592 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.587 ' HE1' ' HB3' ' B' ' 113' ' ' ASP . 4.2 m170 69.09 19.03 8.17 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.417 -0.811 . . . . 10.0 112.866 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.572 ' HA ' ' HE1' ' A' ' 35' ' ' TRP . 2.9 mm-40 -75.7 177.66 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.571 -0.286 . . . . 10.0 110.678 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 33.1 mmtt -63.37 148.09 49.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.949 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HD3' ' H ' ' A' ' 74' ' ' ASP . 6.2 tmtt? -74.75 156.39 36.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.993 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.548 ' H ' ' HD3' ' A' ' 73' ' ' LYS . 5.1 t70 -55.61 143.88 28.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.395 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.24 -52.92 4.12 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.622 -0.991 . . . . 10.0 110.622 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.92 -42.49 76.72 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.22 -47.85 84.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.751 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -66.5 -24.43 66.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 10.0 111.62 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -74.96 -30.87 61.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.434 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -65.67 -48.83 70.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.622 -0.51 . . . . 10.0 109.622 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -62.92 -33.57 75.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.075 0.464 . . . . 10.0 110.852 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.42 -18.62 65.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.351 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.8 30.19 8.65 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.991 -0.844 . . . . 10.0 110.991 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.0 mt -130.85 173.83 10.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.778 0.323 . . . . 10.0 110.27 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.408 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 57.0 t30 -92.87 -165.76 1.4 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.615 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.408 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 41.4 m-85 63.46 68.01 0.95 Allowed Pre-proline 0 C--O 1.233 0.222 0 CA-C-O 121.022 0.439 . . . . 10.0 110.595 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.6 23.82 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.65 2.233 . . . . 10.0 112.698 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.97 13.7 9.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 10.0 110.578 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 20.3 mt -92.17 118.98 68.4 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 10.0 110.964 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 89' ' ' LEU . 3.8 Cg_exo -77.77 69.08 7.51 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.062 2.508 . . . . 10.0 110.689 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 62' ' ' THR . 66.9 t -79.72 115.86 22.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.204 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 3.2 t -98.87 148.11 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.249 -0.432 . . . . 10.0 109.998 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.753 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -105.02 101.78 11.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.767 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 55.5 t0 -86.16 88.65 7.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.089 0.471 . . . . 10.0 110.633 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -64.58 106.94 1.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.989 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.91 -2.33 69.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.814 -0.707 . . . . 10.0 112.924 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.98 55.45 19.23 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.355 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.24 -45.01 95.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.023 0.439 . . . . 10.0 110.608 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.452 ' HB ' ' HZ ' ' A' ' 31' ' ' PHE . 31.8 mm -80.46 -39.09 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.108 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -59.33 -43.93 92.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.521 -0.763 . . . . 10.0 111.899 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -75.17 -36.7 61.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.889 0.376 . . . . 10.0 111.294 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.6 m -65.38 -34.66 78.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.559 0.577 . . . . 10.0 112.559 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.421 HD21 HG21 ' A' ' 120' ' ' VAL . 93.6 mt -101.19 5.29 42.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.524 0.202 . . . . 10.0 111.5 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 53.05 69.51 0.69 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.578 0.704 . . . . 10.0 111.311 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 100' ' ' ALA . 86.1 mt -103.47 114.99 44.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.413 -0.812 . . . . 10.0 111.033 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.8 p -121.37 19.48 11.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.46 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' B' ' 109' ' ' TYR . 11.0 p -163.54 149.73 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.838 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 31' ' ' PHE . 72.0 m-85 -117.33 156.81 48.5 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 126' ' ' GLY . 7.0 Cg_endo -91.13 144.95 14.5 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.937 -1.276 . . . . 10.0 111.431 -1.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.8 m -110.08 129.54 55.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.477 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -107.52 107.05 17.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.935 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.797 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -97.05 116.81 29.93 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.484 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.2 tp -94.55 107.38 19.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.823 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.3 127.28 46.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 117' ' ' ASP . . . -66.33 165.38 39.66 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.909 -0.662 . . . . 10.0 112.124 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -69.68 8.94 0.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.225 0.454 . . . . 10.0 112.225 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 115' ' ' GLY . 6.9 t70 -103.92 -20.02 14.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.295 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 100.96 46.28 1.77 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.989 -0.624 . . . . 10.0 112.421 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -154.14 166.71 32.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.436 0.16 . . . . 10.0 110.599 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.421 HG21 HD21 ' A' ' 103' ' ' LEU . 16.5 t -74.66 111.6 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.071 0.462 . . . . 10.0 110.839 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -93.82 -35.97 12.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.989 -0.551 . . . . 10.0 110.689 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -157.53 153.71 27.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.154 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 tp -136.93 121.52 24.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.069 0.461 . . . . 10.0 110.658 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.52 120.13 63.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.358 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -117.1 114.96 24.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.004 -0.369 . . . . 10.0 110.004 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.52 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 154.69 -87.43 0.13 Allowed Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.26 -0.971 . . . . 10.0 112.739 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.6 m -167.18 146.56 5.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.5 pt -127.24 179.99 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.576 0.227 . . . . 10.0 110.821 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -142.99 171.58 13.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.704 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -61.15 -44.5 97.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.927 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.26 95.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.978 0.418 . . . . 10.0 110.236 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -63.56 -39.3 94.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.488 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.85 94.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 10.0 110.349 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.78 -36.66 84.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.422 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.1 70.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.767 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.09 -42.47 89.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.991 -0.55 . . . . 10.0 111.388 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.4 pt -76.0 -10.53 13.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.213 0.53 . . . . 10.0 110.773 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -91.32 -52.11 4.97 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 25.7 t0 -143.61 110.14 5.27 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.102 -0.954 . . . . 10.0 109.556 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 38.4 Cg_endo -66.51 -7.21 17.15 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.964 2.443 . . . . 10.0 112.217 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -86.83 4.88 39.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.304 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.82 109.41 21.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.719 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.495 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 4.9 t70 -115.38 141.48 47.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.166 -0.921 . . . . 10.0 112.56 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtt . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 111.962 0.356 . . . . 10.0 111.962 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.89 -79.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 10.0 111.712 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 59.4 tp -87.89 -69.26 0.7 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.358 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 60.01 35.11 21.48 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.281 0.562 . . . . 10.0 110.674 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.86 162.76 34.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.275 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 30.3 m120 62.56 -155.95 0.34 Allowed 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.708 0.63 . . . . 10.0 110.897 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -110.22 20.25 18.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.261 0.553 . . . . 10.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -85.39 36.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.801 -0.636 . . . . 10.0 111.629 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -158.93 136.36 7.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.67 148.38 82.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.951 2.434 . . . . 10.0 112.159 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.58 -39.19 76.0 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.344 2.696 . . . . 10.0 113.591 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -68.59 -12.54 61.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 10.0 111.956 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -117.51 -0.15 11.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.249 0.547 . . . . 10.0 110.319 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.78 -19.21 24.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.354 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.54 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 16.5 m-85 -127.21 124.79 39.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.448 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 t -109.66 91.17 9.95 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.519 -0.549 . . . . 10.0 109.519 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 3.4 Cg_exo -75.51 103.98 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.928 2.419 . . . . 10.0 112.785 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -100.71 115.0 29.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.01 117.06 25.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.673 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.11 99.92 9.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.015 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.519 HG21 ' HE2' ' B' ' 124' ' ' TYR . 65.8 t -94.52 118.29 40.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.961 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.15 -166.48 1.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.915 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -89.15 -36.63 15.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.896 0.379 . . . . 10.0 110.657 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -71.24 -40.26 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.899 -0.592 . . . . 10.0 110.96 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.428 ' HA2' ' CE2' ' B' ' 85' ' ' TYR . . . -177.64 -172.72 42.44 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.784 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.15 135.9 32.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -122.36 114.06 20.24 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.511 -0.551 . . . . 10.0 109.511 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.435 HG22 ' HD1' ' B' ' 30' ' ' PHE . 7.7 p -92.31 126.79 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.117 0.484 . . . . 10.0 111.273 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -127.5 88.74 2.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.159 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 5.0 p90 -93.31 115.74 28.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.024 0.44 . . . . 10.0 110.676 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 -75.17 115.71 15.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.554 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mt -94.68 135.8 27.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.911 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.8 150.31 48.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.155 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.53 79.71 2.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.203 0.525 . . . . 10.0 111.757 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.48 -26.65 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -103.77 150.99 23.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.227 -0.657 . . . . 10.0 109.227 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -142.39 146.18 34.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.822 0.344 . . . . 10.0 111.186 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' B' ' 99' ' ' TYR . 57.0 mtt -116.51 154.73 29.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.648 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.631 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 59.2 m-85 -96.48 129.81 43.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.39 -0.596 . . . . 10.0 109.39 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -60.6 -28.58 68.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.958 0.409 . . . . 10.0 111.255 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.97 9.8 21.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.205 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.631 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 38.9 mmtt -127.87 -7.68 5.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 10.0 111.748 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 89.4 mt -83.75 119.69 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.854 0.359 . . . . 10.0 110.188 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' B' ' 98' ' ' THR . 40.3 t -105.19 126.22 60.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.317 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.31 132.39 3.4 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.272 -0.731 . . . . 10.0 111.272 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -159.12 150.46 20.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.863 0.331 . . . . 10.0 111.129 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' B' ' 94' ' ' LYS . 10.2 t -153.66 125.27 7.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.34 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.451 ' HB2' ' HD2' ' B' ' 49' ' ' PRO . 13.3 p30 -178.54 160.76 1.13 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.344 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.464 ' HG3' HG21 ' B' ' 89' ' ' VAL . 55.3 Cg_endo -74.23 -56.54 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.215 1.943 . . . . 10.0 112.093 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.42 69.9 1.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.981 0.42 . . . . 10.0 111.138 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 t70 69.18 9.26 7.27 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.13 0.789 . . . . 10.0 113.13 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.443 ' HA ' HD13 ' B' ' 52' ' ' LEU . 1.4 mm? -81.24 59.9 4.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.043 0.449 . . . . 10.0 111.945 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 45.0 tp -125.87 138.58 53.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.78 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.57 -79.8 0.44 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.571 -0.823 . . . . 10.0 111.667 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 12.3 pt20 -165.72 145.4 5.38 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 23.7 Cg_exo -65.39 107.84 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.545 2.163 . . . . 10.0 111.772 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -83.62 92.65 7.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.467 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -77.27 145.54 37.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.013 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 53.9 m -77.62 -18.01 57.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.811 0.3 . . . . 10.0 111.811 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? 74.54 137.8 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.785 0.678 . . . . 10.0 112.558 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.99 -121.78 2.78 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.817 -0.913 . . . . 10.0 110.817 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -130.15 155.01 46.92 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -87.96 125.55 34.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.075 0.464 . . . . 10.0 110.838 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 71' ' ' ARG . 12.8 ttpp -102.7 131.9 49.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.452 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -73.79 146.73 44.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -145.2 173.78 11.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.803 0.335 . . . . 10.0 110.918 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -108.86 -29.38 8.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.858 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -108.12 -35.14 6.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 4.1 m-30 -94.11 -6.11 45.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.355 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.81 -79.97 1.52 Allowed Glycine 0 C--O 1.227 -0.296 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.435 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' B' ' 64' ' ' LYS . 5.9 ptp180 -176.71 122.61 0.15 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 122.698 0.399 . . . . 10.0 110.352 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -143.17 162.27 36.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.551 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 11.5 m -70.77 125.42 26.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.355 -0.609 . . . . 10.0 109.355 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -125.95 156.25 35.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.43 0.634 . . . . 10.0 112.312 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' TYR . . . . . 0.473 ' HB3' ' O ' ' B' ' 78' ' ' GLU . 53.7 m-85 -117.6 132.21 56.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -122.01 6.66 9.79 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.065 0.765 . . . . 10.0 113.065 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -176.25 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.83 -0.804 . . . . 10.0 108.83 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 1.0 OUTLIER -81.46 136.63 35.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.79 -1.095 . . . . 10.0 109.424 179.451 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -164.05 115.99 1.36 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 10.0 111.053 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -157.3 122.54 4.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.248 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.41 128.68 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.032 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.82 137.59 40.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.438 -0.347 . . . . 10.0 110.234 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -116.4 107.64 46.77 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.802 0.334 . . . . 10.0 111.528 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -91.03 127.47 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.036 2.491 . . . . 10.0 111.335 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' TYR . . . . . 0.428 ' CE2' ' HA2' ' B' ' 25' ' ' GLY . 21.9 m-85 -74.46 148.07 41.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.517 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.1 -5.88 57.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.175 0.512 . . . . 10.0 110.312 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -155.7 142.32 18.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.653 -0.703 . . . . 10.0 109.748 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.45 97.78 11.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.984 0.421 . . . . 10.0 110.74 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.464 HG21 ' HG3' ' B' ' 49' ' ' PRO . 13.6 m -128.24 154.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.685 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.26 7.18 72.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.628 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.22 144.7 92.68 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.89 107.06 1.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.444 2.096 . . . . 10.0 111.97 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.32 135.19 36.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' B' ' 47' ' ' THR . 40.7 tttt -88.7 141.58 28.39 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.605 -0.438 . . . . 10.0 110.328 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 64.6 tp -108.96 114.25 27.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.942 0.401 . . . . 10.0 110.897 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 47.4 t -112.47 122.03 65.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 65.6 mt -127.68 145.83 50.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.006 0.432 . . . . 10.0 111.536 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' THR . . . . . 0.744 ' HB ' ' HB ' ' B' ' 44' ' ' VAL . 24.1 m -147.87 122.93 10.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 16.4 m-85 -107.0 134.78 49.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.875 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 9.2 tp60 -140.61 126.01 18.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.428 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -165.87 -154.74 8.33 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.229 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.1 m -150.1 175.38 11.78 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -113.93 145.7 41.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.93 -2.41 12.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.791 0.663 . . . . 10.0 112.791 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.99 0.2 45.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.134 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.2 -21.13 31.8 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.808 -0.71 . . . . 10.0 112.082 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 3.2 t -64.15 145.15 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.79 0.329 . . . . 10.0 110.275 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 t -134.08 106.33 7.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.013 0.435 . . . . 10.0 110.794 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.5 ' HA ' HG23 ' A' ' 107' ' ' VAL . 31.3 p90 -88.17 146.68 38.71 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.821 0.343 . . . . 10.0 111.735 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 107' ' ' VAL . 63.7 Cg_endo -73.08 163.21 38.83 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.851 2.368 . . . . 10.0 111.782 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' B' ' 99' ' ' TYR . 57.0 Cg_endo -73.04 94.69 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.223 1.949 . . . . 10.0 111.591 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.56 133.7 30.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.33 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ASP . . . . . 0.587 ' HB3' ' HE1' ' A' ' 70' ' ' HIS . 4.8 p-10 -106.85 149.14 27.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.896 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.6 m -151.4 119.63 6.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.512 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.45 132.16 44.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.272 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -116.04 139.82 49.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.065 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.25 124.74 47.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.644 -0.707 . . . . 10.0 109.781 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.8 66.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.398 0.618 . . . . 10.0 109.925 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -73.19 -24.46 60.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.739 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 122.75 73.41 0.28 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.611 -0.804 . . . . 10.0 112.351 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -140.35 -20.15 0.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.103 0.477 . . . . 10.0 110.496 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.08 -65.29 4.0 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.911 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.99 123.66 33.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.305 -0.257 . . . . 10.0 110.305 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.519 ' HE2' HG21 ' B' ' 21' ' ' VAL . 56.4 m-85 -132.05 156.13 46.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.26 149.22 22.53 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.211 -0.449 . . . . 10.0 109.796 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.12 120.53 7.9 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.422 2.081 . . . . 10.0 112.257 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -80.87 75.28 7.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.19 0.519 . . . . 10.0 110.652 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 71.4 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.357 -0.83 . . . . 10.0 109.971 179.764 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 m -125.39 61.85 37.24 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 112.043 0.386 . . . . 10.0 112.043 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.28 -38.34 12.14 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.932 1.755 . . . . 10.0 111.857 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -62.61 -43.69 98.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.871 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -42.79 95.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.626 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -61.87 -30.3 70.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.034 0.445 . . . . 10.0 110.703 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 m -84.12 -7.14 59.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.187 -0.46 . . . . 10.0 111.456 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -91.24 -8.15 49.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.14 0.495 . . . . 10.0 109.907 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.25 110.7 2.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.418 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.47 140.61 30.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.736 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.8 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 25.2 p -81.2 174.06 11.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.324 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.53 -10.86 58.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.239 0.542 . . . . 10.0 110.135 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -91.95 -4.55 54.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.194 -0.912 . . . . 10.0 109.421 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 79.68 9.98 1.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.067 -0.97 . . . . 10.0 111.836 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 15' ' ' ARG . 32.8 mtt85 -94.64 144.79 28.5 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 10.0 109.998 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.78 148.93 78.16 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.242 1.962 . . . . 10.0 111.387 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.79 -8.52 15.38 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -24.04 52.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.795 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.631 HG23 ' HD1' ' A' ' 20' ' ' TYR . 19.2 m -61.53 -21.03 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.039 0.447 . . . . 10.0 111.709 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.631 ' HD1' HG23 ' A' ' 19' ' ' VAL . 35.5 m-85 -131.34 23.66 4.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.257 0.551 . . . . 10.0 110.42 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.7 mt -135.33 56.07 1.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.451 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HG2' ' H ' ' A' ' 23' ' ' LYS . 31.6 tttp -155.94 -179.71 8.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.36 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.484 ' H ' ' HG2' ' A' ' 22' ' ' LYS . 30.2 mttp 69.67 14.8 8.16 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.891 0.7 . . . . 10.0 112.891 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.78 39.18 29.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.013 0.435 . . . . 10.0 111.054 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -107.96 145.29 31.1 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.153 -0.476 . . . . 10.0 111.176 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.17 143.74 94.83 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.687 2.258 . . . . 10.0 111.543 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.516 ' HB ' ' HB ' ' A' ' 114' ' ' ILE . 1.6 m -116.41 143.49 45.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.664 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.636 HD23 ' HG ' ' A' ' 60' ' ' LEU . 28.3 tp -124.01 105.7 9.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.97 0.414 . . . . 10.0 110.047 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 67.6 mt -93.44 117.52 37.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.867 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.736 ' HE2' HG22 ' A' ' 62' ' ' THR . 17.4 ttpt -112.61 119.98 40.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.818 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 110' ' ' SER . 3.9 m-85 -88.7 146.92 24.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.569 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -148.94 166.98 26.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.859 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.28 142.81 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.627 -0.509 . . . . 10.0 109.627 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -67.44 -63.85 0.98 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.561 ' CZ2' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.5 64.16 4.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.494 0.553 . . . . 10.0 112.494 -178.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.6 t -131.94 135.62 26.94 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.076 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.709 ' HD3' ' HE1' ' B' ' 69' ' ' PHE . 33.3 Cg_endo -64.45 -49.54 3.33 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.517 2.145 . . . . 10.0 112.344 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' B' ' 108' ' ' CYS . 78.0 mt -63.17 -44.26 95.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.239 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.434 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 74.9 m -66.33 -31.16 71.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 10.0 111.389 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -62.86 -46.78 86.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.99 -38.68 79.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.93 0.395 . . . . 10.0 110.676 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -66.88 -24.74 66.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.859 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 39' ' ' CYS . 24.1 mt -55.27 -44.56 75.74 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.822 0.344 . . . . 10.0 111.416 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.48 -33.42 81.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.577 -0.821 . . . . 10.0 111.128 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -68.85 -40.01 79.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.355 -0.423 . . . . 10.0 110.662 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.4 m -55.19 -47.55 75.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.424 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.86 -44.14 86.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.061 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -60.63 -44.49 96.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.03 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -71.35 -37.89 71.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 10.0 111.698 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.91 -22.08 66.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.041 0.448 . . . . 10.0 111.234 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -88.55 -6.69 57.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.629 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.2 135.5 50.69 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.769 0.319 . . . . 10.0 110.369 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.42 -33.93 68.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.925 -0.579 . . . . 10.0 112.214 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -73.53 -37.75 65.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.968 0.413 . . . . 10.0 110.919 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -78.21 -10.32 59.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.925 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m -75.64 5.36 6.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.913 0.387 . . . . 10.0 111.53 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -87.04 -15.22 39.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.047 0.451 . . . . 10.0 110.52 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.44 148.4 51.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 10.0 109.814 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -82.87 88.19 6.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.763 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.636 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -81.48 121.54 26.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.542 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.2 pt -133.73 157.62 42.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.991 0.424 . . . . 10.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.736 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -111.83 117.55 33.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.166 -0.47 . . . . 10.0 109.811 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 92' ' ' VAL . 21.5 t -115.96 143.35 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.863 0.364 . . . . 10.0 111.337 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.39 146.76 38.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 4.7 m -104.17 100.9 23.28 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.639 ' HG3' HG22 ' A' ' 93' ' ' THR . 29.9 Cg_endo -62.75 118.51 5.41 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.758 2.305 . . . . 10.0 112.067 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.88 -12.71 67.01 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.965 -0.636 . . . . 10.0 112.539 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.593 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 7.5 t80 -96.92 144.43 26.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.158 -0.312 . . . . 10.0 110.158 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.481 HD11 HG22 ' B' ' 112' ' ' VAL . 0.8 OUTLIER 60.4 30.41 19.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.737 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.7 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 2.6 t60 66.37 19.0 10.97 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.653 -0.703 . . . . 10.0 112.811 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.561 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 2.1 mm-40 -77.6 -175.58 3.91 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 72' ' ' LYS . 48.1 mmtt -65.45 127.89 33.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.795 0.331 . . . . 10.0 111.039 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -66.46 163.41 18.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.961 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.96 125.62 24.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.549 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.97 -17.32 35.38 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -107.23 -41.68 5.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.029 0.442 . . . . 10.0 109.867 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -62.62 -50.92 69.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.594 . . . . 10.0 112.496 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.91 -28.07 69.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.047 0.451 . . . . 10.0 110.687 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 8.1 mmmt -75.55 -30.69 59.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.681 -0.691 . . . . 10.0 109.911 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.436 ' HZ3' ' HE3' ' A' ' 72' ' ' LYS . 5.2 t-105 -65.25 -50.04 67.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.526 -0.761 . . . . 10.0 109.499 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.405 ' HA ' HD12 ' A' ' 84' ' ' LEU . 74.9 t80 -63.89 -30.02 71.15 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.079 -0.51 . . . . 10.0 111.107 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.46 -24.1 67.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.178 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.14 8.15 41.51 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.105 -0.569 . . . . 10.0 111.98 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 81' ' ' TYR . 35.5 mt -95.19 -179.65 4.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.797 0.332 . . . . 10.0 110.879 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -97.93 -178.48 4.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.678 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 66.97 84.06 0.17 Allowed Pre-proline 0 N--CA 1.464 0.269 0 O-C-N 123.647 0.592 . . . . 10.0 112.053 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.1 37.96 0.72 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.633 2.222 . . . . 10.0 111.663 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -150.02 25.08 0.83 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.694 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 19.4 mt -93.36 117.9 67.51 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.545 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 89' ' ' LEU . 6.1 Cg_exo -74.56 66.97 5.59 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.745 2.297 . . . . 10.0 111.489 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 62' ' ' THR . 60.7 t -86.08 117.91 31.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.772 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.8 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 8.3 t -103.2 142.45 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.131 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.639 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -101.64 106.4 17.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.123 -179.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.456 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 40.3 t0 -93.48 91.35 7.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.243 0.545 . . . . 10.0 110.267 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.03 113.72 4.67 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.22 -24.64 26.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.857 -0.687 . . . . 10.0 113.06 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.81 44.15 3.98 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.513 -0.851 . . . . 10.0 111.413 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -33.72 74.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 10.0 110.627 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.2 mm -92.27 -43.45 13.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.224 -0.444 . . . . 10.0 109.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.831 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -60.51 -44.95 95.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.688 -0.687 . . . . 10.0 112.394 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -68.15 -40.77 82.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.9 m -66.54 -22.12 66.16 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.57 5.06 24.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.464 -0.334 . . . . 10.0 110.669 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.3 t30 52.37 50.08 19.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.665 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.831 HD12 ' HA ' ' A' ' 100' ' ' ALA . 98.3 mt -75.26 109.38 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.258 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.4 p -115.59 -10.32 11.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.586 -0.733 . . . . 10.0 112.025 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.859 HG23 ' HB3' ' B' ' 109' ' ' TYR . 7.4 p -147.14 142.1 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.562 0.22 . . . . 10.0 111.293 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' B' ' 108' ' ' CYS . 22.1 m-85 -107.24 153.99 40.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.653 -0.499 . . . . 10.0 109.653 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.07 159.16 83.63 Favored 'Cis proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.339 -1.525 . . . . 10.0 112.058 -0.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 13.0 m -122.18 124.3 43.53 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -108.76 104.2 13.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.02 0.438 . . . . 10.0 110.898 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.19 115.47 29.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.164 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 25.0 tp -95.69 112.62 24.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.584 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 27' ' ' THR . 3.4 mp -98.5 127.25 51.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.3 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.79 171.98 29.66 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 116.016 -0.538 . . . . 10.0 112.618 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -65.58 -14.42 61.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.256 0.465 . . . . 10.0 112.256 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.24 0.95 57.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 10.0 111.87 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.89 37.74 15.41 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.82 -0.705 . . . . 10.0 113.191 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -132.99 146.96 52.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.785 -0.244 . . . . 10.0 110.666 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.6 111.48 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.098 -0.334 . . . . 10.0 110.098 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -96.44 -35.87 11.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.357 -0.383 . . . . 10.0 111.512 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -142.35 150.27 40.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.628 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 tp -144.21 116.94 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 t -119.48 130.76 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.844 0.354 . . . . 10.0 111.637 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -101.96 107.23 18.31 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.158 -0.682 . . . . 10.0 109.158 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.42 -141.93 11.92 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.488 -0.645 . . . . 10.0 111.488 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.7 m -119.5 147.22 44.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.84 0.352 . . . . 10.0 111.066 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.9 pt -104.72 176.57 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.264 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -146.6 171.67 14.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.443 -0.344 . . . . 10.0 110.57 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -61.53 -46.88 88.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.932 0.345 . . . . 10.0 111.932 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.65 88.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 10.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -66.8 -39.19 87.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.351 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.426 ' O ' HG13 ' A' ' 137' ' ' ILE . . . -61.64 -42.88 99.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 10.0 109.75 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.75 -35.92 82.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.603 . . . . 10.0 110.41 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.7 -39.29 88.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 10.0 109.975 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 140' ' ' PRO . 27.5 tp -64.38 -36.32 83.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.585 -0.734 . . . . 10.0 110.523 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 133' ' ' ALA . 85.2 mt -67.11 -29.44 46.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.022 -0.536 . . . . 10.0 109.763 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -83.38 -50.34 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.793 -0.64 . . . . 10.0 111.246 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.491 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 2.8 t70 -144.43 120.67 6.24 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.8 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 139' ' ' ASP . 13.5 Cg_exo -71.24 -6.29 18.88 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.004 2.469 . . . . 10.0 112.707 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -94.11 -3.15 51.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.925 0.393 . . . . 10.0 110.897 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.13 73.44 6.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.526 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -74.2 155.43 38.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.25 -0.881 . . . . 10.0 111.513 -179.522 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 112.203 0.446 . . . . 10.0 112.203 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.3 -10.14 45.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 25.2 tp -142.41 -77.92 0.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.126 -0.23 . . . . 10.0 111.143 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 57.71 39.09 27.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.827 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.13 166.3 31.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.793 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.3 m120 68.4 -172.32 0.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.776 0.673 . . . . 10.0 111.865 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -99.69 13.9 32.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.36 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.43 -13.94 59.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.446 0.535 . . . . 10.0 112.446 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.08 133.27 23.44 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.673 0.273 . . . . 10.0 111.734 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.4 151.41 85.63 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 123.097 2.532 . . . . 10.0 112.453 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.677 ' HG3' ' HB ' ' A' ' 107' ' ' VAL . 11.3 Cg_endo -53.86 -33.75 72.84 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.746 2.964 . . . . 10.0 113.707 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -55.75 -28.15 54.44 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.38 -11.4 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 10.0 111.075 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' B' ' 11' ' ' PRO . . . -75.01 -7.61 54.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.275 -0.421 . . . . 10.0 111.932 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.468 ' HE1' HG23 ' B' ' 32' ' ' ILE . 21.4 m-85 -122.19 129.84 52.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.944 0.402 . . . . 10.0 111.364 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' B' ' 31' ' ' ARG . 42.1 t -114.16 92.06 25.41 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.13 102.0 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.5 2.133 . . . . 10.0 113.428 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -95.81 110.56 22.71 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' B' ' 19' ' ' LEU . 2.8 mm? -92.57 120.55 33.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.477 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.26 100.8 8.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.614 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.11 118.29 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.194 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.67 -170.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 10.0 110.347 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.65 -22.32 20.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.009 0.433 . . . . 10.0 111.608 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -86.73 -39.23 16.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.156 0.503 . . . . 10.0 110.272 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.91 -171.4 36.89 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.663 -0.699 . . . . 10.0 111.629 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -107.75 129.59 61.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.338 -0.616 . . . . 10.0 109.338 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -115.89 117.98 31.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.813 0.339 . . . . 10.0 110.186 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.509 HG22 ' HD1' ' B' ' 30' ' ' PHE . 7.8 p -101.88 118.02 48.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.277 0.56 . . . . 10.0 110.553 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -121.63 90.96 3.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.545 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.509 ' HD1' HG22 ' B' ' 28' ' ' VAL . 4.1 p90 -94.2 119.18 32.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.204 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.448 ' HB2' ' HB ' ' B' ' 16' ' ' VAL . 62.4 mtm-85 -77.0 118.38 19.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.232 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.468 HG23 ' HE1' ' B' ' 15' ' ' PHE . 53.8 mt -92.06 136.49 24.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.354 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 146.07 51.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.403 -0.362 . . . . 10.0 110.284 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.21 92.76 0.57 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.991 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.49 -16.71 1.12 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.404 -0.678 . . . . 10.0 111.404 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -105.78 151.95 23.83 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' B' ' 75' ' ' TYR . 33.0 p90 -143.98 139.9 29.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.945 0.402 . . . . 10.0 111.191 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' MET . . . . . 0.415 ' HA ' ' HA3' ' B' ' 101' ' ' GLY . 43.8 mtt -110.41 150.5 28.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.99 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.549 ' O ' HG13 ' B' ' 43' ' ' ILE . 90.9 m-85 -92.09 116.52 29.0 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.77 -0.456 . . . . 10.0 109.77 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.424 ' OE1' ' HA ' ' B' ' 60' ' ' LYS . 21.7 tt0 -61.32 -23.02 65.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.208 0.528 . . . . 10.0 111.331 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.8 -6.82 59.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.522 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -123.8 0.05 8.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.494 -0.321 . . . . 10.0 111.631 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.549 HG13 ' O ' ' B' ' 39' ' ' TYR . 92.9 mt -78.87 117.77 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.024 0.44 . . . . 10.0 109.817 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' B' ' 98' ' ' THR . 21.7 t -99.56 123.41 52.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.826 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -153.81 120.57 1.05 Allowed Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.643 -0.789 . . . . 10.0 111.995 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -160.46 140.47 11.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.808 0.337 . . . . 10.0 111.015 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' B' ' 94' ' ' LYS . 11.6 t -139.72 126.23 20.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.134 -0.484 . . . . 10.0 109.893 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.502 ' HB2' ' H ' ' B' ' 52' ' ' LEU . 28.2 p30 -174.56 158.36 2.45 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.426 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -74.26 -66.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.256 1.97 . . . . 10.0 111.072 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.64 53.79 1.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.129 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.489 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 0.3 OUTLIER 59.45 51.0 6.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.608 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.502 ' H ' ' HB2' ' B' ' 48' ' ' ASN . 0.6 OUTLIER -108.18 43.58 1.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.8 -0.637 . . . . 10.0 110.422 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' B' ' 83' ' ' PHE . 18.6 tp -107.45 144.64 34.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.092 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.63 -66.72 1.89 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.418 -0.896 . . . . 10.0 111.284 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 2.7 pp0? -171.63 149.7 2.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 122.596 0.358 . . . . 10.0 110.179 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 15.2 Cg_exo -70.81 106.47 1.86 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.495 2.13 . . . . 10.0 110.434 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -86.67 99.58 11.85 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.061 0.458 . . . . 10.0 111.376 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -84.59 157.91 21.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.799 -0.637 . . . . 10.0 110.352 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 50.2 m -86.72 -20.4 27.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.645 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.424 ' HA ' ' OE1' ' B' ' 40' ' ' GLN . 12.8 tmtt? 70.57 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.711 -0.677 . . . . 10.0 112.292 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.87 -127.8 6.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.21 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -116.69 158.88 23.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.624 0.249 . . . . 10.0 110.873 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.24 132.81 34.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' B' ' 71' ' ' ARG . 11.3 ttpp -114.47 127.01 55.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.508 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.88 149.56 46.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.548 -0.908 . . . . 10.0 108.548 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -146.56 171.02 15.72 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.935 -0.306 . . . . 10.0 111.382 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.98 -23.55 14.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.284 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -114.76 -40.74 3.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.887 0.375 . . . . 10.0 110.949 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.709 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 85.5 m-85 -87.68 -6.13 58.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.185 -0.462 . . . . 10.0 111.616 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.7 -73.55 2.07 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 121.105 -0.569 . . . . 10.0 112.16 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' B' ' 64' ' ' LYS . 5.9 ptp180 -173.92 122.89 0.33 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.862 0.465 . . . . 10.0 109.968 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -139.88 162.98 33.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.438 -0.346 . . . . 10.0 110.545 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -74.28 127.2 32.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.96 159.75 38.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.354 0.597 . . . . 10.0 112.091 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' B' ' 37' ' ' TYR . 16.7 m-85 -114.5 127.33 55.76 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.404 -1.332 . . . . 10.0 107.404 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -113.58 -3.79 13.58 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -173.89 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.599 . . . . 10.0 109.472 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -91.19 126.41 36.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.774 -1.103 . . . . 10.0 109.712 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -153.42 112.87 3.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.889 0.376 . . . . 10.0 111.173 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -145.94 119.41 9.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.381 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -127.87 120.95 55.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.069 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.19 134.57 44.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.66 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' PHE . . . . . 0.459 ' HB3' HD11 ' B' ' 53' ' ' LEU . 29.8 m-85 -113.81 98.91 48.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.092 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.14 127.96 3.54 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.949 2.433 . . . . 10.0 111.782 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -74.04 148.29 42.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.881 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.66 -5.19 32.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.465 0.65 . . . . 10.0 109.754 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -134.95 129.48 34.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.166 -0.925 . . . . 10.0 108.785 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.9 80.41 4.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.237 0.542 . . . . 10.0 111.307 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 4.1 m -128.4 143.26 41.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.557 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.19 54.04 4.67 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.336 -0.706 . . . . 10.0 111.336 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -105.78 153.84 39.74 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.68 -0.26 . . . . 10.0 110.47 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.7 141.91 42.52 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.44 2.093 . . . . 10.0 110.436 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -132.57 154.14 50.31 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.232 0.456 . . . . 10.0 112.232 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' B' ' 47' ' ' THR . 43.1 tttt -98.25 150.83 21.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 10.0 109.658 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' B' ' 47' ' ' THR . 60.4 tp -118.97 114.32 22.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.584 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 42.0 t -104.19 114.82 44.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.058 -0.519 . . . . 10.0 109.987 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 93.0 mt -125.1 136.77 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.402 . . . . 10.0 111.154 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' THR . . . . . 0.566 HG23 ' HB3' ' B' ' 113' ' ' ASP . 19.1 m -133.69 118.04 17.67 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.132 -0.485 . . . . 10.0 109.839 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 39.5 m-85 -98.62 109.38 22.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.462 -0.335 . . . . 10.0 111.335 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.73 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 0.8 OUTLIER -123.94 128.87 50.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.444 -0.344 . . . . 10.0 110.945 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -174.49 -155.64 12.58 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.851 -0.69 . . . . 10.0 111.617 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 73.5 m -155.56 176.99 11.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.3 -0.259 . . . . 10.0 110.3 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -116.98 145.03 43.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.89 -10.68 22.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.442 0.534 . . . . 10.0 112.442 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.45 -0.76 55.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.517 -0.31 . . . . 10.0 111.785 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.7 20.63 23.8 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.669 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 4.6 t -103.27 136.73 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.436 -0.579 . . . . 10.0 109.436 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 17.4 t -122.57 97.97 5.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.683 0.277 . . . . 10.0 110.767 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.859 ' HB3' HG23 ' A' ' 107' ' ' VAL . 53.2 p90 -84.23 143.94 43.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.859 0.361 . . . . 10.0 111.361 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.622 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 42.4 Cg_endo -67.31 163.64 33.67 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.586 2.191 . . . . 10.0 111.241 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.73 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 63.7 Cg_endo -75.74 80.56 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.372 2.048 . . . . 10.0 111.86 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.481 HG22 HD11 ' A' ' 69' ' ' LEU . 12.8 t -60.84 108.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.69 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ASP . . . . . 0.566 ' HB3' HG23 ' B' ' 98' ' ' THR . 20.9 p-10 -100.41 130.41 46.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.514 0.673 . . . . 10.0 111.833 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.456 HG21 ' HB3' ' B' ' 126' ' ' PRO . 0.2 OUTLIER -128.6 124.86 36.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.393 -0.822 . . . . 10.0 109.951 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.39 130.26 49.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.077 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -114.86 149.17 37.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.452 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.02 114.28 28.26 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.98 -0.748 . . . . 10.0 108.98 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 23.3 mm -85.61 99.86 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.212 0.529 . . . . 10.0 111.057 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -108.75 -6.66 15.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.529 -0.76 . . . . 10.0 110.195 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.7 97.57 2.51 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.509 -0.769 . . . . 10.0 111.191 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -153.48 -15.94 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.824 0.345 . . . . 10.0 111.504 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.95 -76.91 1.49 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.697 -0.763 . . . . 10.0 111.891 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.76 145.83 28.61 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.311 -0.255 . . . . 10.0 110.311 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -136.88 146.37 45.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 10.0 111.024 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.21 147.71 38.43 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.098 -0.501 . . . . 10.0 109.695 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' PRO . . . . . 0.456 ' HB3' HG21 ' B' ' 114' ' ' THR . 36.7 Cg_endo -66.9 136.92 43.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.401 2.067 . . . . 10.0 111.74 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -91.86 70.28 5.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.137 0.494 . . . . 10.0 111.304 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.602 -0.713 . . . . 10.0 109.741 179.733 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 110.067 -0.346 . . . . 10.0 110.067 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 m -132.05 65.89 76.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 111.981 0.363 . . . . 10.0 111.981 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.91 -40.29 45.13 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.38 2.053 . . . . 10.0 111.617 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -60.54 -38.35 84.19 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 115.949 -0.568 . . . . 10.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.9 m -67.45 -47.22 70.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.703 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.55 -35.25 75.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 10.0 111.005 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m -84.27 -4.73 59.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.437 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.6 m -90.15 -18.6 25.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.384 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -67.59 124.42 23.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.706 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 10' ' ' LYS . 2.1 mppt? -107.77 151.91 25.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.089 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 24.8 p -84.74 174.32 9.99 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.474 -0.565 . . . . 10.0 109.474 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.12 -7.87 33.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.129 0.49 . . . . 10.0 110.515 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.496 ' OD2' ' HD2' ' A' ' 15' ' ' ARG . 28.2 t70 -95.96 1.71 53.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.351 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.0 t30 75.45 16.5 2.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.496 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 24.6 mtt180 -103.89 135.42 19.36 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.037 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.61 145.26 95.22 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.782 2.321 . . . . 10.0 111.551 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.37 -9.7 27.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 10.0 112.043 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.519 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -58.73 -19.9 44.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.394 -0.367 . . . . 10.0 111.817 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.499 HG23 ' HD2' ' A' ' 20' ' ' TYR . 31.3 m -66.21 -16.02 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.027 0.441 . . . . 10.0 111.383 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.499 ' HD2' HG23 ' A' ' 19' ' ' VAL . 19.7 m-85 -127.07 22.55 6.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.572 0.701 . . . . 10.0 109.34 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 17.1 mt -134.02 34.12 3.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.405 -0.816 . . . . 10.0 110.428 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -127.7 176.08 7.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.478 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt 68.18 17.39 9.38 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.504 -0.771 . . . . 10.0 112.53 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 51.51 43.39 29.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.509 -0.768 . . . . 10.0 112.077 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -103.28 145.5 30.72 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.832 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.19 131.83 47.51 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.715 2.277 . . . . 10.0 111.066 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 114' ' ' ILE . 1.3 m -99.79 136.22 40.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.905 0.384 . . . . 10.0 111.226 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.444 HD21 ' HZ3' ' A' ' 111' ' ' TRP . 12.1 tp -117.74 99.58 7.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 70.7 mt -91.87 122.88 43.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 10.0 111.147 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' HE2' HG22 ' A' ' 62' ' ' THR . 3.9 tmmm? -117.24 121.82 42.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.495 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.548 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 5.7 m-85 -95.92 134.49 38.85 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.594 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -134.97 -179.11 5.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.064 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 108' ' ' TYR . . . -134.09 150.05 51.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.223 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.99 -40.86 16.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.066 0.46 . . . . 10.0 110.497 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.473 ' HZ2' ' HE2' ' A' ' 72' ' ' LYS . 27.3 m0 -86.75 65.61 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.98 -0.555 . . . . 10.0 111.466 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.1 t -161.18 129.34 2.87 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.223 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 41.8 Cg_endo -71.13 -41.76 2.43 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.571 2.181 . . . . 10.0 112.094 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.57 -43.21 97.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.928 0.394 . . . . 10.0 111.495 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.8 m -69.29 -23.1 63.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.269 -0.423 . . . . 10.0 111.077 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.6 tp -66.64 -40.54 88.78 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.112 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.45 -34.85 68.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.105 0.479 . . . . 10.0 110.308 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.67 -32.21 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.634 -0.712 . . . . 10.0 111.115 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.2 mt -56.25 -42.51 77.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.787 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.77 -36.82 92.75 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.909 -0.662 . . . . 10.0 111.475 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -69.9 -39.59 76.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.361 . . . . 10.0 110.073 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.6 m -61.61 -45.07 95.64 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.431 -0.581 . . . . 10.0 109.431 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HG3' ' HB3' ' A' ' 86' ' ' TYR . 4.3 tm-20 -61.1 -35.13 76.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.519 -0.764 . . . . 10.0 110.375 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -72.33 -46.03 57.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.729 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -63.71 -33.12 74.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 10.0 111.421 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.06 -13.39 57.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.7 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -105.57 -3.41 22.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.375 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 18.0 t70 -69.39 144.66 53.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.093 0.473 . . . . 10.0 111.822 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.02 84.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.719 -0.673 . . . . 10.0 112.13 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 27.4 mmmt -74.58 -43.75 54.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 10.0 110.943 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.437 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 3.0 m-85 -61.04 -20.44 62.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 10.0 112.13 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -67.73 -5.41 15.95 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.863 0.363 . . . . 10.0 111.826 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 m -77.06 -17.01 59.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 10.0 110.561 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.24 169.42 15.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.923 -0.58 . . . . 10.0 109.998 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.84 98.1 8.0 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.233 -0.284 . . . . 10.0 110.233 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.0 tp -86.15 127.6 34.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.291 -0.413 . . . . 10.0 111.39 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.491 HG22 ' HB2' ' A' ' 90' ' ' PRO . 5.8 pt -137.41 144.94 30.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.497 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.488 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -102.57 110.99 23.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.025 -0.534 . . . . 10.0 109.702 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -109.24 137.39 41.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.052 0.454 . . . . 10.0 111.548 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.39 146.89 52.47 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.437 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 19.2 m -109.91 96.11 23.43 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 112.222 0.453 . . . . 10.0 112.222 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 65' ' ' SER . 33.3 Cg_endo -65.31 132.25 30.92 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.365 2.043 . . . . 10.0 111.357 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.98 6.08 88.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.072 -0.585 . . . . 10.0 112.534 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -121.72 148.49 44.54 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.155 -0.313 . . . . 10.0 110.155 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER 59.92 21.17 10.17 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.5 t60 69.57 27.73 4.74 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.462 -0.79 . . . . 10.0 112.287 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -88.26 -168.35 2.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.487 ' HE3' ' CZ3' ' A' ' 80' ' ' TRP . 23.0 mmtt -63.57 145.08 56.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.711 0.291 . . . . 10.0 111.033 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -80.9 161.78 24.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.806 0.336 . . . . 10.0 111.367 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.44 150.17 27.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.533 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 78' ' ' GLN . . . 83.03 -47.13 3.76 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.273 -0.731 . . . . 10.0 111.273 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -76.65 -39.72 51.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.676 -0.49 . . . . 10.0 109.676 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -63.05 -36.32 83.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.485 -0.779 . . . . 10.0 111.891 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 17.1 pt20 -66.11 -32.14 73.42 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.775 -0.37 . . . . 10.0 111.021 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.92 -27.49 63.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.04 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.537 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.7 t-105 -61.32 -57.71 11.2 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.503 -0.772 . . . . 10.0 109.707 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -65.93 -36.32 83.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.102 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.82 -20.78 58.95 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.224 0.453 . . . . 10.0 112.224 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.21 5.23 38.59 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.592 -0.813 . . . . 10.0 112.192 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 80' ' ' TRP . 88.2 mt -100.46 -178.29 3.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.895 0.378 . . . . 10.0 111.185 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -103.54 -177.78 3.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.136 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.55 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 12.8 m-85 69.0 78.56 0.23 Allowed Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 123.007 0.523 . . . . 10.0 111.035 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.15 12.25 1.83 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.736 2.29 . . . . 10.0 112.063 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -108.57 11.25 26.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.402 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.9 mt -88.5 111.13 41.83 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.574 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.491 ' HB2' HG22 ' A' ' 61' ' ' ILE . 66.5 Cg_endo -75.56 69.83 5.85 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.465 2.11 . . . . 10.0 111.234 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 62' ' ' THR . 57.1 t -78.56 107.78 11.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.844 -0.616 . . . . 10.0 111.305 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 16.5 t -92.34 137.34 22.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.762 -0.653 . . . . 10.0 109.918 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -100.47 100.44 11.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.59 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -94.81 85.35 4.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.171 0.51 . . . . 10.0 110.05 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -62.38 114.75 3.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.655 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.71 -11.92 67.86 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.653 -0.784 . . . . 10.0 112.897 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.53 55.95 7.14 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.632 -0.794 . . . . 10.0 112.269 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.84 -44.15 81.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.178 0.514 . . . . 10.0 110.253 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.5 mm -77.74 -41.14 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.295 -0.631 . . . . 10.0 109.295 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.714 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.67 -41.48 86.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.714 -0.676 . . . . 10.0 111.338 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -70.84 -41.74 71.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.985 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.9 m -65.92 -27.89 68.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.097 0.406 . . . . 10.0 112.097 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.72 -2.74 31.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.723 0.297 . . . . 10.0 110.898 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t30 54.21 55.88 7.66 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.686 -0.688 . . . . 10.0 111.471 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 100' ' ' ALA . 87.5 mt -80.65 126.15 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.659 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 p -127.34 -1.99 6.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.898 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.838 HG23 ' HB3' ' B' ' 109' ' ' TYR . 14.9 p -154.18 151.72 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.575 0.226 . . . . 10.0 111.007 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.548 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 25.3 m-85 -117.3 156.21 49.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -87.33 130.16 11.0 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.734 -1.361 . . . . 10.0 111.585 -0.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.4 m -94.35 130.73 40.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.135 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.693 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 19.3 m95 -112.84 115.34 28.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.462 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -107.09 116.91 32.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.346 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.53 HD22 HD11 ' A' ' 136' ' ' LEU . 52.4 tp -97.12 111.88 23.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.133 0.492 . . . . 10.0 110.939 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 27' ' ' THR . 2.4 mp -98.1 129.31 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.62 -0.881 . . . . 10.0 108.62 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.59 175.58 33.45 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.859 -0.686 . . . . 10.0 112.262 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -72.21 -1.95 17.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.019 0.438 . . . . 10.0 111.176 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.46 -14.02 33.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.135 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.47 21.44 31.93 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.869 -0.682 . . . . 10.0 112.607 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -126.63 166.1 17.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.855 0.36 . . . . 10.0 111.289 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.22 125.33 31.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.688 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -113.76 -39.6 3.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.818 0.342 . . . . 10.0 111.848 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 122' ' ' ARG . 0.1 OUTLIER -141.53 151.3 43.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.688 0.28 . . . . 10.0 110.891 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.12 128.51 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 10.0 110.629 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.693 ' HB ' ' HB2' ' A' ' 111' ' ' TRP . 46.3 t -117.11 128.93 74.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.578 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -129.39 114.8 16.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.272 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.79 -85.58 0.19 Allowed Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.415 -0.898 . . . . 10.0 112.757 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.9 m -160.75 163.21 32.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.077 -0.342 . . . . 10.0 110.077 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.49 HG12 ' CE2' ' A' ' 111' ' ' TRP . 1.5 pp -130.03 170.73 18.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.557 0.218 . . . . 10.0 111.294 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 132' ' ' GLN . 9.6 p30 -147.17 163.34 36.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.007 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -57.66 -45.89 84.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.613 0.598 . . . . 10.0 112.613 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.8 95.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.847 0.356 . . . . 10.0 111.097 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.417 ' HB2' ' ND2' ' A' ' 129' ' ' ASN . 8.9 tt0 -65.0 -40.9 95.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 55' ' ' PHE . . . -60.91 -47.56 85.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.848 -0.615 . . . . 10.0 110.644 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.56 -37.81 88.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.713 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.41 97.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.742 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.53 HD11 HD22 ' A' ' 113' ' ' LEU . 19.1 tp -62.73 -36.11 81.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.134 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.8 mt -73.12 -26.78 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.077 0.465 . . . . 10.0 110.048 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -80.88 -40.99 23.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.311 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 50.4 t0 -154.15 113.9 2.51 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.177 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 36.7 Cg_endo -66.06 -7.88 18.38 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.003 2.469 . . . . 10.0 112.449 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -86.36 -6.69 58.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.876 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.55 96.59 4.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.345 -0.389 . . . . 10.0 111.474 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -102.08 128.38 48.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.417 -0.586 . . . . 10.0 109.417 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 36.2 tp . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.108 -0.948 . . . . 10.0 111.633 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.909 0.385 . . . . 10.0 110.773 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.71 -60.41 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 61.7 tp -113.91 -65.31 1.2 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.847 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 52.79 41.12 31.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.446 0.641 . . . . 10.0 111.246 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.1 170.68 18.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.449 -0.796 . . . . 10.0 110.278 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.39 -159.34 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.855 0.722 . . . . 10.0 111.921 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -105.63 16.19 25.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.482 -0.781 . . . . 10.0 109.757 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -81.04 2.87 25.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 10.0 112.374 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.85 132.77 16.25 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.43 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.89 145.64 96.23 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.031 2.487 . . . . 10.0 112.35 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' B' ' 14' ' ' ALA . 9.4 Cg_endo -52.37 -36.25 68.18 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.532 2.822 . . . . 10.0 113.136 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -62.71 -14.23 41.73 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.07 0.462 . . . . 10.0 111.96 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -121.17 -3.08 9.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.633 0.73 . . . . 10.0 109.93 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' B' ' 11' ' ' PRO . . . -92.6 -3.78 54.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 10.0 112.25 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.529 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 15.4 m-85 -122.29 125.14 45.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.888 0.375 . . . . 10.0 111.165 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.03 90.82 10.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.275 -0.639 . . . . 10.0 109.275 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 6.4 Cg_exo -74.73 96.28 0.99 Allowed 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.955 2.436 . . . . 10.0 112.879 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.42 98.17 10.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 123' ' ' THR . 3.2 mm? -89.05 116.34 27.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.819 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.26 109.95 19.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.703 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.602 HG13 HG22 ' B' ' 26' ' ' VAL . 61.4 t -92.87 114.81 30.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.275 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.96 170.49 7.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.23 -0.656 . . . . 10.0 109.23 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.51 -42.84 77.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.98 0.363 . . . . 10.0 111.98 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.9 -15.03 59.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.567 0.58 . . . . 10.0 112.567 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 165.11 166.4 24.02 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.424 -0.893 . . . . 10.0 112.228 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.602 HG22 HG13 ' B' ' 21' ' ' VAL . 58.7 t -90.52 137.43 21.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.18 -0.304 . . . . 10.0 110.18 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -120.53 112.15 18.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.922 -0.399 . . . . 10.0 109.922 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.573 HG22 ' HD1' ' B' ' 30' ' ' PHE . 6.8 p -91.79 121.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.051 0.453 . . . . 10.0 110.956 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -124.53 79.32 1.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.039 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.573 ' HD1' HG22 ' B' ' 28' ' ' VAL . 12.8 p90 -87.27 112.5 22.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 10.0 111.057 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -76.47 118.9 19.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.414 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 45.9 mt -92.65 140.19 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.719 -0.673 . . . . 10.0 110.33 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.94 149.79 39.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.396 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.08 77.74 1.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.168 0.509 . . . . 10.0 111.486 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 169.57 -21.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.376 -0.69 . . . . 10.0 111.376 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.41 150.17 24.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.221 -0.659 . . . . 10.0 109.221 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' B' ' 75' ' ' TYR . 8.3 p90 -142.15 136.54 30.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.048 0.452 . . . . 10.0 111.597 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 48.4 mtt -108.27 152.92 23.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.653 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 23.8 m-85 -95.1 126.81 40.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.527 -0.546 . . . . 10.0 109.527 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -60.51 -28.96 68.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.051 0.453 . . . . 10.0 111.841 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.16 -0.94 51.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.994 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.55 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 41.4 mmtt -113.06 -26.11 8.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.35 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.426 HG13 ' O ' ' B' ' 39' ' ' TYR . 73.3 mt -70.87 115.41 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.24 0.543 . . . . 10.0 110.882 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.51 122.98 59.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.871 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' B' ' 96' ' ' VAL . . . -145.28 129.37 3.45 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.685 -0.769 . . . . 10.0 111.909 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -157.76 138.24 12.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.806 0.336 . . . . 10.0 111.26 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.598 ' HB ' HD13 ' B' ' 95' ' ' LEU . 4.7 t -139.25 126.9 21.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.732 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.551 ' ND2' ' HA ' ' B' ' 51' ' ' ASP . 29.2 p30 -178.3 164.13 1.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.365 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.11 -76.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.244 1.962 . . . . 10.0 111.148 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.32 49.19 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.983 0.421 . . . . 10.0 110.651 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.551 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 2.8 t0 63.24 56.2 1.75 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.501 -0.772 . . . . 10.0 112.101 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.416 ' H ' ' HB2' ' B' ' 48' ' ' ASN . 1.7 mm? -117.61 57.24 0.82 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.126 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' B' ' 83' ' ' PHE . 21.5 tp -115.6 147.62 40.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.134 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.5 -74.07 0.98 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.627 -0.797 . . . . 10.0 111.563 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.36 145.49 4.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.58 108.61 1.45 Allowed 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.472 2.115 . . . . 10.0 111.236 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 16.7 m -79.15 98.54 6.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.257 -0.429 . . . . 10.0 111.629 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -80.21 144.64 32.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.787 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -86.23 -9.33 56.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt 71.66 127.77 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.864 0.727 . . . . 10.0 112.542 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.77 -127.61 4.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.528 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -119.77 145.4 46.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.647 0.223 . . . . 10.0 110.412 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -85.87 125.61 33.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -111.4 134.56 52.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.038 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -77.14 128.37 34.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -116.17 174.49 6.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.983 0.421 . . . . 10.0 111.241 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -101.09 -26.83 13.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.015 -0.539 . . . . 10.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -118.95 -39.36 2.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.703 0.287 . . . . 10.0 111.487 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.422 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 4.3 m-30 -79.47 -14.0 59.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 10.0 111.405 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.55 -89.71 1.63 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.863 -0.684 . . . . 10.0 112.053 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -159.03 115.45 2.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.029 -0.36 . . . . 10.0 110.029 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -137.23 164.35 28.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.866 0.365 . . . . 10.0 111.209 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -78.11 127.92 33.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.971 -0.751 . . . . 10.0 108.971 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.5 155.72 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.394 0.516 . . . . 10.0 112.394 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' B' ' 37' ' ' TYR . 21.2 m-85 -117.0 128.6 55.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.556 -1.276 . . . . 10.0 107.556 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -118.3 5.87 11.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.397 0.517 . . . . 10.0 112.397 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 179.25 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -87.47 112.06 21.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.677 -1.147 . . . . 10.0 110.867 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 30' ' ' PHE . . . -142.7 120.21 11.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.863 0.363 . . . . 10.0 110.871 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -155.36 120.77 4.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.15 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.04 124.46 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.348 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.72 144.93 28.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.235 -0.439 . . . . 10.0 109.897 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' PHE . . . . . 0.474 ' HB3' HD11 ' B' ' 53' ' ' LEU . 64.1 m-85 -120.66 100.28 46.84 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.41 121.59 3.87 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.8 2.334 . . . . 10.0 111.346 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.97 151.35 35.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.019 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.63 -2.41 48.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.293 0.568 . . . . 10.0 109.817 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.415 ' HG3' HG13 ' B' ' 89' ' ' VAL . 12.9 tppt? -152.63 111.23 3.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.325 -0.852 . . . . 10.0 109.266 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.85 92.29 6.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.982 0.42 . . . . 10.0 110.64 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.415 HG13 ' HG3' ' B' ' 87' ' ' LYS . 15.7 m -119.48 158.05 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.137 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.91 51.96 2.25 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.124 -0.56 . . . . 10.0 111.846 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -117.02 145.84 36.59 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.87 117.06 4.63 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.247 1.965 . . . . 10.0 110.513 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.06 151.95 20.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.329 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 47' ' ' THR . 34.9 tttt -100.35 148.92 24.16 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.4 -0.592 . . . . 10.0 109.4 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.598 HD13 ' HB ' ' B' ' 47' ' ' THR . 35.5 tp -122.32 125.65 46.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.78 0.324 . . . . 10.0 110.852 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.445 ' O ' ' HA2' ' B' ' 45' ' ' GLY . 39.9 t -111.02 122.28 65.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 87.0 mt -127.42 123.84 37.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.856 0.36 . . . . 10.0 111.318 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 17.5 m -113.62 121.69 44.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -102.63 107.5 18.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.759 0.314 . . . . 10.0 111.47 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.645 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 0.4 OUTLIER -126.04 125.33 42.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.91 0.386 . . . . 10.0 110.211 178.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.83 -159.09 13.67 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.675 -0.774 . . . . 10.0 111.359 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 10.3 m -152.7 -177.77 6.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' B' ' 105' ' ' ALA . . . -118.66 149.24 41.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -75.06 21.69 0.12 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.973 0.416 . . . . 10.0 111.502 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' B' ' 103' ' ' ALA . . . -122.78 -1.03 8.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.864 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.95 -26.03 12.1 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.754 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.9 t -62.12 140.19 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.616 0.246 . . . . 10.0 110.77 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 47.5 t -137.2 99.31 3.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.888 0.375 . . . . 10.0 110.465 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.838 ' HB3' HG23 ' A' ' 107' ' ' VAL . 50.5 p90 -80.58 151.79 71.96 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.779 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 43.9 Cg_endo -68.12 161.17 45.57 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.861 2.374 . . . . 10.0 111.651 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.645 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 73.7 Cg_endo -76.75 52.6 3.76 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.864 2.376 . . . . 10.0 113.077 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 33.5 t -56.57 131.44 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.028 0.442 . . . . 10.0 110.784 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -113.21 168.34 9.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.49 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.0 m -147.79 138.44 23.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.499 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -100.49 131.08 46.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.508 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' B' ' 95' ' ' LEU . 76.2 m-85 -112.85 143.22 44.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.286 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -105.98 111.3 23.88 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.38 88.14 2.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.28 0.562 . . . . 10.0 110.846 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -102.92 -11.37 18.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.62 -0.718 . . . . 10.0 110.695 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.09 83.77 1.4 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.037 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -140.2 7.11 2.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.996 0.426 . . . . 10.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.73 -80.0 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.112 -0.565 . . . . 10.0 112.367 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 1.7 m -105.91 145.85 30.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -130.51 152.41 49.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.711 0.291 . . . . 10.0 111.328 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.15 138.72 15.15 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.708 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' PRO . . . . . 0.439 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 61.3 Cg_endo -74.81 138.61 23.75 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.467 2.112 . . . . 10.0 112.335 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -92.01 92.72 8.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.519 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 34.0 m . . . . . 0 C--O 1.252 1.202 0 CA-C-O 118.856 -0.593 . . . . 10.0 109.644 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.54 69.35 79.76 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 120.762 0.315 . . . . 10.0 110.798 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.1 -30.13 90.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.866 2.377 . . . . 10.0 112.877 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -61.71 -39.57 91.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.752 0.311 . . . . 10.0 110.91 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.472 HG21 HG21 ' A' ' 98' ' ' THR . 1.2 m -71.08 -37.69 72.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 10.0 110.1 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 tp -65.04 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.904 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.1 m -84.86 -24.82 28.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.605 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 m -67.04 -28.43 68.21 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.069 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.06 112.51 1.37 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.83 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.01 138.9 40.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.08 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.817 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 33.0 p -77.53 168.72 19.53 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.041 -0.527 . . . . 10.0 109.671 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.28 -8.05 42.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.393 0.616 . . . . 10.0 110.029 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -91.1 2.16 56.54 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.247 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 t30 69.21 30.26 4.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.952 -1.022 . . . . 10.0 111.466 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 30.6 mtt85 -119.08 137.22 24.91 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.931 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 15' ' ' ARG . 38.5 Cg_exo -62.31 144.83 95.82 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.372 2.048 . . . . 10.0 110.899 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.96 -9.93 18.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.024 0.379 . . . . 10.0 112.024 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.612 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 4.5 m -56.17 -21.85 25.34 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.435 0.531 . . . . 10.0 112.435 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 m -64.9 -24.61 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.02 0.438 . . . . 10.0 111.138 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -118.97 17.38 13.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.487 0.661 . . . . 10.0 109.699 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 91.5 mt -125.22 43.66 2.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.313 -0.858 . . . . 10.0 109.618 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -141.65 -179.36 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.142 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.5 mttp 72.48 3.61 4.74 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.988 0.805 . . . . 10.0 112.179 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 54.0 47.77 22.64 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.881 -0.599 . . . . 10.0 111.071 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -116.36 150.09 44.77 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.441 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.82 127.41 26.09 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.053 2.502 . . . . 10.0 112.028 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.406 ' HB ' HD12 ' A' ' 114' ' ' ILE . 2.7 m -102.09 137.07 40.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.242 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.654 HD23 HD12 ' A' ' 60' ' ' LEU . 22.2 tp -118.7 106.09 12.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.84 -0.43 . . . . 10.0 109.84 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 75.7 mt -97.37 123.26 49.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.759 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.768 ' HE2' HG22 ' A' ' 62' ' ' THR . 19.6 ttpt -116.03 126.03 53.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.361 -0.382 . . . . 10.0 110.644 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.51 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 19.2 m-85 -96.33 144.85 26.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.494 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -145.67 166.93 24.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.613 -0.267 . . . . 10.0 111.155 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.51 144.34 39.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.139 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 m -70.51 -52.46 21.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.585 0.587 . . . . 10.0 112.585 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.649 ' HZ2' ' HE3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -90.89 44.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.96 0.409 . . . . 10.0 111.694 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.7 t -119.84 119.67 30.99 Favored Pre-proline 0 C--N 1.317 -0.826 0 C-N-CA 120.88 -0.328 . . . . 10.0 111.368 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 25.6 Cg_endo -62.95 -38.23 48.46 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.687 2.258 . . . . 10.0 111.793 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.536 HD12 ' HG2' ' A' ' 37' ' ' PRO . 6.6 mp -66.47 -44.98 81.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.343 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.436 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 73.6 m -72.19 -24.72 61.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.235 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.57 ' HB3' ' CZ ' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -61.9 -55.31 31.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 10.0 111.474 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.09 -34.03 77.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.024 0.44 . . . . 10.0 110.496 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -65.13 -27.95 69.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.679 -0.692 . . . . 10.0 111.569 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 39' ' ' CYS . 37.3 mt -56.39 -40.64 74.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.914 0.388 . . . . 10.0 110.864 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.76 -32.6 78.28 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.147 -0.781 . . . . 10.0 111.147 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -71.57 -36.63 70.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.936 -0.394 . . . . 10.0 109.936 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.559 HG22 HD21 ' A' ' 60' ' ' LEU . 1.7 m -61.35 -47.7 84.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.037 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -64.77 -37.6 88.15 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.522 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -60.12 -46.16 90.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.23 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.451 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 37.0 m0 -66.5 -32.53 73.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.023 -0.535 . . . . 10.0 111.025 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.51 -16.12 63.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.21 0.528 . . . . 10.0 111.111 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -99.2 -3.57 34.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.472 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.5 147.16 29.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.376 -0.375 . . . . 10.0 110.653 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 -31.13 72.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.862 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -66.61 -51.51 55.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 10.0 111.035 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 49' ' ' TRP . 92.7 m-85 -75.67 -10.25 59.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.674 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -75.74 -7.37 54.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.192 0.52 . . . . 10.0 110.195 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.89 4.62 52.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.836 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.78 173.29 11.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.85 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -106.58 89.36 3.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.899 0.38 . . . . 10.0 110.299 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.654 HD12 HD23 ' A' ' 28' ' ' LEU . 1.2 tt -88.51 127.01 35.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.879 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.528 HG22 ' HB2' ' A' ' 90' ' ' PRO . 7.8 pt -142.28 152.28 18.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.985 0.421 . . . . 10.0 111.27 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.768 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -107.09 126.3 52.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.299 -0.63 . . . . 10.0 109.299 179.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.583 HG22 ' HB ' ' A' ' 92' ' ' VAL . 44.6 t -122.08 141.99 40.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.835 0.35 . . . . 10.0 111.474 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.36 148.28 52.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.46 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 13.8 m -110.74 97.42 33.16 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.663 0.268 . . . . 10.0 111.624 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 23.3 Cg_endo -60.17 123.69 13.68 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.882 2.388 . . . . 10.0 112.525 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.7 -21.5 29.46 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.797 -0.638 . . . . 10.0 112.86 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.0 143.68 28.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.648 0.261 . . . . 10.0 110.508 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.844 HD12 HG22 ' B' ' 112' ' ' VAL . 2.3 mm? 60.02 22.81 11.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.911 -0.586 . . . . 10.0 112.385 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.638 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.9 OUTLIER 71.12 24.54 3.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.78 -0.645 . . . . 10.0 112.561 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.55 -175.34 5.74 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.54 0.21 . . . . 10.0 110.798 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.649 ' HE3' ' HZ2' ' A' ' 35' ' ' TRP . 3.7 mmpt? -58.57 136.16 57.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.494 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -76.25 174.37 10.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.875 0.369 . . . . 10.0 111.866 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.8 144.26 55.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.736 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 -47.02 3.59 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.014 -0.835 . . . . 10.0 111.014 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -47.21 81.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 10.0 109.908 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.78 -32.1 73.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.471 -0.786 . . . . 10.0 110.907 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.12 -44.57 94.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.666 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -71.28 -31.39 67.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.782 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -58.87 -47.06 86.24 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.864 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -73.6 -40.94 63.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.366 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.49 68.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 10.0 111.395 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.44 23.08 36.59 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.955 -0.641 . . . . 10.0 112.623 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 mt -117.53 170.11 9.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.833 0.349 . . . . 10.0 110.766 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -89.58 176.02 7.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.798 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 71.09 73.81 0.26 Allowed Pre-proline 0 N--CA 1.465 0.3 0 O-C-N 123.883 0.739 . . . . 10.0 111.448 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.45 -1.57 11.21 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.482 2.122 . . . . 10.0 112.188 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.88 -0.81 44.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.895 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.69 114.97 39.5 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.764 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.528 ' HB2' HG22 ' A' ' 61' ' ' ILE . 73.0 Cg_endo -78.86 77.65 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.62 2.213 . . . . 10.0 111.581 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 62' ' ' THR . 43.1 t -92.32 118.66 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.094 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.817 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 4.6 t -100.75 144.62 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.74 -0.663 . . . . 10.0 109.963 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.455 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -107.43 117.38 33.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.499 -0.319 . . . . 10.0 111.125 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.483 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 62.3 t0 -108.18 96.03 6.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 10.0 110.044 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.437 ' HA ' ' HG2' ' A' ' 66' ' ' PRO . 13.2 t-20 -67.62 112.52 4.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.766 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.59 -9.45 62.43 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.995 -0.622 . . . . 10.0 112.242 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.21 50.92 41.8 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.964 -0.636 . . . . 10.0 112.187 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.472 HG21 HG21 ' A' ' 5' ' ' THR . 0.2 OUTLIER -60.66 -46.8 88.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.9 0.381 . . . . 10.0 111.262 -179.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.85 -42.47 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.77 -44.96 90.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.541 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -69.64 -36.72 76.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.812 0.339 . . . . 10.0 111.409 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -64.6 -33.51 76.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.215 0.45 . . . . 10.0 112.215 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.418 HD13 HD13 ' A' ' 123' ' ' ILE . 95.9 mt -100.82 -2.86 31.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.673 0.273 . . . . 10.0 110.919 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 43.7 t30 60.58 61.44 1.72 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.92 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 100' ' ' ALA . 94.8 mt -97.84 105.37 17.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.422 -0.808 . . . . 10.0 110.956 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.77 13.24 14.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.926 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.915 HG23 ' HB3' ' B' ' 109' ' ' TYR . 12.4 p -147.0 150.5 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.617 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' B' ' 108' ' ' CYS . 22.5 m-85 -124.18 153.64 68.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -89.74 128.17 7.67 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 124.0 -1.25 . . . . 10.0 111.689 -0.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.9 m -96.21 136.27 36.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.361 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -114.14 110.99 20.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.214 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.21 110.23 22.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.51 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.1 tp -91.72 112.7 24.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.688 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 27' ' ' THR . 84.4 mt -99.74 137.72 26.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.82 173.25 55.12 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.64 -0.791 . . . . 10.0 112.799 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -65.2 -14.49 60.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 10.0 111.716 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.35 -19.72 29.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.151 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 105.06 -0.08 41.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.82 -0.705 . . . . 10.0 111.945 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -96.57 158.48 15.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.232 -0.285 . . . . 10.0 110.232 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.14 118.87 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.921 0.391 . . . . 10.0 111.171 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -51.53 6.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.695 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -156.87 142.26 17.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.119 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.418 HD13 HD13 ' A' ' 103' ' ' LEU . 4.3 tp -116.25 119.25 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.051 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.9 t -107.92 120.51 59.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.786 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -126.39 125.1 41.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.626 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 142.33 -97.22 0.2 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.722 -0.751 . . . . 10.0 111.829 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.766 ' HB2' HG22 ' B' ' 107' ' ' VAL . 3.7 t -160.35 138.2 9.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.022 -0.362 . . . . 10.0 110.022 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.532 ' HA ' ' OE1' ' A' ' 132' ' ' GLN . 12.9 pt -121.71 150.64 25.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.001 0.429 . . . . 10.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -114.28 174.92 5.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.649 . . . . 10.0 110.256 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.18 -45.3 91.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.71 0.263 . . . . 10.0 111.71 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.16 -41.97 84.96 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.515 -0.312 . . . . 10.0 110.59 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.532 ' OE1' ' HA ' ' A' ' 128' ' ' ILE . 41.1 mt-30 -65.18 -44.46 88.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.868 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 137' ' ' ILE . . . -59.31 -45.07 92.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.93 -34.34 75.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.765 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.2 85.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.383 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.44 -33.89 75.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.52 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 133' ' ' ALA . 76.5 mt -67.44 -31.83 54.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.669 -0.493 . . . . 10.0 109.669 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.45 -61.24 2.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.772 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 23.3 t70 -127.64 117.31 21.12 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.341 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 139' ' ' ASP . 14.6 Cg_exo -70.26 -3.55 12.57 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.087 2.525 . . . . 10.0 112.574 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -95.81 -2.52 47.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.624 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.64 116.99 10.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.041 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.7 t70 -122.53 160.25 26.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.633 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.283 0.989 . . . . 10.0 112.972 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.622 0.248 . . . . 10.0 111.354 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.24 -65.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.198 0.444 . . . . 10.0 112.198 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 54.9 tp -85.37 -82.57 0.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 62.24 45.82 6.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.619 0.724 . . . . 10.0 110.899 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.08 154.05 38.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.374 -0.83 . . . . 10.0 110.13 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.76 -163.63 0.23 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.79 0.681 . . . . 10.0 112.145 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -98.78 29.7 3.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.968 0.413 . . . . 10.0 111.085 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.65 15.27 14.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.146 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.63 137.61 11.53 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.789 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.11 151.05 86.78 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.931 2.421 . . . . 10.0 112.356 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.635 ' HG3' ' HB ' ' A' ' 107' ' ' VAL . 11.3 Cg_endo -54.29 -36.03 85.38 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.302 2.668 . . . . 10.0 113.152 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -69.06 -2.86 11.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.932 0.396 . . . . 10.0 112.023 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -131.82 5.86 4.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.473 0.654 . . . . 10.0 109.623 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.74 -1.84 31.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.702 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.509 ' HE1' HG23 ' B' ' 32' ' ' ILE . 43.9 m-85 -134.19 128.97 35.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.814 0.34 . . . . 10.0 110.96 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.6 91.38 20.55 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.539 ' HG2' ' HG3' ' B' ' 126' ' ' PRO . 17.1 Cg_exo -68.67 105.26 1.27 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.679 2.253 . . . . 10.0 112.727 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.12 99.4 12.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.236 -0.653 . . . . 10.0 109.236 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.2 mm? -89.33 102.99 15.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.882 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.26 101.78 10.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.52 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.479 HG13 HG22 ' B' ' 26' ' ' VAL . 81.1 t -89.82 119.59 37.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.616 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.1 -176.37 3.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.175 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.48 -35.9 34.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.403 -0.362 . . . . 10.0 111.29 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.35 -34.95 28.28 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.22 -178.61 40.14 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.762 -0.733 . . . . 10.0 112.077 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.479 HG22 HG13 ' B' ' 21' ' ' VAL . 60.7 t -102.86 135.88 38.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -123.48 114.87 20.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.954 0.407 . . . . 10.0 110.524 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.401 HG22 ' HD1' ' B' ' 30' ' ' PHE . 2.6 p -101.69 122.56 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.403 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -125.03 80.35 1.87 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.951 0.405 . . . . 10.0 110.315 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 7.4 p90 -77.35 111.71 13.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 10.0 111.141 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 -72.35 112.73 8.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.372 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.509 HG23 ' HE1' ' B' ' 15' ' ' PHE . 63.4 mt -90.23 135.73 25.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.975 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.41 149.27 50.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.21 92.65 1.02 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.059 0.457 . . . . 10.0 111.576 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.95 -22.06 0.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.369 -0.692 . . . . 10.0 111.369 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -105.37 154.28 20.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -146.6 139.23 25.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.983 0.42 . . . . 10.0 111.184 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 37.8 mtt -110.99 159.04 18.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.849 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.438 ' O ' HG13 ' B' ' 43' ' ' ILE . 24.2 m-85 -100.91 127.36 47.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -59.31 -30.7 68.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.183 0.438 . . . . 10.0 112.183 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.68 3.84 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.94 0.4 . . . . 10.0 111.181 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' B' ' 100' ' ' GLN . 71.1 mmtt -116.83 -20.47 9.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.336 -0.393 . . . . 10.0 111.801 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.456 HD13 ' HZ ' ' B' ' 30' ' ' PHE . 60.8 mt -77.22 96.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.092 0.472 . . . . 10.0 110.724 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.21 108.88 20.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.315 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.59 138.66 10.21 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.846 -0.692 . . . . 10.0 111.562 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -160.98 145.52 13.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.608 0.242 . . . . 10.0 111.066 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.598 ' HB ' HD13 ' B' ' 95' ' ' LEU . 15.1 t -141.51 125.63 17.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.191 -0.459 . . . . 10.0 109.879 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' B' ' 51' ' ' ASP . 28.1 p30 -179.0 161.75 1.02 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.154 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' B' ' 52' ' ' LEU . 11.3 Cg_exo -73.92 -63.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.435 2.09 . . . . 10.0 110.909 178.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.36 58.49 1.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 10.0 109.809 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.534 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 5.5 t70 61.96 33.62 17.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.53 -0.759 . . . . 10.0 112.455 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.495 ' HA ' HD13 ' B' ' 52' ' ' LEU . 1.4 mm? -90.16 55.09 2.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.4 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.492 ' HB2' HD22 ' B' ' 48' ' ' ASN . 19.0 tp -121.5 145.47 47.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.104 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.46 -76.8 0.85 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.587 -0.816 . . . . 10.0 111.309 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 3.6 pp0? -161.17 143.46 9.18 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 24.5 Cg_exo -64.9 108.52 1.11 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.526 2.151 . . . . 10.0 111.18 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 5.6 m -82.46 103.55 12.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.849 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.4 158.91 18.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 51.0 m -91.79 -14.06 30.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.622 -0.263 . . . . 10.0 110.831 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? 71.82 127.9 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.76 -0.655 . . . . 10.0 112.284 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.81 -133.0 5.61 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.135 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -117.41 140.24 49.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.527 0.203 . . . . 10.0 110.564 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.31 121.65 24.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.457 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -98.72 139.91 33.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -78.56 141.54 38.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.39 170.49 15.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.636 0.255 . . . . 10.0 110.495 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -24.83 10.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.961 0.41 . . . . 10.0 110.994 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 40' ' ' LEU . 11.9 m-85 -102.82 -44.75 5.19 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.202 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.569 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 14.6 m-30 -89.61 -9.62 49.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.583 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.08 -77.78 1.89 Allowed Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.827 -0.624 . . . . 10.0 112.296 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -173.81 117.91 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.752 0.31 . . . . 10.0 110.496 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -141.02 162.16 36.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.144 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.6 m -68.83 127.24 32.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.812 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.2 m -127.3 161.8 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 10.0 111.731 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -118.24 128.1 54.36 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.868 -1.16 . . . . 10.0 107.868 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -112.27 -3.8 14.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.768 0.655 . . . . 10.0 112.768 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -175.93 -36.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.987 -0.746 . . . . 10.0 108.987 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -86.26 125.04 33.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.086 -0.961 . . . . 10.0 109.767 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.37 116.77 4.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.323 . . . . 10.0 111.523 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -153.61 125.38 7.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.163 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.3 t -129.99 131.75 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.252 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' B' ' 57' ' ' SER . . . -108.56 142.01 39.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.704 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' PHE . . . . . 0.44 ' HB3' HD11 ' B' ' 53' ' ' LEU . 67.1 m-85 -120.22 112.26 34.7 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.263 0.468 . . . . 10.0 112.263 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -93.08 124.62 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.521 2.814 . . . . 10.0 111.55 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.01 148.04 40.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.988 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.3 -3.21 53.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.324 0.583 . . . . 10.0 109.73 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.412 ' HB2' ' HE2' ' B' ' 87' ' ' LYS . 6.2 tppt? -153.47 124.7 7.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.867 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.75 89.77 8.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.04 0.448 . . . . 10.0 110.352 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.64 147.15 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.71 47.33 3.83 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.073 -0.584 . . . . 10.0 112.344 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -106.67 145.44 31.07 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.53 116.02 4.54 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.319 2.013 . . . . 10.0 111.288 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.77 165.4 11.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.967 0.413 . . . . 10.0 111.832 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 47' ' ' THR . 67.6 tttt -109.2 151.76 26.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.979 -0.555 . . . . 10.0 109.828 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.598 HD13 ' HB ' ' B' ' 47' ' ' THR . 56.0 tp -120.54 115.55 23.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.974 0.416 . . . . 10.0 110.664 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.88 126.44 64.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.535 -0.542 . . . . 10.0 109.535 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 66.8 mt -133.13 121.06 22.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.925 0.393 . . . . 10.0 111.895 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' THR . . . . . 0.602 HG23 ' HB3' ' B' ' 113' ' ' ASP . 5.0 m -108.8 119.22 38.91 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -100.58 109.48 21.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.777 0.322 . . . . 10.0 111.561 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' B' ' 42' ' ' LYS . 11.6 tp60 -124.32 119.35 29.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.968 0.413 . . . . 10.0 110.533 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.36 -160.79 11.08 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.603 -0.808 . . . . 10.0 111.877 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 13.1 m -151.21 -172.42 4.2 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -131.22 147.73 52.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.259 -0.274 . . . . 10.0 110.259 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.47 6.08 2.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 10.0 111.753 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.19 5.33 29.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.892 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.52 -7.74 56.2 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.626 -0.797 . . . . 10.0 113.087 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.766 HG22 ' HB2' ' A' ' 127' ' ' SER . 2.9 t -74.33 142.75 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.739 0.304 . . . . 10.0 110.471 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 47.9 t -142.52 85.56 1.91 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.941 0.401 . . . . 10.0 110.068 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.915 ' HB3' HG23 ' A' ' 107' ' ' VAL . 52.4 p90 -74.09 152.35 88.44 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.79 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 55.3 Cg_endo -69.82 165.18 31.9 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.827 2.351 . . . . 10.0 111.377 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 70' ' ' HIS . 67.3 Cg_endo -74.42 68.11 5.28 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.657 2.238 . . . . 10.0 112.947 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.844 HG22 HD12 ' A' ' 69' ' ' LEU . 4.8 t -62.65 120.78 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 10.0 109.943 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ASP . . . . . 0.602 ' HB3' HG23 ' B' ' 98' ' ' THR . 4.0 p-10 -108.03 153.91 22.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.094 0.473 . . . . 10.0 111.37 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.68 138.77 41.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.822 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.19 124.45 50.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.82 0.343 . . . . 10.0 110.571 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -111.57 142.73 43.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.618 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -103.98 121.41 43.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.263 -0.426 . . . . 10.0 109.877 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 23.1 mm -94.66 88.83 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.967 0.413 . . . . 10.0 110.787 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' B' ' 121' ' ' ASN . 14.8 p90 -95.03 -35.02 12.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.549 . . . . 10.0 111.45 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.4 60.78 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.43 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' B' ' 119' ' ' PHE . 8.3 t30 -120.0 -0.89 10.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.81 0.338 . . . . 10.0 111.101 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.26 -76.14 1.5 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.002 -0.618 . . . . 10.0 111.658 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 3.9 m -103.21 140.25 37.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.565 -0.531 . . . . 10.0 109.565 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -129.86 161.36 30.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.142 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.18 146.97 24.67 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' PRO . . . . . 0.539 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 28.6 Cg_endo -63.26 121.56 9.43 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.557 2.171 . . . . 10.0 112.42 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -82.64 62.89 6.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.355 0.598 . . . . 10.0 110.01 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.091 -179.285 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 tpt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.098 -0.334 . . . . 10.0 110.098 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.65 82.64 48.26 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.562 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.01 -25.71 58.97 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.55 2.167 . . . . 10.0 111.566 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -46.83 87.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.833 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -60.56 -42.54 96.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.302 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.97 -32.84 74.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.806 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.0 m -81.91 -25.6 34.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.054 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.3 m -65.68 -26.71 67.9 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.756 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 9' ' ' LEU . 2.1 mm? -55.69 128.0 32.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.878 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -115.47 149.55 37.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.638 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 19.4 p -89.34 174.96 7.53 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.046 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.56 -19.36 65.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.411 . . . . 10.0 111.008 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.549 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.0 t70 -89.31 9.13 27.16 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 64.84 30.57 12.11 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.703 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.549 ' HG3' ' HB3' ' A' ' 13' ' ' ASP . 16.4 mtp85 -112.27 137.65 21.59 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.932 -0.577 . . . . 10.0 109.93 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 15' ' ' ARG . 50.3 Cg_exo -57.32 139.48 90.21 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.615 2.21 . . . . 10.0 111.409 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.14 -10.08 20.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 10.0 112.008 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 1.7 t -59.85 -18.41 43.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.647 -0.252 . . . . 10.0 111.494 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.18 -15.54 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-O 120.788 0.328 . . . . 10.0 111.018 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -127.06 22.92 6.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.56 . . . . 10.0 109.714 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 57.4 mt -133.0 27.28 4.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.024 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 18' ' ' SER . 53.7 mttm -118.97 174.6 6.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.6 mttp 69.32 15.7 8.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.127 -0.942 . . . . 10.0 112.902 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.18 51.21 14.89 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.512 0.507 . . . . 10.0 111.242 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.547 ' HD2' ' HD2' ' A' ' 26' ' ' PRO . 16.8 mmtp -112.65 143.37 28.86 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.218 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.547 ' HD2' ' HD2' ' A' ' 25' ' ' LYS . 19.6 Cg_endo -59.26 134.08 56.81 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.725 2.283 . . . . 10.0 110.956 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -106.78 143.91 34.19 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.967 0.413 . . . . 10.0 111.22 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 28' ' ' LEU . 9.5 tp -121.47 97.94 5.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.156 -0.683 . . . . 10.0 109.156 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.571 HG12 HD11 ' A' ' 61' ' ' ILE . 66.0 mt -89.39 112.22 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.025 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HG3' ' CE2' ' A' ' 111' ' ' TRP . 5.7 tmmm? -106.59 120.88 43.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.88 0.371 . . . . 10.0 110.826 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 14.1 m-85 -90.33 127.9 36.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.208 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -121.37 173.89 7.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.078 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB1' ' CZ3' ' A' ' 35' ' ' TRP . . . -124.83 138.48 54.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.102 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -77.49 -47.43 19.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.522 ' CZ3' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -88.36 29.1 1.0 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.077 0.769 . . . . 10.0 113.077 -178.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 5.0 t -119.65 125.98 27.18 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 111.665 0.246 . . . . 10.0 111.665 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 26.2 Cg_endo -63.01 -43.85 17.92 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.832 2.355 . . . . 10.0 112.457 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.97 -44.52 96.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.167 0.508 . . . . 10.0 111.135 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.9 -28.52 67.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.888 -0.596 . . . . 10.0 111.496 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.7 mt -63.62 -44.77 92.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.845 0.355 . . . . 10.0 110.464 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.6 m -69.63 -31.61 69.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.668 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -28.82 70.09 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.057 -0.52 . . . . 10.0 110.646 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.91 -42.48 84.83 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.442 -0.345 . . . . 10.0 111.321 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.04 -44.46 97.3 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.796 -0.716 . . . . 10.0 111.421 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -65.49 -34.67 78.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.867 0.365 . . . . 10.0 110.192 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.3 m -61.33 -46.88 88.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.161 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.56 -40.93 98.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.955 0.407 . . . . 10.0 110.429 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.22 -47.66 78.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 10.0 111.003 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -65.01 -33.93 77.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.576 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.44 -6.28 34.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.918 0.389 . . . . 10.0 111.283 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -113.11 9.07 18.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.207 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.664 ' HB3' ' HD2' ' A' ' 55' ' ' PHE . 14.3 t70 -85.63 146.54 26.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.439 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.32 73.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.856 0.687 . . . . 10.0 112.856 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.479 ' HB3' HD13 ' A' ' 137' ' ' ILE . 32.5 mmmt -74.67 -39.2 62.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.835 0.35 . . . . 10.0 111.155 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.664 ' HD2' ' HB3' ' A' ' 52' ' ' ASP . 94.8 m-85 -75.5 -20.3 58.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.495 0.554 . . . . 10.0 112.495 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.8 m -65.93 -6.54 12.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.34 . . . . 10.0 111.902 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -77.3 -18.37 57.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 10.0 110.147 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -125.91 -178.67 4.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.701 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -113.39 100.36 8.48 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.182 -0.303 . . . . 10.0 110.182 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.07 129.29 35.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.598 -0.273 . . . . 10.0 111.022 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.571 HD11 HG12 ' A' ' 29' ' ' ILE . 10.3 pt -138.22 155.73 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.988 0.423 . . . . 10.0 111.415 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.97 109.43 18.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 10.0 109.648 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 92' ' ' VAL . 36.0 t -111.14 140.99 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.94 0.4 . . . . 10.0 111.482 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . . . -135.44 149.63 49.64 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.498 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 12.3 m -110.03 97.97 32.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 94' ' ' ASP . 18.9 Cg_endo -58.39 126.63 21.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.942 2.428 . . . . 10.0 112.507 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.61 -36.8 3.3 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.8 -0.637 . . . . 10.0 113.171 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -66.44 134.36 52.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.621 0.248 . . . . 10.0 110.999 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD11 HG22 ' B' ' 112' ' ' VAL . 0.4 OUTLIER 59.14 29.7 19.32 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.639 0.607 . . . . 10.0 112.639 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.735 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.1 OUTLIER 73.08 21.14 3.24 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.299 0.852 . . . . 10.0 113.299 178.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.34 178.3 5.95 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 28.2 mmtt -61.52 124.93 22.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -61.73 156.95 18.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.913 0.387 . . . . 10.0 111.734 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -59.27 151.47 23.17 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.403 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.58 -44.97 3.3 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.22 -39.51 17.71 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 80' ' ' TRP . 50.6 t80 -57.44 -46.2 83.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.584 -0.735 . . . . 10.0 112.136 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -63.48 -31.69 72.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.9 0.381 . . . . 10.0 111.541 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -75.6 -22.62 56.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.142 0.496 . . . . 10.0 110.464 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.43 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 65.6 t-105 -65.47 -46.69 78.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.493 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -72.43 -32.71 66.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.819 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.49 -31.71 68.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.963 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.39 23.89 34.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.398 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 80' ' ' TRP . 42.5 mt -115.71 -161.82 0.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.408 . . . . 10.0 111.361 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.4 ' H ' ' HB3' ' A' ' 84' ' ' LEU . 11.2 t-20 -118.59 -168.89 1.62 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 63.24 76.3 0.37 Allowed Pre-proline 0 C--O 1.234 0.24 0 O-C-N 123.456 0.472 . . . . 10.0 111.559 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.4 0.76 9.12 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.666 2.244 . . . . 10.0 112.272 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -104.43 6.47 34.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.089 0.471 . . . . 10.0 110.428 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 89' ' ' LEU . 10.2 mt -84.81 115.21 59.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.125 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HG2' ' HA ' ' A' ' 61' ' ' ILE . 69.2 Cg_endo -77.06 76.9 3.98 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.658 2.239 . . . . 10.0 111.393 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.25 118.47 30.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.982 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 15.9 t -103.88 142.8 16.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.861 -0.609 . . . . 10.0 109.95 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.9 m -107.58 107.51 18.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.145 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 61.9 t0 -97.86 92.32 5.77 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.251 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -63.08 107.91 1.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.918 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.54 -10.53 68.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.823 -0.703 . . . . 10.0 112.872 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.9 55.9 6.91 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.263 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.96 -45.1 87.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.937 0.399 . . . . 10.0 110.642 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.3 mm -78.67 -37.85 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.485 -0.561 . . . . 10.0 109.485 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.23 95.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.586 -0.734 . . . . 10.0 111.599 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -70.08 -37.22 75.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.762 0.315 . . . . 10.0 111.529 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.2 m -62.84 -23.44 67.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.447 -0.342 . . . . 10.0 111.833 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.2 mt -111.87 4.4 18.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.659 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.8 t30 54.3 44.4 29.07 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.429 0.633 . . . . 10.0 111.631 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.8 mt -80.41 101.53 5.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.839 -0.619 . . . . 10.0 111.551 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.9 m -118.95 29.88 7.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.87 -0.605 . . . . 10.0 110.564 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.715 HG23 ' HB3' ' B' ' 109' ' ' TYR . 11.4 p -160.71 151.14 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.281 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -130.89 155.29 81.67 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 126' ' ' GLY . 97.7 Cg_endo -85.74 141.97 30.55 Favored 'Cis proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.355 -1.519 . . . . 10.0 111.26 -1.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.7 m -118.23 126.76 52.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.654 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.421 ' CE2' ' HG3' ' A' ' 30' ' ' LYS . 23.5 m95 -107.72 108.39 19.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.91 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -95.01 115.68 27.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 136' ' ' LEU . 55.4 tp -90.94 115.78 28.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.595 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.9 135.68 41.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.211 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.69 178.95 38.47 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.03 -0.605 . . . . 10.0 112.63 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -71.45 -4.59 27.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.906 0.384 . . . . 10.0 111.984 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -98.92 -4.43 32.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.993 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 86.06 16.79 62.32 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.815 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -109.09 163.09 13.64 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.162 -0.31 . . . . 10.0 110.162 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.34 122.75 25.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.855 0.36 . . . . 10.0 110.418 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.18 -40.92 6.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.95 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 122' ' ' ARG . 14.8 tpt180 -160.78 161.89 32.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.498 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -138.03 120.76 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.013 0.435 . . . . 10.0 110.484 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.4 t -115.66 107.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 10.0 109.872 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -115.21 133.62 55.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.452 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 130.65 -75.72 0.42 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.415 -0.897 . . . . 10.0 112.96 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.9 m -159.88 159.26 32.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.018 -0.364 . . . . 10.0 110.018 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.38 170.6 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.311 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -156.0 174.33 15.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.643 -0.253 . . . . 10.0 111.132 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.19 -40.01 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.57 -46.23 87.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 10.0 110.902 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -67.94 -37.74 81.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.953 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 137' ' ' ILE . . . -61.93 -48.51 80.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.38 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.78 -38.97 92.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.739 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.17 91.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.262 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.619 HD11 HD22 ' A' ' 113' ' ' LEU . 15.1 tp -62.88 -35.65 80.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 10.0 111.646 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.479 HD13 ' HB3' ' A' ' 54' ' ' LYS . 74.2 mt -70.1 -27.89 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.214 0.53 . . . . 10.0 110.552 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -89.11 -47.33 8.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.077 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 24.7 t70 -137.15 110.61 9.14 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.622 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 139' ' ' ASP . 11.8 Cg_exo -72.48 3.45 4.2 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.306 2.67 . . . . 10.0 112.812 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -93.1 -7.27 46.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.458 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.04 131.34 44.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.005 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -133.31 136.9 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.465 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.092 0 N-CA-C 113.944 1.09 . . . . 10.0 113.944 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.716 0.293 . . . . 10.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.75 -53.1 59.49 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.314 -0.403 . . . . 10.0 112.086 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' B' ' 5' ' ' ALA . 49.6 tp -89.73 -73.09 0.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.131 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 57.59 35.46 25.76 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.214 0.531 . . . . 10.0 110.918 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . 0.423 ' H ' ' HG ' ' B' ' 3' ' ' LEU . . . -152.67 167.81 27.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.778 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.8 m120 65.68 -170.36 0.19 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.721 0.638 . . . . 10.0 112.398 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -101.17 19.44 17.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.124 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -88.97 20.24 3.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.614 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.3 136.56 13.26 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.279 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . 0.451 ' HB2' ' OE1' ' B' ' 12' ' ' GLU . 27.9 Cg_endo -61.42 150.23 86.0 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.166 2.577 . . . . 10.0 112.11 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.18 -40.09 60.83 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.682 2.921 . . . . 10.0 113.365 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.451 ' OE1' ' HB2' ' B' ' 10' ' ' PRO . 8.8 pm0 -65.24 -19.65 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.009 0.374 . . . . 10.0 112.009 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -106.91 -10.53 15.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.367 0.604 . . . . 10.0 110.041 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.49 -8.22 59.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.539 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.701 ' HE1' HG23 ' B' ' 32' ' ' ILE . 56.2 m-85 -134.08 131.53 38.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.923 0.392 . . . . 10.0 111.571 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.59 91.57 42.12 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' B' ' 30' ' ' PHE . 12.2 Cg_exo -72.37 108.74 2.58 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.12 2.547 . . . . 10.0 113.32 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -104.43 107.93 19.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.963 -0.755 . . . . 10.0 108.963 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' B' ' 19' ' ' LEU . 2.9 mm? -95.19 120.45 35.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.57 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.71 108.66 14.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.354 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.46 HG22 HG13 ' B' ' 26' ' ' VAL . 85.1 t -98.86 128.13 50.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.218 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.69 -166.94 1.34 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.291 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.31 -38.03 27.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.533 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.09 -41.66 85.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.216 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 178.12 -168.28 39.48 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.664 -0.779 . . . . 10.0 112.274 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.46 HG13 HG22 ' B' ' 21' ' ' VAL . 86.1 t -101.92 131.74 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.79 -0.448 . . . . 10.0 109.79 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -121.42 118.96 30.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.956 0.408 . . . . 10.0 110.765 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 p -103.47 116.96 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.12 0.486 . . . . 10.0 110.439 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' B' ' 79' ' ' ALA . 1.1 tmm_? -123.91 82.25 2.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.484 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.521 ' HB3' ' HA ' ' B' ' 17' ' ' PRO . 33.0 p90 -87.62 134.25 33.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.79 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 71.6 mtm-85 -85.52 129.36 34.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.298 -0.41 . . . . 10.0 111.034 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.701 HG23 ' HE1' ' B' ' 15' ' ' PHE . 76.9 mt -101.78 132.58 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.003 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.38 144.33 57.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.441 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.35 91.79 0.26 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.458 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.43 -23.06 0.95 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.427 -0.669 . . . . 10.0 111.427 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -100.74 159.24 15.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.103 -0.702 . . . . 10.0 109.103 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -150.32 136.57 18.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.131 0.491 . . . . 10.0 111.581 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 23.7 mtt -107.48 153.22 23.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.389 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.473 ' O ' HG13 ' B' ' 43' ' ' ILE . 20.0 m-85 -96.16 127.07 41.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.071 -0.714 . . . . 10.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -59.06 -33.79 71.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.849 0.356 . . . . 10.0 111.402 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.04 1.3 32.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.229 -0.442 . . . . 10.0 111.302 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.497 ' HE3' ' HE2' ' B' ' 69' ' ' PHE . 69.2 mmtt -116.53 -6.72 11.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 10.0 111.427 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.473 HG13 ' O ' ' B' ' 39' ' ' TYR . 81.0 mt -87.97 96.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 10.0 110.055 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 39.1 t -91.34 117.95 35.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.304 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.71 140.89 9.55 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.614 -0.803 . . . . 10.0 111.847 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -163.71 147.46 10.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.789 0.328 . . . . 10.0 110.713 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.457 ' HB ' HD13 ' B' ' 95' ' ' LEU . 9.4 t -144.18 120.41 10.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.143 -0.48 . . . . 10.0 109.854 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.6 ' CG ' ' HA ' ' B' ' 51' ' ' ASP . 24.8 p30 -174.96 155.19 1.83 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.47 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 48' ' ' ASN . 6.0 Cg_exo -80.13 -66.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.837 2.358 . . . . 10.0 111.52 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.42 36.18 2.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.48 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.6 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 13.8 t0 64.58 33.16 11.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.495 -0.775 . . . . 10.0 112.611 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' B' ' 52' ' ' LEU . 2.0 mm? -96.78 76.6 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.92 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.445 HD13 ' O ' ' B' ' 47' ' ' THR . 17.6 tp -131.98 155.51 47.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.681 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.04 -80.46 0.64 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.094 -0.803 . . . . 10.0 111.094 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -168.99 147.8 3.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.841 -0.429 . . . . 10.0 109.841 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.02 110.53 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.637 2.225 . . . . 10.0 110.919 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.9 m -95.25 100.62 12.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.016 0.436 . . . . 10.0 111.401 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -80.58 168.16 19.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.98 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 42.4 m -97.67 -7.2 31.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.713 -0.221 . . . . 10.0 111.39 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt 69.41 117.6 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.829 0.677 . . . . 10.0 112.829 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.53 -125.34 5.57 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.914 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.21 158.4 28.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -94.31 123.31 37.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.932 0.396 . . . . 10.0 110.667 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -100.97 130.02 46.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.982 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.41 120.83 23.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.392 -0.966 . . . . 10.0 108.392 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -110.2 176.05 5.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.104 0.478 . . . . 10.0 111.432 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -110.06 -25.1 10.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.214 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.61 -42.68 3.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.054 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.497 ' HE2' ' HE3' ' B' ' 42' ' ' LYS . 4.3 m-30 -88.32 4.55 45.65 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.072 0.397 . . . . 10.0 112.072 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.98 -89.57 1.18 Allowed Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.715 -0.755 . . . . 10.0 111.859 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -171.09 123.9 0.61 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -136.57 167.3 21.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.337 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 15.2 m -75.34 128.78 36.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.521 -0.918 . . . . 10.0 108.521 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.65 162.69 32.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.433 0.635 . . . . 10.0 112.46 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.539 ' HB3' ' O ' ' B' ' 78' ' ' GLU . 40.6 m-85 -122.09 129.09 52.07 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.718 -1.216 . . . . 10.0 107.718 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -110.39 -15.54 13.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.721 0.637 . . . . 10.0 112.721 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.57 ' HA ' ' HB ' ' B' ' 32' ' ' ILE . 1.7 t60 -159.88 -35.24 0.06 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' B' ' 75' ' ' TYR . 0.6 OUTLIER -83.98 144.33 29.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.031 -0.986 . . . . 10.0 108.779 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' B' ' 29' ' ' ARG . . . -170.13 101.57 0.29 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.857 0.36 . . . . 10.0 111.042 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -140.57 120.37 13.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.118 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.36 123.54 62.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.155 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.27 141.28 36.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.723 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -119.82 104.35 44.59 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.539 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.4 126.12 3.07 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.781 2.321 . . . . 10.0 111.448 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -70.14 151.27 45.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.918 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.05 -11.74 25.95 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' B' ' 87' ' ' LYS . 8.8 tppt? -149.35 122.29 8.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.166 -0.924 . . . . 10.0 109.075 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.84 85.95 6.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.087 0.47 . . . . 10.0 110.651 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.419 ' HB ' ' HG2' ' B' ' 91' ' ' GLU . 10.8 m -114.63 160.55 13.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.858 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.63 2.38 82.54 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.77 -0.728 . . . . 10.0 111.695 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.419 ' HG2' ' HB ' ' B' ' 89' ' ' VAL . 35.3 mm-40 -60.68 125.45 82.78 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.572 -0.314 . . . . 10.0 110.893 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.13 101.31 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.407 2.071 . . . . 10.0 110.6 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.63 163.91 18.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.673 0.619 . . . . 10.0 112.673 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 47' ' ' THR . 63.1 tttt -114.04 160.65 18.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.298 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.457 HD13 ' HB ' ' B' ' 47' ' ' THR . 18.6 tp -127.42 135.84 51.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.922 0.391 . . . . 10.0 110.772 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.37 126.1 71.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 79.9 mt -129.99 126.62 38.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.889 0.376 . . . . 10.0 112.004 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' THR . . . . . 0.679 HG23 ' HB3' ' B' ' 113' ' ' ASP . 4.0 m -111.52 117.87 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 53.4 m-85 -98.52 100.29 11.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.945 0.35 . . . . 10.0 111.945 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.918 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 15.0 tp60 -117.61 122.05 42.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.104 0.478 . . . . 10.0 110.894 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.79 -162.33 12.46 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.937 -0.649 . . . . 10.0 111.685 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.5 m -151.95 -175.13 5.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.43 -0.582 . . . . 10.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.07 144.56 51.11 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -69.37 -4.05 16.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.156 0.503 . . . . 10.0 111.202 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.52 -13.37 43.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.982 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 118.1 -18.15 11.43 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.975 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' GLY . 6.3 t -66.61 141.99 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.606 0.241 . . . . 10.0 110.473 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 13.8 t -137.49 87.74 2.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.14 0.495 . . . . 10.0 110.005 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.715 ' HB3' HG23 ' A' ' 107' ' ' VAL . 55.3 p90 -76.1 151.95 84.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.875 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.451 ' CD ' ' HA ' ' A' ' 107' ' ' VAL . 67.6 Cg_endo -75.35 163.72 34.04 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.8 2.333 . . . . 10.0 111.521 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.918 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 67.5 Cg_endo -77.0 79.15 3.2 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.623 2.215 . . . . 10.0 112.247 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.635 HG22 HD11 ' A' ' 69' ' ' LEU . 3.1 t -68.0 101.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ASP . . . . . 0.679 ' HB3' HG23 ' B' ' 98' ' ' THR . 4.9 p-10 -86.67 149.47 24.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.127 0.489 . . . . 10.0 111.701 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.09 140.89 44.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.205 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.48 137.64 38.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.007 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.81 135.54 53.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.662 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -95.13 119.48 33.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.302 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 16.5 mm -95.74 76.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 10.0 110.665 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . 0.468 ' CZ ' ' HB2' ' B' ' 121' ' ' ASN . 43.3 p90 -88.75 -24.55 22.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.005 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.54 53.89 0.17 Allowed Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.925 -0.655 . . . . 10.0 112.406 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . 0.468 ' HB2' ' CZ ' ' B' ' 119' ' ' PHE . 7.3 t30 -104.6 -4.69 22.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.246 0.546 . . . . 10.0 109.955 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.85 -77.11 1.94 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.276 -0.73 . . . . 10.0 111.276 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 2.3 m -101.81 140.03 36.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' B' ' 19' ' ' LEU . 78.4 m-85 -128.09 152.72 47.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.926 0.393 . . . . 10.0 110.817 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.3 151.72 70.05 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.147 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' PRO . . . . . 0.41 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 30.3 Cg_endo -64.0 116.23 3.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.468 2.112 . . . . 10.0 111.75 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -82.77 81.47 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.241 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.927 -0.559 . . . . 10.0 109.964 -179.801 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.88 71.1 14.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.861 0.362 . . . . 10.0 111.597 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.97 -31.98 55.08 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.387 2.058 . . . . 10.0 112.256 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -61.88 -41.97 98.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.722 0.296 . . . . 10.0 110.874 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.75 -43.06 80.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.614 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.0 tp -61.95 -34.69 76.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.831 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -80.48 -13.74 58.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.236 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.4 m -84.86 -12.31 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 10.0 110.535 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -59.38 120.79 9.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.254 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.73 133.24 51.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.563 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.869 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 34.9 p -74.09 171.17 14.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.638 -0.504 . . . . 10.0 109.638 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.96 -12.24 60.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.432 0.634 . . . . 10.0 110.542 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.555 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 6.2 t70 -96.03 7.92 45.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.291 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 71.01 19.03 5.77 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.399 -0.819 . . . . 10.0 112.401 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.555 ' HG3' ' HB3' ' A' ' 13' ' ' ASP . 11.6 mtp180 -102.79 143.93 27.6 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.918 -0.401 . . . . 10.0 109.918 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.48 142.1 76.77 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.404 2.07 . . . . 10.0 111.318 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.76 -8.52 28.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.429 -0.35 . . . . 10.0 111.783 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -57.66 -24.27 55.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.637 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.569 HG23 ' HD1' ' A' ' 20' ' ' TYR . 29.5 m -63.16 -18.73 22.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.932 0.396 . . . . 10.0 111.579 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.569 ' HD1' HG23 ' A' ' 19' ' ' VAL . 15.4 m-85 -126.03 24.27 6.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.433 0.635 . . . . 10.0 109.927 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 68.9 mt -138.6 58.82 1.65 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.269 -0.878 . . . . 10.0 109.441 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -154.37 -178.7 7.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.98 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? 66.85 12.78 9.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.598 -0.728 . . . . 10.0 112.316 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 55.3 38.31 30.17 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.075 0.464 . . . . 10.0 111.689 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -107.51 151.56 41.03 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.704 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.84 152.16 59.39 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.009 2.472 . . . . 10.0 112.153 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.88 141.71 48.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.64 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD23 ' HG ' ' A' ' 60' ' ' LEU . 19.7 tp -122.33 94.97 4.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.6 mt -93.38 122.51 44.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.613 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HG3' ' CE2' ' A' ' 111' ' ' TRP . 3.6 tmmt? -123.08 129.7 51.82 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.978 0.418 . . . . 10.0 111.134 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.497 ' HB2' ' HB2' ' A' ' 110' ' ' SER . 23.7 m-85 -92.8 137.88 31.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.307 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -132.57 171.91 13.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.145 -0.48 . . . . 10.0 110.475 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.67 137.54 54.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.756 0.312 . . . . 10.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.28 -39.99 46.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.928 -0.578 . . . . 10.0 112.12 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.699 ' HE1' ' HA ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -91.64 25.02 2.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.404 0.52 . . . . 10.0 112.404 -179.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.506 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 46.3 t -115.6 124.33 30.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HA ' HD12 ' A' ' 40' ' ' LEU . 28.0 Cg_endo -63.24 -41.96 24.92 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.771 2.314 . . . . 10.0 112.142 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.72 -31.53 72.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.988 0.423 . . . . 10.0 111.07 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.1 m -84.19 -14.95 48.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.568 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 37' ' ' PRO . 53.1 mt -71.55 -45.79 61.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.556 -0.293 . . . . 10.0 111.752 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -22.04 62.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.426 0.631 . . . . 10.0 110.559 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -23.69 62.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.353 -0.84 . . . . 10.0 111.458 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -58.55 -53.93 52.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.118 0.414 . . . . 10.0 112.118 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.56 -35.76 89.9 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.047 -0.597 . . . . 10.0 111.943 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -66.95 -41.68 86.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.791 0.329 . . . . 10.0 110.46 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.9 m -61.72 -43.92 97.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.96 -0.563 . . . . 10.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.506 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -65.58 -39.82 92.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.774 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.56 -40.09 95.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.114 0.483 . . . . 10.0 110.337 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -73.64 -34.12 64.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.891 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.06 -13.78 60.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.001 0.429 . . . . 10.0 111.623 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -113.01 10.62 18.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.131 0.491 . . . . 10.0 110.699 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -81.1 140.31 35.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.911 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.64 -33.36 74.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.159 0.429 . . . . 10.0 112.159 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.799 ' HB3' HD12 ' A' ' 137' ' ' ILE . 17.5 mmmt -77.31 -37.86 51.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.721 0.296 . . . . 10.0 111.519 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -77.58 -10.26 59.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.017 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.5 t -69.18 -12.32 61.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 10.0 111.521 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 m -80.16 -2.96 46.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.918 0.389 . . . . 10.0 111.167 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.27 159.36 41.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.222 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -94.89 92.4 6.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.816 0.341 . . . . 10.0 110.339 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.501 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -83.76 124.48 30.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.791 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.583 HG22 ' HB2' ' A' ' 90' ' ' PRO . 3.3 pt -140.94 141.63 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.915 0.388 . . . . 10.0 111.434 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -104.49 113.33 26.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.563 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.551 HG22 ' HB ' ' A' ' 92' ' ' VAL . 17.6 t -110.65 142.81 22.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.886 0.374 . . . . 10.0 111.621 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -137.41 140.44 41.32 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 1.7 m -98.19 104.99 25.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.774 0.321 . . . . 10.0 111.854 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.666 ' HG3' HG22 ' A' ' 93' ' ' THR . 39.6 Cg_endo -65.9 121.56 8.93 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.745 2.297 . . . . 10.0 112.261 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.05 -4.78 83.22 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.577 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 25.8 t80 -111.15 148.98 31.56 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.302 -0.259 . . . . 10.0 110.302 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.6 mt 60.61 29.15 18.8 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.412 0.445 . . . . 10.0 111.667 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.528 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.1 OUTLIER 68.0 19.24 9.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.465 -0.788 . . . . 10.0 112.105 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.699 ' HA ' ' HE1' ' A' ' 35' ' ' TRP . 2.7 mm-40 -80.95 179.95 7.61 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.689 0.28 . . . . 10.0 110.893 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 42.8 mmtt -69.18 142.24 54.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 74' ' ' ASP . 77.3 tttt -73.19 165.69 24.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.476 -0.329 . . . . 10.0 111.303 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 73' ' ' LYS . 16.9 t70 -55.16 147.18 16.79 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.763 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.44 -57.24 4.73 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.586 -1.006 . . . . 10.0 110.586 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.86 -44.94 95.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.401 0.619 . . . . 10.0 109.424 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -67.43 -39.01 85.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.258 -0.883 . . . . 10.0 111.33 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -65.14 -42.83 93.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.839 0.352 . . . . 10.0 111.075 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -65.55 -24.67 67.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.402 . . . . 10.0 110.854 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.422 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 2.9 t90 -64.9 -47.15 78.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.658 -0.868 . . . . 10.0 108.658 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -66.27 -41.22 90.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.714 -0.676 . . . . 10.0 110.732 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.23 -31.22 65.3 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.993 -0.549 . . . . 10.0 111.002 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.38 35.33 5.04 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.835 -0.698 . . . . 10.0 112.067 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 84' ' ' LEU . 10.8 mt -118.3 -178.22 3.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.81 0.338 . . . . 10.0 110.814 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -100.31 171.44 7.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.413 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 90.7 m-85 66.6 82.11 0.2 Allowed Pre-proline 0 N--CA 1.466 0.326 0 O-C-N 123.556 0.535 . . . . 10.0 111.41 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.73 1.36 6.45 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.45 2.1 . . . . 10.0 112.915 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 88' ' ' LYS . 16.3 mtpp -104.73 6.24 34.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.534 0.207 . . . . 10.0 111.108 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.506 ' HG ' ' HG3' ' A' ' 47' ' ' GLU . 9.0 mt -69.05 116.84 45.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.755 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.583 ' HB2' HG22 ' A' ' 61' ' ' ILE . 71.8 Cg_endo -78.94 69.01 8.07 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.543 2.162 . . . . 10.0 111.696 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' THR . 44.3 t -87.51 124.78 41.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.717 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.869 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 6.4 t -112.03 142.53 24.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.666 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -98.31 104.3 16.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.814 0.34 . . . . 10.0 110.986 -179.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 57.3 t0 -85.77 79.92 9.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.137 0.494 . . . . 10.0 110.039 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -65.67 110.26 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.601 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.34 -25.18 27.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.875 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.27 51.51 2.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.651 -0.785 . . . . 10.0 111.654 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 102' ' ' SER . 0.5 OUTLIER -62.52 -51.6 66.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.009 0.433 . . . . 10.0 110.45 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.454 ' HB ' ' HZ ' ' A' ' 31' ' ' PHE . 31.5 mm -81.89 -38.18 15.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.021 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.773 ' HA ' HD13 ' A' ' 105' ' ' ILE . . . -57.12 -44.51 83.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.281 -0.872 . . . . 10.0 111.787 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -80.57 -28.28 37.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 10.0 111.184 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 98' ' ' THR . 4.4 t -63.02 -47.03 84.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.57 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -101.37 -5.76 24.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.849 0.314 . . . . 10.0 111.849 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 t30 65.79 70.82 0.43 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.57 0.7 . . . . 10.0 111.638 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.773 HD13 ' HA ' ' A' ' 100' ' ' ALA . 2.6 mp -86.47 126.44 40.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.433 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.41 23.52 2.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.877 0.37 . . . . 10.0 111.245 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.503 HG23 ' HB3' ' B' ' 109' ' ' TYR . 5.5 p -172.05 157.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.409 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -123.51 150.49 61.25 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.511 -0.552 . . . . 10.0 109.511 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -90.09 132.38 9.18 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.315 -1.535 . . . . 10.0 111.978 -0.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 25.7 m -93.61 121.45 35.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.189 -0.46 . . . . 10.0 109.939 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.525 ' CE2' ' HG3' ' A' ' 30' ' ' LYS . 69.0 m95 -106.62 108.47 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.829 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.13 110.12 22.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.208 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 136' ' ' LEU . 38.6 tp -90.81 112.01 23.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.699 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.0 133.11 45.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -71.38 -179.51 30.96 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.056 -0.592 . . . . 10.0 113.121 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -75.56 -4.9 42.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 10.0 111.405 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.98 -12.39 25.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.236 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 99.95 5.08 55.25 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.754 -0.736 . . . . 10.0 113.216 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -106.5 152.91 23.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.686 0.279 . . . . 10.0 111.24 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.92 118.67 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.094 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.53 -48.72 7.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.554 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -147.75 141.79 25.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.592 -0.277 . . . . 10.0 111.132 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -121.89 121.64 64.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.307 -0.406 . . . . 10.0 109.999 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.0 t -113.22 125.89 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.688 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -126.17 110.58 13.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.427 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 157.79 -87.47 0.12 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.173 -1.013 . . . . 10.0 113.2 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.5 t -170.57 131.17 0.89 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt -116.01 158.05 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.726 0.298 . . . . 10.0 110.796 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -108.23 171.48 7.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.473 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.53 -40.4 96.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.021 0.378 . . . . 10.0 112.021 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.4 88.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.556 -0.293 . . . . 10.0 110.767 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -61.89 -41.8 98.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.746 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.3 96.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 10.0 110.364 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.8 mt -71.52 -26.5 62.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.972 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.93 -34.35 29.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.504 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 140' ' ' PRO . 19.5 tp -62.86 -33.95 76.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.25 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.799 HD12 ' HB3' ' A' ' 54' ' ' LYS . 13.3 pt -83.03 15.91 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.124 0.487 . . . . 10.0 111.31 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -133.69 -48.33 0.82 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.655 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -138.25 97.36 9.63 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.302 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.545 ' HA ' HD12 ' A' ' 136' ' ' LEU . 57.7 Cg_endo -70.94 2.57 4.05 Favored 'Trans proline' 0 CA--C 1.526 0.092 0 C-N-CA 123.014 2.476 . . . . 10.0 112.83 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -95.36 -5.32 43.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.825 0.345 . . . . 10.0 110.132 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.17 134.6 36.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.836 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -126.09 155.08 42.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.16 -0.682 . . . . 10.0 109.16 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.98 0 N-CA-C 113.57 0.952 . . . . 10.0 113.57 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 47.4 mtt . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.599 0.238 . . . . 10.0 111.32 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.65 -83.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.462 -0.335 . . . . 10.0 111.287 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 34.8 tp -93.32 -55.04 3.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.005 -0.278 . . . . 10.0 110.896 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . 0.525 ' HA ' HD13 ' B' ' 9' ' ' LEU . 0.6 OUTLIER 53.6 35.58 21.33 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.672 0.608 . . . . 10.0 111.518 -179.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.93 166.44 27.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.441 -0.8 . . . . 10.0 110.555 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.91 -160.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.413 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -107.16 28.46 8.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.302 0.572 . . . . 10.0 109.925 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -92.95 7.68 42.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.96 -0.564 . . . . 10.0 111.391 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.591 HD12 ' HD3' ' B' ' 13' ' ' LYS . 2.6 pt? -133.17 140.81 38.53 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.772 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.88 148.7 93.14 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.125 2.55 . . . . 10.0 112.333 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.28 -37.76 81.18 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.46 2.773 . . . . 10.0 113.456 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -63.98 -20.89 66.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 10.0 111.936 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.591 ' HD3' HD12 ' B' ' 9' ' ' LEU . 2.5 tmtm? -111.57 -6.32 14.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.253 0.549 . . . . 10.0 110.468 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.12 -17.36 46.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.042 -0.527 . . . . 10.0 111.793 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.438 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 13.7 m-85 -127.54 125.81 41.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.711 0.291 . . . . 10.0 110.934 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.76 89.8 16.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.114 -0.494 . . . . 10.0 109.757 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.511 ' HG2' ' HG3' ' B' ' 126' ' ' PRO . 9.5 Cg_exo -73.26 106.5 2.18 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.996 2.464 . . . . 10.0 112.707 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -101.57 110.23 22.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.665 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' B' ' 19' ' ' LEU . 3.5 mm? -92.73 117.08 29.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.152 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.68 98.03 6.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.284 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.528 HG13 HG22 ' B' ' 26' ' ' VAL . 29.2 t -82.18 117.12 27.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.204 -0.453 . . . . 10.0 109.94 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.27 -174.32 2.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.476 -0.329 . . . . 10.0 110.808 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.14 -37.88 53.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.422 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.3 -36.68 39.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.788 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.498 ' HA2' ' CZ ' ' B' ' 85' ' ' TYR . . . -174.52 -179.75 45.32 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.521 -0.847 . . . . 10.0 112.432 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.528 HG22 HG13 ' B' ' 21' ' ' VAL . 46.9 t -90.44 128.74 42.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -114.94 110.23 19.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' B' ' 81' ' ' VAL . 3.8 p -94.94 124.11 47.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.904 0.383 . . . . 10.0 110.944 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -127.03 87.94 2.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.195 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 10.4 p90 -91.55 118.04 30.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.94 0.4 . . . . 10.0 110.765 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 mtm-85 -78.2 126.18 30.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.702 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 23.7 mt -101.93 141.25 18.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.263 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.42 151.21 47.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.039 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.92 81.68 2.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.142 0.496 . . . . 10.0 111.381 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.05 -21.22 0.13 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.063 -0.815 . . . . 10.0 111.063 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.23 147.15 28.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -139.78 136.08 33.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.094 0.474 . . . . 10.0 111.009 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' MET . . . . . 0.408 ' HA ' ' HA3' ' B' ' 101' ' ' GLY . 43.2 mtt -106.91 152.18 24.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.973 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.619 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 38.4 m-85 -92.11 125.59 36.85 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.903 -0.777 . . . . 10.0 108.903 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -59.85 -29.66 68.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.716 0.293 . . . . 10.0 111.668 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.39 -8.62 59.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.36 . . . . 10.0 111.17 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' B' ' 100' ' ' GLN . 37.2 mmtt -107.45 -13.81 15.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.838 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 39' ' ' TYR . 85.3 mt -80.84 102.24 6.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.022 0.439 . . . . 10.0 109.847 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.77 129.85 44.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.683 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.6 129.04 2.64 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.686 -0.769 . . . . 10.0 111.911 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -156.47 137.81 13.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.818 0.342 . . . . 10.0 111.097 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.661 ' HB ' HD13 ' B' ' 95' ' ' LEU . 13.2 t -138.49 125.11 20.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.494 -0.558 . . . . 10.0 109.494 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.54 ' CG ' ' HA ' ' B' ' 51' ' ' ASP . 24.2 p30 -177.9 160.1 1.27 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.316 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.08 -76.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.687 2.258 . . . . 10.0 110.635 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.57 48.62 0.83 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.447 0.641 . . . . 10.0 109.839 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.54 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 6.7 t0 63.63 35.82 11.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.998 -1.001 . . . . 10.0 112.427 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.49 ' HA ' HD13 ' B' ' 52' ' ' LEU . 2.3 mm? -90.65 67.57 6.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.79 -0.641 . . . . 10.0 111.075 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.533 ' HB2' HD22 ' B' ' 48' ' ' ASN . 19.1 tp -125.28 144.45 50.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 10.0 109.798 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.46 -64.94 1.91 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.561 -0.828 . . . . 10.0 112.254 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -169.29 157.71 7.07 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.0 -0.37 . . . . 10.0 110.0 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.99 97.72 1.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.514 2.143 . . . . 10.0 110.427 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m -78.97 100.37 7.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.971 0.415 . . . . 10.0 111.611 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -87.96 149.48 24.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.095 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m -79.98 -14.13 58.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.701 0.286 . . . . 10.0 110.755 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? 72.72 136.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.672 -0.695 . . . . 10.0 112.332 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.38 -133.24 4.33 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.003 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -116.18 149.38 39.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -86.66 136.27 33.09 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -114.8 130.85 56.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.636 0.255 . . . . 10.0 110.791 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.18 119.75 18.82 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.14 -177.76 3.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.79 -0.641 . . . . 10.0 109.429 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -112.2 -51.6 2.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.683 0.277 . . . . 10.0 111.097 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -84.49 -30.13 25.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.253 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.495 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 5.8 m-30 -95.91 -10.11 29.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.997 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.23 -92.66 1.39 Allowed Glycine 0 C--O 1.224 -0.488 0 C-N-CA 120.853 -0.689 . . . . 10.0 112.734 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -165.2 115.57 1.1 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.758 0.313 . . . . 10.0 110.615 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -144.06 170.53 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.258 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 3.4 m -74.14 134.35 42.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.548 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.65 161.02 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.97 0.414 . . . . 10.0 111.131 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -115.98 130.98 57.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.185 -1.043 . . . . 10.0 108.185 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -114.22 -6.84 13.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.793 0.664 . . . . 10.0 112.793 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -173.17 -37.0 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -83.26 135.49 34.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.918 -1.037 . . . . 10.0 109.537 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' B' ' 30' ' ' PHE . . . -161.7 110.98 1.54 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.002 0.43 . . . . 10.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 25.9 tt0 -151.39 121.25 7.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.254 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.421 ' HB ' ' CG1' ' B' ' 28' ' ' VAL . 9.3 t -125.89 131.96 71.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.56 135.74 48.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.875 0.369 . . . . 10.0 110.435 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -113.73 108.28 51.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.374 -0.376 . . . . 10.0 111.626 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.41 131.08 4.02 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.836 2.358 . . . . 10.0 111.655 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' TYR . . . . . 0.498 ' CZ ' ' HA2' ' B' ' 25' ' ' GLY . 14.9 m-85 -76.34 142.77 41.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 10.0 109.942 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.9 11.22 38.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.096 0.474 . . . . 10.0 110.661 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -166.69 128.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.697 -0.683 . . . . 10.0 109.656 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.38 81.41 5.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.995 0.426 . . . . 10.0 111.337 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.5 126.72 73.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.996 -0.547 . . . . 10.0 110.74 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.46 58.26 4.87 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.045 -0.598 . . . . 10.0 111.77 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -113.78 149.17 41.34 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.93 95.23 0.48 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.138 1.892 . . . . 10.0 111.472 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.28 140.16 38.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.262 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' B' ' 47' ' ' THR . 70.6 tttt -91.86 147.3 23.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.661 HD13 ' HB ' ' B' ' 47' ' ' THR . 35.9 tp -118.6 127.79 53.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.881 0.372 . . . . 10.0 110.887 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.37 121.15 66.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.031 -0.729 . . . . 10.0 109.031 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.14 137.61 53.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 10.0 111.324 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 7.3 m -129.02 121.0 27.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 38.2 m-85 -104.77 118.5 36.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.919 0.39 . . . . 10.0 111.457 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.716 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 11.3 tp60 -132.9 123.71 26.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.32 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -161.88 -158.33 9.43 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.66 -0.781 . . . . 10.0 111.737 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 20.3 m -152.05 175.57 12.41 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.283 -0.636 . . . . 10.0 109.283 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -115.71 148.81 39.35 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.142 -0.318 . . . . 10.0 110.142 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.39 -10.55 44.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.237 0.458 . . . . 10.0 112.237 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.52 6.98 46.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 10.0 111.507 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.82 -6.8 67.4 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.761 -0.733 . . . . 10.0 112.549 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 5.7 t -68.35 136.26 26.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.843 -0.429 . . . . 10.0 109.843 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 21.6 t -127.31 107.98 10.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.692 0.282 . . . . 10.0 110.744 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.503 ' HB3' HG23 ' A' ' 107' ' ' VAL . 35.8 p90 -97.72 148.34 34.31 Favored Pre-proline 0 C--N 1.327 -0.402 0 O-C-N 122.226 -0.296 . . . . 10.0 111.625 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.53 159.49 52.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.927 2.418 . . . . 10.0 111.666 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.716 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 59.1 Cg_endo -74.51 83.59 1.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.583 2.189 . . . . 10.0 111.72 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.17 122.86 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.01 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -104.71 150.32 24.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.03 0.443 . . . . 10.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -141.5 138.78 33.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.004 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' B' ' 94' ' ' LYS . 47.4 mt-10 -107.78 134.93 50.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.556 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' B' ' 95' ' ' LEU . 75.6 m-85 -122.38 150.02 43.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.853 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -116.42 116.21 27.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.751 0.31 . . . . 10.0 110.171 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 19.9 mm -94.15 93.13 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.044 0.45 . . . . 10.0 111.06 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -102.08 -13.45 17.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.319 0.58 . . . . 10.0 110.926 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 122.5 110.87 2.07 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.634 -0.793 . . . . 10.0 112.095 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -176.02 -22.13 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 10.0 110.565 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.92 -74.3 2.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.707 -0.758 . . . . 10.0 111.861 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.62 129.45 35.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 10.0 111.238 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -132.84 150.26 52.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.327 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.65 146.99 34.18 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.239 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' PRO . . . . . 0.511 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 34.7 Cg_endo -65.74 118.62 5.63 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.487 2.125 . . . . 10.0 112.407 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -75.51 82.57 2.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.489 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.877 -0.582 . . . . 10.0 109.995 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.463 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 3.6 m -127.49 64.81 64.32 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 112.229 0.455 . . . . 10.0 112.229 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.58 -36.63 63.38 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.062 1.841 . . . . 10.0 111.973 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -65.89 -37.17 85.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.734 0.302 . . . . 10.0 110.985 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 2' ' ' VAL . 1.3 m -70.33 -31.45 68.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.651 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.608 ' HG ' HD13 ' A' ' 21' ' ' LEU . 15.6 tp -63.34 -32.04 73.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.221 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 m -86.79 -8.24 57.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.833 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 5' ' ' THR . 6.8 m -76.5 -23.08 53.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.593 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 94' ' ' ASP . 1.1 mm? -73.52 118.14 16.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.284 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -111.19 147.55 34.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.386 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.799 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 25.1 p -71.3 178.26 3.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.084 -0.507 . . . . 10.0 111.332 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.17 -14.98 62.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.05 0.453 . . . . 10.0 110.465 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -89.0 -2.2 58.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.632 -0.713 . . . . 10.0 109.319 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.6 t30 75.22 19.67 2.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.854 -1.066 . . . . 10.0 110.554 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -101.13 126.54 34.5 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.226 -0.897 . . . . 10.0 109.278 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.49 140.49 35.49 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.132 2.555 . . . . 10.0 112.397 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.41 -2.56 8.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.302 0.482 . . . . 10.0 112.302 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.592 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -60.12 -16.13 29.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 10.0 111.439 179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.73 -23.97 34.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.991 0.425 . . . . 10.0 111.052 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.401 ' HB3' ' HB3' ' A' ' 59' ' ' ASN . 45.3 m-85 -120.42 4.27 10.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.686 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.608 HD13 ' HG ' ' A' ' 6' ' ' LEU . 73.6 mt -108.81 26.65 10.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.267 0.556 . . . . 10.0 110.348 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -128.97 -174.94 3.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.913 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt 68.92 11.15 8.26 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.72 0.638 . . . . 10.0 111.151 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.37 41.54 32.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.36 -0.837 . . . . 10.0 111.82 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -110.42 138.89 21.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.95 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.23 125.67 19.94 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.962 2.441 . . . . 10.0 111.713 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.8 117.86 34.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.757 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.469 HD23 HD13 ' A' ' 60' ' ' LEU . 10.0 tp -89.23 110.03 20.84 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.4 mt -93.58 118.53 39.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 10.0 111.992 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.497 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 14.8 tttt -119.92 129.64 54.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.482 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.656 ' HB3' ' HE1' ' A' ' 108' ' ' TYR . 6.5 m-85 -99.07 135.35 40.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.465 -0.334 . . . . 10.0 111.085 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -122.42 -178.6 3.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 10.0 110.812 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.22 146.38 35.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.571 0.225 . . . . 10.0 111.133 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.7 -31.34 14.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.705 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.544 ' CH2' ' HA ' ' B' ' 110' ' ' PRO . 0.9 OUTLIER -82.32 11.0 5.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.189 0.44 . . . . 10.0 112.189 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.89 125.82 27.19 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.74 0.305 . . . . 10.0 111.449 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.8 -35.44 9.59 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.533 2.156 . . . . 10.0 112.63 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.7 mt -64.52 -47.04 80.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.38 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 76.7 m -69.46 -20.1 63.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.275 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HB3' ' CE2' ' B' ' 68' ' ' PHE . 1.5 tp -69.09 -41.73 77.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.594 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.99 -32.88 69.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.129 0.49 . . . . 10.0 110.223 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -63.12 -23.41 67.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.622 -0.717 . . . . 10.0 110.978 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' HD11 ' A' ' 89' ' ' LEU . 86.9 mt -59.5 -36.73 76.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 10.0 110.352 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.78 -37.09 88.3 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.564 -1.014 . . . . 10.0 110.564 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.33 -36.01 73.99 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -61.87 -41.62 98.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.806 -0.634 . . . . 10.0 109.852 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 88' ' ' LYS . 31.3 tt0 -61.55 -39.18 90.18 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 120.962 0.41 . . . . 10.0 109.945 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -63.08 -44.14 96.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.705 -0.68 . . . . 10.0 109.727 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -68.52 -33.5 74.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.983 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.43 -2.73 20.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.123 0.487 . . . . 10.0 110.821 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -125.3 14.82 8.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.74 -0.663 . . . . 10.0 109.603 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 15.2 t70 -87.05 140.92 29.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.447 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.73 94.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.165 0.431 . . . . 10.0 112.165 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -76.39 -37.81 56.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.77 0.319 . . . . 10.0 111.321 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.702 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 27.7 m-85 -71.16 -16.0 62.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.322 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.9 t -72.26 -0.28 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 10.0 111.673 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -75.49 -22.05 57.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 10.0 110.222 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.96 169.05 15.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 10.0 109.72 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 87.5 m-20 -100.08 97.5 8.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.673 0.273 . . . . 10.0 110.315 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.469 HD13 HD23 ' A' ' 28' ' ' LEU . 54.2 tp -83.29 130.81 35.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.442 -0.344 . . . . 10.0 110.944 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.487 ' HA ' ' HG2' ' A' ' 90' ' ' PRO . 21.6 pt -135.9 146.71 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.966 0.413 . . . . 10.0 111.156 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -107.03 105.98 16.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.236 -0.438 . . . . 10.0 109.908 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.407 HG13 ' HB ' ' A' ' 92' ' ' VAL . 5.4 t -103.31 146.51 10.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.124 0.487 . . . . 10.0 111.71 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . . . -143.44 146.25 33.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.205 -1.035 . . . . 10.0 108.205 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 7.1 m -106.46 98.63 20.68 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 112.196 0.443 . . . . 10.0 112.196 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.582 ' HG3' HG22 ' A' ' 93' ' ' THR . 17.8 Cg_endo -60.0 123.51 13.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.944 2.429 . . . . 10.0 112.27 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.98 -13.36 66.37 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.944 -0.646 . . . . 10.0 112.954 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 52.9 t80 -94.42 139.05 31.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.822 0.311 . . . . 10.0 110.469 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.766 HD11 HG22 ' B' ' 112' ' ' VAL . 0.2 OUTLIER 57.03 35.55 26.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.08 -0.509 . . . . 10.0 112.183 179.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.36 20.73 8.56 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.026 0.75 . . . . 10.0 113.026 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 2.7 mm-40 -75.69 -179.07 4.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.718 0.294 . . . . 10.0 110.723 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -67.39 121.3 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.218 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -66.5 155.56 37.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.706 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.09 130.79 47.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.176 -0.466 . . . . 10.0 111.173 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.16 -40.41 2.53 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.586 -1.406 . . . . 10.0 109.586 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.484 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 2.2 t70 -97.4 -34.84 10.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.965 0.412 . . . . 10.0 110.103 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 64' ' ' ALA . 76.0 t80 -56.26 -50.97 69.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.706 . . . . 10.0 112.432 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -35.31 76.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.457 -0.338 . . . . 10.0 111.482 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 20.5 mtmt -70.65 -28.9 65.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.765 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -60.99 -49.74 76.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.623 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -73.93 -32.06 63.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.605 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.88 -18.99 63.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.6 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.74 5.88 43.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.938 -0.648 . . . . 10.0 111.689 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.0 mt -106.49 177.48 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.958 0.408 . . . . 10.0 111.042 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.405 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 49.3 t30 -98.22 -162.65 0.97 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.765 -0.652 . . . . 10.0 109.942 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.405 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 13.5 m-85 65.43 78.28 0.26 Allowed Pre-proline 0 N--CA 1.464 0.258 0 C-N-CA 122.829 0.451 . . . . 10.0 111.356 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.05 -0.69 10.57 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.616 2.211 . . . . 10.0 112.3 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 4.4 mmpt? -101.22 10.55 40.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.155 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 43' ' ' LEU . 16.5 mt -85.76 112.56 45.71 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.019 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.487 ' HG2' ' HA ' ' A' ' 61' ' ' ILE . 72.9 Cg_endo -79.03 63.44 8.71 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.571 2.181 . . . . 10.0 111.051 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 62' ' ' THR . 99.3 t -73.38 117.89 17.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.825 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.799 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 21.7 t -103.28 138.98 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.439 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -97.68 107.09 19.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.119 -0.492 . . . . 10.0 110.922 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 54.0 t0 -103.18 84.33 2.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.894 0.378 . . . . 10.0 110.237 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.424 ' HA ' ' HG2' ' A' ' 66' ' ' PRO . 28.2 t-20 -63.9 116.87 6.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 10.0 112.109 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.96 -19.66 53.91 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.825 -0.703 . . . . 10.0 112.629 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.77 50.71 5.13 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.106 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 102' ' ' SER . 0.2 OUTLIER -62.46 -42.12 99.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.976 0.417 . . . . 10.0 110.523 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.9 mm -82.88 -40.2 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.889 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.576 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -60.63 -45.12 95.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.759 -0.655 . . . . 10.0 111.655 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -72.0 -30.04 64.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 98' ' ' THR . 1.4 t -65.86 -38.53 89.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.948 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.13 7.2 44.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.947 0.404 . . . . 10.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.3 t30 50.48 60.98 3.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.421 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 100' ' ' ALA . 79.9 mt -87.14 98.46 7.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.752 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.21 8.62 25.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.914 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.617 ' HA ' ' CD ' ' B' ' 110' ' ' PRO . 7.0 p -149.17 154.53 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.67 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.656 ' HE1' ' HB3' ' A' ' 31' ' ' PHE . 57.1 m-85 -131.05 152.63 81.01 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.252 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 126' ' ' GLY . 97.8 Cg_endo -82.39 161.7 76.75 Favored 'Cis proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.935 -1.694 . . . . 10.0 111.372 -1.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 m -127.67 131.34 49.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.698 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -118.82 125.12 48.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.19 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.54 113.08 26.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.843 0.354 . . . . 10.0 110.332 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 140' ' ' PRO . 44.1 tp -89.51 101.12 13.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.168 0.509 . . . . 10.0 111.293 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.28 133.13 32.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.666 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.26 -177.43 49.96 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.088 -0.577 . . . . 10.0 113.244 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -67.86 -11.4 58.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.265 0.469 . . . . 10.0 112.265 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.36 -7.94 30.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 10.0 111.382 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.38 -7.0 63.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.684 -0.769 . . . . 10.0 112.626 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -89.0 156.0 19.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.734 0.302 . . . . 10.0 110.844 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.6 t -78.55 107.75 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.149 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -81.99 -41.52 20.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.263 -0.426 . . . . 10.0 111.507 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -148.76 160.01 43.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.372 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.9 tt -138.14 141.44 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.493 -0.558 . . . . 10.0 109.493 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.3 t -121.92 129.98 74.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.202 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -133.21 124.68 27.84 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.437 -0.347 . . . . 10.0 110.128 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.598 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 132.88 -72.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.44 -0.886 . . . . 10.0 112.511 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.79 ' HB2' HG22 ' B' ' 107' ' ' VAL . 5.1 t -178.83 162.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.6 pt -146.28 152.17 13.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.158 -0.474 . . . . 10.0 109.914 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -109.96 170.41 8.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.836 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -56.41 -43.8 79.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.03 78.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 10.0 110.807 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -67.86 -37.26 81.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.903 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.66 97.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.0 mt -69.37 -40.92 77.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.782 -0.644 . . . . 10.0 110.5 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.29 -36.71 84.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.067 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.604 HD11 HD22 ' A' ' 113' ' ' LEU . 16.8 tp -62.83 -35.75 80.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.933 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.87 -36.81 59.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.343 0.592 . . . . 10.0 109.416 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -70.24 -47.48 61.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.465 -0.789 . . . . 10.0 110.709 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 23.3 t0 -150.42 112.27 3.23 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.495 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.688 ' HB3' HD21 ' A' ' 113' ' ' LEU . 19.3 Cg_exo -68.01 -7.32 19.44 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.922 2.415 . . . . 10.0 112.061 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -92.85 -0.27 57.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.932 0.396 . . . . 10.0 111.187 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.39 84.2 7.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.902 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.546 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 17.0 t70 -75.69 147.33 39.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.051 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.977 -1.011 . . . . 10.0 113.108 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.795 0.331 . . . . 10.0 110.837 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.22 -72.61 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.523 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 38.2 tp -78.98 -77.29 0.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 59.03 36.13 24.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.116 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.95 159.29 42.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.242 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 21.5 m120 64.03 -154.2 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.448 -0.797 . . . . 10.0 111.761 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -107.19 17.54 22.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.965 0.412 . . . . 10.0 111.028 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.35 8.59 4.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.476 0.547 . . . . 10.0 112.476 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.16 132.61 14.74 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.69 -0.232 . . . . 10.0 111.094 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . 0.522 ' HB2' ' OE1' ' B' ' 12' ' ' GLU . 24.1 Cg_endo -60.87 153.93 59.65 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.353 2.702 . . . . 10.0 112.184 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.55 -40.25 54.87 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.591 2.86 . . . . 10.0 113.612 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.522 ' OE1' ' HB2' ' B' ' 10' ' ' PRO . 3.0 pm0 -65.49 -13.81 59.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -117.13 -1.13 11.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.205 0.526 . . . . 10.0 110.412 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.69 -12.48 23.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.116 -0.493 . . . . 10.0 112.077 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -124.01 128.74 49.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.859 0.362 . . . . 10.0 111.486 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' B' ' 31' ' ' ARG . 40.6 t -114.71 91.11 24.27 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.389 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.509 ' HG2' ' HG3' ' B' ' 126' ' ' PRO . 14.2 Cg_exo -70.52 95.78 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.986 2.458 . . . . 10.0 112.367 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.51 97.74 11.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' B' ' 123' ' ' THR . 3.3 mm? -87.93 110.31 20.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.159 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.5 101.92 10.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.158 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.491 HG13 HG22 ' B' ' 26' ' ' VAL . 47.8 t -88.96 130.98 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.186 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.96 176.28 5.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.847 -0.427 . . . . 10.0 109.847 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.22 -34.16 68.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.929 0.395 . . . . 10.0 111.447 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.46 -36.34 53.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.277 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' B' ' 85' ' ' TYR . . . -178.75 -175.93 46.2 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.961 -0.638 . . . . 10.0 111.692 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.491 HG22 HG13 ' B' ' 21' ' ' VAL . 54.5 t -98.09 133.35 40.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 110.228 -0.286 . . . . 10.0 110.228 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -120.28 105.45 10.94 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.967 -0.383 . . . . 10.0 109.967 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.472 HG22 ' HD1' ' B' ' 30' ' ' PHE . 6.3 p -93.57 124.19 45.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.128 0.489 . . . . 10.0 110.969 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -127.47 85.77 2.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.91 -0.586 . . . . 10.0 109.947 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.472 ' HD1' HG22 ' B' ' 28' ' ' VAL . 1.9 p90 -82.71 111.23 18.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.265 0.555 . . . . 10.0 111.004 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.435 ' HB2' ' HB ' ' B' ' 16' ' ' VAL . 32.5 mtm-85 -75.55 112.5 11.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.453 -0.794 . . . . 10.0 110.194 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -91.65 145.21 7.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.819 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.8 155.06 40.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.148 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.15 88.16 2.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.104 0.478 . . . . 10.0 111.27 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.74 -15.46 0.45 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.538 -0.625 . . . . 10.0 111.538 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -109.66 142.37 40.92 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -133.9 136.98 44.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.86 0.362 . . . . 10.0 110.862 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' MET . . . . . 0.48 ' HA ' ' HA3' ' B' ' 101' ' ' GLY . 41.1 mtt -108.52 147.65 31.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.864 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.474 ' O ' HG13 ' B' ' 43' ' ' ILE . 50.0 m-85 -88.25 123.82 33.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.853 -0.425 . . . . 10.0 109.853 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -60.08 -32.42 70.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.517 -0.31 . . . . 10.0 111.403 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.67 5.74 20.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.306 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.446 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 24.0 mmtt -124.58 -8.42 7.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.461 -0.336 . . . . 10.0 111.836 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 39' ' ' TYR . 86.9 mt -83.91 99.21 6.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.251 0.548 . . . . 10.0 110.155 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 41.6 t -90.25 112.0 24.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.09 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' B' ' 96' ' ' VAL . . . -141.73 128.71 3.71 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.893 -0.67 . . . . 10.0 111.545 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -160.56 143.13 13.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.945 0.402 . . . . 10.0 111.444 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.635 ' HB ' HD13 ' B' ' 95' ' ' LEU . 13.4 t -134.6 131.45 37.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.903 -0.59 . . . . 10.0 109.64 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.482 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 9.2 p30 -177.08 158.08 1.37 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.576 -0.284 . . . . 10.0 110.774 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.418 ' HG3' ' HD2' ' B' ' 93' ' ' TYR . 9.3 Cg_exo -74.67 -58.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.614 2.209 . . . . 10.0 110.976 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.63 48.53 2.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 10.0 109.795 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.414 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 0.4 OUTLIER 66.23 36.62 5.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.326 -0.852 . . . . 10.0 111.748 -178.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' B' ' 52' ' ' LEU . 2.4 mm? -97.01 56.69 1.43 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.712 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' B' ' 48' ' ' ASN . 11.8 tp -130.64 152.1 50.38 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.097 -0.705 . . . . 10.0 109.097 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.71 -87.26 0.3 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.542 -0.837 . . . . 10.0 111.726 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.41 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 3.5 pp0? -155.93 149.29 18.67 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 110.008 -0.368 . . . . 10.0 110.008 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 26.4 Cg_exo -63.45 107.15 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.661 2.24 . . . . 10.0 111.168 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 3.1 m -79.2 95.38 5.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.154 0.502 . . . . 10.0 110.78 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -78.04 144.57 36.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.528 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.7 m -82.64 -9.38 59.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.566 -0.288 . . . . 10.0 111.318 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? 71.24 166.22 0.3 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.907 -0.588 . . . . 10.0 111.979 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.14 -134.56 1.74 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.463 -0.655 . . . . 10.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -106.44 151.9 24.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.623 0.212 . . . . 10.0 110.558 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -90.89 125.87 35.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -102.16 128.52 48.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.497 -0.32 . . . . 10.0 110.977 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.76 130.62 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.322 -0.621 . . . . 10.0 109.322 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -133.91 163.53 29.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -93.24 -30.28 15.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.822 0.344 . . . . 10.0 111.301 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -100.27 -39.35 8.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.592 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -89.87 -9.2 49.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.89 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.76 -85.79 0.97 Allowed Glycine 0 C--O 1.227 -0.333 0 C-N-CA 120.758 -0.734 . . . . 10.0 112.673 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -165.24 115.91 1.11 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.645 0.259 . . . . 10.0 110.956 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -138.99 158.72 43.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.288 -0.415 . . . . 10.0 110.447 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 5.6 m -70.79 130.4 41.6 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.425 -0.583 . . . . 10.0 109.425 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.55 150.21 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.377 0.608 . . . . 10.0 112.179 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -110.8 116.36 31.14 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.86 -1.163 . . . . 10.0 107.86 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -103.78 -3.01 25.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.581 0.585 . . . . 10.0 112.581 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.14 -41.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.186 0.517 . . . . 10.0 109.672 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 1.0 OUTLIER -89.26 100.4 13.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.329 -0.85 . . . . 10.0 110.98 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.49 107.39 8.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.979 0.419 . . . . 10.0 111.397 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -138.43 128.01 24.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.689 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 19.0 t -128.65 129.6 68.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.251 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' B' ' 57' ' ' SER . . . -102.72 144.06 31.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.605 -0.271 . . . . 10.0 110.469 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' PHE . . . . . 0.435 ' HD2' ' HB ' ' B' ' 26' ' ' VAL . 58.2 m-85 -119.86 100.54 48.57 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.691 0.282 . . . . 10.0 111.684 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.05 118.81 2.39 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.995 2.463 . . . . 10.0 112.01 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' TYR . . . . . 0.425 ' CE2' ' HA2' ' B' ' 25' ' ' GLY . 36.7 m-85 -66.4 144.47 56.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 10.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.48 11.66 34.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.23 0.538 . . . . 10.0 109.797 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -164.04 124.93 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.317 -0.856 . . . . 10.0 109.955 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.05 92.55 6.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.06 0.457 . . . . 10.0 110.59 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 12.0 m -121.78 163.7 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.614 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.31 21.02 22.64 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.743 -0.741 . . . . 10.0 111.673 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -93.51 138.04 23.13 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.19 127.75 24.12 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.589 2.193 . . . . 10.0 111.039 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' TYR . . . . . 0.418 ' HD2' ' HG3' ' B' ' 49' ' ' PRO . 0.1 OUTLIER -108.54 153.78 22.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.435 -179.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -95.69 152.08 18.78 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.691 -0.485 . . . . 10.0 109.691 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.635 HD13 ' HB ' ' B' ' 47' ' ' THR . 22.7 tp -126.6 124.22 39.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.695 0.283 . . . . 10.0 110.601 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.475 ' O ' ' HA2' ' B' ' 45' ' ' GLY . 24.6 t -108.69 123.05 64.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 81.9 mt -126.63 120.26 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 10.0 111.833 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' THR . . . . . 0.675 HG23 ' HB3' ' B' ' 113' ' ' ASP . 5.5 m -112.96 117.14 31.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.745 -0.661 . . . . 10.0 109.828 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 24.2 m-85 -99.6 107.17 19.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.627 0.251 . . . . 10.0 111.085 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 14.7 tp60 -121.5 126.02 48.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 10.0 110.936 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -167.64 -157.76 11.18 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.432 -0.667 . . . . 10.0 111.432 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.3 m -153.51 167.84 28.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -105.17 144.67 31.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.42 -16.51 60.77 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.107 0.41 . . . . 10.0 112.107 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.27 -12.51 56.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.456 -0.338 . . . . 10.0 111.78 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.48 -14.77 10.77 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.371 -0.918 . . . . 10.0 113.006 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 127' ' ' SER . 46.2 t -63.45 131.8 29.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.94 76.92 1.32 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.961 0.41 . . . . 10.0 110.695 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -66.02 157.14 81.87 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.949 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.649 ' HD3' ' H ' ' A' ' 108' ' ' TYR . 93.8 Cg_endo -85.8 160.22 10.5 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.778 2.319 . . . . 10.0 112.155 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.751 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 85.6 Cg_endo -79.31 70.56 7.45 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.743 2.296 . . . . 10.0 111.62 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.766 HG22 HD11 ' A' ' 69' ' ' LEU . 16.6 t -67.04 93.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.775 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ASP . . . . . 0.675 ' HB3' HG23 ' B' ' 98' ' ' THR . 6.3 p-10 -78.07 150.26 33.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.78 -0.645 . . . . 10.0 111.857 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 10.3 m -137.36 144.99 42.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.513 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -104.29 138.06 41.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.821 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -121.27 153.16 38.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.715 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -114.05 120.58 41.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.985 -0.376 . . . . 10.0 109.985 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 19.8 mm -95.87 79.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.247 0.546 . . . . 10.0 110.328 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -94.01 -14.02 26.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.222 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.44 110.03 2.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.082 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -167.55 -32.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.033 0.444 . . . . 10.0 110.624 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.71 -80.2 0.27 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.924 -0.655 . . . . 10.0 111.552 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 9.1 m -101.01 135.48 42.39 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.083 -0.34 . . . . 10.0 110.083 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -126.04 157.96 36.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.786 0.327 . . . . 10.0 111.217 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.38 148.41 20.97 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' PRO . . . . . 0.509 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 35.7 Cg_endo -66.35 137.99 49.19 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.278 1.986 . . . . 10.0 112.565 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -97.49 62.53 1.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.92 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.396 -0.811 . . . . 10.0 110.294 -179.682 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.17 62.61 39.58 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.73 -31.45 48.97 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.192 1.928 . . . . 10.0 111.514 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.89 -40.91 95.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.463 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.68 -40.43 80.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.557 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.1 tp -60.52 -32.89 71.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.207 0.527 . . . . 10.0 110.273 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.8 m -84.44 -15.92 44.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.959 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 45.8 m -79.94 -23.47 41.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.463 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -64.4 106.55 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.205 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 58.6 mttp -97.28 148.16 23.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.978 -0.556 . . . . 10.0 110.626 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.746 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 39.6 p -81.11 172.72 13.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.003 -0.544 . . . . 10.0 109.667 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.37 -5.52 19.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 10.0 110.212 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -92.53 5.01 52.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.356 -0.838 . . . . 10.0 109.825 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 73.06 13.59 4.83 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.327 0.862 . . . . 10.0 113.327 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -116.83 139.84 26.15 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.442 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 18.1 Cg_endo -57.75 146.31 86.11 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.795 2.33 . . . . 10.0 112.153 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.12 -1.25 7.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 10.0 111.759 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.568 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 4.4 m -59.42 -20.95 58.96 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.145 -0.48 . . . . 10.0 111.535 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 20' ' ' TYR . 21.7 m -65.39 -13.94 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.088 0.47 . . . . 10.0 110.849 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.416 ' HD2' HG23 ' A' ' 19' ' ' VAL . 22.7 m-85 -125.66 20.47 7.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.601 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 70.7 mt -129.61 40.16 3.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.489 -0.778 . . . . 10.0 110.328 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -138.44 -178.46 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.88 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.2 mttp 69.35 12.31 8.3 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.824 0.675 . . . . 10.0 112.824 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 58.56 28.79 17.55 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.192 0.52 . . . . 10.0 111.486 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -94.51 138.19 22.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.46 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.54 141.79 90.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.87 2.38 . . . . 10.0 111.183 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -108.4 144.21 36.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.855 0.36 . . . . 10.0 111.425 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.435 HD23 ' HG ' ' A' ' 60' ' ' LEU . 21.0 tp -123.98 104.34 8.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.697 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 77.8 mt -88.23 118.22 33.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.72 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.541 ' HD2' HG22 ' A' ' 62' ' ' THR . 7.9 tmtm? -110.04 116.46 31.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.666 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -90.43 148.27 22.9 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.293 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -150.53 175.88 11.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.527 -0.306 . . . . 10.0 111.32 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.78 146.97 50.04 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.366 -0.605 . . . . 10.0 109.366 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 m -70.88 -63.75 1.04 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.51 ' CZ2' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.41 59.31 4.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -178.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 1.6 t -135.46 123.34 15.27 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.327 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 52.3 Cg_exo -56.61 -49.02 16.06 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.748 2.299 . . . . 10.0 112.568 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 38' ' ' LEU . 5.7 mp -59.61 -52.74 64.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.996 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 80.5 m -64.88 -33.07 75.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.846 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.483 ' HB3' ' CE2' ' B' ' 68' ' ' PHE . 10.7 tp -62.2 -48.49 79.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.411 -0.358 . . . . 10.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 m -69.94 -32.46 70.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.535 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.86 -35.3 79.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.563 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.7 -39.8 81.8 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.912 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.4 -29.32 72.94 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.964 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -87.76 -27.54 22.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.873 0.368 . . . . 10.0 110.092 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.2 m -61.11 -47.91 84.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 10.0 110.912 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.658 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -62.91 -37.31 86.49 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.939 0.4 . . . . 10.0 110.221 179.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.85 -46.85 83.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.883 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -63.2 -42.68 99.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 10.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.41 -4.93 12.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.773 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -113.35 10.64 18.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.765 0.317 . . . . 10.0 111.496 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' HB3' ' HD1' ' A' ' 55' ' ' PHE . 11.5 t70 -93.75 148.7 21.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.735 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.95 -31.85 72.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.41 -46.22 77.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.107 0.479 . . . . 10.0 111.084 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.405 ' HD1' ' HB3' ' A' ' 52' ' ' ASP . 76.5 m-85 -74.85 -8.02 55.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.639 . . . . 10.0 112.364 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.3 m -70.24 -13.46 62.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.143 0.497 . . . . 10.0 110.86 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 m -69.91 -24.04 63.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.949 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.15 176.45 7.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.453 . . . . 10.0 110.956 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -108.57 98.63 8.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HG ' HD23 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -84.45 124.22 31.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.631 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.66 138.59 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 10.0 111.508 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.541 HG22 ' HD2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -92.38 109.76 21.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.865 -0.607 . . . . 10.0 109.681 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.9 137.4 42.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.092 0.473 . . . . 10.0 111.656 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.09 147.13 39.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.293 -1.002 . . . . 10.0 108.293 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 4.8 m -106.43 98.18 19.04 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 112.268 0.469 . . . . 10.0 112.268 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HG3' HG22 ' A' ' 93' ' ' THR . 30.2 Cg_endo -64.43 123.4 11.72 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.674 2.249 . . . . 10.0 111.882 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.88 3.33 73.84 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.817 -0.629 . . . . 10.0 112.706 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 3.0 t80 -116.0 148.37 40.2 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.71 -0.288 . . . . 10.0 110.487 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER 58.56 27.58 15.87 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.828 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.6 OUTLIER 71.52 20.21 4.88 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.716 -0.675 . . . . 10.0 112.371 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.51 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 2.3 mm-40 -81.72 -172.54 3.93 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.876 0.37 . . . . 10.0 111.155 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.666 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 9.4 mmpt? -69.37 133.13 47.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.402 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -68.66 158.27 34.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 10.0 112.017 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -55.62 141.57 37.11 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.575 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 78' ' ' GLN . . . 95.46 -60.68 1.53 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.813 -0.915 . . . . 10.0 110.813 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.96 -36.71 78.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 10.0 109.917 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.14 -41.15 97.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.407 -0.815 . . . . 10.0 111.643 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 10.9 pt20 -66.53 -29.52 69.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.954 0.407 . . . . 10.0 110.558 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -69.93 -28.59 65.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.287 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -66.07 -44.87 83.24 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.941 -0.763 . . . . 10.0 108.941 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -65.0 -38.47 91.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.198 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.77 -20.97 66.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.44 16.16 52.83 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.037 -0.602 . . . . 10.0 112.231 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 mt -118.43 158.38 25.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.658 0.266 . . . . 10.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.402 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 66.1 t30 -82.95 -173.88 4.95 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.45 -0.574 . . . . 10.0 109.45 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.402 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 89.2 m-85 68.88 76.24 0.25 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-O 121.211 0.529 . . . . 10.0 110.207 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.14 8.82 3.03 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.747 2.298 . . . . 10.0 112.473 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -108.13 4.58 25.07 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.116 -0.234 . . . . 10.0 110.903 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.658 ' HG ' ' HG3' ' A' ' 47' ' ' GLU . 13.2 mt -78.23 112.52 26.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.714 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 89' ' ' LEU . 2.9 Cg_exo -76.45 71.21 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.959 2.439 . . . . 10.0 111.179 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.69 114.24 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.918 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.746 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 20.0 t -96.53 133.53 37.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.047 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.701 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.14 96.01 8.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.012 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -83.37 82.38 8.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.191 0.52 . . . . 10.0 110.058 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -64.31 106.52 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.896 -0.593 . . . . 10.0 111.739 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.61 -24.21 26.24 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.009 -0.615 . . . . 10.0 112.123 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.11 53.41 3.14 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.616 -0.802 . . . . 10.0 111.821 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -47.15 84.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.027 0.441 . . . . 10.0 110.659 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.7 mm -77.05 -40.86 30.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.983 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.44 90.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.851 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -75.39 -42.66 53.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.558 0.218 . . . . 10.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -62.23 -38.42 89.14 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.7 mt -97.1 -2.47 43.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.655 -0.248 . . . . 10.0 111.519 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t30 53.62 58.19 5.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.958 -0.565 . . . . 10.0 111.202 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.1 109.43 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.165 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.13 17.56 14.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.953 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.842 HG23 ' HB3' ' B' ' 109' ' ' TYR . 11.4 p -149.58 147.83 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.543 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.5 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 27.5 m-85 -127.88 160.02 63.44 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.392 -0.596 . . . . 10.0 109.392 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.5 ' HA ' ' HB3' ' A' ' 108' ' ' TYR . 2.1 Cg_endo -88.06 124.41 6.96 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.972 -1.262 . . . . 10.0 111.277 -0.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.0 m -105.68 143.07 34.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.124 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -121.47 129.77 53.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.19 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.697 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -111.33 114.9 28.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.199 -0.455 . . . . 10.0 111.063 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.419 HD22 HD11 ' A' ' 136' ' ' LEU . 24.5 tp -92.13 117.1 29.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.778 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.24 136.2 38.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.605 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -74.59 -173.43 30.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.227 -0.511 . . . . 10.0 113.401 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 116' ' ' LYS . 5.7 mtmt -73.6 -12.97 60.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.975 0.417 . . . . 10.0 111.121 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.27 7.48 46.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.865 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.74 24.71 76.32 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.866 -0.683 . . . . 10.0 111.904 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -114.03 153.5 29.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.784 0.326 . . . . 10.0 110.761 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.3 t -67.78 113.99 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.926 0.393 . . . . 10.0 110.199 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -51.15 5.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.228 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -146.8 139.18 24.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.863 0.363 . . . . 10.0 111.587 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.6 tp -110.37 130.93 62.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.065 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.9 t -122.04 132.26 71.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -138.67 136.96 36.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 10.0 111.372 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.467 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 127.56 -80.43 0.36 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.055 -0.593 . . . . 10.0 112.477 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 p -172.62 142.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.604 -0.517 . . . . 10.0 109.604 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -125.49 171.91 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 10.0 110.843 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 132' ' ' GLN . 11.4 p30 -130.33 167.69 18.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.829 -0.434 . . . . 10.0 109.829 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -58.27 -49.96 75.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.5 89.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.368 . . . . 10.0 110.867 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.402 ' HB2' ' ND2' ' A' ' 129' ' ' ASN . 38.0 tt0 -64.62 -38.79 92.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.041 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.84 92.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 10.0 109.8 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.82 -38.48 91.11 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.962 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.63 90.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 10.0 110.631 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.419 HD11 HD22 ' A' ' 113' ' ' LEU . 15.4 tp -63.92 -34.74 78.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.461 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.98 -33.35 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -70.34 -48.66 55.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.813 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 49.4 t0 -148.67 117.08 3.95 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.29 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 29.1 Cg_endo -63.24 -10.08 19.8 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.01 2.473 . . . . 10.0 112.659 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -81.65 -7.71 59.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.929 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.92 125.4 26.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.785 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.534 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 19.5 t70 -136.1 143.93 44.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.152 -0.477 . . . . 10.0 109.92 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.918 -1.039 . . . . 10.0 112.523 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.754 0.312 . . . . 10.0 110.679 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.07 -85.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.788 0.328 . . . . 10.0 110.685 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.416 ' HG ' ' H ' ' B' ' 5' ' ' ALA . 56.0 tp -97.58 -61.75 1.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.228 -0.442 . . . . 10.0 109.984 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . 0.573 ' HA ' HD13 ' B' ' 9' ' ' LEU . 1.7 m-20 57.23 35.63 26.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.884 -0.598 . . . . 10.0 111.227 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . 0.416 ' H ' ' HG ' ' B' ' 3' ' ' LEU . . . -144.37 165.67 27.27 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.902 -0.59 . . . . 10.0 111.006 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' B' ' 7' ' ' ASP . 0.7 OUTLIER 62.44 -151.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.781 . . . . 10.0 112.235 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' ASP . . . . . 0.456 ' H ' ' HB3' ' B' ' 6' ' ' ASN . 11.7 p-10 -108.47 27.24 9.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.657 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.62 23.07 9.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.739 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' B' ' 4' ' ' ASP . 2.7 pt? -147.99 137.27 11.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.148 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . 0.402 ' HB2' ' OE1' ' B' ' 12' ' ' GLU . 33.6 Cg_endo -63.78 145.41 90.77 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.022 2.482 . . . . 10.0 112.542 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.95 -36.77 76.56 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.464 2.776 . . . . 10.0 113.646 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' B' ' 10' ' ' PRO . 1.5 pm0 -69.8 -4.31 19.47 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.409 ' HD3' HD12 ' B' ' 9' ' ' LEU . 1.8 tmtm? -126.59 -8.68 6.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.526 0.679 . . . . 10.0 109.838 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.67 -7.84 59.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 10.0 112.239 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.475 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 27.7 m-85 -130.49 123.37 29.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.811 0.338 . . . . 10.0 111.011 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.48 95.62 16.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.327 -0.619 . . . . 10.0 109.327 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' B' ' 30' ' ' PHE . 2.9 Cg_exo -75.05 93.59 0.96 Allowed 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.186 2.59 . . . . 10.0 113.217 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -90.37 97.36 11.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.9 mm? -84.59 122.63 29.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.438 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.01 109.37 12.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.199 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.479 HG21 ' HE2' ' B' ' 124' ' ' TYR . 93.7 t -97.57 120.27 46.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.846 0.355 . . . . 10.0 111.082 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.62 169.5 9.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.14 -32.54 72.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.001 0.429 . . . . 10.0 110.975 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -80.28 -37.07 33.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.994 -0.548 . . . . 10.0 111.722 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -175.51 173.82 46.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.532 -0.842 . . . . 10.0 112.444 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.455 HG13 HG22 ' B' ' 21' ' ' VAL . 47.2 t -89.38 140.46 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.615 0.245 . . . . 10.0 110.755 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -129.54 111.01 12.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.736 -0.468 . . . . 10.0 109.736 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' B' ' 80' ' ' GLN . 7.3 p -92.02 125.09 44.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.953 0.406 . . . . 10.0 111.182 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -129.18 80.47 1.97 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.365 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' B' ' 17' ' ' PRO . 21.5 p90 -89.72 126.62 35.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.887 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtm-85 -81.76 124.93 30.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.923 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.494 ' HB ' ' HA ' ' B' ' 77' ' ' HIS . 59.8 mt -99.37 133.7 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.771 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 148.88 33.7 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.517 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.25 74.7 1.82 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.251 0.548 . . . . 10.0 111.675 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.21 -20.77 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.037 -0.825 . . . . 10.0 111.037 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -105.25 153.19 21.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.89 -0.781 . . . . 10.0 108.89 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -145.45 139.62 26.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.005 0.431 . . . . 10.0 111.417 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 40.8 mtt -110.26 156.48 20.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.925 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.679 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 31.3 m-85 -97.78 124.06 41.98 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.738 -0.468 . . . . 10.0 109.738 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -60.71 -28.54 68.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.093 0.473 . . . . 10.0 111.465 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.83 15.03 12.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 10.0 111.284 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.679 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 6.5 mmtm -130.85 -18.26 3.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.637 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.453 HG13 ' O ' ' B' ' 39' ' ' TYR . 80.8 mt -77.61 119.82 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.38 . . . . 10.0 110.23 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' B' ' 98' ' ' THR . 56.5 t -98.23 126.65 51.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.023 -0.535 . . . . 10.0 109.565 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -151.55 119.77 1.02 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.733 -0.746 . . . . 10.0 111.909 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 27.4 pttt -150.74 139.67 20.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.733 0.302 . . . . 10.0 110.965 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.63 ' HB ' HD13 ' B' ' 95' ' ' LEU . 4.8 t -138.75 125.37 20.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.587 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 19.9 p30 179.43 162.33 0.78 Allowed Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.267 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.68 -70.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.663 2.242 . . . . 10.0 111.313 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.29 57.21 0.73 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.87 0.366 . . . . 10.0 111.362 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.3 t70 65.19 32.89 9.75 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.268 0.556 . . . . 10.0 112.089 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' B' ' 52' ' ' LEU . 1.2 mm? -96.1 58.43 1.85 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.684 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 36.4 tp -124.49 139.49 53.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.601 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 -72.51 1.11 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.636 -0.792 . . . . 10.0 111.511 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.88 151.57 9.42 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.06 103.03 1.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.583 2.189 . . . . 10.0 110.392 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 49.4 m -76.79 104.78 7.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.021 0.439 . . . . 10.0 111.684 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -85.02 146.2 27.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.044 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 37.3 m -76.8 -11.64 59.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.448 -0.342 . . . . 10.0 111.485 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? 70.82 119.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.638 0.587 . . . . 10.0 112.513 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.81 -136.02 8.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.879 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -112.18 153.7 26.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.68 0.276 . . . . 10.0 111.002 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.62 119.52 26.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.53 -0.545 . . . . 10.0 109.53 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -101.16 139.85 36.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.841 0.353 . . . . 10.0 111.273 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -77.8 133.16 38.27 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.218 -1.031 . . . . 10.0 108.218 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -132.88 168.52 18.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.804 0.335 . . . . 10.0 110.889 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -101.85 -32.09 10.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.198 -0.455 . . . . 10.0 111.232 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 1.6 m-85 -109.69 -38.6 5.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.625 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.405 ' HD1' ' HA ' ' B' ' 69' ' ' PHE . 8.3 m-30 -84.42 -12.1 55.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.84 0.352 . . . . 10.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.11 -100.56 1.77 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.028 -0.606 . . . . 10.0 112.605 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -136.14 110.24 8.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.522 -0.547 . . . . 10.0 109.522 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -136.39 153.05 51.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.889 0.376 . . . . 10.0 111.588 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.23 127.32 32.3 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.036 -0.727 . . . . 10.0 109.036 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.68 153.6 33.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.509 0.671 . . . . 10.0 112.311 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -110.33 120.65 43.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -106.66 -1.82 22.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.049 0.759 . . . . 10.0 113.049 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.494 ' HA ' ' HB ' ' B' ' 32' ' ' ILE . 2.4 t60 -175.83 -37.53 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.219 -0.66 . . . . 10.0 109.219 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.8 OUTLIER -85.43 138.44 32.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.049 -0.978 . . . . 10.0 109.568 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 30' ' ' PHE . . . -160.39 119.43 2.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.781 0.324 . . . . 10.0 110.612 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 24.3 tt0 -159.62 121.9 3.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.347 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.76 126.66 67.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 10.0 109.665 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' B' ' 57' ' ' SER . . . -98.63 139.08 34.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.068 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -118.81 98.21 51.03 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 112.207 0.447 . . . . 10.0 112.207 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.44 127.94 6.79 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.063 2.509 . . . . 10.0 110.777 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -74.01 147.82 42.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.442 -0.344 . . . . 10.0 111.277 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.16 -5.8 54.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 10.0 110.538 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -153.02 147.1 25.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.709 -0.678 . . . . 10.0 109.867 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.56 85.37 4.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.911 0.386 . . . . 10.0 111.037 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.75 155.15 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.501 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.12 33.38 6.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.92 -0.657 . . . . 10.0 112.607 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -96.68 139.41 21.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.671 -0.492 . . . . 10.0 109.671 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.58 111.91 1.18 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.731 2.287 . . . . 10.0 111.507 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.12 161.07 21.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.134 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' B' ' 47' ' ' THR . 78.9 tttt -110.33 142.44 41.98 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.63 HD13 ' HB ' ' B' ' 47' ' ' THR . 58.6 tp -116.36 111.67 20.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.867 0.365 . . . . 10.0 110.788 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 41.6 t -101.84 113.49 38.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 96.5 mt -117.48 139.18 51.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.965 0.412 . . . . 10.0 111.414 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' THR . . . . . 0.604 ' HB ' ' HB ' ' B' ' 44' ' ' VAL . 20.9 m -134.36 118.55 17.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.036 -0.727 . . . . 10.0 109.036 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 50.6 m-85 -98.69 112.14 24.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.099 0.407 . . . . 10.0 112.099 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.67 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 15.8 tp60 -122.8 118.25 27.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.313 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.19 -160.18 10.22 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.729 -0.748 . . . . 10.0 111.758 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 25.3 m -153.58 -179.57 7.91 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.486 -0.561 . . . . 10.0 109.486 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' ALA . . . . . 0.67 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -120.08 139.29 52.78 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.39 11.66 0.43 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.369 0.418 . . . . 10.0 112.114 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.92 6.08 20.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.453 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.92 26.84 9.34 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.431 -0.89 . . . . 10.0 113.436 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 20.3 t -115.27 141.88 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 53.3 t -136.21 89.53 2.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 10.0 110.907 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.842 ' HB3' HG23 ' A' ' 107' ' ' VAL . 53.3 p90 -78.27 151.09 77.94 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.323 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.566 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 57.9 Cg_endo -71.38 164.42 35.79 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.718 2.279 . . . . 10.0 111.567 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.828 ' HG2' ' HB3' ' A' ' 70' ' ' HIS . 71.9 Cg_endo -77.01 72.91 5.66 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.707 2.271 . . . . 10.0 112.419 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.401 HG22 ' CD1' ' A' ' 69' ' ' LEU . 24.2 t -62.86 124.4 17.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.622 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -104.87 160.95 14.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.148 0.499 . . . . 10.0 111.694 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.2 m -150.31 119.0 6.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.607 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . 0.457 ' HB3' ' HE2' ' B' ' 94' ' ' LYS . 31.6 mt-10 -92.97 126.63 38.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.052 0.453 . . . . 10.0 111.849 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.55 153.71 28.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.734 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -116.34 124.18 49.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.548 -0.538 . . . . 10.0 109.548 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 17.6 mm -90.21 72.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.234 0.54 . . . . 10.0 110.812 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -78.43 -26.61 46.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.361 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.88 48.55 0.15 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.612 -0.804 . . . . 10.0 113.078 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -107.22 -9.91 15.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.95 0.405 . . . . 10.0 110.639 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.63 -77.6 1.86 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.948 -0.644 . . . . 10.0 111.587 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 11.0 m -97.94 131.92 43.96 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.479 ' HE2' HG21 ' B' ' 21' ' ' VAL . 89.9 m-85 -120.26 155.29 33.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.975 0.417 . . . . 10.0 111.874 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -127.97 143.53 48.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.359 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.8 125.8 16.13 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.644 2.229 . . . . 10.0 111.883 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -85.71 82.61 8.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 179.701 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.92 88.67 31.82 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 10.0 111.603 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.93 -18.2 52.1 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.414 2.076 . . . . 10.0 111.906 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -62.53 -32.73 73.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.911 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 98' ' ' THR . 2.0 m -69.75 -41.73 74.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.536 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.29 -31.43 72.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.191 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 m -83.44 -8.43 59.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 10.0 110.636 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.9 m -91.91 -25.88 18.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.645 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -66.46 128.28 35.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.934 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.509 ' HG3' ' HA ' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -116.12 151.92 34.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.39 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.796 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 46.0 p -77.95 171.91 14.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.004 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.51 -15.29 63.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.537 0.684 . . . . 10.0 109.785 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.474 ' OD1' ' HB2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -82.55 -15.58 51.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.977 -1.01 . . . . 10.0 109.593 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.2 t30 97.33 -15.26 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.578 1.151 . . . . 10.0 112.326 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.557 ' HG3' ' HD2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -71.6 140.25 84.19 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 109.543 -0.54 . . . . 10.0 109.543 178.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HD2' ' HG3' ' A' ' 15' ' ' ARG . 34.6 Cg_endo -64.44 147.12 90.53 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.411 2.074 . . . . 10.0 111.703 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.79 -11.92 42.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.914 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 m -55.41 -24.19 28.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.443 . . . . 10.0 112.155 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 m -62.38 -22.74 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.9 0.381 . . . . 10.0 111.598 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.402 ' HB3' ' HB3' ' A' ' 59' ' ' ASN . 60.1 m-85 -127.55 29.17 5.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.282 0.563 . . . . 10.0 110.374 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.7 mt -136.22 28.99 3.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.943 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -134.28 -174.61 3.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.37 -0.377 . . . . 10.0 111.864 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt 71.61 11.19 6.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.772 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 56.82 33.9 23.82 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.395 -0.82 . . . . 10.0 111.686 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -101.16 147.53 33.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.46 142.17 95.18 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.061 2.507 . . . . 10.0 111.41 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 114' ' ' ILE . 2.0 m -112.66 143.3 44.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.858 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.411 HD23 ' HG ' ' A' ' 60' ' ' LEU . 15.2 tp -122.14 99.21 6.31 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.657 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 86.7 mt -90.43 120.95 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.803 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.502 ' HD2' HG22 ' A' ' 62' ' ' THR . 1.1 tmtp? -113.72 124.96 53.53 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.595 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.441 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 3.2 m-85 -101.02 141.74 33.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.514 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -149.02 169.3 20.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.787 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.405 ' HB1' ' CZ3' ' A' ' 35' ' ' TRP . . . -116.81 135.64 53.59 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -62.42 -59.09 5.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.294 0.85 . . . . 10.0 113.294 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.782 ' HZ2' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -85.65 38.49 0.75 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.087 0.773 . . . . 10.0 113.087 -178.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -115.54 126.02 28.18 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.316 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 28.1 Cg_endo -61.43 -44.61 21.85 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.829 2.353 . . . . 10.0 113.358 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.574 HD12 ' HB2' ' B' ' 108' ' ' CYS . 65.9 mt -64.11 -47.0 81.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 10.0 111.589 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.1 m -68.19 -33.73 74.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.507 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB3' ' CZ ' ' B' ' 68' ' ' PHE . 25.8 mt -64.49 -37.34 87.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 10.0 111.701 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m -72.07 -22.8 61.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.024 0.44 . . . . 10.0 111.157 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.24 -6.03 59.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.85 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.1 mt -59.3 -49.13 79.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.006 0.431 . . . . 10.0 111.151 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.86 -33.72 87.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.873 -0.68 . . . . 10.0 112.063 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -70.59 -41.58 72.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 10.0 110.665 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.2 m -60.67 -42.46 97.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.537 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -64.46 -41.18 96.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.128 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -64.9 -38.46 91.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.618 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -70.8 -34.39 71.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.467 . . . . 10.0 110.801 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.38 -13.21 62.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.01 0.434 . . . . 10.0 110.813 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -114.63 16.51 17.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 10.0 110.416 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 18.4 t70 -82.42 148.29 28.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.627 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.36 83.8 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -84.94 -43.09 14.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.537 0.208 . . . . 10.0 111.499 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.633 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 49.7 m-85 -66.22 -20.42 66.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 10.0 111.573 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 13.8 t -69.98 -0.28 7.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.952 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 m -84.62 -5.29 59.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 10.0 110.27 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -134.57 164.65 27.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.653 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 72.4 m-20 -92.3 94.72 9.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.475 -0.329 . . . . 10.0 110.188 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -84.3 121.64 27.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.966 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.6 pt -138.87 142.32 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 10.0 111.395 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.502 HG22 ' HD2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -100.97 113.78 27.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.566 -0.531 . . . . 10.0 109.566 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 92' ' ' VAL . 24.7 t -109.71 138.7 36.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.804 0.335 . . . . 10.0 111.235 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.93 154.48 49.21 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.444 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 9.9 m -112.78 96.16 36.31 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 112.386 0.513 . . . . 10.0 112.386 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.783 ' HG3' HG22 ' A' ' 93' ' ' THR . 38.1 Cg_endo -66.24 131.58 27.12 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.567 2.178 . . . . 10.0 111.437 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.65 10.03 85.68 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.952 -0.642 . . . . 10.0 112.596 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 2.7 t80 -123.29 138.27 54.66 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.577 HD12 HG22 ' B' ' 112' ' ' VAL . 2.1 mm? 60.39 29.33 18.93 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.184 0.516 . . . . 10.0 111.041 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.754 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 2.0 t60 74.26 14.97 3.66 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.781 -1.1 . . . . 10.0 113.45 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.782 ' HA ' ' HZ2' ' A' ' 35' ' ' TRP . 1.5 mm-40 -70.78 168.11 17.39 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 121.066 -0.254 . . . . 10.0 110.428 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' HE3' ' A' ' 80' ' ' TRP . 44.5 mmtt -55.85 136.17 51.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.14 -0.482 . . . . 10.0 111.034 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -67.97 163.06 23.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.156 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.47 137.18 53.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.433 -0.349 . . . . 10.0 110.509 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.05 -49.97 1.94 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.646 -0.981 . . . . 10.0 110.646 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.11 -40.44 71.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.119 0.485 . . . . 10.0 109.829 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -59.59 -48.79 80.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.457 -0.792 . . . . 10.0 111.641 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -66.45 -26.37 67.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 10.0 111.32 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -69.97 -32.69 71.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 10.0 110.289 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.585 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 3.2 t90 -65.6 -45.42 83.25 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -61.86 -36.96 82.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.324 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.41 -24.71 65.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.833 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.33 -0.79 62.89 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.036 -0.602 . . . . 10.0 111.811 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 80' ' ' TRP . 44.8 mt -105.05 169.18 8.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.439 . . . . 10.0 110.541 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -90.19 -155.66 0.38 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.998 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.446 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 55.8 m-85 57.54 73.17 0.8 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.954 0.407 . . . . 10.0 110.656 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.36 -9.61 26.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.537 2.158 . . . . 10.0 112.386 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 88' ' ' LYS . 28.4 mtpp -102.16 20.69 16.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.277 -0.42 . . . . 10.0 111.449 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.547 ' HB3' HG23 ' A' ' 91' ' ' VAL . 7.8 mt -80.96 115.29 54.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.807 0.337 . . . . 10.0 110.529 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.76 58.13 6.7 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.713 2.275 . . . . 10.0 111.675 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.547 HG23 ' HB3' ' A' ' 89' ' ' LEU . 48.5 t -81.56 119.96 32.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.052 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.796 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 12.6 t -102.93 142.78 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.078 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.783 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -101.24 106.28 17.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.291 -179.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 64.1 t0 -98.36 94.01 6.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.074 0.464 . . . . 10.0 109.911 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.96 108.54 2.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.995 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.26 -17.77 55.16 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.871 -0.681 . . . . 10.0 112.425 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.62 4.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.598 -0.81 . . . . 10.0 112.012 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 5' ' ' THR . 1.2 m -62.57 -51.7 66.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.859 0.362 . . . . 10.0 110.377 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.95 -35.84 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -61.99 -41.19 97.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.613 -0.722 . . . . 10.0 111.359 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -70.89 -39.8 72.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.407 -0.361 . . . . 10.0 111.224 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 m -58.8 -33.83 70.8 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.566 HD13 HD13 ' A' ' 123' ' ' ILE . 68.3 mt -113.02 11.18 18.92 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.997 -0.281 . . . . 10.0 111.691 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 62.3 t30 47.39 60.6 3.37 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.493 0.663 . . . . 10.0 111.421 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 100' ' ' ALA . 30.4 mt -86.92 73.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.446 0.641 . . . . 10.0 110.991 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.43 16.94 17.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.392 -0.822 . . . . 10.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.729 HG23 ' HB3' ' B' ' 109' ' ' TYR . 14.8 p -158.05 147.98 9.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.897 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 64.9 m-85 -127.14 160.73 58.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 108' ' ' TYR . 91.2 Cg_endo -81.7 154.12 79.57 Favored 'Cis proline' 0 C--O 1.235 0.33 0 C-N-CA 123.28 -1.55 . . . . 10.0 111.634 -0.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 t -130.45 137.71 49.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.288 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -119.9 116.6 26.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.729 -0.668 . . . . 10.0 110.266 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.657 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.31 108.31 20.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.664 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.4 tp -90.94 114.4 26.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.829 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 27' ' ' THR . 2.0 mp -100.82 134.6 40.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.373 -0.602 . . . . 10.0 109.373 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -70.01 178.67 29.24 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.281 -0.485 . . . . 10.0 113.423 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.15 7.61 3.23 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.944 0.35 . . . . 10.0 111.944 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.65 -19.48 13.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.073 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 109.97 -1.47 30.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.581 -0.819 . . . . 10.0 112.847 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -101.03 162.21 13.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.745 0.307 . . . . 10.0 110.98 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -71.47 122.29 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 10.0 110.259 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -95.41 -46.85 6.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.422 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 122' ' ' ARG . 9.3 tpt180 -152.28 154.2 35.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.718 0.294 . . . . 10.0 110.729 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.566 HD13 HD13 ' A' ' 103' ' ' LEU . 4.8 tp -128.32 123.88 60.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.515 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.1 t -113.42 137.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.67 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -141.94 139.03 32.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.006 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 121.14 -89.92 0.45 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.476 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.4 m -147.68 153.34 39.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 10.0 110.613 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.9 135.85 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.28 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -122.6 179.36 4.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 10.0 111.931 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -64.54 -43.58 93.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 10.0 112.086 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.1 -43.77 95.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.317 . . . . 10.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -62.13 -37.8 86.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.828 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.03 -48.9 76.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.051 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.7 -34.41 78.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.613 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.76 -43.77 87.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.132 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 140' ' ' PRO . 14.4 tp -64.28 -30.13 71.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.871 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 94.2 mt -70.08 -39.69 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.171 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -79.82 -38.94 31.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.226 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -150.86 103.17 3.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.565 -0.288 . . . . 10.0 110.552 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 136' ' ' LEU . 72.5 Cg_endo -75.7 2.84 6.53 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.77 2.313 . . . . 10.0 112.37 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -90.41 -11.79 39.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 10.0 110.622 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.55 113.64 25.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.01 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.419 ' HB3' HD23 ' A' ' 144' ' ' LEU . 4.6 t0 -96.91 170.0 9.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.076 -0.511 . . . . 10.0 109.892 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.419 HD23 ' HB3' ' A' ' 143' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.93 0 N-CA-C 113.977 1.102 . . . . 10.0 113.977 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 111.712 0.264 . . . . 10.0 111.712 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.09 -57.77 3.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.916 0.389 . . . . 10.0 111.73 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 24.9 tp -110.95 -77.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.699 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . 0.575 ' HA ' HD13 ' B' ' 9' ' ' LEU . 2.5 m-20 60.4 41.91 15.42 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.474 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.67 161.95 38.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.343 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.46 -148.7 0.37 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.33 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -113.56 21.65 14.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.251 0.548 . . . . 10.0 110.16 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -93.3 40.91 1.07 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.092 -0.503 . . . . 10.0 111.409 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.575 HD13 ' HA ' ' B' ' 4' ' ' ASP . 2.6 pt? -164.21 138.37 4.39 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.562 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.27 147.11 94.07 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.774 2.316 . . . . 10.0 112.143 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.476 ' HG3' ' HB ' ' A' ' 107' ' ' VAL . 9.6 Cg_endo -52.5 -39.58 74.12 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.467 2.778 . . . . 10.0 113.613 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -64.55 -21.36 66.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 10.0 112.153 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.45 -3.59 19.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.183 0.516 . . . . 10.0 110.358 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.01 -9.73 54.84 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.463 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 19.8 m-85 -133.12 128.76 36.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.931 0.396 . . . . 10.0 111.274 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.48 92.04 15.57 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 3.0 Cg_exo -75.42 103.17 1.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.067 2.511 . . . . 10.0 112.924 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -98.36 103.12 15.04 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.376 -0.602 . . . . 10.0 109.376 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.9 mm? -86.76 110.0 19.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.165 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.98 112.9 25.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.944 0.402 . . . . 10.0 109.923 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.497 HG22 HG13 ' B' ' 26' ' ' VAL . 95.6 t -102.31 121.8 53.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.897 0.38 . . . . 10.0 111.261 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.76 170.25 8.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.533 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.43 -29.17 68.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.098 0.475 . . . . 10.0 110.554 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -75.44 -39.58 58.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.567 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.92 -179.55 47.81 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.833 -0.699 . . . . 10.0 111.904 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.497 HG13 HG22 ' B' ' 21' ' ' VAL . 60.0 t -94.14 135.88 27.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.066 -0.346 . . . . 10.0 110.066 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.428 ' OD1' ' HG3' ' B' ' 80' ' ' GLN . 52.5 t30 -124.95 112.04 16.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.856 -0.424 . . . . 10.0 109.856 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.49 HG22 ' HD1' ' B' ' 30' ' ' PHE . 2.8 p -92.63 124.75 45.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.969 0.414 . . . . 10.0 110.969 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' B' ' 79' ' ' ALA . 2.0 tmm_? -126.97 90.77 3.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.554 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.49 ' HD1' HG22 ' B' ' 28' ' ' VAL . 6.2 p90 -93.81 112.93 24.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.118 0.485 . . . . 10.0 111.238 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mtm-85 -72.45 114.6 10.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.461 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 43.7 mt -91.76 139.56 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.826 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.18 155.74 38.03 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.687 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -75.56 77.49 2.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.106 0.479 . . . . 10.0 111.571 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.0 -20.89 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.568 -0.613 . . . . 10.0 111.568 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -104.55 151.61 23.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -145.44 137.56 25.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.761 0.315 . . . . 10.0 110.724 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 34.4 mtt -107.97 156.18 19.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.964 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.616 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 18.3 m-85 -99.59 126.86 45.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.636 -0.505 . . . . 10.0 109.636 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -61.29 -28.56 69.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.909 0.385 . . . . 10.0 111.1 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.96 5.39 37.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.079 -0.51 . . . . 10.0 111.064 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.616 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 53.2 mmtt -122.19 -10.85 8.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.289 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.454 HG13 ' O ' ' B' ' 39' ' ' TYR . 89.9 mt -86.96 118.05 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 10.0 110.453 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.4 t -108.32 121.51 61.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.889 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.91 137.22 6.56 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.688 -0.767 . . . . 10.0 111.705 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -161.69 145.61 12.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.801 0.334 . . . . 10.0 111.209 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.635 ' HB ' HD13 ' B' ' 95' ' ' LEU . 8.8 t -143.97 120.88 11.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.805 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.583 HD22 ' HB2' ' B' ' 53' ' ' LEU . 24.1 p30 -174.07 159.53 2.86 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.832 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -73.87 -77.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.321 2.014 . . . . 10.0 110.843 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.82 44.44 1.03 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.149 0.499 . . . . 10.0 110.251 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.535 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 9.9 t0 66.79 33.33 6.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.297 -0.865 . . . . 10.0 112.269 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.88 70.26 4.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.921 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.583 ' HB2' HD22 ' B' ' 48' ' ' ASN . 28.5 tp -125.04 149.03 48.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.716 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.32 -72.67 1.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.886 -0.673 . . . . 10.0 111.805 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -169.87 146.83 2.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 122.131 0.172 . . . . 10.0 110.552 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.65 109.76 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.378 2.052 . . . . 10.0 110.494 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 6.4 m -89.07 94.24 9.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.157 0.503 . . . . 10.0 111.763 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -77.58 163.53 26.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.202 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 50.2 m -95.0 -3.65 48.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.518 -0.31 . . . . 10.0 111.141 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? 68.71 124.12 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.607 -0.724 . . . . 10.0 111.992 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.27 -139.89 8.4 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.893 -0.67 . . . . 10.0 112.206 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.88 143.92 44.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.732 0.301 . . . . 10.0 110.646 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -81.28 119.92 24.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.213 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' B' ' 65' ' ' GLU . 14.2 ttpt -98.95 136.03 39.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.456 -0.338 . . . . 10.0 110.799 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.405 ' O ' ' HE3' ' B' ' 64' ' ' LYS . 4.6 tp10 -73.97 126.42 30.45 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.571 -0.9 . . . . 10.0 108.571 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -120.46 -179.53 4.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.765 0.317 . . . . 10.0 110.906 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.23 -25.4 4.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.995 0.426 . . . . 10.0 110.575 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 40' ' ' LEU . 1.1 t80 -102.29 -49.12 3.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.853 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.437 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 22.1 m-30 -88.6 -4.45 58.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.496 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.79 -76.58 2.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.865 -0.683 . . . . 10.0 112.111 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -173.59 118.96 0.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.026 -0.361 . . . . 10.0 110.026 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -133.52 164.74 26.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.799 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -75.51 125.98 30.1 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.3 m -125.87 163.63 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.455 0.645 . . . . 10.0 112.449 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' B' ' 78' ' ' GLU . 28.8 m-85 -120.95 130.91 54.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.815 -1.18 . . . . 10.0 107.815 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -115.22 -10.87 12.06 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.66 0.615 . . . . 10.0 112.66 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.91 -29.31 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.339 0.59 . . . . 10.0 109.653 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.8 OUTLIER -86.09 142.61 28.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.038 -0.983 . . . . 10.0 109.378 178.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' B' ' 29' ' ' ARG . . . -166.79 102.69 0.57 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.793 0.33 . . . . 10.0 110.465 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.428 ' HG3' ' OD1' ' B' ' 27' ' ' ASN . 27.3 tt0 -148.92 117.71 6.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.13 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.38 120.89 52.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.574 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.91 148.13 23.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.349 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' PHE . . . . . 0.562 ' HB3' HD11 ' B' ' 53' ' ' LEU . 77.1 m-85 -125.22 102.96 30.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.61 127.46 8.04 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.766 2.311 . . . . 10.0 111.293 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -74.12 143.08 45.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.921 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.0 -4.18 53.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.335 0.588 . . . . 10.0 110.095 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -152.21 136.86 16.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.644 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.9 96.52 10.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.35 140.27 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.487 -0.324 . . . . 10.0 111.457 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.18 58.76 4.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.895 -0.669 . . . . 10.0 111.594 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -116.4 140.67 26.86 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.94 89.55 0.88 Allowed 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.584 2.189 . . . . 10.0 111.485 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.53 160.03 32.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.752 -0.658 . . . . 10.0 111.66 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 47' ' ' THR . 27.3 tttt -103.56 155.23 18.69 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.379 -0.601 . . . . 10.0 109.379 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.635 HD13 ' HB ' ' B' ' 47' ' ' THR . 42.0 tp -125.89 119.89 29.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.803 0.335 . . . . 10.0 110.762 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.75 123.84 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.525 -0.546 . . . . 10.0 109.525 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 64.2 mt -128.92 131.76 47.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.945 0.403 . . . . 10.0 111.66 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' THR . . . . . 0.416 HG22 ' HB2' ' B' ' 111' ' ' PRO . 5.6 m -120.07 117.13 27.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 34.1 m-85 -98.23 104.34 16.37 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.963 0.357 . . . . 10.0 111.963 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.883 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 11.1 tp60 -117.47 121.39 40.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.901 0.382 . . . . 10.0 110.981 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.91 -160.41 10.68 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.888 -0.673 . . . . 10.0 111.546 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 18.4 m -152.87 -179.57 7.77 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' ALA . . . . . 0.625 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -121.35 142.99 49.45 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.868 -0.419 . . . . 10.0 109.868 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.55 -10.09 56.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.181 -0.463 . . . . 10.0 112.04 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.33 -4.05 59.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.359 . . . . 10.0 111.769 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.13 38.09 2.96 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.561 -0.828 . . . . 10.0 112.928 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.625 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 35.1 t -123.13 141.51 43.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.574 ' HB2' HD12 ' A' ' 38' ' ' LEU . 9.4 t -132.68 86.18 2.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.872 0.368 . . . . 10.0 110.803 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.729 ' HB3' HG23 ' A' ' 107' ' ' VAL . 55.2 p90 -76.73 152.52 82.99 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.497 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.15 161.38 43.31 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.825 2.35 . . . . 10.0 111.512 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.883 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 84.0 Cg_endo -77.91 74.65 5.16 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.861 2.374 . . . . 10.0 112.289 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.577 HG22 HD12 ' A' ' 69' ' ' LEU . 4.5 t -61.05 122.78 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.596 -0.52 . . . . 10.0 109.596 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ASP . . . . . 0.409 ' HB3' HG23 ' B' ' 98' ' ' THR . 4.6 p-10 -106.11 156.66 18.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.993 0.425 . . . . 10.0 111.291 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.28 141.09 30.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.17 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -107.73 123.18 48.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 10.0 110.739 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -112.94 148.29 35.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.571 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -105.12 118.96 37.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.517 -0.31 . . . . 10.0 110.221 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 14.9 mm -94.54 71.1 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.295 0.569 . . . . 10.0 110.53 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' B' ' 121' ' ' ASN . 44.0 p90 -83.98 -19.74 34.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.657 -0.701 . . . . 10.0 111.479 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.39 51.7 0.24 Allowed Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.709 -0.758 . . . . 10.0 112.688 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . 0.44 ' HB2' ' CZ ' ' B' ' 119' ' ' PHE . 21.3 t30 -103.77 -18.13 14.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.166 0.508 . . . . 10.0 110.489 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.19 -78.1 0.67 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.96 -0.856 . . . . 10.0 110.96 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 2.1 m -105.26 141.81 36.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -133.21 156.43 47.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.21 -0.292 . . . . 10.0 110.21 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.3 152.8 54.92 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' PRO . . . . . 0.434 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 28.5 Cg_endo -63.91 114.32 2.55 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.448 2.099 . . . . 10.0 112.139 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -81.13 76.9 8.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.566 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 7.7 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.788 -0.625 . . . . 10.0 109.732 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 109.738 -0.467 . . . . 10.0 109.738 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.503 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 1.4 m -123.02 76.32 50.28 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.068 0.461 . . . . 10.0 111.398 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.34 -33.97 88.2 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.702 2.268 . . . . 10.0 112.017 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -43.81 96.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.385 -0.371 . . . . 10.0 111.179 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -69.27 -40.01 78.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.307 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.4 tp -62.23 -34.16 75.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.729 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 m -84.57 -8.01 59.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.45 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.2 m -82.51 -20.73 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.192 0.52 . . . . 10.0 109.745 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 9' ' ' LEU . 3.2 mm? -56.4 119.34 5.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.696 -0.683 . . . . 10.0 110.636 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.35 140.42 41.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.43 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 22.0 p -81.68 168.97 17.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.866 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -11.04 56.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.984 0.421 . . . . 10.0 111.15 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.38 8.22 45.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.381 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.3 t30 68.12 38.14 2.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.6 -0.727 . . . . 10.0 112.108 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -122.51 140.26 32.49 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.658 -0.497 . . . . 10.0 109.658 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.35 143.82 78.04 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.215 1.943 . . . . 10.0 111.422 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -13.23 34.28 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.2 m -56.87 -22.82 39.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 10.0 112.133 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.96 -20.23 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.109 0.48 . . . . 10.0 111.315 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -132.47 28.76 4.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.18 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -138.73 43.94 2.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.131 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -145.81 -171.57 3.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.389 -0.368 . . . . 10.0 111.269 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 mttp 65.84 13.82 9.22 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 58.26 38.4 26.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.944 0.402 . . . . 10.0 111.682 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -103.22 146.43 32.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.941 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.622 ' HD3' ' HG2' ' A' ' 116' ' ' LYS . 27.1 Cg_endo -63.26 135.76 52.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.659 2.239 . . . . 10.0 110.958 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 114' ' ' ILE . 4.2 m -109.33 146.21 34.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.827 0.346 . . . . 10.0 111.181 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.1 tp -127.34 108.19 10.63 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.872 -0.418 . . . . 10.0 109.872 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 70.9 mt -96.09 119.75 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.969 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.714 ' HD2' HG22 ' A' ' 62' ' ' THR . 1.1 tmtp? -113.2 124.82 53.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.679 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -98.0 142.49 29.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.351 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.426 ' HE1' ' HB ' ' A' ' 62' ' ' THR . 32.7 p-90 -145.81 170.82 15.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.525 -0.307 . . . . 10.0 110.821 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . . . -114.9 139.49 49.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.637 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -73.33 -47.19 44.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.994 -0.548 . . . . 10.0 112.443 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.429 ' CH2' ' HD3' ' B' ' 111' ' ' PRO . 0.0 OUTLIER -90.99 29.27 1.4 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.427 0.529 . . . . 10.0 112.427 -178.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 33.7 t -117.59 121.05 32.39 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.513 0.197 . . . . 10.0 111.288 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.765 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 14.6 Cg_endo -58.0 -43.54 47.58 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.129 2.553 . . . . 10.0 112.467 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.37 -39.53 90.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.948 0.404 . . . . 10.0 111.279 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 78.2 m -76.08 -31.68 58.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.566 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.02 -46.85 85.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 10.0 112.082 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 m -66.61 -33.66 76.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.055 0.455 . . . . 10.0 110.862 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -26.31 68.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.254 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.28 -34.33 72.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.825 0.345 . . . . 10.0 110.643 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.78 92.34 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.935 -0.65 . . . . 10.0 111.853 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -77.31 -29.65 53.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.911 0.386 . . . . 10.0 110.113 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.7 m -60.44 -47.49 85.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.772 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.68 -36.75 85.28 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -61.69 -50.39 72.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.258 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -64.11 -37.28 86.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.049 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.14 -10.84 59.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.433 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -111.78 16.4 20.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.992 0.425 . . . . 10.0 110.73 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -93.31 139.89 30.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.258 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.38 -32.23 69.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.836 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -71.33 -44.09 65.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 10.0 110.658 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.42 ' CZ ' ' HB1' ' A' ' 133' ' ' ALA . 1.7 m-85 -73.6 -14.76 61.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 10.0 112.198 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.9 m -65.01 -11.63 41.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 10.0 111.216 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -78.87 -15.36 58.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.497 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -123.22 176.33 6.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.418 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.437 ' HB2' HG23 ' A' ' 27' ' ' THR . 78.9 m-20 -109.69 87.7 2.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.57 117.26 20.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.445 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.2 pt -134.93 147.2 29.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.786 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.714 HG22 ' HD2' ' A' ' 30' ' ' LYS . 1.6 p -109.0 116.41 31.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.167 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.462 HG22 ' HB ' ' A' ' 92' ' ' VAL . 18.7 t -113.17 137.15 47.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.78 0.324 . . . . 10.0 111.181 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.522 ' O ' ' HD3' ' A' ' 66' ' ' PRO . . . -132.08 138.25 48.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.087 -0.708 . . . . 10.0 109.087 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -100.66 102.35 18.89 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 112.13 0.418 . . . . 10.0 112.13 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 18.4 Cg_exo -68.63 131.23 22.41 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.994 2.463 . . . . 10.0 111.894 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.57 0.64 90.03 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.942 -0.572 . . . . 10.0 112.448 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -112.02 143.03 43.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.499 HD12 HG22 ' B' ' 112' ' ' VAL . 2.0 mm? 60.81 26.56 16.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.837 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.904 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.1 OUTLIER 67.93 26.43 7.48 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.371 -0.831 . . . . 10.0 112.849 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 2.1 mm-40 -81.97 -169.61 2.46 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.451 -0.34 . . . . 10.0 110.187 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -68.35 145.06 54.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.206 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -77.33 162.29 27.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.038 0.447 . . . . 10.0 111.712 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -63.56 150.35 44.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.855 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.56 -40.96 3.03 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.867 -0.893 . . . . 10.0 110.867 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -81.92 -47.62 12.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.913 0.387 . . . . 10.0 110.062 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -57.59 -39.37 76.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.8 -0.637 . . . . 10.0 112.232 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.01 -30.62 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.996 0.427 . . . . 10.0 111.225 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -77.87 -31.72 51.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 10.0 109.866 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -58.16 -45.76 86.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.73 -0.668 . . . . 10.0 109.678 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -66.99 -36.58 82.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.798 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.67 -27.76 69.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.198 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.24 29.21 12.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.889 -0.672 . . . . 10.0 111.998 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HB3' ' H ' ' A' ' 85' ' ' ASN . 38.5 mt -121.66 -162.55 0.99 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.042 0.449 . . . . 10.0 111.059 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.437 ' H ' ' HB3' ' A' ' 84' ' ' LEU . 45.8 t30 -116.99 -171.61 2.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.766 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 66.33 84.74 0.17 Allowed Pre-proline 0 N--CA 1.465 0.314 0 CA-C-O 121.381 0.61 . . . . 10.0 110.705 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.0 -11.57 29.39 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.776 2.318 . . . . 10.0 112.549 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -107.09 22.77 15.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.213 0.449 . . . . 10.0 112.213 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.454 ' HB3' HG23 ' A' ' 91' ' ' VAL . 5.2 mt -81.34 115.27 55.4 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.627 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.04 63.88 8.24 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.443 2.095 . . . . 10.0 111.705 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 89' ' ' LEU . 68.7 t -82.31 117.27 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.13 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.77 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 9.7 t -104.97 142.49 18.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.706 -0.679 . . . . 10.0 109.981 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -99.28 108.45 20.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.05 -179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -94.72 78.58 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.297 0.57 . . . . 10.0 110.222 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -64.17 116.56 6.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.505 0.557 . . . . 10.0 112.505 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.63 -6.31 67.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.563 -0.827 . . . . 10.0 112.65 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.45 41.36 67.03 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.72 -0.752 . . . . 10.0 111.799 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -43.99 98.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.833 0.349 . . . . 10.0 110.775 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.0 mm -80.39 -42.26 21.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.938 0.399 . . . . 10.0 110.07 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.436 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.88 -45.7 89.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.628 -0.714 . . . . 10.0 112.167 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -68.3 -38.01 81.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.8 m -61.2 -35.74 78.0 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.413 0.523 . . . . 10.0 112.413 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -106.37 5.7 29.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.595 0.22 . . . . 10.0 111.595 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.0 t30 53.39 55.71 8.34 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.524 0.678 . . . . 10.0 111.064 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 100' ' ' ALA . 78.2 mt -87.06 99.91 9.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.325 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.92 29.19 8.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.749 -0.66 . . . . 10.0 111.277 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.525 ' HA ' ' CD ' ' B' ' 110' ' ' PRO . 10.8 p -166.78 152.15 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.211 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -126.83 154.48 76.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -91.71 118.43 3.04 Favored 'Cis proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.619 -1.409 . . . . 10.0 111.403 -1.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.5 m -87.17 136.47 32.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.218 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -113.6 113.47 25.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.749 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.86 116.93 33.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.335 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 136' ' ' LEU . 37.3 tp -93.65 116.11 28.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.8 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 27' ' ' THR . 2.9 mp -104.65 129.59 56.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.946 -0.57 . . . . 10.0 109.544 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.75 178.17 40.04 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.962 -0.637 . . . . 10.0 112.895 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.622 ' HG2' ' HD3' ' A' ' 26' ' ' PRO . 3.3 mtmp? -69.77 -13.04 62.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.127 0.489 . . . . 10.0 110.617 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.44 -10.68 58.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.263 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.97 43.0 6.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.556 -0.831 . . . . 10.0 112.206 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -149.72 153.67 37.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.636 0.255 . . . . 10.0 110.573 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.5 t -70.23 120.23 17.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.952 0.406 . . . . 10.0 111.323 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -99.95 -28.97 12.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.013 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -156.24 146.65 21.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.585 -0.279 . . . . 10.0 111.004 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.0 tp -131.3 117.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.911 -0.403 . . . . 10.0 109.911 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.62 133.58 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.543 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -120.69 126.45 50.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.195 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.85 -99.21 0.22 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.499 -0.857 . . . . 10.0 112.931 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.4 m -168.14 135.22 2.11 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.122 -0.696 . . . . 10.0 109.122 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.1 pt -119.19 154.86 21.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.969 -0.293 . . . . 10.0 110.664 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -110.37 169.58 8.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.248 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -57.93 -39.32 77.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.114 0.413 . . . . 10.0 112.114 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.55 -40.85 88.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.104 0.478 . . . . 10.0 110.419 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -68.62 -38.21 80.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.22 -0.9 . . . . 10.0 110.146 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.42 ' HB1' ' CZ ' ' A' ' 55' ' ' PHE . . . -59.77 -45.85 91.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.633 -0.712 . . . . 10.0 110.941 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.15 -36.77 85.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.849 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.23 95.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.752 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.534 HD11 HD22 ' A' ' 113' ' ' LEU . 21.2 tp -62.43 -32.09 72.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.077 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.3 mt -72.68 -32.96 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.118 0.485 . . . . 10.0 110.358 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -78.5 -39.78 37.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.649 -0.705 . . . . 10.0 110.82 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.6 t70 -151.75 119.28 3.27 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.603 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.509 ' HB3' HD21 ' A' ' 113' ' ' LEU . 16.5 Cg_exo -69.25 -7.25 20.4 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.098 2.532 . . . . 10.0 113.42 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -99.12 4.4 46.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 10.0 111.163 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.2 72.09 9.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.411 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -76.61 150.98 36.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.949 -0.568 . . . . 10.0 111.305 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.146 0 N-CA-C 114.006 1.113 . . . . 10.0 114.006 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.452 0.168 . . . . 10.0 111.08 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.88 70.72 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.08 -0.509 . . . . 10.0 112.087 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 35.1 tp -91.91 -80.03 0.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.674 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 55.16 37.23 28.58 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.448 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.67 157.34 44.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.23 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.17 -172.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.253 -0.885 . . . . 10.0 112.693 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -94.6 27.87 2.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.273 -0.876 . . . . 10.0 110.619 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -84.51 -4.33 58.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.985 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.5 143.98 51.07 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.9 150.89 87.05 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.024 2.483 . . . . 10.0 112.4 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.28 -34.42 88.37 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.413 2.742 . . . . 10.0 113.162 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -68.0 -4.73 14.19 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.118 0.414 . . . . 10.0 112.118 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -129.03 1.43 5.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.4 0.619 . . . . 10.0 110.233 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.42 -10.47 43.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.832 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.4 ' HE1' HG23 ' B' ' 32' ' ' ILE . 23.6 m-85 -131.95 126.14 33.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.504 -0.317 . . . . 10.0 111.204 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.38 92.55 36.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' B' ' 30' ' ' PHE . 3.1 Cg_exo -76.49 116.06 4.22 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.169 2.579 . . . . 10.0 113.441 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.1 109.48 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.1 mm? -93.46 118.09 30.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.987 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.16 113.53 22.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.546 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.98 118.91 43.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.025 0.441 . . . . 10.0 111.225 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.0 -164.48 1.14 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.738 -0.665 . . . . 10.0 109.928 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -92.26 -37.29 12.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.789 0.328 . . . . 10.0 111.069 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.64 -37.12 42.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.623 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CZ ' ' B' ' 85' ' ' TYR . . . -168.01 -170.48 32.81 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.586 -0.816 . . . . 10.0 112.392 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.9 135.1 47.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -120.35 111.89 18.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.753 0.311 . . . . 10.0 110.248 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.488 HG22 ' HD1' ' B' ' 30' ' ' PHE . 3.9 p -95.01 122.55 46.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.13 0.491 . . . . 10.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -124.27 92.01 3.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.093 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 6.1 p90 -95.38 122.55 38.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.74 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -79.76 122.33 26.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.625 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.4 HG23 ' HE1' ' B' ' 15' ' ' PHE . 72.1 mt -100.83 130.68 49.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.49 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.65 145.34 55.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.147 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.36 92.99 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.109 0.48 . . . . 10.0 111.675 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.77 -23.86 0.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.663 -0.975 . . . . 10.0 110.663 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 103' ' ' ALA . 37.5 m-85 -103.51 154.04 19.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -144.63 139.01 27.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.965 0.412 . . . . 10.0 111.101 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 34.4 mtt -110.9 150.63 28.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.432 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.695 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 59.7 m-85 -92.6 121.35 33.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' B' ' 60' ' ' LYS . 21.1 tt0 -56.81 -37.12 70.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.752 0.31 . . . . 10.0 111.833 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.66 -9.77 58.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.397 . . . . 10.0 111.576 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.695 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 43.6 mmtt -104.43 -11.03 17.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.747 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.482 HG13 ' O ' ' B' ' 39' ' ' TYR . 75.2 mt -82.28 96.59 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.079 0.466 . . . . 10.0 110.314 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 t -91.46 109.04 20.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.203 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.39 141.51 12.57 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.55 -0.834 . . . . 10.0 111.751 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -162.36 147.48 12.51 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.789 0.328 . . . . 10.0 111.475 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.578 ' HB ' HD13 ' B' ' 95' ' ' LEU . 9.9 t -143.47 123.36 13.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.987 -0.552 . . . . 10.0 109.528 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' B' ' 51' ' ' ASP . 28.0 p30 -177.43 157.28 1.24 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.139 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 48' ' ' ASN . 11.7 Cg_exo -73.83 -69.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.732 2.288 . . . . 10.0 110.559 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.66 55.43 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.235 0.541 . . . . 10.0 109.769 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.564 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 4.9 t70 60.95 27.42 17.29 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.251 -0.886 . . . . 10.0 112.453 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' B' ' 52' ' ' LEU . 1.2 mm? -86.89 59.61 5.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.272 0.558 . . . . 10.0 111.531 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.434 ' HB2' ' HB3' ' B' ' 48' ' ' ASN . 22.9 tp -122.97 148.84 45.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.729 -0.669 . . . . 10.0 109.516 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.84 -80.21 0.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.596 -0.812 . . . . 10.0 111.45 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.447 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 1.5 pp0? -163.0 145.63 8.22 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.402 -0.221 . . . . 10.0 110.402 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 31.9 Cg_exo -63.64 107.5 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.606 2.204 . . . . 10.0 110.75 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.0 m -93.65 96.52 9.88 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.224 0.535 . . . . 10.0 111.536 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -80.25 150.25 30.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.718 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.4 m -81.12 -8.1 59.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.778 0.323 . . . . 10.0 110.678 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.408 ' HA ' ' OE1' ' B' ' 40' ' ' GLN . 3.3 mmtt 71.39 148.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.44 -0.8 . . . . 10.0 112.813 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.79 -128.33 2.93 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.996 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -121.04 149.57 42.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.526 0.203 . . . . 10.0 110.772 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.94 119.24 28.1 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -101.04 130.91 47.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.944 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -69.13 142.86 54.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -137.93 170.87 15.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.709 0.29 . . . . 10.0 111.16 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -109.85 -13.45 14.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.401 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.765 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 10.7 m-85 -121.36 -41.15 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 10.0 111.218 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -90.3 -7.41 53.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.962 0.411 . . . . 10.0 111.207 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.71 -79.46 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.095 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -171.44 110.75 0.31 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.989 0.423 . . . . 10.0 110.678 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -128.29 163.46 24.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.121 -0.491 . . . . 10.0 110.384 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 12.8 m -75.38 125.52 29.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.08 155.28 31.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.397 0.618 . . . . 10.0 112.357 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -112.84 130.34 56.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.611 -1.255 . . . . 10.0 107.611 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -113.03 -10.49 13.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.606 0.595 . . . . 10.0 112.606 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -168.78 -34.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.432 0.634 . . . . 10.0 109.887 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -87.75 134.55 33.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.296 -0.866 . . . . 10.0 109.769 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -159.32 123.79 3.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.883 0.373 . . . . 10.0 111.444 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -160.85 120.72 2.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.328 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 t -125.9 128.33 71.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 10.0 109.998 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.33 138.75 38.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.626 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' PHE . . . . . 0.416 ' HB3' HD11 ' B' ' 53' ' ' LEU . 62.7 m-85 -122.14 98.39 44.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.51 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.8 126.49 3.98 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.2 2.6 . . . . 10.0 111.027 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' TYR . . . . . 0.433 ' CZ ' ' HA2' ' B' ' 25' ' ' GLY . 7.1 m-85 -71.06 149.58 46.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.81 0.338 . . . . 10.0 110.871 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.99 -9.78 41.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.267 0.556 . . . . 10.0 110.107 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -152.24 127.2 9.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.895 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.64 99.32 6.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.143 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -131.83 146.22 33.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.403 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.58 43.63 3.01 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.671 -0.776 . . . . 10.0 111.867 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -104.33 144.44 28.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.43 0.157 . . . . 10.0 110.862 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.39 100.45 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.412 2.075 . . . . 10.0 111.353 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.56 144.13 28.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.923 -0.581 . . . . 10.0 111.208 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -88.81 159.5 17.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.049 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.578 HD13 ' HB ' ' B' ' 47' ' ' THR . 35.3 tp -131.05 121.8 25.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.046 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.42 HG22 ' HG2' ' B' ' 115' ' ' GLU . 40.6 t -117.05 125.0 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 49.2 mt -129.56 126.9 39.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.787 0.327 . . . . 10.0 111.549 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' THR . . . . . 0.497 HG23 ' HB3' ' B' ' 113' ' ' ASP . 1.7 m -115.62 116.85 28.83 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 41.9 m-85 -100.35 110.94 23.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.314 . . . . 10.0 111.366 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.91 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 6.1 tp60 -120.81 121.6 38.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.752 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.99 -157.13 9.84 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.309 -0.717 . . . . 10.0 111.309 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 39.6 m -158.86 -172.98 4.03 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' B' ' 36' ' ' TYR . . . -119.25 146.27 45.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.22 40.35 0.34 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.028 0.442 . . . . 10.0 110.484 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.18 1.06 1.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.223 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.05 -32.56 5.73 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.768 -0.729 . . . . 10.0 113.129 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 12.3 t -62.69 133.17 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.353 . . . . 10.0 111.313 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 10.9 t -129.22 100.35 5.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.947 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.414 ' CB ' HG23 ' A' ' 107' ' ' VAL . 15.3 p90 -89.61 144.81 32.47 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.678 0.275 . . . . 10.0 111.478 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.525 ' CD ' ' HA ' ' A' ' 107' ' ' VAL . 59.4 Cg_endo -73.18 160.83 44.51 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.854 2.37 . . . . 10.0 111.565 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.91 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 72.4 Cg_endo -76.77 75.83 4.32 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.54 2.16 . . . . 10.0 112.657 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.499 HG22 HD12 ' A' ' 69' ' ' LEU . 6.6 t -69.54 104.9 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' B' ' 98' ' ' THR . 5.5 p-10 -72.61 148.51 44.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.846 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.9 m -132.62 128.08 36.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.286 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . 0.42 ' HG2' HG22 ' B' ' 96' ' ' VAL . 39.1 mt-10 -105.59 134.16 49.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.012 0.434 . . . . 10.0 110.616 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.439 ' HB2' HD23 ' B' ' 95' ' ' LEU . 79.9 m-85 -109.17 166.56 10.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.345 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -123.0 117.61 25.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.966 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 18.6 mm -97.23 82.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.152 0.501 . . . . 10.0 110.462 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -97.38 -25.51 15.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.675 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.52 68.16 0.18 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.068 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -128.27 -3.9 5.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.866 0.365 . . . . 10.0 111.363 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.28 -76.72 2.21 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.836 -0.697 . . . . 10.0 111.917 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 0.2 OUTLIER -105.01 135.15 46.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.189 -0.301 . . . . 10.0 110.189 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -123.26 147.21 47.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 10.0 110.925 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.35 145.18 48.54 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.323 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.53 131.61 32.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.592 2.194 . . . . 10.0 111.668 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -84.24 86.55 7.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.209 0.528 . . . . 10.0 110.476 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.245 0.824 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.599 179.777 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.436 ' C ' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 109.788 -0.449 . . . . 10.0 109.788 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.53 63.13 63.37 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.337 . . . . 10.0 111.403 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HD3' ' C ' ' A' ' 1' ' ' MET . 23.0 Cg_exo -65.17 -43.61 10.99 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.411 2.074 . . . . 10.0 111.681 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -58.97 -44.35 91.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.267 -0.424 . . . . 10.0 111.32 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -47.03 80.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.947 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' A' ' 9' ' ' LEU . 28.8 tp -61.21 -36.19 79.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 10.0 111.361 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 m -76.08 -10.43 59.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 10.0 111.685 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.6 m -92.58 -6.33 49.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.035 0.445 . . . . 10.0 110.423 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 6' ' ' LEU . 2.3 mm? -66.37 109.52 2.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.293 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.49 139.43 33.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.931 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.78 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 71.6 p -84.13 172.51 11.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.061 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.29 -9.08 54.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.48 . . . . 10.0 110.263 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -91.71 8.11 38.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.948 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.95 13.33 7.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.258 -0.883 . . . . 10.0 112.956 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.92 143.49 29.2 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.479 -0.328 . . . . 10.0 110.626 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.82 146.79 88.92 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.617 2.211 . . . . 10.0 111.139 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.49 -5.68 25.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.256 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.556 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -56.66 -25.5 53.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.635 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.408 HG23 ' HD2' ' A' ' 20' ' ' TYR . 15.5 m -62.63 -21.45 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.078 0.466 . . . . 10.0 111.047 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.408 ' HD2' HG23 ' A' ' 19' ' ' VAL . 34.8 m-85 -117.68 20.55 13.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.329 0.585 . . . . 10.0 109.764 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 73.3 mt -125.76 25.38 6.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.661 -0.699 . . . . 10.0 110.33 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 18' ' ' SER . 26.4 mtpp -124.24 -170.6 2.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.204 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 mttm 68.31 8.48 6.63 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.733 0.645 . . . . 10.0 111.692 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.68 34.92 25.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.212 0.529 . . . . 10.0 110.32 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -101.67 150.58 37.44 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 10.0 111.449 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.27 142.87 75.05 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.781 2.321 . . . . 10.0 111.093 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.65 142.37 39.23 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.967 0.413 . . . . 10.0 111.286 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.563 HD23 ' HG ' ' A' ' 60' ' ' LEU . 24.7 tp -120.76 101.85 8.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 39.5 mt -87.53 121.92 38.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.817 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' HD2' HG22 ' A' ' 62' ' ' THR . 1.9 tmtp? -114.98 108.91 17.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.253 -0.431 . . . . 10.0 111.192 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 10.3 m-85 -82.86 138.07 34.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.068 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -140.98 171.67 13.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.576 -0.283 . . . . 10.0 111.239 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.46 144.59 49.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.239 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.98 -41.37 18.84 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.611 0.597 . . . . 10.0 112.611 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.572 ' HE1' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -88.56 23.81 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.661 0.615 . . . . 10.0 112.661 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.6 t -115.58 128.3 26.07 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 111.854 0.316 . . . . 10.0 111.854 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 27.2 Cg_endo -63.49 -43.09 18.69 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.884 2.389 . . . . 10.0 112.297 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.46 -41.69 93.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 10.0 111.171 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.5 m -70.32 -21.27 62.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.252 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.3 tp -68.52 -48.01 65.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.363 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.93 -33.07 74.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.172 0.511 . . . . 10.0 109.827 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -32.62 66.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.354 -0.839 . . . . 10.0 111.534 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.99 -46.71 84.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 10.0 111.091 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.91 -44.19 96.42 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.902 -0.59 . . . . 10.0 112.318 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -65.91 -38.13 87.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 10.0 110.785 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.4 m -63.62 -43.22 97.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.362 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -64.41 -39.71 94.37 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.908 -0.405 . . . . 10.0 109.908 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -60.83 -50.49 73.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.087 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -64.93 -40.16 94.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.753 -0.658 . . . . 10.0 111.528 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.59 -18.74 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.135 0.42 . . . . 10.0 112.135 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -103.7 10.24 36.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.753 0.311 . . . . 10.0 111.418 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 23.4 t70 -80.9 148.31 29.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.856 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.13 94.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 54' ' ' LYS . 25.1 mmmt -74.13 -34.85 64.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.885 0.374 . . . . 10.0 110.972 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.419 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -76.82 -10.89 59.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.147 -0.478 . . . . 10.0 111.862 -179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.5 m -74.72 2.15 10.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.028 0.442 . . . . 10.0 111.532 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -87.82 -9.47 53.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.834 0.349 . . . . 10.0 110.468 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.43 168.23 18.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 10.0 109.945 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -104.53 96.82 6.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.813 0.339 . . . . 10.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.563 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -86.29 125.48 33.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.711 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.3 pt -136.6 132.21 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 10.0 111.532 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.487 HG22 ' HD2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -92.18 131.07 37.7 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 179.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' A' ' 92' ' ' VAL . 13.6 p -137.06 147.18 27.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.165 0.507 . . . . 10.0 112.13 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.0 158.55 43.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.257 -1.016 . . . . 10.0 108.257 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 4.8 m -110.47 95.1 21.07 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 112.124 0.416 . . . . 10.0 112.124 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.753 ' HG3' HG22 ' A' ' 93' ' ' THR . 28.5 Cg_endo -63.28 119.27 6.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.58 2.187 . . . . 10.0 111.699 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.95 10.02 65.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.93 -0.652 . . . . 10.0 112.48 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 19.5 t80 -129.03 144.53 51.22 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.407 HD11 ' O ' ' A' ' 105' ' ' ILE . 44.3 mt 60.91 27.21 17.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.896 0.379 . . . . 10.0 111.592 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.587 ' HE1' ' HB3' ' B' ' 113' ' ' ASP . 4.2 m170 69.09 19.03 8.17 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.417 -0.811 . . . . 10.0 112.866 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.572 ' HA ' ' HE1' ' A' ' 35' ' ' TRP . 2.9 mm-40 -75.7 177.66 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.571 -0.286 . . . . 10.0 110.678 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 33.1 mmtt -63.37 148.09 49.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.949 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HD3' ' H ' ' A' ' 74' ' ' ASP . 6.2 tmtt? -74.75 156.39 36.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.993 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.548 ' H ' ' HD3' ' A' ' 73' ' ' LYS . 5.1 t70 -55.61 143.88 28.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.395 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.24 -52.92 4.12 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.622 -0.991 . . . . 10.0 110.622 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.92 -42.49 76.72 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.22 -47.85 84.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.751 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -66.5 -24.43 66.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 10.0 111.62 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -74.96 -30.87 61.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.434 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -65.67 -48.83 70.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.622 -0.51 . . . . 10.0 109.622 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -62.92 -33.57 75.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.075 0.464 . . . . 10.0 110.852 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.42 -18.62 65.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.351 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.8 30.19 8.65 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.991 -0.844 . . . . 10.0 110.991 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.0 mt -130.85 173.83 10.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.778 0.323 . . . . 10.0 110.27 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.408 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 57.0 t30 -92.87 -165.76 1.4 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.615 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.408 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 41.4 m-85 63.46 68.01 0.95 Allowed Pre-proline 0 C--O 1.233 0.222 0 CA-C-O 121.022 0.439 . . . . 10.0 110.595 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.6 23.82 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.65 2.233 . . . . 10.0 112.698 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.97 13.7 9.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 10.0 110.578 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 20.3 mt -92.17 118.98 68.4 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 10.0 110.964 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 89' ' ' LEU . 3.8 Cg_exo -77.77 69.08 7.51 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.062 2.508 . . . . 10.0 110.689 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 62' ' ' THR . 66.9 t -79.72 115.86 22.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.204 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 3.2 t -98.87 148.11 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.249 -0.432 . . . . 10.0 109.998 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.753 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -105.02 101.78 11.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.767 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 55.5 t0 -86.16 88.65 7.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.089 0.471 . . . . 10.0 110.633 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -64.58 106.94 1.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.989 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.91 -2.33 69.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.814 -0.707 . . . . 10.0 112.924 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.98 55.45 19.23 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.355 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.24 -45.01 95.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.023 0.439 . . . . 10.0 110.608 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.452 ' HB ' ' HZ ' ' A' ' 31' ' ' PHE . 31.8 mm -80.46 -39.09 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.108 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -59.33 -43.93 92.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.521 -0.763 . . . . 10.0 111.899 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -75.17 -36.7 61.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.889 0.376 . . . . 10.0 111.294 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.6 m -65.38 -34.66 78.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.559 0.577 . . . . 10.0 112.559 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.421 HD21 HG21 ' A' ' 120' ' ' VAL . 93.6 mt -101.19 5.29 42.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.524 0.202 . . . . 10.0 111.5 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 53.05 69.51 0.69 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.578 0.704 . . . . 10.0 111.311 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 100' ' ' ALA . 86.1 mt -103.47 114.99 44.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.413 -0.812 . . . . 10.0 111.033 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.8 p -121.37 19.48 11.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.46 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' B' ' 109' ' ' TYR . 11.0 p -163.54 149.73 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.838 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 31' ' ' PHE . 72.0 m-85 -117.33 156.81 48.5 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 126' ' ' GLY . 7.0 Cg_endo -91.13 144.95 14.5 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.937 -1.276 . . . . 10.0 111.431 -1.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.8 m -110.08 129.54 55.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.477 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -107.52 107.05 17.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.935 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.797 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -97.05 116.81 29.93 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.484 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.2 tp -94.55 107.38 19.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.823 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.3 127.28 46.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 117' ' ' ASP . . . -66.33 165.38 39.66 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.909 -0.662 . . . . 10.0 112.124 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -69.68 8.94 0.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.225 0.454 . . . . 10.0 112.225 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 115' ' ' GLY . 6.9 t70 -103.92 -20.02 14.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.295 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 100.96 46.28 1.77 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.989 -0.624 . . . . 10.0 112.421 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -154.14 166.71 32.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.436 0.16 . . . . 10.0 110.599 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.421 HG21 HD21 ' A' ' 103' ' ' LEU . 16.5 t -74.66 111.6 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.071 0.462 . . . . 10.0 110.839 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -93.82 -35.97 12.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.989 -0.551 . . . . 10.0 110.689 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -157.53 153.71 27.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.154 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 tp -136.93 121.52 24.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.069 0.461 . . . . 10.0 110.658 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.52 120.13 63.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.358 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -117.1 114.96 24.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.004 -0.369 . . . . 10.0 110.004 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.52 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 154.69 -87.43 0.13 Allowed Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.26 -0.971 . . . . 10.0 112.739 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.6 m -167.18 146.56 5.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.5 pt -127.24 179.99 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.576 0.227 . . . . 10.0 110.821 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -142.99 171.58 13.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.704 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -61.15 -44.5 97.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.927 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.26 95.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.978 0.418 . . . . 10.0 110.236 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -63.56 -39.3 94.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.488 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.85 94.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 10.0 110.349 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.78 -36.66 84.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.422 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.1 70.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.767 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.09 -42.47 89.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.991 -0.55 . . . . 10.0 111.388 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.4 pt -76.0 -10.53 13.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.213 0.53 . . . . 10.0 110.773 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -91.32 -52.11 4.97 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 25.7 t0 -143.61 110.14 5.27 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.102 -0.954 . . . . 10.0 109.556 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 38.4 Cg_endo -66.51 -7.21 17.15 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.964 2.443 . . . . 10.0 112.217 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -86.83 4.88 39.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.304 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.82 109.41 21.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.719 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.495 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 4.9 t70 -115.38 141.48 47.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.166 -0.921 . . . . 10.0 112.56 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtt . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 111.962 0.356 . . . . 10.0 111.962 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.89 -79.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 10.0 111.712 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 59.4 tp -87.89 -69.26 0.7 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.358 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 60.01 35.11 21.48 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.281 0.562 . . . . 10.0 110.674 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.86 162.76 34.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.275 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 30.3 m120 62.56 -155.95 0.34 Allowed 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.708 0.63 . . . . 10.0 110.897 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -110.22 20.25 18.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.261 0.553 . . . . 10.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -85.39 36.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.801 -0.636 . . . . 10.0 111.629 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -158.93 136.36 7.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.67 148.38 82.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.951 2.434 . . . . 10.0 112.159 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.58 -39.19 76.0 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.344 2.696 . . . . 10.0 113.591 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -68.59 -12.54 61.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 10.0 111.956 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -117.51 -0.15 11.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.249 0.547 . . . . 10.0 110.319 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.78 -19.21 24.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.354 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.54 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 16.5 m-85 -127.21 124.79 39.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.448 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 t -109.66 91.17 9.95 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.519 -0.549 . . . . 10.0 109.519 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 3.4 Cg_exo -75.51 103.98 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.928 2.419 . . . . 10.0 112.785 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -100.71 115.0 29.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.01 117.06 25.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.673 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.11 99.92 9.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.015 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.519 HG21 ' HE2' ' B' ' 124' ' ' TYR . 65.8 t -94.52 118.29 40.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.961 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.15 -166.48 1.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.915 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -89.15 -36.63 15.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.896 0.379 . . . . 10.0 110.657 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -71.24 -40.26 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.899 -0.592 . . . . 10.0 110.96 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.428 ' HA2' ' CE2' ' B' ' 85' ' ' TYR . . . -177.64 -172.72 42.44 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.784 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.15 135.9 32.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -122.36 114.06 20.24 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.511 -0.551 . . . . 10.0 109.511 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.435 HG22 ' HD1' ' B' ' 30' ' ' PHE . 7.7 p -92.31 126.79 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.117 0.484 . . . . 10.0 111.273 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -127.5 88.74 2.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.159 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 5.0 p90 -93.31 115.74 28.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.024 0.44 . . . . 10.0 110.676 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 -75.17 115.71 15.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.554 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mt -94.68 135.8 27.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.911 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.8 150.31 48.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.155 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.53 79.71 2.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.203 0.525 . . . . 10.0 111.757 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.48 -26.65 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -103.77 150.99 23.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.227 -0.657 . . . . 10.0 109.227 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -142.39 146.18 34.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.822 0.344 . . . . 10.0 111.186 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' B' ' 99' ' ' TYR . 57.0 mtt -116.51 154.73 29.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.648 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.631 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 59.2 m-85 -96.48 129.81 43.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.39 -0.596 . . . . 10.0 109.39 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -60.6 -28.58 68.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.958 0.409 . . . . 10.0 111.255 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.97 9.8 21.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.205 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.631 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 38.9 mmtt -127.87 -7.68 5.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 10.0 111.748 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 89.4 mt -83.75 119.69 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.854 0.359 . . . . 10.0 110.188 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' B' ' 98' ' ' THR . 40.3 t -105.19 126.22 60.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.317 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.31 132.39 3.4 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.272 -0.731 . . . . 10.0 111.272 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -159.12 150.46 20.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.863 0.331 . . . . 10.0 111.129 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' B' ' 94' ' ' LYS . 10.2 t -153.66 125.27 7.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.34 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.451 ' HB2' ' HD2' ' B' ' 49' ' ' PRO . 13.3 p30 -178.54 160.76 1.13 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.344 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.464 ' HG3' HG21 ' B' ' 89' ' ' VAL . 55.3 Cg_endo -74.23 -56.54 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.215 1.943 . . . . 10.0 112.093 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.42 69.9 1.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.981 0.42 . . . . 10.0 111.138 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 t70 69.18 9.26 7.27 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.13 0.789 . . . . 10.0 113.13 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.443 ' HA ' HD13 ' B' ' 52' ' ' LEU . 1.4 mm? -81.24 59.9 4.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.043 0.449 . . . . 10.0 111.945 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 45.0 tp -125.87 138.58 53.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.78 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.57 -79.8 0.44 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.571 -0.823 . . . . 10.0 111.667 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 12.3 pt20 -165.72 145.4 5.38 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 23.7 Cg_exo -65.39 107.84 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.545 2.163 . . . . 10.0 111.772 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -83.62 92.65 7.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.467 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -77.27 145.54 37.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.013 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 53.9 m -77.62 -18.01 57.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.811 0.3 . . . . 10.0 111.811 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? 74.54 137.8 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.785 0.678 . . . . 10.0 112.558 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.99 -121.78 2.78 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.817 -0.913 . . . . 10.0 110.817 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -130.15 155.01 46.92 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -87.96 125.55 34.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.075 0.464 . . . . 10.0 110.838 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 71' ' ' ARG . 12.8 ttpp -102.7 131.9 49.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.452 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -73.79 146.73 44.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -145.2 173.78 11.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.803 0.335 . . . . 10.0 110.918 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -108.86 -29.38 8.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.858 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -108.12 -35.14 6.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 4.1 m-30 -94.11 -6.11 45.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.355 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.81 -79.97 1.52 Allowed Glycine 0 C--O 1.227 -0.296 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.435 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' B' ' 64' ' ' LYS . 5.9 ptp180 -176.71 122.61 0.15 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 122.698 0.399 . . . . 10.0 110.352 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -143.17 162.27 36.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.551 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 11.5 m -70.77 125.42 26.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.355 -0.609 . . . . 10.0 109.355 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -125.95 156.25 35.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.43 0.634 . . . . 10.0 112.312 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' TYR . . . . . 0.473 ' HB3' ' O ' ' B' ' 78' ' ' GLU . 53.7 m-85 -117.6 132.21 56.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -122.01 6.66 9.79 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.065 0.765 . . . . 10.0 113.065 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -176.25 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.83 -0.804 . . . . 10.0 108.83 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 1.0 OUTLIER -81.46 136.63 35.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.79 -1.095 . . . . 10.0 109.424 179.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -164.05 115.99 1.36 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 10.0 111.053 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -157.3 122.54 4.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.248 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.41 128.68 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.032 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.82 137.59 40.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.438 -0.347 . . . . 10.0 110.234 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -116.4 107.64 46.77 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.802 0.334 . . . . 10.0 111.528 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -91.03 127.47 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.036 2.491 . . . . 10.0 111.335 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' TYR . . . . . 0.428 ' CE2' ' HA2' ' B' ' 25' ' ' GLY . 21.9 m-85 -74.46 148.07 41.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.517 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.1 -5.88 57.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.175 0.512 . . . . 10.0 110.312 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -155.7 142.32 18.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.653 -0.703 . . . . 10.0 109.748 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.45 97.78 11.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.984 0.421 . . . . 10.0 110.74 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.464 HG21 ' HG3' ' B' ' 49' ' ' PRO . 13.6 m -128.24 154.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.685 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.26 7.18 72.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.628 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.22 144.7 92.68 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.89 107.06 1.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.444 2.096 . . . . 10.0 111.97 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.32 135.19 36.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' B' ' 47' ' ' THR . 40.7 tttt -88.7 141.58 28.39 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.605 -0.438 . . . . 10.0 110.328 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 64.6 tp -108.96 114.25 27.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.942 0.401 . . . . 10.0 110.897 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 47.4 t -112.47 122.03 65.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 65.6 mt -127.68 145.83 50.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.006 0.432 . . . . 10.0 111.536 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' THR . . . . . 0.744 ' HB ' ' HB ' ' B' ' 44' ' ' VAL . 24.1 m -147.87 122.93 10.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 16.4 m-85 -107.0 134.78 49.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.875 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 9.2 tp60 -140.61 126.01 18.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.428 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -165.87 -154.74 8.33 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.229 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.1 m -150.1 175.38 11.78 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -113.93 145.7 41.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.93 -2.41 12.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.791 0.663 . . . . 10.0 112.791 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.99 0.2 45.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.134 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.2 -21.13 31.8 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.808 -0.71 . . . . 10.0 112.082 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 3.2 t -64.15 145.15 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.79 0.329 . . . . 10.0 110.275 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 t -134.08 106.33 7.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.013 0.435 . . . . 10.0 110.794 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.5 ' HA ' HG23 ' A' ' 107' ' ' VAL . 31.3 p90 -88.17 146.68 38.71 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.821 0.343 . . . . 10.0 111.735 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 107' ' ' VAL . 63.7 Cg_endo -73.08 163.21 38.83 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.851 2.368 . . . . 10.0 111.782 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' B' ' 99' ' ' TYR . 57.0 Cg_endo -73.04 94.69 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.223 1.949 . . . . 10.0 111.591 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.56 133.7 30.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.33 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ASP . . . . . 0.587 ' HB3' ' HE1' ' A' ' 70' ' ' HIS . 4.8 p-10 -106.85 149.14 27.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.896 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.6 m -151.4 119.63 6.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.512 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.45 132.16 44.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.272 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -116.04 139.82 49.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.065 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.25 124.74 47.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.644 -0.707 . . . . 10.0 109.781 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.8 66.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.398 0.618 . . . . 10.0 109.925 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -73.19 -24.46 60.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.739 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 122.75 73.41 0.28 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.611 -0.804 . . . . 10.0 112.351 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -140.35 -20.15 0.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.103 0.477 . . . . 10.0 110.496 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.08 -65.29 4.0 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.911 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.99 123.66 33.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.305 -0.257 . . . . 10.0 110.305 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.519 ' HE2' HG21 ' B' ' 21' ' ' VAL . 56.4 m-85 -132.05 156.13 46.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.26 149.22 22.53 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.211 -0.449 . . . . 10.0 109.796 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.12 120.53 7.9 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.422 2.081 . . . . 10.0 112.257 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -80.87 75.28 7.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.19 0.519 . . . . 10.0 110.652 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 71.4 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.357 -0.83 . . . . 10.0 109.971 179.764 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 m -125.39 61.85 37.24 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 112.043 0.386 . . . . 10.0 112.043 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.28 -38.34 12.14 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.932 1.755 . . . . 10.0 111.857 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -62.61 -43.69 98.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.871 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -42.79 95.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.626 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -61.87 -30.3 70.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.034 0.445 . . . . 10.0 110.703 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 m -84.12 -7.14 59.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.187 -0.46 . . . . 10.0 111.456 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -91.24 -8.15 49.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.14 0.495 . . . . 10.0 109.907 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.25 110.7 2.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.418 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.47 140.61 30.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.736 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.8 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 25.2 p -81.2 174.06 11.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.324 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.53 -10.86 58.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.239 0.542 . . . . 10.0 110.135 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -91.95 -4.55 54.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.194 -0.912 . . . . 10.0 109.421 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 79.68 9.98 1.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.067 -0.97 . . . . 10.0 111.836 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 15' ' ' ARG . 32.8 mtt85 -94.64 144.79 28.5 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 10.0 109.998 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.78 148.93 78.16 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.242 1.962 . . . . 10.0 111.387 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.79 -8.52 15.38 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -24.04 52.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.795 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.631 HG23 ' HD1' ' A' ' 20' ' ' TYR . 19.2 m -61.53 -21.03 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.039 0.447 . . . . 10.0 111.709 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.631 ' HD1' HG23 ' A' ' 19' ' ' VAL . 35.5 m-85 -131.34 23.66 4.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.257 0.551 . . . . 10.0 110.42 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.7 mt -135.33 56.07 1.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.451 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HG2' ' H ' ' A' ' 23' ' ' LYS . 31.6 tttp -155.94 -179.71 8.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.36 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.484 ' H ' ' HG2' ' A' ' 22' ' ' LYS . 30.2 mttp 69.67 14.8 8.16 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.891 0.7 . . . . 10.0 112.891 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.78 39.18 29.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.013 0.435 . . . . 10.0 111.054 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -107.96 145.29 31.1 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.153 -0.476 . . . . 10.0 111.176 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.17 143.74 94.83 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.687 2.258 . . . . 10.0 111.543 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.516 ' HB ' ' HB ' ' A' ' 114' ' ' ILE . 1.6 m -116.41 143.49 45.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.664 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.636 HD23 ' HG ' ' A' ' 60' ' ' LEU . 28.3 tp -124.01 105.7 9.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.97 0.414 . . . . 10.0 110.047 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 67.6 mt -93.44 117.52 37.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.867 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.736 ' HE2' HG22 ' A' ' 62' ' ' THR . 17.4 ttpt -112.61 119.98 40.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.818 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 110' ' ' SER . 3.9 m-85 -88.7 146.92 24.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.569 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -148.94 166.98 26.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.859 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.28 142.81 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.627 -0.509 . . . . 10.0 109.627 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -67.44 -63.85 0.98 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.561 ' CZ2' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.5 64.16 4.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.494 0.553 . . . . 10.0 112.494 -178.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.6 t -131.94 135.62 26.94 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.076 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.709 ' HD3' ' HE1' ' B' ' 69' ' ' PHE . 33.3 Cg_endo -64.45 -49.54 3.33 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.517 2.145 . . . . 10.0 112.344 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' B' ' 108' ' ' CYS . 78.0 mt -63.17 -44.26 95.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.239 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.434 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 74.9 m -66.33 -31.16 71.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 10.0 111.389 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -62.86 -46.78 86.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.99 -38.68 79.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.93 0.395 . . . . 10.0 110.676 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -66.88 -24.74 66.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.859 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 39' ' ' CYS . 24.1 mt -55.27 -44.56 75.74 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.822 0.344 . . . . 10.0 111.416 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.48 -33.42 81.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.577 -0.821 . . . . 10.0 111.128 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -68.85 -40.01 79.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.355 -0.423 . . . . 10.0 110.662 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.4 m -55.19 -47.55 75.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.424 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.86 -44.14 86.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.061 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -60.63 -44.49 96.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.03 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -71.35 -37.89 71.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 10.0 111.698 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.91 -22.08 66.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.041 0.448 . . . . 10.0 111.234 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -88.55 -6.69 57.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.629 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.2 135.5 50.69 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.769 0.319 . . . . 10.0 110.369 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.42 -33.93 68.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.925 -0.579 . . . . 10.0 112.214 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -73.53 -37.75 65.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.968 0.413 . . . . 10.0 110.919 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -78.21 -10.32 59.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.925 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m -75.64 5.36 6.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.913 0.387 . . . . 10.0 111.53 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -87.04 -15.22 39.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.047 0.451 . . . . 10.0 110.52 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.44 148.4 51.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 10.0 109.814 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -82.87 88.19 6.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.763 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.636 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -81.48 121.54 26.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.542 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.2 pt -133.73 157.62 42.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.991 0.424 . . . . 10.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.736 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -111.83 117.55 33.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.166 -0.47 . . . . 10.0 109.811 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 92' ' ' VAL . 21.5 t -115.96 143.35 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.863 0.364 . . . . 10.0 111.337 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.39 146.76 38.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 4.7 m -104.17 100.9 23.28 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.639 ' HG3' HG22 ' A' ' 93' ' ' THR . 29.9 Cg_endo -62.75 118.51 5.41 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.758 2.305 . . . . 10.0 112.067 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.88 -12.71 67.01 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.965 -0.636 . . . . 10.0 112.539 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.593 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 7.5 t80 -96.92 144.43 26.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.158 -0.312 . . . . 10.0 110.158 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.481 HD11 HG22 ' B' ' 112' ' ' VAL . 0.8 OUTLIER 60.4 30.41 19.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.737 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.7 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 2.6 t60 66.37 19.0 10.97 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.653 -0.703 . . . . 10.0 112.811 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.561 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 2.1 mm-40 -77.6 -175.58 3.91 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 72' ' ' LYS . 48.1 mmtt -65.45 127.89 33.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.795 0.331 . . . . 10.0 111.039 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -66.46 163.41 18.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.961 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.96 125.62 24.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.549 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.97 -17.32 35.38 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -107.23 -41.68 5.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.029 0.442 . . . . 10.0 109.867 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -62.62 -50.92 69.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.594 . . . . 10.0 112.496 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.91 -28.07 69.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.047 0.451 . . . . 10.0 110.687 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 8.1 mmmt -75.55 -30.69 59.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.681 -0.691 . . . . 10.0 109.911 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.436 ' HZ3' ' HE3' ' A' ' 72' ' ' LYS . 5.2 t-105 -65.25 -50.04 67.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.526 -0.761 . . . . 10.0 109.499 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.405 ' HA ' HD12 ' A' ' 84' ' ' LEU . 74.9 t80 -63.89 -30.02 71.15 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.079 -0.51 . . . . 10.0 111.107 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.46 -24.1 67.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.178 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.14 8.15 41.51 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.105 -0.569 . . . . 10.0 111.98 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 81' ' ' TYR . 35.5 mt -95.19 -179.65 4.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.797 0.332 . . . . 10.0 110.879 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -97.93 -178.48 4.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.678 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 66.97 84.06 0.17 Allowed Pre-proline 0 N--CA 1.464 0.269 0 O-C-N 123.647 0.592 . . . . 10.0 112.053 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.1 37.96 0.72 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.633 2.222 . . . . 10.0 111.663 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -150.02 25.08 0.83 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.694 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 19.4 mt -93.36 117.9 67.51 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.545 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 89' ' ' LEU . 6.1 Cg_exo -74.56 66.97 5.59 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.745 2.297 . . . . 10.0 111.489 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 62' ' ' THR . 60.7 t -86.08 117.91 31.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.772 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.8 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 8.3 t -103.2 142.45 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.131 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.639 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -101.64 106.4 17.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.123 -179.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.456 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 40.3 t0 -93.48 91.35 7.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.243 0.545 . . . . 10.0 110.267 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.03 113.72 4.67 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.22 -24.64 26.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.857 -0.687 . . . . 10.0 113.06 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.81 44.15 3.98 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.513 -0.851 . . . . 10.0 111.413 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -33.72 74.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 10.0 110.627 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.2 mm -92.27 -43.45 13.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.224 -0.444 . . . . 10.0 109.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.831 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -60.51 -44.95 95.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.688 -0.687 . . . . 10.0 112.394 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -68.15 -40.77 82.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.9 m -66.54 -22.12 66.16 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.57 5.06 24.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.464 -0.334 . . . . 10.0 110.669 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.3 t30 52.37 50.08 19.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.665 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.831 HD12 ' HA ' ' A' ' 100' ' ' ALA . 98.3 mt -75.26 109.38 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.258 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.4 p -115.59 -10.32 11.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.586 -0.733 . . . . 10.0 112.025 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.859 HG23 ' HB3' ' B' ' 109' ' ' TYR . 7.4 p -147.14 142.1 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.562 0.22 . . . . 10.0 111.293 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' B' ' 108' ' ' CYS . 22.1 m-85 -107.24 153.99 40.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.653 -0.499 . . . . 10.0 109.653 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.07 159.16 83.63 Favored 'Cis proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.339 -1.525 . . . . 10.0 112.058 -0.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 13.0 m -122.18 124.3 43.53 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -108.76 104.2 13.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.02 0.438 . . . . 10.0 110.898 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.19 115.47 29.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.164 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 25.0 tp -95.69 112.62 24.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.584 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 27' ' ' THR . 3.4 mp -98.5 127.25 51.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.3 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.79 171.98 29.66 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 116.016 -0.538 . . . . 10.0 112.618 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -65.58 -14.42 61.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.256 0.465 . . . . 10.0 112.256 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.24 0.95 57.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 10.0 111.87 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.89 37.74 15.41 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.82 -0.705 . . . . 10.0 113.191 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -132.99 146.96 52.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.785 -0.244 . . . . 10.0 110.666 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.6 111.48 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.098 -0.334 . . . . 10.0 110.098 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -96.44 -35.87 11.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.357 -0.383 . . . . 10.0 111.512 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -142.35 150.27 40.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.628 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 tp -144.21 116.94 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 t -119.48 130.76 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.844 0.354 . . . . 10.0 111.637 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -101.96 107.23 18.31 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.158 -0.682 . . . . 10.0 109.158 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.42 -141.93 11.92 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.488 -0.645 . . . . 10.0 111.488 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.7 m -119.5 147.22 44.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.84 0.352 . . . . 10.0 111.066 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.9 pt -104.72 176.57 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.264 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -146.6 171.67 14.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.443 -0.344 . . . . 10.0 110.57 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -61.53 -46.88 88.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.932 0.345 . . . . 10.0 111.932 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.65 88.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 10.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -66.8 -39.19 87.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.351 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.426 ' O ' HG13 ' A' ' 137' ' ' ILE . . . -61.64 -42.88 99.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 10.0 109.75 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.75 -35.92 82.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.603 . . . . 10.0 110.41 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.7 -39.29 88.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 10.0 109.975 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 140' ' ' PRO . 27.5 tp -64.38 -36.32 83.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.585 -0.734 . . . . 10.0 110.523 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 133' ' ' ALA . 85.2 mt -67.11 -29.44 46.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.022 -0.536 . . . . 10.0 109.763 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -83.38 -50.34 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.793 -0.64 . . . . 10.0 111.246 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.491 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 2.8 t70 -144.43 120.67 6.24 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.8 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 139' ' ' ASP . 13.5 Cg_exo -71.24 -6.29 18.88 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.004 2.469 . . . . 10.0 112.707 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -94.11 -3.15 51.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.925 0.393 . . . . 10.0 110.897 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.13 73.44 6.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.526 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -74.2 155.43 38.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.25 -0.881 . . . . 10.0 111.513 -179.522 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 112.203 0.446 . . . . 10.0 112.203 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.3 -10.14 45.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 25.2 tp -142.41 -77.92 0.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.126 -0.23 . . . . 10.0 111.143 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 57.71 39.09 27.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.827 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.13 166.3 31.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.793 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.3 m120 68.4 -172.32 0.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.776 0.673 . . . . 10.0 111.865 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -99.69 13.9 32.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.36 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.43 -13.94 59.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.446 0.535 . . . . 10.0 112.446 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.08 133.27 23.44 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.673 0.273 . . . . 10.0 111.734 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.4 151.41 85.63 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 123.097 2.532 . . . . 10.0 112.453 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.677 ' HG3' ' HB ' ' A' ' 107' ' ' VAL . 11.3 Cg_endo -53.86 -33.75 72.84 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.746 2.964 . . . . 10.0 113.707 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -55.75 -28.15 54.44 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.38 -11.4 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 10.0 111.075 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' B' ' 11' ' ' PRO . . . -75.01 -7.61 54.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.275 -0.421 . . . . 10.0 111.932 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.468 ' HE1' HG23 ' B' ' 32' ' ' ILE . 21.4 m-85 -122.19 129.84 52.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.944 0.402 . . . . 10.0 111.364 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' B' ' 31' ' ' ARG . 42.1 t -114.16 92.06 25.41 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.13 102.0 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.5 2.133 . . . . 10.0 113.428 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -95.81 110.56 22.71 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' B' ' 19' ' ' LEU . 2.8 mm? -92.57 120.55 33.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.477 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.26 100.8 8.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.614 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.11 118.29 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.194 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.67 -170.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 10.0 110.347 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.65 -22.32 20.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.009 0.433 . . . . 10.0 111.608 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -86.73 -39.23 16.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.156 0.503 . . . . 10.0 110.272 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.91 -171.4 36.89 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.663 -0.699 . . . . 10.0 111.629 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -107.75 129.59 61.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.338 -0.616 . . . . 10.0 109.338 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -115.89 117.98 31.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.813 0.339 . . . . 10.0 110.186 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.509 HG22 ' HD1' ' B' ' 30' ' ' PHE . 7.8 p -101.88 118.02 48.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.277 0.56 . . . . 10.0 110.553 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -121.63 90.96 3.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.545 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.509 ' HD1' HG22 ' B' ' 28' ' ' VAL . 4.1 p90 -94.2 119.18 32.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.204 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.448 ' HB2' ' HB ' ' B' ' 16' ' ' VAL . 62.4 mtm-85 -77.0 118.38 19.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.232 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.468 HG23 ' HE1' ' B' ' 15' ' ' PHE . 53.8 mt -92.06 136.49 24.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.354 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 146.07 51.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.403 -0.362 . . . . 10.0 110.284 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.21 92.76 0.57 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.991 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.49 -16.71 1.12 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.404 -0.678 . . . . 10.0 111.404 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -105.78 151.95 23.83 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' B' ' 75' ' ' TYR . 33.0 p90 -143.98 139.9 29.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.945 0.402 . . . . 10.0 111.191 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' MET . . . . . 0.415 ' HA ' ' HA3' ' B' ' 101' ' ' GLY . 43.8 mtt -110.41 150.5 28.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.99 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.549 ' O ' HG13 ' B' ' 43' ' ' ILE . 90.9 m-85 -92.09 116.52 29.0 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.77 -0.456 . . . . 10.0 109.77 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.424 ' OE1' ' HA ' ' B' ' 60' ' ' LYS . 21.7 tt0 -61.32 -23.02 65.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.208 0.528 . . . . 10.0 111.331 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.8 -6.82 59.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.522 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -123.8 0.05 8.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.494 -0.321 . . . . 10.0 111.631 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.549 HG13 ' O ' ' B' ' 39' ' ' TYR . 92.9 mt -78.87 117.77 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.024 0.44 . . . . 10.0 109.817 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' B' ' 98' ' ' THR . 21.7 t -99.56 123.41 52.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.826 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -153.81 120.57 1.05 Allowed Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.643 -0.789 . . . . 10.0 111.995 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -160.46 140.47 11.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.808 0.337 . . . . 10.0 111.015 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' B' ' 94' ' ' LYS . 11.6 t -139.72 126.23 20.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.134 -0.484 . . . . 10.0 109.893 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.502 ' HB2' ' H ' ' B' ' 52' ' ' LEU . 28.2 p30 -174.56 158.36 2.45 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.426 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -74.26 -66.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.256 1.97 . . . . 10.0 111.072 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.64 53.79 1.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.129 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.489 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 0.3 OUTLIER 59.45 51.0 6.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.608 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.502 ' H ' ' HB2' ' B' ' 48' ' ' ASN . 0.6 OUTLIER -108.18 43.58 1.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.8 -0.637 . . . . 10.0 110.422 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' B' ' 83' ' ' PHE . 18.6 tp -107.45 144.64 34.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.092 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.63 -66.72 1.89 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.418 -0.896 . . . . 10.0 111.284 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 2.7 pp0? -171.63 149.7 2.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 122.596 0.358 . . . . 10.0 110.179 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 15.2 Cg_exo -70.81 106.47 1.86 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.495 2.13 . . . . 10.0 110.434 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -86.67 99.58 11.85 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.061 0.458 . . . . 10.0 111.376 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -84.59 157.91 21.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.799 -0.637 . . . . 10.0 110.352 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 50.2 m -86.72 -20.4 27.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.645 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.424 ' HA ' ' OE1' ' B' ' 40' ' ' GLN . 12.8 tmtt? 70.57 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.711 -0.677 . . . . 10.0 112.292 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.87 -127.8 6.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.21 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -116.69 158.88 23.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.624 0.249 . . . . 10.0 110.873 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.24 132.81 34.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' B' ' 71' ' ' ARG . 11.3 ttpp -114.47 127.01 55.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.508 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.88 149.56 46.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.548 -0.908 . . . . 10.0 108.548 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -146.56 171.02 15.72 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.935 -0.306 . . . . 10.0 111.382 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.98 -23.55 14.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.284 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -114.76 -40.74 3.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.887 0.375 . . . . 10.0 110.949 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.709 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 85.5 m-85 -87.68 -6.13 58.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.185 -0.462 . . . . 10.0 111.616 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.7 -73.55 2.07 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 121.105 -0.569 . . . . 10.0 112.16 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' B' ' 64' ' ' LYS . 5.9 ptp180 -173.92 122.89 0.33 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.862 0.465 . . . . 10.0 109.968 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -139.88 162.98 33.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.438 -0.346 . . . . 10.0 110.545 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -74.28 127.2 32.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.96 159.75 38.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.354 0.597 . . . . 10.0 112.091 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' B' ' 37' ' ' TYR . 16.7 m-85 -114.5 127.33 55.76 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.404 -1.332 . . . . 10.0 107.404 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -113.58 -3.79 13.58 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -173.89 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.599 . . . . 10.0 109.472 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -91.19 126.41 36.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.774 -1.103 . . . . 10.0 109.712 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -153.42 112.87 3.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.889 0.376 . . . . 10.0 111.173 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -145.94 119.41 9.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.381 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -127.87 120.95 55.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.069 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.19 134.57 44.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.66 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' PHE . . . . . 0.459 ' HB3' HD11 ' B' ' 53' ' ' LEU . 29.8 m-85 -113.81 98.91 48.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.092 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.14 127.96 3.54 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.949 2.433 . . . . 10.0 111.782 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -74.04 148.29 42.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.881 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.66 -5.19 32.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.465 0.65 . . . . 10.0 109.754 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -134.95 129.48 34.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.166 -0.925 . . . . 10.0 108.785 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.9 80.41 4.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.237 0.542 . . . . 10.0 111.307 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 4.1 m -128.4 143.26 41.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.557 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.19 54.04 4.67 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.336 -0.706 . . . . 10.0 111.336 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -105.78 153.84 39.74 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.68 -0.26 . . . . 10.0 110.47 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.7 141.91 42.52 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.44 2.093 . . . . 10.0 110.436 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -132.57 154.14 50.31 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.232 0.456 . . . . 10.0 112.232 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' B' ' 47' ' ' THR . 43.1 tttt -98.25 150.83 21.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 10.0 109.658 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' B' ' 47' ' ' THR . 60.4 tp -118.97 114.32 22.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.584 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 42.0 t -104.19 114.82 44.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.058 -0.519 . . . . 10.0 109.987 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 93.0 mt -125.1 136.77 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.402 . . . . 10.0 111.154 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' THR . . . . . 0.566 HG23 ' HB3' ' B' ' 113' ' ' ASP . 19.1 m -133.69 118.04 17.67 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.132 -0.485 . . . . 10.0 109.839 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 39.5 m-85 -98.62 109.38 22.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.462 -0.335 . . . . 10.0 111.335 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.73 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 0.8 OUTLIER -123.94 128.87 50.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.444 -0.344 . . . . 10.0 110.945 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -174.49 -155.64 12.58 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.851 -0.69 . . . . 10.0 111.617 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 73.5 m -155.56 176.99 11.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.3 -0.259 . . . . 10.0 110.3 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -116.98 145.03 43.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.89 -10.68 22.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.442 0.534 . . . . 10.0 112.442 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.45 -0.76 55.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.517 -0.31 . . . . 10.0 111.785 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.7 20.63 23.8 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.669 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 4.6 t -103.27 136.73 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.436 -0.579 . . . . 10.0 109.436 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 17.4 t -122.57 97.97 5.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.683 0.277 . . . . 10.0 110.767 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.859 ' HB3' HG23 ' A' ' 107' ' ' VAL . 53.2 p90 -84.23 143.94 43.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.859 0.361 . . . . 10.0 111.361 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.622 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 42.4 Cg_endo -67.31 163.64 33.67 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.586 2.191 . . . . 10.0 111.241 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.73 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 63.7 Cg_endo -75.74 80.56 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.372 2.048 . . . . 10.0 111.86 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.481 HG22 HD11 ' A' ' 69' ' ' LEU . 12.8 t -60.84 108.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.69 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ASP . . . . . 0.566 ' HB3' HG23 ' B' ' 98' ' ' THR . 20.9 p-10 -100.41 130.41 46.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.514 0.673 . . . . 10.0 111.833 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.456 HG21 ' HB3' ' B' ' 126' ' ' PRO . 0.2 OUTLIER -128.6 124.86 36.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.393 -0.822 . . . . 10.0 109.951 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.39 130.26 49.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.077 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -114.86 149.17 37.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.452 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.02 114.28 28.26 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.98 -0.748 . . . . 10.0 108.98 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 23.3 mm -85.61 99.86 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.212 0.529 . . . . 10.0 111.057 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -108.75 -6.66 15.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.529 -0.76 . . . . 10.0 110.195 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.7 97.57 2.51 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.509 -0.769 . . . . 10.0 111.191 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -153.48 -15.94 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.824 0.345 . . . . 10.0 111.504 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.95 -76.91 1.49 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.697 -0.763 . . . . 10.0 111.891 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.76 145.83 28.61 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.311 -0.255 . . . . 10.0 110.311 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -136.88 146.37 45.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 10.0 111.024 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.21 147.71 38.43 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.098 -0.501 . . . . 10.0 109.695 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' PRO . . . . . 0.456 ' HB3' HG21 ' B' ' 114' ' ' THR . 36.7 Cg_endo -66.9 136.92 43.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.401 2.067 . . . . 10.0 111.74 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -91.86 70.28 5.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.137 0.494 . . . . 10.0 111.304 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.602 -0.713 . . . . 10.0 109.741 179.733 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 110.067 -0.346 . . . . 10.0 110.067 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 m -132.05 65.89 76.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 111.981 0.363 . . . . 10.0 111.981 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.91 -40.29 45.13 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.38 2.053 . . . . 10.0 111.617 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -60.54 -38.35 84.19 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 115.949 -0.568 . . . . 10.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.9 m -67.45 -47.22 70.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.703 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.55 -35.25 75.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 10.0 111.005 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m -84.27 -4.73 59.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.437 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.6 m -90.15 -18.6 25.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.384 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -67.59 124.42 23.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.706 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 10' ' ' LYS . 2.1 mppt? -107.77 151.91 25.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.089 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 24.8 p -84.74 174.32 9.99 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.474 -0.565 . . . . 10.0 109.474 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.12 -7.87 33.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.129 0.49 . . . . 10.0 110.515 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.496 ' OD2' ' HD2' ' A' ' 15' ' ' ARG . 28.2 t70 -95.96 1.71 53.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.351 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.0 t30 75.45 16.5 2.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.496 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 24.6 mtt180 -103.89 135.42 19.36 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.037 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.61 145.26 95.22 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.782 2.321 . . . . 10.0 111.551 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.37 -9.7 27.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 10.0 112.043 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.519 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -58.73 -19.9 44.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.394 -0.367 . . . . 10.0 111.817 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.499 HG23 ' HD2' ' A' ' 20' ' ' TYR . 31.3 m -66.21 -16.02 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 121.027 0.441 . . . . 10.0 111.383 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.499 ' HD2' HG23 ' A' ' 19' ' ' VAL . 19.7 m-85 -127.07 22.55 6.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.572 0.701 . . . . 10.0 109.34 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 17.1 mt -134.02 34.12 3.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.405 -0.816 . . . . 10.0 110.428 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -127.7 176.08 7.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.478 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt 68.18 17.39 9.38 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.504 -0.771 . . . . 10.0 112.53 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 51.51 43.39 29.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.509 -0.768 . . . . 10.0 112.077 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -103.28 145.5 30.72 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.832 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.19 131.83 47.51 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.715 2.277 . . . . 10.0 111.066 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 114' ' ' ILE . 1.3 m -99.79 136.22 40.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.905 0.384 . . . . 10.0 111.226 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.444 HD21 ' HZ3' ' A' ' 111' ' ' TRP . 12.1 tp -117.74 99.58 7.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 70.7 mt -91.87 122.88 43.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 10.0 111.147 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' HE2' HG22 ' A' ' 62' ' ' THR . 3.9 tmmm? -117.24 121.82 42.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.495 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.548 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 5.7 m-85 -95.92 134.49 38.85 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.594 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -134.97 -179.11 5.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.064 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 108' ' ' TYR . . . -134.09 150.05 51.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.223 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.99 -40.86 16.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.066 0.46 . . . . 10.0 110.497 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.473 ' HZ2' ' HE2' ' A' ' 72' ' ' LYS . 27.3 m0 -86.75 65.61 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.98 -0.555 . . . . 10.0 111.466 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.1 t -161.18 129.34 2.87 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.223 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 41.8 Cg_endo -71.13 -41.76 2.43 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.571 2.181 . . . . 10.0 112.094 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.57 -43.21 97.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.928 0.394 . . . . 10.0 111.495 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.8 m -69.29 -23.1 63.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.269 -0.423 . . . . 10.0 111.077 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.6 tp -66.64 -40.54 88.78 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.112 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.45 -34.85 68.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.105 0.479 . . . . 10.0 110.308 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.67 -32.21 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.634 -0.712 . . . . 10.0 111.115 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.2 mt -56.25 -42.51 77.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.787 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.77 -36.82 92.75 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.909 -0.662 . . . . 10.0 111.475 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -69.9 -39.59 76.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.361 . . . . 10.0 110.073 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.6 m -61.61 -45.07 95.64 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.431 -0.581 . . . . 10.0 109.431 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HG3' ' HB3' ' A' ' 86' ' ' TYR . 4.3 tm-20 -61.1 -35.13 76.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.519 -0.764 . . . . 10.0 110.375 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -72.33 -46.03 57.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.729 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -63.71 -33.12 74.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 10.0 111.421 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.06 -13.39 57.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.7 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -105.57 -3.41 22.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.375 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 18.0 t70 -69.39 144.66 53.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.093 0.473 . . . . 10.0 111.822 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.02 84.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.719 -0.673 . . . . 10.0 112.13 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 27.4 mmmt -74.58 -43.75 54.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 10.0 110.943 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.437 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 3.0 m-85 -61.04 -20.44 62.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 10.0 112.13 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -67.73 -5.41 15.95 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.863 0.363 . . . . 10.0 111.826 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 m -77.06 -17.01 59.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 10.0 110.561 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.24 169.42 15.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.923 -0.58 . . . . 10.0 109.998 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.84 98.1 8.0 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.233 -0.284 . . . . 10.0 110.233 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.0 tp -86.15 127.6 34.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.291 -0.413 . . . . 10.0 111.39 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.491 HG22 ' HB2' ' A' ' 90' ' ' PRO . 5.8 pt -137.41 144.94 30.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.497 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.488 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -102.57 110.99 23.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.025 -0.534 . . . . 10.0 109.702 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -109.24 137.39 41.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.052 0.454 . . . . 10.0 111.548 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.39 146.89 52.47 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.437 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 19.2 m -109.91 96.11 23.43 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 112.222 0.453 . . . . 10.0 112.222 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 65' ' ' SER . 33.3 Cg_endo -65.31 132.25 30.92 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.365 2.043 . . . . 10.0 111.357 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.98 6.08 88.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.072 -0.585 . . . . 10.0 112.534 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -121.72 148.49 44.54 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.155 -0.313 . . . . 10.0 110.155 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER 59.92 21.17 10.17 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.5 t60 69.57 27.73 4.74 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.462 -0.79 . . . . 10.0 112.287 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -88.26 -168.35 2.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.487 ' HE3' ' CZ3' ' A' ' 80' ' ' TRP . 23.0 mmtt -63.57 145.08 56.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.711 0.291 . . . . 10.0 111.033 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -80.9 161.78 24.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.806 0.336 . . . . 10.0 111.367 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.44 150.17 27.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.533 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 78' ' ' GLN . . . 83.03 -47.13 3.76 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.273 -0.731 . . . . 10.0 111.273 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -76.65 -39.72 51.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.676 -0.49 . . . . 10.0 109.676 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -63.05 -36.32 83.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.485 -0.779 . . . . 10.0 111.891 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 17.1 pt20 -66.11 -32.14 73.42 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.775 -0.37 . . . . 10.0 111.021 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.92 -27.49 63.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.04 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.537 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.7 t-105 -61.32 -57.71 11.2 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.503 -0.772 . . . . 10.0 109.707 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -65.93 -36.32 83.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.102 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.82 -20.78 58.95 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.224 0.453 . . . . 10.0 112.224 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.21 5.23 38.59 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.592 -0.813 . . . . 10.0 112.192 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 80' ' ' TRP . 88.2 mt -100.46 -178.29 3.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.895 0.378 . . . . 10.0 111.185 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -103.54 -177.78 3.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.136 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.55 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 12.8 m-85 69.0 78.56 0.23 Allowed Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 123.007 0.523 . . . . 10.0 111.035 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.15 12.25 1.83 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.736 2.29 . . . . 10.0 112.063 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -108.57 11.25 26.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.402 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.9 mt -88.5 111.13 41.83 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.574 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.491 ' HB2' HG22 ' A' ' 61' ' ' ILE . 66.5 Cg_endo -75.56 69.83 5.85 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.465 2.11 . . . . 10.0 111.234 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 62' ' ' THR . 57.1 t -78.56 107.78 11.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.844 -0.616 . . . . 10.0 111.305 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 16.5 t -92.34 137.34 22.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.762 -0.653 . . . . 10.0 109.918 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -100.47 100.44 11.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.59 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -94.81 85.35 4.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.171 0.51 . . . . 10.0 110.05 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -62.38 114.75 3.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.655 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.71 -11.92 67.86 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.653 -0.784 . . . . 10.0 112.897 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.53 55.95 7.14 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.632 -0.794 . . . . 10.0 112.269 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.84 -44.15 81.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.178 0.514 . . . . 10.0 110.253 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.5 mm -77.74 -41.14 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.295 -0.631 . . . . 10.0 109.295 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.714 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.67 -41.48 86.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.714 -0.676 . . . . 10.0 111.338 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -70.84 -41.74 71.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.985 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.9 m -65.92 -27.89 68.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.097 0.406 . . . . 10.0 112.097 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.72 -2.74 31.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.723 0.297 . . . . 10.0 110.898 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t30 54.21 55.88 7.66 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.686 -0.688 . . . . 10.0 111.471 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 100' ' ' ALA . 87.5 mt -80.65 126.15 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.659 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 p -127.34 -1.99 6.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.898 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.838 HG23 ' HB3' ' B' ' 109' ' ' TYR . 14.9 p -154.18 151.72 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.575 0.226 . . . . 10.0 111.007 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.548 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 25.3 m-85 -117.3 156.21 49.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -87.33 130.16 11.0 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.734 -1.361 . . . . 10.0 111.585 -0.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.4 m -94.35 130.73 40.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.135 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.693 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 19.3 m95 -112.84 115.34 28.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.462 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -107.09 116.91 32.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.346 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.53 HD22 HD11 ' A' ' 136' ' ' LEU . 52.4 tp -97.12 111.88 23.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.133 0.492 . . . . 10.0 110.939 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 27' ' ' THR . 2.4 mp -98.1 129.31 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.62 -0.881 . . . . 10.0 108.62 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.59 175.58 33.45 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.859 -0.686 . . . . 10.0 112.262 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -72.21 -1.95 17.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.019 0.438 . . . . 10.0 111.176 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.46 -14.02 33.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.135 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.47 21.44 31.93 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.869 -0.682 . . . . 10.0 112.607 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -126.63 166.1 17.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.855 0.36 . . . . 10.0 111.289 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.22 125.33 31.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.688 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -113.76 -39.6 3.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.818 0.342 . . . . 10.0 111.848 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 122' ' ' ARG . 0.1 OUTLIER -141.53 151.3 43.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.688 0.28 . . . . 10.0 110.891 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.12 128.51 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 10.0 110.629 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.693 ' HB ' ' HB2' ' A' ' 111' ' ' TRP . 46.3 t -117.11 128.93 74.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.578 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -129.39 114.8 16.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.272 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.79 -85.58 0.19 Allowed Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.415 -0.898 . . . . 10.0 112.757 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.9 m -160.75 163.21 32.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.077 -0.342 . . . . 10.0 110.077 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.49 HG12 ' CE2' ' A' ' 111' ' ' TRP . 1.5 pp -130.03 170.73 18.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.557 0.218 . . . . 10.0 111.294 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 132' ' ' GLN . 9.6 p30 -147.17 163.34 36.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.007 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -57.66 -45.89 84.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.613 0.598 . . . . 10.0 112.613 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.8 95.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.847 0.356 . . . . 10.0 111.097 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.417 ' HB2' ' ND2' ' A' ' 129' ' ' ASN . 8.9 tt0 -65.0 -40.9 95.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 55' ' ' PHE . . . -60.91 -47.56 85.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.848 -0.615 . . . . 10.0 110.644 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.56 -37.81 88.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.713 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.41 97.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.742 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.53 HD11 HD22 ' A' ' 113' ' ' LEU . 19.1 tp -62.73 -36.11 81.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.134 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.8 mt -73.12 -26.78 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.077 0.465 . . . . 10.0 110.048 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -80.88 -40.99 23.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.311 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 50.4 t0 -154.15 113.9 2.51 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.177 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 36.7 Cg_endo -66.06 -7.88 18.38 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.003 2.469 . . . . 10.0 112.449 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -86.36 -6.69 58.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.876 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.55 96.59 4.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.345 -0.389 . . . . 10.0 111.474 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -102.08 128.38 48.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.417 -0.586 . . . . 10.0 109.417 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 36.2 tp . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.108 -0.948 . . . . 10.0 111.633 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.909 0.385 . . . . 10.0 110.773 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.71 -60.41 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 61.7 tp -113.91 -65.31 1.2 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.847 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 52.79 41.12 31.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.446 0.641 . . . . 10.0 111.246 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.1 170.68 18.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.449 -0.796 . . . . 10.0 110.278 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.39 -159.34 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.855 0.722 . . . . 10.0 111.921 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -105.63 16.19 25.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.482 -0.781 . . . . 10.0 109.757 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -81.04 2.87 25.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 10.0 112.374 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.85 132.77 16.25 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.43 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.89 145.64 96.23 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.031 2.487 . . . . 10.0 112.35 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' B' ' 14' ' ' ALA . 9.4 Cg_endo -52.37 -36.25 68.18 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.532 2.822 . . . . 10.0 113.136 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -62.71 -14.23 41.73 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.07 0.462 . . . . 10.0 111.96 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -121.17 -3.08 9.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.633 0.73 . . . . 10.0 109.93 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' B' ' 11' ' ' PRO . . . -92.6 -3.78 54.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 10.0 112.25 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.529 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 15.4 m-85 -122.29 125.14 45.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.888 0.375 . . . . 10.0 111.165 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.03 90.82 10.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.275 -0.639 . . . . 10.0 109.275 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 6.4 Cg_exo -74.73 96.28 0.99 Allowed 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.955 2.436 . . . . 10.0 112.879 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.42 98.17 10.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 123' ' ' THR . 3.2 mm? -89.05 116.34 27.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.819 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.26 109.95 19.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.703 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.602 HG13 HG22 ' B' ' 26' ' ' VAL . 61.4 t -92.87 114.81 30.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.275 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.96 170.49 7.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.23 -0.656 . . . . 10.0 109.23 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.51 -42.84 77.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.98 0.363 . . . . 10.0 111.98 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.9 -15.03 59.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.567 0.58 . . . . 10.0 112.567 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 165.11 166.4 24.02 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.424 -0.893 . . . . 10.0 112.228 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.602 HG22 HG13 ' B' ' 21' ' ' VAL . 58.7 t -90.52 137.43 21.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.18 -0.304 . . . . 10.0 110.18 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -120.53 112.15 18.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.922 -0.399 . . . . 10.0 109.922 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.573 HG22 ' HD1' ' B' ' 30' ' ' PHE . 6.8 p -91.79 121.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.051 0.453 . . . . 10.0 110.956 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -124.53 79.32 1.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.039 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.573 ' HD1' HG22 ' B' ' 28' ' ' VAL . 12.8 p90 -87.27 112.5 22.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 10.0 111.057 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -76.47 118.9 19.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.414 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 45.9 mt -92.65 140.19 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.719 -0.673 . . . . 10.0 110.33 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.94 149.79 39.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.396 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.08 77.74 1.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.168 0.509 . . . . 10.0 111.486 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 169.57 -21.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.376 -0.69 . . . . 10.0 111.376 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.41 150.17 24.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.221 -0.659 . . . . 10.0 109.221 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' B' ' 75' ' ' TYR . 8.3 p90 -142.15 136.54 30.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.048 0.452 . . . . 10.0 111.597 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 48.4 mtt -108.27 152.92 23.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.653 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 23.8 m-85 -95.1 126.81 40.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.527 -0.546 . . . . 10.0 109.527 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -60.51 -28.96 68.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.051 0.453 . . . . 10.0 111.841 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.16 -0.94 51.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.994 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.55 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 41.4 mmtt -113.06 -26.11 8.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.35 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.426 HG13 ' O ' ' B' ' 39' ' ' TYR . 73.3 mt -70.87 115.41 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.24 0.543 . . . . 10.0 110.882 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.51 122.98 59.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.871 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' B' ' 96' ' ' VAL . . . -145.28 129.37 3.45 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.685 -0.769 . . . . 10.0 111.909 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -157.76 138.24 12.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.806 0.336 . . . . 10.0 111.26 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.598 ' HB ' HD13 ' B' ' 95' ' ' LEU . 4.7 t -139.25 126.9 21.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.732 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.551 ' ND2' ' HA ' ' B' ' 51' ' ' ASP . 29.2 p30 -178.3 164.13 1.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.365 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.11 -76.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.244 1.962 . . . . 10.0 111.148 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.32 49.19 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.983 0.421 . . . . 10.0 110.651 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.551 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 2.8 t0 63.24 56.2 1.75 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.501 -0.772 . . . . 10.0 112.101 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.416 ' H ' ' HB2' ' B' ' 48' ' ' ASN . 1.7 mm? -117.61 57.24 0.82 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.126 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' B' ' 83' ' ' PHE . 21.5 tp -115.6 147.62 40.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.134 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.5 -74.07 0.98 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.627 -0.797 . . . . 10.0 111.563 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.36 145.49 4.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.58 108.61 1.45 Allowed 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.472 2.115 . . . . 10.0 111.236 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 16.7 m -79.15 98.54 6.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.257 -0.429 . . . . 10.0 111.629 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -80.21 144.64 32.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.787 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -86.23 -9.33 56.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt 71.66 127.77 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.864 0.727 . . . . 10.0 112.542 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.77 -127.61 4.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.528 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -119.77 145.4 46.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.647 0.223 . . . . 10.0 110.412 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -85.87 125.61 33.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -111.4 134.56 52.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.038 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -77.14 128.37 34.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -116.17 174.49 6.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.983 0.421 . . . . 10.0 111.241 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -101.09 -26.83 13.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.015 -0.539 . . . . 10.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -118.95 -39.36 2.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.703 0.287 . . . . 10.0 111.487 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.422 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 4.3 m-30 -79.47 -14.0 59.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 10.0 111.405 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.55 -89.71 1.63 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.863 -0.684 . . . . 10.0 112.053 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -159.03 115.45 2.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.029 -0.36 . . . . 10.0 110.029 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -137.23 164.35 28.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.866 0.365 . . . . 10.0 111.209 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -78.11 127.92 33.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.971 -0.751 . . . . 10.0 108.971 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.5 155.72 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.394 0.516 . . . . 10.0 112.394 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' B' ' 37' ' ' TYR . 21.2 m-85 -117.0 128.6 55.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.556 -1.276 . . . . 10.0 107.556 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -118.3 5.87 11.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.397 0.517 . . . . 10.0 112.397 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 179.25 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -87.47 112.06 21.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.677 -1.147 . . . . 10.0 110.867 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 30' ' ' PHE . . . -142.7 120.21 11.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.863 0.363 . . . . 10.0 110.871 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -155.36 120.77 4.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.15 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.04 124.46 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.348 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.72 144.93 28.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.235 -0.439 . . . . 10.0 109.897 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' PHE . . . . . 0.474 ' HB3' HD11 ' B' ' 53' ' ' LEU . 64.1 m-85 -120.66 100.28 46.84 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.41 121.59 3.87 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.8 2.334 . . . . 10.0 111.346 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.97 151.35 35.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.019 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.63 -2.41 48.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.293 0.568 . . . . 10.0 109.817 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.415 ' HG3' HG13 ' B' ' 89' ' ' VAL . 12.9 tppt? -152.63 111.23 3.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.325 -0.852 . . . . 10.0 109.266 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.85 92.29 6.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.982 0.42 . . . . 10.0 110.64 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.415 HG13 ' HG3' ' B' ' 87' ' ' LYS . 15.7 m -119.48 158.05 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.137 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.91 51.96 2.25 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.124 -0.56 . . . . 10.0 111.846 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -117.02 145.84 36.59 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.87 117.06 4.63 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.247 1.965 . . . . 10.0 110.513 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.06 151.95 20.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.329 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 47' ' ' THR . 34.9 tttt -100.35 148.92 24.16 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.4 -0.592 . . . . 10.0 109.4 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.598 HD13 ' HB ' ' B' ' 47' ' ' THR . 35.5 tp -122.32 125.65 46.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.78 0.324 . . . . 10.0 110.852 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.445 ' O ' ' HA2' ' B' ' 45' ' ' GLY . 39.9 t -111.02 122.28 65.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 87.0 mt -127.42 123.84 37.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.856 0.36 . . . . 10.0 111.318 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 17.5 m -113.62 121.69 44.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -102.63 107.5 18.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.759 0.314 . . . . 10.0 111.47 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.645 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 0.4 OUTLIER -126.04 125.33 42.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.91 0.386 . . . . 10.0 110.211 178.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.83 -159.09 13.67 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.675 -0.774 . . . . 10.0 111.359 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 10.3 m -152.7 -177.77 6.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' B' ' 105' ' ' ALA . . . -118.66 149.24 41.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -75.06 21.69 0.12 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.973 0.416 . . . . 10.0 111.502 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' B' ' 103' ' ' ALA . . . -122.78 -1.03 8.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.864 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.95 -26.03 12.1 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.754 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.9 t -62.12 140.19 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.616 0.246 . . . . 10.0 110.77 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 47.5 t -137.2 99.31 3.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.888 0.375 . . . . 10.0 110.465 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.838 ' HB3' HG23 ' A' ' 107' ' ' VAL . 50.5 p90 -80.58 151.79 71.96 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.779 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 43.9 Cg_endo -68.12 161.17 45.57 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.861 2.374 . . . . 10.0 111.651 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.645 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 73.7 Cg_endo -76.75 52.6 3.76 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.864 2.376 . . . . 10.0 113.077 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 33.5 t -56.57 131.44 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.028 0.442 . . . . 10.0 110.784 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -113.21 168.34 9.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.49 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.0 m -147.79 138.44 23.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.499 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -100.49 131.08 46.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.508 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' B' ' 95' ' ' LEU . 76.2 m-85 -112.85 143.22 44.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.286 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -105.98 111.3 23.88 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.38 88.14 2.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.28 0.562 . . . . 10.0 110.846 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -102.92 -11.37 18.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.62 -0.718 . . . . 10.0 110.695 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.09 83.77 1.4 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.037 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -140.2 7.11 2.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.996 0.426 . . . . 10.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.73 -80.0 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.112 -0.565 . . . . 10.0 112.367 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 1.7 m -105.91 145.85 30.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -130.51 152.41 49.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.711 0.291 . . . . 10.0 111.328 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.15 138.72 15.15 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.708 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' PRO . . . . . 0.439 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 61.3 Cg_endo -74.81 138.61 23.75 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.467 2.112 . . . . 10.0 112.335 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -92.01 92.72 8.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.519 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 34.0 m . . . . . 0 C--O 1.252 1.202 0 CA-C-O 118.856 -0.593 . . . . 10.0 109.644 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.54 69.35 79.76 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 120.762 0.315 . . . . 10.0 110.798 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.1 -30.13 90.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.866 2.377 . . . . 10.0 112.877 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -61.71 -39.57 91.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.752 0.311 . . . . 10.0 110.91 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.472 HG21 HG21 ' A' ' 98' ' ' THR . 1.2 m -71.08 -37.69 72.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 10.0 110.1 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 tp -65.04 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.904 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.1 m -84.86 -24.82 28.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.605 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 m -67.04 -28.43 68.21 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.069 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.06 112.51 1.37 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.83 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.01 138.9 40.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.08 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.817 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 33.0 p -77.53 168.72 19.53 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.041 -0.527 . . . . 10.0 109.671 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.28 -8.05 42.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.393 0.616 . . . . 10.0 110.029 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -91.1 2.16 56.54 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.247 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 t30 69.21 30.26 4.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.952 -1.022 . . . . 10.0 111.466 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 30.6 mtt85 -119.08 137.22 24.91 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.931 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 15' ' ' ARG . 38.5 Cg_exo -62.31 144.83 95.82 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.372 2.048 . . . . 10.0 110.899 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.96 -9.93 18.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.024 0.379 . . . . 10.0 112.024 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.612 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 4.5 m -56.17 -21.85 25.34 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.435 0.531 . . . . 10.0 112.435 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 m -64.9 -24.61 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.02 0.438 . . . . 10.0 111.138 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -118.97 17.38 13.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.487 0.661 . . . . 10.0 109.699 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 91.5 mt -125.22 43.66 2.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.313 -0.858 . . . . 10.0 109.618 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -141.65 -179.36 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.142 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.5 mttp 72.48 3.61 4.74 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.988 0.805 . . . . 10.0 112.179 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 54.0 47.77 22.64 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.881 -0.599 . . . . 10.0 111.071 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -116.36 150.09 44.77 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.441 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.82 127.41 26.09 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.053 2.502 . . . . 10.0 112.028 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.406 ' HB ' HD12 ' A' ' 114' ' ' ILE . 2.7 m -102.09 137.07 40.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.242 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.654 HD23 HD12 ' A' ' 60' ' ' LEU . 22.2 tp -118.7 106.09 12.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.84 -0.43 . . . . 10.0 109.84 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 75.7 mt -97.37 123.26 49.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.759 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.768 ' HE2' HG22 ' A' ' 62' ' ' THR . 19.6 ttpt -116.03 126.03 53.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.361 -0.382 . . . . 10.0 110.644 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.51 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 19.2 m-85 -96.33 144.85 26.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.494 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -145.67 166.93 24.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.613 -0.267 . . . . 10.0 111.155 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.51 144.34 39.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.139 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 m -70.51 -52.46 21.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.585 0.587 . . . . 10.0 112.585 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.649 ' HZ2' ' HE3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -90.89 44.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.96 0.409 . . . . 10.0 111.694 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.7 t -119.84 119.67 30.99 Favored Pre-proline 0 C--N 1.317 -0.826 0 C-N-CA 120.88 -0.328 . . . . 10.0 111.368 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 25.6 Cg_endo -62.95 -38.23 48.46 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.687 2.258 . . . . 10.0 111.793 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.536 HD12 ' HG2' ' A' ' 37' ' ' PRO . 6.6 mp -66.47 -44.98 81.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.343 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.436 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 73.6 m -72.19 -24.72 61.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.235 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.57 ' HB3' ' CZ ' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -61.9 -55.31 31.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 10.0 111.474 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.09 -34.03 77.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.024 0.44 . . . . 10.0 110.496 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -65.13 -27.95 69.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.679 -0.692 . . . . 10.0 111.569 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 39' ' ' CYS . 37.3 mt -56.39 -40.64 74.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.914 0.388 . . . . 10.0 110.864 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.76 -32.6 78.28 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.147 -0.781 . . . . 10.0 111.147 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -71.57 -36.63 70.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.936 -0.394 . . . . 10.0 109.936 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.559 HG22 HD21 ' A' ' 60' ' ' LEU . 1.7 m -61.35 -47.7 84.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.037 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -64.77 -37.6 88.15 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.522 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -60.12 -46.16 90.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.23 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.451 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 37.0 m0 -66.5 -32.53 73.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.023 -0.535 . . . . 10.0 111.025 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.51 -16.12 63.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.21 0.528 . . . . 10.0 111.111 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -99.2 -3.57 34.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.472 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.5 147.16 29.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.376 -0.375 . . . . 10.0 110.653 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 -31.13 72.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.862 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -66.61 -51.51 55.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 10.0 111.035 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 49' ' ' TRP . 92.7 m-85 -75.67 -10.25 59.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.674 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -75.74 -7.37 54.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.192 0.52 . . . . 10.0 110.195 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.89 4.62 52.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.836 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.78 173.29 11.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.85 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -106.58 89.36 3.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.899 0.38 . . . . 10.0 110.299 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.654 HD12 HD23 ' A' ' 28' ' ' LEU . 1.2 tt -88.51 127.01 35.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.879 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.528 HG22 ' HB2' ' A' ' 90' ' ' PRO . 7.8 pt -142.28 152.28 18.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.985 0.421 . . . . 10.0 111.27 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.768 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -107.09 126.3 52.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.299 -0.63 . . . . 10.0 109.299 179.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.583 HG22 ' HB ' ' A' ' 92' ' ' VAL . 44.6 t -122.08 141.99 40.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.835 0.35 . . . . 10.0 111.474 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.36 148.28 52.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.46 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 13.8 m -110.74 97.42 33.16 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.663 0.268 . . . . 10.0 111.624 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 23.3 Cg_endo -60.17 123.69 13.68 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.882 2.388 . . . . 10.0 112.525 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.7 -21.5 29.46 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.797 -0.638 . . . . 10.0 112.86 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.0 143.68 28.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.648 0.261 . . . . 10.0 110.508 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.844 HD12 HG22 ' B' ' 112' ' ' VAL . 2.3 mm? 60.02 22.81 11.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.911 -0.586 . . . . 10.0 112.385 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.638 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.9 OUTLIER 71.12 24.54 3.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.78 -0.645 . . . . 10.0 112.561 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.55 -175.34 5.74 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.54 0.21 . . . . 10.0 110.798 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.649 ' HE3' ' HZ2' ' A' ' 35' ' ' TRP . 3.7 mmpt? -58.57 136.16 57.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.494 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -76.25 174.37 10.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.875 0.369 . . . . 10.0 111.866 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.8 144.26 55.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.736 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 -47.02 3.59 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.014 -0.835 . . . . 10.0 111.014 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -47.21 81.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 10.0 109.908 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.78 -32.1 73.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.471 -0.786 . . . . 10.0 110.907 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.12 -44.57 94.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.666 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -71.28 -31.39 67.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.782 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -58.87 -47.06 86.24 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.864 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -73.6 -40.94 63.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.366 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.49 68.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 10.0 111.395 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.44 23.08 36.59 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.955 -0.641 . . . . 10.0 112.623 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.2 mt -117.53 170.11 9.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.833 0.349 . . . . 10.0 110.766 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -89.58 176.02 7.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.798 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 71.09 73.81 0.26 Allowed Pre-proline 0 N--CA 1.465 0.3 0 O-C-N 123.883 0.739 . . . . 10.0 111.448 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.45 -1.57 11.21 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.482 2.122 . . . . 10.0 112.188 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.88 -0.81 44.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.895 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.69 114.97 39.5 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.764 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.528 ' HB2' HG22 ' A' ' 61' ' ' ILE . 73.0 Cg_endo -78.86 77.65 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.62 2.213 . . . . 10.0 111.581 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 62' ' ' THR . 43.1 t -92.32 118.66 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.094 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.817 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 4.6 t -100.75 144.62 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.74 -0.663 . . . . 10.0 109.963 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.455 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -107.43 117.38 33.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.499 -0.319 . . . . 10.0 111.125 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.483 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 62.3 t0 -108.18 96.03 6.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 10.0 110.044 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.437 ' HA ' ' HG2' ' A' ' 66' ' ' PRO . 13.2 t-20 -67.62 112.52 4.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.766 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.59 -9.45 62.43 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.995 -0.622 . . . . 10.0 112.242 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.21 50.92 41.8 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.964 -0.636 . . . . 10.0 112.187 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.472 HG21 HG21 ' A' ' 5' ' ' THR . 0.2 OUTLIER -60.66 -46.8 88.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.9 0.381 . . . . 10.0 111.262 -179.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.85 -42.47 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.77 -44.96 90.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.541 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -69.64 -36.72 76.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.812 0.339 . . . . 10.0 111.409 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -64.6 -33.51 76.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.215 0.45 . . . . 10.0 112.215 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.418 HD13 HD13 ' A' ' 123' ' ' ILE . 95.9 mt -100.82 -2.86 31.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.673 0.273 . . . . 10.0 110.919 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 43.7 t30 60.58 61.44 1.72 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.92 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 100' ' ' ALA . 94.8 mt -97.84 105.37 17.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.422 -0.808 . . . . 10.0 110.956 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.77 13.24 14.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.926 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.915 HG23 ' HB3' ' B' ' 109' ' ' TYR . 12.4 p -147.0 150.5 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.617 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' B' ' 108' ' ' CYS . 22.5 m-85 -124.18 153.64 68.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -89.74 128.17 7.67 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 124.0 -1.25 . . . . 10.0 111.689 -0.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.9 m -96.21 136.27 36.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.361 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -114.14 110.99 20.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.214 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.21 110.23 22.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.51 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.1 tp -91.72 112.7 24.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.688 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 27' ' ' THR . 84.4 mt -99.74 137.72 26.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.82 173.25 55.12 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.64 -0.791 . . . . 10.0 112.799 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -65.2 -14.49 60.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 10.0 111.716 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.35 -19.72 29.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.151 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 105.06 -0.08 41.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.82 -0.705 . . . . 10.0 111.945 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -96.57 158.48 15.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.232 -0.285 . . . . 10.0 110.232 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.14 118.87 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.921 0.391 . . . . 10.0 111.171 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -51.53 6.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.695 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -156.87 142.26 17.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.119 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.418 HD13 HD13 ' A' ' 103' ' ' LEU . 4.3 tp -116.25 119.25 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.051 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.9 t -107.92 120.51 59.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.786 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -126.39 125.1 41.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.626 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 142.33 -97.22 0.2 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.722 -0.751 . . . . 10.0 111.829 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.766 ' HB2' HG22 ' B' ' 107' ' ' VAL . 3.7 t -160.35 138.2 9.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.022 -0.362 . . . . 10.0 110.022 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.532 ' HA ' ' OE1' ' A' ' 132' ' ' GLN . 12.9 pt -121.71 150.64 25.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.001 0.429 . . . . 10.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -114.28 174.92 5.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.649 . . . . 10.0 110.256 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.18 -45.3 91.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.71 0.263 . . . . 10.0 111.71 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.16 -41.97 84.96 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.515 -0.312 . . . . 10.0 110.59 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.532 ' OE1' ' HA ' ' A' ' 128' ' ' ILE . 41.1 mt-30 -65.18 -44.46 88.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.868 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 137' ' ' ILE . . . -59.31 -45.07 92.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.93 -34.34 75.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.765 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.2 85.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.383 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.44 -33.89 75.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.52 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 133' ' ' ALA . 76.5 mt -67.44 -31.83 54.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.669 -0.493 . . . . 10.0 109.669 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.45 -61.24 2.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.772 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 23.3 t70 -127.64 117.31 21.12 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.341 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 139' ' ' ASP . 14.6 Cg_exo -70.26 -3.55 12.57 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.087 2.525 . . . . 10.0 112.574 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -95.81 -2.52 47.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.624 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.64 116.99 10.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.041 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.7 t70 -122.53 160.25 26.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.633 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.283 0.989 . . . . 10.0 112.972 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.622 0.248 . . . . 10.0 111.354 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.24 -65.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.198 0.444 . . . . 10.0 112.198 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 54.9 tp -85.37 -82.57 0.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 62.24 45.82 6.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.619 0.724 . . . . 10.0 110.899 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.08 154.05 38.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.374 -0.83 . . . . 10.0 110.13 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.76 -163.63 0.23 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.79 0.681 . . . . 10.0 112.145 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -98.78 29.7 3.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.968 0.413 . . . . 10.0 111.085 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.65 15.27 14.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.146 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.63 137.61 11.53 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.789 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.11 151.05 86.78 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.931 2.421 . . . . 10.0 112.356 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.635 ' HG3' ' HB ' ' A' ' 107' ' ' VAL . 11.3 Cg_endo -54.29 -36.03 85.38 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.302 2.668 . . . . 10.0 113.152 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -69.06 -2.86 11.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.932 0.396 . . . . 10.0 112.023 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -131.82 5.86 4.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.473 0.654 . . . . 10.0 109.623 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.74 -1.84 31.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.702 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.509 ' HE1' HG23 ' B' ' 32' ' ' ILE . 43.9 m-85 -134.19 128.97 35.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.814 0.34 . . . . 10.0 110.96 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.6 91.38 20.55 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.539 ' HG2' ' HG3' ' B' ' 126' ' ' PRO . 17.1 Cg_exo -68.67 105.26 1.27 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.679 2.253 . . . . 10.0 112.727 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.12 99.4 12.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.236 -0.653 . . . . 10.0 109.236 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.2 mm? -89.33 102.99 15.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.882 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.26 101.78 10.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.52 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.479 HG13 HG22 ' B' ' 26' ' ' VAL . 81.1 t -89.82 119.59 37.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.616 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.1 -176.37 3.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.175 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.48 -35.9 34.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.403 -0.362 . . . . 10.0 111.29 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.35 -34.95 28.28 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.22 -178.61 40.14 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.762 -0.733 . . . . 10.0 112.077 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.479 HG22 HG13 ' B' ' 21' ' ' VAL . 60.7 t -102.86 135.88 38.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -123.48 114.87 20.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.954 0.407 . . . . 10.0 110.524 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.401 HG22 ' HD1' ' B' ' 30' ' ' PHE . 2.6 p -101.69 122.56 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.403 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -125.03 80.35 1.87 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.951 0.405 . . . . 10.0 110.315 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 7.4 p90 -77.35 111.71 13.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 10.0 111.141 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 -72.35 112.73 8.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.372 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.509 HG23 ' HE1' ' B' ' 15' ' ' PHE . 63.4 mt -90.23 135.73 25.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.975 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.41 149.27 50.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.21 92.65 1.02 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.059 0.457 . . . . 10.0 111.576 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.95 -22.06 0.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.369 -0.692 . . . . 10.0 111.369 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -105.37 154.28 20.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -146.6 139.23 25.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.983 0.42 . . . . 10.0 111.184 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 37.8 mtt -110.99 159.04 18.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.849 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.438 ' O ' HG13 ' B' ' 43' ' ' ILE . 24.2 m-85 -100.91 127.36 47.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -59.31 -30.7 68.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.183 0.438 . . . . 10.0 112.183 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.68 3.84 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.94 0.4 . . . . 10.0 111.181 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' B' ' 100' ' ' GLN . 71.1 mmtt -116.83 -20.47 9.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.336 -0.393 . . . . 10.0 111.801 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.456 HD13 ' HZ ' ' B' ' 30' ' ' PHE . 60.8 mt -77.22 96.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.092 0.472 . . . . 10.0 110.724 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.21 108.88 20.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.315 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.59 138.66 10.21 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.846 -0.692 . . . . 10.0 111.562 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -160.98 145.52 13.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.608 0.242 . . . . 10.0 111.066 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.598 ' HB ' HD13 ' B' ' 95' ' ' LEU . 15.1 t -141.51 125.63 17.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.191 -0.459 . . . . 10.0 109.879 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' B' ' 51' ' ' ASP . 28.1 p30 -179.0 161.75 1.02 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.154 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' B' ' 52' ' ' LEU . 11.3 Cg_exo -73.92 -63.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.435 2.09 . . . . 10.0 110.909 178.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.36 58.49 1.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 10.0 109.809 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.534 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 5.5 t70 61.96 33.62 17.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.53 -0.759 . . . . 10.0 112.455 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.495 ' HA ' HD13 ' B' ' 52' ' ' LEU . 1.4 mm? -90.16 55.09 2.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.4 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.492 ' HB2' HD22 ' B' ' 48' ' ' ASN . 19.0 tp -121.5 145.47 47.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.104 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.46 -76.8 0.85 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.587 -0.816 . . . . 10.0 111.309 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 3.6 pp0? -161.17 143.46 9.18 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 24.5 Cg_exo -64.9 108.52 1.11 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.526 2.151 . . . . 10.0 111.18 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 5.6 m -82.46 103.55 12.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.849 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.4 158.91 18.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 51.0 m -91.79 -14.06 30.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.622 -0.263 . . . . 10.0 110.831 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? 71.82 127.9 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.76 -0.655 . . . . 10.0 112.284 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.81 -133.0 5.61 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.135 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -117.41 140.24 49.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.527 0.203 . . . . 10.0 110.564 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.31 121.65 24.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.457 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -98.72 139.91 33.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -78.56 141.54 38.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.39 170.49 15.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.636 0.255 . . . . 10.0 110.495 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -24.83 10.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.961 0.41 . . . . 10.0 110.994 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 40' ' ' LEU . 11.9 m-85 -102.82 -44.75 5.19 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.202 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.569 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 14.6 m-30 -89.61 -9.62 49.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.583 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.08 -77.78 1.89 Allowed Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.827 -0.624 . . . . 10.0 112.296 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -173.81 117.91 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.752 0.31 . . . . 10.0 110.496 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -141.02 162.16 36.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.144 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.6 m -68.83 127.24 32.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.812 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.2 m -127.3 161.8 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 10.0 111.731 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -118.24 128.1 54.36 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.868 -1.16 . . . . 10.0 107.868 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -112.27 -3.8 14.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.768 0.655 . . . . 10.0 112.768 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -175.93 -36.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.987 -0.746 . . . . 10.0 108.987 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -86.26 125.04 33.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.086 -0.961 . . . . 10.0 109.767 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.37 116.77 4.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.323 . . . . 10.0 111.523 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -153.61 125.38 7.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.163 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.3 t -129.99 131.75 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.252 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' B' ' 57' ' ' SER . . . -108.56 142.01 39.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.704 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' PHE . . . . . 0.44 ' HB3' HD11 ' B' ' 53' ' ' LEU . 67.1 m-85 -120.22 112.26 34.7 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.263 0.468 . . . . 10.0 112.263 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -93.08 124.62 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.521 2.814 . . . . 10.0 111.55 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.01 148.04 40.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.988 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.3 -3.21 53.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.324 0.583 . . . . 10.0 109.73 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.412 ' HB2' ' HE2' ' B' ' 87' ' ' LYS . 6.2 tppt? -153.47 124.7 7.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.867 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.75 89.77 8.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.04 0.448 . . . . 10.0 110.352 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.64 147.15 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.71 47.33 3.83 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.073 -0.584 . . . . 10.0 112.344 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -106.67 145.44 31.07 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.53 116.02 4.54 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.319 2.013 . . . . 10.0 111.288 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.77 165.4 11.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.967 0.413 . . . . 10.0 111.832 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 47' ' ' THR . 67.6 tttt -109.2 151.76 26.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.979 -0.555 . . . . 10.0 109.828 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.598 HD13 ' HB ' ' B' ' 47' ' ' THR . 56.0 tp -120.54 115.55 23.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.974 0.416 . . . . 10.0 110.664 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.88 126.44 64.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.535 -0.542 . . . . 10.0 109.535 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 66.8 mt -133.13 121.06 22.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.925 0.393 . . . . 10.0 111.895 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' THR . . . . . 0.602 HG23 ' HB3' ' B' ' 113' ' ' ASP . 5.0 m -108.8 119.22 38.91 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -100.58 109.48 21.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.777 0.322 . . . . 10.0 111.561 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' B' ' 42' ' ' LYS . 11.6 tp60 -124.32 119.35 29.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.968 0.413 . . . . 10.0 110.533 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.36 -160.79 11.08 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.603 -0.808 . . . . 10.0 111.877 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 13.1 m -151.21 -172.42 4.2 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.208 -0.664 . . . . 10.0 109.208 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -131.22 147.73 52.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.259 -0.274 . . . . 10.0 110.259 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.47 6.08 2.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 10.0 111.753 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.19 5.33 29.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.892 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.52 -7.74 56.2 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.626 -0.797 . . . . 10.0 113.087 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.766 HG22 ' HB2' ' A' ' 127' ' ' SER . 2.9 t -74.33 142.75 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.739 0.304 . . . . 10.0 110.471 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 47.9 t -142.52 85.56 1.91 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.941 0.401 . . . . 10.0 110.068 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.915 ' HB3' HG23 ' A' ' 107' ' ' VAL . 52.4 p90 -74.09 152.35 88.44 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.79 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 55.3 Cg_endo -69.82 165.18 31.9 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.827 2.351 . . . . 10.0 111.377 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 70' ' ' HIS . 67.3 Cg_endo -74.42 68.11 5.28 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.657 2.238 . . . . 10.0 112.947 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.844 HG22 HD12 ' A' ' 69' ' ' LEU . 4.8 t -62.65 120.78 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 10.0 109.943 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ASP . . . . . 0.602 ' HB3' HG23 ' B' ' 98' ' ' THR . 4.0 p-10 -108.03 153.91 22.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.094 0.473 . . . . 10.0 111.37 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.68 138.77 41.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.822 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.19 124.45 50.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.82 0.343 . . . . 10.0 110.571 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -111.57 142.73 43.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.618 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -103.98 121.41 43.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.263 -0.426 . . . . 10.0 109.877 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 23.1 mm -94.66 88.83 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.967 0.413 . . . . 10.0 110.787 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' B' ' 121' ' ' ASN . 14.8 p90 -95.03 -35.02 12.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.549 . . . . 10.0 111.45 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.4 60.78 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.43 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' B' ' 119' ' ' PHE . 8.3 t30 -120.0 -0.89 10.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.81 0.338 . . . . 10.0 111.101 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.26 -76.14 1.5 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.002 -0.618 . . . . 10.0 111.658 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 3.9 m -103.21 140.25 37.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.565 -0.531 . . . . 10.0 109.565 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -129.86 161.36 30.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.142 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.18 146.97 24.67 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' PRO . . . . . 0.539 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 28.6 Cg_endo -63.26 121.56 9.43 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.557 2.171 . . . . 10.0 112.42 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -82.64 62.89 6.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.355 0.598 . . . . 10.0 110.01 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.091 -179.285 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 tpt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.098 -0.334 . . . . 10.0 110.098 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.65 82.64 48.26 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.562 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.01 -25.71 58.97 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.55 2.167 . . . . 10.0 111.566 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -46.83 87.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.833 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -60.56 -42.54 96.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.302 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.97 -32.84 74.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.806 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.0 m -81.91 -25.6 34.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.054 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.3 m -65.68 -26.71 67.9 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.756 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 9' ' ' LEU . 2.1 mm? -55.69 128.0 32.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.878 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -115.47 149.55 37.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.638 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 19.4 p -89.34 174.96 7.53 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.046 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.56 -19.36 65.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.411 . . . . 10.0 111.008 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.549 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.0 t70 -89.31 9.13 27.16 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 64.84 30.57 12.11 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.703 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.549 ' HG3' ' HB3' ' A' ' 13' ' ' ASP . 16.4 mtp85 -112.27 137.65 21.59 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.932 -0.577 . . . . 10.0 109.93 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 15' ' ' ARG . 50.3 Cg_exo -57.32 139.48 90.21 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.615 2.21 . . . . 10.0 111.409 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.14 -10.08 20.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 10.0 112.008 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 1.7 t -59.85 -18.41 43.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.647 -0.252 . . . . 10.0 111.494 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.18 -15.54 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-O 120.788 0.328 . . . . 10.0 111.018 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -127.06 22.92 6.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.56 . . . . 10.0 109.714 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 57.4 mt -133.0 27.28 4.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.024 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 18' ' ' SER . 53.7 mttm -118.97 174.6 6.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.6 mttp 69.32 15.7 8.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.127 -0.942 . . . . 10.0 112.902 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.18 51.21 14.89 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.512 0.507 . . . . 10.0 111.242 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.547 ' HD2' ' HD2' ' A' ' 26' ' ' PRO . 16.8 mmtp -112.65 143.37 28.86 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.218 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.547 ' HD2' ' HD2' ' A' ' 25' ' ' LYS . 19.6 Cg_endo -59.26 134.08 56.81 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.725 2.283 . . . . 10.0 110.956 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -106.78 143.91 34.19 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.967 0.413 . . . . 10.0 111.22 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 28' ' ' LEU . 9.5 tp -121.47 97.94 5.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.156 -0.683 . . . . 10.0 109.156 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.571 HG12 HD11 ' A' ' 61' ' ' ILE . 66.0 mt -89.39 112.22 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.025 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HG3' ' CE2' ' A' ' 111' ' ' TRP . 5.7 tmmm? -106.59 120.88 43.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.88 0.371 . . . . 10.0 110.826 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 14.1 m-85 -90.33 127.9 36.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.208 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -121.37 173.89 7.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.078 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB1' ' CZ3' ' A' ' 35' ' ' TRP . . . -124.83 138.48 54.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.102 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -77.49 -47.43 19.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.522 ' CZ3' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -88.36 29.1 1.0 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.077 0.769 . . . . 10.0 113.077 -178.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 5.0 t -119.65 125.98 27.18 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 111.665 0.246 . . . . 10.0 111.665 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 26.2 Cg_endo -63.01 -43.85 17.92 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.832 2.355 . . . . 10.0 112.457 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.97 -44.52 96.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.167 0.508 . . . . 10.0 111.135 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.9 -28.52 67.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.888 -0.596 . . . . 10.0 111.496 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.7 mt -63.62 -44.77 92.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.845 0.355 . . . . 10.0 110.464 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.6 m -69.63 -31.61 69.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.668 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -28.82 70.09 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.057 -0.52 . . . . 10.0 110.646 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.91 -42.48 84.83 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.442 -0.345 . . . . 10.0 111.321 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.04 -44.46 97.3 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.796 -0.716 . . . . 10.0 111.421 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -65.49 -34.67 78.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.867 0.365 . . . . 10.0 110.192 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.3 m -61.33 -46.88 88.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.161 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.56 -40.93 98.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.955 0.407 . . . . 10.0 110.429 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.22 -47.66 78.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 10.0 111.003 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -65.01 -33.93 77.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.576 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.44 -6.28 34.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.918 0.389 . . . . 10.0 111.283 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -113.11 9.07 18.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.207 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.664 ' HB3' ' HD2' ' A' ' 55' ' ' PHE . 14.3 t70 -85.63 146.54 26.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.439 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.32 73.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.856 0.687 . . . . 10.0 112.856 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.479 ' HB3' HD13 ' A' ' 137' ' ' ILE . 32.5 mmmt -74.67 -39.2 62.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.835 0.35 . . . . 10.0 111.155 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.664 ' HD2' ' HB3' ' A' ' 52' ' ' ASP . 94.8 m-85 -75.5 -20.3 58.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.495 0.554 . . . . 10.0 112.495 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.8 m -65.93 -6.54 12.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.34 . . . . 10.0 111.902 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -77.3 -18.37 57.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 10.0 110.147 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -125.91 -178.67 4.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.701 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -113.39 100.36 8.48 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.182 -0.303 . . . . 10.0 110.182 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.07 129.29 35.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.598 -0.273 . . . . 10.0 111.022 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.571 HD11 HG12 ' A' ' 29' ' ' ILE . 10.3 pt -138.22 155.73 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.988 0.423 . . . . 10.0 111.415 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.97 109.43 18.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 10.0 109.648 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 92' ' ' VAL . 36.0 t -111.14 140.99 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.94 0.4 . . . . 10.0 111.482 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . . . -135.44 149.63 49.64 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.706 -0.85 . . . . 10.0 108.706 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.498 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 12.3 m -110.03 97.97 32.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 94' ' ' ASP . 18.9 Cg_endo -58.39 126.63 21.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.942 2.428 . . . . 10.0 112.507 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.61 -36.8 3.3 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.8 -0.637 . . . . 10.0 113.171 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -66.44 134.36 52.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.621 0.248 . . . . 10.0 110.999 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD11 HG22 ' B' ' 112' ' ' VAL . 0.4 OUTLIER 59.14 29.7 19.32 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.639 0.607 . . . . 10.0 112.639 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.735 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.1 OUTLIER 73.08 21.14 3.24 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.299 0.852 . . . . 10.0 113.299 178.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.34 178.3 5.95 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 28.2 mmtt -61.52 124.93 22.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -61.73 156.95 18.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.913 0.387 . . . . 10.0 111.734 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -59.27 151.47 23.17 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.403 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.58 -44.97 3.3 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.737 -0.945 . . . . 10.0 110.737 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.22 -39.51 17.71 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 80' ' ' TRP . 50.6 t80 -57.44 -46.2 83.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.584 -0.735 . . . . 10.0 112.136 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -63.48 -31.69 72.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.9 0.381 . . . . 10.0 111.541 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -75.6 -22.62 56.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.142 0.496 . . . . 10.0 110.464 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.43 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 65.6 t-105 -65.47 -46.69 78.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.493 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -72.43 -32.71 66.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.819 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.49 -31.71 68.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.963 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.39 23.89 34.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.398 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 80' ' ' TRP . 42.5 mt -115.71 -161.82 0.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.408 . . . . 10.0 111.361 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.4 ' H ' ' HB3' ' A' ' 84' ' ' LEU . 11.2 t-20 -118.59 -168.89 1.62 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 63.24 76.3 0.37 Allowed Pre-proline 0 C--O 1.234 0.24 0 O-C-N 123.456 0.472 . . . . 10.0 111.559 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.4 0.76 9.12 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.666 2.244 . . . . 10.0 112.272 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -104.43 6.47 34.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.089 0.471 . . . . 10.0 110.428 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 89' ' ' LEU . 10.2 mt -84.81 115.21 59.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.125 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HG2' ' HA ' ' A' ' 61' ' ' ILE . 69.2 Cg_endo -77.06 76.9 3.98 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.658 2.239 . . . . 10.0 111.393 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.25 118.47 30.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.982 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 15.9 t -103.88 142.8 16.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.861 -0.609 . . . . 10.0 109.95 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.9 m -107.58 107.51 18.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.145 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 61.9 t0 -97.86 92.32 5.77 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.251 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -63.08 107.91 1.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.918 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.54 -10.53 68.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.823 -0.703 . . . . 10.0 112.872 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.9 55.9 6.91 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.263 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.96 -45.1 87.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.937 0.399 . . . . 10.0 110.642 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.3 mm -78.67 -37.85 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.485 -0.561 . . . . 10.0 109.485 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.23 95.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.586 -0.734 . . . . 10.0 111.599 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -70.08 -37.22 75.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.762 0.315 . . . . 10.0 111.529 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.2 m -62.84 -23.44 67.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.447 -0.342 . . . . 10.0 111.833 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.2 mt -111.87 4.4 18.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.659 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.8 t30 54.3 44.4 29.07 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.429 0.633 . . . . 10.0 111.631 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.8 mt -80.41 101.53 5.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.839 -0.619 . . . . 10.0 111.551 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.9 m -118.95 29.88 7.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.87 -0.605 . . . . 10.0 110.564 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.715 HG23 ' HB3' ' B' ' 109' ' ' TYR . 11.4 p -160.71 151.14 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.281 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -130.89 155.29 81.67 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 126' ' ' GLY . 97.7 Cg_endo -85.74 141.97 30.55 Favored 'Cis proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.355 -1.519 . . . . 10.0 111.26 -1.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.7 m -118.23 126.76 52.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.654 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.421 ' CE2' ' HG3' ' A' ' 30' ' ' LYS . 23.5 m95 -107.72 108.39 19.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.91 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -95.01 115.68 27.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 136' ' ' LEU . 55.4 tp -90.94 115.78 28.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.595 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.9 135.68 41.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.211 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.69 178.95 38.47 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.03 -0.605 . . . . 10.0 112.63 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -71.45 -4.59 27.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.906 0.384 . . . . 10.0 111.984 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -98.92 -4.43 32.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.993 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 86.06 16.79 62.32 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.815 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -109.09 163.09 13.64 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.162 -0.31 . . . . 10.0 110.162 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.34 122.75 25.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.855 0.36 . . . . 10.0 110.418 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.18 -40.92 6.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.95 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 122' ' ' ARG . 14.8 tpt180 -160.78 161.89 32.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.498 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -138.03 120.76 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.013 0.435 . . . . 10.0 110.484 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.4 t -115.66 107.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 10.0 109.872 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -115.21 133.62 55.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.452 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 130.65 -75.72 0.42 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.415 -0.897 . . . . 10.0 112.96 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.9 m -159.88 159.26 32.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.018 -0.364 . . . . 10.0 110.018 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.38 170.6 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.311 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -156.0 174.33 15.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.643 -0.253 . . . . 10.0 111.132 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.19 -40.01 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.57 -46.23 87.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 10.0 110.902 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -67.94 -37.74 81.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.953 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 137' ' ' ILE . . . -61.93 -48.51 80.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.38 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.78 -38.97 92.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.739 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.17 91.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.262 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.619 HD11 HD22 ' A' ' 113' ' ' LEU . 15.1 tp -62.88 -35.65 80.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 10.0 111.646 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.479 HD13 ' HB3' ' A' ' 54' ' ' LYS . 74.2 mt -70.1 -27.89 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.214 0.53 . . . . 10.0 110.552 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -89.11 -47.33 8.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.077 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 24.7 t70 -137.15 110.61 9.14 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.622 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 139' ' ' ASP . 11.8 Cg_exo -72.48 3.45 4.2 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.306 2.67 . . . . 10.0 112.812 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -93.1 -7.27 46.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.458 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.04 131.34 44.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.005 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -133.31 136.9 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.465 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.092 0 N-CA-C 113.944 1.09 . . . . 10.0 113.944 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.716 0.293 . . . . 10.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.75 -53.1 59.49 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.314 -0.403 . . . . 10.0 112.086 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' B' ' 5' ' ' ALA . 49.6 tp -89.73 -73.09 0.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.131 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 57.59 35.46 25.76 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.214 0.531 . . . . 10.0 110.918 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.423 ' H ' ' HG ' ' B' ' 3' ' ' LEU . . . -152.67 167.81 27.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.778 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.8 m120 65.68 -170.36 0.19 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.721 0.638 . . . . 10.0 112.398 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -101.17 19.44 17.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.124 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -88.97 20.24 3.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.188 -0.46 . . . . 10.0 111.614 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.3 136.56 13.26 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.279 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . 0.451 ' HB2' ' OE1' ' B' ' 12' ' ' GLU . 27.9 Cg_endo -61.42 150.23 86.0 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.166 2.577 . . . . 10.0 112.11 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.18 -40.09 60.83 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.682 2.921 . . . . 10.0 113.365 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.451 ' OE1' ' HB2' ' B' ' 10' ' ' PRO . 8.8 pm0 -65.24 -19.65 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.009 0.374 . . . . 10.0 112.009 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -106.91 -10.53 15.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.367 0.604 . . . . 10.0 110.041 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.49 -8.22 59.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.539 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.701 ' HE1' HG23 ' B' ' 32' ' ' ILE . 56.2 m-85 -134.08 131.53 38.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.923 0.392 . . . . 10.0 111.571 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.59 91.57 42.12 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' B' ' 30' ' ' PHE . 12.2 Cg_exo -72.37 108.74 2.58 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.12 2.547 . . . . 10.0 113.32 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -104.43 107.93 19.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.963 -0.755 . . . . 10.0 108.963 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' B' ' 19' ' ' LEU . 2.9 mm? -95.19 120.45 35.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.57 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.71 108.66 14.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.354 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.46 HG22 HG13 ' B' ' 26' ' ' VAL . 85.1 t -98.86 128.13 50.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.218 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.69 -166.94 1.34 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.291 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.31 -38.03 27.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.533 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.09 -41.66 85.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.216 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 178.12 -168.28 39.48 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.664 -0.779 . . . . 10.0 112.274 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.46 HG13 HG22 ' B' ' 21' ' ' VAL . 86.1 t -101.92 131.74 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.79 -0.448 . . . . 10.0 109.79 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -121.42 118.96 30.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.956 0.408 . . . . 10.0 110.765 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 p -103.47 116.96 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.12 0.486 . . . . 10.0 110.439 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' B' ' 79' ' ' ALA . 1.1 tmm_? -123.91 82.25 2.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.484 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.521 ' HB3' ' HA ' ' B' ' 17' ' ' PRO . 33.0 p90 -87.62 134.25 33.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.79 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 71.6 mtm-85 -85.52 129.36 34.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.298 -0.41 . . . . 10.0 111.034 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.701 HG23 ' HE1' ' B' ' 15' ' ' PHE . 76.9 mt -101.78 132.58 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.003 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.38 144.33 57.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.441 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.35 91.79 0.26 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.458 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.43 -23.06 0.95 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.427 -0.669 . . . . 10.0 111.427 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -100.74 159.24 15.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.103 -0.702 . . . . 10.0 109.103 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -150.32 136.57 18.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.131 0.491 . . . . 10.0 111.581 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 23.7 mtt -107.48 153.22 23.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.389 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.473 ' O ' HG13 ' B' ' 43' ' ' ILE . 20.0 m-85 -96.16 127.07 41.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.071 -0.714 . . . . 10.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -59.06 -33.79 71.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.849 0.356 . . . . 10.0 111.402 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.04 1.3 32.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.229 -0.442 . . . . 10.0 111.302 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.497 ' HE3' ' HE2' ' B' ' 69' ' ' PHE . 69.2 mmtt -116.53 -6.72 11.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 10.0 111.427 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.473 HG13 ' O ' ' B' ' 39' ' ' TYR . 81.0 mt -87.97 96.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 10.0 110.055 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 39.1 t -91.34 117.95 35.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.304 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.71 140.89 9.55 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.614 -0.803 . . . . 10.0 111.847 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -163.71 147.46 10.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.789 0.328 . . . . 10.0 110.713 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.457 ' HB ' HD13 ' B' ' 95' ' ' LEU . 9.4 t -144.18 120.41 10.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.143 -0.48 . . . . 10.0 109.854 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.6 ' CG ' ' HA ' ' B' ' 51' ' ' ASP . 24.8 p30 -174.96 155.19 1.83 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.47 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 48' ' ' ASN . 6.0 Cg_exo -80.13 -66.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.837 2.358 . . . . 10.0 111.52 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.42 36.18 2.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.48 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.6 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 13.8 t0 64.58 33.16 11.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.495 -0.775 . . . . 10.0 112.611 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' B' ' 52' ' ' LEU . 2.0 mm? -96.78 76.6 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.92 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.445 HD13 ' O ' ' B' ' 47' ' ' THR . 17.6 tp -131.98 155.51 47.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.681 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.04 -80.46 0.64 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.094 -0.803 . . . . 10.0 111.094 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -168.99 147.8 3.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.841 -0.429 . . . . 10.0 109.841 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.02 110.53 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.637 2.225 . . . . 10.0 110.919 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.9 m -95.25 100.62 12.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.016 0.436 . . . . 10.0 111.401 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -80.58 168.16 19.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.98 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 42.4 m -97.67 -7.2 31.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.713 -0.221 . . . . 10.0 111.39 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt 69.41 117.6 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.829 0.677 . . . . 10.0 112.829 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.53 -125.34 5.57 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.914 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.21 158.4 28.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -94.31 123.31 37.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.932 0.396 . . . . 10.0 110.667 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -100.97 130.02 46.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.982 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.41 120.83 23.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.392 -0.966 . . . . 10.0 108.392 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -110.2 176.05 5.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.104 0.478 . . . . 10.0 111.432 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -110.06 -25.1 10.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.214 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.61 -42.68 3.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.054 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.497 ' HE2' ' HE3' ' B' ' 42' ' ' LYS . 4.3 m-30 -88.32 4.55 45.65 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.072 0.397 . . . . 10.0 112.072 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.98 -89.57 1.18 Allowed Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.715 -0.755 . . . . 10.0 111.859 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -171.09 123.9 0.61 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -136.57 167.3 21.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.337 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 15.2 m -75.34 128.78 36.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.521 -0.918 . . . . 10.0 108.521 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.65 162.69 32.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.433 0.635 . . . . 10.0 112.46 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.539 ' HB3' ' O ' ' B' ' 78' ' ' GLU . 40.6 m-85 -122.09 129.09 52.07 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.718 -1.216 . . . . 10.0 107.718 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -110.39 -15.54 13.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.721 0.637 . . . . 10.0 112.721 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.57 ' HA ' ' HB ' ' B' ' 32' ' ' ILE . 1.7 t60 -159.88 -35.24 0.06 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' B' ' 75' ' ' TYR . 0.6 OUTLIER -83.98 144.33 29.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.031 -0.986 . . . . 10.0 108.779 179.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' B' ' 29' ' ' ARG . . . -170.13 101.57 0.29 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.857 0.36 . . . . 10.0 111.042 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -140.57 120.37 13.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.118 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.36 123.54 62.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.155 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.27 141.28 36.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.723 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -119.82 104.35 44.59 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.539 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.4 126.12 3.07 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.781 2.321 . . . . 10.0 111.448 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -70.14 151.27 45.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.918 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.05 -11.74 25.95 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' B' ' 87' ' ' LYS . 8.8 tppt? -149.35 122.29 8.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.166 -0.924 . . . . 10.0 109.075 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.84 85.95 6.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.087 0.47 . . . . 10.0 110.651 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.419 ' HB ' ' HG2' ' B' ' 91' ' ' GLU . 10.8 m -114.63 160.55 13.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.858 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.63 2.38 82.54 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.77 -0.728 . . . . 10.0 111.695 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.419 ' HG2' ' HB ' ' B' ' 89' ' ' VAL . 35.3 mm-40 -60.68 125.45 82.78 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.572 -0.314 . . . . 10.0 110.893 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.13 101.31 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.407 2.071 . . . . 10.0 110.6 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.63 163.91 18.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.673 0.619 . . . . 10.0 112.673 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 47' ' ' THR . 63.1 tttt -114.04 160.65 18.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.298 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.457 HD13 ' HB ' ' B' ' 47' ' ' THR . 18.6 tp -127.42 135.84 51.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.922 0.391 . . . . 10.0 110.772 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.37 126.1 71.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 79.9 mt -129.99 126.62 38.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.889 0.376 . . . . 10.0 112.004 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' THR . . . . . 0.679 HG23 ' HB3' ' B' ' 113' ' ' ASP . 4.0 m -111.52 117.87 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 53.4 m-85 -98.52 100.29 11.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.945 0.35 . . . . 10.0 111.945 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.918 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 15.0 tp60 -117.61 122.05 42.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.104 0.478 . . . . 10.0 110.894 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.79 -162.33 12.46 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.937 -0.649 . . . . 10.0 111.685 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.5 m -151.95 -175.13 5.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.43 -0.582 . . . . 10.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.07 144.56 51.11 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -69.37 -4.05 16.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.156 0.503 . . . . 10.0 111.202 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.52 -13.37 43.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.982 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 118.1 -18.15 11.43 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.975 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' GLY . 6.3 t -66.61 141.99 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.606 0.241 . . . . 10.0 110.473 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 13.8 t -137.49 87.74 2.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.14 0.495 . . . . 10.0 110.005 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.715 ' HB3' HG23 ' A' ' 107' ' ' VAL . 55.3 p90 -76.1 151.95 84.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.1 -0.5 . . . . 10.0 111.875 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.451 ' CD ' ' HA ' ' A' ' 107' ' ' VAL . 67.6 Cg_endo -75.35 163.72 34.04 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.8 2.333 . . . . 10.0 111.521 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.918 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 67.5 Cg_endo -77.0 79.15 3.2 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.623 2.215 . . . . 10.0 112.247 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.635 HG22 HD11 ' A' ' 69' ' ' LEU . 3.1 t -68.0 101.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ASP . . . . . 0.679 ' HB3' HG23 ' B' ' 98' ' ' THR . 4.9 p-10 -86.67 149.47 24.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.127 0.489 . . . . 10.0 111.701 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.09 140.89 44.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.205 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.48 137.64 38.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.007 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.81 135.54 53.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.662 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -95.13 119.48 33.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.302 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 16.5 mm -95.74 76.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 10.0 110.665 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . 0.468 ' CZ ' ' HB2' ' B' ' 121' ' ' ASN . 43.3 p90 -88.75 -24.55 22.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.005 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.54 53.89 0.17 Allowed Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.925 -0.655 . . . . 10.0 112.406 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . 0.468 ' HB2' ' CZ ' ' B' ' 119' ' ' PHE . 7.3 t30 -104.6 -4.69 22.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.246 0.546 . . . . 10.0 109.955 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.85 -77.11 1.94 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.276 -0.73 . . . . 10.0 111.276 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 2.3 m -101.81 140.03 36.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' B' ' 19' ' ' LEU . 78.4 m-85 -128.09 152.72 47.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.926 0.393 . . . . 10.0 110.817 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.3 151.72 70.05 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.147 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' PRO . . . . . 0.41 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 30.3 Cg_endo -64.0 116.23 3.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.468 2.112 . . . . 10.0 111.75 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -82.77 81.47 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.241 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.927 -0.559 . . . . 10.0 109.964 -179.801 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.88 71.1 14.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.861 0.362 . . . . 10.0 111.597 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.97 -31.98 55.08 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.387 2.058 . . . . 10.0 112.256 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -61.88 -41.97 98.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.722 0.296 . . . . 10.0 110.874 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.75 -43.06 80.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.614 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.0 tp -61.95 -34.69 76.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.831 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -80.48 -13.74 58.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.236 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.4 m -84.86 -12.31 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 10.0 110.535 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -59.38 120.79 9.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.254 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.73 133.24 51.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.563 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.869 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 34.9 p -74.09 171.17 14.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.638 -0.504 . . . . 10.0 109.638 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.96 -12.24 60.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.432 0.634 . . . . 10.0 110.542 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.555 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 6.2 t70 -96.03 7.92 45.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.291 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 71.01 19.03 5.77 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.399 -0.819 . . . . 10.0 112.401 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.555 ' HG3' ' HB3' ' A' ' 13' ' ' ASP . 11.6 mtp180 -102.79 143.93 27.6 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.918 -0.401 . . . . 10.0 109.918 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.48 142.1 76.77 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.404 2.07 . . . . 10.0 111.318 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.76 -8.52 28.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.429 -0.35 . . . . 10.0 111.783 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -57.66 -24.27 55.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.637 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.569 HG23 ' HD1' ' A' ' 20' ' ' TYR . 29.5 m -63.16 -18.73 22.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.932 0.396 . . . . 10.0 111.579 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.569 ' HD1' HG23 ' A' ' 19' ' ' VAL . 15.4 m-85 -126.03 24.27 6.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.433 0.635 . . . . 10.0 109.927 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 68.9 mt -138.6 58.82 1.65 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.269 -0.878 . . . . 10.0 109.441 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -154.37 -178.7 7.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.98 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? 66.85 12.78 9.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.598 -0.728 . . . . 10.0 112.316 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 55.3 38.31 30.17 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.075 0.464 . . . . 10.0 111.689 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -107.51 151.56 41.03 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.704 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.84 152.16 59.39 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.009 2.472 . . . . 10.0 112.153 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.88 141.71 48.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.64 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD23 ' HG ' ' A' ' 60' ' ' LEU . 19.7 tp -122.33 94.97 4.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.6 mt -93.38 122.51 44.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.613 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HG3' ' CE2' ' A' ' 111' ' ' TRP . 3.6 tmmt? -123.08 129.7 51.82 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.978 0.418 . . . . 10.0 111.134 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.497 ' HB2' ' HB2' ' A' ' 110' ' ' SER . 23.7 m-85 -92.8 137.88 31.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.307 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -132.57 171.91 13.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.145 -0.48 . . . . 10.0 110.475 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.67 137.54 54.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.756 0.312 . . . . 10.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.28 -39.99 46.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.928 -0.578 . . . . 10.0 112.12 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.699 ' HE1' ' HA ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -91.64 25.02 2.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.404 0.52 . . . . 10.0 112.404 -179.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.506 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 46.3 t -115.6 124.33 30.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HA ' HD12 ' A' ' 40' ' ' LEU . 28.0 Cg_endo -63.24 -41.96 24.92 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.771 2.314 . . . . 10.0 112.142 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.72 -31.53 72.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.988 0.423 . . . . 10.0 111.07 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.1 m -84.19 -14.95 48.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.568 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 37' ' ' PRO . 53.1 mt -71.55 -45.79 61.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.556 -0.293 . . . . 10.0 111.752 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -22.04 62.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.426 0.631 . . . . 10.0 110.559 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -23.69 62.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.353 -0.84 . . . . 10.0 111.458 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -58.55 -53.93 52.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.118 0.414 . . . . 10.0 112.118 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.56 -35.76 89.9 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.047 -0.597 . . . . 10.0 111.943 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -66.95 -41.68 86.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.791 0.329 . . . . 10.0 110.46 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.9 m -61.72 -43.92 97.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.96 -0.563 . . . . 10.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.506 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -65.58 -39.82 92.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.774 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.56 -40.09 95.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.114 0.483 . . . . 10.0 110.337 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -73.64 -34.12 64.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.891 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.06 -13.78 60.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.001 0.429 . . . . 10.0 111.623 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -113.01 10.62 18.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.131 0.491 . . . . 10.0 110.699 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -81.1 140.31 35.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.911 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.64 -33.36 74.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.159 0.429 . . . . 10.0 112.159 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.799 ' HB3' HD12 ' A' ' 137' ' ' ILE . 17.5 mmmt -77.31 -37.86 51.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.721 0.296 . . . . 10.0 111.519 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -77.58 -10.26 59.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.017 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.5 t -69.18 -12.32 61.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 10.0 111.521 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 m -80.16 -2.96 46.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.918 0.389 . . . . 10.0 111.167 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.27 159.36 41.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.222 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -94.89 92.4 6.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.816 0.341 . . . . 10.0 110.339 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.501 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -83.76 124.48 30.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.791 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.583 HG22 ' HB2' ' A' ' 90' ' ' PRO . 3.3 pt -140.94 141.63 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.915 0.388 . . . . 10.0 111.434 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -104.49 113.33 26.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.563 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.551 HG22 ' HB ' ' A' ' 92' ' ' VAL . 17.6 t -110.65 142.81 22.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.886 0.374 . . . . 10.0 111.621 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -137.41 140.44 41.32 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 1.7 m -98.19 104.99 25.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.774 0.321 . . . . 10.0 111.854 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.666 ' HG3' HG22 ' A' ' 93' ' ' THR . 39.6 Cg_endo -65.9 121.56 8.93 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.745 2.297 . . . . 10.0 112.261 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.05 -4.78 83.22 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.577 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 25.8 t80 -111.15 148.98 31.56 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.302 -0.259 . . . . 10.0 110.302 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.6 mt 60.61 29.15 18.8 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.412 0.445 . . . . 10.0 111.667 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.528 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.1 OUTLIER 68.0 19.24 9.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.465 -0.788 . . . . 10.0 112.105 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.699 ' HA ' ' HE1' ' A' ' 35' ' ' TRP . 2.7 mm-40 -80.95 179.95 7.61 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.689 0.28 . . . . 10.0 110.893 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 42.8 mmtt -69.18 142.24 54.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 74' ' ' ASP . 77.3 tttt -73.19 165.69 24.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.476 -0.329 . . . . 10.0 111.303 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 73' ' ' LYS . 16.9 t70 -55.16 147.18 16.79 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.763 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.44 -57.24 4.73 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.586 -1.006 . . . . 10.0 110.586 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.86 -44.94 95.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.401 0.619 . . . . 10.0 109.424 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -67.43 -39.01 85.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.258 -0.883 . . . . 10.0 111.33 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -65.14 -42.83 93.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.839 0.352 . . . . 10.0 111.075 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -65.55 -24.67 67.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.402 . . . . 10.0 110.854 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.422 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 2.9 t90 -64.9 -47.15 78.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.658 -0.868 . . . . 10.0 108.658 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -66.27 -41.22 90.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.714 -0.676 . . . . 10.0 110.732 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.23 -31.22 65.3 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.993 -0.549 . . . . 10.0 111.002 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.38 35.33 5.04 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.835 -0.698 . . . . 10.0 112.067 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 84' ' ' LEU . 10.8 mt -118.3 -178.22 3.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.81 0.338 . . . . 10.0 110.814 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -100.31 171.44 7.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.413 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 90.7 m-85 66.6 82.11 0.2 Allowed Pre-proline 0 N--CA 1.466 0.326 0 O-C-N 123.556 0.535 . . . . 10.0 111.41 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.73 1.36 6.45 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.45 2.1 . . . . 10.0 112.915 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 88' ' ' LYS . 16.3 mtpp -104.73 6.24 34.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.534 0.207 . . . . 10.0 111.108 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.506 ' HG ' ' HG3' ' A' ' 47' ' ' GLU . 9.0 mt -69.05 116.84 45.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.755 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.583 ' HB2' HG22 ' A' ' 61' ' ' ILE . 71.8 Cg_endo -78.94 69.01 8.07 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.543 2.162 . . . . 10.0 111.696 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' THR . 44.3 t -87.51 124.78 41.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.717 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.869 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 6.4 t -112.03 142.53 24.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.666 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -98.31 104.3 16.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.814 0.34 . . . . 10.0 110.986 -179.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 57.3 t0 -85.77 79.92 9.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.137 0.494 . . . . 10.0 110.039 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -65.67 110.26 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.601 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.34 -25.18 27.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.875 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.27 51.51 2.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.651 -0.785 . . . . 10.0 111.654 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 102' ' ' SER . 0.5 OUTLIER -62.52 -51.6 66.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.009 0.433 . . . . 10.0 110.45 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.454 ' HB ' ' HZ ' ' A' ' 31' ' ' PHE . 31.5 mm -81.89 -38.18 15.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.021 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.773 ' HA ' HD13 ' A' ' 105' ' ' ILE . . . -57.12 -44.51 83.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.281 -0.872 . . . . 10.0 111.787 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -80.57 -28.28 37.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 10.0 111.184 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 98' ' ' THR . 4.4 t -63.02 -47.03 84.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.57 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -101.37 -5.76 24.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.849 0.314 . . . . 10.0 111.849 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 t30 65.79 70.82 0.43 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.57 0.7 . . . . 10.0 111.638 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.773 HD13 ' HA ' ' A' ' 100' ' ' ALA . 2.6 mp -86.47 126.44 40.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.433 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.41 23.52 2.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.877 0.37 . . . . 10.0 111.245 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.503 HG23 ' HB3' ' B' ' 109' ' ' TYR . 5.5 p -172.05 157.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.409 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -123.51 150.49 61.25 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.511 -0.552 . . . . 10.0 109.511 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -90.09 132.38 9.18 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.315 -1.535 . . . . 10.0 111.978 -0.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 25.7 m -93.61 121.45 35.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.189 -0.46 . . . . 10.0 109.939 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.525 ' CE2' ' HG3' ' A' ' 30' ' ' LYS . 69.0 m95 -106.62 108.47 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.829 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.13 110.12 22.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.208 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 136' ' ' LEU . 38.6 tp -90.81 112.01 23.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.699 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.0 133.11 45.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -71.38 -179.51 30.96 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.056 -0.592 . . . . 10.0 113.121 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -75.56 -4.9 42.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 10.0 111.405 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.98 -12.39 25.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.236 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 99.95 5.08 55.25 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.754 -0.736 . . . . 10.0 113.216 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -106.5 152.91 23.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.686 0.279 . . . . 10.0 111.24 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.92 118.67 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.094 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.53 -48.72 7.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.554 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -147.75 141.79 25.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.592 -0.277 . . . . 10.0 111.132 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.3 tp -121.89 121.64 64.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.307 -0.406 . . . . 10.0 109.999 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.0 t -113.22 125.89 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.688 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -126.17 110.58 13.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.427 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 157.79 -87.47 0.12 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.173 -1.013 . . . . 10.0 113.2 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.5 t -170.57 131.17 0.89 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt -116.01 158.05 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.726 0.298 . . . . 10.0 110.796 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -108.23 171.48 7.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.473 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.53 -40.4 96.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.021 0.378 . . . . 10.0 112.021 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.4 88.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.556 -0.293 . . . . 10.0 110.767 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -61.89 -41.8 98.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.746 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.3 96.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 10.0 110.364 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.8 mt -71.52 -26.5 62.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.972 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.93 -34.35 29.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.504 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 140' ' ' PRO . 19.5 tp -62.86 -33.95 76.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.25 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.799 HD12 ' HB3' ' A' ' 54' ' ' LYS . 13.3 pt -83.03 15.91 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.124 0.487 . . . . 10.0 111.31 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -133.69 -48.33 0.82 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.655 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -138.25 97.36 9.63 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.302 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.545 ' HA ' HD12 ' A' ' 136' ' ' LEU . 57.7 Cg_endo -70.94 2.57 4.05 Favored 'Trans proline' 0 CA--C 1.526 0.092 0 C-N-CA 123.014 2.476 . . . . 10.0 112.83 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -95.36 -5.32 43.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.825 0.345 . . . . 10.0 110.132 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.17 134.6 36.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.836 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -126.09 155.08 42.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.16 -0.682 . . . . 10.0 109.16 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.98 0 N-CA-C 113.57 0.952 . . . . 10.0 113.57 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 47.4 mtt . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.599 0.238 . . . . 10.0 111.32 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.65 -83.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.462 -0.335 . . . . 10.0 111.287 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 34.8 tp -93.32 -55.04 3.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.005 -0.278 . . . . 10.0 110.896 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . 0.525 ' HA ' HD13 ' B' ' 9' ' ' LEU . 0.6 OUTLIER 53.6 35.58 21.33 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.672 0.608 . . . . 10.0 111.518 -179.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.93 166.44 27.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.441 -0.8 . . . . 10.0 110.555 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.91 -160.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.413 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -107.16 28.46 8.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.302 0.572 . . . . 10.0 109.925 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -92.95 7.68 42.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.96 -0.564 . . . . 10.0 111.391 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.591 HD12 ' HD3' ' B' ' 13' ' ' LYS . 2.6 pt? -133.17 140.81 38.53 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.772 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.88 148.7 93.14 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.125 2.55 . . . . 10.0 112.333 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.28 -37.76 81.18 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.46 2.773 . . . . 10.0 113.456 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -63.98 -20.89 66.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 10.0 111.936 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.591 ' HD3' HD12 ' B' ' 9' ' ' LEU . 2.5 tmtm? -111.57 -6.32 14.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.253 0.549 . . . . 10.0 110.468 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.12 -17.36 46.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.042 -0.527 . . . . 10.0 111.793 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.438 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 13.7 m-85 -127.54 125.81 41.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.711 0.291 . . . . 10.0 110.934 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.76 89.8 16.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.114 -0.494 . . . . 10.0 109.757 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.511 ' HG2' ' HG3' ' B' ' 126' ' ' PRO . 9.5 Cg_exo -73.26 106.5 2.18 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.996 2.464 . . . . 10.0 112.707 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -101.57 110.23 22.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.665 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' B' ' 19' ' ' LEU . 3.5 mm? -92.73 117.08 29.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.152 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.68 98.03 6.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.284 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.528 HG13 HG22 ' B' ' 26' ' ' VAL . 29.2 t -82.18 117.12 27.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.204 -0.453 . . . . 10.0 109.94 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.27 -174.32 2.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.476 -0.329 . . . . 10.0 110.808 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.14 -37.88 53.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.422 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.3 -36.68 39.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.788 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.498 ' HA2' ' CZ ' ' B' ' 85' ' ' TYR . . . -174.52 -179.75 45.32 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.521 -0.847 . . . . 10.0 112.432 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.528 HG22 HG13 ' B' ' 21' ' ' VAL . 46.9 t -90.44 128.74 42.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -114.94 110.23 19.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' B' ' 81' ' ' VAL . 3.8 p -94.94 124.11 47.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.904 0.383 . . . . 10.0 110.944 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -127.03 87.94 2.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.195 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 10.4 p90 -91.55 118.04 30.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.94 0.4 . . . . 10.0 110.765 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 mtm-85 -78.2 126.18 30.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.702 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 23.7 mt -101.93 141.25 18.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.263 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.42 151.21 47.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.039 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.92 81.68 2.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.142 0.496 . . . . 10.0 111.381 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.05 -21.22 0.13 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.063 -0.815 . . . . 10.0 111.063 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.23 147.15 28.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -139.78 136.08 33.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.094 0.474 . . . . 10.0 111.009 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' MET . . . . . 0.408 ' HA ' ' HA3' ' B' ' 101' ' ' GLY . 43.2 mtt -106.91 152.18 24.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.973 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.619 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 38.4 m-85 -92.11 125.59 36.85 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.903 -0.777 . . . . 10.0 108.903 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -59.85 -29.66 68.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.716 0.293 . . . . 10.0 111.668 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.39 -8.62 59.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.36 . . . . 10.0 111.17 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' B' ' 100' ' ' GLN . 37.2 mmtt -107.45 -13.81 15.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.838 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 39' ' ' TYR . 85.3 mt -80.84 102.24 6.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.022 0.439 . . . . 10.0 109.847 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.77 129.85 44.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.683 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.6 129.04 2.64 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.686 -0.769 . . . . 10.0 111.911 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -156.47 137.81 13.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.818 0.342 . . . . 10.0 111.097 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.661 ' HB ' HD13 ' B' ' 95' ' ' LEU . 13.2 t -138.49 125.11 20.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.494 -0.558 . . . . 10.0 109.494 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.54 ' CG ' ' HA ' ' B' ' 51' ' ' ASP . 24.2 p30 -177.9 160.1 1.27 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.316 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.08 -76.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.687 2.258 . . . . 10.0 110.635 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.57 48.62 0.83 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.447 0.641 . . . . 10.0 109.839 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.54 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 6.7 t0 63.63 35.82 11.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.998 -1.001 . . . . 10.0 112.427 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.49 ' HA ' HD13 ' B' ' 52' ' ' LEU . 2.3 mm? -90.65 67.57 6.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.79 -0.641 . . . . 10.0 111.075 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.533 ' HB2' HD22 ' B' ' 48' ' ' ASN . 19.1 tp -125.28 144.45 50.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 10.0 109.798 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.46 -64.94 1.91 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.561 -0.828 . . . . 10.0 112.254 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -169.29 157.71 7.07 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.0 -0.37 . . . . 10.0 110.0 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.99 97.72 1.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.514 2.143 . . . . 10.0 110.427 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m -78.97 100.37 7.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.971 0.415 . . . . 10.0 111.611 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -87.96 149.48 24.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.095 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m -79.98 -14.13 58.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.701 0.286 . . . . 10.0 110.755 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? 72.72 136.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.672 -0.695 . . . . 10.0 112.332 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.38 -133.24 4.33 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.003 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -116.18 149.38 39.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -86.66 136.27 33.09 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -114.8 130.85 56.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.636 0.255 . . . . 10.0 110.791 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.18 119.75 18.82 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.14 -177.76 3.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.79 -0.641 . . . . 10.0 109.429 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -112.2 -51.6 2.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.683 0.277 . . . . 10.0 111.097 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -84.49 -30.13 25.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.253 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.495 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 5.8 m-30 -95.91 -10.11 29.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.997 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.23 -92.66 1.39 Allowed Glycine 0 C--O 1.224 -0.488 0 C-N-CA 120.853 -0.689 . . . . 10.0 112.734 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -165.2 115.57 1.1 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.758 0.313 . . . . 10.0 110.615 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -144.06 170.53 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.258 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 3.4 m -74.14 134.35 42.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.548 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.65 161.02 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.97 0.414 . . . . 10.0 111.131 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -115.98 130.98 57.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.185 -1.043 . . . . 10.0 108.185 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -114.22 -6.84 13.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.793 0.664 . . . . 10.0 112.793 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -173.17 -37.0 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -83.26 135.49 34.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.918 -1.037 . . . . 10.0 109.537 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' B' ' 30' ' ' PHE . . . -161.7 110.98 1.54 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.002 0.43 . . . . 10.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 25.9 tt0 -151.39 121.25 7.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.254 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.421 ' HB ' ' CG1' ' B' ' 28' ' ' VAL . 9.3 t -125.89 131.96 71.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.56 135.74 48.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.875 0.369 . . . . 10.0 110.435 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -113.73 108.28 51.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.374 -0.376 . . . . 10.0 111.626 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.41 131.08 4.02 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.836 2.358 . . . . 10.0 111.655 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' TYR . . . . . 0.498 ' CZ ' ' HA2' ' B' ' 25' ' ' GLY . 14.9 m-85 -76.34 142.77 41.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 10.0 109.942 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.9 11.22 38.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.096 0.474 . . . . 10.0 110.661 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -166.69 128.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.697 -0.683 . . . . 10.0 109.656 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.38 81.41 5.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.995 0.426 . . . . 10.0 111.337 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.5 126.72 73.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.996 -0.547 . . . . 10.0 110.74 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.46 58.26 4.87 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.045 -0.598 . . . . 10.0 111.77 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -113.78 149.17 41.34 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.93 95.23 0.48 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.138 1.892 . . . . 10.0 111.472 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.28 140.16 38.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.262 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' B' ' 47' ' ' THR . 70.6 tttt -91.86 147.3 23.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.661 HD13 ' HB ' ' B' ' 47' ' ' THR . 35.9 tp -118.6 127.79 53.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.881 0.372 . . . . 10.0 110.887 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.37 121.15 66.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.031 -0.729 . . . . 10.0 109.031 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.14 137.61 53.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 10.0 111.324 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' THR . . . . . . . . . . . . . 7.3 m -129.02 121.0 27.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 38.2 m-85 -104.77 118.5 36.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.919 0.39 . . . . 10.0 111.457 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.716 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 11.3 tp60 -132.9 123.71 26.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.32 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -161.88 -158.33 9.43 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.66 -0.781 . . . . 10.0 111.737 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 20.3 m -152.05 175.57 12.41 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.283 -0.636 . . . . 10.0 109.283 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -115.71 148.81 39.35 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.142 -0.318 . . . . 10.0 110.142 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.39 -10.55 44.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.237 0.458 . . . . 10.0 112.237 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.52 6.98 46.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 10.0 111.507 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.82 -6.8 67.4 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.761 -0.733 . . . . 10.0 112.549 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 5.7 t -68.35 136.26 26.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.843 -0.429 . . . . 10.0 109.843 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 21.6 t -127.31 107.98 10.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.692 0.282 . . . . 10.0 110.744 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.503 ' HB3' HG23 ' A' ' 107' ' ' VAL . 35.8 p90 -97.72 148.34 34.31 Favored Pre-proline 0 C--N 1.327 -0.402 0 O-C-N 122.226 -0.296 . . . . 10.0 111.625 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.53 159.49 52.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.927 2.418 . . . . 10.0 111.666 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.716 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 59.1 Cg_endo -74.51 83.59 1.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.583 2.189 . . . . 10.0 111.72 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.17 122.86 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.01 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -104.71 150.32 24.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.03 0.443 . . . . 10.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -141.5 138.78 33.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.004 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' B' ' 94' ' ' LYS . 47.4 mt-10 -107.78 134.93 50.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.556 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' B' ' 95' ' ' LEU . 75.6 m-85 -122.38 150.02 43.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.853 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -116.42 116.21 27.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.751 0.31 . . . . 10.0 110.171 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 19.9 mm -94.15 93.13 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.044 0.45 . . . . 10.0 111.06 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -102.08 -13.45 17.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.319 0.58 . . . . 10.0 110.926 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 122.5 110.87 2.07 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.634 -0.793 . . . . 10.0 112.095 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -176.02 -22.13 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 10.0 110.565 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.92 -74.3 2.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.707 -0.758 . . . . 10.0 111.861 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.62 129.45 35.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 10.0 111.238 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -132.84 150.26 52.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.327 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.65 146.99 34.18 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.239 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' PRO . . . . . 0.511 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 34.7 Cg_endo -65.74 118.62 5.63 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.487 2.125 . . . . 10.0 112.407 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -75.51 82.57 2.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.489 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.877 -0.582 . . . . 10.0 109.995 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.463 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 3.6 m -127.49 64.81 64.32 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 112.229 0.455 . . . . 10.0 112.229 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.58 -36.63 63.38 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.062 1.841 . . . . 10.0 111.973 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -65.89 -37.17 85.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.734 0.302 . . . . 10.0 110.985 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 2' ' ' VAL . 1.3 m -70.33 -31.45 68.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.651 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.608 ' HG ' HD13 ' A' ' 21' ' ' LEU . 15.6 tp -63.34 -32.04 73.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.221 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 m -86.79 -8.24 57.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.833 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 5' ' ' THR . 6.8 m -76.5 -23.08 53.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.593 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 94' ' ' ASP . 1.1 mm? -73.52 118.14 16.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.284 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -111.19 147.55 34.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.386 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.799 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 25.1 p -71.3 178.26 3.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.084 -0.507 . . . . 10.0 111.332 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.17 -14.98 62.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.05 0.453 . . . . 10.0 110.465 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -89.0 -2.2 58.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.632 -0.713 . . . . 10.0 109.319 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.6 t30 75.22 19.67 2.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.854 -1.066 . . . . 10.0 110.554 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -101.13 126.54 34.5 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.226 -0.897 . . . . 10.0 109.278 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.49 140.49 35.49 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.132 2.555 . . . . 10.0 112.397 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.41 -2.56 8.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.302 0.482 . . . . 10.0 112.302 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.592 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -60.12 -16.13 29.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 10.0 111.439 179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.73 -23.97 34.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.991 0.425 . . . . 10.0 111.052 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.401 ' HB3' ' HB3' ' A' ' 59' ' ' ASN . 45.3 m-85 -120.42 4.27 10.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.686 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.608 HD13 ' HG ' ' A' ' 6' ' ' LEU . 73.6 mt -108.81 26.65 10.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.267 0.556 . . . . 10.0 110.348 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -128.97 -174.94 3.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.913 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt 68.92 11.15 8.26 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.72 0.638 . . . . 10.0 111.151 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.37 41.54 32.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.36 -0.837 . . . . 10.0 111.82 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -110.42 138.89 21.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.95 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.23 125.67 19.94 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.962 2.441 . . . . 10.0 111.713 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.8 117.86 34.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.757 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD23 HD13 ' A' ' 60' ' ' LEU . 10.0 tp -89.23 110.03 20.84 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.4 mt -93.58 118.53 39.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 10.0 111.992 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.497 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 14.8 tttt -119.92 129.64 54.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.482 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.656 ' HB3' ' HE1' ' A' ' 108' ' ' TYR . 6.5 m-85 -99.07 135.35 40.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.465 -0.334 . . . . 10.0 111.085 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -122.42 -178.6 3.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 10.0 110.812 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.22 146.38 35.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.571 0.225 . . . . 10.0 111.133 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.7 -31.34 14.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.705 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.544 ' CH2' ' HA ' ' B' ' 110' ' ' PRO . 0.9 OUTLIER -82.32 11.0 5.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.189 0.44 . . . . 10.0 112.189 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.89 125.82 27.19 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.74 0.305 . . . . 10.0 111.449 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.8 -35.44 9.59 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.533 2.156 . . . . 10.0 112.63 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.7 mt -64.52 -47.04 80.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.38 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 76.7 m -69.46 -20.1 63.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.275 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HB3' ' CE2' ' B' ' 68' ' ' PHE . 1.5 tp -69.09 -41.73 77.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.594 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.99 -32.88 69.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.129 0.49 . . . . 10.0 110.223 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' CD ' ' HZ2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -63.12 -23.41 67.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.622 -0.717 . . . . 10.0 110.978 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' HD11 ' A' ' 89' ' ' LEU . 86.9 mt -59.5 -36.73 76.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 10.0 110.352 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.78 -37.09 88.3 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.564 -1.014 . . . . 10.0 110.564 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.33 -36.01 73.99 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -61.87 -41.62 98.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.806 -0.634 . . . . 10.0 109.852 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 88' ' ' LYS . 31.3 tt0 -61.55 -39.18 90.18 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 120.962 0.41 . . . . 10.0 109.945 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -63.08 -44.14 96.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.705 -0.68 . . . . 10.0 109.727 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -68.52 -33.5 74.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.983 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.43 -2.73 20.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.123 0.487 . . . . 10.0 110.821 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -125.3 14.82 8.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.74 -0.663 . . . . 10.0 109.603 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 15.2 t70 -87.05 140.92 29.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.447 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.73 94.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.165 0.431 . . . . 10.0 112.165 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -76.39 -37.81 56.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.77 0.319 . . . . 10.0 111.321 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.702 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 27.7 m-85 -71.16 -16.0 62.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.322 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.9 t -72.26 -0.28 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 10.0 111.673 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -75.49 -22.05 57.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 10.0 110.222 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.96 169.05 15.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 10.0 109.72 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 87.5 m-20 -100.08 97.5 8.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.673 0.273 . . . . 10.0 110.315 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.469 HD13 HD23 ' A' ' 28' ' ' LEU . 54.2 tp -83.29 130.81 35.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.442 -0.344 . . . . 10.0 110.944 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.487 ' HA ' ' HG2' ' A' ' 90' ' ' PRO . 21.6 pt -135.9 146.71 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.966 0.413 . . . . 10.0 111.156 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -107.03 105.98 16.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.236 -0.438 . . . . 10.0 109.908 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.407 HG13 ' HB ' ' A' ' 92' ' ' VAL . 5.4 t -103.31 146.51 10.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.124 0.487 . . . . 10.0 111.71 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . . . -143.44 146.25 33.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.205 -1.035 . . . . 10.0 108.205 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 7.1 m -106.46 98.63 20.68 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 112.196 0.443 . . . . 10.0 112.196 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.582 ' HG3' HG22 ' A' ' 93' ' ' THR . 17.8 Cg_endo -60.0 123.51 13.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.944 2.429 . . . . 10.0 112.27 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.98 -13.36 66.37 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.944 -0.646 . . . . 10.0 112.954 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 52.9 t80 -94.42 139.05 31.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.822 0.311 . . . . 10.0 110.469 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.766 HD11 HG22 ' B' ' 112' ' ' VAL . 0.2 OUTLIER 57.03 35.55 26.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.08 -0.509 . . . . 10.0 112.183 179.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.36 20.73 8.56 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.026 0.75 . . . . 10.0 113.026 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 2.7 mm-40 -75.69 -179.07 4.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.718 0.294 . . . . 10.0 110.723 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -67.39 121.3 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.218 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -66.5 155.56 37.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.706 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.09 130.79 47.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.176 -0.466 . . . . 10.0 111.173 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.16 -40.41 2.53 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.586 -1.406 . . . . 10.0 109.586 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.484 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 2.2 t70 -97.4 -34.84 10.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.965 0.412 . . . . 10.0 110.103 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 64' ' ' ALA . 76.0 t80 -56.26 -50.97 69.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.706 . . . . 10.0 112.432 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -35.31 76.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.457 -0.338 . . . . 10.0 111.482 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 20.5 mtmt -70.65 -28.9 65.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.765 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -60.99 -49.74 76.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.623 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -73.93 -32.06 63.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.605 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.88 -18.99 63.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.6 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.74 5.88 43.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.938 -0.648 . . . . 10.0 111.689 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.0 mt -106.49 177.48 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.958 0.408 . . . . 10.0 111.042 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.405 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 49.3 t30 -98.22 -162.65 0.97 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.765 -0.652 . . . . 10.0 109.942 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.405 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 13.5 m-85 65.43 78.28 0.26 Allowed Pre-proline 0 N--CA 1.464 0.258 0 C-N-CA 122.829 0.451 . . . . 10.0 111.356 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.05 -0.69 10.57 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.616 2.211 . . . . 10.0 112.3 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 4.4 mmpt? -101.22 10.55 40.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.155 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 43' ' ' LEU . 16.5 mt -85.76 112.56 45.71 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.019 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.487 ' HG2' ' HA ' ' A' ' 61' ' ' ILE . 72.9 Cg_endo -79.03 63.44 8.71 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.571 2.181 . . . . 10.0 111.051 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 62' ' ' THR . 99.3 t -73.38 117.89 17.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.825 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.799 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 21.7 t -103.28 138.98 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.439 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -97.68 107.09 19.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.119 -0.492 . . . . 10.0 110.922 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 54.0 t0 -103.18 84.33 2.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.894 0.378 . . . . 10.0 110.237 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.424 ' HA ' ' HG2' ' A' ' 66' ' ' PRO . 28.2 t-20 -63.9 116.87 6.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 10.0 112.109 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.96 -19.66 53.91 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.825 -0.703 . . . . 10.0 112.629 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.77 50.71 5.13 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.106 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 102' ' ' SER . 0.2 OUTLIER -62.46 -42.12 99.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.976 0.417 . . . . 10.0 110.523 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.9 mm -82.88 -40.2 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.889 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.576 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -60.63 -45.12 95.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.759 -0.655 . . . . 10.0 111.655 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -72.0 -30.04 64.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 98' ' ' THR . 1.4 t -65.86 -38.53 89.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.948 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.13 7.2 44.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.947 0.404 . . . . 10.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.3 t30 50.48 60.98 3.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.421 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 100' ' ' ALA . 79.9 mt -87.14 98.46 7.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.752 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.21 8.62 25.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.914 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.617 ' HA ' ' CD ' ' B' ' 110' ' ' PRO . 7.0 p -149.17 154.53 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.67 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.656 ' HE1' ' HB3' ' A' ' 31' ' ' PHE . 57.1 m-85 -131.05 152.63 81.01 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.252 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 126' ' ' GLY . 97.8 Cg_endo -82.39 161.7 76.75 Favored 'Cis proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.935 -1.694 . . . . 10.0 111.372 -1.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 m -127.67 131.34 49.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.698 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -118.82 125.12 48.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.19 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.54 113.08 26.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.843 0.354 . . . . 10.0 110.332 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 140' ' ' PRO . 44.1 tp -89.51 101.12 13.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.168 0.509 . . . . 10.0 111.293 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.28 133.13 32.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.666 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.26 -177.43 49.96 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.088 -0.577 . . . . 10.0 113.244 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -67.86 -11.4 58.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.265 0.469 . . . . 10.0 112.265 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.36 -7.94 30.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 10.0 111.382 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.38 -7.0 63.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.684 -0.769 . . . . 10.0 112.626 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -89.0 156.0 19.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.734 0.302 . . . . 10.0 110.844 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.6 t -78.55 107.75 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.149 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -81.99 -41.52 20.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.263 -0.426 . . . . 10.0 111.507 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -148.76 160.01 43.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.372 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.9 tt -138.14 141.44 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.493 -0.558 . . . . 10.0 109.493 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.3 t -121.92 129.98 74.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.202 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -133.21 124.68 27.84 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.437 -0.347 . . . . 10.0 110.128 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.598 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 132.88 -72.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.44 -0.886 . . . . 10.0 112.511 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.79 ' HB2' HG22 ' B' ' 107' ' ' VAL . 5.1 t -178.83 162.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.6 pt -146.28 152.17 13.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.158 -0.474 . . . . 10.0 109.914 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -109.96 170.41 8.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.836 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -56.41 -43.8 79.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.03 78.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 10.0 110.807 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -67.86 -37.26 81.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.903 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.66 97.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.0 mt -69.37 -40.92 77.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.782 -0.644 . . . . 10.0 110.5 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.29 -36.71 84.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.067 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.604 HD11 HD22 ' A' ' 113' ' ' LEU . 16.8 tp -62.83 -35.75 80.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.933 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.87 -36.81 59.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.343 0.592 . . . . 10.0 109.416 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -70.24 -47.48 61.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.465 -0.789 . . . . 10.0 110.709 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 23.3 t0 -150.42 112.27 3.23 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.495 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.688 ' HB3' HD21 ' A' ' 113' ' ' LEU . 19.3 Cg_exo -68.01 -7.32 19.44 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.922 2.415 . . . . 10.0 112.061 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -92.85 -0.27 57.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.932 0.396 . . . . 10.0 111.187 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.39 84.2 7.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.902 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.546 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 17.0 t70 -75.69 147.33 39.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.051 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.977 -1.011 . . . . 10.0 113.108 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.795 0.331 . . . . 10.0 110.837 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.22 -72.61 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.523 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 38.2 tp -78.98 -77.29 0.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 59.03 36.13 24.23 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.116 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.95 159.29 42.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.242 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 21.5 m120 64.03 -154.2 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.448 -0.797 . . . . 10.0 111.761 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -107.19 17.54 22.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.965 0.412 . . . . 10.0 111.028 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.35 8.59 4.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.476 0.547 . . . . 10.0 112.476 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.16 132.61 14.74 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.69 -0.232 . . . . 10.0 111.094 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . 0.522 ' HB2' ' OE1' ' B' ' 12' ' ' GLU . 24.1 Cg_endo -60.87 153.93 59.65 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.353 2.702 . . . . 10.0 112.184 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.55 -40.25 54.87 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.591 2.86 . . . . 10.0 113.612 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.522 ' OE1' ' HB2' ' B' ' 10' ' ' PRO . 3.0 pm0 -65.49 -13.81 59.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -117.13 -1.13 11.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.205 0.526 . . . . 10.0 110.412 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.69 -12.48 23.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.116 -0.493 . . . . 10.0 112.077 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -124.01 128.74 49.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.859 0.362 . . . . 10.0 111.486 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' B' ' 31' ' ' ARG . 40.6 t -114.71 91.11 24.27 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.389 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.509 ' HG2' ' HG3' ' B' ' 126' ' ' PRO . 14.2 Cg_exo -70.52 95.78 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.986 2.458 . . . . 10.0 112.367 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.51 97.74 11.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' B' ' 123' ' ' THR . 3.3 mm? -87.93 110.31 20.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.159 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.5 101.92 10.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.158 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.491 HG13 HG22 ' B' ' 26' ' ' VAL . 47.8 t -88.96 130.98 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.186 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.96 176.28 5.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.847 -0.427 . . . . 10.0 109.847 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.22 -34.16 68.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.929 0.395 . . . . 10.0 111.447 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.46 -36.34 53.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.277 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' B' ' 85' ' ' TYR . . . -178.75 -175.93 46.2 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.961 -0.638 . . . . 10.0 111.692 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.491 HG22 HG13 ' B' ' 21' ' ' VAL . 54.5 t -98.09 133.35 40.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 110.228 -0.286 . . . . 10.0 110.228 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -120.28 105.45 10.94 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.967 -0.383 . . . . 10.0 109.967 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.472 HG22 ' HD1' ' B' ' 30' ' ' PHE . 6.3 p -93.57 124.19 45.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.128 0.489 . . . . 10.0 110.969 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -127.47 85.77 2.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.91 -0.586 . . . . 10.0 109.947 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.472 ' HD1' HG22 ' B' ' 28' ' ' VAL . 1.9 p90 -82.71 111.23 18.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.265 0.555 . . . . 10.0 111.004 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.435 ' HB2' ' HB ' ' B' ' 16' ' ' VAL . 32.5 mtm-85 -75.55 112.5 11.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.453 -0.794 . . . . 10.0 110.194 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -91.65 145.21 7.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.819 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.8 155.06 40.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.148 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.15 88.16 2.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.104 0.478 . . . . 10.0 111.27 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.74 -15.46 0.45 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.538 -0.625 . . . . 10.0 111.538 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -109.66 142.37 40.92 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -133.9 136.98 44.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.86 0.362 . . . . 10.0 110.862 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' MET . . . . . 0.48 ' HA ' ' HA3' ' B' ' 101' ' ' GLY . 41.1 mtt -108.52 147.65 31.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.864 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.474 ' O ' HG13 ' B' ' 43' ' ' ILE . 50.0 m-85 -88.25 123.82 33.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.853 -0.425 . . . . 10.0 109.853 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -60.08 -32.42 70.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.517 -0.31 . . . . 10.0 111.403 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.67 5.74 20.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.306 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.446 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 24.0 mmtt -124.58 -8.42 7.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.461 -0.336 . . . . 10.0 111.836 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 39' ' ' TYR . 86.9 mt -83.91 99.21 6.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.251 0.548 . . . . 10.0 110.155 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 41.6 t -90.25 112.0 24.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.09 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' B' ' 96' ' ' VAL . . . -141.73 128.71 3.71 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.893 -0.67 . . . . 10.0 111.545 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -160.56 143.13 13.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.945 0.402 . . . . 10.0 111.444 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.635 ' HB ' HD13 ' B' ' 95' ' ' LEU . 13.4 t -134.6 131.45 37.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.903 -0.59 . . . . 10.0 109.64 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.482 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 9.2 p30 -177.08 158.08 1.37 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.576 -0.284 . . . . 10.0 110.774 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.418 ' HG3' ' HD2' ' B' ' 93' ' ' TYR . 9.3 Cg_exo -74.67 -58.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.614 2.209 . . . . 10.0 110.976 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.63 48.53 2.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.955 -0.566 . . . . 10.0 109.795 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.414 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 0.4 OUTLIER 66.23 36.62 5.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.326 -0.852 . . . . 10.0 111.748 -178.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' B' ' 52' ' ' LEU . 2.4 mm? -97.01 56.69 1.43 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.712 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' B' ' 48' ' ' ASN . 11.8 tp -130.64 152.1 50.38 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.097 -0.705 . . . . 10.0 109.097 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.71 -87.26 0.3 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.542 -0.837 . . . . 10.0 111.726 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.41 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 3.5 pp0? -155.93 149.29 18.67 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 110.008 -0.368 . . . . 10.0 110.008 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 26.4 Cg_exo -63.45 107.15 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.661 2.24 . . . . 10.0 111.168 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 3.1 m -79.2 95.38 5.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.154 0.502 . . . . 10.0 110.78 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -78.04 144.57 36.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.528 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.7 m -82.64 -9.38 59.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.566 -0.288 . . . . 10.0 111.318 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? 71.24 166.22 0.3 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.907 -0.588 . . . . 10.0 111.979 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.14 -134.56 1.74 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.463 -0.655 . . . . 10.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -106.44 151.9 24.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.623 0.212 . . . . 10.0 110.558 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -90.89 125.87 35.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -102.16 128.52 48.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.497 -0.32 . . . . 10.0 110.977 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.76 130.62 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.322 -0.621 . . . . 10.0 109.322 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -133.91 163.53 29.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -93.24 -30.28 15.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.822 0.344 . . . . 10.0 111.301 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -100.27 -39.35 8.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.592 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -89.87 -9.2 49.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.89 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.76 -85.79 0.97 Allowed Glycine 0 C--O 1.227 -0.333 0 C-N-CA 120.758 -0.734 . . . . 10.0 112.673 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -165.24 115.91 1.11 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.645 0.259 . . . . 10.0 110.956 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -138.99 158.72 43.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.288 -0.415 . . . . 10.0 110.447 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 5.6 m -70.79 130.4 41.6 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.425 -0.583 . . . . 10.0 109.425 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.55 150.21 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.377 0.608 . . . . 10.0 112.179 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -110.8 116.36 31.14 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.86 -1.163 . . . . 10.0 107.86 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -103.78 -3.01 25.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.581 0.585 . . . . 10.0 112.581 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.14 -41.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.186 0.517 . . . . 10.0 109.672 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 1.0 OUTLIER -89.26 100.4 13.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.329 -0.85 . . . . 10.0 110.98 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.49 107.39 8.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.979 0.419 . . . . 10.0 111.397 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -138.43 128.01 24.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.689 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 19.0 t -128.65 129.6 68.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.251 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' B' ' 57' ' ' SER . . . -102.72 144.06 31.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.605 -0.271 . . . . 10.0 110.469 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' PHE . . . . . 0.435 ' HD2' ' HB ' ' B' ' 26' ' ' VAL . 58.2 m-85 -119.86 100.54 48.57 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.691 0.282 . . . . 10.0 111.684 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.05 118.81 2.39 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.995 2.463 . . . . 10.0 112.01 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' TYR . . . . . 0.425 ' CE2' ' HA2' ' B' ' 25' ' ' GLY . 36.7 m-85 -66.4 144.47 56.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 10.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.48 11.66 34.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.23 0.538 . . . . 10.0 109.797 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -164.04 124.93 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.317 -0.856 . . . . 10.0 109.955 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.05 92.55 6.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.06 0.457 . . . . 10.0 110.59 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 12.0 m -121.78 163.7 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.614 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.31 21.02 22.64 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.743 -0.741 . . . . 10.0 111.673 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -93.51 138.04 23.13 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.19 127.75 24.12 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.589 2.193 . . . . 10.0 111.039 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . 0.418 ' HD2' ' HG3' ' B' ' 49' ' ' PRO . 0.1 OUTLIER -108.54 153.78 22.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.435 -179.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -95.69 152.08 18.78 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.691 -0.485 . . . . 10.0 109.691 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.635 HD13 ' HB ' ' B' ' 47' ' ' THR . 22.7 tp -126.6 124.22 39.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.695 0.283 . . . . 10.0 110.601 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.475 ' O ' ' HA2' ' B' ' 45' ' ' GLY . 24.6 t -108.69 123.05 64.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 81.9 mt -126.63 120.26 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 10.0 111.833 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' THR . . . . . 0.675 HG23 ' HB3' ' B' ' 113' ' ' ASP . 5.5 m -112.96 117.14 31.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.745 -0.661 . . . . 10.0 109.828 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 24.2 m-85 -99.6 107.17 19.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.627 0.251 . . . . 10.0 111.085 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 14.7 tp60 -121.5 126.02 48.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 10.0 110.936 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -167.64 -157.76 11.18 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.432 -0.667 . . . . 10.0 111.432 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.3 m -153.51 167.84 28.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -105.17 144.67 31.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.42 -16.51 60.77 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.107 0.41 . . . . 10.0 112.107 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.27 -12.51 56.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.456 -0.338 . . . . 10.0 111.78 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.48 -14.77 10.77 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.371 -0.918 . . . . 10.0 113.006 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 127' ' ' SER . 46.2 t -63.45 131.8 29.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.94 76.92 1.32 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.961 0.41 . . . . 10.0 110.695 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -66.02 157.14 81.87 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.949 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.649 ' HD3' ' H ' ' A' ' 108' ' ' TYR . 93.8 Cg_endo -85.8 160.22 10.5 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.778 2.319 . . . . 10.0 112.155 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.751 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 85.6 Cg_endo -79.31 70.56 7.45 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.743 2.296 . . . . 10.0 111.62 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.766 HG22 HD11 ' A' ' 69' ' ' LEU . 16.6 t -67.04 93.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.775 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ASP . . . . . 0.675 ' HB3' HG23 ' B' ' 98' ' ' THR . 6.3 p-10 -78.07 150.26 33.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.78 -0.645 . . . . 10.0 111.857 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 10.3 m -137.36 144.99 42.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.513 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -104.29 138.06 41.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.821 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -121.27 153.16 38.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.715 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -114.05 120.58 41.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.985 -0.376 . . . . 10.0 109.985 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 19.8 mm -95.87 79.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.247 0.546 . . . . 10.0 110.328 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -94.01 -14.02 26.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.222 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.44 110.03 2.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.082 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -167.55 -32.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.033 0.444 . . . . 10.0 110.624 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.71 -80.2 0.27 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.924 -0.655 . . . . 10.0 111.552 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 9.1 m -101.01 135.48 42.39 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.083 -0.34 . . . . 10.0 110.083 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -126.04 157.96 36.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.786 0.327 . . . . 10.0 111.217 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.38 148.41 20.97 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' PRO . . . . . 0.509 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 35.7 Cg_endo -66.35 137.99 49.19 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.278 1.986 . . . . 10.0 112.565 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -97.49 62.53 1.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.92 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.396 -0.811 . . . . 10.0 110.294 -179.682 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.17 62.61 39.58 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.73 -31.45 48.97 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.192 1.928 . . . . 10.0 111.514 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.89 -40.91 95.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.463 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.68 -40.43 80.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.557 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.1 tp -60.52 -32.89 71.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.207 0.527 . . . . 10.0 110.273 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.8 m -84.44 -15.92 44.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.959 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 45.8 m -79.94 -23.47 41.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.463 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -64.4 106.55 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.205 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 58.6 mttp -97.28 148.16 23.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.978 -0.556 . . . . 10.0 110.626 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.746 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 39.6 p -81.11 172.72 13.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.003 -0.544 . . . . 10.0 109.667 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.37 -5.52 19.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 10.0 110.212 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -92.53 5.01 52.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.356 -0.838 . . . . 10.0 109.825 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 73.06 13.59 4.83 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.327 0.862 . . . . 10.0 113.327 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -116.83 139.84 26.15 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.442 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 18.1 Cg_endo -57.75 146.31 86.11 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.795 2.33 . . . . 10.0 112.153 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.12 -1.25 7.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 10.0 111.759 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.568 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 4.4 m -59.42 -20.95 58.96 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.145 -0.48 . . . . 10.0 111.535 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 20' ' ' TYR . 21.7 m -65.39 -13.94 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.088 0.47 . . . . 10.0 110.849 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.416 ' HD2' HG23 ' A' ' 19' ' ' VAL . 22.7 m-85 -125.66 20.47 7.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.601 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 70.7 mt -129.61 40.16 3.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.489 -0.778 . . . . 10.0 110.328 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -138.44 -178.46 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.88 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.2 mttp 69.35 12.31 8.3 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.824 0.675 . . . . 10.0 112.824 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 58.56 28.79 17.55 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.192 0.52 . . . . 10.0 111.486 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -94.51 138.19 22.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.46 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.54 141.79 90.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.87 2.38 . . . . 10.0 111.183 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -108.4 144.21 36.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.855 0.36 . . . . 10.0 111.425 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.435 HD23 ' HG ' ' A' ' 60' ' ' LEU . 21.0 tp -123.98 104.34 8.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.697 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 77.8 mt -88.23 118.22 33.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.72 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.541 ' HD2' HG22 ' A' ' 62' ' ' THR . 7.9 tmtm? -110.04 116.46 31.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.666 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -90.43 148.27 22.9 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.293 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -150.53 175.88 11.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.527 -0.306 . . . . 10.0 111.32 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.78 146.97 50.04 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.366 -0.605 . . . . 10.0 109.366 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 m -70.88 -63.75 1.04 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.51 ' CZ2' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.41 59.31 4.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -178.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 1.6 t -135.46 123.34 15.27 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.327 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 52.3 Cg_exo -56.61 -49.02 16.06 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.748 2.299 . . . . 10.0 112.568 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 38' ' ' LEU . 5.7 mp -59.61 -52.74 64.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.996 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 80.5 m -64.88 -33.07 75.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.846 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.483 ' HB3' ' CE2' ' B' ' 68' ' ' PHE . 10.7 tp -62.2 -48.49 79.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.411 -0.358 . . . . 10.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 m -69.94 -32.46 70.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.535 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.86 -35.3 79.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.563 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.7 -39.8 81.8 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.912 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.4 -29.32 72.94 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.964 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -87.76 -27.54 22.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.873 0.368 . . . . 10.0 110.092 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.2 m -61.11 -47.91 84.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 10.0 110.912 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.658 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -62.91 -37.31 86.49 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.939 0.4 . . . . 10.0 110.221 179.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.85 -46.85 83.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.883 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -63.2 -42.68 99.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 10.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.41 -4.93 12.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.773 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -113.35 10.64 18.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.765 0.317 . . . . 10.0 111.496 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' HB3' ' HD1' ' A' ' 55' ' ' PHE . 11.5 t70 -93.75 148.7 21.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.735 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.95 -31.85 72.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.41 -46.22 77.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.107 0.479 . . . . 10.0 111.084 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.405 ' HD1' ' HB3' ' A' ' 52' ' ' ASP . 76.5 m-85 -74.85 -8.02 55.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.639 . . . . 10.0 112.364 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.3 m -70.24 -13.46 62.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.143 0.497 . . . . 10.0 110.86 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 m -69.91 -24.04 63.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.949 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.15 176.45 7.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.453 . . . . 10.0 110.956 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -108.57 98.63 8.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HG ' HD23 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -84.45 124.22 31.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.631 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.66 138.59 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 10.0 111.508 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.541 HG22 ' HD2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -92.38 109.76 21.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.865 -0.607 . . . . 10.0 109.681 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.9 137.4 42.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.092 0.473 . . . . 10.0 111.656 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.09 147.13 39.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.293 -1.002 . . . . 10.0 108.293 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 4.8 m -106.43 98.18 19.04 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 112.268 0.469 . . . . 10.0 112.268 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HG3' HG22 ' A' ' 93' ' ' THR . 30.2 Cg_endo -64.43 123.4 11.72 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.674 2.249 . . . . 10.0 111.882 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.88 3.33 73.84 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.817 -0.629 . . . . 10.0 112.706 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 3.0 t80 -116.0 148.37 40.2 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.71 -0.288 . . . . 10.0 110.487 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER 58.56 27.58 15.87 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.828 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.6 OUTLIER 71.52 20.21 4.88 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.716 -0.675 . . . . 10.0 112.371 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.51 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 2.3 mm-40 -81.72 -172.54 3.93 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.876 0.37 . . . . 10.0 111.155 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.666 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 9.4 mmpt? -69.37 133.13 47.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.402 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -68.66 158.27 34.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 10.0 112.017 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -55.62 141.57 37.11 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.575 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 78' ' ' GLN . . . 95.46 -60.68 1.53 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.813 -0.915 . . . . 10.0 110.813 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.96 -36.71 78.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 10.0 109.917 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.14 -41.15 97.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.407 -0.815 . . . . 10.0 111.643 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 10.9 pt20 -66.53 -29.52 69.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.954 0.407 . . . . 10.0 110.558 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -69.93 -28.59 65.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.287 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -66.07 -44.87 83.24 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.941 -0.763 . . . . 10.0 108.941 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -65.0 -38.47 91.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.198 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.77 -20.97 66.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.44 16.16 52.83 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.037 -0.602 . . . . 10.0 112.231 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 mt -118.43 158.38 25.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.658 0.266 . . . . 10.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.402 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 66.1 t30 -82.95 -173.88 4.95 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.45 -0.574 . . . . 10.0 109.45 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.402 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 89.2 m-85 68.88 76.24 0.25 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-O 121.211 0.529 . . . . 10.0 110.207 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.14 8.82 3.03 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.747 2.298 . . . . 10.0 112.473 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -108.13 4.58 25.07 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.116 -0.234 . . . . 10.0 110.903 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.658 ' HG ' ' HG3' ' A' ' 47' ' ' GLU . 13.2 mt -78.23 112.52 26.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.714 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 89' ' ' LEU . 2.9 Cg_exo -76.45 71.21 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.959 2.439 . . . . 10.0 111.179 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.69 114.24 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.918 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.746 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 20.0 t -96.53 133.53 37.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.047 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.701 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.14 96.01 8.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.012 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -83.37 82.38 8.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.191 0.52 . . . . 10.0 110.058 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -64.31 106.52 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.896 -0.593 . . . . 10.0 111.739 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.61 -24.21 26.24 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.009 -0.615 . . . . 10.0 112.123 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.11 53.41 3.14 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.616 -0.802 . . . . 10.0 111.821 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -47.15 84.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.027 0.441 . . . . 10.0 110.659 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.7 mm -77.05 -40.86 30.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.983 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.44 90.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.851 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -75.39 -42.66 53.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.558 0.218 . . . . 10.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -62.23 -38.42 89.14 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.7 mt -97.1 -2.47 43.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.655 -0.248 . . . . 10.0 111.519 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t30 53.62 58.19 5.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.958 -0.565 . . . . 10.0 111.202 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.1 109.43 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.165 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.13 17.56 14.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.953 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.842 HG23 ' HB3' ' B' ' 109' ' ' TYR . 11.4 p -149.58 147.83 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.543 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.5 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 27.5 m-85 -127.88 160.02 63.44 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.392 -0.596 . . . . 10.0 109.392 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.5 ' HA ' ' HB3' ' A' ' 108' ' ' TYR . 2.1 Cg_endo -88.06 124.41 6.96 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.972 -1.262 . . . . 10.0 111.277 -0.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.0 m -105.68 143.07 34.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.124 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -121.47 129.77 53.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.19 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.697 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -111.33 114.9 28.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.199 -0.455 . . . . 10.0 111.063 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.419 HD22 HD11 ' A' ' 136' ' ' LEU . 24.5 tp -92.13 117.1 29.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.778 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.24 136.2 38.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.605 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -74.59 -173.43 30.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.227 -0.511 . . . . 10.0 113.401 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 116' ' ' LYS . 5.7 mtmt -73.6 -12.97 60.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.975 0.417 . . . . 10.0 111.121 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.27 7.48 46.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.865 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.74 24.71 76.32 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.866 -0.683 . . . . 10.0 111.904 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -114.03 153.5 29.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.784 0.326 . . . . 10.0 110.761 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.3 t -67.78 113.99 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.926 0.393 . . . . 10.0 110.199 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -51.15 5.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.228 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -146.8 139.18 24.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.863 0.363 . . . . 10.0 111.587 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.6 tp -110.37 130.93 62.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.065 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.9 t -122.04 132.26 71.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -138.67 136.96 36.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 10.0 111.372 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.467 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 127.56 -80.43 0.36 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.055 -0.593 . . . . 10.0 112.477 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 p -172.62 142.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.604 -0.517 . . . . 10.0 109.604 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -125.49 171.91 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 10.0 110.843 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 132' ' ' GLN . 11.4 p30 -130.33 167.69 18.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.829 -0.434 . . . . 10.0 109.829 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -58.27 -49.96 75.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.5 89.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.368 . . . . 10.0 110.867 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.402 ' HB2' ' ND2' ' A' ' 129' ' ' ASN . 38.0 tt0 -64.62 -38.79 92.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.041 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.84 92.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 10.0 109.8 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.82 -38.48 91.11 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.962 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.63 90.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 10.0 110.631 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.419 HD11 HD22 ' A' ' 113' ' ' LEU . 15.4 tp -63.92 -34.74 78.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.461 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.98 -33.35 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -70.34 -48.66 55.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.813 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 49.4 t0 -148.67 117.08 3.95 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.29 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 29.1 Cg_endo -63.24 -10.08 19.8 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.01 2.473 . . . . 10.0 112.659 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -81.65 -7.71 59.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.929 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.92 125.4 26.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.785 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.534 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 19.5 t70 -136.1 143.93 44.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.152 -0.477 . . . . 10.0 109.92 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.918 -1.039 . . . . 10.0 112.523 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.754 0.312 . . . . 10.0 110.679 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.07 -85.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.788 0.328 . . . . 10.0 110.685 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.416 ' HG ' ' H ' ' B' ' 5' ' ' ALA . 56.0 tp -97.58 -61.75 1.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.228 -0.442 . . . . 10.0 109.984 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . 0.573 ' HA ' HD13 ' B' ' 9' ' ' LEU . 1.7 m-20 57.23 35.63 26.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.884 -0.598 . . . . 10.0 111.227 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.416 ' H ' ' HG ' ' B' ' 3' ' ' LEU . . . -144.37 165.67 27.27 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.902 -0.59 . . . . 10.0 111.006 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' B' ' 7' ' ' ASP . 0.7 OUTLIER 62.44 -151.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.781 . . . . 10.0 112.235 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . 0.456 ' H ' ' HB3' ' B' ' 6' ' ' ASN . 11.7 p-10 -108.47 27.24 9.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.657 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.62 23.07 9.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.739 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' B' ' 4' ' ' ASP . 2.7 pt? -147.99 137.27 11.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.148 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . 0.402 ' HB2' ' OE1' ' B' ' 12' ' ' GLU . 33.6 Cg_endo -63.78 145.41 90.77 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.022 2.482 . . . . 10.0 112.542 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.95 -36.77 76.56 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.464 2.776 . . . . 10.0 113.646 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' B' ' 10' ' ' PRO . 1.5 pm0 -69.8 -4.31 19.47 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.409 ' HD3' HD12 ' B' ' 9' ' ' LEU . 1.8 tmtm? -126.59 -8.68 6.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.526 0.679 . . . . 10.0 109.838 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.67 -7.84 59.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 10.0 112.239 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.475 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 27.7 m-85 -130.49 123.37 29.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.811 0.338 . . . . 10.0 111.011 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.48 95.62 16.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.327 -0.619 . . . . 10.0 109.327 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' B' ' 30' ' ' PHE . 2.9 Cg_exo -75.05 93.59 0.96 Allowed 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.186 2.59 . . . . 10.0 113.217 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -90.37 97.36 11.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.9 mm? -84.59 122.63 29.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.438 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.01 109.37 12.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.199 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.479 HG21 ' HE2' ' B' ' 124' ' ' TYR . 93.7 t -97.57 120.27 46.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.846 0.355 . . . . 10.0 111.082 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.62 169.5 9.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.14 -32.54 72.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.001 0.429 . . . . 10.0 110.975 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -80.28 -37.07 33.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.994 -0.548 . . . . 10.0 111.722 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -175.51 173.82 46.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.532 -0.842 . . . . 10.0 112.444 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.455 HG13 HG22 ' B' ' 21' ' ' VAL . 47.2 t -89.38 140.46 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.615 0.245 . . . . 10.0 110.755 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -129.54 111.01 12.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.736 -0.468 . . . . 10.0 109.736 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' B' ' 80' ' ' GLN . 7.3 p -92.02 125.09 44.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.953 0.406 . . . . 10.0 111.182 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -129.18 80.47 1.97 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.365 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' B' ' 17' ' ' PRO . 21.5 p90 -89.72 126.62 35.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.887 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtm-85 -81.76 124.93 30.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.08 -0.509 . . . . 10.0 110.923 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.494 ' HB ' ' HA ' ' B' ' 77' ' ' HIS . 59.8 mt -99.37 133.7 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.771 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 148.88 33.7 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.517 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.25 74.7 1.82 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.251 0.548 . . . . 10.0 111.675 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.21 -20.77 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.037 -0.825 . . . . 10.0 111.037 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -105.25 153.19 21.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.89 -0.781 . . . . 10.0 108.89 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -145.45 139.62 26.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.005 0.431 . . . . 10.0 111.417 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 40.8 mtt -110.26 156.48 20.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.925 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.679 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 31.3 m-85 -97.78 124.06 41.98 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.738 -0.468 . . . . 10.0 109.738 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -60.71 -28.54 68.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.093 0.473 . . . . 10.0 111.465 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.83 15.03 12.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 10.0 111.284 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.679 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 6.5 mmtm -130.85 -18.26 3.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.637 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.453 HG13 ' O ' ' B' ' 39' ' ' TYR . 80.8 mt -77.61 119.82 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.38 . . . . 10.0 110.23 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' B' ' 98' ' ' THR . 56.5 t -98.23 126.65 51.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.023 -0.535 . . . . 10.0 109.565 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -151.55 119.77 1.02 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.733 -0.746 . . . . 10.0 111.909 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 27.4 pttt -150.74 139.67 20.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.733 0.302 . . . . 10.0 110.965 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.63 ' HB ' HD13 ' B' ' 95' ' ' LEU . 4.8 t -138.75 125.37 20.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.587 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . . . . . . . . . 19.9 p30 179.43 162.33 0.78 Allowed Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.267 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.68 -70.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.663 2.242 . . . . 10.0 111.313 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.29 57.21 0.73 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.87 0.366 . . . . 10.0 111.362 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.3 t70 65.19 32.89 9.75 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.268 0.556 . . . . 10.0 112.089 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' B' ' 52' ' ' LEU . 1.2 mm? -96.1 58.43 1.85 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.684 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 36.4 tp -124.49 139.49 53.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.601 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 -72.51 1.11 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.636 -0.792 . . . . 10.0 111.511 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.88 151.57 9.42 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.06 103.03 1.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.583 2.189 . . . . 10.0 110.392 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 49.4 m -76.79 104.78 7.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.021 0.439 . . . . 10.0 111.684 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -85.02 146.2 27.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.044 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 37.3 m -76.8 -11.64 59.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.448 -0.342 . . . . 10.0 111.485 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? 70.82 119.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.638 0.587 . . . . 10.0 112.513 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.81 -136.02 8.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.879 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -112.18 153.7 26.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.68 0.276 . . . . 10.0 111.002 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.62 119.52 26.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.53 -0.545 . . . . 10.0 109.53 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -101.16 139.85 36.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.841 0.353 . . . . 10.0 111.273 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -77.8 133.16 38.27 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.218 -1.031 . . . . 10.0 108.218 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -132.88 168.52 18.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.804 0.335 . . . . 10.0 110.889 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -101.85 -32.09 10.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.198 -0.455 . . . . 10.0 111.232 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 1.6 m-85 -109.69 -38.6 5.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.625 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.405 ' HD1' ' HA ' ' B' ' 69' ' ' PHE . 8.3 m-30 -84.42 -12.1 55.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.84 0.352 . . . . 10.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.11 -100.56 1.77 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.028 -0.606 . . . . 10.0 112.605 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -136.14 110.24 8.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.522 -0.547 . . . . 10.0 109.522 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -136.39 153.05 51.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.889 0.376 . . . . 10.0 111.588 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.23 127.32 32.3 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.036 -0.727 . . . . 10.0 109.036 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.68 153.6 33.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.509 0.671 . . . . 10.0 112.311 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -110.33 120.65 43.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -106.66 -1.82 22.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.049 0.759 . . . . 10.0 113.049 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.494 ' HA ' ' HB ' ' B' ' 32' ' ' ILE . 2.4 t60 -175.83 -37.53 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.219 -0.66 . . . . 10.0 109.219 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.8 OUTLIER -85.43 138.44 32.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.049 -0.978 . . . . 10.0 109.568 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 30' ' ' PHE . . . -160.39 119.43 2.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.781 0.324 . . . . 10.0 110.612 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 24.3 tt0 -159.62 121.9 3.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.347 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.76 126.66 67.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 10.0 109.665 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' B' ' 57' ' ' SER . . . -98.63 139.08 34.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.068 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -118.81 98.21 51.03 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 112.207 0.447 . . . . 10.0 112.207 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.44 127.94 6.79 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.063 2.509 . . . . 10.0 110.777 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -74.01 147.82 42.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.442 -0.344 . . . . 10.0 111.277 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.16 -5.8 54.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 10.0 110.538 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -153.02 147.1 25.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.709 -0.678 . . . . 10.0 109.867 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.56 85.37 4.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.911 0.386 . . . . 10.0 111.037 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.75 155.15 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.501 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.12 33.38 6.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.92 -0.657 . . . . 10.0 112.607 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -96.68 139.41 21.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.671 -0.492 . . . . 10.0 109.671 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.58 111.91 1.18 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.731 2.287 . . . . 10.0 111.507 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.12 161.07 21.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.134 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' B' ' 47' ' ' THR . 78.9 tttt -110.33 142.44 41.98 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.63 HD13 ' HB ' ' B' ' 47' ' ' THR . 58.6 tp -116.36 111.67 20.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.867 0.365 . . . . 10.0 110.788 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 41.6 t -101.84 113.49 38.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 96.5 mt -117.48 139.18 51.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.965 0.412 . . . . 10.0 111.414 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' THR . . . . . 0.604 ' HB ' ' HB ' ' B' ' 44' ' ' VAL . 20.9 m -134.36 118.55 17.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.036 -0.727 . . . . 10.0 109.036 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 50.6 m-85 -98.69 112.14 24.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.099 0.407 . . . . 10.0 112.099 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.67 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 15.8 tp60 -122.8 118.25 27.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.313 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.19 -160.18 10.22 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.729 -0.748 . . . . 10.0 111.758 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 25.3 m -153.58 -179.57 7.91 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.486 -0.561 . . . . 10.0 109.486 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ALA . . . . . 0.67 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -120.08 139.29 52.78 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.39 11.66 0.43 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.369 0.418 . . . . 10.0 112.114 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.92 6.08 20.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.453 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.92 26.84 9.34 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.431 -0.89 . . . . 10.0 113.436 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 20.3 t -115.27 141.88 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 53.3 t -136.21 89.53 2.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 10.0 110.907 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.842 ' HB3' HG23 ' A' ' 107' ' ' VAL . 53.3 p90 -78.27 151.09 77.94 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.323 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.566 ' HD2' ' HA ' ' A' ' 107' ' ' VAL . 57.9 Cg_endo -71.38 164.42 35.79 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.718 2.279 . . . . 10.0 111.567 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.828 ' HG2' ' HB3' ' A' ' 70' ' ' HIS . 71.9 Cg_endo -77.01 72.91 5.66 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.707 2.271 . . . . 10.0 112.419 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.401 HG22 ' CD1' ' A' ' 69' ' ' LEU . 24.2 t -62.86 124.4 17.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.622 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -104.87 160.95 14.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.148 0.499 . . . . 10.0 111.694 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.2 m -150.31 119.0 6.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.607 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . 0.457 ' HB3' ' HE2' ' B' ' 94' ' ' LYS . 31.6 mt-10 -92.97 126.63 38.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.052 0.453 . . . . 10.0 111.849 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.55 153.71 28.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.734 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -116.34 124.18 49.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.548 -0.538 . . . . 10.0 109.548 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 17.6 mm -90.21 72.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.234 0.54 . . . . 10.0 110.812 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -78.43 -26.61 46.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.361 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.88 48.55 0.15 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.612 -0.804 . . . . 10.0 113.078 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -107.22 -9.91 15.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.95 0.405 . . . . 10.0 110.639 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.63 -77.6 1.86 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.948 -0.644 . . . . 10.0 111.587 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 11.0 m -97.94 131.92 43.96 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.479 ' HE2' HG21 ' B' ' 21' ' ' VAL . 89.9 m-85 -120.26 155.29 33.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.975 0.417 . . . . 10.0 111.874 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -127.97 143.53 48.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.359 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.8 125.8 16.13 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.644 2.229 . . . . 10.0 111.883 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -85.71 82.61 8.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 179.701 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.92 88.67 31.82 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 10.0 111.603 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.93 -18.2 52.1 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.414 2.076 . . . . 10.0 111.906 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -62.53 -32.73 73.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.911 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 98' ' ' THR . 2.0 m -69.75 -41.73 74.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.536 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.29 -31.43 72.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.191 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 m -83.44 -8.43 59.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 10.0 110.636 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.9 m -91.91 -25.88 18.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.645 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -66.46 128.28 35.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.934 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.509 ' HG3' ' HA ' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -116.12 151.92 34.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.39 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.796 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 46.0 p -77.95 171.91 14.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.004 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.51 -15.29 63.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.537 0.684 . . . . 10.0 109.785 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.474 ' OD1' ' HB2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -82.55 -15.58 51.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.977 -1.01 . . . . 10.0 109.593 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.2 t30 97.33 -15.26 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.578 1.151 . . . . 10.0 112.326 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.557 ' HG3' ' HD2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -71.6 140.25 84.19 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 109.543 -0.54 . . . . 10.0 109.543 178.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HD2' ' HG3' ' A' ' 15' ' ' ARG . 34.6 Cg_endo -64.44 147.12 90.53 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.411 2.074 . . . . 10.0 111.703 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.79 -11.92 42.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.914 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 m -55.41 -24.19 28.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.443 . . . . 10.0 112.155 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 m -62.38 -22.74 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.9 0.381 . . . . 10.0 111.598 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.402 ' HB3' ' HB3' ' A' ' 59' ' ' ASN . 60.1 m-85 -127.55 29.17 5.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.282 0.563 . . . . 10.0 110.374 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.7 mt -136.22 28.99 3.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.943 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -134.28 -174.61 3.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.37 -0.377 . . . . 10.0 111.864 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt 71.61 11.19 6.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.772 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 56.82 33.9 23.82 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.395 -0.82 . . . . 10.0 111.686 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -101.16 147.53 33.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.46 142.17 95.18 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.061 2.507 . . . . 10.0 111.41 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 114' ' ' ILE . 2.0 m -112.66 143.3 44.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.858 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.411 HD23 ' HG ' ' A' ' 60' ' ' LEU . 15.2 tp -122.14 99.21 6.31 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.657 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 86.7 mt -90.43 120.95 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.803 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.502 ' HD2' HG22 ' A' ' 62' ' ' THR . 1.1 tmtp? -113.72 124.96 53.53 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.595 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.441 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 3.2 m-85 -101.02 141.74 33.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.514 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -149.02 169.3 20.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.787 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.405 ' HB1' ' CZ3' ' A' ' 35' ' ' TRP . . . -116.81 135.64 53.59 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -62.42 -59.09 5.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.294 0.85 . . . . 10.0 113.294 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.782 ' HZ2' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -85.65 38.49 0.75 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.087 0.773 . . . . 10.0 113.087 -178.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -115.54 126.02 28.18 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.316 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 28.1 Cg_endo -61.43 -44.61 21.85 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.829 2.353 . . . . 10.0 113.358 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.574 HD12 ' HB2' ' B' ' 108' ' ' CYS . 65.9 mt -64.11 -47.0 81.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 10.0 111.589 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.1 m -68.19 -33.73 74.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.507 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB3' ' CZ ' ' B' ' 68' ' ' PHE . 25.8 mt -64.49 -37.34 87.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 10.0 111.701 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m -72.07 -22.8 61.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.024 0.44 . . . . 10.0 111.157 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.24 -6.03 59.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.85 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.1 mt -59.3 -49.13 79.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.006 0.431 . . . . 10.0 111.151 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.86 -33.72 87.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.873 -0.68 . . . . 10.0 112.063 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -70.59 -41.58 72.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 10.0 110.665 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.2 m -60.67 -42.46 97.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.537 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -64.46 -41.18 96.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.128 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -64.9 -38.46 91.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.618 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -70.8 -34.39 71.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.467 . . . . 10.0 110.801 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.38 -13.21 62.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.01 0.434 . . . . 10.0 110.813 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -114.63 16.51 17.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 10.0 110.416 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 18.4 t70 -82.42 148.29 28.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.627 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.36 83.8 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -84.94 -43.09 14.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.537 0.208 . . . . 10.0 111.499 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.633 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 49.7 m-85 -66.22 -20.42 66.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 10.0 111.573 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 13.8 t -69.98 -0.28 7.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.952 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 m -84.62 -5.29 59.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 10.0 110.27 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -134.57 164.65 27.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.653 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 72.4 m-20 -92.3 94.72 9.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.475 -0.329 . . . . 10.0 110.188 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -84.3 121.64 27.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.966 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.6 pt -138.87 142.32 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 10.0 111.395 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.502 HG22 ' HD2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -100.97 113.78 27.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.566 -0.531 . . . . 10.0 109.566 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 92' ' ' VAL . 24.7 t -109.71 138.7 36.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.804 0.335 . . . . 10.0 111.235 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.93 154.48 49.21 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.444 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 9.9 m -112.78 96.16 36.31 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 112.386 0.513 . . . . 10.0 112.386 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.783 ' HG3' HG22 ' A' ' 93' ' ' THR . 38.1 Cg_endo -66.24 131.58 27.12 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.567 2.178 . . . . 10.0 111.437 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.65 10.03 85.68 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.952 -0.642 . . . . 10.0 112.596 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 2.7 t80 -123.29 138.27 54.66 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.577 HD12 HG22 ' B' ' 112' ' ' VAL . 2.1 mm? 60.39 29.33 18.93 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.184 0.516 . . . . 10.0 111.041 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.754 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 2.0 t60 74.26 14.97 3.66 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.781 -1.1 . . . . 10.0 113.45 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.782 ' HA ' ' HZ2' ' A' ' 35' ' ' TRP . 1.5 mm-40 -70.78 168.11 17.39 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 121.066 -0.254 . . . . 10.0 110.428 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' HE3' ' A' ' 80' ' ' TRP . 44.5 mmtt -55.85 136.17 51.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.14 -0.482 . . . . 10.0 111.034 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -67.97 163.06 23.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.156 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.47 137.18 53.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.433 -0.349 . . . . 10.0 110.509 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.05 -49.97 1.94 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.646 -0.981 . . . . 10.0 110.646 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.11 -40.44 71.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.119 0.485 . . . . 10.0 109.829 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -59.59 -48.79 80.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.457 -0.792 . . . . 10.0 111.641 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -66.45 -26.37 67.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 10.0 111.32 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -69.97 -32.69 71.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 10.0 110.289 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.585 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 3.2 t90 -65.6 -45.42 83.25 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -61.86 -36.96 82.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.324 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.41 -24.71 65.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.833 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.33 -0.79 62.89 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.036 -0.602 . . . . 10.0 111.811 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 80' ' ' TRP . 44.8 mt -105.05 169.18 8.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.439 . . . . 10.0 110.541 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -90.19 -155.66 0.38 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.998 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.446 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 55.8 m-85 57.54 73.17 0.8 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.954 0.407 . . . . 10.0 110.656 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.36 -9.61 26.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.537 2.158 . . . . 10.0 112.386 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 88' ' ' LYS . 28.4 mtpp -102.16 20.69 16.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.277 -0.42 . . . . 10.0 111.449 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.547 ' HB3' HG23 ' A' ' 91' ' ' VAL . 7.8 mt -80.96 115.29 54.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.807 0.337 . . . . 10.0 110.529 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.76 58.13 6.7 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.713 2.275 . . . . 10.0 111.675 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.547 HG23 ' HB3' ' A' ' 89' ' ' LEU . 48.5 t -81.56 119.96 32.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.052 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.796 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 12.6 t -102.93 142.78 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.078 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.783 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -101.24 106.28 17.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.291 -179.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 64.1 t0 -98.36 94.01 6.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.074 0.464 . . . . 10.0 109.911 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.96 108.54 2.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.995 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.26 -17.77 55.16 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.871 -0.681 . . . . 10.0 112.425 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.62 4.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.598 -0.81 . . . . 10.0 112.012 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 5' ' ' THR . 1.2 m -62.57 -51.7 66.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.859 0.362 . . . . 10.0 110.377 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.95 -35.84 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -61.99 -41.19 97.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.613 -0.722 . . . . 10.0 111.359 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -70.89 -39.8 72.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.407 -0.361 . . . . 10.0 111.224 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 m -58.8 -33.83 70.8 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.566 HD13 HD13 ' A' ' 123' ' ' ILE . 68.3 mt -113.02 11.18 18.92 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.997 -0.281 . . . . 10.0 111.691 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 62.3 t30 47.39 60.6 3.37 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.493 0.663 . . . . 10.0 111.421 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 100' ' ' ALA . 30.4 mt -86.92 73.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.446 0.641 . . . . 10.0 110.991 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.43 16.94 17.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.392 -0.822 . . . . 10.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.729 HG23 ' HB3' ' B' ' 109' ' ' TYR . 14.8 p -158.05 147.98 9.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.897 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 64.9 m-85 -127.14 160.73 58.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 108' ' ' TYR . 91.2 Cg_endo -81.7 154.12 79.57 Favored 'Cis proline' 0 C--O 1.235 0.33 0 C-N-CA 123.28 -1.55 . . . . 10.0 111.634 -0.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 t -130.45 137.71 49.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.288 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -119.9 116.6 26.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.729 -0.668 . . . . 10.0 110.266 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.657 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.31 108.31 20.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.664 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.4 tp -90.94 114.4 26.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.829 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 27' ' ' THR . 2.0 mp -100.82 134.6 40.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.373 -0.602 . . . . 10.0 109.373 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -70.01 178.67 29.24 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.281 -0.485 . . . . 10.0 113.423 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.15 7.61 3.23 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.944 0.35 . . . . 10.0 111.944 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.65 -19.48 13.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.073 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 109.97 -1.47 30.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.581 -0.819 . . . . 10.0 112.847 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -101.03 162.21 13.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.745 0.307 . . . . 10.0 110.98 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -71.47 122.29 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 10.0 110.259 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -95.41 -46.85 6.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.422 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 122' ' ' ARG . 9.3 tpt180 -152.28 154.2 35.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.718 0.294 . . . . 10.0 110.729 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.566 HD13 HD13 ' A' ' 103' ' ' LEU . 4.8 tp -128.32 123.88 60.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.515 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.1 t -113.42 137.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.67 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -141.94 139.03 32.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.006 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 121.14 -89.92 0.45 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.476 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.4 m -147.68 153.34 39.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 10.0 110.613 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.9 135.85 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.28 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -122.6 179.36 4.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 10.0 111.931 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -64.54 -43.58 93.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 10.0 112.086 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.1 -43.77 95.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.317 . . . . 10.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -62.13 -37.8 86.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.828 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.03 -48.9 76.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.051 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.7 -34.41 78.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.613 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.76 -43.77 87.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.132 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 140' ' ' PRO . 14.4 tp -64.28 -30.13 71.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.871 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 94.2 mt -70.08 -39.69 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.171 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -79.82 -38.94 31.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.226 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -150.86 103.17 3.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.565 -0.288 . . . . 10.0 110.552 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 136' ' ' LEU . 72.5 Cg_endo -75.7 2.84 6.53 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.77 2.313 . . . . 10.0 112.37 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -90.41 -11.79 39.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 10.0 110.622 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.55 113.64 25.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.01 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.419 ' HB3' HD23 ' A' ' 144' ' ' LEU . 4.6 t0 -96.91 170.0 9.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.076 -0.511 . . . . 10.0 109.892 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.419 HD23 ' HB3' ' A' ' 143' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.93 0 N-CA-C 113.977 1.102 . . . . 10.0 113.977 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 111.712 0.264 . . . . 10.0 111.712 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.09 -57.77 3.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.916 0.389 . . . . 10.0 111.73 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 24.9 tp -110.95 -77.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.699 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . 0.575 ' HA ' HD13 ' B' ' 9' ' ' LEU . 2.5 m-20 60.4 41.91 15.42 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.474 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.67 161.95 38.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.343 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.46 -148.7 0.37 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.33 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -113.56 21.65 14.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.251 0.548 . . . . 10.0 110.16 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -93.3 40.91 1.07 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.092 -0.503 . . . . 10.0 111.409 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.575 HD13 ' HA ' ' B' ' 4' ' ' ASP . 2.6 pt? -164.21 138.37 4.39 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.562 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.27 147.11 94.07 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.774 2.316 . . . . 10.0 112.143 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.476 ' HG3' ' HB ' ' A' ' 107' ' ' VAL . 9.6 Cg_endo -52.5 -39.58 74.12 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.467 2.778 . . . . 10.0 113.613 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -64.55 -21.36 66.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 10.0 112.153 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.45 -3.59 19.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.183 0.516 . . . . 10.0 110.358 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.01 -9.73 54.84 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.463 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 19.8 m-85 -133.12 128.76 36.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.931 0.396 . . . . 10.0 111.274 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.48 92.04 15.57 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 3.0 Cg_exo -75.42 103.17 1.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.067 2.511 . . . . 10.0 112.924 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -98.36 103.12 15.04 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.376 -0.602 . . . . 10.0 109.376 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.9 mm? -86.76 110.0 19.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.165 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.98 112.9 25.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.944 0.402 . . . . 10.0 109.923 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.497 HG22 HG13 ' B' ' 26' ' ' VAL . 95.6 t -102.31 121.8 53.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.897 0.38 . . . . 10.0 111.261 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.76 170.25 8.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.533 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.43 -29.17 68.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.098 0.475 . . . . 10.0 110.554 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -75.44 -39.58 58.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.567 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.92 -179.55 47.81 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.833 -0.699 . . . . 10.0 111.904 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.497 HG13 HG22 ' B' ' 21' ' ' VAL . 60.0 t -94.14 135.88 27.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.066 -0.346 . . . . 10.0 110.066 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.428 ' OD1' ' HG3' ' B' ' 80' ' ' GLN . 52.5 t30 -124.95 112.04 16.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.856 -0.424 . . . . 10.0 109.856 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.49 HG22 ' HD1' ' B' ' 30' ' ' PHE . 2.8 p -92.63 124.75 45.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.969 0.414 . . . . 10.0 110.969 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' B' ' 79' ' ' ALA . 2.0 tmm_? -126.97 90.77 3.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.554 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.49 ' HD1' HG22 ' B' ' 28' ' ' VAL . 6.2 p90 -93.81 112.93 24.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.118 0.485 . . . . 10.0 111.238 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mtm-85 -72.45 114.6 10.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.461 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 43.7 mt -91.76 139.56 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.826 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.18 155.74 38.03 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.687 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -75.56 77.49 2.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.106 0.479 . . . . 10.0 111.571 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.0 -20.89 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.568 -0.613 . . . . 10.0 111.568 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -104.55 151.61 23.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -145.44 137.56 25.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.761 0.315 . . . . 10.0 110.724 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 34.4 mtt -107.97 156.18 19.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.964 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.616 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 18.3 m-85 -99.59 126.86 45.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.636 -0.505 . . . . 10.0 109.636 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -61.29 -28.56 69.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.909 0.385 . . . . 10.0 111.1 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.96 5.39 37.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.079 -0.51 . . . . 10.0 111.064 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.616 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 53.2 mmtt -122.19 -10.85 8.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.289 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.454 HG13 ' O ' ' B' ' 39' ' ' TYR . 89.9 mt -86.96 118.05 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 10.0 110.453 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.4 t -108.32 121.51 61.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.889 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.91 137.22 6.56 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.688 -0.767 . . . . 10.0 111.705 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -161.69 145.61 12.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.801 0.334 . . . . 10.0 111.209 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.635 ' HB ' HD13 ' B' ' 95' ' ' LEU . 8.8 t -143.97 120.88 11.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.805 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.583 HD22 ' HB2' ' B' ' 53' ' ' LEU . 24.1 p30 -174.07 159.53 2.86 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.832 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -73.87 -77.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.321 2.014 . . . . 10.0 110.843 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.82 44.44 1.03 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.149 0.499 . . . . 10.0 110.251 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.535 ' HA ' ' CG ' ' B' ' 48' ' ' ASN . 9.9 t0 66.79 33.33 6.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.297 -0.865 . . . . 10.0 112.269 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.88 70.26 4.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.921 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.583 ' HB2' HD22 ' B' ' 48' ' ' ASN . 28.5 tp -125.04 149.03 48.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.716 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.32 -72.67 1.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.886 -0.673 . . . . 10.0 111.805 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -169.87 146.83 2.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 122.131 0.172 . . . . 10.0 110.552 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.65 109.76 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.378 2.052 . . . . 10.0 110.494 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 6.4 m -89.07 94.24 9.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.157 0.503 . . . . 10.0 111.763 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -77.58 163.53 26.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.202 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 50.2 m -95.0 -3.65 48.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.518 -0.31 . . . . 10.0 111.141 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? 68.71 124.12 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.607 -0.724 . . . . 10.0 111.992 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.27 -139.89 8.4 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.893 -0.67 . . . . 10.0 112.206 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.88 143.92 44.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.732 0.301 . . . . 10.0 110.646 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -81.28 119.92 24.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.213 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' B' ' 65' ' ' GLU . 14.2 ttpt -98.95 136.03 39.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.456 -0.338 . . . . 10.0 110.799 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.405 ' O ' ' HE3' ' B' ' 64' ' ' LYS . 4.6 tp10 -73.97 126.42 30.45 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.571 -0.9 . . . . 10.0 108.571 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -120.46 -179.53 4.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.765 0.317 . . . . 10.0 110.906 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.23 -25.4 4.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.995 0.426 . . . . 10.0 110.575 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 40' ' ' LEU . 1.1 t80 -102.29 -49.12 3.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.853 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.437 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 22.1 m-30 -88.6 -4.45 58.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.496 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.79 -76.58 2.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.865 -0.683 . . . . 10.0 112.111 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -173.59 118.96 0.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.026 -0.361 . . . . 10.0 110.026 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -133.52 164.74 26.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.799 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -75.51 125.98 30.1 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.3 m -125.87 163.63 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.455 0.645 . . . . 10.0 112.449 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' B' ' 78' ' ' GLU . 28.8 m-85 -120.95 130.91 54.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.815 -1.18 . . . . 10.0 107.815 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -115.22 -10.87 12.06 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.66 0.615 . . . . 10.0 112.66 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.91 -29.31 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.339 0.59 . . . . 10.0 109.653 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.8 OUTLIER -86.09 142.61 28.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.038 -0.983 . . . . 10.0 109.378 178.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' B' ' 29' ' ' ARG . . . -166.79 102.69 0.57 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.793 0.33 . . . . 10.0 110.465 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.428 ' HG3' ' OD1' ' B' ' 27' ' ' ASN . 27.3 tt0 -148.92 117.71 6.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.13 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.38 120.89 52.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.574 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.91 148.13 23.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.349 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' PHE . . . . . 0.562 ' HB3' HD11 ' B' ' 53' ' ' LEU . 77.1 m-85 -125.22 102.96 30.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.61 127.46 8.04 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.766 2.311 . . . . 10.0 111.293 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -74.12 143.08 45.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.921 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.0 -4.18 53.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.335 0.588 . . . . 10.0 110.095 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -152.21 136.86 16.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.644 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.9 96.52 10.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.35 140.27 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.487 -0.324 . . . . 10.0 111.457 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.18 58.76 4.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.895 -0.669 . . . . 10.0 111.594 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -116.4 140.67 26.86 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.94 89.55 0.88 Allowed 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.584 2.189 . . . . 10.0 111.485 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.53 160.03 32.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.752 -0.658 . . . . 10.0 111.66 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 47' ' ' THR . 27.3 tttt -103.56 155.23 18.69 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.379 -0.601 . . . . 10.0 109.379 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.635 HD13 ' HB ' ' B' ' 47' ' ' THR . 42.0 tp -125.89 119.89 29.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.803 0.335 . . . . 10.0 110.762 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.75 123.84 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.525 -0.546 . . . . 10.0 109.525 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 64.2 mt -128.92 131.76 47.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.945 0.403 . . . . 10.0 111.66 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' THR . . . . . 0.416 HG22 ' HB2' ' B' ' 111' ' ' PRO . 5.6 m -120.07 117.13 27.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 34.1 m-85 -98.23 104.34 16.37 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.963 0.357 . . . . 10.0 111.963 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.883 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 11.1 tp60 -117.47 121.39 40.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.901 0.382 . . . . 10.0 110.981 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.91 -160.41 10.68 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.888 -0.673 . . . . 10.0 111.546 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 18.4 m -152.87 -179.57 7.77 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ALA . . . . . 0.625 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -121.35 142.99 49.45 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.868 -0.419 . . . . 10.0 109.868 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.55 -10.09 56.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.181 -0.463 . . . . 10.0 112.04 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.33 -4.05 59.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.359 . . . . 10.0 111.769 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.13 38.09 2.96 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.561 -0.828 . . . . 10.0 112.928 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.625 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 35.1 t -123.13 141.51 43.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.574 ' HB2' HD12 ' A' ' 38' ' ' LEU . 9.4 t -132.68 86.18 2.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.872 0.368 . . . . 10.0 110.803 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.729 ' HB3' HG23 ' A' ' 107' ' ' VAL . 55.2 p90 -76.73 152.52 82.99 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.497 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.15 161.38 43.31 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.825 2.35 . . . . 10.0 111.512 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.883 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 84.0 Cg_endo -77.91 74.65 5.16 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.861 2.374 . . . . 10.0 112.289 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.577 HG22 HD12 ' A' ' 69' ' ' LEU . 4.5 t -61.05 122.78 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.596 -0.52 . . . . 10.0 109.596 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ASP . . . . . 0.409 ' HB3' HG23 ' B' ' 98' ' ' THR . 4.6 p-10 -106.11 156.66 18.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.993 0.425 . . . . 10.0 111.291 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.28 141.09 30.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.17 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -107.73 123.18 48.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 10.0 110.739 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -112.94 148.29 35.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.571 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -105.12 118.96 37.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.517 -0.31 . . . . 10.0 110.221 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 14.9 mm -94.54 71.1 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.295 0.569 . . . . 10.0 110.53 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' B' ' 121' ' ' ASN . 44.0 p90 -83.98 -19.74 34.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.657 -0.701 . . . . 10.0 111.479 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.39 51.7 0.24 Allowed Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.709 -0.758 . . . . 10.0 112.688 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . 0.44 ' HB2' ' CZ ' ' B' ' 119' ' ' PHE . 21.3 t30 -103.77 -18.13 14.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.166 0.508 . . . . 10.0 110.489 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.19 -78.1 0.67 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.96 -0.856 . . . . 10.0 110.96 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 2.1 m -105.26 141.81 36.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -133.21 156.43 47.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.21 -0.292 . . . . 10.0 110.21 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.3 152.8 54.92 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' PRO . . . . . 0.434 ' HG3' ' HG2' ' B' ' 17' ' ' PRO . 28.5 Cg_endo -63.91 114.32 2.55 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.448 2.099 . . . . 10.0 112.139 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -81.13 76.9 8.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.566 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 7.7 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.788 -0.625 . . . . 10.0 109.732 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 109.738 -0.467 . . . . 10.0 109.738 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.503 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 1.4 m -123.02 76.32 50.28 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.068 0.461 . . . . 10.0 111.398 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.34 -33.97 88.2 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.702 2.268 . . . . 10.0 112.017 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -43.81 96.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.385 -0.371 . . . . 10.0 111.179 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -69.27 -40.01 78.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.307 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.4 tp -62.23 -34.16 75.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.729 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 m -84.57 -8.01 59.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.45 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.2 m -82.51 -20.73 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.192 0.52 . . . . 10.0 109.745 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 9' ' ' LEU . 3.2 mm? -56.4 119.34 5.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.696 -0.683 . . . . 10.0 110.636 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.35 140.42 41.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.43 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 22.0 p -81.68 168.97 17.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.866 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -11.04 56.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.984 0.421 . . . . 10.0 111.15 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.38 8.22 45.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.381 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.3 t30 68.12 38.14 2.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.6 -0.727 . . . . 10.0 112.108 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -122.51 140.26 32.49 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.658 -0.497 . . . . 10.0 109.658 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.35 143.82 78.04 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.215 1.943 . . . . 10.0 111.422 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -13.23 34.28 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.2 m -56.87 -22.82 39.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 10.0 112.133 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.96 -20.23 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.109 0.48 . . . . 10.0 111.315 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -132.47 28.76 4.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.18 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -138.73 43.94 2.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.131 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -145.81 -171.57 3.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.389 -0.368 . . . . 10.0 111.269 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 mttp 65.84 13.82 9.22 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 58.26 38.4 26.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.944 0.402 . . . . 10.0 111.682 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -103.22 146.43 32.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.941 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.622 ' HD3' ' HG2' ' A' ' 116' ' ' LYS . 27.1 Cg_endo -63.26 135.76 52.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.659 2.239 . . . . 10.0 110.958 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 114' ' ' ILE . 4.2 m -109.33 146.21 34.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.827 0.346 . . . . 10.0 111.181 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.1 tp -127.34 108.19 10.63 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.872 -0.418 . . . . 10.0 109.872 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 70.9 mt -96.09 119.75 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.969 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.714 ' HD2' HG22 ' A' ' 62' ' ' THR . 1.1 tmtp? -113.2 124.82 53.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.679 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -98.0 142.49 29.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.351 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.426 ' HE1' ' HB ' ' A' ' 62' ' ' THR . 32.7 p-90 -145.81 170.82 15.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.525 -0.307 . . . . 10.0 110.821 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . . . -114.9 139.49 49.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.637 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -73.33 -47.19 44.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.994 -0.548 . . . . 10.0 112.443 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.429 ' CH2' ' HD3' ' B' ' 111' ' ' PRO . 0.0 OUTLIER -90.99 29.27 1.4 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.427 0.529 . . . . 10.0 112.427 -178.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 33.7 t -117.59 121.05 32.39 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.513 0.197 . . . . 10.0 111.288 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.765 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 14.6 Cg_endo -58.0 -43.54 47.58 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.129 2.553 . . . . 10.0 112.467 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.37 -39.53 90.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.948 0.404 . . . . 10.0 111.279 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 78.2 m -76.08 -31.68 58.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.566 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.02 -46.85 85.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 10.0 112.082 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 m -66.61 -33.66 76.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.055 0.455 . . . . 10.0 110.862 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -26.31 68.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.254 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.28 -34.33 72.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.825 0.345 . . . . 10.0 110.643 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.78 92.34 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.935 -0.65 . . . . 10.0 111.853 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -77.31 -29.65 53.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.911 0.386 . . . . 10.0 110.113 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.7 m -60.44 -47.49 85.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.772 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.68 -36.75 85.28 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -61.69 -50.39 72.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.258 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -64.11 -37.28 86.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.049 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.14 -10.84 59.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.433 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -111.78 16.4 20.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.992 0.425 . . . . 10.0 110.73 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -93.31 139.89 30.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.258 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.38 -32.23 69.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.836 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -71.33 -44.09 65.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 10.0 110.658 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.42 ' CZ ' ' HB1' ' A' ' 133' ' ' ALA . 1.7 m-85 -73.6 -14.76 61.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 10.0 112.198 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.9 m -65.01 -11.63 41.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 10.0 111.216 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -78.87 -15.36 58.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.497 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -123.22 176.33 6.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.418 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.437 ' HB2' HG23 ' A' ' 27' ' ' THR . 78.9 m-20 -109.69 87.7 2.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.57 117.26 20.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.445 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.2 pt -134.93 147.2 29.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.786 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.714 HG22 ' HD2' ' A' ' 30' ' ' LYS . 1.6 p -109.0 116.41 31.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.167 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.462 HG22 ' HB ' ' A' ' 92' ' ' VAL . 18.7 t -113.17 137.15 47.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.78 0.324 . . . . 10.0 111.181 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.522 ' O ' ' HD3' ' A' ' 66' ' ' PRO . . . -132.08 138.25 48.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.087 -0.708 . . . . 10.0 109.087 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -100.66 102.35 18.89 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 112.13 0.418 . . . . 10.0 112.13 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 18.4 Cg_exo -68.63 131.23 22.41 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.994 2.463 . . . . 10.0 111.894 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.57 0.64 90.03 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.942 -0.572 . . . . 10.0 112.448 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -112.02 143.03 43.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.499 HD12 HG22 ' B' ' 112' ' ' VAL . 2.0 mm? 60.81 26.56 16.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.837 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.904 ' HB3' ' HG2' ' B' ' 111' ' ' PRO . 0.1 OUTLIER 67.93 26.43 7.48 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.371 -0.831 . . . . 10.0 112.849 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 2.1 mm-40 -81.97 -169.61 2.46 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.451 -0.34 . . . . 10.0 110.187 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -68.35 145.06 54.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.206 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -77.33 162.29 27.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.038 0.447 . . . . 10.0 111.712 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -63.56 150.35 44.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.855 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.56 -40.96 3.03 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.867 -0.893 . . . . 10.0 110.867 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -81.92 -47.62 12.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.913 0.387 . . . . 10.0 110.062 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -57.59 -39.37 76.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.8 -0.637 . . . . 10.0 112.232 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.01 -30.62 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.996 0.427 . . . . 10.0 111.225 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -77.87 -31.72 51.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 10.0 109.866 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -58.16 -45.76 86.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.73 -0.668 . . . . 10.0 109.678 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -66.99 -36.58 82.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.798 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.67 -27.76 69.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.198 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.24 29.21 12.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.889 -0.672 . . . . 10.0 111.998 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HB3' ' H ' ' A' ' 85' ' ' ASN . 38.5 mt -121.66 -162.55 0.99 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.042 0.449 . . . . 10.0 111.059 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.437 ' H ' ' HB3' ' A' ' 84' ' ' LEU . 45.8 t30 -116.99 -171.61 2.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.766 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 66.33 84.74 0.17 Allowed Pre-proline 0 N--CA 1.465 0.314 0 CA-C-O 121.381 0.61 . . . . 10.0 110.705 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.0 -11.57 29.39 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.776 2.318 . . . . 10.0 112.549 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -107.09 22.77 15.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.213 0.449 . . . . 10.0 112.213 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.454 ' HB3' HG23 ' A' ' 91' ' ' VAL . 5.2 mt -81.34 115.27 55.4 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.627 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.04 63.88 8.24 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.443 2.095 . . . . 10.0 111.705 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 89' ' ' LEU . 68.7 t -82.31 117.27 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.13 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.77 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 9.7 t -104.97 142.49 18.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.706 -0.679 . . . . 10.0 109.981 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -99.28 108.45 20.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.05 -179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -94.72 78.58 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.297 0.57 . . . . 10.0 110.222 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -64.17 116.56 6.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.505 0.557 . . . . 10.0 112.505 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.63 -6.31 67.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.563 -0.827 . . . . 10.0 112.65 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.45 41.36 67.03 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.72 -0.752 . . . . 10.0 111.799 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -43.99 98.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.833 0.349 . . . . 10.0 110.775 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.0 mm -80.39 -42.26 21.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.938 0.399 . . . . 10.0 110.07 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.436 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.88 -45.7 89.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.628 -0.714 . . . . 10.0 112.167 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -68.3 -38.01 81.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.8 m -61.2 -35.74 78.0 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.413 0.523 . . . . 10.0 112.413 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -106.37 5.7 29.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.595 0.22 . . . . 10.0 111.595 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.0 t30 53.39 55.71 8.34 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.524 0.678 . . . . 10.0 111.064 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 100' ' ' ALA . 78.2 mt -87.06 99.91 9.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.325 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.92 29.19 8.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.749 -0.66 . . . . 10.0 111.277 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.525 ' HA ' ' CD ' ' B' ' 110' ' ' PRO . 10.8 p -166.78 152.15 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.211 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -126.83 154.48 76.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -91.71 118.43 3.04 Favored 'Cis proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.619 -1.409 . . . . 10.0 111.403 -1.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.5 m -87.17 136.47 32.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.218 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -113.6 113.47 25.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.749 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -100.86 116.93 33.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.335 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 136' ' ' LEU . 37.3 tp -93.65 116.11 28.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.8 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 27' ' ' THR . 2.9 mp -104.65 129.59 56.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.946 -0.57 . . . . 10.0 109.544 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.75 178.17 40.04 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.962 -0.637 . . . . 10.0 112.895 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.622 ' HG2' ' HD3' ' A' ' 26' ' ' PRO . 3.3 mtmp? -69.77 -13.04 62.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.127 0.489 . . . . 10.0 110.617 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.44 -10.68 58.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.263 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.97 43.0 6.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.556 -0.831 . . . . 10.0 112.206 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -149.72 153.67 37.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.636 0.255 . . . . 10.0 110.573 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.5 t -70.23 120.23 17.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.952 0.406 . . . . 10.0 111.323 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -99.95 -28.97 12.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.013 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -156.24 146.65 21.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.585 -0.279 . . . . 10.0 111.004 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.0 tp -131.3 117.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.911 -0.403 . . . . 10.0 109.911 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.62 133.58 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.543 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -120.69 126.45 50.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.195 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.85 -99.21 0.22 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.499 -0.857 . . . . 10.0 112.931 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.4 m -168.14 135.22 2.11 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.122 -0.696 . . . . 10.0 109.122 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.1 pt -119.19 154.86 21.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.969 -0.293 . . . . 10.0 110.664 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -110.37 169.58 8.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.248 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -57.93 -39.32 77.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.114 0.413 . . . . 10.0 112.114 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.55 -40.85 88.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.104 0.478 . . . . 10.0 110.419 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -68.62 -38.21 80.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.22 -0.9 . . . . 10.0 110.146 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.42 ' HB1' ' CZ ' ' A' ' 55' ' ' PHE . . . -59.77 -45.85 91.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.633 -0.712 . . . . 10.0 110.941 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.15 -36.77 85.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.849 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.23 95.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.752 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.534 HD11 HD22 ' A' ' 113' ' ' LEU . 21.2 tp -62.43 -32.09 72.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.077 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.3 mt -72.68 -32.96 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.118 0.485 . . . . 10.0 110.358 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -78.5 -39.78 37.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.649 -0.705 . . . . 10.0 110.82 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.6 t70 -151.75 119.28 3.27 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.603 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.509 ' HB3' HD21 ' A' ' 113' ' ' LEU . 16.5 Cg_exo -69.25 -7.25 20.4 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.098 2.532 . . . . 10.0 113.42 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -99.12 4.4 46.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 10.0 111.163 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.2 72.09 9.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.411 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -76.61 150.98 36.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.949 -0.568 . . . . 10.0 111.305 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.146 0 N-CA-C 114.006 1.113 . . . . 10.0 114.006 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.452 0.168 . . . . 10.0 111.08 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.88 70.72 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.08 -0.509 . . . . 10.0 112.087 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 35.1 tp -91.91 -80.03 0.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.674 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 55.16 37.23 28.58 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.448 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.67 157.34 44.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.23 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.17 -172.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.253 -0.885 . . . . 10.0 112.693 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -94.6 27.87 2.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.273 -0.876 . . . . 10.0 110.619 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -84.51 -4.33 58.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.985 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.5 143.98 51.07 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.9 150.89 87.05 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.024 2.483 . . . . 10.0 112.4 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.28 -34.42 88.37 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.413 2.742 . . . . 10.0 113.162 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -68.0 -4.73 14.19 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.118 0.414 . . . . 10.0 112.118 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -129.03 1.43 5.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.4 0.619 . . . . 10.0 110.233 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.42 -10.47 43.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.832 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.4 ' HE1' HG23 ' B' ' 32' ' ' ILE . 23.6 m-85 -131.95 126.14 33.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.504 -0.317 . . . . 10.0 111.204 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.38 92.55 36.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' B' ' 30' ' ' PHE . 3.1 Cg_exo -76.49 116.06 4.22 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.169 2.579 . . . . 10.0 113.441 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.1 109.48 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' B' ' 123' ' ' THR . 2.1 mm? -93.46 118.09 30.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.987 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.16 113.53 22.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.9 -0.591 . . . . 10.0 109.546 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.98 118.91 43.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.025 0.441 . . . . 10.0 111.225 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.0 -164.48 1.14 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.738 -0.665 . . . . 10.0 109.928 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -92.26 -37.29 12.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.789 0.328 . . . . 10.0 111.069 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.64 -37.12 42.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.623 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CZ ' ' B' ' 85' ' ' TYR . . . -168.01 -170.48 32.81 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.586 -0.816 . . . . 10.0 112.392 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.9 135.1 47.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -120.35 111.89 18.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.753 0.311 . . . . 10.0 110.248 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.488 HG22 ' HD1' ' B' ' 30' ' ' PHE . 3.9 p -95.01 122.55 46.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.13 0.491 . . . . 10.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -124.27 92.01 3.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.093 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 6.1 p90 -95.38 122.55 38.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.74 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -79.76 122.33 26.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.625 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.4 HG23 ' HE1' ' B' ' 15' ' ' PHE . 72.1 mt -100.83 130.68 49.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.49 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.65 145.34 55.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.147 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.36 92.99 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.109 0.48 . . . . 10.0 111.675 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.77 -23.86 0.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.663 -0.975 . . . . 10.0 110.663 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 103' ' ' ALA . 37.5 m-85 -103.51 154.04 19.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -144.63 139.01 27.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.965 0.412 . . . . 10.0 111.101 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' MET . . . . . . . . . . . . . 34.4 mtt -110.9 150.63 28.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.432 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.695 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 59.7 m-85 -92.6 121.35 33.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' B' ' 60' ' ' LYS . 21.1 tt0 -56.81 -37.12 70.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.752 0.31 . . . . 10.0 111.833 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.66 -9.77 58.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.397 . . . . 10.0 111.576 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.695 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 43.6 mmtt -104.43 -11.03 17.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.747 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.482 HG13 ' O ' ' B' ' 39' ' ' TYR . 75.2 mt -82.28 96.59 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.079 0.466 . . . . 10.0 110.314 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 t -91.46 109.04 20.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.203 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.39 141.51 12.57 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.55 -0.834 . . . . 10.0 111.751 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -162.36 147.48 12.51 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.789 0.328 . . . . 10.0 111.475 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.578 ' HB ' HD13 ' B' ' 95' ' ' LEU . 9.9 t -143.47 123.36 13.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.987 -0.552 . . . . 10.0 109.528 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' B' ' 51' ' ' ASP . 28.0 p30 -177.43 157.28 1.24 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.139 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 48' ' ' ASN . 11.7 Cg_exo -73.83 -69.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.732 2.288 . . . . 10.0 110.559 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.66 55.43 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.235 0.541 . . . . 10.0 109.769 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.564 ' HA ' ' ND2' ' B' ' 48' ' ' ASN . 4.9 t70 60.95 27.42 17.29 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.251 -0.886 . . . . 10.0 112.453 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' B' ' 52' ' ' LEU . 1.2 mm? -86.89 59.61 5.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.272 0.558 . . . . 10.0 111.531 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.434 ' HB2' ' HB3' ' B' ' 48' ' ' ASN . 22.9 tp -122.97 148.84 45.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.729 -0.669 . . . . 10.0 109.516 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.84 -80.21 0.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.596 -0.812 . . . . 10.0 111.45 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.447 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 1.5 pp0? -163.0 145.63 8.22 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.402 -0.221 . . . . 10.0 110.402 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 31.9 Cg_exo -63.64 107.5 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.606 2.204 . . . . 10.0 110.75 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.0 m -93.65 96.52 9.88 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.224 0.535 . . . . 10.0 111.536 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -80.25 150.25 30.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.718 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.4 m -81.12 -8.1 59.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.778 0.323 . . . . 10.0 110.678 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.408 ' HA ' ' OE1' ' B' ' 40' ' ' GLN . 3.3 mmtt 71.39 148.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.44 -0.8 . . . . 10.0 112.813 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.79 -128.33 2.93 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.996 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -121.04 149.57 42.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.526 0.203 . . . . 10.0 110.772 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.94 119.24 28.1 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -101.04 130.91 47.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.944 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -69.13 142.86 54.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -137.93 170.87 15.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.709 0.29 . . . . 10.0 111.16 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -109.85 -13.45 14.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.401 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.765 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 10.7 m-85 -121.36 -41.15 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 10.0 111.218 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -90.3 -7.41 53.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.962 0.411 . . . . 10.0 111.207 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.71 -79.46 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.095 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -171.44 110.75 0.31 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.989 0.423 . . . . 10.0 110.678 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -128.29 163.46 24.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.121 -0.491 . . . . 10.0 110.384 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 12.8 m -75.38 125.52 29.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.08 155.28 31.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.397 0.618 . . . . 10.0 112.357 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -112.84 130.34 56.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.611 -1.255 . . . . 10.0 107.611 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -113.03 -10.49 13.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.606 0.595 . . . . 10.0 112.606 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -168.78 -34.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.432 0.634 . . . . 10.0 109.887 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 0.5 OUTLIER -87.75 134.55 33.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.296 -0.866 . . . . 10.0 109.769 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -159.32 123.79 3.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.883 0.373 . . . . 10.0 111.444 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -160.85 120.72 2.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.328 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 t -125.9 128.33 71.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 10.0 109.998 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.33 138.75 38.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.626 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' PHE . . . . . 0.416 ' HB3' HD11 ' B' ' 53' ' ' LEU . 62.7 m-85 -122.14 98.39 44.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.51 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.8 126.49 3.98 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.2 2.6 . . . . 10.0 111.027 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' TYR . . . . . 0.433 ' CZ ' ' HA2' ' B' ' 25' ' ' GLY . 7.1 m-85 -71.06 149.58 46.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.81 0.338 . . . . 10.0 110.871 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.99 -9.78 41.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.267 0.556 . . . . 10.0 110.107 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -152.24 127.2 9.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.895 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.64 99.32 6.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.143 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -131.83 146.22 33.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.403 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.58 43.63 3.01 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.671 -0.776 . . . . 10.0 111.867 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -104.33 144.44 28.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.43 0.157 . . . . 10.0 110.862 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.39 100.45 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.412 2.075 . . . . 10.0 111.353 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.56 144.13 28.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.923 -0.581 . . . . 10.0 111.208 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -88.81 159.5 17.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.049 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.578 HD13 ' HB ' ' B' ' 47' ' ' THR . 35.3 tp -131.05 121.8 25.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.046 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.42 HG22 ' HG2' ' B' ' 115' ' ' GLU . 40.6 t -117.05 125.0 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 49.2 mt -129.56 126.9 39.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.787 0.327 . . . . 10.0 111.549 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' THR . . . . . 0.497 HG23 ' HB3' ' B' ' 113' ' ' ASP . 1.7 m -115.62 116.85 28.83 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 41.9 m-85 -100.35 110.94 23.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.314 . . . . 10.0 111.366 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.91 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 6.1 tp60 -120.81 121.6 38.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.752 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.99 -157.13 9.84 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.309 -0.717 . . . . 10.0 111.309 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 39.6 m -158.86 -172.98 4.03 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' B' ' 36' ' ' TYR . . . -119.25 146.27 45.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.22 40.35 0.34 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.028 0.442 . . . . 10.0 110.484 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.18 1.06 1.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.223 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.05 -32.56 5.73 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.768 -0.729 . . . . 10.0 113.129 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 12.3 t -62.69 133.17 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.353 . . . . 10.0 111.313 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 10.9 t -129.22 100.35 5.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.947 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.414 ' CB ' HG23 ' A' ' 107' ' ' VAL . 15.3 p90 -89.61 144.81 32.47 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.678 0.275 . . . . 10.0 111.478 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.525 ' CD ' ' HA ' ' A' ' 107' ' ' VAL . 59.4 Cg_endo -73.18 160.83 44.51 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.854 2.37 . . . . 10.0 111.565 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.91 ' HB3' ' HB2' ' B' ' 100' ' ' GLN . 72.4 Cg_endo -76.77 75.83 4.32 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.54 2.16 . . . . 10.0 112.657 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.499 HG22 HD12 ' A' ' 69' ' ' LEU . 6.6 t -69.54 104.9 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' B' ' 98' ' ' THR . 5.5 p-10 -72.61 148.51 44.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.846 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.9 m -132.62 128.08 36.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.286 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . 0.42 ' HG2' HG22 ' B' ' 96' ' ' VAL . 39.1 mt-10 -105.59 134.16 49.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.012 0.434 . . . . 10.0 110.616 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.439 ' HB2' HD23 ' B' ' 95' ' ' LEU . 79.9 m-85 -109.17 166.56 10.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.345 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -123.0 117.61 25.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.966 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 18.6 mm -97.23 82.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.152 0.501 . . . . 10.0 110.462 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -97.38 -25.51 15.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.675 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.52 68.16 0.18 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.068 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -128.27 -3.9 5.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.866 0.365 . . . . 10.0 111.363 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.28 -76.72 2.21 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.836 -0.697 . . . . 10.0 111.917 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' B' ' 19' ' ' LEU . 0.2 OUTLIER -105.01 135.15 46.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.189 -0.301 . . . . 10.0 110.189 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -123.26 147.21 47.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 10.0 110.925 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.35 145.18 48.54 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.323 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.53 131.61 32.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.592 2.194 . . . . 10.0 111.668 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -84.24 86.55 7.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.209 0.528 . . . . 10.0 110.476 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.245 0.824 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.599 179.777 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' C ' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 109.788 -0.449 . . . . 10.0 109.788 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.53 63.13 63.37 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.337 . . . . 10.0 111.403 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HD3' ' C ' ' A' ' 1' ' ' MET . 23.0 Cg_exo -65.17 -43.61 10.99 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.411 2.074 . . . . 10.0 111.681 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -58.97 -44.35 91.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.267 -0.424 . . . . 10.0 111.32 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -47.03 80.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.947 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' A' ' 9' ' ' LEU . 28.8 tp -61.21 -36.19 79.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 10.0 111.361 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 m -76.08 -10.43 59.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 10.0 111.685 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.6 m -92.58 -6.33 49.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.035 0.445 . . . . 10.0 110.423 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 6' ' ' LEU . 2.3 mm? -66.37 109.52 2.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.293 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.49 139.43 33.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.931 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.78 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 71.6 p -84.13 172.51 11.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.061 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.29 -9.08 54.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.48 . . . . 10.0 110.263 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -91.71 8.11 38.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.948 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.95 13.33 7.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.258 -0.883 . . . . 10.0 112.956 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.92 143.49 29.2 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.479 -0.328 . . . . 10.0 110.626 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.82 146.79 88.92 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.617 2.211 . . . . 10.0 111.139 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.49 -5.68 25.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.256 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.556 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -56.66 -25.5 53.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.635 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.408 HG23 ' HD2' ' A' ' 20' ' ' TYR . 15.5 m -62.63 -21.45 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.078 0.466 . . . . 10.0 111.047 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.408 ' HD2' HG23 ' A' ' 19' ' ' VAL . 34.8 m-85 -117.68 20.55 13.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.329 0.585 . . . . 10.0 109.764 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 18' ' ' SER . 73.3 mt -125.76 25.38 6.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.661 -0.699 . . . . 10.0 110.33 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 18' ' ' SER . 26.4 mtpp -124.24 -170.6 2.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.204 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 mttm 68.31 8.48 6.63 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.733 0.645 . . . . 10.0 111.692 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.68 34.92 25.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.212 0.529 . . . . 10.0 110.32 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -101.67 150.58 37.44 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 10.0 111.449 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.27 142.87 75.05 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.781 2.321 . . . . 10.0 111.093 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.65 142.37 39.23 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.967 0.413 . . . . 10.0 111.286 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.563 HD23 ' HG ' ' A' ' 60' ' ' LEU . 24.7 tp -120.76 101.85 8.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 39.5 mt -87.53 121.92 38.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.817 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' HD2' HG22 ' A' ' 62' ' ' THR . 1.9 tmtp? -114.98 108.91 17.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.253 -0.431 . . . . 10.0 111.192 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 10.3 m-85 -82.86 138.07 34.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.068 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -140.98 171.67 13.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.576 -0.283 . . . . 10.0 111.239 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.46 144.59 49.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.239 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.98 -41.37 18.84 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.611 0.597 . . . . 10.0 112.611 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.572 ' HE1' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -88.56 23.81 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.661 0.615 . . . . 10.0 112.661 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.6 t -115.58 128.3 26.07 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 111.854 0.316 . . . . 10.0 111.854 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HD3' ' CZ ' ' B' ' 69' ' ' PHE . 27.2 Cg_endo -63.49 -43.09 18.69 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.884 2.389 . . . . 10.0 112.297 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.46 -41.69 93.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 10.0 111.171 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.5 m -70.32 -21.27 62.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.252 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.3 tp -68.52 -48.01 65.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.363 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.93 -33.07 74.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.172 0.511 . . . . 10.0 109.827 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -32.62 66.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.354 -0.839 . . . . 10.0 111.534 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.99 -46.71 84.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 10.0 111.091 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.91 -44.19 96.42 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.902 -0.59 . . . . 10.0 112.318 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -65.91 -38.13 87.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 10.0 110.785 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.4 m -63.62 -43.22 97.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.362 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -64.41 -39.71 94.37 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.908 -0.405 . . . . 10.0 109.908 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -60.83 -50.49 73.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.087 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -64.93 -40.16 94.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.753 -0.658 . . . . 10.0 111.528 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.59 -18.74 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.135 0.42 . . . . 10.0 112.135 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -103.7 10.24 36.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.753 0.311 . . . . 10.0 111.418 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 23.4 t70 -80.9 148.31 29.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.856 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.13 94.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 54' ' ' LYS . 25.1 mmmt -74.13 -34.85 64.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.885 0.374 . . . . 10.0 110.972 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.419 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -76.82 -10.89 59.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.147 -0.478 . . . . 10.0 111.862 -179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.5 m -74.72 2.15 10.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.028 0.442 . . . . 10.0 111.532 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -87.82 -9.47 53.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.834 0.349 . . . . 10.0 110.468 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.43 168.23 18.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 10.0 109.945 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -104.53 96.82 6.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.813 0.339 . . . . 10.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.563 ' HG ' HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -86.29 125.48 33.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.711 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.3 pt -136.6 132.21 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 10.0 111.532 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.487 HG22 ' HD2' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -92.18 131.07 37.7 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 179.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' A' ' 92' ' ' VAL . 13.6 p -137.06 147.18 27.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.165 0.507 . . . . 10.0 112.13 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.0 158.55 43.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.257 -1.016 . . . . 10.0 108.257 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . 4.8 m -110.47 95.1 21.07 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 112.124 0.416 . . . . 10.0 112.124 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.753 ' HG3' HG22 ' A' ' 93' ' ' THR . 28.5 Cg_endo -63.28 119.27 6.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.58 2.187 . . . . 10.0 111.699 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.95 10.02 65.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.93 -0.652 . . . . 10.0 112.48 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 19.5 t80 -129.03 144.53 51.22 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.407 HD11 ' O ' ' A' ' 105' ' ' ILE . 44.3 mt 60.91 27.21 17.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.896 0.379 . . . . 10.0 111.592 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.587 ' HE1' ' HB3' ' B' ' 113' ' ' ASP . 4.2 m170 69.09 19.03 8.17 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.417 -0.811 . . . . 10.0 112.866 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.572 ' HA ' ' HE1' ' A' ' 35' ' ' TRP . 2.9 mm-40 -75.7 177.66 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.571 -0.286 . . . . 10.0 110.678 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 33.1 mmtt -63.37 148.09 49.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.949 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HD3' ' H ' ' A' ' 74' ' ' ASP . 6.2 tmtt? -74.75 156.39 36.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.993 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.548 ' H ' ' HD3' ' A' ' 73' ' ' LYS . 5.1 t70 -55.61 143.88 28.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.395 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.24 -52.92 4.12 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.622 -0.991 . . . . 10.0 110.622 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.92 -42.49 76.72 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.22 -47.85 84.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.751 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -66.5 -24.43 66.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 10.0 111.62 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -74.96 -30.87 61.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.434 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -65.67 -48.83 70.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.622 -0.51 . . . . 10.0 109.622 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -62.92 -33.57 75.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.075 0.464 . . . . 10.0 110.852 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.42 -18.62 65.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.351 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.8 30.19 8.65 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.991 -0.844 . . . . 10.0 110.991 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.0 mt -130.85 173.83 10.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.778 0.323 . . . . 10.0 110.27 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.408 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 57.0 t30 -92.87 -165.76 1.4 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.615 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.408 ' H ' ' CG ' ' A' ' 85' ' ' ASN . 41.4 m-85 63.46 68.01 0.95 Allowed Pre-proline 0 C--O 1.233 0.222 0 CA-C-O 121.022 0.439 . . . . 10.0 110.595 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.6 23.82 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.65 2.233 . . . . 10.0 112.698 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.97 13.7 9.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 10.0 110.578 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 20.3 mt -92.17 118.98 68.4 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 10.0 110.964 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 89' ' ' LEU . 3.8 Cg_exo -77.77 69.08 7.51 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.062 2.508 . . . . 10.0 110.689 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 62' ' ' THR . 66.9 t -79.72 115.86 22.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.204 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 3.2 t -98.87 148.11 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.249 -0.432 . . . . 10.0 109.998 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.753 HG22 ' HG3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -105.02 101.78 11.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.767 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 55.5 t0 -86.16 88.65 7.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.089 0.471 . . . . 10.0 110.633 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -64.58 106.94 1.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.989 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.91 -2.33 69.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.814 -0.707 . . . . 10.0 112.924 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.98 55.45 19.23 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.355 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.24 -45.01 95.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.023 0.439 . . . . 10.0 110.608 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.452 ' HB ' ' HZ ' ' A' ' 31' ' ' PHE . 31.8 mm -80.46 -39.09 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.108 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -59.33 -43.93 92.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.521 -0.763 . . . . 10.0 111.899 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -75.17 -36.7 61.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.889 0.376 . . . . 10.0 111.294 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.6 m -65.38 -34.66 78.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.559 0.577 . . . . 10.0 112.559 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.421 HD21 HG21 ' A' ' 120' ' ' VAL . 93.6 mt -101.19 5.29 42.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.524 0.202 . . . . 10.0 111.5 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 53.05 69.51 0.69 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.578 0.704 . . . . 10.0 111.311 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 100' ' ' ALA . 86.1 mt -103.47 114.99 44.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.413 -0.812 . . . . 10.0 111.033 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.8 p -121.37 19.48 11.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.46 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' B' ' 109' ' ' TYR . 11.0 p -163.54 149.73 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.838 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 31' ' ' PHE . 72.0 m-85 -117.33 156.81 48.5 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 126' ' ' GLY . 7.0 Cg_endo -91.13 144.95 14.5 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.937 -1.276 . . . . 10.0 111.431 -1.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.8 m -110.08 129.54 55.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.477 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -107.52 107.05 17.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.935 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.797 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . . . -97.05 116.81 29.93 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.484 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.2 tp -94.55 107.38 19.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.823 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.3 127.28 46.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 117' ' ' ASP . . . -66.33 165.38 39.66 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.909 -0.662 . . . . 10.0 112.124 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -69.68 8.94 0.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.225 0.454 . . . . 10.0 112.225 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 115' ' ' GLY . 6.9 t70 -103.92 -20.02 14.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.295 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 100.96 46.28 1.77 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.989 -0.624 . . . . 10.0 112.421 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -154.14 166.71 32.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.436 0.16 . . . . 10.0 110.599 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.421 HG21 HD21 ' A' ' 103' ' ' LEU . 16.5 t -74.66 111.6 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.071 0.462 . . . . 10.0 110.839 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -93.82 -35.97 12.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.989 -0.551 . . . . 10.0 110.689 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -157.53 153.71 27.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.154 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 tp -136.93 121.52 24.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.069 0.461 . . . . 10.0 110.658 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.52 120.13 63.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.358 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -117.1 114.96 24.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.004 -0.369 . . . . 10.0 110.004 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.52 ' O ' ' HD2' ' A' ' 109' ' ' PRO . . . 154.69 -87.43 0.13 Allowed Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.26 -0.971 . . . . 10.0 112.739 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.6 m -167.18 146.56 5.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.5 pt -127.24 179.99 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.576 0.227 . . . . 10.0 110.821 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -142.99 171.58 13.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.704 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -61.15 -44.5 97.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.927 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.26 95.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.978 0.418 . . . . 10.0 110.236 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -63.56 -39.3 94.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.488 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.85 94.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 10.0 110.349 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.78 -36.66 84.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.422 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.1 70.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.767 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.09 -42.47 89.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.991 -0.55 . . . . 10.0 111.388 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.4 pt -76.0 -10.53 13.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.213 0.53 . . . . 10.0 110.773 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -91.32 -52.11 4.97 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 25.7 t0 -143.61 110.14 5.27 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.102 -0.954 . . . . 10.0 109.556 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 38.4 Cg_endo -66.51 -7.21 17.15 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.964 2.443 . . . . 10.0 112.217 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -86.83 4.88 39.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.304 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.82 109.41 21.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.719 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.495 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 4.9 t70 -115.38 141.48 47.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.166 -0.921 . . . . 10.0 112.56 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtt . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 111.962 0.356 . . . . 10.0 111.962 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.89 -79.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 10.0 111.712 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 59.4 tp -87.89 -69.26 0.7 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.358 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 60.01 35.11 21.48 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.281 0.562 . . . . 10.0 110.674 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.86 162.76 34.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.275 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 30.3 m120 62.56 -155.95 0.34 Allowed 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.708 0.63 . . . . 10.0 110.897 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -110.22 20.25 18.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.261 0.553 . . . . 10.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -85.39 36.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.801 -0.636 . . . . 10.0 111.629 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -158.93 136.36 7.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.67 148.38 82.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.951 2.434 . . . . 10.0 112.159 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.58 -39.19 76.0 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.344 2.696 . . . . 10.0 113.591 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -68.59 -12.54 61.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 10.0 111.956 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -117.51 -0.15 11.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.249 0.547 . . . . 10.0 110.319 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.78 -19.21 24.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.354 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.54 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 16.5 m-85 -127.21 124.79 39.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.448 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 t -109.66 91.17 9.95 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.519 -0.549 . . . . 10.0 109.519 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 3.4 Cg_exo -75.51 103.98 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.928 2.419 . . . . 10.0 112.785 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -100.71 115.0 29.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.01 117.06 25.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.673 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.11 99.92 9.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.015 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.519 HG21 ' HE2' ' B' ' 124' ' ' TYR . 65.8 t -94.52 118.29 40.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.961 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.15 -166.48 1.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.915 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -89.15 -36.63 15.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.896 0.379 . . . . 10.0 110.657 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -71.24 -40.26 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.899 -0.592 . . . . 10.0 110.96 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.428 ' HA2' ' CE2' ' B' ' 85' ' ' TYR . . . -177.64 -172.72 42.44 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.784 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.15 135.9 32.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -122.36 114.06 20.24 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.511 -0.551 . . . . 10.0 109.511 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.435 HG22 ' HD1' ' B' ' 30' ' ' PHE . 7.7 p -92.31 126.79 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.117 0.484 . . . . 10.0 111.273 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -127.5 88.74 2.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.159 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' B' ' 17' ' ' PRO . 5.0 p90 -93.31 115.74 28.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.024 0.44 . . . . 10.0 110.676 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 -75.17 115.71 15.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.554 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mt -94.68 135.8 27.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.911 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.8 150.31 48.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.155 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.53 79.71 2.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.203 0.525 . . . . 10.0 111.757 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.48 -26.65 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -103.77 150.99 23.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.227 -0.657 . . . . 10.0 109.227 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -142.39 146.18 34.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.822 0.344 . . . . 10.0 111.186 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' B' ' 99' ' ' TYR . 57.0 mtt -116.51 154.73 29.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.648 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.631 ' HB2' ' HB2' ' B' ' 42' ' ' LYS . 59.2 m-85 -96.48 129.81 43.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.39 -0.596 . . . . 10.0 109.39 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -60.6 -28.58 68.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.958 0.409 . . . . 10.0 111.255 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.97 9.8 21.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.205 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.631 ' HB2' ' HB2' ' B' ' 39' ' ' TYR . 38.9 mmtt -127.87 -7.68 5.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 10.0 111.748 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 89.4 mt -83.75 119.69 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.854 0.359 . . . . 10.0 110.188 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' B' ' 98' ' ' THR . 40.3 t -105.19 126.22 60.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.317 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.31 132.39 3.4 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.272 -0.731 . . . . 10.0 111.272 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -159.12 150.46 20.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.863 0.331 . . . . 10.0 111.129 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' B' ' 94' ' ' LYS . 10.2 t -153.66 125.27 7.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.34 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.451 ' HB2' ' HD2' ' B' ' 49' ' ' PRO . 13.3 p30 -178.54 160.76 1.13 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.344 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.464 ' HG3' HG21 ' B' ' 89' ' ' VAL . 55.3 Cg_endo -74.23 -56.54 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.215 1.943 . . . . 10.0 112.093 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.42 69.9 1.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.981 0.42 . . . . 10.0 111.138 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 t70 69.18 9.26 7.27 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.13 0.789 . . . . 10.0 113.13 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.443 ' HA ' HD13 ' B' ' 52' ' ' LEU . 1.4 mm? -81.24 59.9 4.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.043 0.449 . . . . 10.0 111.945 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 45.0 tp -125.87 138.58 53.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.78 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.57 -79.8 0.44 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.571 -0.823 . . . . 10.0 111.667 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 12.3 pt20 -165.72 145.4 5.38 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 55' ' ' GLN . 23.7 Cg_exo -65.39 107.84 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.545 2.163 . . . . 10.0 111.772 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -83.62 92.65 7.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.467 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -77.27 145.54 37.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.013 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 53.9 m -77.62 -18.01 57.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.811 0.3 . . . . 10.0 111.811 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? 74.54 137.8 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.785 0.678 . . . . 10.0 112.558 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.99 -121.78 2.78 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.817 -0.913 . . . . 10.0 110.817 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -130.15 155.01 46.92 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -87.96 125.55 34.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.075 0.464 . . . . 10.0 110.838 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 71' ' ' ARG . 12.8 ttpp -102.7 131.9 49.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.452 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -73.79 146.73 44.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -145.2 173.78 11.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.803 0.335 . . . . 10.0 110.918 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -108.86 -29.38 8.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.858 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -108.12 -35.14 6.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 37' ' ' PRO . 4.1 m-30 -94.11 -6.11 45.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.355 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.81 -79.97 1.52 Allowed Glycine 0 C--O 1.227 -0.296 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.435 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' B' ' 64' ' ' LYS . 5.9 ptp180 -176.71 122.61 0.15 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 122.698 0.399 . . . . 10.0 110.352 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -143.17 162.27 36.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.551 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 11.5 m -70.77 125.42 26.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.355 -0.609 . . . . 10.0 109.355 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -125.95 156.25 35.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.43 0.634 . . . . 10.0 112.312 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' TYR . . . . . 0.473 ' HB3' ' O ' ' B' ' 78' ' ' GLU . 53.7 m-85 -117.6 132.21 56.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -122.01 6.66 9.79 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.065 0.765 . . . . 10.0 113.065 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -176.25 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.83 -0.804 . . . . 10.0 108.83 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' B' ' 78' ' ' GLU . 1.0 OUTLIER -81.46 136.63 35.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.79 -1.095 . . . . 10.0 109.424 179.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -164.05 115.99 1.36 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 10.0 111.053 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -157.3 122.54 4.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.248 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.41 128.68 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.032 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.82 137.59 40.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.438 -0.347 . . . . 10.0 110.234 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -116.4 107.64 46.77 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.802 0.334 . . . . 10.0 111.528 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -91.03 127.47 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.036 2.491 . . . . 10.0 111.335 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' TYR . . . . . 0.428 ' CE2' ' HA2' ' B' ' 25' ' ' GLY . 21.9 m-85 -74.46 148.07 41.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.517 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.1 -5.88 57.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.175 0.512 . . . . 10.0 110.312 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -155.7 142.32 18.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.653 -0.703 . . . . 10.0 109.748 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.45 97.78 11.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.984 0.421 . . . . 10.0 110.74 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.464 HG21 ' HG3' ' B' ' 49' ' ' PRO . 13.6 m -128.24 154.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.685 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.26 7.18 72.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.628 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.22 144.7 92.68 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.89 107.06 1.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.444 2.096 . . . . 10.0 111.97 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.32 135.19 36.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' B' ' 47' ' ' THR . 40.7 tttt -88.7 141.58 28.39 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.605 -0.438 . . . . 10.0 110.328 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 64.6 tp -108.96 114.25 27.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.942 0.401 . . . . 10.0 110.897 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 47.4 t -112.47 122.03 65.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 65.6 mt -127.68 145.83 50.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.006 0.432 . . . . 10.0 111.536 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' THR . . . . . 0.744 ' HB ' ' HB ' ' B' ' 44' ' ' VAL . 24.1 m -147.87 122.93 10.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' B' ' 111' ' ' PRO . 16.4 m-85 -107.0 134.78 49.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.875 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' B' ' 111' ' ' PRO . 9.2 tp60 -140.61 126.01 18.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.428 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' B' ' 38' ' ' MET . . . -165.87 -154.74 8.33 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.229 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.1 m -150.1 175.38 11.78 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' B' ' 107' ' ' VAL . . . -113.93 145.7 41.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.93 -2.41 12.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.791 0.663 . . . . 10.0 112.791 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.99 0.2 45.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.134 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.2 -21.13 31.8 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.808 -0.71 . . . . 10.0 112.082 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' B' ' 103' ' ' ALA . 3.2 t -64.15 145.15 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.79 0.329 . . . . 10.0 110.275 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 t -134.08 106.33 7.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.013 0.435 . . . . 10.0 110.794 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.5 ' HA ' HG23 ' A' ' 107' ' ' VAL . 31.3 p90 -88.17 146.68 38.71 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.821 0.343 . . . . 10.0 111.735 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 107' ' ' VAL . 63.7 Cg_endo -73.08 163.21 38.83 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.851 2.368 . . . . 10.0 111.782 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' B' ' 99' ' ' TYR . 57.0 Cg_endo -73.04 94.69 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.223 1.949 . . . . 10.0 111.591 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.56 133.7 30.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.33 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ASP . . . . . 0.587 ' HB3' ' HE1' ' A' ' 70' ' ' HIS . 4.8 p-10 -106.85 149.14 27.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.896 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.6 m -151.4 119.63 6.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.182 -0.463 . . . . 10.0 110.512 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.45 132.16 44.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.272 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -116.04 139.82 49.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.065 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.25 124.74 47.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.644 -0.707 . . . . 10.0 109.781 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.8 66.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.398 0.618 . . . . 10.0 109.925 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -73.19 -24.46 60.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.739 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 122.75 73.41 0.28 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.611 -0.804 . . . . 10.0 112.351 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -140.35 -20.15 0.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.103 0.477 . . . . 10.0 110.496 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.08 -65.29 4.0 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.911 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.99 123.66 33.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.305 -0.257 . . . . 10.0 110.305 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.519 ' HE2' HG21 ' B' ' 21' ' ' VAL . 56.4 m-85 -132.05 156.13 46.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.26 149.22 22.53 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.211 -0.449 . . . . 10.0 109.796 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.12 120.53 7.9 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.422 2.081 . . . . 10.0 112.257 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -80.87 75.28 7.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.19 0.519 . . . . 10.0 110.652 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 71.4 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.357 -0.83 . . . . 10.0 109.971 179.764 . . . . . . . . 0 0 . 1 stop_ save_